Citrus Sinensis ID: 041230
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 485 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.575 | 0.276 | 0.351 | 1e-49 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.591 | 0.278 | 0.350 | 2e-46 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.569 | 0.269 | 0.350 | 5e-45 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.358 | 0.177 | 0.397 | 1e-29 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.422 | 0.200 | 0.357 | 1e-28 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.329 | 0.136 | 0.393 | 1e-28 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.397 | 0.235 | 0.382 | 5e-27 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.336 | 0.349 | 0.388 | 2e-26 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.360 | 0.153 | 0.389 | 2e-26 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.356 | 0.339 | 0.361 | 2e-26 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 111/316 (35%), Positives = 176/316 (55%), Gaps = 37/316 (11%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECK 243
+S+ DL +ATNGFSS+N++G+G+FG+VY L + +AVKV N+ R G +SF +EC+
Sbjct: 690 ISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECE 749
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
+ +IRHRN+V++ TA S +D+QG F+A++Y+FMPNGSL+ WLH ++ +
Sbjct: 750 SLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLT 809
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ ++L+IAIDVA L YLH C IAHC+LKPSNVLLDD++ HV DF +AR L DE
Sbjct: 810 LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869
Query: 364 QTRF--IGKLNVRNFVKMALSQ-------RVEEILNDFNLQEIE-------------EDR 401
++ F + VR + A + + + F + +E +
Sbjct: 870 ESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNF 929
Query: 402 TMCMHASSS---------SSTSTHVSI-----ILECVNSICEIGVACSAERPRERMKLND 447
T+ + S+ + H+ + ++EC+ + E+G+ C E P R+ +
Sbjct: 930 TLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSI 989
Query: 448 VESRLRLIRKKILETS 463
V L IR++ + S
Sbjct: 990 VVKELISIRERFFKAS 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 114/325 (35%), Positives = 184/325 (56%), Gaps = 38/325 (11%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECK 243
+S+++L+ AT+ FSS NLIG+GNFG+V+ G L + +AVKV NL++ G +SF +EC+
Sbjct: 700 VSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECE 759
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD----DTHWRLLN 299
IRHRN+V++ T S +D +G F+A+VY+FMP GSL+ WL +D + H R L
Sbjct: 760 TFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLT 819
Query: 300 FDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359
+KL+IAIDVA AL+YLH C +AHC++KPSN+LLDD++ HV DF +A+ L
Sbjct: 820 ----PAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLY 875
Query: 360 DTDEQTRFIGKLN---VRNFVKMALSQ-------RVEEILNDFNLQEIE-------EDRT 402
D ++ F+ + + VR + A + ++ + F + +E D +
Sbjct: 876 KYDRES-FLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDES 934
Query: 403 MC----MHASSSS-----STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453
+H+ + S ++S + I E + + ++G+ CS E PR+RM+ ++ L
Sbjct: 935 FAGDYNLHSYTKSILSGCTSSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELI 994
Query: 454 LIRKKIL--ETSVCPEDKKKKISMP 476
IR K +T++ + S P
Sbjct: 995 SIRSKFFSSKTTITESPRDAPQSSP 1019
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 5e-45, Method: Compositional matrix adjust.
Identities = 110/314 (35%), Positives = 167/314 (53%), Gaps = 38/314 (12%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECK 243
+S+ +LY T GFSS+NLIG+GNFG+V+ G L +A+KV NL + G A+SF +EC+
Sbjct: 707 ISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECE 766
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
A IRHRN+V++ T S D++G F+A+VY+FMPNG+L+ WLH + +
Sbjct: 767 ALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLG 826
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ +L+IAIDVA AL YLH C IAHC++KPSN+LLD ++ HV DF +A+ L D
Sbjct: 827 LFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR 886
Query: 364 QTRFI--GKLNVRNFVKMALSQRV----EEILNDFN-----LQEIEEDR---------TM 403
T I VR + A + I+ D L EI + +
Sbjct: 887 DTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGL 946
Query: 404 CMHASSSSSTSTHVSI-----------------ILECVNSICEIGVACSAERPRERMKLN 446
+H+ + S+ ++ ++EC+ + +GV+CS E P R+ +
Sbjct: 947 TLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMA 1006
Query: 447 DVESRLRLIRKKIL 460
+ S+L IR+
Sbjct: 1007 EAISKLVSIRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 131 bits (329), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 78/196 (39%), Positives = 111/196 (56%), Gaps = 22/196 (11%)
Query: 177 EEKQTINN-----LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR 231
EEKQ N+ +S++ L AT GF++++LIG+G FG VY G L + T +AVKV +
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLD--- 692
Query: 232 PGGA----RSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL 287
P A SFK EC+ RHRN++R+ T S F A+V MPNGSLE L
Sbjct: 693 PKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHL 747
Query: 288 HGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347
+ + + N D + + ++I DVA + YLH ++ HC+LKPSN+LLDDEM
Sbjct: 748 YPGE---YSSKNLDLI--QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTA 802
Query: 348 HVGDFSMARFLPDTDE 363
V DF ++R + +E
Sbjct: 803 LVTDFGISRLVQGVEE 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 128 bits (321), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 80/224 (35%), Positives = 120/224 (53%), Gaps = 19/224 (8%)
Query: 150 PDERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFG 209
P+++ D +++E RS+ + + K + N LS D+ +T+ F+ AN+IG G FG
Sbjct: 703 PEKKADADEIELGSRSVVL-------FHNKDSNNELSLDDILKSTSSFNQANIIGCGGFG 755
Query: 210 SVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269
VY TL DGT +A+K + R F++E + +H N+V + +Y+
Sbjct: 756 LVYKATLPDGTKVAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYC---NYKND- 811
Query: 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329
K ++Y +M NGSL+ WLH K D L D+ K +L IA A L YLH C+P I
Sbjct: 812 -KLLIYSYMDNGSLDYWLHEKVDGPPSL---DW--KTRLRIARGAAEGLAYLHQSCEPHI 865
Query: 330 AHCNLKPSNVLLDDEMIGHVGDFSMARF-LP-DTDEQTRFIGKL 371
H ++K SN+LL D + H+ DF +AR LP DT T +G L
Sbjct: 866 LHRDIKSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTL 909
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 128 bits (321), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 68/173 (39%), Positives = 100/173 (57%), Gaps = 13/173 (7%)
Query: 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGARSFKSECKAA 245
K+L AT+ F+SAN+IG+ + +VY G L DGT IAVKV NL + F +E K
Sbjct: 861 KELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTL 920
Query: 246 INIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIK 305
++HRN+V++ G ++ + KA+V FM NG+LE+ +HG LL
Sbjct: 921 SQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLL------- 969
Query: 306 KKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
+K+D+ + +A + YLH I HC+LKP+N+LLD + + HV DF AR L
Sbjct: 970 EKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (307), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 83/217 (38%), Positives = 117/217 (53%), Gaps = 24/217 (11%)
Query: 159 VESRLRSIKMKLLKTP--VYEEKQTINNLS-------FKDLYDATNGFSSANLIGAGNFG 209
V R+ K +L+ P EE + NLS +KDL ATN FS +G G FG
Sbjct: 448 VAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVK--LGQGGFG 505
Query: 210 SVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269
SVY GTL DG+ +AVK I G + F++E +I H ++VR+ G +GA
Sbjct: 506 SVYEGTLPDGSRLAVKKLEGIGQG-KKEFRAEVSIIGSIHHLHLVRL----RGFCAEGAH 560
Query: 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329
+ + Y+F+ GSLE W+ K D LL++D + +IA+ A+ L YLH DC RI
Sbjct: 561 -RLLAYEFLSKGSLERWIFRKKDGD-VLLDWD----TRFNIALGTAKGLAYLHEDCDARI 614
Query: 330 AHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
HC++KP N+LLDD V DF +A+ + T EQ+
Sbjct: 615 VHCDIKPENILLDDNFNAKVSDFGLAKLM--TREQSH 649
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 120 bits (302), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/175 (38%), Positives = 106/175 (60%), Gaps = 12/175 (6%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGA-RSFKSECK 243
+ +DL ATN FS ++IG G +G VY+GTL + T +AVK L PG A + F+ E +
Sbjct: 142 FTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKL-LNNPGQADKDFRVEVE 200
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
A ++RH+N+VR+ G +G + +VY++M NG+LE+WLHG D H L ++
Sbjct: 201 AIGHVRHKNLVRLL----GYCVEGTH-RMLVYEYMNNGNLEQWLHG-DMIHKGHLTWEAR 254
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
IK + + A+AL YLH +P++ H ++K SN+L+DD + DF +A+ L
Sbjct: 255 IK----VLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLL 305
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 120 bits (302), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 72/185 (38%), Positives = 106/185 (57%), Gaps = 10/185 (5%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSF 238
++ + L F L +ATNGFS+A++IG G FG V+ TL DG+++A+K + G R F
Sbjct: 820 QRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKKLIRLSCQGDREF 879
Query: 239 KSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG-KDDTHWRL 297
+E + I+HRN+V + G G + +VY+FM GSLEE LHG + R+
Sbjct: 880 MAEMETLGKIKHRNLVPLL----GYCKIGEE-RLLVYEFMQYGSLEEVLHGPRTGEKRRI 934
Query: 298 LNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
L ++ ++ IA A+ L +LH +C P I H ++K SNVLLD +M V DF MAR
Sbjct: 935 LGWE----ERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARL 990
Query: 358 LPDTD 362
+ D
Sbjct: 991 ISALD 995
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 120 bits (301), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 69/191 (36%), Positives = 105/191 (54%), Gaps = 18/191 (9%)
Query: 183 NNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSEC 242
N +++DL AT+ FS+ NL+G G FG V+ G L DGT +A+K G R F++E
Sbjct: 129 NLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEI 188
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDT--HWRLLNF 300
+ + HR++V + G GA+ + +VY+F+PN +LE LH K+ W
Sbjct: 189 QTISRVHHRHLVSLL----GYCITGAQ-RLLVYEFVPNKTLEFHLHEKERPVMEW----- 238
Query: 301 DFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
K++ IA+ A+ L YLH DC P+ H ++K +N+L+DD + DF +AR D
Sbjct: 239 ----SKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLD 294
Query: 361 TDEQ--TRFIG 369
TD TR +G
Sbjct: 295 TDTHVSTRIMG 305
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 485 | ||||||
| 222615599 | 2393 | hypothetical protein OsJ_33139 [Oryza sa | 0.707 | 0.143 | 0.439 | 2e-75 | |
| 449440271 | 1343 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.682 | 0.246 | 0.415 | 7e-74 | |
| 449483700 | 1343 | PREDICTED: LOW QUALITY PROTEIN: putative | 0.682 | 0.246 | 0.407 | 7e-71 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.562 | 0.266 | 0.443 | 1e-67 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.562 | 0.266 | 0.443 | 2e-67 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.571 | 0.287 | 0.450 | 3e-66 | |
| 255586722 | 936 | serine-threonine protein kinase, plant-t | 0.554 | 0.287 | 0.450 | 4e-65 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.616 | 0.287 | 0.427 | 9e-65 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.616 | 0.157 | 0.424 | 2e-64 | |
| 224121306 | 966 | predicted protein [Populus trichocarpa] | 0.589 | 0.296 | 0.409 | 2e-63 |
| >gi|222615599|gb|EEE51731.1| hypothetical protein OsJ_33139 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 290 bits (741), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 160/364 (43%), Positives = 222/364 (60%), Gaps = 21/364 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF-LPVETSFID----VMGTIGYVAPEYGMGSEVS 55
HCDLKPSN+ LDD M AH+GDFG+ARF + +TSF + + GTIGYVAPE +G +VS
Sbjct: 837 HCDLKPSNILLDDNMIAHVGDFGLARFRIDSKTSFGNSNSTINGTIGYVAPECAIGGQVS 896
Query: 56 SYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
+ DVYSFG++LLE+F RP + MFKD L + + +P + QI+D QE+ +
Sbjct: 897 TAADVYSFGVVLLEIFIRRRPTDDMFKDGLTIAKYTEINIPDKMLQIVDPQLVQELGLSQ 956
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKLLKTPV 175
+ T T CL+S+ IG+ C+ P ER+ + + + R SI + P
Sbjct: 957 EDPVRVDETATH------CLLSVLNIGLCCTKSSPSERISMQEGKKRTNSIPL-----PS 1005
Query: 176 YEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGG 234
++ + +S+ DL ATN FS ANLIG G + SVY LF D +A+KVF+L G
Sbjct: 1006 FDTE--FPKVSYSDLARATNRFSIANLIGKGRYSSVYQRQLFQDLNVVAIKVFSLETRGA 1063
Query: 235 ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG-KDDT 293
+SF +EC N+ HRN+V + TA S +D G FKA+VY+FMP G L + L+ +DD
Sbjct: 1064 QKSFIAECSTLRNVWHRNLVPILTACSSIDSSGNDFKALVYQFMPRGDLHKLLYSTRDDG 1123
Query: 294 HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353
LN L ++++I +DV+ AL+YLH + Q I HC+LKPSN+LL D MI HVGDF
Sbjct: 1124 DASNLNHTTL-AQRINIVVDVSDALEYLHHNNQGTIIHCDLKPSNILLGDNMIAHVGDFG 1182
Query: 354 MARF 357
+ARF
Sbjct: 1183 LARF 1186
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440271|ref|XP_004137908.1| PREDICTED: LOW QUALITY PROTEIN: putative receptor-like protein kinase At3g47110-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 284 bits (727), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 159/383 (41%), Positives = 226/383 (59%), Gaps = 52/383 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVM-----GTIGYVAPEYGMG 51
HCDLKPSN+ LDD M AH+GDFG+ARF+ +S F M G+IGY+ PEYG G
Sbjct: 828 HCDLKPSNILLDDNMVAHVGDFGLARFMLERSSDQIFFSQTMSLVLKGSIGYIPPEYGTG 887
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVA-FFQE 110
S +S GD++S+GILLLEM G RP + F +D+++ + ALP A I+D + F+E
Sbjct: 888 SIISIEGDIFSYGILLLEMIIGKRPTDDTFGNDMDIHLFTRRALPRDALSIIDPSILFEE 947
Query: 111 IEEEETLYKKASSTCTQSSII----LECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+EE K S I+ +ECL+SI RIG+ CS P ER ++ V + L++I
Sbjct: 948 TCQEENNDDKVKSGEDHKEIVPRWKVECLVSIMRIGLTCSLRAPSERTSMSVVVNELQAI 1007
Query: 167 KMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV 226
K LK T+ L+ +D+ G+ +AVKV
Sbjct: 1008 KSSYLK-------GTLKVLALRDIS-------------------------LHGSMVAVKV 1035
Query: 227 FNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEW 286
NL + G ++S EC A NIRHRN++++ T+ S +D QG FKA+V+ FM NG+L+ W
Sbjct: 1036 LNLQQQGASKSTVDECNALSNIRHRNLLKIITSCSSIDGQGDEFKALVFNFMSNGNLDSW 1095
Query: 287 LHGKDD-THWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345
LH + T+ R L+ + ++L+IAID+A L YLH C+P IAHC+LKPSN+LLDD+M
Sbjct: 1096 LHSTNQGTNQRRLS----LIQRLNIAIDIACGLDYLHNHCEPPIAHCDLKPSNILLDDDM 1151
Query: 346 IGHVGDFSMARF-LPDTDEQTRF 367
+ HVGDF +AR L ++++Q F
Sbjct: 1152 VAHVGDFGLARLMLEESNDQISF 1174
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449483700|ref|XP_004156664.1| PREDICTED: LOW QUALITY PROTEIN: putative receptor-like protein kinase At3g47110-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 274 bits (701), Expect = 7e-71, Method: Compositional matrix adjust.
Identities = 156/383 (40%), Positives = 222/383 (57%), Gaps = 52/383 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVM-----GTIGYVAPEYGMG 51
HCDLKPSN+ LDD M AH+GDFG+ARF+ +S F M G+IGY+ PEYG G
Sbjct: 828 HCDLKPSNILLDDNMVAHVGDFGLARFMLERSSDQIFFSQTMSLVLKGSIGYIPPEYGTG 887
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVA-FFQE 110
S +S GD++S+GILLLEM G RP + F +D+++ + ALP A I+D + F+E
Sbjct: 888 SIISIEGDIFSYGILLLEMIIGKRPTDDTFGNDMDIHLFTRRALPRDALSIIDPSILFEE 947
Query: 111 IEEEETLYKKASSTCTQSSII----LECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+EE K S I+ +ECL+SI RIG+ CS P ER ++ V + L++I
Sbjct: 948 TCQEENNDDKVKSGEDHKEIVPRWKVECLVSIMRIGLTCSLRAPSERTSMSVVVNELQAI 1007
Query: 167 KMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV 226
K L K T+ L+ +D+ G+ +AVKV
Sbjct: 1008 KSSYL-------KGTLKVLALRDIS-------------------------LHGSMVAVKV 1035
Query: 227 FNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEW 286
NL + G ++S EC A NIRHRN++++ T+ S +D QG FKA+V+ FM N L+ W
Sbjct: 1036 LNLQQQGASKSTVDECNALSNIRHRNLLKIITSCSSIDGQGDEFKALVFNFMSNXKLDSW 1095
Query: 287 LHGKDD-THWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345
LH + T+ R L+ + ++L+IAID+A L YLH C+ I HC++KPSNVLLDD+M
Sbjct: 1096 LHSTNQGTNQRRLS----LIQRLNIAIDIACGLDYLHNHCETPIIHCDIKPSNVLLDDDM 1151
Query: 346 IGHVGDFSMARF-LPDTDEQTRF 367
+ HVGDF +AR L ++++Q F
Sbjct: 1152 VAHVGDFGLARLMLEESNDQISF 1174
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 263 bits (672), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 150/338 (44%), Positives = 194/338 (57%), Gaps = 65/338 (19%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARS 237
+ T ++++DL AT GFS ANLIGAG+FGSVY G L DG +AVKVFNL+R G ++S
Sbjct: 687 ESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 746
Query: 238 FKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG---KDDTH 294
F +EC A INIRHRN+V+V TA SG+D+QG FKA+VY+FM NGSLEEWLH D+ H
Sbjct: 747 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAH 806
Query: 295 WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
R D + ++L+IAIDVA AL YLH CQ +AHC+LKPSNVLLD +M HVGDF +
Sbjct: 807 VRR---DLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGL 863
Query: 355 ARFLPDTD-----EQTRFIG---------------------------------------- 369
AR LP +QT IG
Sbjct: 864 ARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRP 923
Query: 370 -------KLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILE 422
LN+ NF K AL V E+L+ + E EE + +S +H+ +E
Sbjct: 924 TNGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEET------SGDASRRMSHIGNHME 977
Query: 423 CVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460
C+ +I ++GVACSAE PRERM+++ V LR IR +L
Sbjct: 978 CLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILL 1015
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 263 bits (671), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 150/338 (44%), Positives = 194/338 (57%), Gaps = 65/338 (19%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARS 237
+ T ++++DL ATNGFS ANLIGAG+FGSVY G L DG +AVKVFNL+R G ++S
Sbjct: 689 ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748
Query: 238 FKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG---KDDTH 294
F +EC A INIRHRN+V+V TA SG+D+QG FKA+VY+FM NGSLEEWLH D+ H
Sbjct: 749 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808
Query: 295 WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
R D + ++L+IAIDVA AL YLH CQ I HC+LKPSNVLLD ++ HVGDF +
Sbjct: 809 RRR---DLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGL 865
Query: 355 ARFLPDTD-----EQTRFIG---------------------------------------- 369
AR LP +QT IG
Sbjct: 866 ARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRP 925
Query: 370 -------KLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILE 422
LN+ NF K AL V E+L+ + E EE + +S +H+ +E
Sbjct: 926 TDGLFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEET------SGDASRRMSHIGNHME 979
Query: 423 CVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460
C+ +I ++GVACSAE PRERM+++ V LR IR +L
Sbjct: 980 CLAAIVKVGVACSAEFPRERMEISSVAVELRRIRHILL 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 259 bits (661), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 156/346 (45%), Positives = 194/346 (56%), Gaps = 69/346 (19%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECK 243
+S++ L AT+GFSS+NLIG G+FGSVY G L DGT IAVKV NL+R G ++SF +EC+
Sbjct: 626 VSYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECE 685
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW-----RLL 298
A NIRHRN+V+V TA SGVDYQG FKAVVY+FM NGSLE+WLH T R L
Sbjct: 686 ALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKL 745
Query: 299 NFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
NF ++L+IAIDVA AL YLH CQ I HC+LKPSNVLLD EM GHVGDF +A+FL
Sbjct: 746 NF----LQRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFL 801
Query: 359 PDTDEQT------------------------------------------RFIGK------ 370
P+ + F GK
Sbjct: 802 PEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDM 861
Query: 371 ----LNVRNFVKMALSQRVEEILNDFNLQE-IEEDRTMCMHASSSSSTSTHVSIILECVN 425
LN+ NFVK A+ +RV EI + LQE +E D T +SS + EC+
Sbjct: 862 FKDSLNIHNFVKTAVPERVAEIADPVLLQEGVEMDNTTSQRRMASSHDAQ------ECLI 915
Query: 426 SICEIGVACSAERPRERMKLNDVESRLRLIRKKILETSVCPEDKKK 471
SI IG+ACSAE PRER + D + L +R L T + D ++
Sbjct: 916 SIFGIGLACSAELPRERKNITDAAAELNSVRDIFLGTGLHIRDDRQ 961
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 255 bits (651), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 146/324 (45%), Positives = 194/324 (59%), Gaps = 55/324 (16%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNLIRPGGARSFKSECK 243
LS+ LY AT+GFSSAN +GAG+FG+V+ G L G T+IAVKVFNL+R G +SF +EC+
Sbjct: 618 LSYHTLYKATDGFSSANTLGAGSFGTVFKGELGGGETSIAVKVFNLMRHGAFKSFIAECE 677
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
A NIRHRN+V+V TA S VDYQG FKA+VY+FM NGSLEEWLH D+ N +
Sbjct: 678 ALRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEWLHPPDEAKAIPRN-NLN 736
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
I ++L+IA+DVA AL YLH C+ I HC+LKPSN+LLD+EM GHVGDF +A+F +
Sbjct: 737 ILQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNEMTGHVGDFGLAKFYRERSH 796
Query: 364 QTRFIG-----------------------------------------------KLNVRNF 376
Q+ IG +++ N+
Sbjct: 797 QSSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIFTGKRPMDDWFNEDVSLHNY 856
Query: 377 VKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSA 436
VK AL ++V EIL+ QE E ++ +++S ++ +EC+ SICEIGVACSA
Sbjct: 857 VKNALPEQVVEILDPTLFQEGEGGISLIRRSNAS------INRTMECLISICEIGVACSA 910
Query: 437 ERPRERMKLNDVESRLRLIRKKIL 460
E P ERM + DV +L IR K+L
Sbjct: 911 ETPGERMNICDVAGQLVSIRNKLL 934
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 254 bits (648), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 156/365 (42%), Positives = 205/365 (56%), Gaps = 66/365 (18%)
Query: 159 VESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF- 217
V +RLR +K + +T K I N+S+ L+ AT GFSSANLIG G FGSVY G L
Sbjct: 676 VINRLRRVKREPSQTSA-SSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQ 734
Query: 218 DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKF 277
D T +AVKV L + G +SFK+EC+A NIRHRN+V+V T S VDYQG FKA+VY+F
Sbjct: 735 DETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEF 794
Query: 278 MPNGSLEEWLH---GKDDTH--WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHC 332
MPNGSLE WLH D+ + R+L+ + ++L+IAIDVA AL YLH C I HC
Sbjct: 795 MPNGSLENWLHPVPTPDEINDVLRILS----LPQRLNIAIDVASALDYLHHHCHKPIVHC 850
Query: 333 NLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR-------------------------- 366
+LKPSN+LLD++M HVGDF +ARF+P+ ++
Sbjct: 851 DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 910
Query: 367 ----------------FIGK----------LNVRNFVKMALSQRVEEILNDFNL-QEIEE 399
F GK LN+ NFVKMAL +R+ +I++ F L E +E
Sbjct: 911 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 970
Query: 400 DRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459
+ T A SS+ + EC+ SI IGV+CS E PRERM + + L+LIRK +
Sbjct: 971 EETTA--ADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKIL 1028
Query: 460 LETSV 464
L V
Sbjct: 1029 LGNGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 253 bits (645), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 155/365 (42%), Positives = 205/365 (56%), Gaps = 66/365 (18%)
Query: 159 VESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF- 217
V +RLR +K + +T K I N+S+ L+ AT GFSSANLIG G FGSVY G L
Sbjct: 707 VINRLRRVKREPSQTSA-SSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQ 765
Query: 218 DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKF 277
D T +AVKV L + G +SFK+EC+A NIRHRN+V+V T S VDYQG FKA+VY+F
Sbjct: 766 DETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEF 825
Query: 278 MPNGSLEEWLH---GKDDTH--WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHC 332
MPNGSLE WLH D+ + R+L+ + ++L+IAIDVA AL YLH C I HC
Sbjct: 826 MPNGSLENWLHPVPTPDEINDVLRILS----LPQRLNIAIDVASALDYLHHHCHKPIVHC 881
Query: 333 NLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR-------------------------- 366
+LKPSN+LLD++M HVGDF +ARF+P+ ++
Sbjct: 882 DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 941
Query: 367 ----------------FIGK----------LNVRNFVKMALSQRVEEILNDFNL-QEIEE 399
F GK LN+ NFVKMAL +R+ +I++ F L E +E
Sbjct: 942 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 1001
Query: 400 DRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459
+ T A SS+ + EC+ SI IGV+CS E PRERM + + L+LIRK +
Sbjct: 1002 EETTA--ADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKIL 1059
Query: 460 LETSV 464
L +
Sbjct: 1060 LGNGI 1064
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121306|ref|XP_002330794.1| predicted protein [Populus trichocarpa] gi|222872596|gb|EEF09727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 249 bits (637), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 147/359 (40%), Positives = 205/359 (57%), Gaps = 73/359 (20%)
Query: 165 SIKMKLLK----TPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDG 219
++ MKL K TP E ++ +S++ L AT+GFS NL+G G FGSVY G L D
Sbjct: 606 TLAMKLRKKVEPTPTSPEN-SVFQMSYRSLLKATDGFSLTNLLGVGGFGSVYKGILDNDE 664
Query: 220 TTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMP 279
+AVKV NL+ P ++SFK+EC+ N+RHRN+V++ TA SG DYQG FKA+VY+FM
Sbjct: 665 KLVAVKVLNLLNPRASKSFKAECEVLRNVRHRNLVKLLTACSGSDYQGNDFKALVYEFMV 724
Query: 280 NGSLEEWLH----GKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335
NGSLEEWLH G D+ + +F+ ++L+IAID++ AL+YLH C+ I HC+LK
Sbjct: 725 NGSLEEWLHPITPGIDEARESSRSLNFV--QRLNIAIDISCALEYLHRGCRTPIVHCDLK 782
Query: 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF-----------IG--------------- 369
PSNVLLDDEMIGHVGDF +ARF P+ F IG
Sbjct: 783 PSNVLLDDEMIGHVGDFGLARFFPEATNNLSFNRSSTNGVRGTIGYTAPEYGMGNEVSTS 842
Query: 370 --------------------------KLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTM 403
LN+ ++K AL +VEEIL+ +QEI+ +R
Sbjct: 843 GDVFSYGILLLEMFSGKRPTDVIFEDSLNLHTYMKAALPGKVEEILDPILVQEIKGER-- 900
Query: 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKILET 462
SS+ S + +CV S+ E+G+ACSAE P ERM +++V + L+ I++K+L +
Sbjct: 901 -------SSSYMWNSKVQDCVVSVFEVGIACSAELPSERMDISEVTAELQAIKEKLLRS 952
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 485 | ||||||
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.389 | 0.376 | 0.472 | 1.8e-50 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.441 | 0.211 | 0.440 | 1.4e-49 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.404 | 0.194 | 0.447 | 1.1e-48 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.402 | 0.192 | 0.425 | 1.5e-46 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.385 | 0.182 | 0.462 | 6.7e-45 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.385 | 0.181 | 0.449 | 8.8e-45 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.354 | 0.167 | 0.477 | 7.2e-43 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.327 | 0.135 | 0.402 | 2.9e-26 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.360 | 0.178 | 0.4 | 4.9e-26 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.346 | 0.231 | 0.386 | 5.9e-26 |
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 1.8e-50, Sum P(2) = 1.8e-50
Identities = 94/199 (47%), Positives = 138/199 (69%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARS 237
K+ + +S+++LY+AT+GFSS+NLIG+GNF V+ G L + +AVKV NL++ G +S
Sbjct: 191 KKKNDKISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKS 250
Query: 238 FKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD----DT 293
F +EC++ IRHRN+ ++ T S +D QG F+A+VY+FMP GSL+ WL +D +
Sbjct: 251 FIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANN 310
Query: 294 HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353
H R L F +K++IAIDVA AL+YLH C +AHC++KPSNVLLDD++ HV DF
Sbjct: 311 HSRSLTF----AEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFG 366
Query: 354 MARFLPDTDEQTRFIGKLN 372
+AR L + DE+T F+ + +
Sbjct: 367 LARLLYNFDEKT-FLNQFS 384
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 482 (174.7 bits), Expect = 1.4e-49, Sum P(2) = 1.4e-49
Identities = 96/218 (44%), Positives = 141/218 (64%)
Query: 167 KMKLLKTPVYEEKQTINN-LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAV 224
K K P + ++ +S+ DL +ATNGFSS+N++G+G+FG+VY L + +AV
Sbjct: 671 KNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAV 730
Query: 225 KVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLE 284
KV N+ R G +SF +EC++ +IRHRN+V++ TA S +D+QG F+A++Y+FMPNGSL+
Sbjct: 731 KVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLD 790
Query: 285 EWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344
WLH ++ + + ++L+IAIDVA L YLH C IAHC+LKPSNVLLDD+
Sbjct: 791 MWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDD 850
Query: 345 MIGHVGDFSMARFLPDTDEQTRF--IGKLNVRNFVKMA 380
+ HV DF +AR L DE++ F + VR + A
Sbjct: 851 LTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYA 888
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 1.1e-48, Sum P(2) = 1.1e-48
Identities = 89/199 (44%), Positives = 136/199 (68%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECK 243
LS+ DL +AT+GFSS+N++G+G+FG+V+ L + +AVKV N+ R G +SF +EC+
Sbjct: 689 LSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECE 748
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
+ +IRHRN+V++ TA + +D+QG F+A++Y+FMPNGSL++WLH ++ +
Sbjct: 749 SLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLT 808
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ ++L+IAIDVA L YLH C IAHC+LKPSN+LLDD++ HV DF +AR L D+
Sbjct: 809 LLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQ 868
Query: 364 QTRF--IGKLNVRNFVKMA 380
++ F + VR + A
Sbjct: 869 ESFFNQLSSAGVRGTIGYA 887
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 1.5e-46, Sum P(2) = 1.5e-46
Identities = 86/202 (42%), Positives = 136/202 (67%)
Query: 172 KTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI 230
K ++ EK +S+ DL +ATNGFSS+N++G+G+FG+V+ L + +AVKV N+
Sbjct: 683 KLEIFHEK-----ISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQ 737
Query: 231 RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGK 290
R G +SF +EC++ + RHRN+V++ TA + D+QG F+A++Y+++PNGS++ WLH +
Sbjct: 738 RRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPE 797
Query: 291 DDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350
+ R + ++L+I IDVA L YLH C IAHC+LKPSNVLL+D++ HV
Sbjct: 798 EVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVS 857
Query: 351 DFSMARFLPDTDEQTRFIGKLN 372
DF +AR L D+++ F+ +L+
Sbjct: 858 DFGLARLLLKFDKES-FLNQLS 878
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 6.7e-45, Sum P(2) = 6.7e-45
Identities = 87/188 (46%), Positives = 122/188 (64%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARS 237
K +S+ +LY T GFSS+NLIG+GNFG+V+ G L +A+KV NL + G A+S
Sbjct: 701 KSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKS 760
Query: 238 FKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRL 297
F +EC+A IRHRN+V++ T S D++G F+A+VY+FMPNG+L+ WLH +
Sbjct: 761 FIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGN 820
Query: 298 LNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
+ + +L+IAIDVA AL YLH C IAHC++KPSN+LLD ++ HV DF +A+
Sbjct: 821 PSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQL 880
Query: 358 LPDTDEQT 365
L D T
Sbjct: 881 LLKFDRDT 888
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 8.8e-45, Sum P(2) = 8.8e-45
Identities = 85/189 (44%), Positives = 128/189 (67%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECK 243
+S+++L+ AT+ FSS NLIG+GNFG+V+ G L + +AVKV NL++ G +SF +EC+
Sbjct: 700 VSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECE 759
Query: 244 AAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
IRHRN+V++ T S +D +G F+A+VY+FMP GSL+ WL +D +
Sbjct: 760 TFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLT 819
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+KL+IAIDVA AL+YLH C +AHC++KPSN+LLDD++ HV DF +A+ L D
Sbjct: 820 PAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDR 879
Query: 364 QTRFIGKLN 372
++ F+ + +
Sbjct: 880 ES-FLNQFS 887
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 7.2e-43, Sum P(2) = 7.2e-43
Identities = 85/178 (47%), Positives = 117/178 (65%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKA 244
+S+ L AT+GF+ NL+G+G+FGSVY G L +AVKV L P +SF +EC+A
Sbjct: 696 VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEA 755
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGK--DDTHWRLLNFDF 302
N+RHRN+V++ T S +D +G FKA+VY FMPNGSLE+W+H + D R LN
Sbjct: 756 LRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLN--- 812
Query: 303 LIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
+ +++ I +DVA AL YLH + HC++K SNVLLD +M+ HVGDF +AR L D
Sbjct: 813 -LHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVD 869
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 312 (114.9 bits), Expect = 2.9e-26, Sum P(2) = 2.9e-26
Identities = 70/174 (40%), Positives = 102/174 (58%)
Query: 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARS---FKSECKA 244
K+L AT+ F+SAN+IG+ + +VY G L DGT IAVKV NL + A S F +E K
Sbjct: 861 KELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNL-KEFSAESDKWFYTEAKT 919
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
++HRN+V++ G ++ + KA+V FM NG+LE+ +HG LL
Sbjct: 920 LSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLL------ 969
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
+K+D+ + +A + YLH I HC+LKP+N+LLD + + HV DF AR L
Sbjct: 970 -EKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL 1022
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 316 (116.3 bits), Expect = 4.9e-26, Sum P(2) = 4.9e-26
Identities = 78/195 (40%), Positives = 112/195 (57%)
Query: 177 EEKQTINN-----LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFN--- 228
EEKQ N+ +S++ L AT GF++++LIG+G FG VY G L + T +AVKV +
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKT 695
Query: 229 LIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLH 288
+ G SFK EC+ RHRN++R+ T S G F A+V MPNGSLE L+
Sbjct: 696 ALEFSG--SFKRECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLY 748
Query: 289 GKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348
+ + N D + + ++I DVA + YLH ++ HC+LKPSN+LLDDEM
Sbjct: 749 PGE---YSSKNLDLI--QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTAL 803
Query: 349 VGDFSMARFLPDTDE 363
V DF ++R + +E
Sbjct: 804 VTDFGISRLVQGVEE 818
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 5.9e-26, Sum P(2) = 5.9e-26
Identities = 68/176 (38%), Positives = 101/176 (57%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKA 244
LS+++L +AT+ F SA+++G G FG VY G L DGT +A+K P G + F+ E
Sbjct: 368 LSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDM 427
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
+ HRN+V++ S D + + Y+ +PNGSLE WLHG + L ++D +
Sbjct: 428 LSRLHHRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLEAWLHGPLGLNCPL-DWDTRM 483
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
K IA+D AR L YLH D QP + H + K SN+LL++ V DF +A+ P+
Sbjct: 484 K----IALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPE 535
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 485 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-18 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-16 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-16 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-09 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-08 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-08 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-08 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-08 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-08 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-07 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-07 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-06 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-05 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-05 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.001 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.001 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.001 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.001 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.002 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 0.002 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.002 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.002 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.003 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.003 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.003 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.003 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.003 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.003 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 0.003 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.003 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.004 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 0.004 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVRVFTAV 260
+G G FG+VY G +A+K+ E + + H NIV+++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV ++ +V ++ GSL++ L + L+ D +++ I + + L+Y
Sbjct: 58 -GV-FEDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILR----ILLQILEGLEY 107
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR 366
LH I H +LKP N+LLD + G V DF +++ L +
Sbjct: 108 LH---SNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLK 151
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 21/178 (11%)
Query: 203 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
+G G FG VY GTL +AVK F E + + H NIV++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
GV + +V ++MP G L ++L + + L A+ +AR
Sbjct: 67 L----GVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPK-------ELSLSDLLSFALQIAR 114
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
++YL H +L N L+ + ++ + DF ++R L D D GKL +R
Sbjct: 115 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 22/178 (12%)
Query: 203 IGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
+G G FG VY G L +AVK F E + + H N+V++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
GV + +V ++M G L +L + L A+ +AR
Sbjct: 67 L----GVCTEEEPLY-IVMEYMEGGDLLSYLRKNRPK--------LSLSDLLSFALQIAR 113
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
++YL H +L N L+ + ++ + DF ++R L D D + GKL +R
Sbjct: 114 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 1e-19
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 203 IGAGNFGSVYNGTLFD-----GTTIAVKVFNLI-RPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG VY GTL T +AVK F E + H NIVR+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
GV QG +V ++MP G L ++L + +K L +A+ +A+
Sbjct: 67 L----GVCTQGEPLY-IVTEYMPGGDLLDFLRKHGEK--------LTLKDLLQMALQIAK 113
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE-QTRFIGKLNVR 374
++YL H +L N L+ + ++ + DF ++R + + D + R GKL ++
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 35/92 (38%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ LD++ L DFG+AR L +GT Y+APE +G D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
+S G++L E+ TG P F D L L K
Sbjct: 180 WSLGVILYELLTGKPP----FPGDDQLLELFK 207
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 23/173 (13%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFT 258
+G G+FG VY G +A+KV + E K ++H NIVR++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
++ +V ++ G L + L + L+ D + AL
Sbjct: 65 V-----FEDEDKLYLVMEYCEGGDLFDLLKKR-----GRLSEDEARF----YLRQILSAL 110
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+YLH I H +LKP N+LLD++ GHV DF +AR L ++ T F+G
Sbjct: 111 EYLH---SKGIVHRDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVG 158
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 14/180 (7%)
Query: 201 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+G G FG VY G L T +AVK R F E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ GV + +V ++M G L ++L +K L AI +A
Sbjct: 61 LL----GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF-IGKLNVR 374
+ ++YL + H +L N L+ ++++ + DF ++R + D D + GKL +R
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 34/166 (20%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVFTA 259
+G+G+FG+VY G +AVK+ + ++ + E + + H NIVR+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-------LDIAI 312
+V ++ G L FD+L + IA+
Sbjct: 65 --DAFEDKDHL-YLVMEYCEGGDL----------------FDYLSRGGPLSEDEAKKIAL 105
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
+ R L+YLH + I H +LKP N+LLD+ + + DF +A+ L
Sbjct: 106 QILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL 148
|
Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 29/75 (38%), Positives = 42/75 (56%), Gaps = 2/75 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPE-YGMGSEVSSYG 58
H DLKP N+ LD+ + DFG+A+ L +S + GT Y+APE G+
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 59 DVYSFGILLLEMFTG 73
DV+S G++L E+ TG
Sbjct: 181 DVWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 28/73 (38%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSY- 57
H DLKP N+ LD D L DFG+++ L + S ++GT Y+APE +G S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 58 GDVYSFGILLLEM 70
D++S G++L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 2e-14
Identities = 36/96 (37%), Positives = 47/96 (48%), Gaps = 10/96 (10%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGDVY 61
DLKP N+ LD + L DFG+A+ L E S + GT Y+APE +G D +
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWW 177
Query: 62 SFGILLLEMFTGLRP-----NNGMF----KDDLNLP 88
S G+LL EM TG P ++ KD L P
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP 213
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL---PVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H D+K +N+ +D + L DFG A+ L V GT ++APE G E
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 58 GDVYSFGILLLEMFTGLRP 76
D++S G ++EM TG P
Sbjct: 184 ADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 29/79 (36%), Positives = 39/79 (49%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KP N+ LD++ H+ DF IA + +T GT GY+APE S D
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDW 182
Query: 61 YSFGILLLEMFTGLRPNNG 79
+S G+ E G RP G
Sbjct: 183 WSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 9e-14
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 24/102 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL----PVETSFIDVMGTIGYVAPE------YGM 50
H D+KP N+FL LGDFGI++ L + + + GT Y++PE Y
Sbjct: 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELCQNKPYNY 182
Query: 51 GSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
S D++S G +L E+ T P F+ + NL L
Sbjct: 183 KS------DIWSLGCVLYELCTLKHP----FEGE-NLLELAL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 201 NLIGAGNFGSVYNGT---LFDGTT--IAVKVFNLIRPGGARS-FKSECKAAINIRHRNIV 254
+G G+FG V L D T +AVK N RS F+ E + + H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDD--THWRLLNFDFLIKKKLDIAI 312
+ + V + G R ++ +++P+GSL ++L D RLL F +
Sbjct: 70 K-YKGVC--EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF----------SS 116
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ + + YL R H +L N+L++ E + + DF +A+ LP+ +
Sbjct: 117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 28/170 (16%)
Query: 201 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVF 257
L+G G+FGSVY D G +AVK L + + E + +++H NIVR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 258 TAVSGVDYQGARFKAVVYKFM---PNGSLEEWLH--GKDDTHWRLLNFDFLIKKKLDIAI 312
G + K + F+ GSL L GK + +I+K
Sbjct: 66 ----GSERD--EEKNTLNIFLEYVSGGSLSSLLKKFGKLP--------EPVIRK---YTR 108
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+ L YLH I H ++K +N+L+D + + + DF A+ L D +
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-ARSFKSECKAAINIRHRNIVRVFTAV 260
IG G FG V G + G +AVK L A++F +E +RH N+V++
Sbjct: 13 TIGKGEFGDVMLGD-YRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLL--- 66
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV QG +V ++M GSL ++L + + ++L A+DV ++Y
Sbjct: 67 -GVVLQGNPL-YIVTEYMAKGSLVDYLRSRGRAV---ITL----AQQLGFALDVCEGMEY 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
L + H +L NVL+ ++++ V DF +A+ Q + GKL V+
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVK 164
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 21/174 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V+ GT T +A+K ++PG +F E + +RH +V+++ V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
S +V ++M GSL ++L G+ + RL + +D+A +A + Y
Sbjct: 71 SEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRL-------PQLVDMAAQIASGMAY 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+ + H +L+ +N+L+ + ++ V DF +AR + D + R K ++
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 168
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 25/167 (14%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+GAG FG V+ GT T +AVK ++PG +F E + +RH +V+++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 261 SGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
S + Y +V ++M GSL ++L + RL + +D+A +A +
Sbjct: 71 SEEEPIY-------IVTEYMSKGSLLDFLKSGEGKKLRL-------PQLVDMAAQIAEGM 116
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
YL H +L N+L+ + ++ + DF +AR + D DE T
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED-DEYT 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 40/166 (24%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 197 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV 256
F+ +G+G FG V+ G + +A+K+ + F+ E +A +RH++++ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 257 FTAVSGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
F S + Y ++ + M GSL +L + ++L LI D+A V
Sbjct: 68 FAVCSVGEPVY-------IITELMEKGSLLAFLRSPEG---QVLPVASLI----DMACQV 113
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
A + YL + H +L N+L+ ++++ V DF +AR + +
Sbjct: 114 AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 28/170 (16%)
Query: 203 IGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTA 259
+GAG FG V+ G L++ TT +AVK ++PG + F +E + +RH +++++ A
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQLY-A 68
Query: 260 VSGVD---YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
V ++ Y +V + M GSL E+L G +L + +D+A VA
Sbjct: 69 VCTLEEPIY-------IVTELMKYGSLLEYLQGGAGRALKL-------PQLIDMAAQVAS 114
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
+ YL + Q I H +L NVL+ + I V DF +AR + + + R
Sbjct: 115 GMAYL--EAQNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 66.3 bits (160), Expect = 1e-11
Identities = 34/87 (39%), Positives = 46/87 (52%), Gaps = 11/87 (12%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETS-------FIDVMGTIGYVAPEYGMGS 52
H D+KP N+ LD D L DFG+A+ LP S +GT GY+APE +G
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRP 76
++ D++S GI L E+ TGL P
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V+ GT T +AVK ++PG SF E + +RH +V+++ V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
S +V ++M GSL ++L + +L N +D+A VA + Y
Sbjct: 71 S------EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-------VDMAAQVAAGMAY 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+ + H +L+ +N+L+ D ++ + DF +AR + D + R K ++
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK 168
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 23/175 (13%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
IG+G FG V+ G + +A+K IR G F E + + + H +V+++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLY--- 65
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV + + +V++FM +G L ++L + F + L + +DV + Y
Sbjct: 66 -GVCTERSPI-CLVFEFMEHGCLSDYLRAQRGK--------FSQETLLGMCLDVCEGMAY 115
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG-KLNVR 374
L + H +L N L+ + + V DF M RF+ D D+ T G K V+
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVK 166
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 36/180 (20%)
Query: 203 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVR 255
+G G FG V+ G + D +AVK AR F+ E + N +H NIV+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKK------ 307
+ GV +G +V+++M +G L ++L HG D FL
Sbjct: 73 FY----GVCTEGDPP-IMVFEYMEHGDLNKFLRSHGPD--------AAFLKSPDSPMGEL 119
Query: 308 -----LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
L IA+ +A + YL H +L N L+ +++ +GDF M+R + TD
Sbjct: 120 TLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 17/156 (10%)
Query: 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNL-IRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG GNFG VY G L T +AVK + P R F E + H NIV++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI--- 58
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV Q +V + +P GSL +L K + +KK L +++D A ++Y
Sbjct: 59 -GVCVQKQPI-YIVMELVPGGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEY 108
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L H +L N L+ + + + DF M+R
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV-MGTIGYVAPEYGMGSEVSSYGD 59
H DLKP+N+FLD LGDFG+A+ L ++SF +GT Y++PE D
Sbjct: 133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSD 192
Query: 60 VYSFGILLLEMFTGLRP 76
++S G L+ E+ L P
Sbjct: 193 IWSLGCLIYELCA-LSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 44/176 (25%), Positives = 87/176 (49%), Gaps = 24/176 (13%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+GAG FG V+ G + T +AVK ++PG ++F E ++H +VR++ V
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 261 SGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+ + Y ++ ++M GSL ++L K D ++L + K +D + +A +
Sbjct: 71 TKEEPIY-------IITEYMAKGSLLDFL--KSDEGGKVL-----LPKLIDFSAQIAEGM 116
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
Y+ + H +L+ +NVL+ + ++ + DF +AR + D + R K ++
Sbjct: 117 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK 169
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 33/84 (39%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL-----PVETSFIDVMGTIGYVAPEYGMGSEVS 55
H D+KP+N+FLD LGDFG A L + + GT Y+APE G +
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 56 SYG---DVYSFGILLLEMFTGLRP 76
+G D++S G ++LEM TG RP
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 26/164 (15%)
Query: 201 NLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVF 257
N IG G FG VY L G +AVK + + E K ++H N+V+ +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 258 TAVSGVDYQGARFKAVVYKFMP---NGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
GV+ + VY FM G+LEE L R+L+ + +I+ + +
Sbjct: 66 ----GVEVHREK----VYIFMEYCSGGTLEELLEHG-----RILD-EHVIRV---YTLQL 108
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
L YLH I H ++KP+N+ LD + +GDF A L
Sbjct: 109 LEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 27/179 (15%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVR 255
F IG G FG VY G +A+KV L +E + +H NIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA---I 312
+ + Y +V +F GSL++ L + + L + IA
Sbjct: 62 YYGS-----YLKKDELWIVMEFCSGGSLKDLL----KSTNQTLT-------ESQIAYVCK 105
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
++ + L+YLH I H ++K +N+LL + G V DF ++ L DT + +G
Sbjct: 106 ELLKGLEYLH---SNGIIHRDIKAANILLTSD--GEVKLIDFGLSAQLSDTKARNTMVG 159
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 44/174 (25%), Positives = 82/174 (47%), Gaps = 21/174 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V+ GT T +A+K ++PG +F E + +RH +V ++ V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
S +V +FM GSL ++L D + +L + +D+A +A + Y
Sbjct: 71 SEEPIY------IVTEFMGKGSLLDFLKEGDGKYLKL-------PQLVDMAAQIADGMAY 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+ + H +L+ +N+L+ D ++ + DF +AR + D + R K ++
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK 168
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 62.5 bits (150), Expect = 2e-10
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNL---IRPGGARSFKSECKAAINIRH-RNIVRVF 257
+G G+FG VY D +A+KV + F E + ++ H NIV+++
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+Q +V +++ GSLE+ L K L + L I + A
Sbjct: 65 DF-----FQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEAL-----FILAQILSA 113
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFSMARFLPDTDE 363
L+YLH I H ++KP N+LLD D + + DF +A+ LPD
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
|
Length = 384 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 21/182 (11%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSG 262
IG G FG V G + G +AVK A++F +E +RH N+V++ +
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLH 322
V+ +G + +V ++M GSL ++L + + +L D L+K ++DV A++YL
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS---VLGGDCLLK----FSLDVCEAMEYLE 119
Query: 323 CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNFVKMALS 382
+ H +L NVL+ ++ + V DF + + T + GKL V+ AL
Sbjct: 120 AN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALR 172
Query: 383 QR 384
++
Sbjct: 173 EK 174
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 33/195 (16%)
Query: 202 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGA----RSFKSECKAAINIRHRNI 253
+IGAG FG V+ G L +A+K ++PG + F SE H NI
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKT---LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 254 VRVFTAVSGVDYQGARFK--AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311
+R+ V+ +FK ++ ++M NG+L+++L D +F + + +
Sbjct: 69 IRLEGVVT-------KFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGML 113
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFI--G 369
+A +KYL H +L N+L++ + V DF ++R L D E T G
Sbjct: 114 RGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 370 KLNVRNFVKMALSQR 384
K+ +R A++ R
Sbjct: 171 KIPIRWTAPEAIAYR 185
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 197 FSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRPGGARS----FKSECKAAINIRH 250
++G G FGSV G L DG+ + V V + S F SE + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 251 RNIVRVF-TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRL--LNFDFLIKKK 307
N++++ Q V+ FM +G L +L + RL L ++
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFL-----LYSRLGGLPEKLPLQTL 115
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD--EQT 365
L +D+A ++YL H +L N +L ++M V DF +++ + D Q
Sbjct: 116 LKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172
Query: 366 RFIGKLNVRNFVKMALSQRVEEILND 391
R I K+ V+ +L+ RV +D
Sbjct: 173 R-IAKMPVKWIAIESLADRVYTSKSD 197
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N+ ++ E + DFG+A+ LP + + V I + APE S+ SS
Sbjct: 132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSS 191
Query: 57 YGDVYSFGILLLEMFTGLRPN 77
DV+SFG+ L E+FT P+
Sbjct: 192 ASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 42/167 (25%), Positives = 66/167 (39%), Gaps = 21/167 (12%)
Query: 202 LIGAGNFGSVYNGT----LFDGTTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
+G G+FG V G +AVK + F E ++ H N++R+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
+ V +V + P GSL + L H FLI D A+ +A
Sbjct: 62 YGVVL------THPLMMVTELAPLGSLLDRLRKDALGH-------FLISTLCDYAVQIAN 108
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
++YL R H +L N+LL + +GDF + R LP ++
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 28/74 (37%), Positives = 33/74 (44%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
DLKP NV LDD + D G+A L GT GY+APE G D ++
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179
Query: 63 FGILLLEMFTGLRP 76
G L EM G P
Sbjct: 180 LGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 19/157 (12%)
Query: 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVRVFTAV 260
L+G GNFG V+ GTL D T +AVK P + F SE + H NIV++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI--- 58
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV Q +V + +P G +L K D + K+ + A+D A + Y
Sbjct: 59 -GVCTQRQPI-YIVMELVPGGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAY 108
Query: 321 LHC-DCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L +C H +L N L+ + + + DF M+R
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 24/166 (14%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARS---FKSECKAAINIRHRNIVRVFTA 259
+G+G FG V+ G +A+K+ GA S F E K + + H N+V+++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
+ Q F +V ++M NG L +L L ++L LD+ DV A++
Sbjct: 68 CT---KQRPIF--IVTEYMANGCLLNYLR----ERKGKLGTEWL----LDMCSDVCEAME 114
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
YL + H +L N L+ ++ + V DF +AR++ D D+ T
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD-DQYT 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 27/171 (15%)
Query: 202 LIGAGNFGSV----YNGTLFDGT--TIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVR 255
+G GNFGSV Y+ L D T +AVK R F+ E + +++H NIV+
Sbjct: 11 QLGKGNFGSVELCRYD-PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 256 VFTAVSGVDYQ-GARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKKLDIAI 312
GV Y G R +V +++P GSL ++L H + H +LL + I K +
Sbjct: 70 Y----KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK----GM 121
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ + +Y+H D R N+L++ E +GDF + + LP E
Sbjct: 122 EYLGSKRYVHRDLATR---------NILVESENRVKIGDFGLTKVLPQDKE 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 26/70 (37%), Positives = 41/70 (58%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+K N+F++D +GD G A+F V +F+ + GT+ APE + +S D+
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADI 239
Query: 61 YSFGILLLEM 70
+S GI+L EM
Sbjct: 240 WSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSG 262
IG G FG+V G + G +AVK N+ A++F E + H+N+VR+ +
Sbjct: 14 IGEGEFGAVLQGE-YTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL- 69
Query: 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLH 322
+ G +V + M G+L +L T R L + + L ++DVA ++YL
Sbjct: 70 --HNGLY---IVMELMSKGNLVNFLR----TRGRAL---VSVIQLLQFSLDVAEGMEYLE 117
Query: 323 CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
++ H +L N+L+ ++ + V DF +AR + ++
Sbjct: 118 ---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL 159
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 12/113 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KP N+ +D L DFG++R F+ GT Y+APE +G D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV---GTPDYLAPETILGVGDDKMSDW 176
Query: 61 YSFGILLLEMFTGLRPNNG-----MFKD----DLNLPNLVKSALPARAEQILD 104
+S G ++ E G P + +F + +N P VK A +++
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 32/83 (38%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL N+ + +++ + DFG+AR + V S D + APE S+
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DKKIPYKWTAPEAASHGTFSTKS 185
Query: 59 DVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL EMFT G P GM
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 6/88 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+K +N+ L + L DFG++ L + ++GT ++APE G D+
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 61 YSFGILLLEMFTG------LRPNNGMFK 82
+S GI +E+ G L P +FK
Sbjct: 181 WSLGITAIELAEGKPPYSELPPMKALFK 208
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 7/80 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP----VETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+KPSN+ ++ + + DFGI++ L +F+ GT+ Y++PE G S
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSPERIQGESYSY 179
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D++S G+ LLE G P
Sbjct: 180 AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 39/169 (23%)
Query: 202 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGA-----RSFKSECKAAINIRHRNIVR 255
L+G+G+FGSVY G L DG AVK +L G + + E ++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 256 VFTAVSGVDYQG-ARFKAVVYKFM---PNGSLEEWLHGK----DDTHWRLLNFDFLIKKK 307
Y G R + +Y F+ P GSL + L K + RL L+
Sbjct: 67 ---------YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILL--- 113
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L+YLH H ++K +N+L+D + + DF MA+
Sbjct: 114 ---------GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 32/185 (17%)
Query: 201 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+IG G FG V G L +A+K R F +E H NI+R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 256 ---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
V T V ++ ++M NGSL+++L D F + + + +
Sbjct: 70 LEGVVTKSRPV--------MIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLR 113
Query: 313 DVARALKYL--HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD-EQTRFIG 369
+A +KYL H +L N+L++ ++ V DF ++R L D++ T G
Sbjct: 114 GIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 370 KLNVR 374
K+ +R
Sbjct: 169 KIPIR 173
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 38/166 (22%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+GAG FG V+ G T +A+K ++ G +F +E ++H +VR++ V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+ ++ ++M NGSL ++L + I K +D+A +A + +
Sbjct: 71 TQEPIY------IITEYMENGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAF 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
+ + H +L+ +N+L+ + + + DF +AR + D + R
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APEYGMGSEVS 55
H DL N + + + + DFG++R + + G + APE + +
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDY--YRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 56 SYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+SFG+LL E+FT G +P GM
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 35/178 (19%)
Query: 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNL-IRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G+ G VY G A+K ++ + E K + +V+ +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY--- 65
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL--------DIAI 312
G Y+ ++V ++M GSL + L+KK IA
Sbjct: 66 -GAFYKEGEI-SIVLEYMDGGSLAD-----------------LLKKVGKIPEPVLAYIAR 106
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR-FIG 369
+ + L YLH I H ++KPSN+L++ + + DF +++ L +T +Q F+G
Sbjct: 107 QILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG 162
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 27/77 (35%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H D+K N+FLD +GD G+A+ L T+F + + GT Y++PE + D
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSD 183
Query: 60 VYSFGILLLEMFTGLRP 76
V++ G++L E TG P
Sbjct: 184 VWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 203 IGAGNFGSV----YNGTLFDGTTIAVKVFNLIRPGGAR---SFKSECKAAINIRHRNIVR 255
+G G+FG V Y+ DGT V V L R G + +K E + H NIV+
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
S QG + ++ +++P GSL ++L +LL F A +
Sbjct: 71 YKGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF----------AQQIC 117
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
+ YLH H +L NVLLD++ + +GDF +A+ +P+ E R
Sbjct: 118 EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 165
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+GAG FG V+ T T +AVK ++PG +F +E ++H +V++ V
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+ ++ +FM GSL ++L + + L K +D + +A + +
Sbjct: 71 TKEPIY------IITEFMAKGSLLDFLKSDEGSKQPL-------PKLIDFSAQIAEGMAF 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+ Q H +L+ +N+L+ ++ + DF +AR + D + R K ++
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 30/87 (34%), Positives = 40/87 (45%), Gaps = 1/87 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLK +N+ L +GD GI++ L + +GT Y+APE G S D+
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNL 87
+S G LL EM T P DL
Sbjct: 185 WSLGCLLYEMATFAPPFEARSMQDLRY 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 7/78 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+K SN+ ++++ L DFG+AR + + + T+ Y PE +G+ YG
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT--RYG 180
Query: 59 ---DVYSFGILLLEMFTG 73
D++S G +L E+F G
Sbjct: 181 PEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 3e-08
Identities = 29/76 (38%), Positives = 44/76 (57%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ + L DFG+AR +P+ T + + T+ Y APE +GS+ S
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSKHYSTA 179
Query: 59 -DVYSFGILLLEMFTG 73
D++S G + EM TG
Sbjct: 180 VDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+FL LGDFGI++ L E S + V+GT Y++PE G + + D
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLV 91
+++ G +L E+ T R F N NLV
Sbjct: 184 IWALGCVLYELLTLKR----TFDAT-NPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 30/77 (38%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ L DFG+AR +PV T +V+ T+ Y AP+ +GS S
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 59 -DVYSFGILLLEMFTGL 74
D++S G ++ EM TG
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 31/77 (40%), Positives = 37/77 (48%), Gaps = 6/77 (7%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGD 59
DLKP N+ LD L DFG A+ L +F GT YVAPE + D
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGYDFSVD 174
Query: 60 VYSFGILLLEMFTGLRP 76
+S GILL E+ TG P
Sbjct: 175 YWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 1/76 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KPSN+ ++ L DFG++ L V + +GT Y+APE G++ S D+
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 61 YSFGILLLEMFTGLRP 76
+S G+ L+E+ TG P
Sbjct: 183 WSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 27/74 (36%), Positives = 38/74 (51%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
DLKP N+ LDD + D G+A +P + +GT+GY+APE + D ++
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 186
Query: 63 FGILLLEMFTGLRP 76
G LL EM G P
Sbjct: 187 LGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K +N+ + L DFG+A L V V+GT ++APE S S+ D
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASD 181
Query: 60 VYSFGILLLEMFTG------LRPNNGMFK 82
++S G ++E+ TG L P +F+
Sbjct: 182 IWSLGCTVIELLTGNPPYYDLNPMAALFR 210
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + + + + DFG++R L + + G I ++APE + +S
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFG+LL E+FT G +P GM
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 8/91 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APEYGMGSEVS 55
H DL N + +++ + DFG++R + + T G + APE +
Sbjct: 128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY--YRKKTGGKLPIRWMAPESLKDGIFT 185
Query: 56 SYGDVYSFGILLLEMFT-GLRPNNGMFKDDL 85
S DV+SFG+LL E+FT G P G+ +++
Sbjct: 186 SKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 1/83 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KPSN+ ++ L DFG++ L V + +GT Y+APE G + + DV
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 61 YSFGILLLEMFTGLRPNNGMFKD 83
+S GI +E+ G P + K+
Sbjct: 177 WSLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 40/183 (21%)
Query: 197 FSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNI 253
+ +LIG G FG VY G L G +A+K +L I+ +S E N++H NI
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKK-----KL 308
V+ + + + ++ ++ NGSL + +IKK +
Sbjct: 62 VKYIGS-----IETSDSLYIILEYAENGSLRQ-----------------IIKKFGPFPES 99
Query: 309 DIAIDVA---RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDE 363
+A+ V + L YLH + + H ++K +N+L + G V DF +A L D +
Sbjct: 100 LVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKD--GVVKLADFGVATKLNDVSK 154
Query: 364 QTR 366
Sbjct: 155 DDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 56/193 (29%), Positives = 84/193 (43%), Gaps = 34/193 (17%)
Query: 201 NLIGAGNFGSVYNGTLFD----GT---TIAVKVFNLIRPGGARSFKSE--CKAAI--NIR 249
N +G+G FG VY GT D G+ +AVK +R G K E +A + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT---LRKGATDQEKKEFLKEAHLMSNFN 57
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG--KDDTHWRLLNFDFLIKKK 307
H NIV++ + Q ++ + M G L +L + LL +K+
Sbjct: 58 HPNIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLT----LKEL 108
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL-----DDEMIGHVGDFSMARFLPDTD 362
LDI +DVA+ YL Q H +L N L+ D + + +GDF +AR + +D
Sbjct: 109 LDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165
Query: 363 -EQTRFIGKLNVR 374
+ G L VR
Sbjct: 166 YYRKEGEGLLPVR 178
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 1 HCDLKPSNVFLDD-EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H DLK N+ LD +M +GDFGI++ L ++ V+GT Y++PE G + D
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSD 183
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLV 91
+++ G +L E+ + R NLP LV
Sbjct: 184 IWALGCVLYELASLKRAFEAA-----NLPALV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 28/101 (27%), Positives = 41/101 (40%), Gaps = 21/101 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV---------------------MG 39
H DLKP N+ LD +M + DFG A+ L +S +G
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184
Query: 40 TIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80
T YV+PE D+++ G ++ +M TG P G
Sbjct: 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 29/83 (34%), Positives = 44/83 (53%), Gaps = 3/83 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG--TIGYVAPEYGMGSEVSSYG 58
H DL N + + + + DFG++R L + + G I ++APE + +S
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKS 185
Query: 59 DVYSFGILLLEMFT-GLRPNNGM 80
DV+SFG+LL E+FT G P GM
Sbjct: 186 DVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 41/185 (22%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAIN-------IRHRN 252
IG G+FG VY DG +K +L + + E + A+N + H N
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDL-----SNMSEKEREDALNEVKILKKLNHPN 60
Query: 253 IVRVFTAVSGVDYQGARFKA-----VVYKFMPNGSLEEWLH--GKDDTHWRLLNFDFLIK 305
I++ + F+ +V ++ G L + + K+ F +
Sbjct: 61 IIKYY----------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP-------FPEE 103
Query: 306 KKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
+ LD + + ALKYLH +I H ++KP N+ L + +GDF +++ L T +
Sbjct: 104 QILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160
Query: 366 R-FIG 369
+ +G
Sbjct: 161 KTVVG 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 27/171 (15%)
Query: 202 LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGARSFKSECKAAINI---RHRNIVR 255
L+G+G FG+V+ G D I V + + G ++F+ + + H IVR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDT--HWRLLNFDFLIKKKLDIAID 313
+ G Q +V + P GSL + + D+ RLLN+ +
Sbjct: 74 LLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----------CVQ 117
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364
+A+ + YL + R+ H NL N+LL + I + DF +A L D++
Sbjct: 118 IAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 11/84 (13%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLP--------VETSFIDVMGTIGYVAPEYG 49
H DLKP N+ + A + DFGI LP T +V+GT Y APE
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
Query: 50 MGSEVSSYGDVYSFGILLLEMFTG 73
G V+ D+Y++G++ LE TG
Sbjct: 162 RGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 203 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG V+ + D +AVK + F+ E + N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKD-----DTHWRLLNFDFLIKKKLD 309
+ GV G +V+++M +G L ++L HG D D R + + + L
Sbjct: 73 Y----GVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
IA +A + YL H +L N L+ ++ +GDF M+R + TD
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLKP N+ LD+E L DFG+++ + E GT+ Y+APE + D +
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 182
Query: 62 SFGILLLEMFTGLRPNNG 79
SFG+L+ EM TG P G
Sbjct: 183 SFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 34/86 (39%), Positives = 46/86 (53%), Gaps = 14/86 (16%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL---------PVETSFIDVMGTIGYVAPEYGMG 51
H DLKPSN+ L+ + L DFG+AR L PV T ++ T Y APE +G
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV---ATRWYRAPEILLG 186
Query: 52 SEVSSYG-DVYSFGILLLEMFTGLRP 76
S + G D++S G +L EM G +P
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLG-KP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGDVY 61
DLKP N+ LD + L DFG+ + + + GT Y+APE +G + D +
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWW 177
Query: 62 SFGILLLEMFTGLRP-----NNGMFKDDLNLPNLVKSALPARAEQIL 103
+ G+LL EM TGL P N M++ L P A+ +L
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLL 224
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 26/181 (14%)
Query: 202 LIGAGNFGSVYNGTLF-DGTTI----AVKVFN-LIRPGGARSFKSECKAAINIRHRNIVR 255
++G+G FG+VY G +G T+ A+K+ N P F E ++ H ++VR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLH-GKDDTHWRLLNFDFLIKKKLDIAIDV 314
+ Q +V + MP+G L +++H KD+ +LL L+ + +
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL---------LNWCVQI 118
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP-DTDEQTRFIGKLNV 373
A+ + YL + R+ H +L NVL+ + DF +AR L D E GK+ +
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 374 R 374
+
Sbjct: 176 K 176
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM----GTIGYVAPEYGMGSEVSS 56
H DL N+ ++ E +GDFG+ + LP + + V I + APE S+ S
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV 190
Query: 57 YGDVYSFGILLLEMFT 72
DV+SFG++L E+FT
Sbjct: 191 ASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI-DVMGTIGYVAPEYGMGSEVSSYGD 59
H D+KP+NVF+ LGD G+ RF +T+ ++GT Y++PE + + D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
++S G LL EM P + D +NL +L K
Sbjct: 189 IWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 43/151 (28%), Positives = 63/151 (41%), Gaps = 37/151 (24%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVSSY 57
DLKP N+ LD + L DFG+ + E+ + GTI Y+APE M S
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA 180
Query: 58 GDVYSFGILLLEMFTGLRPNNG---------MFKDDLNLP--------NLVKSAL----- 95
D +S G L+ +M TG P + K LNLP +L+K L
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240
Query: 96 ------PARAEQILDVAFFQEIEEEETLYKK 120
P A ++ FF+ + ++ L +K
Sbjct: 241 SRLGAGPGDAAEVQSHPFFRHVNWDDLLARK 271
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI-DVMGTIGYVAPEYGMGSEVSSYGD 59
H D+KP+NVF+ LGD G+ RF +T+ ++GT Y++PE + + D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
++S G LL EM P G D +NL +L K
Sbjct: 189 IWSLGCLLYEMAALQSPFYG---DKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 1/84 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARF-LPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLK NV LD + + DFG+ + + E GT Y+APE G + + D +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180
Query: 62 SFGILLLEMFTGLRPNNGMFKDDL 85
SFG+LL EM G P +G +D+L
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 5/79 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR-F-LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ +D E L DFG+AR F +PV T +V+ T+ Y APE +GS S
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 59 -DVYSFGILLLEMFTGLRP 76
D++S G + EM RP
Sbjct: 181 VDIWSIGCIFAEMVNR-RP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 11/81 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVS 55
H D+KPSN+ ++ L DFG++ L ID M GT Y++PE G+ +
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYT 176
Query: 56 SYGDVYSFGILLLEMFTGLRP 76
D++S G+ L+EM G P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 23/175 (13%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARS--FKSECKAAINIRHRNIVRVFTAV 260
+G G FG V G +A+K +I+ G F E K + + H +V+++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+ R +V ++M NG L +L R F + L++ DV + Y
Sbjct: 69 TK-----QRPIYIVTEYMSNGCLLNYL--------REHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG-KLNVR 374
L + H +L N L+DD+ V DF ++R++ D DE T +G K VR
Sbjct: 116 LE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 25/71 (35%), Positives = 38/71 (53%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ + L DFG+AR + + V+ T+ Y APE + S ++ D+
Sbjct: 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDM 190
Query: 61 YSFGILLLEMF 71
+S G + EMF
Sbjct: 191 WSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 29/179 (16%)
Query: 202 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGG-----ARSFKSECKAAINIRHRN 252
+IGAG FG V G L +A+K G R F SE H N
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK----SGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
I+ + V+ +R ++ +FM NG+L+ +L R + F + + + +
Sbjct: 67 IIHLEGVVTK-----SRPVMIITEFMENGALDSFL--------RQNDGQFTVIQLVGMLR 113
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKL 371
+A +KYL + H +L N+L++ ++ V DF ++RFL D + L
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ E L DFG+AR +PV T +V+ T+ Y APE +G + S
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTA 181
Query: 59 -DVYSFGILLLEMFT 72
D++S G + EM T
Sbjct: 182 VDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 16/87 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--------PVETSFIDVMGTIGYVAPEYGMGS 52
H D+K N+ L ++ + + DFG++ L V +F+ GT ++APE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV---GTPCWMAPE--VME 179
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRP 76
+V Y D++SFGI +E+ TG P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 28/77 (36%), Positives = 38/77 (49%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
DLKP N+ LDD + D G+A +P S +GT+GY+APE + D +
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWG 186
Query: 63 FGILLLEMFTGLRPNNG 79
G L+ EM G P G
Sbjct: 187 LGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ + + + DFG+AR E + V+ T+ Y APE + S ++ D+
Sbjct: 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDM 189
Query: 61 YSFGILLLEMFTGLRP 76
+S G + E+F RP
Sbjct: 190 WSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 28/169 (16%)
Query: 202 LIGAGNFGSVYNGTLF-DGTTIAVKVFN---LIRPGGARSFKSECKAAIN--IRHRNIVR 255
+IG G+F +V A+K+ + LI+ + K E K + H I++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLNGHPGIIK 66
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
++ +Q V ++ PNG L +++ + + D + A ++
Sbjct: 67 LYYT-----FQDEENLYFVLEYAPNGELLQYIR-------KYGSLDEKCTRF--YAAEIL 112
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTD 362
AL+YLH I H +LKP N+LLD +M H+ DF A+ L
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNS 156
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI-DVMGTIGYVAPEYGMGSEVSSYGD 59
H D+KP+NVF+ LGD G+ RF +T+ ++GT Y++PE + + D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNL 90
++S G LL EM P + D +NL +L
Sbjct: 189 IWSLGCLLYEMAALQSP---FYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 28/86 (32%), Positives = 45/86 (52%), Gaps = 14/86 (16%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL-----PVETSFIDVMGTIGYVAPE-----YGM 50
H D+KPSN+ ++ + DFG++R L P +S +GTI Y++PE
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYMSPERINTDLNH 246
Query: 51 GSEVSSYGDVYSFGILLLEMFTGLRP 76
G+ GD++S G+ +LE + G P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 18/170 (10%)
Query: 203 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG V+ + D +AVK + F E + N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLN--FDFLIKKKLDIAI 312
+ GV +G +V+++M +G L ++L HG D N + + L IA
Sbjct: 73 Y----GVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+A + YL H +L N L+ + ++ +GDF M+R + TD
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 9/88 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---------DVMGTIGYVAPEYGMG 51
H DLKP N+ +D L DFG+++ V ++GT Y+APE +G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRPNNG 79
S D +S G +L E G+ P +G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 22/75 (29%), Positives = 45/75 (60%), Gaps = 4/75 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N +DD+ + DFG++R++ ++ + +G+ + + PE + S+ SS
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 58 GDVYSFGILLLEMFT 72
DV++FG+L+ E+++
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 31/86 (36%), Positives = 39/86 (45%), Gaps = 16/86 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM------GTIGYVAPE-YGMGSE 53
H D+KPSN+ LD L DFGI+ L +D G Y+APE
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRL------VDSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 54 VSSY---GDVYSFGILLLEMFTGLRP 76
Y DV+S GI L+E+ TG P
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 31/84 (36%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL NV + + + DFG+AR + E + G I + APE + + S
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 30/81 (37%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
D+KP NV LDD+ L D G+A L + GT GY+APE S D ++
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 63 FGILLLEMFTGLRPNNGMFKD 83
G + EM G P FKD
Sbjct: 180 MGCSIYEMVAGRTP----FKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 26/74 (35%), Positives = 38/74 (51%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
DLKP N+ LDD + D G+A +P + +GT+GY+APE + + D +
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWG 186
Query: 63 FGILLLEMFTGLRP 76
G L+ EM G P
Sbjct: 187 LGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL+ +N+ + + + + DFG+AR + + + G I + APE + +
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 30/75 (40%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ +D++ L DFG+AR +PV +V+ T+ Y APE +GS S
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182
Query: 59 -DVYSFGILLLEMFT 72
D++S G + EM T
Sbjct: 183 VDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 33/88 (37%), Positives = 45/88 (51%), Gaps = 9/88 (10%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-----VMGTIGYVAPEYGMGSEVSSY 57
DLK NV LD + + DFG+ + E F D GT Y+APE G + +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDL 85
D +SFG+LL EM G P +G +D+L
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (120), Expect = 1e-06
Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 13/82 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------APEYGMGSEV 54
H DLKPSN+ ++ + DFG+AR + + + T YV APE + S
Sbjct: 126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-T-EYVVTRWYRAPELLLSS-- 181
Query: 55 SSYG---DVYSFGILLLEMFTG 73
S Y D++S G + E+ T
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 20/161 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVR 255
+IG G+FG VY+GTL D AVK N I F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL- 59
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
++ G+ VV +M +G L ++ + +TH + +K + + VA
Sbjct: 60 ---SLLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETH------NPTVKDLIGFGLQVA 108
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
+ ++YL + H +L N +LD+ V DF +AR
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 31/88 (35%), Positives = 41/88 (46%), Gaps = 18/88 (20%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE------YGMGSEVSS 56
DLKP N+ LD + + DFG A+ + T + GT Y+APE YG
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL--CGTPEYLAPEIILSKGYGKAV---- 179
Query: 57 YGDVYSFGILLLEMFTGLRPNNGMFKDD 84
D ++ GIL+ EM G P F DD
Sbjct: 180 --DWWALGILIYEMLAGYPP----FFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL+ +N+ + D + + DFG+AR + + + G I + APE + +
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL+ +N+ + D + + DFG+AR + + + G I + APE + +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 27/75 (36%), Positives = 41/75 (54%), Gaps = 2/75 (2%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-DVY 61
DLKP N+ LDD + D G+A +P + +GT+GY+APE + +E ++ D +
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV-VKNERYTFSPDWW 185
Query: 62 SFGILLLEMFTGLRP 76
G L+ EM G P
Sbjct: 186 GLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 8/81 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ + + L DFG AR L + D + T Y APE +G ++YG
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD--TNYG 180
Query: 59 ---DVYSFGILLLEMFTGLRP 76
DV++ G ++ E+ G P
Sbjct: 181 KPVDVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 25/71 (35%), Positives = 38/71 (53%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ + L DFG+AR + + V+ T+ Y APE + S ++ D+
Sbjct: 133 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 192
Query: 61 YSFGILLLEMF 71
+S G + EMF
Sbjct: 193 WSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 26/175 (14%)
Query: 203 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG V+ D +AVK + F+ E + ++H++IVR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLN-------FDFLIKKK 307
+ GV +G R +V+++M +G L +L HG D ++L + +
Sbjct: 73 Y----GVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDA---KILAGGEDVAPGQLTLGQM 124
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
L IA +A + YL H +L N L+ ++ +GDF M+R + TD
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+ L++E A L DFG++ L + + V+GT ++APE ++ D
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 60 VYSFGILLLEMFTG------LRPNNGMF 81
++S GI +EM G + P +F
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAIF 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 27/78 (34%), Positives = 40/78 (51%), Gaps = 3/78 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H DLKP N+ ++ E L DFG+AR F + + T Y APE +G + S
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G + E+ + RP
Sbjct: 181 DIWSVGCIFAELLSR-RP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 21/163 (12%)
Query: 201 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGAR--SFKSECKAAINIRHRNIVRVF 257
+ +G G +G VY G T+AVK ++ F E I+H N+V++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
GV + F ++ +FM G+L ++L + +N L L +A ++ A
Sbjct: 69 ----GVCTREPPF-YIITEFMTYGNLLDYLRECNRQ---EVNAVVL----LYMATQISSA 116
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
++YL + H +L N L+ + + V DF ++R +
Sbjct: 117 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 1/84 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLK N+ LD + + DFG+ + + + GT Y+APE +G + ++ D +
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 62 SFGILLLEMFTGLRPNNGMFKDDL 85
SFG+LL EM G P +G +++L
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N+ + + + + DFG+AR + + + G I + APE +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 185 SDVWSFGILLTEIVTYGRVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 32/85 (37%), Positives = 43/85 (50%), Gaps = 9/85 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR------FLPVETSFIDVMGTIGYVAPEYGMGSEV 54
H DLK +N+FL LGDFG ++ L V +SF GT Y+APE
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC---GTPYYLAPELWERKRY 248
Query: 55 SSYGDVYSFGILLLEMFTGLRPNNG 79
S D++S G++L E+ T RP G
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL NV L + A + DFG+++ L + ++ + + APE + SS
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFG+L+ E F+ G +P GM
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGS-EVSSYG 58
H DLKP N+ ++++ L DFG+AR V T ++ + + T+ Y P+ +GS E S+
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 59 DVYSFGILLLEMFTGLRPNNGMF-----KDDLNL 87
D++ G +L EM TG RP MF K++L+L
Sbjct: 186 DMWGVGCILYEMATG-RP---MFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KPSN+ ++ L DFG++ L + SF+ GT Y++PE G+ S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQS 183
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G+ L+EM G P
Sbjct: 184 DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 29/74 (39%), Positives = 42/74 (56%), Gaps = 3/74 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+K N+FL + T LGDFGIAR L VE + +GT Y++PE ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRPYNNKS 182
Query: 59 DVYSFGILLLEMFT 72
D+++ G +L EM T
Sbjct: 183 DIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/78 (38%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ + L DFG AR L P E + D + T Y APE +G + YG
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGD--TKYG 179
Query: 59 ---DVYSFGILLLEMFTG 73
D+++ G L+ EM TG
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + ++ + DFG+AR++ ++ + GT + + PE S SS
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 58 GDVYSFGILLLEMFTG 73
DV+SFG+L+ E+F+
Sbjct: 182 SDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 27/74 (36%), Positives = 41/74 (55%), Gaps = 6/74 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP--VETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL N+ + ++ A + DFG+AR V+ S + V T APE + SS
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178
Query: 59 DVYSFGILLLEMFT 72
DV+S+G+LL E+F+
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 1/76 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KPSN+ ++ L DFG++ L +++ +GT Y++PE G+ S D+
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185
Query: 61 YSFGILLLEMFTGLRP 76
+S G+ L+E+ G P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 30/81 (37%), Positives = 41/81 (50%), Gaps = 2/81 (2%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDV-MGTIGYVAPEYGMGSEVSSYG 58
H D+K N+FL M A LGDFGIAR L +GT Y++PE ++
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 59 DVYSFGILLLEMFTGLRPNNG 79
D++S G +L E+ T P G
Sbjct: 184 DIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DL P+N+ L ++ + DFG+A+ E+ V+GTI Y PE DV
Sbjct: 137 HRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADV 196
Query: 61 YSFGILLLEMFTGLRP 76
++FG +L +M T L+P
Sbjct: 197 WAFGCILYQMCT-LQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 24/166 (14%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARS---FKSECKAAINIRHRNIVRVFTA 259
+G+G FG V+ G +A+K N GA S F E K + + H +V+++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLY-- 65
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
GV Q + +V +FM NG L +L + L+ D L L + DV ++
Sbjct: 66 --GVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGK----LSKDML----LSMCQDVCEGME 114
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
YL + H +L N L+ + V DF M R++ D DE T
Sbjct: 115 YLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYT 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 35/110 (31%), Positives = 52/110 (47%), Gaps = 11/110 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL NV L + DFG+AR + +++++ V G + ++APE +
Sbjct: 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV-VKGNARLPVKWMAPESIFNCVYTF 222
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKS----ALPARAEQ 101
DV+S+GILL E+F+ G P GM D L+K A P A
Sbjct: 223 ESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGYRMAQPEHAPA 271
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 6/74 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL NV + +++ A + DFG+A+ ++ + V T APE + S+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180
Query: 59 DVYSFGILLLEMFT 72
DV+SFGILL E+++
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 13/85 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR-----FLPVETSFIDVMGTIGYVAPE----YGMG 51
H DLK N+ +D + + DFGI++ + + + + G++ ++APE Y G
Sbjct: 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN--MSMQGSVFWMAPEVIHSYSQG 188
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRP 76
S+ D++S G ++LEMF G RP
Sbjct: 189 --YSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 48/183 (26%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 203 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVR 255
+G G+FG VY G T +A+K N R F +E ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGK--DDTHWRLLNFDFLIKKKLDIAID 313
+ VS G VV + M G L+ +L + + + L L K + +A +
Sbjct: 74 LLGVVS----TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-IQMAAE 127
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGK--L 371
+A + YL + H +L N ++ +++ +GDF M R + +TD R GK L
Sbjct: 128 IADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD-YYRKGGKGLL 183
Query: 372 NVR 374
VR
Sbjct: 184 PVR 186
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 6e-06
Identities = 47/187 (25%), Positives = 73/187 (39%), Gaps = 52/187 (27%)
Query: 203 IGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNI 253
+G G+FG V G L+ A+KV +I+ +E I H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
V++ A +Q +V ++ P G L + K+ + +
Sbjct: 56 VKLHYA-----FQTEEKLYLVLEYAPGGEL-----------------FSHLSKEGRFSEE 93
Query: 314 VAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDE 363
AR AL+YLH I + +LKP N+LLD + GH+ DF +A+ L
Sbjct: 94 RARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDAD--GHIKLTDFGLAKELSSEGS 148
Query: 364 QTR-FIG 369
+T F G
Sbjct: 149 RTNTFCG 155
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KPSN+ ++ L DFG++ L + +F+ GT Y++PE G + +
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGKYTVKS 183
Query: 59 DVYSFGILLLEMFTGLRP 76
DV+S GI ++E+ G P
Sbjct: 184 DVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 26/76 (34%), Positives = 35/76 (46%), Gaps = 12/76 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG----TIGYVAPEYGMGSEVSS 56
H DLKP+N+ + + L DFG+AR S M T Y APE G+
Sbjct: 125 HRDLKPNNLLIASDGVLKLADFGLARSFG---SPNRKMTHQVVTRWYRAPELLFGAR--H 179
Query: 57 YG---DVYSFGILLLE 69
YG D++S G + E
Sbjct: 180 YGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 32/86 (37%), Positives = 43/86 (50%), Gaps = 14/86 (16%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEY----GMGSEVSSYG 58
DLKP N+ LD++ + DFG A+ +P T + GT Y+APE G G V
Sbjct: 143 DLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAV---- 196
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDD 84
D ++ G+LL E G P F DD
Sbjct: 197 DWWTMGVLLYEFIAGYPP----FFDD 218
|
Length = 329 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 25/86 (29%), Positives = 38/86 (44%), Gaps = 25/86 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR--------------FLPVETSFIDVMGTIGYVAP 46
H DL N + +++T +GDFG+ R LPV ++AP
Sbjct: 142 HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-----------WMAP 190
Query: 47 EYGMGSEVSSYGDVYSFGILLLEMFT 72
E ++ DV+SFG++L EM T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 28/169 (16%)
Query: 203 IGAGNFGSVYNGT---LFDGTTIAVKVFNLIRPGGARSFKS---ECKAAINIRHRNIVRV 256
+G+G FG+VY G + I V + L ++ K E ++ H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDT--HWRLLNFDFLIKKKLDIAIDV 314
Q ++ + MP G L +++ D LLN+ + +
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYVRNHKDNIGSQYLLNW----------CVQI 118
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
A+ + YL + R+ H +L NVL+ + DF +A+ L D DE
Sbjct: 119 AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 32/81 (39%), Positives = 38/81 (46%), Gaps = 7/81 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM--GTIGYVAPEYGMGSEVSSY- 57
H D+KPSN+ LD L DFGI+ L S G Y+APE S Y
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSARDGYD 188
Query: 58 --GDVYSFGILLLEMFTGLRP 76
DV+S GI L E+ TG P
Sbjct: 189 VRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 30/82 (36%), Positives = 40/82 (48%), Gaps = 12/82 (14%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVET----SFIDVMGTIGYVAPEYGMGSEVSSY 57
D+K N+ LD E L DFG+++ FL E SF GTI Y+APE G +
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPEVIRGGS-GGH 185
Query: 58 GDV---YSFGILLLEMFTGLRP 76
+S G+L E+ TG P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 34/86 (39%), Positives = 41/86 (47%), Gaps = 14/86 (16%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEY----GMGSEVSSYG 58
DLKP N+ LD E L DFG A+ L T + GT Y+APE G V
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL--CGTPEYLAPEVIQSKGHNKAV---- 179
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDD 84
D ++ GIL+ EM G P F DD
Sbjct: 180 DWWALGILIYEMLVGYPP----FFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + + DFG+ R++ ++ + G + + PE S+ SS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 58 GDVYSFGILLLEMFT 72
DV+SFG+L+ E+FT
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 27/77 (35%), Positives = 38/77 (49%), Gaps = 1/77 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF-IDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+FL LGDFG AR L ++ +GT YV PE ++ D
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSD 182
Query: 60 VYSFGILLLEMFTGLRP 76
++S G +L E+ T P
Sbjct: 183 IWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 44/167 (26%), Positives = 66/167 (39%), Gaps = 24/167 (14%)
Query: 203 IGAGNFGSVYNGTLF--DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVF 257
+G GNFGSV G G + V V L + G + F E + H IVR+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
GV +G +V + P G L ++L + + + ++A VA
Sbjct: 63 ----GV-CKGEPL-MLVMELAPLGPLLKYLKKRREIP---------VSDLKELAHQVAMG 107
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL-PDTDE 363
+ YL H +L NVLL + + DF M+R L +D
Sbjct: 108 MAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 2/74 (2%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
DLKP N+ LD + + DFG A+ V+T + GT Y+APE + D ++
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWT 213
Query: 63 FGILLLEMFTGLRP 76
GI + E+ G P
Sbjct: 214 LGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 25/75 (33%), Positives = 36/75 (48%), Gaps = 1/75 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIA-RFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLKP NV LD++ + D G+A ++ GT G++APE G E D +
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYF 181
Query: 62 SFGILLLEMFTGLRP 76
+ G+ L EM P
Sbjct: 182 ALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 11/87 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPE---YGMGSEV 54
H DL+ +N+ + + + + DFG+AR + + + G I + APE YG +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 55 SSYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+SFGILL E+ T G P GM
Sbjct: 184 S---DVWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 32/166 (19%)
Query: 203 IGAGNFGSVYNG-TLFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVR---- 255
IG G +G VY G +A+K + + G + E K +RH NIVR
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 256 VFTAVSGVDYQGARFKAVVYKFMP---NGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
V + G Y +V+++M G L+ ++ + +K+ L
Sbjct: 67 VTSKGKGSIY-------MVFEYMDHDLTGLLDSPEVKFTESQIK-----CYMKQLL---- 110
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
L+YLH I H ++K SN+L++++ + + DF +AR
Sbjct: 111 ---EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H D+ NV L D A + DFG+AR + +++++ V G + ++APE +
Sbjct: 235 HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNARLPVKWMAPESIFDCVYTV 293
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKD 83
DV+S+GILL E+F+ G P G+ +
Sbjct: 294 QSDVWSYGILLWEIFSLGKSPYPGILVN 321
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 27/169 (15%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVR---V 256
IG G G V+ G T+A+K L R G E KA +H +V+ V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
F SG +V ++MP L E L ++ +K + +
Sbjct: 68 FPHGSGF--------VLVMEYMP-SDLSEVLRDEERPLPEAQ-----VKS---YMRMLLK 110
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR-FLPDTDEQ 364
+ Y+H I H +LKP+N+L+ + + + DF +AR F +
Sbjct: 111 GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA-RFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K +NV L ++ L DFG+A + + +GT ++APE S S D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 60 VYSFGILLLEMFTGLRPNNGM 80
++S GI +E+ G PN+ M
Sbjct: 184 IWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 28/70 (40%), Positives = 38/70 (54%), Gaps = 1/70 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KPSN+ L + L DFG++ L V + GT Y+APE G S DV
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERIQGKPYSITSDV 186
Query: 61 YSFGILLLEM 70
+S G+ LLE+
Sbjct: 187 WSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 45/186 (24%), Positives = 64/186 (34%), Gaps = 55/186 (29%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFN-----------LIRPGGARSFKSECKAAINIRH 250
IG G+FG+V DG + K + L+ SE ++H
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---------SEVNILRELKH 58
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK--- 307
NIVR + D R +Y M E+ G D L LI+K
Sbjct: 59 PNIVRYY------DRIIDRSNQTLYIVM------EYCEGGD-----LAQ---LIQKCKKE 98
Query: 308 ---------LDIAIDVARALKYLH--CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
I + AL H D + H +LKP+N+ LD +GDF +A+
Sbjct: 99 RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
Query: 357 FLPDTD 362
L
Sbjct: 159 ILGHDS 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 31/83 (37%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV----MGTIGYVAPEYGMGSEVSS 56
H D+K +N+ L LGDFG ++ S DV GT YVAPE S
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSK 224
Query: 57 YGDVYSFGILLLEMFTGLRPNNG 79
D++S G+LL E+ T RP +G
Sbjct: 225 KADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 34/84 (40%), Positives = 43/84 (51%), Gaps = 17/84 (20%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVET----SFIDVMGTIGYVAPEY-----GMGS 52
D+K N+ LD E L DFG+++ FL E SF GTI Y+APE G G
Sbjct: 130 DIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYMAPEIIRGKGGHGK 186
Query: 53 EVSSYGDVYSFGILLLEMFTGLRP 76
V D +S GIL+ E+ TG P
Sbjct: 187 AV----DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 36/96 (37%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 1 HCDLKPSNVFLDDEMTA-HLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGS-EVSS 56
H DLKP N+ +D A L DFG+AR +PV T +V+ T+ Y APE +GS S+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYST 183
Query: 57 YGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
D++S G + EM +P +F D + L K
Sbjct: 184 PVDIWSVGCIFAEMVNQ-KP---LFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 27/77 (35%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL-PVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+KP N+ + + L DFG AR L + D + T Y APE +G + YG
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD--TQYGP 180
Query: 59 --DVYSFGILLLEMFTG 73
DV++ G + E+ TG
Sbjct: 181 PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 7/92 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL------PVETSFIDVMGTIGYVAPEYGMGSEV 54
H DL N+ ++ + + DFG++RFL P TS + I + APE +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 55 SSYGDVYSFGILLLE-MFTGLRPNNGMFKDDL 85
+S DV+S+GI++ E M G RP M D+
Sbjct: 189 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 29/79 (36%), Positives = 46/79 (58%), Gaps = 5/79 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGS-EVSSY 57
H DLKP N+ +++ L DFG+AR +P +T +V+ T+ Y P+ +GS + S+
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 58 GDVYSFGILLLEMFTGLRP 76
D++ G + EM TG RP
Sbjct: 186 IDMWGVGCIFYEMSTG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 28/82 (34%), Positives = 45/82 (54%), Gaps = 2/82 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGS-EVSSYG 58
H DLKP N+ + D L DFG+AR V + ++ + + T+ Y P+ +GS E S+
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL 185
Query: 59 DVYSFGILLLEMFTGLRPNNGM 80
D++ G + +EM G+ GM
Sbjct: 186 DMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 27/182 (14%)
Query: 202 LIGAGNFGSVYNGTL-FDG---TTIAVKVFNL-IRPGGARSFKSECKAAINIRHRNIVRV 256
+IGAG FG V +G L G +A+K R F SE H NI+ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 257 FTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
V+ + K V V ++M NGSL+ +L K D F + + + + +
Sbjct: 71 EGVVT-------KSKPVMIVTEYMENGSLDAFLR-KHDGQ-------FTVIQLVGMLRGI 115
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--TRFIGKLN 372
A +KYL H +L N+L++ ++ V DF ++R L D E T GK+
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172
Query: 373 VR 374
+R
Sbjct: 173 IR 174
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 16/89 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR---FLPVETSFIDVMG------------TIGYVA 45
H DL P+N+F++ + + DFG+AR + P + T+ Y A
Sbjct: 142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRA 201
Query: 46 PEYGMGSEVSSYG-DVYSFGILLLEMFTG 73
PE MG+E + D++S G + E+ TG
Sbjct: 202 PELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 30/163 (18%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHRNIVR-- 255
+G G +G VY G +A+K L S I++ +H NIV+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 256 -VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
V + +V+++ + L D L+ + LIK I +
Sbjct: 65 DVIHTERKL--------YLVFEYC-----DMDLKKYLDKRPGPLSPN-LIKS---IMYQL 107
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
R L Y H RI H +LKP N+L++ + + + DF +AR
Sbjct: 108 LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 25/168 (14%)
Query: 202 LIGAGNFGSVYN--GTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----------- 248
+G+G FG VY +A+K N+ P + + K+ +I
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 249 RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL 308
RH NIVR + + R +V + L E + + R F ++
Sbjct: 67 RHPNIVRYYKTFL----ENDRL-YIVMDLIEGAPLGEHFNSLKEKKQR-----FTEERIW 116
Query: 309 DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
+I + + AL+YLH + RI H +L P+N++L ++ + DF +A+
Sbjct: 117 NIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 7/78 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP+N+ + + + DFG+AR + + T Y APE G+ Y
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR--KYD 179
Query: 59 ---DVYSFGILLLEMFTG 73
D+++ G + E+ G
Sbjct: 180 PGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGS-EVSSY 57
H DLKP N+ + L DFG+AR +P +T +V+ T+ Y P+ +G+ + SS
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 58 GDVYSFGILLLEMFTG 73
D++ G + +EM G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 25/73 (34%), Positives = 36/73 (49%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 200
Query: 61 YSFGILLLEMFTG 73
+S G ++ EM G
Sbjct: 201 WSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 5/98 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL NV L + DFG+AR + +++++ T + ++APE + ++
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSA 94
DV+S+GILL E+F+ G P GM D N +KS
Sbjct: 320 SDVWSYGILLWEIFSLGGTPYPGMIVDS-TFYNKIKSG 356
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 30/79 (37%), Positives = 45/79 (56%), Gaps = 5/79 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGS-EVSSY 57
H DLKP N+ + + L DFG+AR +P +T +V+ T+ Y P+ +GS E S+
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTS 184
Query: 58 GDVYSFGILLLEMFTGLRP 76
D++ G + EM TG RP
Sbjct: 185 LDMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 11/95 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+K SN+ L+++ L DFG+AR E S + + + T+ Y PE +G E YG
Sbjct: 139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE--RYG 196
Query: 59 ---DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNL 90
DV+S G +L E+FT +P +F+ + L L
Sbjct: 197 PAIDVWSCGCILGELFTK-KP---IFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 26/75 (34%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-YGMGSEVSSYGDVY 61
DLKP+N+ LD+ + D G+A + V GT GY+APE G+ S D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSADWF 180
Query: 62 SFGILLLEMFTGLRP 76
S G +L ++ G P
Sbjct: 181 SLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 29/172 (16%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGA-----RSFKSECKAAINIRHRNIV 254
+G G + VY G +A+K L A + E K ++H NI+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 255 R---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311
VF S ++ +V++FM LE+ + D L D IK
Sbjct: 66 GLLDVFGHKSNIN--------LVFEFME-TDLEKVI---KDKSIVLTPAD--IKS---YM 108
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ R L+YLH I H +LKP+N+L+ + + + DF +AR +
Sbjct: 109 LMTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 26/75 (34%), Positives = 43/75 (57%), Gaps = 3/75 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL NV + + + DFG+AR + ++++I T + ++APE + ++
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL 321
Query: 58 GDVYSFGILLLEMFT 72
DV+SFGILL E+FT
Sbjct: 322 SDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 31/88 (35%), Positives = 41/88 (46%), Gaps = 9/88 (10%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVSSY 57
DLK NV LD E + DFG+ + E F GT Y+APE
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDL 85
D ++FG+LL EM G P +G +D+L
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 26/78 (33%), Positives = 40/78 (51%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGM-GSEVSSYG 58
H D+K +N+ + + L DFG+A L +S +GT ++APE G +
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S GI + EM TG P
Sbjct: 184 DIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 3/78 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMG-SEVSSYG 58
H DLKP N+ +++ L DFG+AR V T ++ + + T+ Y P+ +G SE S+
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 59 DVYSFGILLLEMFTGLRP 76
D++ G + EM +G RP
Sbjct: 187 DMWGVGCIFFEMASG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
R LKY+H + H +LKPSN+L++++ +GDF MAR
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 25/76 (32%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV----ETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K +N+ D LGDFG ++ L T V GT +++PE G
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186
Query: 57 YGDVYSFGILLLEMFT 72
DV+S G ++EM T
Sbjct: 187 KADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 32/86 (37%), Positives = 41/86 (47%), Gaps = 5/86 (5%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
DLK NV LD E + DFG+ + L V TS GT Y+APE D
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF--CGTPDYIAPEILSYQPYGPAVD 178
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDL 85
++ G+LL EM G P G +D+L
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 203 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGARSFKSECKAAI----NIRHRN 252
+G G+FG V +D G +AVK ++P + ++ K I N+ H N
Sbjct: 12 LGEGHFGKV-ELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
IV+ + + D G ++ +F+P+GSL+E+L ++ L K++L A+
Sbjct: 68 IVK-YKGICTED--GGNGIKLIMEFLPSGSLKEYL-PRNKNKINL-------KQQLKYAV 116
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ + + YL + H +L NVL++ E +GDF + + + E
Sbjct: 117 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 6e-05
Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 1/81 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H D+K +N+ L +E L DFG++ L S + GT ++APE S D
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKAD 180
Query: 60 VYSFGILLLEMFTGLRPNNGM 80
++S GI +E+ G P + +
Sbjct: 181 IWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 13/89 (14%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIG-----YVAPE---YGMGS 52
H DL NV L + A + DFG++R L + + T G + APE YG
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT-TAGRWPLKWYAPECINYG--- 173
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ SS DV+S+G+ L E F+ G +P M
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 39/173 (22%), Positives = 71/173 (41%), Gaps = 32/173 (18%)
Query: 203 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+G G FG VY G L T++A+K + F+ E + +++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL------------HGKDDTHWRLLNFDFL 303
+ + + ++++++ +G L E+L G + L DF
Sbjct: 73 LLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF- 126
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L IAI +A ++YL H +L N L+ + + + DF ++R
Sbjct: 127 ----LHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 23/85 (27%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID---------VMGTIGYVAPEYGMG 51
H D+K +N+ +D++ + DFGI++ +E + + + G++ ++APE
Sbjct: 129 HRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRP 76
+ + D++S G L++EM TG P
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVETS-FIDVMGTIGYVAPEYGMGSEV--SSYG 58
D+K N+ LD L DFG+++ F E GTI Y+AP+ G +
Sbjct: 130 DIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAV 189
Query: 59 DVYSFGILLLEMFTGLRP 76
D +S G+L+ E+ TG P
Sbjct: 190 DWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 20/88 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM------GTIGYVAPEY------ 48
H D+KPSNV ++ L DFGI+ +L +D + G Y+APE
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPERINPELN 180
Query: 49 GMGSEVSSYGDVYSFGILLLEMFTGLRP 76
G +V S DV+S GI ++E+ TG P
Sbjct: 181 QKGYDVKS--DVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 23/95 (24%), Positives = 47/95 (49%), Gaps = 17/95 (17%)
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
++H NIV++ + + ++++++ +L E L W +++
Sbjct: 740 LQHPNIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLRN---LSW---------ERR 782
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342
IAI +A+AL++LHC C P + NL P +++D
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 27/83 (32%), Positives = 38/83 (45%), Gaps = 2/83 (2%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-YGMGSEVSSYGDVY 61
DLKP+N+ LD+ + D G+A + V GT GY+APE G S D +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWF 180
Query: 62 SFGILLLEMFTGLRPNNGMFKDD 84
S G +L ++ G P D
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 19/91 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFID----------------VMGTI 41
H DLKP N+ L + D+G A F +E ID ++GT
Sbjct: 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTP 195
Query: 42 GYVAPEYGMGSEVSSYGDVYSFGILLLEMFT 72
Y+APE +G S D+Y+ G++L +M T
Sbjct: 196 DYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 5/89 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL+ +NV + + + + DFG+AR + + + G I + APE +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDDL 85
DV+SFGILL E+ T G P GM D+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG----TIGYVAPEYGMGSEVSS 56
H DL N + + +GDFG++R + T + V G I ++ PE M + ++
Sbjct: 146 HRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 204
Query: 57 YGDVYSFGILLLEMFT-GLRP 76
DV+SFG++L E+FT G +P
Sbjct: 205 ESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 3/48 (6%)
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ALKY+H + H +LKPSN+LL+ + + DF +AR L + +E
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 37/166 (22%)
Query: 203 IGAGNFGSVYNG-TLFDGTTIAVKVFNL-----------IRPGGARSFKSECKAAINIRH 250
IG G +G VY G +A+K L IR E + H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISLLKELNH 57
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
NIVR+ V + + +V++F+ + L++++ D+ LIK L
Sbjct: 58 PNIVRLLDVV----HSENKL-YLVFEFL-DLDLKKYM----DSSPLTGLDPPLIKSYL-- 105
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
+ + + Y H R+ H +LKP N+L+D E + DF +AR
Sbjct: 106 -YQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/124 (30%), Positives = 49/124 (39%), Gaps = 27/124 (21%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR---FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
DLK NV LD E + DFG+ + + V T GT Y+APE D
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK--TFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYK 119
++FG+LL EM G P G +D+L FQ I E Y
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDEL----------------------FQSIMEHNVAYP 221
Query: 120 KASS 123
K+ S
Sbjct: 222 KSMS 225
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 37/112 (33%), Positives = 51/112 (45%), Gaps = 19/112 (16%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYG 58
DL P+N+ LDD L F R+ VE S ++ M Y APE G SE +
Sbjct: 110 DLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM----YCAPEVGGISEETEAC 163
Query: 59 DVYSFGILLLEMFTGL-----RPNNGMFKDDLNLPNLVKSALPARA--EQIL 103
D +S G +L E+ TG P+ LN+P V AR+ +Q+L
Sbjct: 164 DWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE--EARSLLQQLL 213
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 1/84 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLK NV LD E + DFG+ + V+ + GT Y+APE D +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185
Query: 62 SFGILLLEMFTGLRPNNGMFKDDL 85
++G+LL EM G P +G +D+L
Sbjct: 186 AYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 27/74 (36%), Positives = 40/74 (54%), Gaps = 8/74 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL----PVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLK N+FL + + +GDFG++R L + T+F GT Y++PE S
Sbjct: 129 HRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF---TGTPYYMSPEALKHQGYDS 184
Query: 57 YGDVYSFGILLLEM 70
D++S G +L EM
Sbjct: 185 KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 7/87 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSY 57
H D+K N+F++ LGDFG A F PV+ + + GTI APE
Sbjct: 205 HRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPA 263
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDD 84
D++S GI+L EM T ++ +F+ D
Sbjct: 264 VDIWSAGIVLFEMATC---HDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 27/76 (35%), Positives = 38/76 (50%), Gaps = 3/76 (3%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
DLK NV LD E L D+G+ + P +T+ GT Y+APE G + D
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 61 YSFGILLLEMFTGLRP 76
++ G+L+ EM G P
Sbjct: 180 WALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 39/170 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N+ + +++ + D G++R + + V I ++ PE M + SS
Sbjct: 147 HKDLAARNILIGEQLHVKISDLGLSREI-YSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
D++SFG++L E+F+ GL+P G F E E
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYG----------------------------FSNQEVIE 237
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRS 165
+ K+ C++ +C + + C E P R D+ +RLRS
Sbjct: 238 MVRKRQLLPCSE-----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 51/203 (25%), Positives = 77/203 (37%), Gaps = 51/203 (25%)
Query: 190 LYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINI 248
L D T F +IG G +G VY G +A+K+ ++I + E K NI
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNI 55
Query: 249 -----RHRNIVRVFTAVSGVDYQGARFKAV----------VYKFMPNGSLEEWLHGKDDT 293
H NI + GA K V + GS+ + + G
Sbjct: 56 LRKYSNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG---- 102
Query: 294 HWRLLNFDFLIKKKLDIAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350
L +K++ IA + R L YLH + ++ H ++K N+LL V
Sbjct: 103 ---LRKKGKRLKEEW-IAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKN--AEVK 153
Query: 351 --DFSMARFLPDTDEQTR--FIG 369
DF ++ L D+ R FIG
Sbjct: 154 LVDFGVSAQL-DSTLGRRNTFIG 175
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DL N+ L + + DFG+AR + + ++ D + ++APE +
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDD 84
DV+SFG+LL E+F+ G P G+ D+
Sbjct: 262 SDVWSFGVLLWEIFSLGASPYPGVKIDE 289
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL+ +N+ + + + DFG+AR + + + G I + APE +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL+E+ T G P GM
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 25/81 (30%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG----TIGYVAPEYGMGSEVSS 56
H DL N + + +GDFG++R + T + V G I ++ PE + + ++
Sbjct: 145 HRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMPPESILYRKFTT 203
Query: 57 YGDVYSFGILLLEMFT-GLRP 76
D++SFG++L E+FT G +P
Sbjct: 204 ESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + + + DFG++R + +T + G I + APE ++ S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV++FG+LL E+ T G+ P G+
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGI 209
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 57/211 (27%), Positives = 85/211 (40%), Gaps = 46/211 (21%)
Query: 191 YDATNGFSSANL-----IGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGARSFK-- 239
YD F NL +GAG FG V T + + V V +++P S +
Sbjct: 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAV-KMLKPTAHSSEREA 84
Query: 240 --SECKAAINI-RHRNIVRVFTA--VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDD-- 292
SE K ++ H NIV + A + G V+ ++ G L +L K +
Sbjct: 85 LMSELKIMSHLGNHENIVNLLGACTIGGPIL-------VITEYCCYGDLLNFLRRKRESF 137
Query: 293 -THWRLLNFDFLIKKKLDIAIDVARALKYLHC-DCQPRIAHCNLKPSNVLLDDEMIGHVG 350
T LL+F + VA+ + +L +C H +L NVLL I +
Sbjct: 138 LTLEDLLSFSY----------QVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKIC 183
Query: 351 DFSMARFLPDTDEQTRFIGKLNVRNFVK-MA 380
DF +AR D + ++ K N R VK MA
Sbjct: 184 DFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 37/170 (21%), Positives = 72/170 (42%), Gaps = 39/170 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N + + +T + DFG++R + V + ++ PE + + ++
Sbjct: 147 HRDLAARNCLVGEGLTVKISDFGLSR-DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT 205
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
D++SFG++L E+F+ GL+P G + + ++ R+ Q+L
Sbjct: 206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI------RSRQLL------------ 245
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRS 165
C + +C + + + C E+P R D+ +RLRS
Sbjct: 246 --------PCPE-----DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 24/73 (32%), Positives = 36/73 (49%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 61 YSFGILLLEMFTG 73
+S G ++ E+ G
Sbjct: 206 WSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 31/83 (37%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFG-IARFLPVETSFIDV-MGTIGYVAPEY--GMGSEVSS 56
H D+KP NV LD L DFG R L T +V +GT Y++PE M
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 57 YG---DVYSFGILLLEMFTGLRP 76
YG D +S G+ + EM G P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 39/170 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL NV + D++ + D G+ R + + +MG I +++PE M + S
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREV-YAADYYKLMGNSLLPIRWMSPEAIMYGKFSI 205
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
D++S+G++L E+F+ GL+P G D+ R Q+L
Sbjct: 206 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--------IEMIRNRQVL------------ 245
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRS 165
C +C + + + C E P R D+ SRLR+
Sbjct: 246 --------PCPD-----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGA---RSFKSECKAAINI-RHRNIVR 255
++IG GNFG V + DG + + + R F E + + H NI+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFD--FLI--------- 304
+ A +++G + A+ ++ P+G+L ++L R+L D F I
Sbjct: 73 LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKS-----RVLETDPAFAIANSTASTLS 122
Query: 305 -KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
++ L A DVAR + YL Q + H +L N+L+ + + + DF ++R +
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179
Query: 364 QTRFIGKLNVR 374
+T +G+L VR
Sbjct: 180 KT--MGRLPVR 188
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 17/192 (8%)
Query: 203 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARS----FKSECKAAINIRHRNIVRVF 257
+G G FGSV G L D + + V V + RS F SE H N++R+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 258 -TAVSGVDYQGARFKAVVYKFMPNGSLEEW-LHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ V+ +G V+ FM +G L + L+ + + L L+K D+A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK----FMTDIA 122
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD--EQTRFIGKLNV 373
++YL H +L N +L++ M V DF +++ + + D Q R I K+ V
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR-IAKMPV 178
Query: 374 RNFVKMALSQRV 385
+ +L+ RV
Sbjct: 179 KWIAIESLADRV 190
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 197 FSSANLIGAGNFGSVYNG-TLFDGTTIAVKV--FNLIRPGGARSFKSECKAAINIRHRNI 253
F N IG G +G VY G +A+K + R G S E +N+RH NI
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLN---FDFLIKKKLDI 310
V + V G ++ F+ E+ L LL+ F + +
Sbjct: 69 VELKEVV-----VGKHLDSI---FLVMEYCEQDLA-------SLLDNMPTPFSESQVKCL 113
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
+ + R L+YLH + I H +LK SN+LL D+ + DF +AR
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 45/157 (28%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 203 IGAGNFGSVYNGTL-FDGTTIAVK-VFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG GNFG V++G L D T +AVK + P F E + H NIVR+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI--- 59
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKD-DTHWRLLNFDFLIKKKLDIAIDVARALK 319
GV Q K +Y M E + G D T R +K+ + + + A ++
Sbjct: 60 -GVCTQ----KQPIYIVM------ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME 108
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
YL H +L N L+ ++ + + DF M+R
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 36/173 (20%), Positives = 72/173 (41%), Gaps = 22/173 (12%)
Query: 196 GFSSANLIGAGNFGSVYNGTLFDGTT-----IAVK-VFNLIRPGGARSFKSECKAAINIR 249
+ ++L+ G FG ++ G L D + VK V + E +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL----HGKDDTHWRLLNFDFLIK 305
H+NI+ + V + V+Y +M G+L+ +L G+ + L
Sbjct: 67 HQNIL----PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL--- 119
Query: 306 KKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
+ +AI +A + YLH + + H ++ N ++D+E+ + D +++R L
Sbjct: 120 --VHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGI-ARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K NV L + + L DFG A+ P ++ ++GT ++APE D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 60 VYSFGILLLEMFTGLRP 76
++S GI+ +EM G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 25/76 (32%), Positives = 39/76 (51%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM----GTIGYVAPEYGMGSEVSS 56
H DL NV LD++ +GDFG+A+ +P + V + + A E ++ S
Sbjct: 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY 189
Query: 57 YGDVYSFGILLLEMFT 72
DV+SFG+ L E+ T
Sbjct: 190 ASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 23/76 (30%), Positives = 39/76 (51%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI----DVMGTIGYVAPEYGMGSEVSS 56
H DL NV ++ E +GDFG+ + + + + D+ + + APE + S+
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI 191
Query: 57 YGDVYSFGILLLEMFT 72
DV+SFG+ L E+ T
Sbjct: 192 ASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 10/86 (11%)
Query: 1 HCDLKPSNVFLDDEMTAH---LGDFGIARFLPVETSFID-----VMGTIGYVAPEYGMGS 52
H D+K +N+ +D T + DFG A L + + ++GTI ++APE G
Sbjct: 126 HRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183
Query: 53 EVSSYGDVYSFGILLLEMFTGLRPNN 78
+ DV+S G +++EM T P N
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 27/80 (33%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H DLKP N +D L DFG+++ + S V+G+ Y+APE G D
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS---VVGSPDYMAPEVLRGKGYDFTVD 180
Query: 60 VYSFGILLLEMFTGLRPNNG 79
+S G +L E G P +G
Sbjct: 181 YWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DL N+ L + + DFG+AR + + ++ D + ++APE ++
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ 255
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDD 84
DV+SFG+LL E+F+ G P G+ D+
Sbjct: 256 SDVWSFGVLLWEIFSLGASPYPGVQIDE 283
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 32/108 (29%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLKP N+ LD + L DFG+ + + + GT Y+APE D +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180
Query: 62 SFGILLLEMFTGLRP-----NNGMFKDDLNLPNLVKSALPARAEQILD 104
G +L EM GL P M+ + LN P +K + A +L+
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 27/76 (35%), Positives = 38/76 (50%), Gaps = 3/76 (3%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
DLK NV LD + L D+G+ + P +T+ GT Y+APE G E D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDW 179
Query: 61 YSFGILLLEMFTGLRP 76
++ G+L+ EM G P
Sbjct: 180 WALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA-RFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K +NV L + L DFG+A + + +GT ++APE S S D
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 60 VYSFGILLLEMFTGLRPNN 78
++S GI +E+ G P++
Sbjct: 184 IWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 26/73 (35%), Positives = 35/73 (47%), Gaps = 1/73 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H DLK NVFL +GD GIAR L + + GT Y++PE + D
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSD 184
Query: 60 VYSFGILLLEMFT 72
V++ G + EM T
Sbjct: 185 VWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 28/80 (35%), Positives = 37/80 (46%), Gaps = 10/80 (12%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARF-LPVETSFIDVMGTIGYVAPEY-----GMGSEVSS 56
DLKP N+ LD L DFG+++ L + GT Y+APE G V
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV-- 178
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D +S G+L+ EM G P
Sbjct: 179 --DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 26/80 (32%), Positives = 37/80 (46%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV----ETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K +N+ D LGDFG ++ L T V GT +++PE G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGR 188
Query: 57 YGDVYSFGILLLEMFTGLRP 76
DV+S G ++EM T P
Sbjct: 189 KADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGS-EVSS 56
H DLKP N+ +D + + D G+ R +PV+ S+ + T+ Y APE +GS S+
Sbjct: 133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYST 191
Query: 57 YGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
D++S G + EM +F D L L+
Sbjct: 192 PVDIWSVGCIFAEMSRK----QPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGI-ARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+ L + + L DFG A+ P ++ ++GT ++APE D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 60 VYSFGILLLEMFTGLRP 76
++S GI+ +EM G P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 17/51 (33%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
++ AL+YLH I H ++KP N+LLD++ H+ DF++A +
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + + + DFG+ RF+ ++ + GT + + +PE S+ SS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 58 GDVYSFGILLLEMFT-GLRP----NNGMFKDDLN 86
DV+SFG+L+ E+F+ G P +N + +N
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 43/176 (24%), Positives = 74/176 (42%), Gaps = 49/176 (27%)
Query: 203 IGAGNFGSV----YNGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVR 255
+G G+FG V + G+ G A+K+ + +++ +E + +IRH +V
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
++ + +Q +V +++P G L F L K VA
Sbjct: 66 LYGS-----FQDDSNLYLVMEYVPGGEL----------------FSHLRKSGR-FPEPVA 103
Query: 316 R--------ALKYLH-CDCQPRIAHCNLKPSNVLLDDEMIGH--VGDFSMARFLPD 360
R AL+YLH D I + +LKP N+LLD + G+ + DF A+ +
Sbjct: 104 RFYAAQVVLALEYLHSLD----IVYRDLKPENLLLDSD--GYIKITDFGFAKRVKG 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 41/167 (24%), Positives = 65/167 (38%), Gaps = 40/167 (23%)
Query: 203 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIR---------HRN 252
IG G +G VY G +A+K F+SE +R H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-------KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 253 IVR---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD 309
I++ VF + +V++FM + L + + R L LIK
Sbjct: 60 IIKLLDVFRHKGDL--------YLVFEFM-DTDLYKLI----KDRQRGLPES-LIKS--- 102
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
+ + L + H I H +LKP N+L++ E + + DF +AR
Sbjct: 103 YLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG---TIGYVAPEYGMGSEVSSY 57
H DL NV + + DFG+A+ L V+ G I ++A E + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK 191
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVK 92
DV+S+G+ + E+ T G +P G + +P+L++
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYEG--IPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 2/75 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H DLK SN+ L D+ + DFG+AR + + T+ Y APE +G +
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 59 DVYSFGILLLEMFTG 73
D+++ G +L E+
Sbjct: 191 DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 32/86 (37%), Positives = 39/86 (45%), Gaps = 5/86 (5%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR---FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
DLK NV LD E L DFG+ + F TS GT Y+APE D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS--TFCGTPDYIAPEILQEMLYGPSVD 178
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDL 85
++ G+LL EM G P +DDL
Sbjct: 179 WWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ L DFG+AR +PV +V+ T+ Y P+ G+++ S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180
Query: 59 -DVYSFGILLLEMFTGLRP 76
D++S G + E+ RP
Sbjct: 181 IDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA-RFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K +NV L ++ L DFG+A + + +GT ++APE S D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 60 VYSFGILLLEMFTGLRPNNGM 80
++S GI +E+ G PN+ +
Sbjct: 184 IWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 47/167 (28%), Positives = 64/167 (38%), Gaps = 22/167 (13%)
Query: 201 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNL---IRPGGARSFKSECKAAINIRHRNI 253
+G G FG VY G D + V V L F E H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 254 VRVFTAVSGVDYQG-ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
VR+ GV ++ RF ++ + M G L+ +L R +K L A
Sbjct: 72 VRLI----GVSFERLPRF--ILLELMAGGDLKSFLRENRPRPER--PSSLTMKDLLFCAR 123
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV---GDFSMAR 356
DVA+ KYL + H ++ N LL + G V DF MAR
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 42/204 (20%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTT-IAVKVFNLIRP----- 232
+Q +N K +++ + + + +G+G +GSV FD T + V V L RP
Sbjct: 5 RQELN----KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSII 58
Query: 233 GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDD 292
R+++ E + +++H N++ + F P SLEE+
Sbjct: 59 HAKRTYR-ELRLLKHMKHENVIGLLDV-----------------FTPARSLEEFNDVYLV 100
Query: 293 THWRLLNFDFLIK-KKLD------IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345
TH + + ++K +KL + + R LKY+H I H +LKPSN+ ++++
Sbjct: 101 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 157
Query: 346 IGHVGDFSMARFLPDTDEQTRFIG 369
+ DF +AR DE T ++
Sbjct: 158 ELKILDFGLARH--TDDEMTGYVA 179
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 12/89 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLK N+ L + L DFG++ +FI GT ++APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKD 182
Query: 57 --Y---GDVYSFGILLLEMFTGLRPNNGM 80
Y D++S GI L+E+ P++ +
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 44/170 (25%), Positives = 68/170 (40%), Gaps = 46/170 (27%)
Query: 213 NGTLFD------GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV--SGVD 264
NG +F +AVK L P + E K + H NIV+V+ + SG D
Sbjct: 18 NGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD 77
Query: 265 YQ---GARFK-AVVY-----------KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD 309
G+ + VY + G L E H RL + L
Sbjct: 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE-------EHARLFMYQLL------ 124
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFSMARFL 358
R LKY+H + H +LKP+NV ++ ++++ +GDF +AR +
Sbjct: 125 ------RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP--VETSFIDVMGTIG--YVAPEYGMGSEVSS 56
H DL N+ ++ + + DFG++R L E ++ G I + APE + +S
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 57 YGDVYSFGILLLEMFT-GLRP 76
DV+SFGI++ E+ + G RP
Sbjct: 190 ASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG---TIGYVAPEYGMGSEVSSY 57
H DL N+ ++ + + DFG++R L + G I + APE + +S
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA 188
Query: 58 GDVYSFGILLLEMFT-GLRP 76
DV+SFGI++ E+ + G RP
Sbjct: 189 SDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 42/175 (24%), Positives = 68/175 (38%), Gaps = 34/175 (19%)
Query: 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSEC--KAAI--NIRHR 251
F N IG G+FG V+ D A+K +L R + E +A + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAIDEARVLAKLDSS 59
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGK------DDTHWRLLNFDFLIK 305
I+R + S +D +V ++ NG L + L + +D WR
Sbjct: 60 YIIRYYE--SFLDKGKL---NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------- 107
Query: 306 KKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
I + L +LH +I H ++K N+ LD +GD +A+ L D
Sbjct: 108 ------IQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 5e-04
Identities = 45/186 (24%), Positives = 70/186 (37%), Gaps = 53/186 (28%)
Query: 201 NLIGAGNFGSV---YNGTLFDGTTIAVKVFNLIRPGGARSFKS---------ECKAAINI 248
IG+G +G V + G +A+K + + F E K ++
Sbjct: 6 KPIGSGAYGVVCSAVDKRT--GRKVAIKKISNV-------FDDLIDAKRILREIKLLRHL 56
Query: 249 RHRNIVR---VFTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGK---DDTHWRLLNF 300
RH NI+ + S D F V V + M L + + D H + +
Sbjct: 57 RHENIIGLLDILRPPSPED-----FNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLY 110
Query: 301 DFLIKKKLDIAIDVARALKYLH-CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359
L R LKYLH + + H +LKPSN+L++ + DF +AR +
Sbjct: 111 QIL------------RGLKYLHSAN----VIHRDLKPSNILVNSNCDLKICDFGLARGV- 153
Query: 360 DTDEQT 365
D DE
Sbjct: 154 DPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 25/165 (15%)
Query: 202 LIGAGNFGSVY-NGTLFDGTTIAVKVFNL---IRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G FG V+ A+KV + IR + +E + + H I+R+F
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
RF ++ +++P G L +L F A ++ A
Sbjct: 68 WT-----EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF---------YASEIVCA 113
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPD 360
L+YLH I + +LKP N+LLD E GH+ DF A+ L D
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKE--GHIKLTDFGFAKKLRD 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 25/80 (31%), Positives = 37/80 (46%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV----ETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K +N+ D LGDFG ++ L T V GT +++PE G
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D++S G ++EM T P
Sbjct: 189 KADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 25/73 (34%), Positives = 36/73 (49%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 61 YSFGILLLEMFTG 73
+S G ++ EM G
Sbjct: 209 WSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 27/76 (35%), Positives = 38/76 (50%), Gaps = 3/76 (3%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
DLK NV LD E L D+G+ + P +T+ GT Y+APE G + D
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDW 179
Query: 61 YSFGILLLEMFTGLRP 76
++ G+L+ EM G P
Sbjct: 180 WALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 45/187 (24%), Positives = 75/187 (40%), Gaps = 44/187 (23%)
Query: 203 IGAGNFGSVY----NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVR 255
I G +G V+ T G A+KV +IR +E + +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLH--GKDDTHWRLLNFDFLIKKKLDIAID 313
++ + +QG + +V +++P G L L G D ++ IA +
Sbjct: 58 LYYS-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----------ARIYIA-E 101
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARF---------LPDTD 362
+ AL+YLH I H +LKP N+L+D GH+ DF +++ D
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 363 EQTRFIG 369
E R +G
Sbjct: 157 EDKRIVG 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 24/79 (30%), Positives = 43/79 (54%), Gaps = 6/79 (7%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMG-SEV 54
H DLKP+NVF++ +++ +GDFG+AR + S + + T Y +P + +
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196
Query: 55 SSYGDVYSFGILLLEMFTG 73
+ D+++ G + EM TG
Sbjct: 197 TKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 203 IGAGNFGSVYNGTLFDG-------TTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIV 254
+G G+FG VY G + G T +A+K N R F +E ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG-KDDTHWRLLNFDFLIKKKLDIAID 313
R+ VS QG + V+ + M G L+ +L + + + +KK + +A +
Sbjct: 73 RLLGVVS----QG-QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+A + YL+ + + H +L N ++ ++ +GDF M R + +TD
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N + ++ T +GDFG+ R + ET + G + +++PE ++
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTT 200
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGM 80
Y DV+SFG++L E+ T +P GM
Sbjct: 201 YSDVWSFGVVLWEIATLAEQPYQGM 225
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 30/84 (35%), Positives = 38/84 (45%), Gaps = 8/84 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM--GTIGYVAPEY--GM-GSEVS 55
H D+KP NV +D L DFG A L + GT Y+APE M G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 56 SYG---DVYSFGILLLEMFTGLRP 76
+YG D +S G++ EM G P
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 25/73 (34%), Positives = 37/73 (50%), Gaps = 6/73 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H D+K N+ L + T L DFG A + SF+ GT ++APE + + Y
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---GTPYWMAPEVILAMDEGQYDGK 194
Query: 59 -DVYSFGILLLEM 70
DV+S GI +E+
Sbjct: 195 VDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 31/87 (35%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLP--VETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
DLK N+ LD E L DFG+ + L T+F GT Y+APE E
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEILQELEYGPSV 177
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDL 85
D ++ G+L+ EM G P +DDL
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 26/150 (17%)
Query: 249 RHRNIVRVFTAVSGVDYQ-GARFKAVVYKFMPNGSLEEWLH-----GKDDT------HWR 296
+H+NI+ + GV Q G + V+ ++ G+L E+L G D T
Sbjct: 76 KHKNIINLL----GVCTQEGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 297 LLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L+F L+ A VAR ++YL R H +L NVL+ ++ + + DF +AR
Sbjct: 130 QLSFKDLVS----CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 357 FLPDTDEQTRFI-GKLNVRNFVKMALSQRV 385
+ D D + G+L V+ AL RV
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDRV 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 32/108 (29%), Positives = 46/108 (42%), Gaps = 24/108 (22%)
Query: 1 HCDLKPSNVFLDD-EMTAHLGDFG----IARFLPVETSFIDVMGTIGYVAPEYGMGSEVS 55
H D+K NV ++ + DFG +A P +F GT+ Y+APE +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV-IDKGPR 186
Query: 56 SYG---DVYSFGILLLEMFTGLRP------------NNGMFKDDLNLP 88
YG D++S G ++EM TG P GMFK +P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP 234
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 24/70 (34%), Positives = 35/70 (50%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 61 YSFGILLLEM 70
+S G ++ EM
Sbjct: 202 WSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 6/74 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT--IGYVAPEYGMGSEVSSYG 58
H DL NV + ++ A + DFG+ + E S G + + APE + S+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 59 DVYSFGILLLEMFT 72
DV+SFGILL E+++
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 47/184 (25%)
Query: 194 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIA---VKVFNLIRPGGARSFKSECKAAINIR 249
F IG G F VY L DG +A V++F ++ + E +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLE---EWLHGKDDTHWRLLNFDFLIK- 305
H N+++ + F+ N L E D + +IK
Sbjct: 61 HPNVIKYLAS-----------------FIENNELNIVLELADAGDLSR--------MIKH 95
Query: 306 -KKLDIAID----------VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
KK I + AL+++H RI H ++KP+NV + + +GD +
Sbjct: 96 FKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGL 152
Query: 355 ARFL 358
RF
Sbjct: 153 GRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 26/81 (32%), Positives = 44/81 (54%), Gaps = 6/81 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG----TIGYVAPEYGMGSEVSS 56
H DL N + + + +GDFG++R + T + V G I ++ PE M + ++
Sbjct: 143 HRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 201
Query: 57 YGDVYSFGILLLEMFT-GLRP 76
DV+S G++L E+FT G +P
Sbjct: 202 ESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 27/77 (35%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT-----IGYVAPEYGMGSEVS 55
H DL N+ L + +GDFG+ R LP VM + APE S
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY-VMEEHLKVPFAWCAPESLRTRTFS 178
Query: 56 SYGDVYSFGILLLEMFT 72
DV+ FG+ L EMFT
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 29/80 (36%), Positives = 43/80 (53%), Gaps = 7/80 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYG- 58
H D+K +N+ +D L DFG+A+ + VE SF G+ ++APE + YG
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIA--QQGGYGL 181
Query: 59 --DVYSFGILLLEMFTGLRP 76
D++S G +LEM TG P
Sbjct: 182 AADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 33/109 (30%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
DLKP N+ LD + L DFG+ + T+ GT Y+APE D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 61 YSFGILLLEMFTGLRP-----NNGMFKDDLNLPNLVKSALPARAEQILD 104
+ G +L EM GL P M+ + LN P +K + A +L+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL NV L ++ A + DFG+++ L + S+ + + APE + SS
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGM 80
DV+S+GI + E F+ G +P M
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 48/184 (26%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHRNIVRV 256
+G G++GSVY G +A+KV + + E I+I IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKE----ISILKQCDSPYIVK- 62
Query: 257 FTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD--- 309
Y G+ FK +V ++ GS+ + ++ + K L
Sbjct: 63 --------YYGSYFKNTDLWIVMEYCGAGSVSD-----------IMK---ITNKTLTEEE 100
Query: 310 IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT-DEQT 365
IA + L+YLH + H ++K N+LL++E + DF ++ L DT ++
Sbjct: 101 IAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157
Query: 366 RFIG 369
IG
Sbjct: 158 TVIG 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 26/175 (14%)
Query: 203 IGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGARSFKS---ECKAAINIRHRNIVR 255
+G G++G V +L DG +K NL R R K+ E + ++H NIV
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNL-RNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ G D +V F G L H + +LL + ++ + +A
Sbjct: 64 YRESWEGEDGL----LYIVMGFCEGGDL---YHKLKEQKGKLL----PENQVVEWFVQIA 112
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD-TDEQTRFIG 369
AL+YLH + I H +LK NV L I VGD +AR L + D + IG
Sbjct: 113 MALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGI-ARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+ L + + L DFG A+ P ++ ++GT ++APE D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 60 VYSFGILLLEMFTGLRP 76
++S GI+ +EM G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N+ L + DFG+AR + +++++ V G + ++APE +
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-VKGNARLPVKWMAPESIFNCVYTF 295
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGM 80
DV+S+GILL E+F+ G P GM
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 24/77 (31%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGI-ARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+ L + + L DFG A+ P ++ ++GT ++APE D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 60 VYSFGILLLEMFTGLRP 76
++S GI+ +EM G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 28/80 (35%), Positives = 39/80 (48%), Gaps = 8/80 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL----PVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKP N+ + + + DFG+AR P + D + T Y APE GS S
Sbjct: 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSK 184
Query: 57 YG---DVYSFGILLLEMFTG 73
Y D++S G + E+ TG
Sbjct: 185 YTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 24/73 (32%), Positives = 36/73 (49%), Gaps = 6/73 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H D+K N+ L + LGDFG A + F+ GT ++APE + + Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV---GTPYWMAPEVILAMDEGQYDGK 194
Query: 59 -DVYSFGILLLEM 70
DV+S GI +E+
Sbjct: 195 VDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 25/84 (29%), Positives = 43/84 (51%), Gaps = 4/84 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DL N+ L + + DFG+AR + + ++ + ++APE ++
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFG+LL E+F+ G P G+
Sbjct: 257 SDVWSFGVLLWEIFSLGASPYPGV 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 30/173 (17%)
Query: 201 NLIGAGNFGSVYNGTLF-DGTTI--AVKVFN-LIRPGGARSFKSECKAAINI-RHRNIVR 255
++IG GNFG V + DG + A+K+ R F E + + H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-------- 307
+ A +G + A+ Y P G+L ++L R+L D K+
Sbjct: 68 LLGACEN---RGYLYIAIEYA--PYGNLLDFLRKS-----RVLETDPAFAKEHGTASTLT 117
Query: 308 ----LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L A DVA ++YL + + H +L NVL+ + + + DF ++R
Sbjct: 118 SQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 30/81 (37%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFI-DVMGTIGYVAPEYGMGS-EVS 55
H DLKPSN+ L+ + DFG+AR E T F+ + + T Y APE + S +
Sbjct: 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYT 188
Query: 56 SYGDVYSFGILLLEMFTGLRP 76
D++S G +L EM + RP
Sbjct: 189 KAIDIWSVGCILAEMLSN-RP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 7/82 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEY---GMGSEVSSY 57
H D+KP+NV ++ L DFG++ L + ++ G Y+APE G ++ +Y
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPTY 184
Query: 58 ---GDVYSFGILLLEMFTGLRP 76
DV+S G+ +LEM G P
Sbjct: 185 TVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 31/90 (34%), Positives = 42/90 (46%), Gaps = 16/90 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI----DVMGTI--GYVAPE---YGMG 51
H DL N + + + DFG++R E I D + I + APE YG
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYG-- 170
Query: 52 SEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+S DV+S+GILL E F+ G P GM
Sbjct: 171 -RYTSESDVWSYGILLWETFSLGDTPYPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 22/84 (26%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSY 57
H +L N+ L + + DFG+A L + + + I ++A E + +
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+S+G+ + EM + G P GM
Sbjct: 192 SDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 16/89 (17%)
Query: 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHC 332
V+ +FM GSLE G + L D+A + + YLH + I H
Sbjct: 149 VLLEFMDGGSLE----GTHIADEQFLA---------DVARQILSGIAYLH---RRHIVHR 192
Query: 333 NLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
++KPSN+L++ + DF ++R L T
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRILAQT 221
|
Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP--VETSFIDVMGTIG--YVAPEYGMGSEVSS 56
H DL N+ ++ + + DFG++R L E ++ G I + APE + +S
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188
Query: 57 YGDVYSFGILLLE-MFTGLRPNNGMFKDDL 85
DV+S+GI++ E M G RP M D+
Sbjct: 189 ASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 8/77 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL---PVETSFI--DVMGTIGYVAPEYGMGS--E 53
H DLKPSN+ ++++ +GDFG+AR L P E + + + T Y APE + S E
Sbjct: 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL-LLSLPE 188
Query: 54 VSSYGDVYSFGILLLEM 70
++ D++S G + EM
Sbjct: 189 YTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 23/80 (28%), Positives = 35/80 (43%), Gaps = 8/80 (10%)
Query: 4 LKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTI--GYVAPEYGMGSEVSSYGDVY 61
L P + +D + HL R D I YVAPE +++ D+Y
Sbjct: 809 LSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIY 862
Query: 62 SFGILLLEMFTGLRPNNGMF 81
FG++L+E+ TG P + F
Sbjct: 863 GFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 22/76 (28%), Positives = 39/76 (51%), Gaps = 5/76 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N + + T +GDFG+ R + ET + G + ++APE ++
Sbjct: 142 HRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTT 200
Query: 57 YGDVYSFGILLLEMFT 72
D++SFG++L E+ +
Sbjct: 201 SSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 16/168 (9%)
Query: 203 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVR 255
+G G+FG VY G D T +AVK N R F +E ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG-KDDTHWRLLNFDFLIKKKLDIAIDV 314
+ VS + VV + M +G L+ +L + + +++ + +A ++
Sbjct: 74 LLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
A + YL+ + H +L N ++ + +GDF M R + +TD
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 25/74 (33%), Positives = 38/74 (51%), Gaps = 2/74 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV--MGTIGYVAPEYGMGSEVSSYG 58
H D+K N+FL+ + LGDFG A E D +GT+ +PE G
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 59 DVYSFGILLLEMFT 72
D++S G++LL+M +
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 15/98 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIAR-FLP---VETSFI-DVMGTIGYVAPEYGMG-SEV 54
H DLKP N+ ++ + + DFG+AR F F+ + + T Y APE +
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187
Query: 55 SSYGDVYSFGILLLEMFTGLRPNNGMFK-----DDLNL 87
+ DV+S G +L E G +P +FK D LN
Sbjct: 188 TKAIDVWSVGCILAE-LLGRKP---VFKGKDYVDQLNQ 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.002
Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 7/77 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYG- 58
H D+K N+ L + + L DFG A L E S + + GT ++APE + YG
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD---YGP 195
Query: 59 --DVYSFGILLLEMFTG 73
D++S GI+ +EM G
Sbjct: 196 KVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 25/78 (32%), Positives = 37/78 (47%), Gaps = 11/78 (14%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM-----GSEVS 55
H DLKPSN+ +++ + DFG+AR + + T Y APE + EV
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEV- 187
Query: 56 SYGDVYSFGILLLEMFTG 73
D++S G + EM G
Sbjct: 188 ---DIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 33/179 (18%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG----ARSFKSE 241
F +++ TN + +G G FG V + G +A+K +++P A+ E
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRE 59
Query: 242 CKAAINIRHRNIVR---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLL 298
K ++RH NI+ +F + Y V + + D H RLL
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIY-------FVTELLGT-----------DLH-RLL 100
Query: 299 NFDFLIKKKLD-IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
L K+ + + R LKY+H + H +LKPSN+L+++ + DF +AR
Sbjct: 101 TSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 28/76 (36%), Positives = 36/76 (47%), Gaps = 3/76 (3%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
DLKP N+ LD + L DFG+ + P ET+ GT Y+APE D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 61 YSFGILLLEMFTGLRP 76
+ G +L EM GL P
Sbjct: 180 WCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG---TIGYVAPEYGMGSEVSSY 57
H DL NV + + + DFG++R + E S++ + ++A E ++
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKS 93
DV+SFG+LL E+ T G P G+ + L NL+K+
Sbjct: 210 SDVWSFGVLLWEIVTLGGNPYPGIAPE--RLFNLLKT 244
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 18/146 (12%)
Query: 249 RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD--------DTHWRLLNF 300
+H+NI+ + A + Q +V ++ G+L E+L + DT +L
Sbjct: 76 KHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDT-CKLPEE 129
Query: 301 DFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
K + A VAR ++YL + H +L NVL+ ++ + + DF +AR + +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN 186
Query: 361 TDEQTRFI-GKLNVRNFVKMALSQRV 385
D + G+L V+ AL RV
Sbjct: 187 IDYYKKTTNGRLPVKWMAPEALFDRV 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 12/93 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT-------IGYVAPEYGMGSE 53
H DL NV + ++ + DFG+AR + ID + ++APE
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212
Query: 54 VSSYGDVYSFGILLLEMFT-GLRPNNGMFKDDL 85
+ DV+SFG+LL E+FT G P G+ ++L
Sbjct: 213 YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 14/87 (16%)
Query: 1 HCDLKPSNVFLDDEMTAH----LGDFGIARFL--PVETSFID--VMGTIGYVAPEYGMGS 52
H DLKP+N+ + E +GD G+AR P++ V+ TI Y APE +G+
Sbjct: 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRP 76
Y D+++ G + E+ T L P
Sbjct: 191 R--HYTKAIDIWAIGCIFAELLT-LEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 47/173 (27%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPEYGMGSEVSS 56
H DL N + ++ +GDFG++R + T + V G I ++ PE M + ++
Sbjct: 145 HRDLATRNCLVGYDLVVKIGDFGMSRDV-YTTDYYRVGGHTMLPIRWMPPESIMYRKFTT 203
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
DV+SFG++L E+FT G +P ++ EE
Sbjct: 204 ESDVWSFGVVLWEIFTYGKQP------------------------------WYGLSNEE- 232
Query: 116 TLYKKASSTCTQSSIILE----CLISICRIGVACSAELPDERMDINDVESRLR 164
C +L+ C + I + C P +R++I D+ RL+
Sbjct: 233 ------VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 42/179 (23%)
Query: 196 GFSSANLIGAGNFGSVYN-GTLFDGTTIAVKVFNLIRPGGARSFKSECKAAIN------- 247
F +G G++GSVY L D A+K +L G+ S + E + A+N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMS-QKEREDAVNEIRILAS 55
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHG--------KDDTHWRLLN 299
+ H NI+ A + +V ++ P G L + + + WR
Sbjct: 56 VNHPNIISYKEA-----FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--- 107
Query: 300 FDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
I I + R L+ LH + +I H +LK +N+LL + +GD +++ L
Sbjct: 108 ----------IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL 153
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 26/78 (33%), Positives = 37/78 (47%), Gaps = 7/78 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSE------V 54
H DL N LD+ T + DFG+AR + + + V G P M E
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 55 SSYGDVYSFGILLLEMFT 72
++ DV+SFG+LL E+ T
Sbjct: 180 TTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 41/147 (27%), Positives = 61/147 (41%), Gaps = 25/147 (17%)
Query: 202 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
++G G +G VY L IA+K + E ++HRNIV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL--- 71
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFD-----FLIKKKLDIAIDVA 315
G D + FK + + +P GSL L K W L + F K+ L+
Sbjct: 72 -GSDSENGFFK-IFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILE------ 119
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLD 342
LKYLH +I H ++K NVL++
Sbjct: 120 -GLKYLH---DNQIVHRDIKGDNVLVN 142
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 53/213 (24%)
Query: 180 QTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSF 238
++++++ L D F ++G G +G VY G + G A+KV ++
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TEDE 55
Query: 239 KSECKAAINI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDT 293
+ E K IN+ HRNI Y GA K K P G DD
Sbjct: 56 EEEIKLEINMLKKYSHHRNI---------ATYYGAFIK----KSPP---------GHDDQ 93
Query: 294 HWRLLNF-------DFLIKKKLD---------IAIDVARALKYLHCDCQPRIAHCNLKPS 337
W ++ F D + K + I ++ R L +LH ++ H ++K
Sbjct: 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQ 150
Query: 338 NVLLDDEMIGHVGDFSMARFLPDT-DEQTRFIG 369
NVLL + + DF ++ L T + FIG
Sbjct: 151 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 25/75 (33%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR-FLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61
DLKP N+ LD + L DFG+ + + + GT Y+APE + D +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180
Query: 62 SFGILLLEMFTGLRP 76
G +L EM GL P
Sbjct: 181 CLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 12/93 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT-------IGYVAPEYGMGSE 53
H DL NV + ++ + DFG+AR + ID + ++APE
Sbjct: 163 HRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218
Query: 54 VSSYGDVYSFGILLLEMFT-GLRPNNGMFKDDL 85
+ DV+SFG+LL E+FT G P G+ ++L
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 56/193 (29%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSV---YNGTLFDGTTIAVKVFNLIRP-----GGARSF 238
K +++ + + + + +G+G +G V ++ G +A+K L RP R++
Sbjct: 7 NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKT--GRKVAIK--KLSRPFQSAIHAKRTY 62
Query: 239 KSECKAAINIRHRNIV---RVFTAVSGV-DYQGARFKAVVYKFMPNGSLEEWLHGKD--- 291
+ E + ++ H N++ VFT S + D+Q VY L G D
Sbjct: 63 R-ELRLLKHMDHENVIGLLDVFTPASSLEDFQD------VYLVTH-------LMGADLNN 108
Query: 292 --------DTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343
D H + L + L R LKY+H I H +LKPSN+ +++
Sbjct: 109 IVKCQKLSDDHIQFLVYQIL------------RGLKYIH---SAGIIHRDLKPSNIAVNE 153
Query: 344 EMIGHVGDFSMAR 356
+ + DF +AR
Sbjct: 154 DCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 29/85 (34%), Positives = 40/85 (47%), Gaps = 11/85 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL----PVETSFIDVMGTIGYVAPEY--GMGSEV 54
H D+KP NV LD L DFG + V++S +GT Y++PE M +
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVGTPDYISPEILQAMEDGM 182
Query: 55 SSYG---DVYSFGILLLEMFTGLRP 76
YG D +S G+ + EM G P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 45/191 (23%), Positives = 70/191 (36%), Gaps = 68/191 (35%)
Query: 197 FSSANLIGAGNFGSVYNGTLFD---GTTIAVKVFNL-------------IRPGGARSFKS 240
F+ IG G+FG VY D +A+KV +L I F S
Sbjct: 3 FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEI------QFLS 54
Query: 241 ECKAAINIRHRNIVRVFTAVSGVDYQGARFK----AVVYKFMPNGSLEEWLHGKDDTHWR 296
+C++ I + Y G+ K ++ ++ GS
Sbjct: 55 QCRSP------YITK---------YYGSFLKGSKLWIIMEYCGGGSC------------- 86
Query: 297 LLNFDFLIKKKLD---IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350
D L KLD IA +V L+YLH + H ++K +N+LL +E +
Sbjct: 87 ---LDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLA 140
Query: 351 DFSMARFLPDT 361
DF ++ L T
Sbjct: 141 DFGVSGQLTST 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 10/84 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA----RFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K +N+ L ++ L DFG++ + SFI GT ++APE
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI---GTPYWMAPEVAAVERKGG 180
Query: 57 YG---DVYSFGILLLEMFTGLRPN 77
Y D+++ GI +E+ P
Sbjct: 181 YDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 29/79 (36%), Positives = 40/79 (50%), Gaps = 12/79 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA----RFLPVETSFIDVMGTIGYVAPEYGMGSEV-- 54
H DLK NV L + L DFG++ + L SFI GT ++APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETMKD 189
Query: 55 SSY---GDVYSFGILLLEM 70
+ Y D++S GI L+EM
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 485 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.98 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.94 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.93 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.93 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.92 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.92 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.92 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.92 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.91 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.91 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.91 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.91 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.91 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.91 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.9 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.9 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.9 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.9 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.9 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.9 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.9 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.89 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.89 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.89 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.89 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.89 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.89 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.89 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.88 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.87 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.87 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.86 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.85 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.85 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.84 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.84 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.84 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.84 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.83 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.83 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.81 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.81 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.8 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.8 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.8 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.8 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.79 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.78 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.78 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.78 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.77 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.77 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.77 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.76 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.76 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.76 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.76 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.75 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.75 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.75 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.74 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.74 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.73 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.73 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.73 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.72 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.72 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.71 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.71 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.7 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.7 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.7 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.7 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.69 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.69 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.69 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.69 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.69 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.69 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.68 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.68 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.68 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.68 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.68 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.68 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.68 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.68 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.67 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.67 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.67 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.67 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.67 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.66 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.66 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.66 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.66 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.66 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.66 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.66 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.66 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.65 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.65 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.65 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.65 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.65 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.65 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.65 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.65 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.65 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.65 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.64 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.64 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.64 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.64 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.64 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.64 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.64 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.64 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.64 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.63 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.63 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.63 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.63 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.63 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.63 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.63 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.63 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.63 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.63 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.63 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.63 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.63 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.62 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.62 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=410.55 Aligned_cols=245 Identities=34% Similarity=0.571 Sum_probs=195.7
Q ss_pred cccccCccchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeee
Q 041230 181 TINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260 (485)
Q Consensus 181 ~~~~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~ 260 (485)
..+.|+|.++..||++|+..++||+|+||.||+|.+.+|+.||||+++.......++|.+|+.++++++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999988754332156699999999999999999999999
Q ss_pred cccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceE
Q 041230 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340 (485)
Q Consensus 261 ~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NIL 340 (485)
.+.. ...+||||||+||||.++|++.... .++|.+|++||.|+|+||+|||..+.++||||||||+|||
T Consensus 141 ~e~~----~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 141 LEGG----EHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred ecCC----ceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 8532 1489999999999999999986531 6799999999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecccccccCC-CCc-----c-------------eeeeccccHHHHHHHHhh-------------------
Q 041230 341 LDDEMIGHVGDFSMARFLPD-TDE-----Q-------------TRFIGKLNVRNFVKMALS------------------- 382 (485)
Q Consensus 341 ld~~~~~ki~DFGla~~~~~-~~~-----~-------------~~~~~~~~l~~~~~~~~~------------------- 382 (485)
||++++|||+|||+|+..+. ... . ...+.+.++++|+...++
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred ECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999988765 211 0 011223455555432222
Q ss_pred ----------hhhhhhccccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 383 ----------QRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 383 ----------~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
+++.+++|+.+... . ....+++.+++.+|+.|++.+|..||+|.||+++|
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~----------------~----~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEG----------------E----YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCC----------------C----CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 12333344433210 0 00115788899999999999999999999999999
Q ss_pred HHHH
Q 041230 453 RLIR 456 (485)
Q Consensus 453 ~~i~ 456 (485)
+.+.
T Consensus 350 ~~~~ 353 (361)
T KOG1187|consen 350 EGIL 353 (361)
T ss_pred Hhhc
Confidence 6553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=306.09 Aligned_cols=239 Identities=27% Similarity=0.394 Sum_probs=177.6
Q ss_pred cceeecccCceEEEEeEeeCCcE-EEEEEeeccCCcc--hHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 199 SANLIGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 199 ~~~~iG~G~fg~Vy~g~~~~~~~-vavK~~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
....||+|+||+||+|.+. |+. ||||++....... .+.|.+|+.+|.+++|||||+|+|+|..... ..++|+
T Consensus 45 ~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~iVt 119 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCIVT 119 (362)
T ss_pred hhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEEEE
Confidence 3455999999999999875 555 9999987543222 4589999999999999999999999985321 478999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCC-eeeeccCCCceEecCCC-cEEEeecc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPR-IAHCNLKPSNVLLDDEM-IGHVGDFS 353 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~-ivHrdlK~~NILld~~~-~~ki~DFG 353 (485)
|||++|+|.++|+... ...++|..+++||.+||+||.|||+ .. ||||||||+|||++.++ ++||+|||
T Consensus 120 Ey~~~GsL~~~l~~~~-------~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKR-------KRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EeCCCCcHHHHHhhcc-------cCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 9999999999999741 1478999999999999999999994 34 99999999999999997 99999999
Q ss_pred cccccCCCC---c-----------------ceeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 354 MARFLPDTD---E-----------------QTRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 354 la~~~~~~~---~-----------------~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+++...... + ...|+.+.++++|+...++-...++.-..+.. ............+..
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp~- 266 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRPP- 266 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCCC-
Confidence 998765321 0 11356677888887654442222222111111 000011111222221
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHh
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~ 460 (485)
.+.+|...+..+...||+.+|..||++.+++.+|+.+...+.
T Consensus 267 -----~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 -----IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -----CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 122377778889999999999999999999999999987654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=301.39 Aligned_cols=227 Identities=23% Similarity=0.402 Sum_probs=173.2
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
.+...+.||+|-||.||.|.+.....||||.++.. .-..+.|.+|+++|.+|+|+|||+++|+|... ...+||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence 34456789999999999999877779999998754 23457899999999999999999999999752 2579999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
|||++|||.+||+.... ..+...+-+.++.|||.||+||. +.++|||||.++|||++++..+||+|||||
T Consensus 281 E~m~~GsLl~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred EecccCcHHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccc
Confidence 99999999999997332 24666788999999999999999 789999999999999999999999999999
Q ss_pred cccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhhhcccc-----------chhhhhhhhhhhc
Q 041230 356 RFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEILNDF-----------NLQEIEEDRTMCM 405 (485)
Q Consensus 356 ~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~-----------~~~~~~~~~~~~~ 405 (485)
|...++... ..|+-+.++.+|+...+ |++.-. ....++.++
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~-----E~fT~G~~py~~msn~ev~~~le~Gy---- 421 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLW-----ELFTYGRVPYPGMSNEEVLELLERGY---- 421 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHH-----HHhccCCCCCCCCCHHHHHHHHhccC----
Confidence 955443322 22344455555554332 221110 001111111
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+-+.+..|...+.+|+..||+.+|++|||+......|+.+..
T Consensus 422 ----------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 ----------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 112234689999999999999999999999987777776643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.78 Aligned_cols=244 Identities=20% Similarity=0.332 Sum_probs=179.0
Q ss_pred hccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
...+....+.||+|.||+||+|+... .+.||||.++..... ..++|++|++++++++|||||+|+|.|...
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-- 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-- 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--
Confidence 34455566789999999999998543 457999999866554 567999999999999999999999999753
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCccc-----ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceE
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHW-----RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-----~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NIL 340 (485)
+..++|+|||..|||.+||....+... ......|+-.+-+.||.|||.||+||- +..+|||||.++|+|
T Consensus 562 ---~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 562 ---DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCL 635 (774)
T ss_pred ---CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhce
Confidence 468999999999999999975432111 011245888999999999999999998 678999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhh----
Q 041230 341 LDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQE---- 396 (485)
Q Consensus 341 ld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~---- 396 (485)
+.+++.+||+||||+|..=..+.. ..|+-..++.+|+.. +|||+.-.....
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVv-----LWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVV-----LWEIFSYGKQPYYGLS 710 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhh-----hhhhhccccCcccccc
Confidence 999999999999999864222211 234444555555432 244433221100
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
-.++-....... .++.++.|+.+|..|++.||+.+|.+||+++||-.+|+..-
T Consensus 711 n~EVIe~i~~g~-------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 711 NQEVIECIRAGQ-------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred hHHHHHHHHcCC-------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 001111100000 01234568999999999999999999999999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=282.08 Aligned_cols=242 Identities=20% Similarity=0.309 Sum_probs=173.4
Q ss_pred hhccccccceeecccCceEEEEeEeeCC----cE-EEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeeccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLFDG----TT-IAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGV 263 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~~~----~~-vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~ 263 (485)
-..++-...+.||+|+||.||+|.+..+ .. ||||..+.. ......+|.+|+++|.+++|||||+++|++..
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~- 232 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL- 232 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-
Confidence 3444555568999999999999997542 23 899988742 23446789999999999999999999999874
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
.+..++|+|+|+||+|.++|..... .++..++++++.++|+||+||| ..++|||||.++|+|++.
T Consensus 233 ----~~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 233 ----EEPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSK 297 (474)
T ss_pred ----CCccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecC
Confidence 3468999999999999999997652 4788899999999999999999 789999999999999999
Q ss_pred CCcEEEeecccccccCCCC------------------cceeeeccccHHHHHHHHhhhhhhhhcc----ccchhhhhhhh
Q 041230 344 EMIGHVGDFSMARFLPDTD------------------EQTRFIGKLNVRNFVKMALSQRVEEILN----DFNLQEIEEDR 401 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~~------------------~~~~~~~~~~l~~~~~~~~~~~~~~~~d----~~~~~~~~~~~ 401 (485)
+..+||+||||++...... ....|+...++++|+...+ |+.. |+..-...+..
T Consensus 298 ~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~-----Eif~~g~~Py~g~~~~~v~ 372 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLW-----EIFENGAEPYPGMKNYEVK 372 (474)
T ss_pred CCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEE-----eeeccCCCCCCCCCHHHHH
Confidence 9999999999998753111 1123445556666553322 2221 11111101111
Q ss_pred hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHh
Q 041230 402 TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460 (485)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~ 460 (485)
.-......+...+ ......+..+.-.||..+|++||+|.+|.+.|+.+.....
T Consensus 373 ~kI~~~~~r~~~~------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 373 AKIVKNGYRMPIP------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHhcCccCCCC------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1110111111111 1123445567779999999999999999999999976543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.58 Aligned_cols=315 Identities=24% Similarity=0.320 Sum_probs=200.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
+||+|++||+++.+|++++.|||+++.....+. .|||..|||||+.. .+...+|.||||++.+||++|..||.+.
T Consensus 120 yrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~ 194 (612)
T KOG0603|consen 120 YRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD 194 (612)
T ss_pred HhcccccceeecccCccccCCchhhhHhHhhhh---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH
Confidence 689999999999999999999999987644332 29999999999987 4667789999999999999999998761
Q ss_pred -----CCCCCChhHHHhhhc-------------------hhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHH
Q 041230 81 -----FKDDLNLPNLVKSAL-------------------PARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLI 136 (485)
Q Consensus 81 -----~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (485)
...+...|.-+.... +....++..+.|++.+++.+...+...+........ +...
T Consensus 195 ~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~-e~~~ 273 (612)
T KOG0603|consen 195 TMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSIT-ERDV 273 (612)
T ss_pred HHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccc-hhhh
Confidence 000111111111000 112344445555555555443333322211110000 0000
Q ss_pred HHHHHHHhhhccCCCcccccchhhHHHHHHhhhhccCccccccccccccCccch---h-----hhccccccceeecccCc
Q 041230 137 SICRIGVACSAELPDERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDL---Y-----DATNGFSSANLIGAGNF 208 (485)
Q Consensus 137 ~~~~l~~~C~~~~p~~RP~m~~v~~~L~~i~~~~~~~~~~~~~~~~~~~~~~~l---~-----~~t~~f~~~~~iG~G~f 208 (485)
....-.-++..|..-|.... .-........++|... . ..++.|.....+|+|+|
T Consensus 274 --~~fd~eft~~~P~dsp~~~~----------------~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~ 335 (612)
T KOG0603|consen 274 --AQFDPEFTSQVPADSPLLSA----------------SGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSF 335 (612)
T ss_pred --hhcCchhccCCcccCCCCCC----------------CccccchhcCCCccChHHhhccccCCcchhhccccccCCCCc
Confidence 00000000001111010000 0000011122222211 1 12455666667999999
Q ss_pred eEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEEEecCCCCHHHh
Q 041230 209 GSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEW 286 (485)
Q Consensus 209 g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~ 286 (485)
+.|-++.. .+++..+||++..... +-.+|+.++... .||||+++.+.+.+ ....++|+|++.+|-|.+.
T Consensus 336 s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~~~~v~e~l~g~ell~r 406 (612)
T KOG0603|consen 336 SAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYED-----GKEIYLVMELLDGGELLRR 406 (612)
T ss_pred cceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecC-----CceeeeeehhccccHHHHH
Confidence 99988874 5578899999865422 223466555544 79999999988653 4568999999999999888
Q ss_pred hcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe-cCCCcEEEeecccccccCCC
Q 041230 287 LHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL-DDEMIGHVGDFSMARFLPDT 361 (485)
Q Consensus 287 L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl-d~~~~~ki~DFGla~~~~~~ 361 (485)
+.... .+. ..+..|+.+++.++.||| ..+||||||||+|||+ +..++.+|+|||+++..+..
T Consensus 407 i~~~~---------~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 407 IRSKP---------EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred HHhcc---------hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 76543 222 567789999999999999 6899999999999999 58899999999999987655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.43 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=184.5
Q ss_pred ccCccchhhhcccc---------ccceeecccCceEEEEeEeeC----CcEEEEEEeeccCCc-chHHHHHHHHHHHhcC
Q 041230 184 NLSFKDLYDATNGF---------SSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPG-GARSFKSECKAAINIR 249 (485)
Q Consensus 184 ~~~~~~l~~~t~~f---------~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~ 249 (485)
.++|++-..|...| ..+.+||.|.||.||+|.+.- ...||||.||..... ...+|+.|+.+|+++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 34555544444444 456899999999999999743 346999999865543 4568999999999999
Q ss_pred CCcceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 041230 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329 (485)
Q Consensus 250 H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~i 329 (485)
||||++|-|.... .+..++|.|||+||+|+.||+.+++ +|.|.+-+.+..|||.||.||- ..++
T Consensus 689 HPNIIrLEGVVTk-----s~PvMIiTEyMENGsLDsFLR~~DG--------qftviQLVgMLrGIAsGMkYLs---dm~Y 752 (996)
T KOG0196|consen 689 HPNIIRLEGVVTK-----SKPVMIITEYMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIASGMKYLS---DMNY 752 (996)
T ss_pred CCcEEEEEEEEec-----CceeEEEhhhhhCCcHHHHHhhcCC--------ceEeehHHHHHHHHHHHhHHHh---hcCc
Confidence 9999999998753 3568999999999999999998763 5888889999999999999998 7899
Q ss_pred eeeccCCCceEecCCCcEEEeecccccccCCCCcc--eeeeccccHHHHHHHHhhhh----hhhhcc-ccchhhhhhhhh
Q 041230 330 AHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--TRFIGKLNVRNFVKMALSQR----VEEILN-DFNLQEIEEDRT 402 (485)
Q Consensus 330 vHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~----~~~~~d-~~~~~~~~~~~~ 402 (485)
|||||..+|||+|.+..+||+||||+|.+.++.+. +..+|++++++-+.+++..+ ..++.. .....++..-.+
T Consensus 753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred hhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 99999999999999999999999999988665432 33456666654333333211 011100 000000000000
Q ss_pred hhcccCCCCC------CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 403 MCMHASSSSS------TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 403 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
...|.++.+. ...+.+-+.+|+..+.+|++.||+.+-.+||++.|+|..|.++-
T Consensus 833 RPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 833 RPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred CcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 1111111110 00111224579999999999999999999999999999998763
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=275.45 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=179.7
Q ss_pred cchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
++.....+.+.....||+|.||+||+|.+. ..||||+++..... ..+.|.+|+..+++-||.||+=++|||...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-- 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-- 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--
Confidence 344444455667789999999999999875 36999999876543 457899999999999999999999999853
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
..++|..+|++-||+.+||-.+ ..|...+-++||.|||+||.||| .++|||||||+.||+|.+++
T Consensus 461 ----~~AIiTqwCeGsSLY~hlHv~e--------tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 461 ----PLAIITQWCEGSSLYTHLHVQE--------TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDL 525 (678)
T ss_pred ----ceeeeehhccCchhhhhccchh--------hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCC
Confidence 2489999999999999999754 35777888999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCCCC--c---------------------ceeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhh
Q 041230 346 IGHVGDFSMARFLPDTD--E---------------------QTRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRT 402 (485)
Q Consensus 346 ~~ki~DFGla~~~~~~~--~---------------------~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 402 (485)
++||+||||+.....-. . ...|+...+||.|+...++....++.-..-. .++
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~----~dq- 600 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN----RDQ- 600 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC----hhh-
Confidence 99999999986532110 0 0235566677777655544222222111000 000
Q ss_pred hhcccCCCCC-CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 403 MCMHASSSSS-TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 403 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
..+...+.. .++.......|...+.+|...||..++++||.+.+++.+|+.+-.
T Consensus 601 -IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 601 -IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 000111110 011111223578889999999999999999999999998887754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.01 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=180.3
Q ss_pred ccccceeecccCceEEEEeEeeC--Cc----EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD--GT----TIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~--~~----~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+....+.||+|.||.||+|.+.+ |. .||||.++... .+...+|.+|..+|+++.|||||+++|.|.. .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 44556889999999999999755 33 38999887543 4556789999999999999999999999975 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++++|||++|+|..||+........ ...+....-+.||.|||+|+.||+ ..++|||||..+|+||++...+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEE
Confidence 3578999999999999999976443222 356888889999999999999999 78999999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccc----cchhhhhhhhhhh
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILND----FNLQEIEEDRTMC 404 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~----~~~~~~~~~~~~~ 404 (485)
|+||||||.+-+.+.. ..|+-+.++.+|+... ||++.- +......+...+.
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVll-----WEifslG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLL-----WEIFSLGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHH-----HHHHhCCCCCCCCcchHHHHHHH
Confidence 9999999954222210 2344555666665432 333321 1110000111111
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHh
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~ 460 (485)
.... + .+.+..|...+.+|+..||+.+|++||++..+++++..|.+...
T Consensus 918 ~~gg-R------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 918 LEGG-R------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HhCC-c------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 1111 1 11223599999999999999999999999999999999977543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=260.63 Aligned_cols=247 Identities=20% Similarity=0.277 Sum_probs=168.2
Q ss_pred ccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||.||+|.. .++..||||+++.... ...+.|.+|+.++.++ +|||||+++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 45778889999999999999963 2346799999864322 2345789999999999 899999999987632
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCccc--------------------------------------------------
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------------------------------------------------- 295 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------------------------------------------------- 295 (485)
....++||||+++|+|.++|........
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2357899999999999999975321000
Q ss_pred ---ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCCCc---------
Q 041230 296 ---RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE--------- 363 (485)
Q Consensus 296 ---~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~--------- 363 (485)
......+.+...+.++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 000124788889999999999999999 67999999999999999999999999999986432111
Q ss_pred -----------ceeeeccccHHHHHHHHhhhhh-hhhc--cccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHH
Q 041230 364 -----------QTRFIGKLNVRNFVKMALSQRV-EEIL--NDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICE 429 (485)
Q Consensus 364 -----------~~~~~~~~~l~~~~~~~~~~~~-~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (485)
...++...++++++...+.--. .... +......+... . .... .... ...+...+.+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--~-~~~~-~~~~------~~~~~~~l~~ 308 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--L-KDGT-RMRA------PENATPEIYR 308 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--H-hcCC-CCCC------CCCCCHHHHH
Confidence 0112334566666644332110 0000 00000000000 0 0000 0000 0113345678
Q ss_pred HHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 430 IGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 430 ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
|+..|++.+|.+||+|.+|+++|+.+..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=249.87 Aligned_cols=236 Identities=19% Similarity=0.273 Sum_probs=166.0
Q ss_pred ceeecccCceEEEEeEeeCCcEEEEEEeeccCCcc---hHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 200 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG---ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
...||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.+|.+++|||||+++|++.... .+....++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 36899999999999986 78999999987543332 467889999999999999999999876411 12245789999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|.+++.... .++|..+++++.+++.||.|||. ..+++||||||+|||+++++.+||+|||+++
T Consensus 103 y~~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 103 YCTRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred eCCCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 999999999997542 46788899999999999999994 2367899999999999999999999999998
Q ss_pred ccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcchhhh
Q 041230 357 FLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSI 419 (485)
Q Consensus 357 ~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (485)
.+...... ..++...++++++...+.-..... |.......+............. .
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~--Pf~~~~~~~~~~~i~~~~~~~~------~ 243 (283)
T PHA02988 172 ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI--PFENLTTKEIYDLIINKNNSLK------L 243 (283)
T ss_pred hhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC--CCCCCCHHHHHHHHHhcCCCCC------C
Confidence 64332110 112334566666544332111111 1000000000000000011100 0
Q ss_pred HHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 420 ILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 420 ~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
+..+...+.++...||+.+|++||||.+|++.|+.++
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1124456778999999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=254.40 Aligned_cols=247 Identities=19% Similarity=0.263 Sum_probs=163.0
Q ss_pred cccccceeecccCceEEEEeEeeC-----------------CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-----------------GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRV 256 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-----------------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l 256 (485)
+.|...+.||+|+||.||++...+ +..||||.+..... .....|.+|++++.+++|||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 356677899999999999997532 23699998864322 234579999999999999999999
Q ss_pred eeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCccc----------ccccccccHHHHHHHHHHHHHHHHHhhcCCC
Q 041230 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW----------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQ 326 (485)
Q Consensus 257 ~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~----------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~ 326 (485)
++++... ...++|+||+++|+|.+++........ ......++|....+|+.+++.||.||| .
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~ 156 (304)
T cd05096 85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S 156 (304)
T ss_pred EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence 9987642 357999999999999999864321100 011135788899999999999999999 6
Q ss_pred CCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhh
Q 041230 327 PRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVE 386 (485)
Q Consensus 327 ~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~ 386 (485)
.+|+||||||+|||+++++.+||+|||+++........ ..+....++++++...+.-...
T Consensus 157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 78999999999999999999999999999865322110 0112234555554332220000
Q ss_pred hhccccc---hhhh-hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 387 EILNDFN---LQEI-EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 387 ~~~d~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
.-..+.. .... ...... .......... .....+...+.++...||+.+|.+||||.+|++.|+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEF-FRDQGRQVYL---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHH-hhhccccccc---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 0000000 0000 000000 0000000000 000124456789999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=261.03 Aligned_cols=240 Identities=20% Similarity=0.261 Sum_probs=168.4
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
.....+.||+|.||.|-.++...+..||||.++.... ....+|.+|+++|++++|||||+|+|.|... +..++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePicmI 613 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLCMI 613 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchHHH
Confidence 3445678999999999999988889999999986543 3357899999999999999999999999852 457999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+|||+||+|.++|..+..-. +.-..-++||.|||.||+||. +.++|||||.+.|+|+|.++++||+|||+
T Consensus 614 ~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccc
Confidence 99999999999998764321 222345779999999999998 67899999999999999999999999999
Q ss_pred ccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhh---hhhhcccC--C
Q 041230 355 ARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEED---RTMCMHAS--S 409 (485)
Q Consensus 355 a~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~---~~~~~~~~--~ 409 (485)
+|.+-..+.. ..|+-..++..|+.. ++|++--+-.+.+++. +....... .
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvT-----lwE~~~~C~e~Py~~lt~e~vven~~~~~~ 758 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT-----LWEVFMLCREQPYSQLTDEQVVENAGEFFR 758 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHH-----HHHHHHHHhhCchhhhhHHHHHHhhhhhcC
Confidence 9965443322 112222233322221 2222211111111100 00000000 0
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.+....-...+.-|...++++.+.||..+.++||+++++..-|++.
T Consensus 759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0000000112234888999999999999999999999999888753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=249.62 Aligned_cols=152 Identities=28% Similarity=0.478 Sum_probs=128.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..+|.....||+|+||+||+|+. .++..||||.+.... ....+....|+.+|+.++|||||+|+.++... ++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----Ce
Confidence 45677778899999999999995 457899999986542 23345678899999999999999999998653 47
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC------
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE------ 344 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~------ 344 (485)
.+||||||.+|||..||+..+ .++.........|+|.||++|| ..+||||||||.||||...
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~---------~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~ 151 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRG---------RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTS 151 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCC
Confidence 899999999999999999764 3556667778999999999999 7899999999999999865
Q ss_pred CcEEEeecccccccCCCC
Q 041230 345 MIGHVGDFSMARFLPDTD 362 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~ 362 (485)
-.+||+|||+||.+.+..
T Consensus 152 ~~LKIADFGfAR~L~~~~ 169 (429)
T KOG0595|consen 152 PVLKIADFGFARFLQPGS 169 (429)
T ss_pred ceEEecccchhhhCCchh
Confidence 568999999999986543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=246.12 Aligned_cols=228 Identities=27% Similarity=0.453 Sum_probs=158.1
Q ss_pred ceeecccCceEEEEeEee-----CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 200 ANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+.+++||||++++|+|... ...++
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~l 78 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLFL 78 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----ccccc
Confidence 468999999999999987 256799999965332 2357899999999999999999999999732 24789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.++|+.... ..+++..+..|+.++|.||.||| +.+++|+||+++|||+++++.+||+|||
T Consensus 79 v~e~~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~ 148 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFG 148 (259)
T ss_dssp EEE--TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred ccccccccccccccccccc-------ccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 9999999999999987621 35789999999999999999999 5689999999999999999999999999
Q ss_pred cccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCC
Q 041230 354 MARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 354 la~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
+++........ ..++...++++|+...++-.. ... ........+... . ..... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~--~-~~~~~-~ 224 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK--L-KQGQR-L 224 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH--H-HTTEE-T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--c-ccccc-c
Confidence 99876221110 123345567777654443111 000 000000110000 0 00000 0
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
.....+...+.++...||+.+|++||+|.+++++|
T Consensus 225 ------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00112445677999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=252.00 Aligned_cols=237 Identities=17% Similarity=0.333 Sum_probs=166.8
Q ss_pred cccccceeecccCceEEEEeEee-CCc----EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGT----TIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~----~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.+|+..+.||+|+||.||+|... ++. .||||.++... ....+.|.+|+.++..++||||++++|+|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 45888899999999999999853 343 38999886432 23356789999999999999999999998642
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
..++|+||+++|+|.+++.... ..+.+...+.++.+++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~k 149 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK--------DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVK 149 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEE
Confidence 3579999999999999998643 24677888999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..++...++++|+...+.--. ... .+......+. .....
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~---~~~~~ 226 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK 226 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHhC
Confidence 9999999876432211 011122355555533222100 000 0000000000 00000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...... ...+...+.+++..||+.+|++||+|.+++..|..+...
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 GERLPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 000000 012345677899999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=255.33 Aligned_cols=150 Identities=25% Similarity=0.387 Sum_probs=132.7
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeec---cCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL---IRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..|...+.||+|||++||.++. ..|..||+|++.+ .+....+...+|+++.++|+|||||++++++. +.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-----Ds~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-----DSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-----cCCc
Confidence 3477789999999999999995 8899999999864 24455678899999999999999999999965 4567
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.|+|.|+|++|+|..++... ..++++....+..||+.||.||| +.+|||||||-.|++|++++++||+
T Consensus 93 VYivLELC~~~sL~el~Krr---------k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIg 160 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRR---------KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIG 160 (592)
T ss_pred eEEEEEecCCccHHHHHHhc---------CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEec
Confidence 99999999999999998743 36788888999999999999999 7889999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||||..+...
T Consensus 161 DFGLAt~le~~ 171 (592)
T KOG0575|consen 161 DFGLATQLEYD 171 (592)
T ss_pred ccceeeeecCc
Confidence 99999988644
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=247.53 Aligned_cols=152 Identities=28% Similarity=0.437 Sum_probs=129.2
Q ss_pred cccccceeecccCceEEEEeEee-----CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..|...+.||+|+||.||++... ++..||||.++.......+.|.+|++++.+++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 35667789999999999998742 4788999998755444556899999999999999999999987532 234
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..+.|..+..++.+++.||.||| ..+|+||||||+||++++++.+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l 149 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--------ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKI 149 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEE
Confidence 5789999999999999997532 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 150 ~dfg~~~~~~~ 160 (284)
T cd05081 150 GDFGLTKVLPQ 160 (284)
T ss_pred CCCcccccccC
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=255.28 Aligned_cols=245 Identities=19% Similarity=0.214 Sum_probs=165.8
Q ss_pred ccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||.||+|+. .++..||||+++... ....+.|.+|+.++..+ +|||||+++++|...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 44688889999999999999863 235689999986432 23345788999999999 899999999998643
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCccc--------------------------------------------------
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------------------------------------------------- 295 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------------------------------------------------- 295 (485)
...++||||+++|+|.++|+.......
T Consensus 112 ---~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 112 ---GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ---CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 357899999999999999975321000
Q ss_pred ----------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccC
Q 041230 296 ----------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 296 ----------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
......++|...++|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 000124788999999999999999999 6789999999999999999999999999997653
Q ss_pred CCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcchhh
Q 041230 360 DTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVS 418 (485)
Q Consensus 360 ~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (485)
..... ..+....++++++...+.--. ........... ........... ....+ .
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~-~~~~~---~ 340 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGY-RMLSP---E 340 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCc-cCCCC---C
Confidence 32110 112223466666543322100 00000000000 00000000000 00000 0
Q ss_pred hHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 419 IILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 419 ~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
.....+.++...|++.+|++||+|.+|+++|++
T Consensus 341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 122456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=257.60 Aligned_cols=233 Identities=20% Similarity=0.315 Sum_probs=174.1
Q ss_pred cccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.+....+.||-|-||.||.|.+.. ...||||.++... -..++|+.|+.+|..|+|||+|+|+|.|... ..+|+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYI 340 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYI 340 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEE
Confidence 345567899999999999999765 4579999997532 3468999999999999999999999999852 35799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|.|||.+|+|.+||+..... .+..---+.+|.||+.||+||. ...+|||||..+|+|+.++..+||+|||
T Consensus 341 iTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999864422 2233345779999999999998 7899999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhhhc----cccchhhhhhhhhhhcccCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEIL----NDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~----d~~~~~~~~~~~~~~~~~~~~ 410 (485)
|+|++..+... ..|..+.++..|+... |+|. .++..-+..+++... ....+
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLL-----WEIATYGMsPYPGidlSqVY~LL-EkgyR 484 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLL-----WEIATYGMSPYPGIDLSQVYGLL-EKGYR 484 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHH-----HHHHhcCCCCCCCccHHHHHHHH-hcccc
Confidence 99998765432 2233444555555433 3332 232222222221110 01111
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
. ..++.|...+.++++.||+-+|.+||++.|+-+.++.+
T Consensus 485 M------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 485 M------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred c------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1 12346999999999999999999999999998888765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=244.17 Aligned_cols=150 Identities=27% Similarity=0.362 Sum_probs=124.8
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+...+.||+|+.|+|||+.. .+++.+|.|.+.... +...++..+|++++.+..||+||.++|.+... +. ...++
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~---~~-~isI~ 156 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN---GE-EISIC 156 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC---Cc-eEEee
Confidence 33457899999999999985 457889999985432 33456789999999999999999999997632 12 58999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
||||.+|||+..+...+ .++...--+||.+|.+||.|||+ .+.||||||||+|||++..+++||+|||.
T Consensus 157 mEYMDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred hhhcCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 99999999999998543 24555667899999999999995 38899999999999999999999999999
Q ss_pred ccccCCC
Q 041230 355 ARFLPDT 361 (485)
Q Consensus 355 a~~~~~~ 361 (485)
++.+..+
T Consensus 226 S~~lvnS 232 (364)
T KOG0581|consen 226 SGILVNS 232 (364)
T ss_pred cHHhhhh
Confidence 9987544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=249.79 Aligned_cols=241 Identities=26% Similarity=0.350 Sum_probs=178.8
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHH--hcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.....+||+|.||.||||++. ++.||||++.. ...+.|++|-.+.+ .++|+||++++++-...+.. ....+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeE
Confidence 3344568999999999999975 59999999853 45678888877765 57999999999875443322 335789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcC------CCCCeeeeccCCCceEecCCCcE
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCD------CQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~------~~~~ivHrdlK~~NILld~~~~~ 347 (485)
|++|.++|||.+||..+ .++|....+||..+|+||+|||+. .+++|+|||||+.|||+..|+++
T Consensus 286 Vt~fh~kGsL~dyL~~n----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred EeeeccCCcHHHHHHhc----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 99999999999999864 478999999999999999999954 46899999999999999999999
Q ss_pred EEeecccccccCCCCccee---------------eecccc-----------HHHHHHHHhhhhhhhhccccc--------
Q 041230 348 HVGDFSMARFLPDTDEQTR---------------FIGKLN-----------VRNFVKMALSQRVEEILNDFN-------- 393 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~~~---------------~~~~~~-----------l~~~~~~~~~~~~~~~~d~~~-------- 393 (485)
.|+|||||..+..+...+. ..+.++ +++.+.. +||++.++-
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLV-----LWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLV-----LWEIASRCTDADPGPVP 430 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHH-----HHHHHhhcccccCCCCC
Confidence 9999999988765443211 112222 2222211 233332211
Q ss_pred ---h---------hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 394 ---L---------QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 394 ---~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+ ..+++.+..+.+.+.++.-+..|... .-+..+++..-.||..||++|-|..-|.+++.++..
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1 12234455566666666655445443 456778899999999999999999999999988754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=239.20 Aligned_cols=236 Identities=17% Similarity=0.263 Sum_probs=164.0
Q ss_pred cccccceeecccCceEEEEeEee----CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||+|.+. .+..||+|.++.... ...+.|.+|+..+.+++||||+++++++.. ..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence 46777889999999999999753 356899999875322 234578999999999999999999998753 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... ..++|...+.++.+++.||+||| ..+++||||||+|||++.++.+|+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l 148 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE--------GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKI 148 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEE
Confidence 5799999999999999997542 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCC
Q 041230 350 GDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 350 ~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~ 409 (485)
+|||.+......... ..++...++++|+...+.--. ... |..................
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~--p~~~~~~~~~~~~~~~~~~ 226 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER--PYWDMSGQDVIKAVEDGFR 226 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCC--CcCcCCHHHHHHHHHCCCC
Confidence 999987653211100 011123455555433221000 000 0000000000000000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.. ....+...+.++...||+.+|++||+|.++.+.|.++
T Consensus 227 ~~-------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LP-------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC-------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 0112455677899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=234.61 Aligned_cols=231 Identities=20% Similarity=0.323 Sum_probs=162.5
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+.|...+.||+|+||.||++...++..+|+|.++.. ....+.|.+|+.++.+++||||++++++|.. ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEEE
Confidence 346667889999999999999888888999987632 2234678999999999999999999998754 2357999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++++... ..++|..+..++.+++.||.||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ--------GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred EEcCCCCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCC
Confidence 99999999999997543 24778889999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
++........ ..+....++++++...+..-. ... .+....... ........... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~~~~~~-~ 222 (256)
T cd05114 147 TRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISRGFRLY-R 222 (256)
T ss_pred ccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCCCCC-C
Confidence 8764321110 011123455555433322110 000 000000000 00000000000 0
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
+ ......+.+++..||+.+|++||+|.+++++|
T Consensus 223 ~------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 P------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 01223567999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=251.26 Aligned_cols=244 Identities=19% Similarity=0.232 Sum_probs=165.4
Q ss_pred ccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||.||++.. .++..||||+++... ....+.+.+|+.++..+ +|+|||+++++|...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 45788889999999999999863 234579999986432 22345688999999999 899999999987642
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCc----------------------------------------------------
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDT---------------------------------------------------- 293 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~---------------------------------------------------- 293 (485)
...++||||+++|+|.++++.....
T Consensus 115 ---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 115 ---GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred ---CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 3579999999999999998643210
Q ss_pred ---------ccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc
Q 041230 294 ---------HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364 (485)
Q Consensus 294 ---------~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~ 364 (485)
........+++...++|+.+++.||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 00011135788889999999999999999 679999999999999999999999999999764322110
Q ss_pred --------------------eeeeccccHHHHHHHHhhhhh-hhhccccc--hhhhhhhhhhhcccCCCCCCcchhhhHH
Q 041230 365 --------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN--LQEIEEDRTMCMHASSSSSTSTHVSIIL 421 (485)
Q Consensus 365 --------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (485)
..++...++++++...+..-. ....-+.. ...... ..... .....+ .
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~---~~~~~-~~~~~~---~--- 338 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK---MVKRG-YQMSRP---D--- 338 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH---HHHcc-cCccCC---C---
Confidence 111223456666543322100 00000000 000000 00000 000000 0
Q ss_pred HHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 422 ECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 422 ~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.....+.++...|++.+|.+||++.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0124567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=244.41 Aligned_cols=154 Identities=24% Similarity=0.386 Sum_probs=130.5
Q ss_pred ccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|.....||+|.||.|||++ +.+|+.||+|++.... .+......+|+.+|.+|.|||||+|.+...... ...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---Cce
Confidence 4467777899999999999998 6779999999986543 444556678999999999999999998876431 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.|||+|||++ ||.-++.... ..|+..+.-.+..|++.||+|+| ..+|+|||||.+|||||.++.+||+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEEecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEec
Confidence 8999999997 8888877544 46778888889999999999999 7899999999999999999999999
Q ss_pred ecccccccCCCC
Q 041230 351 DFSMARFLPDTD 362 (485)
Q Consensus 351 DFGla~~~~~~~ 362 (485)
|||||+++....
T Consensus 261 DFGLAr~y~~~~ 272 (560)
T KOG0600|consen 261 DFGLARFYTPSG 272 (560)
T ss_pred cccceeeccCCC
Confidence 999999875543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=235.48 Aligned_cols=235 Identities=22% Similarity=0.365 Sum_probs=166.3
Q ss_pred cccccceeecccCceEEEEeEeeC----CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||+||+|.+.. ...||||.++.... .....|.+|+.++.+++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----SR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----CC
Confidence 568888999999999999998643 35799998864332 234578999999999999999999998753 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... ..++|....+++.+++.||.||| +.+|+||||||+|||+++++.+||
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l 147 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND--------GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKV 147 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEE
Confidence 5789999999999999997543 25788999999999999999999 688999999999999999999999
Q ss_pred eecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhc-cccchhhhhhhhhhhccc
Q 041230 350 GDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEIL-NDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 350 ~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~-d~~~~~~~~~~~~~~~~~ 407 (485)
+|||+++........ ..++...++++++...+.... .... ......... ......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~~~ 224 (266)
T cd05033 148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAVEDG 224 (266)
T ss_pred CccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH---HHHHcC
Confidence 999999876421110 111223455555543322100 0000 000000000 000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.... ....+...+.+++..|++.+|++||+|.+|++.|+.+
T Consensus 225 ~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRLP-------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0112345677999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=249.37 Aligned_cols=247 Identities=19% Similarity=0.241 Sum_probs=166.8
Q ss_pred hccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCC-cchHHHHHHHHHHHhcC-CCcceeEeeeecccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGARSFKSECKAAINIR-HRNIVRVFTAVSGVD 264 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~ 264 (485)
..+.|...+.||+|+||.||+|+... +..||||+++.... ...+.|.+|+.++.++. |||||+++++|...
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~- 113 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS- 113 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-
Confidence 34577788999999999999997421 34699999864322 23467999999999996 99999999998642
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCccc-------------------------------------------------
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHW------------------------------------------------- 295 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~------------------------------------------------- 295 (485)
...++||||+++|+|.++|+.......
T Consensus 114 ----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 114 ----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 457999999999999999875321000
Q ss_pred --------------------------------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCC
Q 041230 296 --------------------------------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPS 337 (485)
Q Consensus 296 --------------------------------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~ 337 (485)
......++|...+.++.+++.||.||| ..+|+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChH
Confidence 000124788889999999999999999 678999999999
Q ss_pred ceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhh
Q 041230 338 NVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQE 396 (485)
Q Consensus 338 NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~ 396 (485)
|||++.++.+||+|||+++........ ..+....++++|+...+.--. ....-+.....
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999999865322110 011223456666543322100 00000000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
............ . .....+...+.+++..|++.+|++||+|.+|+++|+.+
T Consensus 347 -~~~~~~~~~~~~-~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 -STFYNKIKSGYR-M------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -HHHHHHHhcCCC-C------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 000000000000 0 00112345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=233.57 Aligned_cols=236 Identities=22% Similarity=0.331 Sum_probs=169.2
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++|...+.||+|+||.||+|...+++.||||.++... ...+.|.+|+.++.+++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCeee
Confidence 45688889999999999999997778889999986432 235679999999999999999999998753 235799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++..... ..++|.....++.+++.||.||| ..+|+||||||+||++++++.+||+|||
T Consensus 79 v~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred eeecccCCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcc
Confidence 9999999999999975431 35788999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+++........ ..++...++++++...+.... ....-..... ...............
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~~- 225 (261)
T cd05068 149 LARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGYRMPC- 225 (261)
T ss_pred eEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCCCCC-
Confidence 99865422110 011223466666544332111 1110000000 000000000000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
...+...+.+++..|++.+|++||+|.++.++|+.
T Consensus 226 ------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 ------PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11234567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=235.45 Aligned_cols=239 Identities=21% Similarity=0.339 Sum_probs=171.5
Q ss_pred hccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+..+|...+.||+|+||.||+|...++..+|+|.+..........+..|+.++..++|+||+++++++... ...+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeE
Confidence 44578888999999999999999878899999998765444567789999999999999999999987643 3578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.++++.... ..+.+.....++.+++.||.||| ..+|+||||||+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~ 148 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADF 148 (261)
T ss_pred EEEeecccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccc
Confidence 99999999999999986432 35788899999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|++......... ..+....++++++...+.... .......... .+........ ...
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~-~~~-- 223 (261)
T cd05148 149 GLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQITAG-YRM-- 223 (261)
T ss_pred cchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHHhC-CcC--
Confidence 999765332110 111223455555543322110 0110000000 0000000000 000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
+....+...+.+++..|++.+|++||||.++.+.|+.+
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 ----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00112445677999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=233.97 Aligned_cols=235 Identities=21% Similarity=0.367 Sum_probs=165.7
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||.||+|...++..||+|.+.... ...+.|.+|+.++.+++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcEEE
Confidence 4677788999999999999998888899999876432 235689999999999999999999988653 3457999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.++++.... ..+.+.++..++.+++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred EecCCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999975432 35778889999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
++........ ..++...++++++...+.--. ....-+.... ...............
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~~~~-- 225 (261)
T cd05072 150 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGYRMPR-- 225 (261)
T ss_pred ceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCCCCCC--
Confidence 9865432110 001112355555433222100 0000000000 000000000000000
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
...+...+.++...|+..+|++||+|.++.+.|+.
T Consensus 226 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 -----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=234.54 Aligned_cols=243 Identities=19% Similarity=0.271 Sum_probs=162.2
Q ss_pred ccceeecccCceEEEEeEeeCCc---EEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCceee
Q 041230 198 SSANLIGAGNFGSVYNGTLFDGT---TIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGARFK 271 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~~~~---~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~ 271 (485)
+....||+|+||.||+|...++. .||||.++... ....+.|..|++++.+++|+||++++++|..... ......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 44678999999999999865432 58999876432 2335678999999999999999999998753211 122346
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++|+|.+++...... .....++|.....++.+++.||.||| ..+|+||||||+|||+++++.+||+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECC
Confidence 8999999999999988532110 01134788889999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCC
Q 041230 352 FSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 352 FGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
||+++........ ..++...++++++...+.... ....-+.. ...............
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--~~~~~~~~~~~~~~~ 233 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--ENSEIYDYLRQGNRL 233 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCC
Confidence 9999875332110 001122455555543322110 00000000 000000000000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
... ..+...+.+++..|++.+|++||||.+++++|+.+
T Consensus 234 ~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 KQP-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 12344567999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=251.78 Aligned_cols=229 Identities=21% Similarity=0.341 Sum_probs=166.7
Q ss_pred cccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.+...-||+|+-|.||+|++. +..||||+++..+ ..+++.|.+|+|+||+.|.|.|... ...++|||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 345678999999999999975 6889999875332 2478899999999999999999753 35799999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
||+.|-|.+.|+.... ..-..-+....+||.||.||| .+.|||||||+-||||..+-.+||+|||.++
T Consensus 193 fCa~GqL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred ccccccHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchH
Confidence 9999999999987543 222334567789999999999 6789999999999999999999999999999
Q ss_pred ccCCCCcceee-----------------eccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcchhhh
Q 041230 357 FLPDTDEQTRF-----------------IGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSI 419 (485)
Q Consensus 357 ~~~~~~~~~~~-----------------~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (485)
.+.+..+...| .+++++++|+...++.-..|+.-..... ....|+.... ..+.+.
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGVGsN--sL~Lpv 332 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGVGSN--SLHLPV 332 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------heeEEeccCC--cccccC
Confidence 87655433223 2455666665544332223322111100 0011111111 122233
Q ss_pred HHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 420 ILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 420 ~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
+.+|..-+.-+...||...|..||++++++..|+-....
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 456888888888999999999999999999988765443
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=232.65 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=166.0
Q ss_pred cccceeecccCceEEEEeEeeC----CcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCce
Q 041230 197 FSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGAR 269 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 269 (485)
|...+.||+|+||.||+|.... +..||||.++.... .....|.+|++.+.+++|+||+++++++..... .+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3456789999999999998643 36799999874322 234578999999999999999999998764332 2234
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|..++....... ....+++.....++.+++.||.||| ..+|+||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEE
Confidence 5789999999999999986532110 1135788889999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccC
Q 041230 350 GDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 350 ~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~ 408 (485)
+|||+++........ ..+....++++++...+..-. ... +.......+.........
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~--p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT--PYPGVENHEIYDYLRHGN 232 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHcCC
Confidence 999999865322110 111223456666543332110 000 000000000000000000
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
. . .....+...+.+++..|++.+|++||++.+|++.|+.+
T Consensus 233 ~-~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 R-L------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-C------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 00112445678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=243.43 Aligned_cols=245 Identities=18% Similarity=0.237 Sum_probs=164.7
Q ss_pred cccccceeecccCceEEEEeEe------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecccccC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 266 (485)
+.|...+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +|+|||+++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 4677889999999999999962 3567899999864322 2345688999999999 789999999987532
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCccc---------------------------------------------------
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHW--------------------------------------------------- 295 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~--------------------------------------------------- 295 (485)
....++|+||+++|+|.++++.......
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 2356899999999999999975321000
Q ss_pred -------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc----
Q 041230 296 -------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ---- 364 (485)
Q Consensus 296 -------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~---- 364 (485)
......+.|..+..++.+++.||.||| ..+|+||||||+|||+++++.+||+|||+++........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 000124688889999999999999999 689999999999999999999999999998764221110
Q ss_pred ----------------eeeeccccHHHHHHHHhhhhh-hhhccccc--hhhhhhhhhhhcccCCCCCCcchhhhHHHHHH
Q 041230 365 ----------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN--LQEIEEDRTMCMHASSSSSTSTHVSIILECVN 425 (485)
Q Consensus 365 ----------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (485)
..+....++++++...+..-. .....+.. ....... .... .....+ .....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~-~~~~~~------~~~~~ 309 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKEG-TRMRAP------DYTTP 309 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH---Hhcc-CCCCCC------CCCCH
Confidence 111223455555433222100 00000000 0000000 0000 000000 00123
Q ss_pred HHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 426 SICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 426 ~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
.+.+++..||+.+|++||++.+|++.|+.+-
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5678999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=234.96 Aligned_cols=237 Identities=21% Similarity=0.315 Sum_probs=164.7
Q ss_pred cccceeecccCceEEEEeEe-----eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|.....||+|+||+||.+.. .++..||+|.++.... .....|.+|++++.+++||||++++++|... ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence 35668899999999987542 3577899999864322 2356788999999999999999999987642 2345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++... .++|..+..|+.+++.||.||| ..+|+||||||+|||+++++.+||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEe
Confidence 78999999999999999642 4788899999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh------------hhhccccchhh-
Q 041230 351 DFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV------------EEILNDFNLQE- 396 (485)
Q Consensus 351 DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~------------~~~~d~~~~~~- 396 (485)
|||+++........ .......++++++...+.... .+..+......
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 99999865432110 111223456666543322110 01110000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
.............. +....+...+.++...|++.+|++||+|.+|++.|+.+.
T Consensus 230 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 230 VVRLIELLERGMRL-------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhhcCCCC-------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000000000000 001123456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=234.29 Aligned_cols=237 Identities=19% Similarity=0.303 Sum_probs=160.2
Q ss_pred cccccceeecccCceEEEEeEee-CCc----EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGT----TIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~----~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.|...+.||+|+||+||+|... +|. .+++|.+..... ....++..|+..++++.|||||+++++|.+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 35667789999999999999853 454 367777643221 123567788889999999999999998753
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++++||+++|+|.++++... ..++|.....++.|++.||.||| ..+++||||||+|||+++++.+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~k 149 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR--------DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQ 149 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEE
Confidence 23578999999999999997543 24788899999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
|+|||+++........ ..++...++++++...+.-.. ... +................
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~--p~~~~~~~~~~~~~~~~ 227 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAE--PYAGMRPHEVPDLLEKG 227 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHCC
Confidence 9999999865332110 001122355555433222100 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.....+ ..+...+..+...|++.+|+.||+|.++++.|..+.+
T Consensus 228 -~~~~~~------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 -ERLAQP------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 000000 1133456678899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-28 Score=234.93 Aligned_cols=224 Identities=17% Similarity=0.214 Sum_probs=151.4
Q ss_pred eecccCceEEEEeEeeC-------------------------CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeE
Q 041230 202 LIGAGNFGSVYNGTLFD-------------------------GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV 256 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~-------------------------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l 256 (485)
.||+|+||.||+|.+.. ...||+|.++.........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 13588898865433345678899999999999999999
Q ss_pred eeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 257 ~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
+++|... ...++||||+++|+|..++.... ..+++..++.++.|+++||.||| ..+|+||||||
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp 145 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEK--------GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCA 145 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCc
Confidence 9998743 35789999999999999987532 24677889999999999999999 67899999999
Q ss_pred CceEecCCC-------cEEEeecccccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccc
Q 041230 337 SNVLLDDEM-------IGHVGDFSMARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN 393 (485)
Q Consensus 337 ~NILld~~~-------~~ki~DFGla~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~ 393 (485)
+|||+++++ .+|++|||++......... ..+....++++|+...+.-.. ... +..
T Consensus 146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~--p~~ 223 (274)
T cd05076 146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEV--PLK 223 (274)
T ss_pred ccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC--Ccc
Confidence 999998654 3799999988643221100 112223456666543322100 000 000
Q ss_pred hhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 394 LQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
................... .....+.+++..|++.+|++||+|.+|++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 224 ERTPSEKERFYEKKHRLPE---------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccChHHHHHHHHhccCCCC---------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0000000000000000000 0113467899999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-27 Score=230.43 Aligned_cols=235 Identities=19% Similarity=0.297 Sum_probs=165.2
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+|...+.||+|+||.||+|... +++.||+|.++.. ......|.+|++++.+++|+||++++++|... ...++|
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 80 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYII 80 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEEE
Confidence 5777789999999999999854 4788999988643 23356789999999999999999999987642 356899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++..... ..+.|..++.++.|++.||.||| ..+++||||||+|||+++++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 81 TEFMTYGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred EEeCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcc
Confidence 999999999999975432 25788899999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
++........ ..++...++++++...+..-. ... +.......+............
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~--p~~~~~~~~~~~~~~~~~~~~--- 225 (263)
T cd05052 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEKGYRME--- 225 (263)
T ss_pred ccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHCCCCCC---
Confidence 9875432110 001112355555433222110 000 000000000000000000000
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
....+...+.++...|++.+|++||+|.+++++|+.+
T Consensus 226 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 ----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0011335677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=234.54 Aligned_cols=246 Identities=20% Similarity=0.329 Sum_probs=169.2
Q ss_pred ccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
+|...+.||+|+||.||+|... ++..+++|.++.......+.|.+|++++++++|+||+++++++... .
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----D 80 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----C
Confidence 4667789999999999999743 3456899987654444456799999999999999999999987642 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
..++||||+++|+|.+++....... .......++|..++.|+.+++.||.||| ..+|+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEc
Confidence 5799999999999999997543210 0011135889999999999999999999 77899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDR 401 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~ 401 (485)
.++.+||+|||+++........ ..+....++++++...+.... ... +.......+..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~--p~~~~~~~~~~ 235 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ--PWFQLSNTEVI 235 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCC--CCCCCCHHHHH
Confidence 9999999999999764322110 111223456666543322111 000 00000000000
Q ss_pred hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 402 TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
.......... ....+...+.++...|++.+|++||+|.+|+++|+.+.+.
T Consensus 236 ~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLE-------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCC-------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0000000000 0011345577999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=234.09 Aligned_cols=240 Identities=20% Similarity=0.329 Sum_probs=167.2
Q ss_pred ccccceeecccCceEEEEeEee-----CCcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-----~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.|...+.||+|+||.||++... ++..||||.++..... ..+.|.+|++++.++.|+||+++++++... +..
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CCC
Confidence 4555688999999999999853 3678999998754433 356899999999999999999999887532 234
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..++|..+..++.+++.||.||| ..+++||||||+||+++.++.+||
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l 150 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKI 150 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc--------cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEE
Confidence 6799999999999999997643 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhhhhccccchhh------------
Q 041230 350 GDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQE------------ 396 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~------------ 396 (485)
+|||++......... ..+....++++++...+..-............
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc
Confidence 999999876522110 01112235555543332210000000000000
Q ss_pred -hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 397 -IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 397 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
........... .. ......+...+.+++..|++.+|++||+|.+|+++|+.|+
T Consensus 231 ~~~~~~~~~~~~-~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 231 IVTRLLELLKEG-ER------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cHHHHHHHHHcC-Cc------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 00000000000 00 0001124456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=236.53 Aligned_cols=149 Identities=23% Similarity=0.351 Sum_probs=120.9
Q ss_pred ccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcc-------hHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 196 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG-------ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.|-..+.||+|+||.|-+|. -.+|+.||||+++...... .....+|+++|.+++|||||++.+++...
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~---- 248 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP---- 248 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC----
Confidence 44556889999999999997 4679999999997533211 12346899999999999999999997643
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC---
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE--- 344 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~--- 344 (485)
++.|+|+|||.+|+|.+.+-+++.. ....---++.|+..|+.||| +.+|+||||||+||||..+
T Consensus 249 -ds~YmVlE~v~GGeLfd~vv~nk~l---------~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 249 -DSSYMVLEYVEGGELFDKVVANKYL---------REDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred -CceEEEEEEecCccHHHHHHhcccc---------ccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcc
Confidence 4569999999999999999765432 22223348899999999999 7899999999999999765
Q ss_pred CcEEEeecccccccCCC
Q 041230 345 MIGHVGDFSMARFLPDT 361 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~ 361 (485)
..+||+|||+|++..+.
T Consensus 316 ~llKItDFGlAK~~g~~ 332 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEG 332 (475)
T ss_pred eEEEecccchhhccccc
Confidence 88999999999987543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=229.40 Aligned_cols=147 Identities=24% Similarity=0.424 Sum_probs=126.1
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+|.....||+|+||+||+|...++..+|||.++... .....|.+|+.++.+++||||++++++|... ...++||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 78 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYIVT 78 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEEEE
Confidence 455667899999999999987777789999876432 2356799999999999999999999987642 3468999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... ..+.|...+.|+.+++.||.||| ..+++|+||||+||+++.++.+||+|||++
T Consensus 79 e~~~~~~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 79 EYMSNGCLLNYLREHG--------KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred EcCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999997532 24788899999999999999999 779999999999999999999999999998
Q ss_pred cccC
Q 041230 356 RFLP 359 (485)
Q Consensus 356 ~~~~ 359 (485)
+...
T Consensus 148 ~~~~ 151 (256)
T cd05113 148 RYVL 151 (256)
T ss_pred eecC
Confidence 8653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=230.91 Aligned_cols=237 Identities=22% Similarity=0.362 Sum_probs=165.4
Q ss_pred ccccccceeecccCceEEEEeEee-CCc---EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGT---TIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~---~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+++|...+.||+|+||.||+|... ++. .+|||.++... ....+.|.+|++++.+++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 357778899999999999999864 333 68999876432 22346789999999999999999999987643
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++.... ..++|..+..++.+++.||.||| ..+++||||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~k 147 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD--------GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECK 147 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEE
Confidence 35789999999999999997543 24788899999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..+....++++++...+..-. ... +...............
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~--p~~~~~~~~~~~~i~~ 225 (268)
T cd05063 148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER--PYWDMSNHEVMKAIND 225 (268)
T ss_pred ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCC--CCCcCCHHHHHHHHhc
Confidence 9999999865432110 001122355555433222100 000 0000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.... +....+...+.+++..|++.+|++||+|.+|++.|+++
T Consensus 226 ~~~~-------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRL-------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 00112445678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=241.34 Aligned_cols=245 Identities=19% Similarity=0.272 Sum_probs=166.2
Q ss_pred cccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecccccC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 266 (485)
+.|...+.||+|+||.||+|... +++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 46777899999999999998632 246899999864322 2235678899999999 899999999987532
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcc----------------------------------------------------
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTH---------------------------------------------------- 294 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~---------------------------------------------------- 294 (485)
....++++||+++|+|.++|.......
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 235789999999999999986432100
Q ss_pred cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc----------
Q 041230 295 WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ---------- 364 (485)
Q Consensus 295 ~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~---------- 364 (485)
.......++|..+..++.+|+.||.||| ..+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 0000125789999999999999999999 679999999999999999999999999999865321110
Q ss_pred ----------eeeeccccHHHHHHHHhhhhh-hhhccc--cchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHH
Q 041230 365 ----------TRFIGKLNVRNFVKMALSQRV-EEILND--FNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIG 431 (485)
Q Consensus 365 ----------~~~~~~~~l~~~~~~~~~~~~-~~~~d~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ia 431 (485)
..+....++++++...+.... ...... .....+... + ... ..... .......+.+|+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--~-~~~-~~~~~------~~~~~~~~~~l~ 309 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--L-KEG-TRMRA------PEYATPEIYSIM 309 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--H-hcc-CCCCC------CccCCHHHHHHH
Confidence 111223466666543322100 000000 000000000 0 000 00000 011334677999
Q ss_pred HhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 432 VACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 432 l~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
..|++.+|++||++.+|+++|+.+-
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=232.70 Aligned_cols=247 Identities=19% Similarity=0.325 Sum_probs=169.2
Q ss_pred cccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||++... ++..+|+|.+..........|.+|++++.+++||||++++++|...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----
Confidence 46778899999999999999742 2456899988654444456799999999999999999999987642
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCccc----ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHW----RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~----~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
...++||||+++|+|.+++........ ......+++.....++.+++.||.||| ..+++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence 457999999999999999975432100 011135899999999999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhh
Q 041230 345 MIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTM 403 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~ 403 (485)
+.+||+|||+++........ ..+....++++++...+.... ... +............
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~--p~~~~~~~~~~~~ 234 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ--PWYQLSNNEVIEC 234 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC--CCCCCCHHHHHHH
Confidence 99999999999754322110 011223455555433222110 000 0000000000000
Q ss_pred hcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
......... ...+...+.++...|++.+|.+||||.+|++.|+.+...
T Consensus 235 i~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQR-------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000000000 001234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=233.25 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=164.5
Q ss_pred hccccccceeecccCceEEEEeEee------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
.+++|...+.||+|+||.||+|... ++..||||.++... .....+|.+|+.++.+++|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 4667888999999999999998742 24679999875432 2234568999999999999999999998753
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCc-ccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDT-HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~-~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
....++|+||+++|+|.++++..... ........++|...+.++.+++.||.||| ..+++||||||+|||++++
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence 23578999999999999999753211 00011134678889999999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhh
Q 041230 345 MIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTM 403 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~ 403 (485)
+.+||+|||+++........ ..++...++++++...+..-. ... +............
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~--p~~~~~~~~~~~~ 233 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGMSNEQVLRF 233 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence 99999999998754322110 011122345555433222100 000 0000000000000
Q ss_pred hcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
......... ...+...+.++...|++.+|++||++.++++.|+
T Consensus 234 ~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000000000 0123446778999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=243.91 Aligned_cols=246 Identities=17% Similarity=0.200 Sum_probs=166.1
Q ss_pred hhccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcC-CCcceeEeeeeccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIR-HRNIVRVFTAVSGV 263 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~ 263 (485)
...++|.....||+|+||.||+|... .++.||||+++.... ...+.|.+|+.++.++. |||||+++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456777889999999999999853 245799999975322 23457889999999997 99999999998642
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCccc------------------------------------------------
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW------------------------------------------------ 295 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~------------------------------------------------ 295 (485)
...++|+||+++|+|.++|+.......
T Consensus 114 -----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 114 -----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred -----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 357999999999999999975421000
Q ss_pred -----------------------------------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 296 -----------------------------------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 296 -----------------------------------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
......++|...+.|+.+++.||.||| ..+|+||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccC
Confidence 001124688888999999999999999 678999999
Q ss_pred CCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhcccc-
Q 041230 335 KPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDF- 392 (485)
Q Consensus 335 K~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~- 392 (485)
||+|||+++++.+||+|||+++........ ..+....++++|+...+.... ....-+.
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999864321110 001122355555433222100 0000000
Q ss_pred -chhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 393 -NLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 393 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
....... ....... ...+ ..+...+.+++..||+.+|++||+|.+|+..|+.+
T Consensus 346 ~~~~~~~~---~~~~~~~-~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 346 PMNEQFYN---AIKRGYR-MAKP------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CchHHHHH---HHHcCCC-CCCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0000000 0000000 0000 01234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=233.19 Aligned_cols=243 Identities=18% Similarity=0.289 Sum_probs=164.2
Q ss_pred ccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+|...+.||+|+||.||+|... ....+|+|.+..... ...+.|.+|+.++..++|||||+++++|.. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence 3566789999999999999743 235688888764332 234678999999999999999999998764 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcc---------------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTH---------------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCN 333 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~---------------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrd 333 (485)
...++|+||+++|+|.+++....... .......++|...+.++.+++.||.||| ..+|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 35789999999999999987432110 0011135789999999999999999999 67899999
Q ss_pred cCCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccc
Q 041230 334 LKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LND 391 (485)
Q Consensus 334 lK~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~ 391 (485)
|||+|||+++++.+||+|||+++........ ..+....++++++...+..-. ... .+.
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999764221110 001122355555533222110 000 000
Q ss_pred cchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 392 FNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
.....+ .......... .....+...+.+++..|++.+|++||+|.++++.|+.+-
T Consensus 233 ~~~~~~---~~~~~~~~~~-------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 233 IAPERL---FNLLKTGYRM-------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCHHHH---HHHHhCCCCC-------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 000010 0000000000 001123346778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=232.50 Aligned_cols=244 Identities=20% Similarity=0.338 Sum_probs=165.5
Q ss_pred cccccceeecccCceEEEEeEeeCC------cEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDG------TTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~------~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|.....||+|+||.||+|..... ..||+|.++.... .....|.+|+.++.+++||||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----- 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----
Confidence 3567778999999999999985432 5799998864322 234568999999999999999999998753
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NIL 340 (485)
....+++|||+++|+|.++|........ ......+++...+.++.+++.||.||| ..+++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence 2357899999999999999975422110 011135788889999999999999999 678999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhh
Q 041230 341 LDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEED 400 (485)
Q Consensus 341 ld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 400 (485)
+++++.+||+|||+++........ ..++...++++++...+...... .-+.......+.
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g-~~p~~~~~~~~~ 235 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYG-LQPYYGFSNQEV 235 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCC-CCCCCCCCHHHH
Confidence 999999999999999764322110 11122345555554332211000 000000000000
Q ss_pred hhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 401 RTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
.......... .....+...+.+|...||+.+|.+||++.+|+++|+.
T Consensus 236 ~~~i~~~~~~-------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLL-------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcC-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0000000000 0112355677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=237.15 Aligned_cols=247 Identities=20% Similarity=0.266 Sum_probs=162.3
Q ss_pred cccccceeecccCceEEEEeEeeC-------------C--cEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-------------G--TTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFT 258 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-------------~--~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~ 258 (485)
+.|...+.||+|+||.||++.... + ..||||.++.... .....|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 457777899999999999986432 2 2489998864322 23457999999999999999999999
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCcc---cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTH---WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~---~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
++.. ....++||||+++|+|.+++....... .......+.|..++.|+.+++.||.||| ..+++|||||
T Consensus 85 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk 156 (295)
T cd05097 85 VCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA 156 (295)
T ss_pred EEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence 9764 245799999999999999996532110 0011124688899999999999999999 6789999999
Q ss_pred CCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccc--
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFN-- 393 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~-- 393 (485)
|+||++++++.+||+|||+++........ ..++...++++++...+.....--..+..
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999999999764322110 01122345555553332210000000000
Q ss_pred -hhh-hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 394 -LQE-IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 394 -~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
... ................ . .....+...+.+++..|++.+|++||+|.+|++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SDEQVIENTGEFFRNQGRQIY-L---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ChHHHHHHHHHhhhhcccccc-C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000 0000000000000000 0 000012356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=230.58 Aligned_cols=237 Identities=19% Similarity=0.328 Sum_probs=164.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCc----EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~----~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.|...+.||+|+||+||+|.. .+|. .||+|.++... ....+.+.+|+.++..++|+||++++++|..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------ 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------ 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence 4677788999999999999984 3454 47999886432 2234678899999999999999999998853
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++++||+++|+|.++++... ..+.+...+.++.+++.||.||| +.+|+||||||+|||+++++.+|
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~k 149 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK--------DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVK 149 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEE
Confidence 23579999999999999997543 24778899999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..+....++++++...+.--. ... .+........ .....
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~ 226 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLLEK 226 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHC
Confidence 9999999865322110 011122355555433222100 000 0000000000 00000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... ....+...+.++...|++.+|+.||++.+++..|+.+...
T Consensus 227 ~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 227 GERLP-------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCcCC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 00000 0112345567899999999999999999999988877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=231.20 Aligned_cols=247 Identities=17% Similarity=0.261 Sum_probs=170.0
Q ss_pred ccccccceeecccCceEEEEeEeeC-----CcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.++|...++||+|+||.||+|...+ +..|++|.++... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4567788999999999999999765 6789999886432 23346788999999999999999999987532
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++++||+++|+|.++|......... ....+++..+..++.+++.||.||| +.+++||||||+||++++++.+
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEAN-NPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcE
Confidence 24578999999999999999754221100 1135889999999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhc
Q 041230 348 HVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~ 405 (485)
||+|||+++.+.....+ ..+....++++++...+..-. ... .+.....++. .
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~ 230 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA------A 230 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH------H
Confidence 99999999865322111 001122344444432221000 000 0000000000 0
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... ... .....+...+.+++..|++.+|++||++.+|++.|+.+.++
T Consensus 231 ~~~~~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 YLKDG-YRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHcC-CCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00000 000 00112345678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=219.44 Aligned_cols=148 Identities=26% Similarity=0.436 Sum_probs=125.4
Q ss_pred cccceeecccCceEEEEeE-eeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|.....||+|.||.||+|. ..+|+.||||+++... .+....-.+|+..|..++|+|||.|++++.. ....-|
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-----~~~l~l 78 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-----KSNLSL 78 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-----CCceEE
Confidence 4456789999999999998 5679999999987542 3445678899999999999999999988654 235789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+|||+. +|+..++.+. ..|....--.++.++.+||+||| ...|+||||||.|+|+++++..||+|||
T Consensus 79 VfEfm~t-dLe~vIkd~~--------i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKN--------IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred EEEeccc-cHHHHhcccc--------cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeeccc
Confidence 9999985 9999998764 24555666678999999999999 7889999999999999999999999999
Q ss_pred cccccCCC
Q 041230 354 MARFLPDT 361 (485)
Q Consensus 354 la~~~~~~ 361 (485)
+|+.+...
T Consensus 147 LAr~f~~p 154 (318)
T KOG0659|consen 147 LARFFGSP 154 (318)
T ss_pred chhccCCC
Confidence 99988644
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=228.47 Aligned_cols=232 Identities=23% Similarity=0.355 Sum_probs=157.6
Q ss_pred eeecccCceEEEEeEeeC----CcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||.||+|...+ +..||||.+.... ....+.|.+|+.++++++||||++++++|... +...++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 468999999999998542 3579999875332 23356788999999999999999999977532 23468999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... ..+.+...+.++.+++.||.||| ..+++||||||+|||+++++.+||+|||++
T Consensus 77 e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~ 145 (262)
T cd05058 77 PYMKHGDLRNFIRSET--------HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLA 145 (262)
T ss_pred ecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccc
Confidence 9999999999997543 13466778889999999999999 678999999999999999999999999998
Q ss_pred cccCCCCc-----------c-----------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCC
Q 041230 356 RFLPDTDE-----------Q-----------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 356 ~~~~~~~~-----------~-----------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
+....... . ..++...++++|+...+.--. ........ ................
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~- 222 (262)
T cd05058 146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQGRRLL- 222 (262)
T ss_pred ccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhcCCCCC-
Confidence 75432110 0 011123355555433222100 00000000 0000000000000000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
....+...+.++...|++.+|++||++.+|+++|+.+.
T Consensus 223 ------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 ------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00112346779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=228.74 Aligned_cols=156 Identities=23% Similarity=0.311 Sum_probs=130.7
Q ss_pred chhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
|++.+++++.....||+|+||.||+|.. .++..||+|.+........+.|.+|+.++.+++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 77 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN---- 77 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC----
Confidence 3456788888889999999999999985 45778999988755444567899999999999999999999987642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCc
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMI 346 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~ 346 (485)
...++|+||+++++|.++++..... ....+.....++.+++.||.||| ..+|+||||||+||+++. ++.
T Consensus 78 -~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 78 -GFFKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred -CEEEEEEecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCe
Confidence 4678999999999999999753211 11266777889999999999999 679999999999999986 679
Q ss_pred EEEeeccccccc
Q 041230 347 GHVGDFSMARFL 358 (485)
Q Consensus 347 ~ki~DFGla~~~ 358 (485)
+||+|||++...
T Consensus 148 ~~l~dfg~~~~~ 159 (268)
T cd06624 148 VKISDFGTSKRL 159 (268)
T ss_pred EEEecchhheec
Confidence 999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=227.12 Aligned_cols=226 Identities=20% Similarity=0.312 Sum_probs=156.2
Q ss_pred ecccCceEEEEeEee---CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||.||+|.+. .+..||||.+..... ...+.|.+|+.++.+++|+||++++++|.. ...++|+||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEeC
Confidence 899999999999754 345699998864432 234568999999999999999999998742 2468999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++.... ..+++..+++++.+++.||.||| ..+++||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 77 SGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred CCCCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence 9999999997533 24778899999999999999999 678999999999999999999999999999765
Q ss_pred CCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccc-hhhhhhhhhhhcccCCCCCCcc
Q 041230 359 PDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN-LQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 359 ~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~-~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
...... ..++...++++++...+.... ........ ..+. ............
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~--- 219 (257)
T cd05115 146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIEQGKRLDC--- 219 (257)
T ss_pred cCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHCCCCCCC---
Confidence 332110 001112344554432221000 00000000 0000 000000000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
+..+...+.++...||+.+|++||+|.+|.+.|+.+
T Consensus 220 ----~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 ----PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 012345667899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=231.28 Aligned_cols=243 Identities=19% Similarity=0.310 Sum_probs=162.2
Q ss_pred cccccceeecccCceEEEEeEe-----eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|+..+.||+|+||+||+|.. .++..||+|.++.... .....|.+|++++.+++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence 3566778999999999999974 2457899999864322 233578899999999999999999998653 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCc--------ccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDT--------HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~--------~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NIL 340 (485)
...++||||+++|+|.+++...... ........+++...+.++.+++.||.||| ..+|+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence 3579999999999999999643210 00011134788889999999999999999 678999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhh
Q 041230 341 LDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEED 400 (485)
Q Consensus 341 ld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 400 (485)
+++++.+||+|||+++........ ..++...++++|+...+....... .+.........
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~-~p~~~~~~~~~ 235 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL-QPYYGFSNQEV 235 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCC-CCCCCCCHHHH
Confidence 999999999999999764321100 011223455555433222100000 01000000000
Q ss_pred hhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 401 RTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
............ ...+...+.++...|++.+|++||++.+|.++|.
T Consensus 236 ~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 236 IEMVRKRQLLPC-------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHcCCcCCC-------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 000000000000 0113445678899999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=270.60 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=167.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
...|...+.||+|+||.||+|.. .+|..||||+++.... ....|++.+.+++|||||+++|+|... ...+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCE
Confidence 34577888999999999999986 5789999998864322 123468899999999999999998643 3578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.++++ .++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. |
T Consensus 760 lv~Ey~~~g~L~~~l~------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred EEEeCCCCCcHHHHHh------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 9999999999999995 26789999999999999999998888999999999999999999998886 6
Q ss_pred ccccccCCC--------------CcceeeeccccHHHHHHHHhhhhhhhh-ccccch--hhhhh-hhhh---h-cccCCC
Q 041230 353 SMARFLPDT--------------DEQTRFIGKLNVRNFVKMALSQRVEEI-LNDFNL--QEIEE-DRTM---C-MHASSS 410 (485)
Q Consensus 353 Gla~~~~~~--------------~~~~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~--~~~~~-~~~~---~-~~~~~~ 410 (485)
|.+...... -....++...++++|+...++--.... .|.... ....+ .+.. . ...+..
T Consensus 827 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 827 SLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence 665432111 011223445677777654433111110 010000 00000 0000 0 000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
...........+++..+.+++..||+.+|++||+|.||+++|+.+..
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00000001123466788899999999999999999999999998755
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=228.66 Aligned_cols=160 Identities=23% Similarity=0.359 Sum_probs=127.1
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.+|.....||+|+||+|||+. +.+|..||.|.++-.. ....+....|+.+|++++|||||+.+++-.. .+.+..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 357778899999999999997 6889999999886322 2234567889999999999999998764211 122347
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeeccCCCceEecCCCcEEEe
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQ-PRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~-~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.+||||+..|+|.+++..-.. ....+..+.-.++..|+++||..+|.... ..|+||||||.||+|+.++.+|++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~-----qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKK-----QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHh-----ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 899999999999999864211 11346677788899999999999995322 239999999999999999999999
Q ss_pred ecccccccCCCC
Q 041230 351 DFSMARFLPDTD 362 (485)
Q Consensus 351 DFGla~~~~~~~ 362 (485)
||||++++....
T Consensus 171 DfGL~r~l~s~~ 182 (375)
T KOG0591|consen 171 DFGLGRFLSSKT 182 (375)
T ss_pred cchhHhHhcchh
Confidence 999999986543
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=228.95 Aligned_cols=236 Identities=22% Similarity=0.353 Sum_probs=162.5
Q ss_pred cccccceeecccCceEEEEeEee-C---CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-D---GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~---~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||+|... + +..+|+|.++.... ...+.|.+|+.++.+++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence 45677789999999999999853 2 23689998864322 234678999999999999999999998753 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... ..+++.+.+.|+.+++.||.||| +.+++||||||+|||++.++.+|+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l 147 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKV 147 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEe
Confidence 5799999999999999997543 24788889999999999999999 688999999999999999999999
Q ss_pred eecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 350 GDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
+|||+++........ ..++...++++++...+.--. ... +.......+........
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~--p~~~~~~~~~~~~~~~~ 225 (267)
T cd05066 148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER--PYWEMSNQDVIKAIEEG 225 (267)
T ss_pred CCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCC--CcccCCHHHHHHHHhCC
Confidence 999999865432110 001112344444432221000 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
... +....+...+.+++..|++.+|++||+|.+|++.|+.+
T Consensus 226 ~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRL-------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcC-------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 00011334567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=232.84 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=173.2
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHH--hcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.....+.||+|.||.|++|.+ .|..||||++.. .+.+.|.+|.++.. .|||+||+.+++.-... ...--..+|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQLwL 286 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQLWL 286 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEEEE
Confidence 345568899999999999986 588999999863 24466777777654 57999999998763211 111235799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhc-----CCCCCeeeeccCCCceEecCCCcEE
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHC-----DCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~-----~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
|.+|.++|||++||... .++-...++++..+|.||+|||. ..+|.|.|||||+.|||+..++.+.
T Consensus 287 vTdYHe~GSL~DyL~r~----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eeecccCCcHHHHHhhc----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 99999999999999863 35667889999999999999993 4578999999999999999999999
Q ss_pred EeecccccccCCCCcc-----------ee------eecc-----------ccHHHHHHHHhh--------hhhhhhcccc
Q 041230 349 VGDFSMARFLPDTDEQ-----------TR------FIGK-----------LNVRNFVKMALS--------QRVEEILNDF 392 (485)
Q Consensus 349 i~DFGla~~~~~~~~~-----------~~------~~~~-----------~~l~~~~~~~~~--------~~~~~~~d~~ 392 (485)
|+|+|||......... .. ..+. .++++|+...++ +.+.+-.-|+
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999765443221 00 1111 134444433222 1111111111
Q ss_pred c-----hhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 393 N-----LQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 393 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
. ...+++.+..++....++..+.+|.. .+++..+.+|+..||..+|..|-|.--+-+.|.++-
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 0 12234445555666666666656653 368889999999999999999988876666666553
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=225.85 Aligned_cols=226 Identities=22% Similarity=0.331 Sum_probs=158.1
Q ss_pred eecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecC
Q 041230 202 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMP 279 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~ 279 (485)
.||+|+||.||+|.. .+++.||+|.+.... ......|.+|++++.+++||||++++++|... ...++|+||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~ 76 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQ 76 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeecc
Confidence 689999999999986 468899999875332 22346799999999999999999999987642 35789999999
Q ss_pred CCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccC
Q 041230 280 NGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 280 ~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
+|+|.+++.... ..+.|.....++.+++.||.||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 77 ~~~L~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 77 GGDFLTFLRTEG--------PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred CCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccc
Confidence 999999997532 24678889999999999999999 6789999999999999999999999999987543
Q ss_pred CCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCCCcchh
Q 041230 360 DTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSSTSTHV 417 (485)
Q Consensus 360 ~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (485)
..... ..+....++++++...+.... ... .+...... ............
T Consensus 146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~~~~~~~------ 216 (252)
T cd05084 146 DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIEQGVRLP------ 216 (252)
T ss_pred cccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCCCC------
Confidence 21100 001122355555543322110 000 00000000 000000000000
Q ss_pred hhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 418 SIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 418 ~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
....+...+.++...|++.+|++||++.+|.++|+
T Consensus 217 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 -CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 01123456778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=233.90 Aligned_cols=250 Identities=18% Similarity=0.227 Sum_probs=163.5
Q ss_pred cccccceeecccCceEEEEeEee-----------------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-----------------DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRV 256 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-----------------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 256 (485)
++|...+.||+|+||.||++... ++..||+|.++... ......|.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46778889999999999987532 23468999886432 2234679999999999999999999
Q ss_pred eeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcc--cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTH--WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 257 ~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~--~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
++++... ...++|+||+++|+|.+++....... .......+++.....++.+++.||.||| +.+++||||
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl 156 (296)
T cd05095 85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL 156 (296)
T ss_pred EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence 9987542 35799999999999999997643211 0111135788899999999999999999 678999999
Q ss_pred CCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccch
Q 041230 335 KPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNL 394 (485)
Q Consensus 335 K~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 394 (485)
||+|||++.++.+||+|||+++.+...... ..++...++++++...+.-....-..+...
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999864322100 011123455555433222100000000000
Q ss_pred hhhhhhh-hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 395 QEIEEDR-TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 395 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
....+.. ............. ..+....+...+.+++..|++.+|++||+|.+|.+.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQVIENTGEFFRDQGRQV-YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHHHHHHHHHHHhhccccc-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000000 0000000000000 00001124466789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=224.69 Aligned_cols=243 Identities=16% Similarity=0.280 Sum_probs=167.4
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++.+++|+||+++++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 57888899999999999999865 78999999886422 2235678999999999999999999988754 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++...... ...+.+.....++.+++.||.||| ..+|+||||||+||+++.++.++|+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~ 148 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEe
Confidence 79999999999999998642211 134778889999999999999999 6799999999999999999999999
Q ss_pred ecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCC
Q 041230 351 DFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 351 DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
|||+++........ ..+....++.+++...+...... .+....... .............
T Consensus 149 d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~--~p~~~~~~~-~~~~~~~~~~~~~ 225 (267)
T cd08224 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMN-LYSLCKKIEKCDY 225 (267)
T ss_pred ccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCC--CCcccCCcc-HHHHHhhhhcCCC
Confidence 99998765332110 01112335555543332211000 000000000 0000000000000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
... + .......+.++...|+..+|++||++.+|+++|+.++
T Consensus 226 ~~~--~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPL--P-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCC--C-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 0 0023345678999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-27 Score=226.65 Aligned_cols=240 Identities=15% Similarity=0.243 Sum_probs=164.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||+|.. .+++.||||.++... ......|.+|++++.+++||||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 4677889999999999999985 468899999876422 2223568899999999999999999988653 235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|.+++...... ...++......++.+++.||.||| ..+++|+||||+||+++.++.++|+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~ 148 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEEC
Confidence 78999999999999988632111 124667788899999999999999 6799999999999999999999999
Q ss_pred ecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhc--cccc-hhhhhhhhhhhcccCC
Q 041230 351 DFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFN-LQEIEEDRTMCMHASS 409 (485)
Q Consensus 351 DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~-~~~~~~~~~~~~~~~~ 409 (485)
|||++......... ..+....++++++...+........ +... ...... ... .
T Consensus 149 d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~---~~~---~ 222 (267)
T cd08228 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ---KIE---Q 222 (267)
T ss_pred ccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH---HHh---c
Confidence 99998765432110 0111223455554332221100000 0000 000000 000 0
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
..... .........+.++...||+.+|++||++.+|++.|++++
T Consensus 223 ~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000 000123345778899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=224.54 Aligned_cols=228 Identities=23% Similarity=0.357 Sum_probs=159.6
Q ss_pred eecccCceEEEEeEeeCCcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecCC
Q 041230 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPN 280 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~ 280 (485)
+||+|+||.||+|...+++.+|+|.++..... ....|.+|++++.+++||||++++++|... ...++||||+++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~ 76 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELVPG 76 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECCCC
Confidence 68999999999999888899999988644322 234688999999999999999999987642 357899999999
Q ss_pred CCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCC
Q 041230 281 GSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 281 GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~ 360 (485)
|+|.+++.... ..+.|...+.++.+++.||.||| ..+++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 77 GDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred CcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence 99999987543 24678899999999999999999 67899999999999999999999999999875432
Q ss_pred CCcc-------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcchhhhHH
Q 041230 361 TDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIIL 421 (485)
Q Consensus 361 ~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (485)
.... ..+....++++++...+....... .+.................. ...+ .
T Consensus 146 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~-~p~~~~~~~~~~~~~~~~~~-~~~~------~ 217 (250)
T cd05085 146 GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGV-CPYPGMTNQQAREQVEKGYR-MSCP------Q 217 (250)
T ss_pred cccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHcCCC-CCCC------C
Confidence 1100 011223456666543332110000 01000000000000000000 0000 1
Q ss_pred HHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 422 ECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 422 ~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
.+...+.+++..|++.+|++||+|.+++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23456779999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=228.43 Aligned_cols=235 Identities=23% Similarity=0.360 Sum_probs=162.6
Q ss_pred ccccceeecccCceEEEEeEeeC-C---cEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD-G---TTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~-~---~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.|...+.||+|+||.||+|.... + ..||||.++... ....+.|..|+.++.+++||||+++++++.. ...
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CCc
Confidence 35667899999999999998643 3 359999986432 2235679999999999999999999988653 345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|.+++.... ..+++.++..++.+++.||.||| ..+++||||||+||+++.++.+|++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~ 148 (269)
T cd05065 80 VMIITEFMENGALDSFLRQND--------GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVS 148 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEEC
Confidence 789999999999999997543 24788899999999999999999 6799999999999999999999999
Q ss_pred ecccccccCCCCcce-----------------------eeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 351 DFSMARFLPDTDEQT-----------------------RFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 351 DFGla~~~~~~~~~~-----------------------~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|||++.......... .++...++++++...+.... ... +...............
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~--p~~~~~~~~~~~~i~~ 226 (269)
T cd05065 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMSNQDVINAIEQ 226 (269)
T ss_pred CCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC--CCCCCCHHHHHHHHHc
Confidence 999987654322110 01112344444432221000 000 0000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.... +...++...+.++...|++.+|++||+|.+|+..|+.+
T Consensus 227 ~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRL-------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcC-------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 11123445677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=226.27 Aligned_cols=231 Identities=22% Similarity=0.309 Sum_probs=161.4
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+|...+.||+|+||.||+|...++..+|+|.+... ......|.+|++++.+++|+||+++++++... ...++|+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEEEE
Confidence 35667889999999999998777778999987532 22345788999999999999999999887542 3578999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.++++... ..++|.....|+.+++.||.||| ..+|+||||||+||++++++.+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 79 EYMANGCLLNYLRERK--------GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ecCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999997543 24788899999999999999999 678999999999999999999999999998
Q ss_pred cccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcc
Q 041230 356 RFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 356 ~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
+...+.... ..++...++++++...+.... ........ ...+............
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~~~~~~---- 221 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF--SNSEVVESVSAGYRLY---- 221 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC--CHHHHHHHHHcCCcCC----
Confidence 765321100 011122455555433222100 00000000 0000000000000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
....+...+.+++..|+..+|++||+|.+|++.|
T Consensus 222 ---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 ---RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0011345677999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=230.83 Aligned_cols=150 Identities=25% Similarity=0.410 Sum_probs=126.5
Q ss_pred ccccceeecccCceEEEEeEe-----eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.|...+.||+|+||.||.+.. .++..||+|.++... ....+.|.+|++++++++||||+++.+++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 466778999999999999874 357789999986443 22346789999999999999999999987542 234
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..++|..+..++.+++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK--------NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEE
Confidence 5789999999999999996432 24788899999999999999999 789999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++.+.
T Consensus 151 ~dfg~~~~~~ 160 (284)
T cd05079 151 GDFGLTKAIE 160 (284)
T ss_pred CCCccccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=231.35 Aligned_cols=246 Identities=19% Similarity=0.280 Sum_probs=165.4
Q ss_pred hccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVD 264 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~ 264 (485)
..++|...+.||+|+||.||++...+ ...+|+|.+..... .....+.+|+.++.++ +|+||++++++|..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 34567788899999999999998532 35789998864322 2335688999999999 89999999998754
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPS 337 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~ 337 (485)
....++||||+++|+|..+++....... ......++|...+.++.+++.||.||| ..+|+||||||+
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~ 161 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAAR 161 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccccee
Confidence 2357999999999999999975321000 011246889999999999999999999 688999999999
Q ss_pred ceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhh
Q 041230 338 NVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQE 396 (485)
Q Consensus 338 NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~ 396 (485)
|||+++++.+||+|||+++.+...... ..+....++++++...+.... ... +.....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~--p~~~~~ 239 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS--PYPGIP 239 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC--CCCCCC
Confidence 999999999999999999865432110 001112234444322211000 000 000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
............ . . .....+...+.++...|++.+|++||||.+|++.|+.+
T Consensus 240 ~~~~~~~~~~~~-~---~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 240 VEELFKLLKEGY-R---M---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHHcCC-c---C---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 000000000000 0 0 00112345677999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=225.74 Aligned_cols=233 Identities=22% Similarity=0.365 Sum_probs=164.7
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+.|.....||+|+||.||+|...+...||+|.++... ...+.|.+|++++.+++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEEE
Confidence 4577788999999999999987777789999986422 234679999999999999999999887532 246899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++++.... ..++|..+..++.+++.||.||| +.+|+||||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~ 148 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGL 148 (262)
T ss_pred EEcCCCCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCc
Confidence 999999999999975321 24688899999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccc-hhhhhhhhhhhcccCCCCCC
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN-LQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~-~~~~~~~~~~~~~~~~~~~~ 413 (485)
++........ ..++...++++++...+.... ........ .... ..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~~~~~~--- 222 (262)
T cd05071 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVERGYRM--- 222 (262)
T ss_pred eeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHhcCCCC---
Confidence 9765332210 001123455555543322111 00000000 0000 0000000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
....++...+.++...|++.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0011345567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=225.43 Aligned_cols=225 Identities=21% Similarity=0.299 Sum_probs=156.7
Q ss_pred eecccCceEEEEeEe---eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 202 LIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~---~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.||+|+||.||+|.+ .++..+|+|+++.... ...+.|.+|+.++.++.|+||+++++++.. +..++|+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999975 3567899999864322 234678999999999999999999998743 24689999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|.+++.... .+++.....++.+++.||.||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~ 143 (257)
T cd05116 76 LAELGPLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSK 143 (257)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccc
Confidence 999999999996432 4677889999999999999999 6789999999999999999999999999998
Q ss_pred ccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 357 FLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 357 ~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
........ .......++++|+...+.... ... .+........ .......... .
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~i~~~~~~~-~ 219 (257)
T cd05116 144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT---QMIESGERME-C 219 (257)
T ss_pred ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHCCCCCC-C
Confidence 65432210 001112344454433222110 000 0000000000 0000000000 0
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
+..+...+.++...|++.+|++||+|.+|+++|+.
T Consensus 220 ------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 ------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 01234456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=231.51 Aligned_cols=237 Identities=19% Similarity=0.363 Sum_probs=162.8
Q ss_pred cccccceeecccCceEEEEeEee-CCc----EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGT----TIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~----~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.|...+.||+|+||.||+|... +|. .||+|.+..... .....|.+|+.++.+++||||++++++|...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 45667789999999999999853 444 468888764322 2234688999999999999999999988532
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
..++++||+++|+|.+++.... ..+.+...+.++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~k 149 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK--------DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVK 149 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceE
Confidence 3579999999999999987543 24678888999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhc-cccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEIL-NDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~-d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..++...++++++...+..-. .... ........ ......
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~~~~ 226 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDLLEK 226 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHC
Confidence 9999999865422110 001112345555433222100 0000 00000000 000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...... ...+...+..+...||..+|++||+|.++++.|+.+.+.
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 227 GERLPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000000 011334567899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=229.31 Aligned_cols=242 Identities=21% Similarity=0.366 Sum_probs=166.0
Q ss_pred cccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|...+.||+|+||.||+|...+ +..||||.++..... ..+.|.+|++++.+++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence 457777899999999999998643 478999998754333 356899999999999999999999987642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCccc-----ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHW-----RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~-----~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
...++||||+++|+|.++|........ ......+.+.....++.+++.||.||| ..+++||||||+||+++
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 156 (280)
T cd05049 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG 156 (280)
T ss_pred -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence 457999999999999999976432100 011235788899999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDR 401 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~ 401 (485)
.++.+||+|||+++........ ..+....++++++...+..-. ... +.......+..
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~--p~~~~~~~~~~ 234 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ--PWYGLSNEEVI 234 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCC--CCCCCCHHHHH
Confidence 9999999999999754222110 011223455555433222110 000 00000000000
Q ss_pred hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 402 TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
........... ...+...+.++...|++.+|++||++.||+++|+
T Consensus 235 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGRLLQR-------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCCcCCC-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00000000000 0113456779999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=225.07 Aligned_cols=235 Identities=22% Similarity=0.388 Sum_probs=165.7
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||.||+|.. .|+.||||.++.... ..+.|.+|+.++.+++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence 4677788999999999999985 488999999875433 45689999999999999999999998753 2457899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++..... ..+.|.....++.+++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGR-------AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred EEecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999975432 24788999999999999999999 78899999999999999999999999999
Q ss_pred ccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcchhh
Q 041230 355 ARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVS 418 (485)
Q Consensus 355 a~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (485)
++........ ..+....++++++...+..-. ... +.................. ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~--p~~~~~~~~~~~~~~~~~~-~~~----- 220 (256)
T cd05039 149 AKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPHVEKGYR-MEA----- 220 (256)
T ss_pred ccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHHhcCCC-CCC-----
Confidence 8865322110 011122355555433222110 000 0000000000000000000 000
Q ss_pred hHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 419 IILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 419 ~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
...+...+.++...|+..+|++||++.+++++|+.+
T Consensus 221 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011335567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=223.72 Aligned_cols=147 Identities=19% Similarity=0.314 Sum_probs=119.3
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|.....+|+|+||.|||++.. +|+.||||++...... ..+--++|+++|.+++|+|+|.|+..|.. ....+|
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krklhL 78 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKLHL 78 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----cceeEE
Confidence 445568999999999999854 5899999998643321 23456899999999999999999988653 346799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+...-|+++=+-.. .++...-.+|+.|+++|+.|+| +..+|||||||+|||+..++.+|++|||
T Consensus 79 VFE~~dhTvL~eLe~~p~---------G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFG 146 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPN---------GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFG 146 (396)
T ss_pred EeeecchHHHHHHHhccC---------CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccch
Confidence 999999866655433222 2344556779999999999999 7889999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
+||.+..
T Consensus 147 FAR~L~~ 153 (396)
T KOG0593|consen 147 FARTLSA 153 (396)
T ss_pred hhHhhcC
Confidence 9999863
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=231.50 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=167.7
Q ss_pred ccccccceeecccCceEEEEeEee--------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
-++|.....||+|+||.||++... ++..||+|.++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 346777889999999999998631 24479999876432 23346788999999999 89999999998764
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
....++||||+++|+|.++|........ ......++|..++.++.+++.||.||| ..+|+||||||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 165 (304)
T cd05101 93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA 165 (304)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence 2457899999999999999976432100 011235788999999999999999999 67999999999
Q ss_pred CceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccch
Q 041230 337 SNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNL 394 (485)
Q Consensus 337 ~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~ 394 (485)
+|||+++++.+||+|||+++........ ..++...++++++...+.... ... .+....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999865332110 001123455555543322110 000 000000
Q ss_pred hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 395 QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.+.. .......... ....+...+.++...|++.+|++||+|.+|++.|+++-.
T Consensus 246 ~~~~---~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 246 EELF---KLLKEGHRMD-------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHH---HHHHcCCcCC-------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 0000 0000000000 011244567789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=224.65 Aligned_cols=234 Identities=21% Similarity=0.311 Sum_probs=162.7
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+|...+.||+|+||.||++.. .|..||+|.++.. ...+.|.+|+.++.+++|+||+++++++.. .....++|+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 567778999999999999975 4788999987642 234679999999999999999999987542 223578999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++..... ..+.|...+.++.+++.||.||| ..+|+||||||+||++++++.+||+|||++
T Consensus 80 e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred ECCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccc
Confidence 99999999999975432 24778889999999999999999 678999999999999999999999999998
Q ss_pred cccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcchhhh
Q 041230 356 RFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSI 419 (485)
Q Consensus 356 ~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (485)
+........ ..++...++++++...+..-. ....-+. ................. .
T Consensus 150 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~--~~~~~~~~~~~~~~~~~-------~ 220 (256)
T cd05082 150 KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--IPLKDVVPRVEKGYKMD-------A 220 (256)
T ss_pred eeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC--CCHHHHHHHHhcCCCCC-------C
Confidence 864322110 011122455555433221100 0000000 00000000000000000 0
Q ss_pred HHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 420 ILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 420 ~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
...+...+.++...|++.+|++||||.++++.|+.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 012345667899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=230.07 Aligned_cols=248 Identities=19% Similarity=0.295 Sum_probs=166.6
Q ss_pred cccccceeecccCceEEEEeEeeC-Cc--EEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GT--TIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~--~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|.....||+|+||.||+|...+ +. .+++|.++... ....+.|.+|++++.++ +||||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence 467778899999999999998643 33 47888876422 23346789999999999 799999999987542 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccc-------cccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWR-------LLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~-------~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
..++|+||+++|+|.++++........ .....+.+.....|+.+++.||+||| ..+|+||||||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 578999999999999999754321000 01124788899999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMC 404 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~ 404 (485)
+++.+||+|||++......... ..++...++++++...+.... ... +.............
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~--pf~~~~~~~~~~~~ 231 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGT--PYCGMTCAELYEKL 231 (297)
T ss_pred CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHH
Confidence 9999999999998643211000 112233456665543322110 000 00000000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
....... ....+...+.+++..|++.+|.+||++.+|+++|+.+.++.
T Consensus 232 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRME-------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000000 00112345678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=229.75 Aligned_cols=149 Identities=24% Similarity=0.316 Sum_probs=125.6
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+|...+.||+|+||+||++.. .+|+.||||.+.... ......+.+|+.++.+++|+||+++++++.. ....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence 366778999999999999985 568999999886432 2233467899999999999999999988653 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++|+|..++..... ..+++.....++.+++.||.||| +.+|+||||||+|||+++++.+||+|
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~D 145 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISD 145 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 999999999999988864321 24778889999999999999999 78999999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 146 fg~~~~~~ 153 (285)
T cd05631 146 LGLAVQIP 153 (285)
T ss_pred CCCcEEcC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=223.67 Aligned_cols=233 Identities=24% Similarity=0.378 Sum_probs=164.2
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+.|...+.||+|+||.||++...++..||+|.++.... ..+.|.+|+.++.+++|+||+++++++.. ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEEE
Confidence 35667789999999999999888888899999865332 34679999999999999999999987632 246899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++++.... ..+++.++..++.+++.||.||| ..+|+||||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred EEecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCcee
Confidence 999999999999975432 24788999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccc-hhhhhhhhhhhcccCCCCCC
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN-LQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~-~~~~~~~~~~~~~~~~~~~~ 413 (485)
+......... ...+...++++++...+.-.. ........ ..+... .+. ... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~--~~~-~~~-~--- 221 (260)
T cd05070 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE--QVE-RGY-R--- 221 (260)
T ss_pred eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHH-cCC-C---
Confidence 9765332110 001123455555433222110 00000000 000000 000 000 0
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
. +........+.++...|+..+|++||||.++.+.|+.
T Consensus 222 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 M---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0001233457789999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=225.31 Aligned_cols=236 Identities=20% Similarity=0.347 Sum_probs=165.5
Q ss_pred cccccceeecccCceEEEEeEeeCC----cEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~----~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||+|...+. ..||||...... ....+.|.+|+.++.+++||||++++++|.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 3466778999999999999986443 468999876433 2334679999999999999999999998753 2
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..+.+..+..++.+++.||.||| ..+++||||||+||+++.++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l 148 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK--------YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKL 148 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEE
Confidence 4689999999999999997532 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccC
Q 041230 350 GDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 350 ~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~ 408 (485)
+|||+++........ ..+....++++++...+.... ... .+.....+.. .......
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~~~ 225 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIENGE 225 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCC
Confidence 999998765322110 011223455665543332110 000 0000000000 0000000
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
... ....+...+.++...|+..+|++||++.++++.|+.+++
T Consensus 226 ~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 RLP-------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred cCC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 011234567788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=237.80 Aligned_cols=151 Identities=23% Similarity=0.351 Sum_probs=127.0
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchH-HHHHHHHHHHhcC-CCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR-SFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~-~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+.|...+.||.|+||.||+|+ ..+|..||||+++..-....+ .=++|+..|.+|. |||||+|.....+. +...
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~L 85 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRIL 85 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----CceE
Confidence 456667889999999999998 567899999998753322222 2367999999999 99999999876542 2368
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|||||.- +|++++.++. ..|+......|+.||.+||+|+| .+++.|||+||+|||+.....+||+|
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~--------r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRN--------RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcC--------CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecc
Confidence 999999975 9999998763 46888999999999999999999 78999999999999999999999999
Q ss_pred cccccccCCC
Q 041230 352 FSMARFLPDT 361 (485)
Q Consensus 352 FGla~~~~~~ 361 (485)
|||||.....
T Consensus 154 FGLARev~Sk 163 (538)
T KOG0661|consen 154 FGLAREVRSK 163 (538)
T ss_pred cccccccccC
Confidence 9999987543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=223.48 Aligned_cols=234 Identities=22% Similarity=0.353 Sum_probs=165.3
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||.||+|...+++.||+|.+.... ...+.|.+|+.++.+++|+||++++++.. ....++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEE
Confidence 4677788999999999999998889999999986433 34568999999999999999999987753 2347899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++..... ..+++..+..++.+++.||.||| ..+++||||||+||+++.++.++|+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 79 TEYMENGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred EEcCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcc
Confidence 999999999999875432 35788899999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
+......... ..+....++++++...+.--. ....-... ...+............ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~~~~~~~~~~~~-~~ 225 (260)
T cd05067 149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--TNPEVIQNLERGYRMP-RP 225 (260)
T ss_pred eeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHcCCCCC-CC
Confidence 9765421110 011223456665543322110 00000000 0000000000000000 00
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
......+.+++..|++.+|++||++.++.+.|+.
T Consensus 226 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 ------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0123457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-27 Score=225.86 Aligned_cols=242 Identities=16% Similarity=0.228 Sum_probs=164.6
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||++.. .++..+|||.+..... .....|.+|+.++..++|+||+++++++.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 4677788999999999999984 5789999998764322 233578899999999999999999988753 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.+++|||+++|+|.+++...... ...++|.....++.+++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEC
Confidence 78999999999999998742211 135788889999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCC
Q 041230 351 DFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 351 DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
|||++......... ..+....++++++...+........-......................
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 149 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228 (267)
T ss_pred cchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCC
Confidence 99998765332110 011122355555533322111100000000000000000000000000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.. ......+.++...|++.+|++||||.+|++++.++
T Consensus 229 ~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 PS------DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred Cc------ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00 11234566888899999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-26 Score=222.07 Aligned_cols=234 Identities=23% Similarity=0.341 Sum_probs=161.5
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+.|.....||+|+||.||++...++..+|+|.+.... ...+.|.+|++++.+++|+|++++++++.. ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEEE
Confidence 3466678899999999999987777789999875432 234678999999999999999999887632 346899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++++.... ..++|..+..++.+++.||.||| ..+++||||||+||++++++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~ 148 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGL 148 (260)
T ss_pred EEcCCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCcc
Confidence 999999999999975432 24788899999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
++........ ...+...++++++...+..-. ....-..... .+......... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~-~~--- 222 (260)
T cd05069 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGY-RM--- 222 (260)
T ss_pred ceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC-CC---
Confidence 9765332110 001112344444432221110 0000000000 00000000000 00
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
.........+.++...|++.+|++||+|.+|.+.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001123456788899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-27 Score=228.84 Aligned_cols=244 Identities=20% Similarity=0.298 Sum_probs=166.0
Q ss_pred ccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.++|...+.||+|+||.||++... ++..||+|.+..... ...+.|.+|+.++++++||||++++++|...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence 457888899999999999998753 467899998864322 2345799999999999999999999987642
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCccc-------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHW-------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCN 333 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrd 333 (485)
...++|+||+++|+|.+++........ ......+.+..++.++.+++.||.||| ..+++|||
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d 155 (288)
T cd05050 81 --KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD 155 (288)
T ss_pred --CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence 357899999999999999974321100 001135788899999999999999999 67899999
Q ss_pred cCCCceEecCCCcEEEeecccccccCCCCc-----c---------------eeeeccccHHHHHHHHhhhhhhhhccccc
Q 041230 334 LKPSNVLLDDEMIGHVGDFSMARFLPDTDE-----Q---------------TRFIGKLNVRNFVKMALSQRVEEILNDFN 393 (485)
Q Consensus 334 lK~~NILld~~~~~ki~DFGla~~~~~~~~-----~---------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~ 393 (485)
|||+||+++.++.+||+|||+++....... . ..+....++++++...+...... ..+..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~-~~p~~ 234 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-MQPYY 234 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC-CCCCC
Confidence 999999999999999999999875422210 0 01122345555554332211000 01110
Q ss_pred hhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 394 LQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
.....+............. ...+...+.+++..|++.+|++||++.|+++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAHEEVIYYVRDGNVLSC-------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCHHHHHHHHhcCCCCCC-------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 0000000000000000000 0123456788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=228.45 Aligned_cols=242 Identities=19% Similarity=0.290 Sum_probs=162.9
Q ss_pred ccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.|...+.||+|+||.||+|...+ +..||||+++..... ..+.|.+|+.++.+++|||||++++++...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~----- 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE----- 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence 45566789999999999998533 467999998743322 235688999999999999999999987642
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCc-------ccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDT-------HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~-------~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl 341 (485)
...++++||+++++|.+++...... ........+.+.....++.+++.||.||| +.+|+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEe
Confidence 3578999999999999998632210 01111234788889999999999999999 6789999999999999
Q ss_pred cCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhh
Q 041230 342 DDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDR 401 (485)
Q Consensus 342 d~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 401 (485)
++++.+||+|||+++........ ..+....++++++...+..-... ..+.......+..
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g-~~p~~~~~~~~~~ 236 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG-LQPYCGYSNQDVI 236 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCCHHHHH
Confidence 99999999999998765322110 11122345555543322210000 0000000000000
Q ss_pred hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 402 TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
......... .....+...+..+...|++.+|++||+|.+|++.|+
T Consensus 237 ~~i~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 237 EMIRNRQVL-------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHcCCcC-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 000000000 001134556789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=230.41 Aligned_cols=248 Identities=19% Similarity=0.238 Sum_probs=163.7
Q ss_pred cccccceeecccCceEEEEeEeeC-----------------CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-----------------GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRV 256 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-----------------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l 256 (485)
..|.....||+|+||.||++...+ +..||+|.+..... ...+.|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467778899999999999987532 24589998864332 335678999999999999999999
Q ss_pred eeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCccc--ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW--RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 257 ~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~--~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
+++|... ...++|+||+++|+|.++|........ ......+++.....++.+++.||.||| ..+|+||||
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dl 156 (296)
T cd05051 85 LGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDL 156 (296)
T ss_pred EEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccccc
Confidence 9987642 457999999999999999975431100 001125788999999999999999999 678999999
Q ss_pred CCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh--hhhcccc
Q 041230 335 KPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV--EEILNDF 392 (485)
Q Consensus 335 K~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~--~~~~d~~ 392 (485)
||+||+++.++.++|+|||+++........ ..+....++++++...+.... ... +.
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~--p~ 234 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ--PY 234 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC--CC
Confidence 999999999999999999999864322110 011223455555533222100 000 00
Q ss_pred chhhhhhh-hhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 393 NLQEIEED-RTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 393 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
........ .............. .......+...+.+++..|++.+|++||+|.+|++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTDQQVIENAGHFFRDDGRQI-YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcChHHHHHHHHhccccccccc-cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 00000000 00000000000000 00000112356789999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=224.86 Aligned_cols=224 Identities=18% Similarity=0.237 Sum_probs=152.1
Q ss_pred eecccCceEEEEeEeeC-------------CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 202 LIGAGNFGSVYNGTLFD-------------GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~-------------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.++..++|||||+++++|...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----- 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----- 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 58999999999998532 225888887654444456788999999999999999999998642
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc--
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI-- 346 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~-- 346 (485)
...++|+||+++|+|..+++... ..+++..+..|+.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~ 145 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKS--------DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDG 145 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccC
Confidence 34689999999999999987533 24778888999999999999999 789999999999999987664
Q ss_pred -----EEEeecccccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhc
Q 041230 347 -----GHVGDFSMARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 347 -----~ki~DFGla~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~ 405 (485)
+|++|||++......... ..+....++++++...+.-.. ... +.......+.... .
T Consensus 146 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~--p~~~~~~~~~~~~-~ 222 (262)
T cd05077 146 ECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI--PLKDKTLAEKERF-Y 222 (262)
T ss_pred CCCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC--CCCCcchhHHHHH-H
Confidence 899999998754321110 011223456655543222100 000 0000000000000 0
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
........ .....+.++...|++.+|++||++.+++..|
T Consensus 223 ~~~~~~~~--------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQCMLVT--------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCccCCC--------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000000 1124567899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=224.58 Aligned_cols=157 Identities=25% Similarity=0.376 Sum_probs=130.9
Q ss_pred hhhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCC-
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQG- 267 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~- 267 (485)
..+++.|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++......+
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456778888899999999999999854 57889999986432 3446788999999998 7999999999986432221
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+++|+|.+++..... ..+.|.....++.|++.||.||| ..+|+||||||+||++++++.+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence 2457899999999999999975322 24778888999999999999999 6789999999999999999999
Q ss_pred EEeeccccccc
Q 041230 348 HVGDFSMARFL 358 (485)
Q Consensus 348 ki~DFGla~~~ 358 (485)
||+|||+++..
T Consensus 151 ~l~Dfg~~~~~ 161 (272)
T cd06637 151 KLVDFGVSAQL 161 (272)
T ss_pred EEccCCCceec
Confidence 99999999765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=226.98 Aligned_cols=246 Identities=20% Similarity=0.276 Sum_probs=163.1
Q ss_pred hccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
.++.|...+.||+|+||.||+|...+ +..||+|.++.... .....|.+|+.++..++|+||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 45678888999999999999997532 45799998764322 2234688999999999999999999987542
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCccc-ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHW-RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
...++||||+++|+|.+++........ ......+.+.....++.+++.||.||| .++|+||||||+|||++++
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence 357999999999999999975321100 001124567778899999999999999 7899999999999999999
Q ss_pred CcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhh
Q 041230 345 MIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTM 403 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~ 403 (485)
+.+|++|||+++........ ..++...++.+++...+.... .+. +.......+....
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~--p~~~~~~~~~~~~ 233 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ--PYQGLSNEQVLKF 233 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCC--CCCCCCHHHHHHH
Confidence 99999999998854322110 011122344444433221100 000 0000000000000
Q ss_pred hcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
....... .....+...+.+++..|++.+|++||+|.++++.|+..
T Consensus 234 ~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYL-------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0000000 00112335678999999999999999999998877754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=229.20 Aligned_cols=237 Identities=19% Similarity=0.234 Sum_probs=163.8
Q ss_pred ccccccceeecccCceEEEEeEee------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||.||++... ++..||||+++... ....+.|.+|+.++.++ +|+||++++++|...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 357888899999999999998742 24579999886432 22345789999999999 799999999987642
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
...++|+||+++|+|.++++.... ..+.+.+...++.+++.||.||| +.+|+|+||||+|||++.+.
T Consensus 112 ---~~~~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~ 178 (302)
T cd05055 112 ---GPILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGK 178 (302)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCC
Confidence 357999999999999999975432 23788999999999999999999 67899999999999999999
Q ss_pred cEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhcccc--chhhhhhhhh
Q 041230 346 IGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDF--NLQEIEEDRT 402 (485)
Q Consensus 346 ~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~--~~~~~~~~~~ 402 (485)
.+|++|||+++........ ..+....++++++...+..-. ....... ...... .
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~---~ 255 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY---K 255 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH---H
Confidence 9999999999865432110 001112355555433222100 0000000 000000 0
Q ss_pred hhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 403 MCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
......... .. . .....+.++...|+..+|++||++.+|++.|+.+
T Consensus 256 ~~~~~~~~~-~~---~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMA-QP---E---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCC-CC---C---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000000 00 0 1123567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=215.64 Aligned_cols=154 Identities=23% Similarity=0.356 Sum_probs=129.9
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.++|...+.||+|.||.||.|... ++-.||+|++.+. ..+...++.+|+++-++++||||+++++|+.+ .
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-----~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-----S 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-----c
Confidence 3467888999999999999999854 4668999998643 23445789999999999999999999999653 4
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
.-.||++||.++|+|...|.+... ..++......++.|+|.||.|+| .+.||||||||+|+|++.++..|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~-------~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRM-------KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhccc-------ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence 568999999999999999985432 23555555669999999999999 78999999999999999999999
Q ss_pred EeecccccccCCC
Q 041230 349 VGDFSMARFLPDT 361 (485)
Q Consensus 349 i~DFGla~~~~~~ 361 (485)
|+|||.+..-+.+
T Consensus 165 iAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 165 IADFGWSVHAPSN 177 (281)
T ss_pred ccCCCceeecCCC
Confidence 9999999876533
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-26 Score=224.61 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=164.3
Q ss_pred hccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
.+++|...+.||+|+||.||+|...+ +..||+|.+...... ....|.+|+.++.+++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 45678889999999999999998653 457899987643322 345799999999999999999999987542
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
...++|+||+++|+|.++++....... ....+.|..++.++.+++.||.||| ..+++||||||+|||++.++
T Consensus 82 ---~~~~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 82 ---LPRFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccC
Confidence 346899999999999999976432111 1135889999999999999999999 67899999999999998754
Q ss_pred ---cEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhh
Q 041230 346 ---IGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDR 401 (485)
Q Consensus 346 ---~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~ 401 (485)
.+||+|||+++........ ..++...++++++...+..-. ... +..........
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~--pf~~~~~~~~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM--PYPGRTNQEVM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence 6999999999865321110 112223455555433222000 000 00000000000
Q ss_pred hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 402 TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
...... ..... ...+...+.++...|++.+|++||++.+|++.|+
T Consensus 232 ~~~~~~-~~~~~------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGG-GRLDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcC-CcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000000 00000 0123356778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=226.70 Aligned_cols=241 Identities=21% Similarity=0.327 Sum_probs=164.1
Q ss_pred ccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
+|.....||+|+||.||++... ++..+|+|.++.........|.+|++++..++|+||+++++++... .
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 80 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-----R 80 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----C
Confidence 5666788999999999998642 3567899988655444567899999999999999999999987642 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcc------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTH------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
..++|+||+++|+|.++++...... .......+.+..++.++.+++.||.||| ..+++||||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcC
Confidence 5799999999999999997543210 0011135788999999999999999999 788999999999999999
Q ss_pred CCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhh
Q 041230 344 EMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRT 402 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~ 402 (485)
++.+||+|||+++........ ..+....++++|+...+.... ....-... ........
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHH
Confidence 999999999998754221100 111223455555533322110 00000000 00000000
Q ss_pred hhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 403 MCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
. ....... ....+...+.++...|++.+|++||++.+|.+.|+
T Consensus 237 ~-~~~~~~~-------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 I-TQGRELE-------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HcCccCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 0000000 00123455678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=223.14 Aligned_cols=222 Identities=18% Similarity=0.258 Sum_probs=153.9
Q ss_pred eecccCceEEEEeEeeCCc-----------EEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 202 LIGAGNFGSVYNGTLFDGT-----------TIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~~~-----------~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||++++++|.. ..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 6899999999999975433 4777876543322 6789999999999999999999998764 23
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-----
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM----- 345 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~----- 345 (485)
.++|+||+++|+|.+++.... ..+++..++.++.+++.||.||| ..+|+||||||+|||++.++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~ 143 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK--------NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGY 143 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCC
Confidence 589999999999999997543 14678889999999999999999 68899999999999999888
Q ss_pred --cEEEeecccccccCCCCcc---------e-------eeeccccHHHHHHHHhhhhhh-hhccccc-hhhhhhhhhhhc
Q 041230 346 --IGHVGDFSMARFLPDTDEQ---------T-------RFIGKLNVRNFVKMALSQRVE-EILNDFN-LQEIEEDRTMCM 405 (485)
Q Consensus 346 --~~ki~DFGla~~~~~~~~~---------~-------~~~~~~~l~~~~~~~~~~~~~-~~~d~~~-~~~~~~~~~~~~ 405 (485)
.+||+|||++......... . ..+...++++++...+..... ....... ...... ...
T Consensus 144 ~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~ 220 (259)
T cd05037 144 VPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ 220 (259)
T ss_pred ceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh
Confidence 8999999999874321100 0 112234555555333221100 0000000 000000 000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
....... . ....+.++...|+..+|++||++.+|++.|+
T Consensus 221 ~~~~~~~-~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRLPM-P--------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCCCC-C--------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 0 1146678999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-26 Score=228.31 Aligned_cols=247 Identities=20% Similarity=0.266 Sum_probs=166.5
Q ss_pred cccccceeecccCceEEEEeEee--------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeecccc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVD 264 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~ 264 (485)
+.|...+.||+|+||.||++... ++..+|+|.++... ......+..|+.++.++ +|+||++++++|...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~- 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD- 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence 56778899999999999998742 23469999886432 22345688899999999 899999999987642
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPS 337 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~ 337 (485)
...++|+||+++|+|.+++....... .......++|..+++++.+++.||.||| ..+++||||||+
T Consensus 97 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 169 (307)
T cd05098 97 ----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR 169 (307)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence 35789999999999999997643210 0011135889999999999999999999 679999999999
Q ss_pred ceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhh
Q 041230 338 NVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQE 396 (485)
Q Consensus 338 NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~ 396 (485)
|||++.++.+||+|||+++........ ..+....++++++...+..-. ... +.....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~--p~~~~~ 247 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVP 247 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC--CCCcCC
Confidence 999999999999999998765321100 001112344444433221100 000 000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
.............. .....+...+.++...|++.+|++||+|.+|++.|+.+...
T Consensus 248 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKLLKEGHRM-------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHcCCCC-------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 00000000000000 00112334667899999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=227.44 Aligned_cols=155 Identities=25% Similarity=0.383 Sum_probs=117.8
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
.|...+++|.|+||.||+|.+. ++..||||+....+... .+|+++|.++.|||||+|+.++......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666789999999999999964 46899999876543322 358999999999999999988765432223456789
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-CcEEEeecc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MIGHVGDFS 353 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-~~~ki~DFG 353 (485)
+||||. +|.+.++.-.... ..++.-.---+..|+.+||.||| ..+|+||||||+|+|+|.+ +..||+|||
T Consensus 101 leymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 999997 9999887311000 00111111127889999999999 6899999999999999987 999999999
Q ss_pred cccccCCCCc
Q 041230 354 MARFLPDTDE 363 (485)
Q Consensus 354 la~~~~~~~~ 363 (485)
.|+.+.....
T Consensus 172 SAK~L~~~ep 181 (364)
T KOG0658|consen 172 SAKVLVKGEP 181 (364)
T ss_pred cceeeccCCC
Confidence 9998765443
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-26 Score=223.76 Aligned_cols=237 Identities=20% Similarity=0.331 Sum_probs=158.8
Q ss_pred eeecccCceEEEEeEeeC-Cc--EEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLFD-GT--TIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~-~~--~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||.||+|...+ +. .+|+|.++... ....+.|.+|++++.++ +||||++++++|... ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence 368999999999998644 43 46888876432 23446788999999999 899999999988642 3578999
Q ss_pred EecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 276 KFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
||+++|+|.++++....... ......+.+.....++.+++.||+||| ..+++||||||+|||+++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 99999999999975431100 001124788999999999999999999 67999999999999999999999
Q ss_pred EeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCC
Q 041230 349 VGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 349 i~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~ 409 (485)
|+|||+++........ ..+....++++++...+.... ... ........... .......
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~~~~~~~ 229 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KLPQGYR 229 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH---HHhCCCC
Confidence 9999998532111000 111223455555533322110 000 00000000000 0000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
. .....+...+.+++..|++.+|.+||++.+++++|+.+
T Consensus 230 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 L-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred C-------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0 00011234567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=231.38 Aligned_cols=154 Identities=22% Similarity=0.371 Sum_probs=125.3
Q ss_pred hhccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCC--------------cchHHHHHHHHHHHhcCCCcceeE
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--------------GGARSFKSECKAAINIRHRNIVRV 256 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~l 256 (485)
...|+|.....||+|.||.|-+|. ..+++.||||++.+... ...+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345778888999999999999997 45689999999964221 112578899999999999999999
Q ss_pred eeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 257 ~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
+.+..+. .....|||+|||..|.+. |..... ..|...+..+|..++..||+||| ..+||||||||
T Consensus 174 iEvLDDP---~s~~~YlVley~s~G~v~-w~p~d~--------~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKP 238 (576)
T KOG0585|consen 174 IEVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDK--------PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKP 238 (576)
T ss_pred EEeecCc---ccCceEEEEEeccCCccc-cCCCCc--------ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccch
Confidence 9876543 245689999999998884 222111 12777888899999999999999 68999999999
Q ss_pred CceEecCCCcEEEeecccccccCC
Q 041230 337 SNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 337 ~NILld~~~~~ki~DFGla~~~~~ 360 (485)
+|+||++++++||+|||.+-..+.
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~ 262 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQ 262 (576)
T ss_pred hheEEcCCCcEEeeccceeeeccc
Confidence 999999999999999999987643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=232.55 Aligned_cols=149 Identities=26% Similarity=0.386 Sum_probs=124.2
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||+|.. .+|..||||+++... ......+.+|+.++.+++||||+++++++...+.......++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 56678999999999999984 468899999986422 223456889999999999999999999876433333345799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+. ++|.+++.... .+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 82 v~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg 148 (338)
T cd07859 82 VFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFG 148 (338)
T ss_pred EEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCc
Confidence 999996 69999886432 4778888999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 149 ~~~~~ 153 (338)
T cd07859 149 LARVA 153 (338)
T ss_pred ccccc
Confidence 99754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=222.97 Aligned_cols=145 Identities=22% Similarity=0.331 Sum_probs=119.1
Q ss_pred eecccCceEEEEeEeeC---CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEe
Q 041230 202 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKF 277 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~---~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey 277 (485)
.||+|+||.||+|...+ +..+|+|.++.... .....|.+|+.++.+++||||+++++++... ...++||||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~ 76 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVMEF 76 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEEC
Confidence 58999999999998644 35689998764432 2335788999999999999999999987643 346899999
Q ss_pred cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 278 MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 278 ~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
+++|+|.++++...... ...+.+.....++.+++.||.||| ..+++||||||+||+++.++.+|++|||+++.
T Consensus 77 ~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 77 CPLGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred CCCCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence 99999999997543210 124567778889999999999999 67899999999999999999999999999865
Q ss_pred c
Q 041230 358 L 358 (485)
Q Consensus 358 ~ 358 (485)
.
T Consensus 150 ~ 150 (269)
T cd05087 150 K 150 (269)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=225.48 Aligned_cols=166 Identities=20% Similarity=0.276 Sum_probs=136.9
Q ss_pred cCccchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecc
Q 041230 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSG 262 (485)
Q Consensus 185 ~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~ 262 (485)
+.++.+..++++|.....||+|+||.||++.. .+++.+|+|.++... .....+.+|+.++.++ +|+||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 55677788999999999999999999999985 457889999876422 2346788899999999 69999999998764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
.........++||||+++|+|.++++..... ...+.+.....++.+++.||.||| ..+|+||||||+||+++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~ 158 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLT 158 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEEC
Confidence 4334445689999999999999988642111 124677788889999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccC
Q 041230 343 DEMIGHVGDFSMARFLP 359 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~ 359 (485)
.++.+||+|||+++...
T Consensus 159 ~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 159 TEGGVKLVDFGVSAQLT 175 (286)
T ss_pred CCCCEEEccCCceeecc
Confidence 99999999999987653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=226.78 Aligned_cols=248 Identities=20% Similarity=0.305 Sum_probs=164.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcE--EEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTT--IAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~--vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|+..+.||+|+||.||+|... ++.. +|+|.++... ....+.|.+|+.++.++ +|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----C
Confidence 356778899999999999999864 4543 5777765322 22345788999999999 89999999998754 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccc-------cccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWR-------LLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~-------~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl 341 (485)
...++|+||+++|+|.++++........ .....+.+.+.+.++.+++.||.||| +.+|+||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEe
Confidence 4579999999999999999754321100 01135788999999999999999999 6899999999999999
Q ss_pred cCCCcEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhh
Q 041230 342 DDEMIGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTM 403 (485)
Q Consensus 342 d~~~~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~ 403 (485)
++++.+||+|||+++........ ..+....++++++...+..-. ... +.......+....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~--p~~~~~~~~~~~~ 235 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEK 235 (303)
T ss_pred cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCC--CcccCChHHHHHH
Confidence 99999999999998643111000 011122344454432221100 000 0000000000000
Q ss_pred hcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... . . .........+.++...|++.+|++||++.+++.+|..+...
T Consensus 236 ~~~~~-~---~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 236 LPQGY-R---L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HhcCC-c---C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 0 0 00011223567899999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=220.92 Aligned_cols=227 Identities=25% Similarity=0.374 Sum_probs=158.2
Q ss_pred eeecccCceEEEEeEeeC----CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||.||+|.... +..+|+|.+..... ...+.|.+|++++.++.|+|||++++++.+ ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 369999999999997432 25799998864432 244678999999999999999999998653 2468999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.++|.... .+.+..+..++.+++.||.||| ..+++||||||+|||++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~ 142 (257)
T cd05060 75 ELAPLGPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMS 142 (257)
T ss_pred EeCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccc
Confidence 9999999999997542 4678899999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCC
Q 041230 356 RFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 356 ~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
+........ ..+....++++++...+.... ... .+........ .........
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~---~~~~~~~~~-- 217 (257)
T cd05060 143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---AMLESGERL-- 217 (257)
T ss_pred ceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHcCCcC--
Confidence 865322210 001112345555433221110 000 0000000000 000000000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.....+...+.++...|+..+|++||++.+|++.|+.+
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00112345677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=228.06 Aligned_cols=151 Identities=28% Similarity=0.460 Sum_probs=126.4
Q ss_pred cccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++...+.||+|+||+||++...+ |...|||..........+.+.+|+.+|.+++|||||+.+|..... . ....++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~-~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--E-NDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--c-CeeeEe
Confidence 356677899999999999998644 889999988654322256789999999999999999999863321 1 135789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEeec
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVGDF 352 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~DF 352 (485)
+|||+++|||.+++...++ .|+......++.+|++||.||| +++||||||||+||||+. ++.+||+||
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccC
Confidence 9999999999999986542 3677778889999999999999 789999999999999999 799999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 163 G~a~~~~ 169 (313)
T KOG0198|consen 163 GLAKKLE 169 (313)
T ss_pred ccccccc
Confidence 9998765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=227.40 Aligned_cols=148 Identities=26% Similarity=0.372 Sum_probs=127.1
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...++||+|+||+||..+- ++++.+|+|++++.. ....+....|..+|.+++||.||+|+.. +|...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence 46799999999999999999874 558899999997533 2345677889999999999999999744 56667
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..|||+||++||.|..+|...+ .|+....--++.+|+.||.||| +.+||||||||+|||||++|+++|
T Consensus 99 kLylVld~~~GGeLf~hL~~eg---------~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~L 166 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG---------RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKL 166 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC---------CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEE
Confidence 8999999999999999998653 4555555557889999999999 789999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+||||++..
T Consensus 167 tDFgL~k~~ 175 (357)
T KOG0598|consen 167 TDFGLCKED 175 (357)
T ss_pred eccccchhc
Confidence 999999964
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=223.88 Aligned_cols=242 Identities=21% Similarity=0.306 Sum_probs=163.8
Q ss_pred cccccceeecccCceEEEEeEeeC------CcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|...+.||+|+||.||+|...+ +..||+|.+.... ......|.+|+.++..++|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG---- 81 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC----
Confidence 567778999999999999998643 3679999976432 22345788999999999999999999987642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccc-cccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWR-LLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~-~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
...++|+||+++|+|.+++......... .....+.|...+.++.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCC
Confidence 4579999999999999999754321100 11134788899999999999999999 689999999999999999999
Q ss_pred EEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhc
Q 041230 347 GHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~ 405 (485)
+||+|||+++........ ..+....++++++...+.... ... +.......+......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~--p~~~~~~~~~~~~~~ 235 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQ--PYQGLSNEEVLKFVI 235 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCC--CCccCCHHHHHHHHh
Confidence 999999998764322110 011122344444432221000 000 000000000000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
...... ....+...+.+++..|++.+|++|||+.++++.|+
T Consensus 236 ~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLD-------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCC-------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000000 01123456789999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=221.40 Aligned_cols=243 Identities=20% Similarity=0.319 Sum_probs=161.8
Q ss_pred cccceeecccCceEEEEeEee----CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC-ce
Q 041230 197 FSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG-AR 269 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~----~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~-~~ 269 (485)
|...+.||+|+||.||+|... ++..||||+++... ....+.+.+|++++++++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345678999999999999853 36789999986432 223467889999999999999999999876432211 12
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..+++++|+++|+|..++....... ....+++.....++.+++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence 3578999999999999886322110 0134778888999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccc-hhhhhhhhhhhccc
Q 041230 350 GDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN-LQEIEEDRTMCMHA 407 (485)
Q Consensus 350 ~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~-~~~~~~~~~~~~~~ 407 (485)
+|||+++........ ..+....++++++...+.... ........ .... ..... .
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~-~ 230 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLI-K 230 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHH-c
Confidence 999999865322110 001122344454432221100 00000000 0000 00000 0
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
..... ....+...+.+++..|++.+|++||++.+|.+.|+.+
T Consensus 231 ~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 0012345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=246.99 Aligned_cols=155 Identities=22% Similarity=0.279 Sum_probs=129.2
Q ss_pred cccccceeecccCceEEEEeEeeCC-cEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccc-cCC-cee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVD-YQG-ARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~-~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~-~~~ 270 (485)
......+.|.+|||+.||.+....+ ..+|+|++-.......+...+|+++|++|+ |+|||.+++...... ..+ .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3556778999999999999997666 999999986555556677899999999997 999999998422111 112 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.+|.||||++|+|-+++..+.. ..|...+.++|+.++++|+++|| .+.++|||||||.+||||+.++.-||+
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq-------~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ-------TRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh-------ccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeC
Confidence 7899999999999999974332 24888999999999999999999 568999999999999999999999999
Q ss_pred ecccccc
Q 041230 351 DFSMARF 357 (485)
Q Consensus 351 DFGla~~ 357 (485)
|||-|..
T Consensus 189 DFGSatt 195 (738)
T KOG1989|consen 189 DFGSATT 195 (738)
T ss_pred ccccccc
Confidence 9998864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-27 Score=236.33 Aligned_cols=235 Identities=24% Similarity=0.408 Sum_probs=171.2
Q ss_pred cceeecccCceEEEEeEeeC---Cc--EEEEEEeecc-CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 199 SANLIGAGNFGSVYNGTLFD---GT--TIAVKVFNLI-RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 199 ~~~~iG~G~fg~Vy~g~~~~---~~--~vavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
...+||+|-||.||+|.+.+ |. .||||..+.. .+...+.|++|..+|.+++|||||+|+|.|.. ...+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~W 466 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPMW 466 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------ccee
Confidence 45789999999999999644 32 4899988763 34557899999999999999999999999985 4579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|||.++-|.|..||..+.. .|+...-+.++.|++.+|+||| +..+|||||..+|||+...--+|++||
T Consensus 467 ivmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred EEEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeeccc
Confidence 99999999999999987553 4666677889999999999999 788999999999999999999999999
Q ss_pred ccccccCCCCcceeeecc----------ccHHHHHH----HHhhhhhhhhcc----ccchhhhhhhhhhhcccCCCCCCc
Q 041230 353 SMARFLPDTDEQTRFIGK----------LNVRNFVK----MALSQRVEEILN----DFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 353 Gla~~~~~~~~~~~~~~~----------~~l~~~~~----~~~~~~~~~~~d----~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
||+|-+.+.+.-....+. ++.+.|.. ++|.--.|||+. |+.+-.- .+ ..+.... .
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-sD----VI~~iEn--G 608 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-SD----VIGHIEN--G 608 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-cc----eEEEecC--C
Confidence 999988665432111222 22222210 111112334332 1111000 00 0000000 0
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.+.+-+..|+..+.-|+-.||+.+|.+||++.++...|..+..
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1112344699999999999999999999999999999988865
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=220.45 Aligned_cols=231 Identities=20% Similarity=0.386 Sum_probs=161.4
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||.||+|. .+++.||+|.++.. ...+.|.+|+.++.+++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEE
Confidence 356778899999999999997 46788999987542 234678999999999999999999988753 236899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++..... ..+.+..+..++.+++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 77 MELMSKGNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EECCCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 999999999999975432 24678889999999999999999 68999999999999999999999999999
Q ss_pred ccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcchhh
Q 041230 355 ARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVS 418 (485)
Q Consensus 355 a~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (485)
++........ ..++...++++++...+..-. ... +.......+......... .....
T Consensus 147 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~--p~~~~~~~~~~~~~~~~~-~~~~~---- 219 (254)
T cd05083 147 ARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA--PYPKMSLKEVKECVEKGY-RMEPP---- 219 (254)
T ss_pred ceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCC--CCccCCHHHHHHHHhCCC-CCCCC----
Confidence 8764322110 112223455555533222100 000 000000000000000000 00000
Q ss_pred hHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 419 IILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 419 ~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
..+...+.++...|++.+|+.||+|.+++..|+
T Consensus 220 --~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 --EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred --CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 113345678999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=221.73 Aligned_cols=242 Identities=17% Similarity=0.255 Sum_probs=163.7
Q ss_pred cccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|.....||+|+||.||+|... +.+.|++|.+...... ..+.|.+|++++.+++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence 46777889999999999999853 2457899987643333 346799999999999999999999987642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++|+||+++|+|.++++.............+.|..+..++.+++.||.||| +.+|+||||||+||+++.++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence 357999999999999999975432110001125789999999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCc----c---------------eeeeccccHHHHHHHHhhhhh-hhhccccc-hhhhhhhhhhhcc
Q 041230 348 HVGDFSMARFLPDTDE----Q---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN-LQEIEEDRTMCMH 406 (485)
Q Consensus 348 ki~DFGla~~~~~~~~----~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~-~~~~~~~~~~~~~ 406 (485)
+++|||+++....... . .......++++++...+.... ....-... ...+... ...
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~---~~~ 233 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR---LQA 233 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH---HHc
Confidence 9999999875422110 0 001112355555533222100 00000000 0000000 000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
... .+ .....+...+.++...|++.+|++||++.++++.|.
T Consensus 234 ~~~---~~---~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKL---EL---PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCc---CC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000 00 000123456778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=242.17 Aligned_cols=244 Identities=18% Similarity=0.240 Sum_probs=164.3
Q ss_pred hhhccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccC-
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ- 266 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~- 266 (485)
....+.|...+.||+|+||+||++. ..+|+.||||++.... ......+.+|+..+..++|+||+++...+...+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 4455788899999999999999997 4568999999986432 22345688999999999999999987765432111
Q ss_pred --CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 267 --GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 267 --~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
.....++||||+++|+|.++|+..... ...+.+.....|+.+++.||.||| ..+|+||||||+|||++.+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSN 179 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCC
Confidence 112467999999999999999753211 135777888899999999999999 6899999999999999999
Q ss_pred CcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhh
Q 041230 345 MIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMC 404 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 404 (485)
+.+||+|||+++.+...... ..+....++++++...+....... +.............
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~--Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR--PFDGENMEEVMHKT 257 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC--CCCCCCHHHHHHHH
Confidence 99999999999865332110 112233456666543332111100 00000000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
......... ..+...+.++...|++.+|.+||++.+++..
T Consensus 258 ~~~~~~~~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDPLP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000000000 1123456688999999999999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=228.71 Aligned_cols=150 Identities=24% Similarity=0.273 Sum_probs=126.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
-++|...+.||+|+||.||++... +|..||+|.+..... ...+.|.+|++++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence 357888899999999999999854 578899998864322 234578999999999999999999998753 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+.+.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~D 147 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCD 147 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEcc
Confidence 99999999999999997532 35677788899999999999994 24699999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 148 fg~~~~~~ 155 (331)
T cd06649 148 FGVSGQLI 155 (331)
T ss_pred Cccccccc
Confidence 99987653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=222.76 Aligned_cols=237 Identities=17% Similarity=0.324 Sum_probs=164.3
Q ss_pred cccccceeecccCceEEEEeEeeC-Cc----EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GT----TIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~----~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
..|...+.||+|+||.||+|...+ |. .||+|.++.... .....|.+|+.++.+++|+||++++++|.+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 356667899999999999998543 33 589998764432 234678899999999999999999999864
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+++|+|.++++... ..+++...+.++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK--------DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEE
Confidence 35789999999999999997543 24788899999999999999999 68999999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hh-hccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EE-ILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~-~~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..+....++++++...+.--. .. ..+.....+.. .....
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~ 226 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---DLLEK 226 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHhC
Confidence 9999999865432211 011112344444432221000 00 00000001100 00000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...... +..+...+..+...|+..+|.+||++.++++.|..+.++
T Consensus 227 ~~~~~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GERLPQ-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCC-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 000000 011234567889999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=222.95 Aligned_cols=147 Identities=22% Similarity=0.320 Sum_probs=126.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
++|...+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence 4677789999999999999985 5688999999875444445668899999999999999999988753 246789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.++++... .+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|||
T Consensus 84 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred EEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCc
Confidence 999999999999987432 3677888899999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 152 ~~~~~ 156 (267)
T cd06646 152 VAAKI 156 (267)
T ss_pred cceee
Confidence 98765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=219.00 Aligned_cols=227 Identities=24% Similarity=0.348 Sum_probs=158.9
Q ss_pred eecccCceEEEEeEeeC--Cc--EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 202 LIGAGNFGSVYNGTLFD--GT--TIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~--~~--~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.||+|+||.||+|...+ ++ .||||.+..... ...+.|.+|+.++++++|||||++++.+.. ...++|+|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e 75 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVTE 75 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEEE
Confidence 68999999999998643 32 589999875444 445689999999999999999999988653 35789999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|.+++..... ..+.|.....++.+++.||.||| ..+++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~ 145 (257)
T cd05040 76 LAPLGSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMR 145 (257)
T ss_pred ecCCCcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccc
Confidence 9999999999976431 24788899999999999999999 6799999999999999999999999999998
Q ss_pred ccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhc-cccchhhhhhhhhhhcccCCCCCC
Q 041230 357 FLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEIL-NDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 357 ~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~-d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
.+...... ..+....++++++...+.... .... +.....+... ...... . .
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--~~~~~~-~---~ 219 (257)
T cd05040 146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK--KIDKEG-E---R 219 (257)
T ss_pred cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHhcC-C---c
Confidence 76432110 011123455555533322110 0000 0000000000 000000 0 0
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
. .........+.++...|++.+|++||++.+|++.|.
T Consensus 220 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 L---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 001123456778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=218.02 Aligned_cols=231 Identities=18% Similarity=0.226 Sum_probs=161.5
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||++.. .+++.|++|.+.... ......|.+|++++++++||||+++++++.. ....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-----KGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-----CCEEE
Confidence 466778999999999999985 458899999986432 2345678999999999999999999988764 24679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++++|.++++.... ..+.+.....++.+++.||.||| ..+++|+||||+||++++++.+||+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df 145 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDL 145 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEccc
Confidence 99999999999999985421 25778888999999999999999 679999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
|+++........ ..+....++++++...+....... +.................. ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~--p~~~~~~~~~~~~~~~~~~---~~ 220 (256)
T cd08529 146 GVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH--PFDANNQGALILKIIRGVF---PP 220 (256)
T ss_pred ccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCC--CCCCCCHHHHHHHHHcCCC---CC
Confidence 998865432210 011223456665533222110000 0000000000000000000 00
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
........+.++...|++.+|++||+|.++++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 ----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ----CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 00123356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=241.52 Aligned_cols=150 Identities=19% Similarity=0.242 Sum_probs=124.3
Q ss_pred cccceeecccCceEEEEeEee-C-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-D-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
|...+.||+|+||.||++... + +..||+|.+..........+.+|+.+++.++|||||++++++.. ....++|
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~lv 143 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLLI 143 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEEE
Confidence 667789999999999999743 3 56788887654333344567889999999999999999998764 2468999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++|+..... ...+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||+
T Consensus 144 ~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred EECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcC
Confidence 9999999999988642111 135677888889999999999999 67999999999999999999999999999
Q ss_pred ccccC
Q 041230 355 ARFLP 359 (485)
Q Consensus 355 a~~~~ 359 (485)
++...
T Consensus 216 a~~~~ 220 (478)
T PTZ00267 216 SKQYS 220 (478)
T ss_pred ceecC
Confidence 98754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=222.81 Aligned_cols=165 Identities=25% Similarity=0.300 Sum_probs=136.6
Q ss_pred cCccchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecc
Q 041230 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSG 262 (485)
Q Consensus 185 ~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~ 262 (485)
+...++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 45567778899999999999999999999985 468899999886432 2345678899999998 89999999999865
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
.+.......++|+||+++|+|.++++..... ...+.+.....++.+++.||.||| ..+|+||||||+||+++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~ 162 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLT 162 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEc
Confidence 4332334579999999999999998642110 135788889999999999999999 67899999999999999
Q ss_pred CCCcEEEeeccccccc
Q 041230 343 DEMIGHVGDFSMARFL 358 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~ 358 (485)
.++.+||+|||+++..
T Consensus 163 ~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 163 TEGGVKLVDFGVSAQL 178 (291)
T ss_pred CCCCEEEeecccchhc
Confidence 9999999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-26 Score=222.32 Aligned_cols=153 Identities=23% Similarity=0.376 Sum_probs=122.8
Q ss_pred ccccceeecccCceEEEEeEe-e-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCcceeEeeeecccccCCc
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-F-DGTTIAVKVFNLIR--PGGARSFKSECKAAINI---RHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~ 268 (485)
.|...+.||+|+||.||++.. . +|+.||||.++... ......+.+|+.++..+ +||||++++++|........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 466778999999999999975 2 46789999986432 22334567787777665 69999999998864333334
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||++ |+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~k 150 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 150 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEE
Confidence 46789999997 699999875332 24678889999999999999999 67899999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 151 l~Dfg~~~~~~ 161 (290)
T cd07862 151 LADFGLARIYS 161 (290)
T ss_pred EccccceEecc
Confidence 99999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=240.50 Aligned_cols=229 Identities=23% Similarity=0.345 Sum_probs=165.7
Q ss_pred ccceeecccCceEEEEeEee--CCc--EEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 198 SSANLIGAGNFGSVYNGTLF--DGT--TIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~--~~~--~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
..-++||+|+||.|.+|.+. +|+ .||||++...... ...+|++|+.+|.+|+|+|+|+|+|...+ +..+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m 186 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM 186 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence 34568999999999999864 355 4799999876655 56789999999999999999999999764 3568
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+|.++.|||.+.|+.-.. ..|....--.+|.|||.||.||- ..+.|||||..+|+||...-.+||+||
T Consensus 187 MV~ELaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred HHhhhcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecc
Confidence 99999999999999997221 24556666789999999999998 788999999999999999999999999
Q ss_pred ccccccCCCCcce---------------------eeeccccHHHHHHHHhhhhhhhhccc----cchhhhhhhhhhhccc
Q 041230 353 SMARFLPDTDEQT---------------------RFIGKLNVRNFVKMALSQRVEEILND----FNLQEIEEDRTMCMHA 407 (485)
Q Consensus 353 Gla~~~~~~~~~~---------------------~~~~~~~l~~~~~~~~~~~~~~~~d~----~~~~~~~~~~~~~~~~ 407 (485)
||.|-+......= .|+...++..|+.. +||++.- +..-.-........
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVT-----iWEMFtyGEePW~G~~g~qIL~~iD-- 329 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVT-----IWEMFTYGEEPWVGCRGIQILKNID-- 329 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhh-----HHhhhccCCCCCCCCCHHHHHHhcc--
Confidence 9999887665421 12223333333321 2222211 10000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
...+...+..|.+.+++|+..||+.+|.+|||+.++.+.+-.
T Consensus 330 -----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 -----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 001112233588999999999999999999999999765543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=225.52 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=166.9
Q ss_pred cccccceeecccCceEEEEeEee--------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeecccc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVD 264 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~--------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~ 264 (485)
+.|...+.||+|+||.||++... +...+|+|.++... ......|.+|+.++.++ +||||++++++|...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE- 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-
Confidence 46777899999999999998632 24568999876432 22345788999999999 699999999987642
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPS 337 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~ 337 (485)
...++|+||+++|+|.+++....... .......+.|...+.++.+++.||.||| ..+|+||||||+
T Consensus 91 ----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~ 163 (314)
T cd05099 91 ----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR 163 (314)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence 35789999999999999997532100 0011135889999999999999999999 679999999999
Q ss_pred ceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhh
Q 041230 338 NVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQE 396 (485)
Q Consensus 338 NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~ 396 (485)
|||+++++.+||+|||+++........ ..++...++++++...+.-.. ... +.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~--p~~~~~ 241 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS--PYPGIP 241 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC--CCCCCC
Confidence 999999999999999999865332110 001122345555433222100 000 000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
.............. ..+..+...+.++...|+..+|++||++.++++.|+.+....
T Consensus 242 ~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 242 VEELFKLLREGHRM-------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHcCCCC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 00000000000000 001123445678999999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=220.90 Aligned_cols=145 Identities=23% Similarity=0.315 Sum_probs=117.9
Q ss_pred eecccCceEEEEeEeeCC---cEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEe
Q 041230 202 LIGAGNFGSVYNGTLFDG---TTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKF 277 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~~---~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey 277 (485)
.||+|+||+||+|...++ ..+|+|.+..... .....|.+|++.+..++|+||++++++|... ...++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEEe
Confidence 589999999999986544 3577777653322 2345788999999999999999999987642 357999999
Q ss_pred cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 278 MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 278 ~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
+++|+|.++|....... ...+.+.....++.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 77 CPLGDLKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CCCCcHHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccc
Confidence 99999999997643211 123456777889999999999999 67899999999999999999999999999865
Q ss_pred c
Q 041230 358 L 358 (485)
Q Consensus 358 ~ 358 (485)
.
T Consensus 150 ~ 150 (269)
T cd05042 150 Q 150 (269)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=224.39 Aligned_cols=148 Identities=27% Similarity=0.392 Sum_probs=125.7
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++.+++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence 35777889999999999999854 58899999986422 1234568899999999999999999877543 356
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~ 143 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLT 143 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEE
Confidence 899999999999999997532 4667788889999999999999 6899999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 144 Dfg~~~~~~ 152 (291)
T cd05612 144 DFGFAKKLR 152 (291)
T ss_pred ecCcchhcc
Confidence 999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=217.73 Aligned_cols=234 Identities=21% Similarity=0.340 Sum_probs=162.8
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+.|...+.||+|+||.||++...++..+|+|.++.. ....+.|.+|++++.+++|+||+++.+++.. ...+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v 78 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII 78 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence 457778999999999999998777788999987642 2234678999999999999999999888653 346899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++..... ..++|..++.++.+++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred EEeCCCCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcc
Confidence 999999999999976432 35678889999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
+......... ..++...++++++...+..-. ....-+... ................ .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~~~~~-~ 225 (260)
T cd05073 149 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPR-P 225 (260)
T ss_pred eeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCCCC-c
Confidence 8765432110 001112345555433221110 000000000 0000000000000000 0
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
......+.++...|++.+|++||++.++.+.|+.
T Consensus 226 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1123456788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=217.16 Aligned_cols=235 Identities=22% Similarity=0.361 Sum_probs=166.2
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
-++|...+.||+|+||.||++...++..||||.+.... ...+.|.+|+.++.+++|+||+++++++.. ....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceEE
Confidence 35788889999999999999998778889999987432 345679999999999999999999988653 235799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.+++..... ..+++.....++.+++.||.||| ..+++|+||||+||++++++.+|++|||
T Consensus 79 v~e~~~~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred EEeccCCCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccc
Confidence 9999999999999976432 25788899999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccc-hhhhhhhhhhhcccCCCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFN-LQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~-~~~~~~~~~~~~~~~~~~~ 412 (485)
+++........ ...+...++++++...+..-. ........ ...... ...... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~~~~~-~~- 223 (261)
T cd05034 149 LARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE---QVERGY-RM- 223 (261)
T ss_pred cceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC-CC-
Confidence 98765421100 011122345555433221100 00000000 000000 000000 00
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
.....+...+.++...|++.+|+.||++.++.+.|+.
T Consensus 224 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123457789999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=227.97 Aligned_cols=149 Identities=24% Similarity=0.318 Sum_probs=125.8
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||++... ++..+|+|.++... ......|.+|++++.+++|+|||+++++|.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 367888899999999999999854 57889999886432 2234678999999999999999999999764 2468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+.+.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~D 147 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 147 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEee
Confidence 99999999999999997532 35667778899999999999994 24699999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||+++..
T Consensus 148 fg~~~~~ 154 (333)
T cd06650 148 FGVSGQL 154 (333)
T ss_pred CCcchhh
Confidence 9999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=227.27 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=165.5
Q ss_pred ccccceeecccCceEEEEeEeeC--------CcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeeccccc
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~--------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~ 265 (485)
.|...+.||+|+||.||++.... +..||+|.++... ....+.|.+|++++.++ +||||++++++|...
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 90 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-- 90 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC--
Confidence 46677899999999999986321 2368999876432 22346789999999999 899999999988642
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
...++++||+++|+|.++|....... .......+.|..++.++.+++.||.||| ..+|+||||||+|
T Consensus 91 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N 164 (334)
T cd05100 91 ---GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARN 164 (334)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccce
Confidence 35789999999999999997543210 0011235889999999999999999999 6799999999999
Q ss_pred eEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhh
Q 041230 339 VLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEI 397 (485)
Q Consensus 339 ILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~ 397 (485)
||++.++.+||+|||+++........ ..+....++++++...+.... ... +......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~--p~~~~~~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS--PYPGIPV 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC--CCCCCCH
Confidence 99999999999999999865332110 001112345555433222110 000 0000000
Q ss_pred hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 398 EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.............. ....+...+.+++..|++.+|++||+|.++++.|+.+..
T Consensus 243 ~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLLKEGHRMD-------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcCCCCC-------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 00000000000000 011234567789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=232.33 Aligned_cols=144 Identities=27% Similarity=0.355 Sum_probs=119.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|++++.+++|+|||++++++.. ....+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeEE
Confidence 3455667899999999999985 4689999999864322 234678999999999999999999988653 34678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|..... ..+.....|+.+++.||.||| ..+|+||||||+|||+++++.+||+||
T Consensus 149 lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 149 VLLEFMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred EEEecCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 9999999999964321 234556779999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++.+.
T Consensus 213 G~~~~~~ 219 (353)
T PLN00034 213 GVSRILA 219 (353)
T ss_pred ccceecc
Confidence 9998653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=223.59 Aligned_cols=225 Identities=16% Similarity=0.162 Sum_probs=152.8
Q ss_pred eecccCceEEEEeEeeC--------CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 202 LIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.||+|+||.||+|.... ...||+|.+........+.|.+|+.++..++|||||++++++... ...++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEE
Confidence 58999999999997532 234888887544334456789999999999999999999987642 34689
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc-------
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI------- 346 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~------- 346 (485)
||||+++|+|.++++... ..+.|..++.++.|++.||.||| ..+|+||||||+|||++.+..
T Consensus 77 v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~ 145 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK--------NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPP 145 (258)
T ss_pred EEecCCCCcHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCc
Confidence 999999999999998643 24678888999999999999999 789999999999999987765
Q ss_pred -EEEeecccccccCCCCcc---------------eeeeccccHHHHHHHHhhhhhh-hhccccchhhhhhhhhhhcccCC
Q 041230 347 -GHVGDFSMARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRVE-EILNDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 347 -~ki~DFGla~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~ 409 (485)
+|++|||++......... ..+....++++++...+..... ........ ....... ....
T Consensus 146 ~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~~---~~~~ 221 (258)
T cd05078 146 FIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQF---YEDR 221 (258)
T ss_pred eEEecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHHH---HHcc
Confidence 599999998654321110 0112234566655433221110 00000000 0000000 0000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
..... .....+.++...|++.+|++||||.+++++|+
T Consensus 222 ~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPA-------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCC-------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 01234678999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=235.45 Aligned_cols=152 Identities=26% Similarity=0.418 Sum_probs=127.7
Q ss_pred hccccccceeecccCceEEEEeE-eeCCcEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 267 (485)
-.++|....+||+|+|++||+++ ...++++|||++.+. +....+-...|-..|.+| .||.||+|+.. +++
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----eec
Confidence 34578888999999999999998 456899999998532 222234456688888888 89999999755 556
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....|+|+||++||+|.++|+..+ .|+......+|.+|..||+||| +.+||||||||+|||||+||+.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~G---------sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYG---------SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHI 213 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhC---------cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcE
Confidence 678999999999999999998754 4566666679999999999999 7899999999999999999999
Q ss_pred EEeecccccccCCC
Q 041230 348 HVGDFSMARFLPDT 361 (485)
Q Consensus 348 ki~DFGla~~~~~~ 361 (485)
||+|||-|+.+++.
T Consensus 214 kITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 214 KITDFGSAKILSPS 227 (604)
T ss_pred EEeeccccccCChh
Confidence 99999999998653
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=215.33 Aligned_cols=227 Identities=24% Similarity=0.342 Sum_probs=159.0
Q ss_pred eecccCceEEEEeEeeCCcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecCC
Q 041230 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPN 280 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~ 280 (485)
+||+|+||.||++...+++.||+|.+...... ....|.+|++++.++.|+||+++++++.. ....++|+||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~ 76 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELVPG 76 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcCCC
Confidence 68999999999999777999999988654333 44679999999999999999999988754 2457899999999
Q ss_pred CCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCC
Q 041230 281 GSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 281 GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~ 360 (485)
++|.+++.... ..+.+...+.++.+++.||.||| ..+++||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~l~~~l~~~~--------~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 77 GSLLTFLRKKK--------NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG 145 (251)
T ss_pred CcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence 99999997543 24677888999999999999999 67899999999999999999999999999875431
Q ss_pred CCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcchhhh
Q 041230 361 TDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSI 419 (485)
Q Consensus 361 ~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (485)
.... ..+....++++++...+.... ....-..... ........... ....
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~~~-~~~~------ 216 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGY-RMPA------ 216 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhcCC-CCCC------
Confidence 1100 011122355555543322111 0000000000 00000000000 0000
Q ss_pred HHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 420 ILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 420 ~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
...+...+.+++..|+..+|.+||++.+|++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0123346778999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=220.70 Aligned_cols=143 Identities=19% Similarity=0.301 Sum_probs=115.4
Q ss_pred eecccCceEEEEeEeeCCc---EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEe
Q 041230 202 LIGAGNFGSVYNGTLFDGT---TIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKF 277 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~~~---~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey 277 (485)
.||+|+||.||+|...++. .+++|.++... ....+.|.+|+.++..++|||||+++++|... ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEec
Confidence 5899999999999865544 35566654332 23356799999999999999999999988642 357999999
Q ss_pred cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 278 MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 278 ~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
+++|+|.++++..... ...+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 77 CELGDLKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CCCCcHHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccc
Confidence 9999999999854321 023455566789999999999999 67899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=228.35 Aligned_cols=149 Identities=24% Similarity=0.335 Sum_probs=126.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++.+++|||||++++++.. ...
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----ENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CCE
Confidence 56778899999999999999864 57899999986432 2234568899999999999999999988754 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 160 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVT 160 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEe
Confidence 899999999999999997542 3556677779999999999999 6789999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 161 Dfg~~~~~~~ 170 (329)
T PTZ00263 161 DFGFAKKVPD 170 (329)
T ss_pred eccCceEcCC
Confidence 9999987643
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=215.04 Aligned_cols=147 Identities=24% Similarity=0.488 Sum_probs=125.6
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
..|.....||+|+||.||++...++..+|+|.+... ......|.+|++++.++.||||+++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEEE
Confidence 356667889999999999998777889999987632 2234679999999999999999999988653 2357899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++.... ..+.|.....++.+++.||.||| ..+++||||||+||+++.++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~ 146 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR--------GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGM 146 (256)
T ss_pred EEcCCCCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcc
Confidence 99999999999997543 24678888999999999999999 67899999999999999999999999999
Q ss_pred cccc
Q 041230 355 ARFL 358 (485)
Q Consensus 355 a~~~ 358 (485)
++..
T Consensus 147 ~~~~ 150 (256)
T cd05112 147 TRFV 150 (256)
T ss_pred eeec
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=230.34 Aligned_cols=139 Identities=22% Similarity=0.246 Sum_probs=119.3
Q ss_pred ecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||.||++... +++.||+|+++.. .......+..|+.++.+++|||||++++++.. ....++|+||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 699999999999854 5788999998642 22334568889999999999999999887653 34679999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 76 NGGELFHHLQREG---------RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 9999999997532 4677888899999999999999 688999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=227.96 Aligned_cols=141 Identities=21% Similarity=0.240 Sum_probs=120.3
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
+.||+|+||.||++.. .+|+.||||+++... ......+.+|+.++.+++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 3699999999999985 468899999987432 2234567889999999999999999987653 346899999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|.+++.... .+.+.....|+.|++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 76 YANGGELFFHLSRER---------VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 999999999987532 4677888889999999999999 6789999999999999999999999999987
Q ss_pred cc
Q 041230 357 FL 358 (485)
Q Consensus 357 ~~ 358 (485)
..
T Consensus 144 ~~ 145 (323)
T cd05571 144 EG 145 (323)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=228.61 Aligned_cols=146 Identities=18% Similarity=0.296 Sum_probs=125.5
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+|.....||+|+||.||+|... +++.||||+++... ....+.+.+|+.++..++||||+++++++.. ....
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCEE
Confidence 5777889999999999999864 48899999987432 2234578899999999999999999988653 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~D 144 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTD 144 (333)
T ss_pred EEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEe
Confidence 99999999999999997532 4667788889999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||+++..
T Consensus 145 fg~a~~~ 151 (333)
T cd05600 145 FGLSKGI 151 (333)
T ss_pred CcCCccc
Confidence 9999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=220.93 Aligned_cols=229 Identities=17% Similarity=0.204 Sum_probs=161.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
..|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.++..++|+||+++++++.. ....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence 4677778999999999999984 5688999999876554556778999999999999999999988753 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++... .+.+.+...++.+++.||.||| ..+|+||||||+||+++.++.+||+|||
T Consensus 95 v~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg 161 (296)
T cd06654 95 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (296)
T ss_pred eecccCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccc
Confidence 99999999999998642 3567788999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhc--cccchhhhhhhhhhhcccCCCCCC
Q 041230 354 MARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 354 la~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
++......... ..+....++++|+...+..-..... +......... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~------~~~~~~~~ 235 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGTPE 235 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH------HhcCCCCC
Confidence 98754321100 1122345666665443321111100 0000000000 00000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. .........+.++...|+..+|++||++.+|+.
T Consensus 236 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 L---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 000112234667889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=220.81 Aligned_cols=149 Identities=25% Similarity=0.317 Sum_probs=125.1
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+|...+.||+|+||+||++.. .+++.||||++.... ......+.+|+.++.+++||||+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 366678999999999999985 468899999986432 1223467889999999999999999988653 2468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++..... ..+++.....++.+++.||.||| ..+|+||||||+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~D 145 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEee
Confidence 999999999999998864321 24778888999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 146 fg~~~~~~ 153 (285)
T cd05605 146 LGLAVEIP 153 (285)
T ss_pred CCCceecC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=226.38 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=120.1
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++.+++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 3699999999999984 468899999986432 2234567889999999999999999888653 346799999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|..++.... .+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 76 YANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 999999999886532 4678888899999999999999 6789999999999999999999999999987
Q ss_pred cc
Q 041230 357 FL 358 (485)
Q Consensus 357 ~~ 358 (485)
..
T Consensus 144 ~~ 145 (323)
T cd05595 144 EG 145 (323)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=238.06 Aligned_cols=237 Identities=20% Similarity=0.363 Sum_probs=165.6
Q ss_pred cccceeecccCceEEEEeEe-eCC----cEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDG----TTIAVKVFNLI-RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~----~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+....+||+|+||+||||.+ +.| .+||||++... ......+|+.|+.+|++++||||++|+|.|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 34467899999999999985 444 46899988543 234467899999999999999999999999863 3
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
..||++|||.|+|.+|++.+.. .+-.+.-+.+..|||+||.||| ...++||||.++|||+..-..+||+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEE
Confidence 6799999999999999986542 3444567889999999999999 7889999999999999999999999
Q ss_pred ecccccccCCCCcc-eeeeccccHHHHHHHHh--------------hhhhhhhcc----ccchhhhhhhhhhhcccCCCC
Q 041230 351 DFSMARFLPDTDEQ-TRFIGKLNVRNFVKMAL--------------SQRVEEILN----DFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 351 DFGla~~~~~~~~~-~~~~~~~~l~~~~~~~~--------------~~~~~~~~d----~~~~~~~~~~~~~~~~~~~~~ 411 (485)
|||+|+.+..+..+ ..-++++.+.+.+...+ --.+||++. |...-...+.......+
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g---- 916 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG---- 916 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc----
Confidence 99999998655432 11122222221111110 011223221 11000000000000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.+.+.+.-|..-|.-+.+.||..++..||++++...+..+.-+
T Consensus 917 ---eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 917 ---ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 0111223477788899999999999999999999888877644
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=228.66 Aligned_cols=228 Identities=17% Similarity=0.261 Sum_probs=164.0
Q ss_pred ccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
...|..-..||+|+.|.||.+. ..+++.||||++........+-..+|+.+|...+|+|||+++..+.. .+..+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-----~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-----GDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-----cceeE
Confidence 3345556789999999999987 56788999999987665556678899999999999999999876542 25689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|||||++|+|.+.+... .++..+-..|+.++.+||+||| ..+|+|||||+.||||+.++.+||+||
T Consensus 347 VVMEym~ggsLTDvVt~~----------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT----------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEEeecCCCchhhhhhcc----------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeee
Confidence 999999999999888652 4677788889999999999999 789999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccc---cchh-hhhhhhhhhcccCCC
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILND---FNLQ-EIEEDRTMCMHASSS 410 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~---~~~~-~~~~~~~~~~~~~~~ 410 (485)
||+..+...... ..|+.++++.+++..+++ +++. ++.+ .+...+.+...+...
T Consensus 414 GFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIE-----MveGEPPYlnE~PlrAlyLIa~ng~P~ 488 (550)
T KOG0578|consen 414 GFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIE-----MVEGEPPYLNENPLRALYLIATNGTPK 488 (550)
T ss_pred eeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHH-----HhcCCCCccCCChHHHHHHHhhcCCCC
Confidence 999876543311 234556677666654432 3332 2211 111111111111111
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
-..+ + ..=..+-+.-..|.+.|+++||+.++.++
T Consensus 489 lk~~---~---klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNP---E---KLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCc---c---ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1111 1 01122335567899999999999999754
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-25 Score=215.59 Aligned_cols=149 Identities=22% Similarity=0.371 Sum_probs=124.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-----GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.+|...+.||+|+||.||++.. .++..||+|++..... ...+.+.+|+.++.+++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 4788889999999999999985 4588999998864321 1234688899999999999999999876431 12
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++++||+++++|.+++.... .+++.....++.+++.||.||| ..+|+||||||+||+++.++.+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 45789999999999999997532 3567788889999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++.+
T Consensus 147 l~dfg~~~~~ 156 (266)
T cd06651 147 LGDFGASKRL 156 (266)
T ss_pred EccCCCcccc
Confidence 9999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=225.77 Aligned_cols=141 Identities=22% Similarity=0.265 Sum_probs=120.6
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
+.||+|+||.||++.. .+|+.||||+++... ......+.+|+.++.+++||||+++.+++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 3699999999999984 468899999986432 2234578889999999999999999887653 346799999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|..++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 76 y~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~ 143 (328)
T cd05593 76 YVNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143 (328)
T ss_pred CCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence 999999999886532 4678888899999999999999 6799999999999999999999999999987
Q ss_pred cc
Q 041230 357 FL 358 (485)
Q Consensus 357 ~~ 358 (485)
..
T Consensus 144 ~~ 145 (328)
T cd05593 144 EG 145 (328)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=217.47 Aligned_cols=234 Identities=24% Similarity=0.345 Sum_probs=158.0
Q ss_pred eeecccCceEEEEeEeeC-------CcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 201 NLIGAGNFGSVYNGTLFD-------GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~-------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.||+|+||.||+|+..+ +..+|||.+.... ......|.+|+.++++++||||++++++|.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 368999999999998543 2578999875432 2345678999999999999999999998754 23579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-----cE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-----IG 347 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-----~~ 347 (485)
+|+||+++|+|.++++..... ......+.|.+++.++.+++.||.||| +.+++|+||||+||+++.+. .+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~ 150 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVE--RFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhc--ccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcce
Confidence 999999999999999753211 001134788999999999999999999 67899999999999999877 89
Q ss_pred EEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 348 HVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|++|||+++........ ..+....++++++...+.... .....+.... . +.......
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~-~~~~~~~~ 228 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-Q-EVLQHVTA 228 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-H-HHHHHHhc
Confidence 99999998754322110 111223455665543322110 1110000000 0 00000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
.. .... .......+.++...|++.+|.+||+|.+|.+.|+
T Consensus 229 ~~-~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GG-RLQK------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CC-ccCC------cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 0000 0113345678999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=217.77 Aligned_cols=151 Identities=26% Similarity=0.330 Sum_probs=127.0
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcc-hHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG-ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
..|.....||.|..++||+|. .+.+..||||+++..+.+. ....++|+..|+-++|||||+.+..+. .+...+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSELW 100 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ecceeE
Confidence 356667899999999999998 5678999999998655433 477899999999999999999875544 345789
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||.||.+||+.+.+...-. ..+.......|..++.+||.||| ..+-||||||+.|||||.+|.+||+||
T Consensus 101 vVmpfMa~GS~ldIik~~~~-------~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYP-------DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred EeehhhcCCcHHHHHHHHcc-------ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCc
Confidence 99999999999999975322 24666777789999999999999 788999999999999999999999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|.+..+.+
T Consensus 171 gvsa~l~~ 178 (516)
T KOG0582|consen 171 GVSASLFD 178 (516)
T ss_pred eeeeeecc
Confidence 98876543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=218.70 Aligned_cols=153 Identities=27% Similarity=0.370 Sum_probs=127.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...|.|++|+||.||+|+. .++..||.|+++..+. +-.-.-++|+.+|.+++|||||.+-....+.+. +.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ce
Confidence 35688889999999999999984 4578899999986542 223355889999999999999999888776543 45
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.|+|||||+. +|...++... ..|...+.--+..|+.+||.||| ...|+|||||+||+|+.+.|..||+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~--------q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMK--------QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhcc--------CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEec
Confidence 8999999987 9999998654 23555555568899999999999 6789999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
||||||.+.+.
T Consensus 220 DFGLAR~ygsp 230 (419)
T KOG0663|consen 220 DFGLAREYGSP 230 (419)
T ss_pred ccchhhhhcCC
Confidence 99999987654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=217.87 Aligned_cols=146 Identities=21% Similarity=0.290 Sum_probs=124.2
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
|.....||+|+||.||+|... ++..+++|.+........+.|.+|++++..++||||+++++++.. ....++|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence 345577999999999999864 467889998865444445678999999999999999999998754 24679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... ..++|..+..++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 82 EFCAGGAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred EecCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccc
Confidence 9999999999887532 24788899999999999999999 679999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
...
T Consensus 151 ~~~ 153 (282)
T cd06643 151 AKN 153 (282)
T ss_pred ccc
Confidence 754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=224.81 Aligned_cols=149 Identities=23% Similarity=0.328 Sum_probs=126.6
Q ss_pred ccccccceeecccCceEEEEeEeeC--CcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~--~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.++..++|||||++++++.. .
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----E 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----C
Confidence 3568888999999999999998543 3589999986422 2334578899999999999999999998754 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEE
Confidence 46899999999999999997542 4677788889999999999999 68999999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 172 L~DFG~a~~~~ 182 (340)
T PTZ00426 172 MTDFGFAKVVD 182 (340)
T ss_pred EecCCCCeecC
Confidence 99999998754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=218.45 Aligned_cols=148 Identities=24% Similarity=0.299 Sum_probs=124.2
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
|...+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++.+++|+||+++.+++.. .+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEEE
Confidence 55568899999999999985 468899999986432 1223457889999999999999999877653 34689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|.+++..... ..+++.....++.|++.||.||| +.+|+||||||+||++++++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Df 146 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred EEEEeccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecC
Confidence 99999999999998874321 25788999999999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|++....
T Consensus 147 g~~~~~~ 153 (285)
T cd05632 147 GLAVKIP 153 (285)
T ss_pred CcceecC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=212.47 Aligned_cols=235 Identities=22% Similarity=0.355 Sum_probs=160.9
Q ss_pred eeecccCceEEEEeEeeC----CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||.||++.... +..|+||.++..... ..+.+.+|++.+..++|+||+++++++.. ....++|+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 368999999999998654 778999998754333 25788999999999999999999998764 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++..............+++..+..++.+++.||.||| ..+++||||||+||+++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999986421100000135789999999999999999999 689999999999999999999999999999
Q ss_pred cccCCCCc----c----------------eeeeccccHHHHHHHHhhhhhh-hh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 356 RFLPDTDE----Q----------------TRFIGKLNVRNFVKMALSQRVE-EI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 356 ~~~~~~~~----~----------------~~~~~~~~l~~~~~~~~~~~~~-~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
........ . ..++...++++++...+..... .. .+........ ....... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~-~~-- 226 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRKGY-RL-- 226 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCC-CC--
Confidence 87654320 0 0111223444444332211000 00 0000000000 0000000 00
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
.....+...+.++...|++.+|++||++.|+++.|+
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001122356778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=220.30 Aligned_cols=147 Identities=21% Similarity=0.293 Sum_probs=127.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
..|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++..++|+||+++++++.. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEE
Confidence 5677788999999999999984 5789999999875544455778899999999999999999998764 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++... .+.+..+..++.+++.||.||| ..+|+||||||+|||++.++.+||+|||
T Consensus 94 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg 160 (297)
T cd06656 94 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (297)
T ss_pred eecccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCc
Confidence 99999999999998642 3567788999999999999999 6789999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
++....
T Consensus 161 ~~~~~~ 166 (297)
T cd06656 161 FCAQIT 166 (297)
T ss_pred cceEcc
Confidence 987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=218.53 Aligned_cols=228 Identities=21% Similarity=0.248 Sum_probs=157.8
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
|+..+.||+|+||.||+|.. .++..||+|.++... ....+.|.+|+.++++++||||+++++++.. ....++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEEE
Confidence 55567899999999999985 457789999886432 2334578999999999999999999988754 3467999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++... .+.+.....++.+++.||.||| ..+++|+||+|+||++++++.+|++|||+
T Consensus 81 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06642 81 MEYLGGGSALDLLKPG----------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred EEccCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccc
Confidence 9999999999998642 3667788899999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcch
Q 041230 355 ARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTH 416 (485)
Q Consensus 355 a~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (485)
++.+...... ..+....++++++...+..-.......... ....... .. .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~---~~--~~~~~-- 219 (277)
T cd06642 148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFL---IP--KNSPP-- 219 (277)
T ss_pred cccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhh---hh--cCCCC--
Confidence 9765432110 111223455555543322110000000000 0000000 00 00000
Q ss_pred hhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 417 VSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 417 ~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.....+...+.++...|++.+|++||+|.+|++.
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0001233456789999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=217.10 Aligned_cols=148 Identities=22% Similarity=0.292 Sum_probs=123.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||+||++... +++.||||+++... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 35777889999999999999864 57889999987432 2234678899999999999999999988653 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|..+.... ..+.+.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~D 143 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP---------NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCD 143 (287)
T ss_pred EEEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEee
Confidence 9999999998876554321 24677788899999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 144 fg~~~~~~ 151 (287)
T cd07848 144 FGFARNLS 151 (287)
T ss_pred ccCccccc
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=219.34 Aligned_cols=148 Identities=24% Similarity=0.402 Sum_probs=124.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-----KETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-----CCeE
Confidence 467888899999999999999854 688999999864332 233467889999999999999999988653 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||++ |+|.+++.... ..+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D 146 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHP--------GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLAD 146 (303)
T ss_pred EEEEECCC-cCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECC
Confidence 99999996 68888876432 23566778889999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||+++..
T Consensus 147 fg~~~~~ 153 (303)
T cd07869 147 FGLARAK 153 (303)
T ss_pred CCcceec
Confidence 9998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=214.55 Aligned_cols=145 Identities=25% Similarity=0.372 Sum_probs=123.6
Q ss_pred cccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||+||+|...+|..+|||.++..... ....+.+|++++.+++|+||++++++|... ..
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 76 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----NT 76 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----Ce
Confidence 4556789999999999998878999999988643211 124588899999999999999999998642 46
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+|+||||+||++++++.+||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEec
Confidence 799999999999999996532 3567777889999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||++...
T Consensus 145 dfg~~~~~ 152 (265)
T cd06631 145 DFGCARRL 152 (265)
T ss_pred cchhhHhh
Confidence 99998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=220.50 Aligned_cols=148 Identities=26% Similarity=0.303 Sum_probs=124.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||.||++.. .++..+|+|.++... ......+.+|++++.+++||||++++++|.. ....+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence 3678889999999999999985 357788999876432 2223568899999999999999999998764 34689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|.++++... .+.+.....++.+++.||.|||+ ..+++||||||+|||++.++.+||+||
T Consensus 76 lv~ey~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~df 144 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144 (308)
T ss_pred EEeeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccC
Confidence 9999999999999997542 35677788999999999999994 257999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 145 g~~~~~ 150 (308)
T cd06615 145 GVSGQL 150 (308)
T ss_pred CCcccc
Confidence 998765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=228.64 Aligned_cols=150 Identities=23% Similarity=0.383 Sum_probs=126.8
Q ss_pred hccccccceeecccCceEEEEeE-eeCCcEEEEEEeecc----CC-cchHHHHHHHHHHHhcC-CCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI----RP-GGARSFKSECKAAINIR-HRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~ 265 (485)
....|...+.||+|+||+||.|. ..+|..||||.++.. .. ...+...+|+.++..++ ||||++++.+....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 35578888999999999999997 456899999977543 11 23445668999999999 99999999887643
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE- 344 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~- 344 (485)
...++||||+.+|+|.+++...+ .+.......+..|++.|++|+| +.+|+||||||+|||||.+
T Consensus 93 ---~~~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 93 ---TKIYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNE 157 (370)
T ss_pred ---CeEEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCC
Confidence 34899999999999999998733 3555677789999999999999 7899999999999999999
Q ss_pred CcEEEeecccccccC
Q 041230 345 MIGHVGDFSMARFLP 359 (485)
Q Consensus 345 ~~~ki~DFGla~~~~ 359 (485)
+++||+|||++....
T Consensus 158 ~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISP 172 (370)
T ss_pred CCEEEeccccccccC
Confidence 999999999999873
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=215.05 Aligned_cols=238 Identities=20% Similarity=0.296 Sum_probs=158.4
Q ss_pred ccccceeecccCceEEEEeEeeC--CcEEEEEEeeccCC----------cchHHHHHHHHHHHh-cCCCcceeEeeeecc
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFNLIRP----------GGARSFKSECKAAIN-IRHRNIVRVFTAVSG 262 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~--~~~vavK~~~~~~~----------~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~ 262 (485)
+|...+.||+|+||.||+|.... ++.+|||.+..... ....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46677889999999999999655 67899998753211 123457788888865 799999999998764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
....++||||+++++|.+++...... ...+++....+++.+++.||.|||+ ..+++|+||||+||+++
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~ 148 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLG 148 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEEC
Confidence 34689999999999999988532110 1357778889999999999999993 35799999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhc
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 405 (485)
.++.+||+|||++......... ..+....++++++...+...... .+..............
T Consensus 149 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~--~p~~~~~~~~~~~~~~ 226 (269)
T cd08528 149 EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ--PPFYSTNMLSLATKIV 226 (269)
T ss_pred CCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCC--CcccccCHHHHHHHHh
Confidence 9999999999999765433210 11122345555543332211000 0000000000000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
.....+... ......+.++...|++.+|++||+|.||.++|.
T Consensus 227 ~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPLPE------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcCCc------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000000 012245668888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=212.42 Aligned_cols=147 Identities=23% Similarity=0.390 Sum_probs=125.5
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc-----chHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-----GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||.||++.. .+++.||+|.+...... ..+.+.+|++++.+++||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence 5788899999999999999985 45889999988643221 23568889999999999999999998764 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+||++++++.++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 46899999999999999987532 3566778889999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 145 l~dfg~~~~~ 154 (263)
T cd06625 145 LGDFGASKRL 154 (263)
T ss_pred Eeecccceec
Confidence 9999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=217.57 Aligned_cols=147 Identities=22% Similarity=0.409 Sum_probs=123.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeEE
Confidence 45777899999999999999854 57899999986433 2334567899999999999999999988653 34678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||++ |+|.+++.... ..+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 80 lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 147 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCG--------NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADF 147 (288)
T ss_pred EEEeCCC-cCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcC
Confidence 9999998 59999886433 23567788889999999999999 689999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 148 G~~~~~ 153 (288)
T cd07871 148 GLARAK 153 (288)
T ss_pred cceeec
Confidence 998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=218.21 Aligned_cols=147 Identities=21% Similarity=0.313 Sum_probs=127.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.+|...+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence 4577788999999999999974 5688999999875544456778999999999999999999998753 246899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.+++... .+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 94 v~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg 160 (296)
T cd06655 94 VMEYLAGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFG 160 (296)
T ss_pred EEEecCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999988642 3678899999999999999999 6789999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
++....
T Consensus 161 ~~~~~~ 166 (296)
T cd06655 161 FCAQIT 166 (296)
T ss_pred cchhcc
Confidence 987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=217.81 Aligned_cols=144 Identities=28% Similarity=0.319 Sum_probs=119.6
Q ss_pred ecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||+||++.. .+|+.||||.+..... ...+.|..|++++.+++|+||+++.+++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 69999999999985 4688999999864321 223567889999999999999999887653 34579999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|..++...... ...+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 76 ~~g~L~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 76 NGGDLRYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 999999888642211 135788899999999999999999 678999999999999999999999999999765
Q ss_pred C
Q 041230 359 P 359 (485)
Q Consensus 359 ~ 359 (485)
.
T Consensus 148 ~ 148 (280)
T cd05608 148 K 148 (280)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=212.86 Aligned_cols=148 Identities=22% Similarity=0.343 Sum_probs=128.5
Q ss_pred cccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
++|...+.||+|+||.||+|...+ +..+++|.+..... .+.|.+|++++.+++|+||+++++++.. ....++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEE
Confidence 577888899999999999998755 78999999864322 6789999999999999999999998754 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
++||+++++|.+++.... ..++|.....++.+++.||.||| ..+|+||||+|+||+++.++.+||+|||
T Consensus 76 ~~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg 144 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN--------KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFG 144 (256)
T ss_pred EEecCCCCcHHHHHHhCc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccc
Confidence 999999999999997533 25788899999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
++.....
T Consensus 145 ~~~~~~~ 151 (256)
T cd06612 145 VSGQLTD 151 (256)
T ss_pred cchhccc
Confidence 9887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=214.72 Aligned_cols=230 Identities=20% Similarity=0.281 Sum_probs=159.4
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|+..+.||+|+||.||++.. .+|+.||+|.++... ....+++.+|+.++++++||||+++++++.. ....++
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLYI 76 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEEE
Confidence 66678999999999999884 468899999986432 2334578999999999999999999988653 346899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.+++..... ..+++...+.++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||
T Consensus 77 v~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~ 146 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFG 146 (256)
T ss_pred EEecCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999875332 24677888999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcc
Q 041230 354 MARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 354 la~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
++......... ..+....++++++...+....... +.......+............
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~--~~~~~~~~~~~~~~~~~~~~~---- 220 (256)
T cd08218 147 IARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH--AFEAGNMKNLVLKIIRGSYPP---- 220 (256)
T ss_pred ceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCC--CccCCCHHHHHHHHhcCCCCC----
Confidence 99765332110 111223455555533322110000 000000000000000000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
........+.++...|++.+|++||+|.+|++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 ---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01123345678899999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=217.12 Aligned_cols=142 Identities=23% Similarity=0.300 Sum_probs=118.9
Q ss_pred ecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||.||++.. .+|+.+|+|.+.... ......+..|++++.+++||||+++.+++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 69999999999985 458999999986321 1223456679999999999999999887653 34679999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++..... ..+.+.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|||++...
T Consensus 76 ~g~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 76 NGGDLKYHIYNVGE-------RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CCCCHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 99999998864332 24778888999999999999999 689999999999999999999999999998765
Q ss_pred C
Q 041230 359 P 359 (485)
Q Consensus 359 ~ 359 (485)
.
T Consensus 146 ~ 146 (277)
T cd05607 146 K 146 (277)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=211.37 Aligned_cols=231 Identities=15% Similarity=0.206 Sum_probs=161.6
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|+..+.||+|+||.||.+.. .++..+++|.+.... ....+.|.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 366778999999999988773 568899999886432 3345678999999999999999999998764 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++..... ..+++.....++.+++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~ 145 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDF 145 (256)
T ss_pred EEEEecCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcC
Confidence 99999999999999975421 35778889999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhh-hccccchhhhhhhhhhhcccCCCCCC
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEE-ILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|++......... ..+....++++++...+...... ..+.....+.. ...........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~- 221 (256)
T cd08221 146 GISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV---VKIVQGNYTPV- 221 (256)
T ss_pred cceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHcCCCCCC-
Confidence 998865433210 01122346666654333211110 00110000000 00000101000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.......+.++...|++.+|++||++.++++.
T Consensus 222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01123446688889999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=211.68 Aligned_cols=148 Identities=20% Similarity=0.313 Sum_probs=125.0
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
|...+.||+|+||.||++.. .++..+|+|.++... ....+.+.+|+.++.+++|+||+++++++.+ ....++|
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 76 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYIV 76 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEEE
Confidence 56678999999999999984 458899999886432 2345678899999999999999999988654 3468999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++..... ..+++.....++.+++.||.||| ..+|+|+||||+||++++++.++++|||+
T Consensus 77 ~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~ 146 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGS 146 (255)
T ss_pred EeeCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCc
Confidence 999999999999864322 24667788899999999999999 68999999999999999999999999999
Q ss_pred ccccC
Q 041230 355 ARFLP 359 (485)
Q Consensus 355 a~~~~ 359 (485)
++...
T Consensus 147 ~~~~~ 151 (255)
T cd08219 147 ARLLT 151 (255)
T ss_pred ceeec
Confidence 87654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=225.52 Aligned_cols=150 Identities=23% Similarity=0.310 Sum_probs=124.3
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|++++..++|+||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477788999999999999984 568999999885422 12345788999999999999999999987653322223579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+. ++|.+++... ..+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---------QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeeccc-cCHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccc
Confidence 9999997 6888887643 24677888899999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 148 g~a~~~ 153 (372)
T cd07853 148 GLARVE 153 (372)
T ss_pred cceeec
Confidence 999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=217.61 Aligned_cols=148 Identities=26% Similarity=0.306 Sum_probs=125.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||+||++.. .+|+.||+|++.... ....+.|.+|++++..++||||+++++++... ...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEE
Confidence 4566778999999999999985 458899999876432 23356789999999999999999999997642 4679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++...+ .+.+.....++.+++.||.|||+ ..+++||||||+||++++++.++|+||
T Consensus 80 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~ 148 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDF 148 (284)
T ss_pred EEEecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccC
Confidence 9999999999999987532 46778888999999999999994 357999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|++...
T Consensus 149 gl~~~~ 154 (284)
T cd06620 149 GVSGEL 154 (284)
T ss_pred Ccccch
Confidence 998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=217.05 Aligned_cols=150 Identities=21% Similarity=0.287 Sum_probs=129.4
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
..++|.....||+|+||.||++... ++..||+|.++.......+.|..|++++.+++|+||+++++++.. ....
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeE
Confidence 3456888889999999999999864 588999999876544455789999999999999999999998753 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+|+||||+||+++.++.++|+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE--------RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEcc
Confidence 99999999999999987532 24677888999999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||++...
T Consensus 147 ~g~~~~~ 153 (280)
T cd06611 147 FGVSAKN 153 (280)
T ss_pred Cccchhh
Confidence 9988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=211.96 Aligned_cols=236 Identities=17% Similarity=0.217 Sum_probs=161.2
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||++.. .+|..||+|.++... ....+.+..|++++++++|+||+++++++... .....++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~~ 78 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLYI 78 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEEE
Confidence 56678899999999999974 467889999886432 22345688899999999999999999876532 2345789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC--CCCeeeeccCCCceEecCCCcEEEee
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC--QPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~--~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
+|||+++|+|.+++...... ...+++.....++.+++.||.|||..+ ..+++|+||||+||+++.++.+||+|
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred EehhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 99999999999999643110 135788899999999999999999554 67899999999999999999999999
Q ss_pred cccccccCCCCc-c-----------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCCCC
Q 041230 352 FSMARFLPDTDE-Q-----------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 352 FGla~~~~~~~~-~-----------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
||++........ . .......++++++...+.-..... .+........ ..........
T Consensus 154 ~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~- 229 (265)
T cd08217 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIKEGKFRR- 229 (265)
T ss_pred ccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH---HHHhcCCCCC-
Confidence 999987644321 0 001122355555533322100000 0000000000 0000000000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
........+.++...|++.+|++||+|.+|++
T Consensus 230 ------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 230 ------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00123345678999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=212.04 Aligned_cols=229 Identities=18% Similarity=0.237 Sum_probs=159.7
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.|+..+.||+|+||.||+|... ++..||||.++... ......|.+|+.++.++.|+||+++++++.. ....++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEEE
Confidence 4556678999999999999854 57899999986432 2335678999999999999999999998764 346899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++... .+.+.....++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg 146 (277)
T cd06640 80 IMEYLGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EEecCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccc
Confidence 99999999999998642 3566777889999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcc
Q 041230 354 MARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 354 la~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
++......... ..++...++++++...+............ ....... .......+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~--~~~~~~~----~~~~~~~~- 219 (277)
T cd06640 147 VAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM--HPMRVLF----LIPKNNPP- 219 (277)
T ss_pred cceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc--ChHhHhh----hhhcCCCC-
Confidence 99765432210 01122344555543332211111100000 0000000 00000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.....+...+.++...|++.+|++||++.+|++.
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 --TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112345667899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=216.45 Aligned_cols=143 Identities=25% Similarity=0.316 Sum_probs=120.2
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+|.....||+|+||.||+|.. .+++.||+|.+.... ....+.|.+|+.++.+++||||+++++++... ...++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence 456678899999999999984 568899999986432 22346789999999999999999999987642 35789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|..+. .+.+.....++.+++.||.||| +.+|+|+||||+|||++.++.+||+|||
T Consensus 77 v~e~~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg 140 (279)
T cd06619 77 CTEFMDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFG 140 (279)
T ss_pred EEecCCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999997552 2455667789999999999999 6899999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
++....
T Consensus 141 ~~~~~~ 146 (279)
T cd06619 141 VSTQLV 146 (279)
T ss_pred cceecc
Confidence 997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-25 Score=215.20 Aligned_cols=148 Identities=24% Similarity=0.293 Sum_probs=126.9
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
++|...+.||+|+||.||+|... ++..|++|.+........+.|.+|+.++++++|+||+++++++.. ....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence 45777789999999999999864 478999999875544456778999999999999999999998653 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|..++.... ..+.+.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg 155 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD--------RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFG 155 (292)
T ss_pred EEecCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCc
Confidence 999999999998876432 24778889999999999999999 6799999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
++...
T Consensus 156 ~~~~~ 160 (292)
T cd06644 156 VSAKN 160 (292)
T ss_pred cceec
Confidence 98653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=209.95 Aligned_cols=231 Identities=20% Similarity=0.276 Sum_probs=159.3
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++|+|++++++.+... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 3666789999999999999853 478899999864322 2345688999999999999999998765421 23578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++..... ..+++.+...++.+++.||.||| ..+|+||||||+||+++.++.++|+||
T Consensus 77 lv~e~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df 146 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDL 146 (257)
T ss_pred EEecccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecc
Confidence 99999999999999975321 24788899999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|++......... ..+....++++++...+....... .+....... .............
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~ 223 (257)
T cd08223 147 GIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---VYRIIEGKLPPMP 223 (257)
T ss_pred cceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHhcCCCCCc
Confidence 999765322110 111223466666543332111110 111000000 0000000000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
...-..+.++...|++.+|++||+|.++++
T Consensus 224 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 -------KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -------cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=222.53 Aligned_cols=141 Identities=21% Similarity=0.220 Sum_probs=118.2
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||.||++.. .+++.||+|+++... ......+..|+.++.++ +|||||++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 3699999999999985 457889999987532 22334577888888776 89999999988653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+.+.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 E~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~ 143 (329)
T cd05618 76 EYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 143 (329)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 9999999998886432 4677888899999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (329)
T cd05618 144 KEG 146 (329)
T ss_pred ccc
Confidence 753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-25 Score=224.58 Aligned_cols=140 Identities=24% Similarity=0.320 Sum_probs=120.0
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
++|...+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++|||||++++++.. ....++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEE
Confidence 4688889999999999999984 457889999643 2457889999999999999999988653 245789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+. |+|..++.... .+.+...+.|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||
T Consensus 161 v~e~~~-~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG 227 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG 227 (391)
T ss_pred EEecCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCC
Confidence 999985 79988886532 4677888999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+|+..
T Consensus 228 ~a~~~ 232 (391)
T PHA03212 228 AACFP 232 (391)
T ss_pred ccccc
Confidence 99753
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=222.82 Aligned_cols=142 Identities=21% Similarity=0.246 Sum_probs=119.7
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
+.||+|+||.||++.. .+|+.||+|.++... ......+..|++++..++||||+++.+++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 3699999999999974 468899999987432 2234567889999999999999999887653 346899999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|..++.... .+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 76 YANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144 (325)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence 999999999886532 46788889999999999999993 2689999999999999999999999999987
Q ss_pred cc
Q 041230 357 FL 358 (485)
Q Consensus 357 ~~ 358 (485)
..
T Consensus 145 ~~ 146 (325)
T cd05594 145 EG 146 (325)
T ss_pred ec
Confidence 53
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=212.28 Aligned_cols=148 Identities=21% Similarity=0.317 Sum_probs=125.7
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|.....||+|+||.||+|... +|+.||+|++.... ....+.|.+|+.++.+++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEEE
Confidence 5677789999999999999865 58899999886432 2234568899999999999999999998753 34678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++++|..++... ..+.|..+..++.+++.||.||| ..+++||||||+||+++.++.+||+||
T Consensus 77 ~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~df 144 (286)
T cd07847 77 LVFEYCDHTVLNELEKNP---------RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDF 144 (286)
T ss_pred EEEeccCccHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcc
Confidence 999999999998877542 24788899999999999999999 688999999999999999999999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|++.....
T Consensus 145 g~~~~~~~ 152 (286)
T cd07847 145 GFARILTG 152 (286)
T ss_pred ccceecCC
Confidence 99987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=209.79 Aligned_cols=146 Identities=27% Similarity=0.431 Sum_probs=124.5
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-----GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||+||+|... ++..|++|.+..... ...+.|.+|+.++.+++|+||+++++++.. ...
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----EDN 76 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CCe
Confidence 455678999999999999865 789999999864331 234578899999999999999999998753 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++++|.+++.... .+++.....++.+++.||.||| ..+|+|+||||+||+++.++.+||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~ 144 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLA 144 (258)
T ss_pred EEEEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEc
Confidence 789999999999999997432 4677888899999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||++....
T Consensus 145 d~~~~~~~~ 153 (258)
T cd06632 145 DFGMAKQVV 153 (258)
T ss_pred cCccceecc
Confidence 999987653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-25 Score=215.31 Aligned_cols=153 Identities=23% Similarity=0.256 Sum_probs=125.9
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||.|+||.||++... +++.+|+|.+..... .....|.+|++++++++||||++++++|... .....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 35777889999999999999864 578899999864322 2346789999999999999999999987532 123578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++...... ...+.+.....|+.+++.||.||| ..+++|+||+|+||+++.++.++|+||
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 999999999999987632110 134677788899999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|++...
T Consensus 150 g~~~~~ 155 (287)
T cd06621 150 GVSGEL 155 (287)
T ss_pred cccccc
Confidence 998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=213.92 Aligned_cols=152 Identities=24% Similarity=0.354 Sum_probs=121.8
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINI---RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||+||+|... +|+.||+|.++... ......+.+|+.++..+ +||||+++++++..........
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 566788999999999999854 58899999886432 22234566777777655 7999999999876433333345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||++ ++|.+++..... ..+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~ 150 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLA 150 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence 789999998 589998875332 24778888999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 151 dfg~~~~~~ 159 (288)
T cd07863 151 DFGLARIYS 159 (288)
T ss_pred ccCcccccc
Confidence 999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=219.45 Aligned_cols=141 Identities=23% Similarity=0.319 Sum_probs=118.3
Q ss_pred eeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 201 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.||+|+||.||++.. .+++.||||+++... ......+.+|+.++..++||||+++++++.. ....+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence 5799999999999874 357889999986421 1223467889999999999999999988653 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 77 LILEYLSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred EEEeCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999997532 3556677788999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 145 g~~~~~ 150 (323)
T cd05584 145 GLCKES 150 (323)
T ss_pred cCCeec
Confidence 998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=214.82 Aligned_cols=146 Identities=24% Similarity=0.377 Sum_probs=124.7
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc-----chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-----GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||.||+|... +|+.||||.+...... ....+..|++++.+++|+||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KSN 76 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CCE
Confidence 566788999999999999854 5889999998654322 23457789999999999999999998764 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+ +|+|.+++.... ..+++.....++.+++.||.||| ..+|+|+||||+||+++.++.+||+
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~ 144 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLA 144 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEc
Confidence 79999999 999999997543 14788899999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 145 dfg~~~~~~ 153 (298)
T cd07841 145 DFGLARSFG 153 (298)
T ss_pred cceeeeecc
Confidence 999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=220.85 Aligned_cols=148 Identities=18% Similarity=0.372 Sum_probs=126.2
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
|.....||+|.||+|-++.- ..|+.||||.+++.+-. ..-.+++|+++|+.++||||+.++..+. ..+...
T Consensus 55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----NkdKIv 129 (668)
T KOG0611|consen 55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKDKIV 129 (668)
T ss_pred HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCceEE
Confidence 44456799999999999874 67999999988754432 2345789999999999999999987754 345678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||..+|.|++|+...+ .|+......+..||..|+.|+| ..+++|||||-+|||||.|+++||+||
T Consensus 130 ivMEYaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred EEEEecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeecc
Confidence 9999999999999998653 5777888889999999999999 789999999999999999999999999
Q ss_pred ccccccCCC
Q 041230 353 SMARFLPDT 361 (485)
Q Consensus 353 Gla~~~~~~ 361 (485)
||+-.+.+.
T Consensus 198 GLSNly~~~ 206 (668)
T KOG0611|consen 198 GLSNLYADK 206 (668)
T ss_pred chhhhhccc
Confidence 999876543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=210.65 Aligned_cols=150 Identities=23% Similarity=0.319 Sum_probs=128.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.++|.....||+|+||.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEE
Confidence 35677888999999999999985 3578899999876544456789999999999999999999988653 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
++|||+++++|.+++.... ..++......++.+++.||.||| ..+|+|+||||+||++++++.+||+||
T Consensus 77 l~~e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR--------GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECcc
Confidence 9999999999999987542 24677888899999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|++....
T Consensus 146 g~~~~~~ 152 (262)
T cd06613 146 GVSAQLT 152 (262)
T ss_pred ccchhhh
Confidence 9987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-25 Score=214.23 Aligned_cols=150 Identities=25% Similarity=0.283 Sum_probs=125.8
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+|...+.||+|+||.||++... +|..||+|.++... ......|.+|+.++.+++|+||+++++++.. ....++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence 4666788999999999999864 68899999886432 2234678999999999999999999987653 346799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.++++..... ..+++.....++.+++.||.|||+ ..+|+||||||+||+++.++.+||+|||
T Consensus 77 v~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVAT------EGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred EEeecCCCCHHHHHHhcccc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999998753211 257888999999999999999994 3589999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
++...
T Consensus 149 ~~~~~ 153 (286)
T cd06622 149 VSGNL 153 (286)
T ss_pred Ccccc
Confidence 98754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-25 Score=239.88 Aligned_cols=156 Identities=22% Similarity=0.242 Sum_probs=127.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+.|...+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|++++++++|||||++++++.. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 4677789999999999999985 3588999999864322 124579999999999999999999998764 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCC--cccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDD--THWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~--~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
.++||||+++|+|.+++..... .........+++...++|+.+++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 7999999999999999864211 000111134677888999999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 154 LiDFGLAk~i 163 (932)
T PRK13184 154 ILDWGAAIFK 163 (932)
T ss_pred EEecCcceec
Confidence 9999999865
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=223.84 Aligned_cols=149 Identities=23% Similarity=0.347 Sum_probs=127.0
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++... +|+.||||+++... ......|..|+.++..++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence 35777889999999999999854 68899999986432 2345678899999999999999999877643 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~ 143 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLA 143 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEee
Confidence 899999999999999997542 3667778889999999999999 6899999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 144 Dfg~~~~~~~ 153 (350)
T cd05573 144 DFGLCKKMNK 153 (350)
T ss_pred cCCCCccCcc
Confidence 9999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=215.35 Aligned_cols=148 Identities=26% Similarity=0.333 Sum_probs=124.0
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
|...+.||+|+||.||++.. .+++.||||.+..... .....+.+|+.++.+++|+||+++++.+.. ....+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEEE
Confidence 55668899999999999985 4588999998864321 123457889999999999999999988753 24689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|.+++..... ..+.+.....++.+++.||.||| ..+|+||||||+||++++++.++|+||
T Consensus 77 lv~e~~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Df 146 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDL 146 (285)
T ss_pred EEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999864321 24778889999999999999999 689999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|++....
T Consensus 147 g~~~~~~ 153 (285)
T cd05630 147 GLAVHVP 153 (285)
T ss_pred cceeecC
Confidence 9987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=222.30 Aligned_cols=147 Identities=22% Similarity=0.328 Sum_probs=125.3
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+++.||||++.... ......+..|+.++.+++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 3677889999999999999974 458899999986422 2233567889999999999999999988653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~ 143 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLS 143 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEe
Confidence 799999999999999997542 4677788889999999999999 6899999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++.+
T Consensus 144 DFGla~~~ 151 (363)
T cd05628 144 DFGLCTGL 151 (363)
T ss_pred eccCcccc
Confidence 99998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=207.84 Aligned_cols=148 Identities=26% Similarity=0.463 Sum_probs=125.6
Q ss_pred ccceeecccCceEEEEeEeeC-----CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 198 SSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
...+.||.|+||.||++...+ +..||+|.++..... ..+.|..|+..+.+++|+||+++++++... ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence 345789999999999998654 378999998654332 456899999999999999999999987642 457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
+++|||+++|+|.+++..... ..+++.....++.+++.||.||| ..+++||||||+||+++.++.++|+|
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~d 146 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISD 146 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhh-------ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcc
Confidence 999999999999999976432 12788999999999999999999 67999999999999999999999999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||+++....
T Consensus 147 fg~~~~~~~ 155 (258)
T smart00219 147 FGLSRDLYD 155 (258)
T ss_pred cCCceeccc
Confidence 999976543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=213.24 Aligned_cols=148 Identities=24% Similarity=0.327 Sum_probs=126.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.++|...+.||+|+||.||++.. .+++.||+|.++.........+.+|+.++.+++||||+++++++.. ....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEE
Confidence 35777788999999999999985 4588999999875544445678899999999999999999988653 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|.+++.... .+++.+...++.+++.||.||| ..+++|+||||+||+++.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEEeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence 9999999999999987532 4677888999999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|++...
T Consensus 151 g~~~~~ 156 (267)
T cd06645 151 GVSAQI 156 (267)
T ss_pred eeeeEc
Confidence 998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=209.50 Aligned_cols=146 Identities=26% Similarity=0.427 Sum_probs=122.7
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcc---------hHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG---------ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~---------~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
|.....||+|+||.||+|.. .+++.+|+|.+....... .+.|.+|+.++.+++||||+++++++...
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 78 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--- 78 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC---
Confidence 44567899999999999985 457899999886433221 24578899999999999999999987642
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
...++|+||+++++|.+++.... .+++.....++.+++.||.||| ..+++||||||+||++++++.
T Consensus 79 --~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~ 144 (267)
T cd06628 79 --DHLNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGG 144 (267)
T ss_pred --CccEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCC
Confidence 45789999999999999997532 4667788899999999999999 678999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 145 ~~l~dfg~~~~~~ 157 (267)
T cd06628 145 IKISDFGISKKLE 157 (267)
T ss_pred EEecccCCCcccc
Confidence 9999999987664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=215.65 Aligned_cols=147 Identities=20% Similarity=0.342 Sum_probs=124.9
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.|.+|++++.+++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence 35677789999999999999865 47899999875432 2234578899999999999999999988753 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++++|..+.... ..+.|.....++.+++.||.||| +.+|+||||+|+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~d 143 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP---------NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCD 143 (286)
T ss_pred EEEEecCCccHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEe
Confidence 9999999999998877543 23678899999999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||++...
T Consensus 144 fg~~~~~ 150 (286)
T cd07846 144 FGFARTL 150 (286)
T ss_pred eeeeeec
Confidence 9998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=211.08 Aligned_cols=145 Identities=21% Similarity=0.338 Sum_probs=123.9
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
|...+.||+|+||.||+|.. .++..||||.+.... ....+.|.+|+.++.+++||||+++++++.. ....++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEEE
Confidence 55667899999999999985 467899999875432 2234578899999999999999999998764 3467999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++... .+++.....++.+++.||.||| ..+++|+||||+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~ 147 (277)
T cd06641 81 MEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGV 147 (277)
T ss_pred EEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeeccc
Confidence 9999999999998642 4678888999999999999999 68999999999999999999999999999
Q ss_pred ccccC
Q 041230 355 ARFLP 359 (485)
Q Consensus 355 a~~~~ 359 (485)
+..+.
T Consensus 148 ~~~~~ 152 (277)
T cd06641 148 AGQLT 152 (277)
T ss_pred ceecc
Confidence 87653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=225.85 Aligned_cols=150 Identities=23% Similarity=0.296 Sum_probs=125.5
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
...++|...+.||+|+||.||++.. .+++.||||+++.. .....+.|.+|+.++..++||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----- 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----- 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3456888889999999999999985 45889999998642 12234557889999999999999999987653
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+++|+|.+++... .++......++.+++.||.||| +.+|+||||||+|||++.++.+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNY----------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCE
Confidence 34689999999999999998642 2445566778999999999999 6789999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||+++...
T Consensus 182 kL~DfG~~~~~~ 193 (370)
T cd05596 182 KLADFGTCMKMD 193 (370)
T ss_pred EEEeccceeecc
Confidence 999999987653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-25 Score=217.97 Aligned_cols=140 Identities=21% Similarity=0.276 Sum_probs=115.3
Q ss_pred eecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 202 LIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.||+|+||.||+|... +++.||||+++... ....+.+..|..++.. .+||||+++++++.. ....++|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~e 76 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVME 76 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEEc
Confidence 6999999999999854 47789999987432 2233455667777764 489999999987643 346899999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
|+++|+|..++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~gg~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~ 144 (316)
T cd05592 77 YLNGGDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144 (316)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence 999999999987532 3566777889999999999999 6789999999999999999999999999997
Q ss_pred cc
Q 041230 357 FL 358 (485)
Q Consensus 357 ~~ 358 (485)
..
T Consensus 145 ~~ 146 (316)
T cd05592 145 EN 146 (316)
T ss_pred EC
Confidence 54
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=202.93 Aligned_cols=159 Identities=21% Similarity=0.236 Sum_probs=134.9
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+-|.....+|+|||.-||.++ +.++..+|+|++......+.+..++|++..++++||||+++++++....-.+....|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 457778899999999999988 6778899999987655556778899999999999999999999987443335677899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
++.|...|||.+.+...... ...++..+-+.|..||++||.+||.. .++..||||||.|||+.+.+.+++.|||
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~k-----g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIK-----GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EeehhccccHHHHHHHHhhc-----CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 99999999999999754321 12578888999999999999999954 5679999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
.+...+
T Consensus 175 S~~~a~ 180 (302)
T KOG2345|consen 175 SATQAP 180 (302)
T ss_pred Cccccc
Confidence 887643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=225.42 Aligned_cols=145 Identities=18% Similarity=0.229 Sum_probs=123.2
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.|.....||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++.+++|+|||++++++.. ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCEE
Confidence 577788999999999999984 457899999986432 2234568899999999999999999988764 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~D 144 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTD 144 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEee
Confidence 99999999999999997543 3566667778999999999999 68999999999999999999999999
Q ss_pred cccccc
Q 041230 352 FSMARF 357 (485)
Q Consensus 352 FGla~~ 357 (485)
||+++.
T Consensus 145 FGl~~~ 150 (381)
T cd05626 145 FGLCTG 150 (381)
T ss_pred CcCCcc
Confidence 999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-25 Score=219.63 Aligned_cols=141 Identities=22% Similarity=0.261 Sum_probs=118.4
Q ss_pred eeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||.||+|... +++.||||+++.. .....+.+..|.+++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 36899999999999854 4789999998643 223345677899988866 79999999988653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 E~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~ 143 (321)
T cd05591 76 EYVNGGDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMC 143 (321)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccc
Confidence 9999999999886432 4677888889999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (321)
T cd05591 144 KEG 146 (321)
T ss_pred eec
Confidence 753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=220.10 Aligned_cols=140 Identities=21% Similarity=0.233 Sum_probs=119.0
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||.||++.. .+++.||||+++... ......+..|..++.++ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 3699999999999985 457899999997432 22335678899999888 79999999988653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... .+++..+..++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 143 (329)
T cd05588 76 EFVSGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 143 (329)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccc
Confidence 9999999999886432 4778888999999999999999 789999999999999999999999999998
Q ss_pred cc
Q 041230 356 RF 357 (485)
Q Consensus 356 ~~ 357 (485)
+.
T Consensus 144 ~~ 145 (329)
T cd05588 144 KE 145 (329)
T ss_pred cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-24 Score=208.27 Aligned_cols=146 Identities=26% Similarity=0.406 Sum_probs=125.2
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||+|... +++.|++|.++..... ..+.+.+|+.++.+++|+||+++++.+.. ....++
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l 76 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVYI 76 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEEE
Confidence 556689999999999999854 6889999998754432 45678999999999999999999998653 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++++|.++++... .+.+..+..|+.+++.||.||| ..+|+|+||||+||++++++.+||+|||
T Consensus 77 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g 144 (264)
T cd06626 77 FMEYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFG 144 (264)
T ss_pred EEecCCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccc
Confidence 999999999999997532 3567778889999999999999 6789999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
++....
T Consensus 145 ~~~~~~ 150 (264)
T cd06626 145 CAVKLK 150 (264)
T ss_pred cccccC
Confidence 987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=211.14 Aligned_cols=145 Identities=26% Similarity=0.416 Sum_probs=122.0
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---c-------chHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---G-------GARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~-------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
|...+.||+|+||.||+|.. .+|+.||||.++.... . ..+.|..|+.++.+++|+||+++++++...
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-- 80 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--
Confidence 44567899999999999974 4688999998753211 1 124678899999999999999999987642
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
...++|+||+++|+|.+++.... .+.+..+..++.+++.||.||| +.+++||||||+||+++.++
T Consensus 81 ---~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~ 145 (272)
T cd06629 81 ---EYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADG 145 (272)
T ss_pred ---CceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCC
Confidence 45789999999999999997542 4677778889999999999999 67899999999999999999
Q ss_pred cEEEeeccccccc
Q 041230 346 IGHVGDFSMARFL 358 (485)
Q Consensus 346 ~~ki~DFGla~~~ 358 (485)
.++++|||+++..
T Consensus 146 ~~~l~d~~~~~~~ 158 (272)
T cd06629 146 ICKISDFGISKKS 158 (272)
T ss_pred eEEEeeccccccc
Confidence 9999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=220.49 Aligned_cols=146 Identities=20% Similarity=0.271 Sum_probs=121.9
Q ss_pred ccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccC
Q 041230 196 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 266 (485)
+|...+.||+|+||.||++.. .+|+.||+|++.... ....+.+..|+.++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 466778999999999999874 357899999986421 12335678899999999 59999999877543
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++||||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~ 143 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGH 143 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCC
Confidence 346789999999999999997532 4667788889999999999999 678999999999999999999
Q ss_pred EEEeeccccccc
Q 041230 347 GHVGDFSMARFL 358 (485)
Q Consensus 347 ~ki~DFGla~~~ 358 (485)
+||+|||+++..
T Consensus 144 ~kl~DfG~~~~~ 155 (332)
T cd05614 144 VVLTDFGLSKEF 155 (332)
T ss_pred EEEeeCcCCccc
Confidence 999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=218.10 Aligned_cols=144 Identities=25% Similarity=0.345 Sum_probs=119.1
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHH---HhcCCCcceeEeeeecccccCCce
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAA---INIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
|...+.||+|+||.||++.. .+|+.||||+++... ....+.+..|.+++ .+++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 44567899999999999985 458899999987432 22234566666554 56789999999998653 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|..+++.. .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL 142 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKI 142 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEe
Confidence 689999999999999888642 4778889999999999999999 679999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 143 ~Dfg~~~~~ 151 (324)
T cd05589 143 ADFGLCKEG 151 (324)
T ss_pred CcccCCccC
Confidence 999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=223.22 Aligned_cols=142 Identities=25% Similarity=0.276 Sum_probs=120.3
Q ss_pred eeecccCceEEEEeEe----eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 201 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+.||+|+||.||++.. .+|+.||||+++... ......+..|++++.+++||||+++++++.. ....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 5799999999998863 357899999987432 1223457789999999999999999988653 3467999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 144 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL 144 (318)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccC
Confidence 99999999999996532 4678888999999999999999 67899999999999999999999999999
Q ss_pred ccccC
Q 041230 355 ARFLP 359 (485)
Q Consensus 355 a~~~~ 359 (485)
++...
T Consensus 145 ~~~~~ 149 (318)
T cd05582 145 SKESI 149 (318)
T ss_pred CcccC
Confidence 97653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=222.47 Aligned_cols=149 Identities=23% Similarity=0.240 Sum_probs=126.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+|+.||||+++.... ...+.|.+|+.++..++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 3677889999999999999985 4688999999874321 234568889999999999999999887653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... ..+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~ 144 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE--------DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLA 144 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEec
Confidence 799999999999999997542 24677778889999999999999 7899999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++.+.
T Consensus 145 Dfg~a~~~~ 153 (330)
T cd05601 145 DFGSAARLT 153 (330)
T ss_pred cCCCCeECC
Confidence 999998654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=226.60 Aligned_cols=143 Identities=20% Similarity=0.235 Sum_probs=121.9
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
..+|.....||+|+||.||++... .++.||||... ...+.+|++++.+++|+|||++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 447888999999999999999854 47789999632 2356789999999999999999998753 23578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+. |+|.+++.... ..++|..++.|+.|++.||.||| ..+|+||||||+||||+.++.+||+||
T Consensus 237 lv~e~~~-~~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DF 304 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARL--------RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDF 304 (461)
T ss_pred EEEEccC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEccc
Confidence 9999995 79999886432 25789999999999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 305 Gla~~~~ 311 (461)
T PHA03211 305 GAACFAR 311 (461)
T ss_pred CCceecc
Confidence 9998653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=214.43 Aligned_cols=232 Identities=16% Similarity=0.217 Sum_probs=159.6
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
...|...+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|++++.+++||||+++.++|... .
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----H 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----C
Confidence 345777889999999999999854 688999998864322 2235688999999999999999999998642 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||++ |+|.+++.... ..+.+..+..++.|++.||.||| ..+|+||||+|+||++++++.+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHK--------KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEE
Confidence 5789999997 67877775322 24678889999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCc-----------------ceeeeccccHHHHHHHHhhhhhhhhccccchhh-hhhhhhhhcccCCCC
Q 041230 350 GDFSMARFLPDTDE-----------------QTRFIGKLNVRNFVKMALSQRVEEILNDFNLQE-IEEDRTMCMHASSSS 411 (485)
Q Consensus 350 ~DFGla~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~~~~ 411 (485)
+|||++........ ...+....++++++...+.-..... +..... ....... .......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~--p~~~~~~~~~~~~~-~~~~~~~ 233 (307)
T cd06607 157 ADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP--PLFNMNAMSALYHI-AQNDSPT 233 (307)
T ss_pred eecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCC--CCCCccHHHHHHHH-hcCCCCC
Confidence 99999876532211 0112234566666644332111100 000000 0000000 0000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.. ...+...+..+...|++.+|++||+|.+|+..
T Consensus 234 ~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 LS------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01233456788899999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=217.12 Aligned_cols=140 Identities=20% Similarity=0.293 Sum_probs=117.1
Q ss_pred eeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||+|... +++.||||+++... ....+.+..|..++.. ++||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 36999999999999864 47889999987431 2334556778888876 499999999988653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 ey~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05619 76 EYLNGGDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMC 143 (316)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcc
Confidence 9999999999987432 4677788889999999999999 679999999999999999999999999998
Q ss_pred cc
Q 041230 356 RF 357 (485)
Q Consensus 356 ~~ 357 (485)
+.
T Consensus 144 ~~ 145 (316)
T cd05619 144 KE 145 (316)
T ss_pred eE
Confidence 75
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=217.76 Aligned_cols=141 Identities=25% Similarity=0.300 Sum_probs=118.5
Q ss_pred eeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||++... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 36999999999999854 5789999998642 223445677888888876 69999999988653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 Ey~~~g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~ 143 (320)
T cd05590 76 EFVNGGDLMFHIQKSR---------RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 143 (320)
T ss_pred cCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCC
Confidence 9999999999987532 4667788889999999999999 688999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (320)
T cd05590 144 KEG 146 (320)
T ss_pred eec
Confidence 753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=226.17 Aligned_cols=153 Identities=25% Similarity=0.348 Sum_probs=120.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccC---Cce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ---GAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~---~~~ 269 (485)
..+|...+.||+|+||.||+|.. .+++.||||++... .....+|+.++.+++|||||++.+++...++. ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45788889999999999999985 45789999987532 22345799999999999999998876433221 123
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGH 348 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~k 348 (485)
+.++||||+++ +|.+++..... ....+++.....++.+++.||.||| ..+|+||||||+||||+.+. .+|
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYAR-----NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCcee
Confidence 56799999984 77777653111 0135677788889999999999999 67899999999999999664 799
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+|+.+.
T Consensus 212 L~DFGla~~~~ 222 (440)
T PTZ00036 212 LCDFGSAKNLL 222 (440)
T ss_pred eeccccchhcc
Confidence 99999998653
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=209.37 Aligned_cols=148 Identities=22% Similarity=0.379 Sum_probs=123.8
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||+|... ++..||||.++... ....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 3666788999999999999864 58899999986432 2234678899999999999999999998753 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||++ |+|.+++...... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 145 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG------QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADF 145 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC------CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcc
Confidence 9999998 7999988653211 35778888999999999999999 679999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|++...
T Consensus 146 g~~~~~ 151 (285)
T cd07861 146 GLARAF 151 (285)
T ss_pred cceeec
Confidence 998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=210.47 Aligned_cols=147 Identities=22% Similarity=0.295 Sum_probs=126.3
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+|...+.||.|+||.||+|... +++.||+|.+.... ......|.+|++++++++|+||+++++++.+ ....++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence 4667788999999999999854 58899999986433 2334678899999999999999999988654 246899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.+++... .+.+.....++.+++.||.||| ..+++||||+|+||++++++.++|+|||
T Consensus 77 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g 143 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFG 143 (274)
T ss_pred EEEeeCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccc
Confidence 99999999999998742 4677888999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
+++....
T Consensus 144 ~~~~~~~ 150 (274)
T cd06609 144 VSGQLTS 150 (274)
T ss_pred cceeecc
Confidence 9987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=216.46 Aligned_cols=145 Identities=20% Similarity=0.231 Sum_probs=120.3
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCC-cceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHR-NIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~~ 270 (485)
+|...+.||+|+||.||+|... +++.||||++... .....+.+..|.+++..+.|+ +|+++.+++.. .+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 4667789999999999999854 4678999998642 223456788899999999775 57777766543 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~ 143 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIA 143 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEe
Confidence 899999999999999986532 4677888899999999999999 6799999999999999999999999
Q ss_pred ecccccc
Q 041230 351 DFSMARF 357 (485)
Q Consensus 351 DFGla~~ 357 (485)
|||+++.
T Consensus 144 Dfg~~~~ 150 (324)
T cd05587 144 DFGMCKE 150 (324)
T ss_pred ecCccee
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=223.63 Aligned_cols=147 Identities=21% Similarity=0.329 Sum_probs=126.2
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+|+.||||+++... ......+.+|+.++..++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 4678889999999999999985 458899999986432 2234567889999999999999999988654 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 143 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLS 143 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEe
Confidence 899999999999999997532 4677788889999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++.+
T Consensus 144 Dfg~~~~~ 151 (364)
T cd05599 144 DFGLCTGL 151 (364)
T ss_pred ecccceec
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=213.99 Aligned_cols=147 Identities=20% Similarity=0.383 Sum_probs=123.1
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.|...+.||+|+||.||+|... ++..||+|.++.... .....+.+|+.++.+++||||+++++++.. ....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence 45777889999999999999853 577899999874432 234567889999999999999999998753 24579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++ +|.+++.... ..+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Df 148 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCG--------NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADF 148 (309)
T ss_pred EEEeCCCC-CHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence 99999985 8888886532 23567778889999999999999 679999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 149 g~~~~~ 154 (309)
T cd07872 149 GLARAK 154 (309)
T ss_pred ccceec
Confidence 998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=219.05 Aligned_cols=152 Identities=19% Similarity=0.227 Sum_probs=123.2
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~ 268 (485)
..+.|...+.||+|+||.||++.. ..++.||||.+.... ....+.+.+|+.++..++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456888889999999999999974 457899999986432 2234567889999999999999999998753221 122
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++ +|.+++.. .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEE
Confidence 357899999975 67666642 3567777889999999999999 68999999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 160 l~Dfg~~~~~~ 170 (355)
T cd07874 160 ILDFGLARTAG 170 (355)
T ss_pred EeeCcccccCC
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=214.07 Aligned_cols=146 Identities=21% Similarity=0.298 Sum_probs=124.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||++.. .+++.||+|.++... ......+.+|+.++..++||||+++++.+.. ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence 3677789999999999999985 347889999886432 1234568899999999999999999988653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+.....++.+++.||.||| ..+++||||||+||+++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~ 143 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLT 143 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEe
Confidence 799999999999999996532 3677788889999999999999 6789999999999999999999999
Q ss_pred ecccccc
Q 041230 351 DFSMARF 357 (485)
Q Consensus 351 DFGla~~ 357 (485)
|||+++.
T Consensus 144 dfg~~~~ 150 (305)
T cd05609 144 DFGLSKI 150 (305)
T ss_pred eCCCccc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=216.61 Aligned_cols=140 Identities=23% Similarity=0.282 Sum_probs=118.9
Q ss_pred eeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||++... +++.||||+++... ......+..|..++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 36999999999999864 47899999987432 23345677888888877 79999999988653 34689999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+++.....++.+++.||.||| ..+|+||||||+|||+++++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 143 (318)
T cd05570 76 EYVNGGDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC 143 (318)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCC
Confidence 9999999999887532 4778889999999999999999 679999999999999999999999999998
Q ss_pred cc
Q 041230 356 RF 357 (485)
Q Consensus 356 ~~ 357 (485)
+.
T Consensus 144 ~~ 145 (318)
T cd05570 144 KE 145 (318)
T ss_pred ee
Confidence 75
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=220.55 Aligned_cols=142 Identities=21% Similarity=0.345 Sum_probs=119.8
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
..+|...+.||+|+||.||+|... ++..||+|.... ..+..|+.++.+++|+|||++++++.. ....+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-----CCeeE
Confidence 457888899999999999999854 467899997432 233569999999999999999998764 23578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+. |+|.+++.... ..++|..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 134 lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS--------RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred EEEEccC-CcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecC
Confidence 9999995 79999886432 35788999999999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 202 G~a~~~ 207 (357)
T PHA03209 202 GAAQFP 207 (357)
T ss_pred cccccc
Confidence 999753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=217.73 Aligned_cols=150 Identities=21% Similarity=0.255 Sum_probs=121.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 269 (485)
.+.|...+.||+|+||.||++.. .+|..||||.++... ......+.+|+.++..++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46788889999999999999984 458899999986422 2334678899999999999999999998753221 1123
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+.+ +|.+.++. .+++.....++.|++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl 164 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 164 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEE
Confidence 46899999975 56666642 3556677789999999999999 679999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 165 ~Dfg~a~~~ 173 (359)
T cd07876 165 LDFGLARTA 173 (359)
T ss_pred ecCCCcccc
Confidence 999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=208.27 Aligned_cols=158 Identities=23% Similarity=0.356 Sum_probs=131.1
Q ss_pred hhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeeccccc-CCc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY-QGA 268 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~-~~~ 268 (485)
.++++|...+.||+|+||.||+|... +++.+++|.+.... ...+.|.+|+.++.++ .|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46788999999999999999999864 57789999886533 2346789999999999 79999999999865332 224
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+++++|.+++...... ...+.+.....++.+++.||.||| +.+++|+||+|+||++++++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEE
Confidence 5679999999999999998743210 135678888999999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||++...
T Consensus 154 l~d~~~~~~~ 163 (275)
T cd06608 154 LVDFGVSAQL 163 (275)
T ss_pred ECCCccceec
Confidence 9999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=222.54 Aligned_cols=149 Identities=22% Similarity=0.308 Sum_probs=125.9
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
..++|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++..++||||+++++++.. .
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----D 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 4567888899999999999999854 5788999998642 12234568889999999999999999988653 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~----------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY----------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEE
Confidence 5689999999999999998642 2456677889999999999999 68999999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 183 L~DFG~a~~~~ 193 (370)
T cd05621 183 LADFGTCMKMD 193 (370)
T ss_pred EEecccceecc
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=205.87 Aligned_cols=230 Identities=18% Similarity=0.295 Sum_probs=158.5
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||++.. .+++.+|||.+.... ....+.|.+|++++++++||||+++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 366778999999999999875 467889999986432 2335678999999999999999999887543 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-CcEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MIGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-~~~ki~D 351 (485)
+|+||+++|+|.+++..... ..+++.....++.+++.||.||| ..+|+|+||||+||+++.+ ..+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d 145 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGD 145 (256)
T ss_pred EEEecCCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 99999999999999975432 24678888999999999999999 6799999999999999854 5689999
Q ss_pred cccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhh-hccccchhhhhhhhhhhcccCCCCCC
Q 041230 352 FSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEE-ILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 352 FGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
||+++........ ..++...++++++...+...... ..+....... .. ........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~---~~~~~~~~ 219 (256)
T cd08220 146 FGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VL---KIMSGTFA 219 (256)
T ss_pred CCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HH---HHHhcCCC
Confidence 9999865432110 11122356666654333211100 0010000000 00 00000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. ........+.++...|++.+|++||||.|+++
T Consensus 220 ~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 P----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 00112345668899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=214.28 Aligned_cols=144 Identities=24% Similarity=0.339 Sum_probs=122.4
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
|.....||+|+||.||++.. .++..||||.+........+.|.+|+..+.+++|+||+++++.+.. ....++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEEE
Confidence 33345799999999999985 4588999999865444445678899999999999999999988653 24679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++++|.+++... .+.+.....++.+++.||.||| +.+|+||||||+||++++++.+||+|||++
T Consensus 99 e~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 99 EFLEGGALTDIVTHT----------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred eCCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence 999999999998532 3567888999999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
...
T Consensus 166 ~~~ 168 (292)
T cd06658 166 AQV 168 (292)
T ss_pred hhc
Confidence 754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=210.45 Aligned_cols=156 Identities=19% Similarity=0.303 Sum_probs=126.0
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||+|... +|+.||||.++... ......+.+|+.++.+++ |+||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36778899999999999999854 68899999876432 223467888999999995 699999998876433323334
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHV 349 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki 349 (485)
.++||||+++ +|.+++...... ....+++.....++.+|+.||.||| ..+|+||||||+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEE
Confidence 7899999985 899988753221 0135788899999999999999999 678999999999999998 899999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 153 ~dfg~~~~~ 161 (295)
T cd07837 153 ADLGLGRAF 161 (295)
T ss_pred eecccceec
Confidence 999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=212.15 Aligned_cols=146 Identities=22% Similarity=0.307 Sum_probs=126.2
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.|...+.||+|+||.||+|.. .++..||+|.+........+.|.+|+.++.+++||||++++++|.. .+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEEE
Confidence 5677788999999999999974 4678999999865444455678999999999999999999988753 245799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.+++... .+.+..+..++.+++.||.||| ..+++||||||+||+++.++.+||+|||
T Consensus 94 v~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg 160 (293)
T cd06647 94 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (293)
T ss_pred EEecCCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCc
Confidence 99999999999998742 3567788999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
++...
T Consensus 161 ~~~~~ 165 (293)
T cd06647 161 FCAQI 165 (293)
T ss_pred ceecc
Confidence 88654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=210.04 Aligned_cols=151 Identities=21% Similarity=0.304 Sum_probs=120.7
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHH-HHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKA-AINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||.||++... +|+.||+|+++.... .....+..|+.. +...+|||||++++++.. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence 46778889999999999999854 589999999865322 223455566665 566789999999998753 2357
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||++ |+|.+++...... ...+++.....++.|++.||.|||. ..+++||||||+|||++.++.+||+|
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999997 7898888642211 1357888999999999999999993 23899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||+++..
T Consensus 148 fg~~~~~ 154 (283)
T cd06617 148 FGISGYL 154 (283)
T ss_pred ccccccc
Confidence 9998765
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-24 Score=211.51 Aligned_cols=151 Identities=18% Similarity=0.269 Sum_probs=118.5
Q ss_pred ceeecccCceEEEEeEeeC---CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 200 ANLIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~~---~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
...||+|+||+||+|...+ +..||+|.++.. .....+.+|+.++.+++|||||++++++... .....++|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence 3689999999999998643 468999987642 2345688999999999999999999987532 2346789999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe----cCCCcEEEeec
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGHVGDF 352 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl----d~~~~~ki~DF 352 (485)
|+++ +|.+++..............+++.....|+.|++.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 78777753221111111235788888899999999999999 6789999999999999 56689999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 157 G~a~~~~ 163 (317)
T cd07867 157 GFARLFN 163 (317)
T ss_pred cceeccC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=209.59 Aligned_cols=162 Identities=23% Similarity=0.331 Sum_probs=131.8
Q ss_pred CccchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 186 ~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
+..++..+.+.|.....||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455566778888899999999999999985 457889999886432 2345688899999988 799999999987532
Q ss_pred cc-CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 264 DY-QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 264 ~~-~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
.. ......+++|||+++|+|.+++..... ..+.+.....++.+++.||.||| ..+|+||||||+||+++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~ 155 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLT 155 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence 21 123467999999999999999875332 23566777889999999999999 67899999999999999
Q ss_pred CCCcEEEeeccccccc
Q 041230 343 DEMIGHVGDFSMARFL 358 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~ 358 (485)
+++.++|+|||++...
T Consensus 156 ~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 156 ENAEVKLVDFGVSAQL 171 (282)
T ss_pred CCCCEEEeeCcchhhh
Confidence 9999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=209.38 Aligned_cols=237 Identities=18% Similarity=0.224 Sum_probs=167.1
Q ss_pred hhhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.+++|...+.||+|+||.||+|... ++..|++|++..... ..+.|.+|++.+..++|+||+++++++... .
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 88 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----D 88 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----C
Confidence 356778888899999999999999865 588999999875433 456788999999999999999999987642 4
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++++|.+++.... ..+++..+..|+.+++.||.||| ..+|+|+||||+||+++.++.++|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEE
Confidence 6799999999999999998643 25788899999999999999999 689999999999999999999999
Q ss_pred eecccccccCCCCc------------------ceeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCC
Q 041230 350 GDFSMARFLPDTDE------------------QTRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 350 ~DFGla~~~~~~~~------------------~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
+|||++........ ...+....++++++...+.-..... +....................
T Consensus 158 ~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~--p~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06614 158 ADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP--PYLREPPLRALFLITTKGIPP 235 (286)
T ss_pred CccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC--CCCCCCHHHHHHHHHhcCCCC
Confidence 99998765432110 0112334566666544332111000 000000000000000000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
. .....+...+.++...|++.+|..||++.+|+..
T Consensus 236 ~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 L-----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C-----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 0011133456789999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-24 Score=204.59 Aligned_cols=148 Identities=23% Similarity=0.333 Sum_probs=128.3
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||.||+++.. +++.|+||++..... .....|.+|+..+.+++|+||+++++++.. ....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEE
Confidence 36777899999999999999865 489999999865432 345679999999999999999999998764 24689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeeccCCCceEecCCCcEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQ-PRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~-~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
+|+||+++++|.+++... ..+++.....++.++++||.||| . .+++||||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~d 143 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV---------GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIAD 143 (264)
T ss_pred EEEEecCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999999753 24677888999999999999999 6 8999999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||++....
T Consensus 144 f~~~~~~~ 151 (264)
T cd06623 144 FGISKVLE 151 (264)
T ss_pred Cccceecc
Confidence 99988654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=208.84 Aligned_cols=149 Identities=23% Similarity=0.369 Sum_probs=123.7
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++++|...+.||+|+||.||+|.. .+|..||+|++.... ......+.+|+.++.+++|+||+++.+++.. ...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCe
Confidence 567888899999999999999985 468899999986432 2334567889999999999999999998753 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+. ++|.+++.... ..+.+.....++.+++.||.||| ..+|+|+||||+|||++.++.+||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~ 145 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP--------GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLA 145 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEe
Confidence 789999996 78877775432 13566777789999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 146 Dfg~~~~~ 153 (291)
T cd07870 146 DFGLARAK 153 (291)
T ss_pred cccccccc
Confidence 99998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-24 Score=205.55 Aligned_cols=149 Identities=23% Similarity=0.357 Sum_probs=123.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-----GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||.||+|.. .+|..||||.+..... ...+.+.+|+.++.+++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 4678889999999999999985 4588999998753221 1235688899999999999999999876432 12
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+++|+|.+++.... .+++....+++.+++.||.||| +.+|+|+||||+||+++.++.+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEE
Confidence 35789999999999999986432 3566777889999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 147 l~Dfg~~~~~ 156 (265)
T cd06652 147 LGDFGASKRL 156 (265)
T ss_pred ECcCcccccc
Confidence 9999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=218.75 Aligned_cols=141 Identities=28% Similarity=0.348 Sum_probs=116.1
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECK-AAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||++.. .+|+.||||++.... ......+..|.. ++..++||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 3699999999999984 468899999986421 122345555655 4678999999999987653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~ 143 (325)
T cd05604 76 DFVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLC 143 (325)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCc
Confidence 9999999999886432 4677788889999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (325)
T cd05604 144 KEG 146 (325)
T ss_pred ccC
Confidence 753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=215.00 Aligned_cols=140 Identities=22% Similarity=0.302 Sum_probs=116.7
Q ss_pred eeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||.||++... +|+.||||.++... ....+.+..|..++.. .+||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 36999999999999854 57899999987431 2234556778888775 489999999988653 34689999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+++.....++.+++.||+||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05620 76 EFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMC 143 (316)
T ss_pred CCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCC
Confidence 9999999999987532 4567778889999999999999 679999999999999999999999999998
Q ss_pred cc
Q 041230 356 RF 357 (485)
Q Consensus 356 ~~ 357 (485)
+.
T Consensus 144 ~~ 145 (316)
T cd05620 144 KE 145 (316)
T ss_pred ee
Confidence 74
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=219.63 Aligned_cols=149 Identities=20% Similarity=0.347 Sum_probs=127.3
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
..++|.....||+|+||.||.++- .+|..+|+|++++. ..+..+..+.|-.+|....+++||+|+.. +++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 457888999999999999999985 45889999999754 34556778899999999999999999755 5667
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
++.||||||+|||++..+|...+. |......-++.+++.|+.-|| ..++|||||||.|+|||..|+.|
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEe
Confidence 789999999999999999987653 333444457888999999999 88999999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
++||||+.-+
T Consensus 282 LSDFGLs~gl 291 (550)
T KOG0605|consen 282 LSDFGLSTGL 291 (550)
T ss_pred eccccccchh
Confidence 9999999654
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=213.86 Aligned_cols=146 Identities=20% Similarity=0.217 Sum_probs=120.7
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+|...+.||+|+||.||+|... +++.||||.++... ....+.+..|..++..+ +|+||+++++++.. ...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 4667789999999999999854 46789999987432 22334567788888777 57889989887653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+..+..++.+++.||.||| ..+|+||||||+|||+++++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~ 143 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEc
Confidence 799999999999999986532 4677888999999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 144 DfG~~~~~ 151 (323)
T cd05616 144 DFGMCKEN 151 (323)
T ss_pred cCCCceec
Confidence 99999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=208.62 Aligned_cols=147 Identities=23% Similarity=0.409 Sum_probs=124.1
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||+|.. .+|+.||||.++... ......|.+|++++.+++||||+++++++.+ ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 477788999999999999985 468899999886432 2233578899999999999999999998653 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||++ ++|.+++..... ..+.+.....++.+++.||.||| ..+++||||||+||+++.++.+||+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~df 144 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 144 (284)
T ss_pred EEeeccc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999996 689999875432 25778889999999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 145 g~~~~~ 150 (284)
T cd07860 145 GLARAF 150 (284)
T ss_pred cchhhc
Confidence 998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=207.91 Aligned_cols=147 Identities=24% Similarity=0.375 Sum_probs=125.0
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeecc-CCcchHHHHHHHHHHHhcC---CCcceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI-RPGGARSFKSECKAAINIR---HRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~~ 270 (485)
.|+..+.||+|+||.||+|.. .+++.||||.++.. .......+.+|+.++++++ |||++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 466678899999999999985 56889999998643 2334567889999999997 9999999998753 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++++|.+++... .+.+.....++.+++.||.||| ..+|+|+||+|+||+++.++.++|+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~ 143 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLC 143 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEc
Confidence 79999999999999998642 4677888899999999999999 6789999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||++.....
T Consensus 144 dfg~~~~~~~ 153 (277)
T cd06917 144 DFGVAALLNQ 153 (277)
T ss_pred cCCceeecCC
Confidence 9999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-25 Score=210.42 Aligned_cols=143 Identities=29% Similarity=0.465 Sum_probs=120.6
Q ss_pred ccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcch--HHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 198 SSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~--~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
...+.||+|+||+||++.... ++.+|+|.+........ ....+|+.++.+++||||+++++++.. ....++|
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~v 76 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYIV 76 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----ccccccc
Confidence 346789999999999998644 56899999975432222 234569999999999999999988754 3467899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++|... ..+++..+..++.++++||.||| ..+|+|+||||+||++++++.++|+|||.
T Consensus 77 ~~~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~ 144 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKN---------KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGS 144 (260)
T ss_dssp EEEETTEBHHHHHHHH---------SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred cccccccccccccccc---------ccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999821 35788899999999999999999 57999999999999999999999999999
Q ss_pred ccc
Q 041230 355 ARF 357 (485)
Q Consensus 355 a~~ 357 (485)
+..
T Consensus 145 ~~~ 147 (260)
T PF00069_consen 145 SVK 147 (260)
T ss_dssp TEE
T ss_pred ccc
Confidence 975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=212.33 Aligned_cols=142 Identities=21% Similarity=0.303 Sum_probs=122.0
Q ss_pred ceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 200 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
...||+|+||.||++.. .+++.||||.++.......+.+.+|+.++..++||||+++++++.. ....++|+||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEEecC
Confidence 45799999999999985 4688999999865444445678899999999999999999988653 24679999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|..++.. ..+.+.....++.+++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~~~~L~~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 101 QGGALTDIVSQ----------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CCCCHHHHHhh----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 99999998753 23677888999999999999999 678999999999999999999999999998754
Q ss_pred C
Q 041230 359 P 359 (485)
Q Consensus 359 ~ 359 (485)
.
T Consensus 168 ~ 168 (297)
T cd06659 168 S 168 (297)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=220.42 Aligned_cols=141 Identities=28% Similarity=0.336 Sum_probs=115.6
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECK-AAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||+|.. .+|+.||||++.... ......+..|.. ++..++|||||++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 3699999999999985 468899999986421 122344555554 5678999999999887653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~ 143 (323)
T cd05575 76 DYVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC 143 (323)
T ss_pred cCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCC
Confidence 9999999999987532 4667778889999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (323)
T cd05575 144 KEG 146 (323)
T ss_pred ccc
Confidence 753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=217.70 Aligned_cols=152 Identities=22% Similarity=0.354 Sum_probs=127.7
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+++|...+.||+|+||.||+|.. .+|+.||||.++... ......+.+|+.++.+++|+||+++++++...++.....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 356888899999999999999974 568899999986422 223456888999999999999999998876555444456
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++ +|.+++... .+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEC
Confidence 7999999974 888877542 4677888889999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 149 dfg~~~~~ 156 (336)
T cd07849 149 DFGLARIA 156 (336)
T ss_pred cccceeec
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=214.02 Aligned_cols=146 Identities=19% Similarity=0.218 Sum_probs=120.9
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 270 (485)
+|...+.||+|+||+||++.. .+|+.||||+++... ....+.+..|..++..+. |++|+++.+++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 366678999999999999985 458899999986432 233456788999988886 4677778776543 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~ 143 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEe
Confidence 899999999999999986532 4778889999999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 144 Dfg~~~~~ 151 (323)
T cd05615 144 DFGMCKEH 151 (323)
T ss_pred cccccccc
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=235.17 Aligned_cols=161 Identities=21% Similarity=0.285 Sum_probs=127.8
Q ss_pred hhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
....+.|.....||+|+||+||++.. .++..||+|.+.... ......|..|+.++.+++|||||++++++... .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence 34456788899999999999999985 446788999886432 22346789999999999999999999886532 2
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC----CCCeeeeccCCCceEecC
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC----QPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~----~~~ivHrdlK~~NILld~ 343 (485)
....++||||+++|+|.++|...... ...+++...+.|+.||+.||.|||... ..+||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 34679999999999999999742211 135788888999999999999999532 146999999999999964
Q ss_pred -----------------CCcEEEeecccccccC
Q 041230 344 -----------------EMIGHVGDFSMARFLP 359 (485)
Q Consensus 344 -----------------~~~~ki~DFGla~~~~ 359 (485)
...+||+|||+++.+.
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~ 193 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccc
Confidence 3458999999998653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=204.95 Aligned_cols=150 Identities=24% Similarity=0.409 Sum_probs=125.4
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+.. ....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 4667789999999999999864 57889999986432 2234578899999999999999999988753 24679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~ki~D 351 (485)
+|+||+++++|.+++..... ..++|..+..++.+++.||.||| ..+++|+||||+||+++++. .+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d 145 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGD 145 (257)
T ss_pred EEEecCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecc
Confidence 99999999999999975332 24688999999999999999999 67899999999999999885 579999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||.+.....
T Consensus 146 ~~~~~~~~~ 154 (257)
T cd08225 146 FGIARQLND 154 (257)
T ss_pred cccchhccC
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=230.90 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=172.2
Q ss_pred hccccccceeecccCceEEEEeEeeC--------CcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSG 262 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~ 262 (485)
..+++...+.||+|.||.|++|.+.. ...||||.++.... ...+.+..|+++|..+ +|+|||.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34455555699999999999997531 34699999875432 3457899999999988 59999999999985
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCC-Cccccc----cc--ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKD-DTHWRL----LN--FDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~-~~~~~~----~~--~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
....++|.||+.+|+|.++|+... ...... .. ..+.-...+.++.|||.|++||+ +.++|||||.
T Consensus 374 -----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLA 445 (609)
T KOG0200|consen 374 -----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLA 445 (609)
T ss_pred -----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhh
Confidence 245799999999999999998765 100000 01 13777889999999999999999 6789999999
Q ss_pred CCceEecCCCcEEEeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhh-hhhhhccccc
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQ-RVEEILNDFN 393 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~-~~~~~~d~~~ 393 (485)
.+|||+.++..+||+|||+||........ ..|+.+.++.+|+...++- .+.. .|+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~--~PYp 523 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG--TPYP 523 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC--CCCC
Confidence 99999999999999999999954332111 1244455666666533320 0011 1111
Q ss_pred hhh-hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 394 LQE-IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 394 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.-. ..+... +... ..+.+.+..|...+..|+..||+.+|++||++.+.++.++..
T Consensus 524 ~~~~~~~l~~---~l~~----G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 524 GIPPTEELLE---FLKE----GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCcHHHHHH---HHhc----CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 100 000000 0000 001122335778889999999999999999999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-24 Score=210.47 Aligned_cols=151 Identities=18% Similarity=0.260 Sum_probs=117.9
Q ss_pred ceeecccCceEEEEeEee---CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 200 ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
...||+|+||+||+|... +++.||+|.+... .....+.+|+.++.+++|||||++++++... .....++|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence 468999999999999854 4578999988632 2345678899999999999999999886532 2345789999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe----cCCCcEEEeec
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGHVGDF 352 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl----d~~~~~ki~DF 352 (485)
|+. ++|.+++..............+++.....|+.|++.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 986 588888753321111111134777888899999999999999 6789999999999999 46689999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 157 G~a~~~~ 163 (317)
T cd07868 157 GFARLFN 163 (317)
T ss_pred CceeccC
Confidence 9998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=216.01 Aligned_cols=152 Identities=19% Similarity=0.228 Sum_probs=123.7
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~ 268 (485)
..+.|...+.||+|+||.||++.. ..++.||||++.... ......+.+|+.++..++||||+++++++...+. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356788889999999999999974 457889999986432 2234568889999999999999999987653221 122
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++ +|.+++.. .+++.....++.|++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEE
Confidence 357999999975 77777642 3566778889999999999999 67999999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 167 L~DfG~a~~~~ 177 (364)
T cd07875 167 ILDFGLARTAG 177 (364)
T ss_pred EEeCCCccccC
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=215.44 Aligned_cols=154 Identities=21% Similarity=0.290 Sum_probs=124.9
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CC
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QG 267 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~ 267 (485)
...+.|.....||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3456788889999999999999984 467899999986422 1234567889999999999999999987653211 11
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....+++++|+ +++|.+++... .+++.....|+.|++.||.||| ..+|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCE
Confidence 23468999987 78998887532 4677888899999999999999 6789999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||+++...
T Consensus 158 kl~Dfg~~~~~~ 169 (343)
T cd07878 158 RILDFGLARQAD 169 (343)
T ss_pred EEcCCccceecC
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=214.12 Aligned_cols=149 Identities=23% Similarity=0.277 Sum_probs=125.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+++.||||+++.. .....+.|.+|..++..++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 3577788999999999999985 45889999998642 22234568899999999999999999988653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|.+++.... ..+.+.....++.|++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 144 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLA 144 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEE
Confidence 899999999999999996432 24667778889999999999999 7889999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||++..+.
T Consensus 145 Dfg~~~~~~ 153 (331)
T cd05597 145 DFGSCLRLL 153 (331)
T ss_pred ECCceeecC
Confidence 999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-24 Score=210.47 Aligned_cols=147 Identities=21% Similarity=0.402 Sum_probs=123.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.|.....||+|+||.||+|... +++.||+|.++... ......+.+|+.++.+++||||+++++++.. ....+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-----~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-----CCeEE
Confidence 45777889999999999999854 57889999986433 2334567889999999999999999998753 24679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||++ |+|.+++.... ..+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 148 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCG--------NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADF 148 (301)
T ss_pred EEEeccc-cCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcC
Confidence 9999998 69999887532 24667788889999999999999 689999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 149 g~~~~~ 154 (301)
T cd07873 149 GLARAK 154 (301)
T ss_pred cchhcc
Confidence 998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=210.22 Aligned_cols=231 Identities=18% Similarity=0.220 Sum_probs=157.9
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.|...+.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++|+|+|+++++|.. ....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence 367778999999999999985 4678999999864322 223568889999999999999999998764 2357
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||++ |+|.+++.... ..+.|..+..++.+++.||.||| ..+|+||||+|+||+++.++.+||+|
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~d 168 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD 168 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEec
Confidence 89999997 58888775322 24788899999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhh--ccccchhhhhhhhhhhcccCCCCC
Q 041230 352 FSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEI--LNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 352 FGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~--~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
||++......... ..+....++++++...+....... .+........ ....... ...
T Consensus 169 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~~~~~-~~~ 244 (317)
T cd06635 169 FGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNES-PTL 244 (317)
T ss_pred CCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH---HHHhccC-CCC
Confidence 9998765432110 112223455665543322110000 0000000000 0000000 000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
. .......+.++...|++.+|.+||++.+|++.+-
T Consensus 245 ~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 245 Q------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred C------CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0 0112334678888999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=212.85 Aligned_cols=142 Identities=20% Similarity=0.169 Sum_probs=118.6
Q ss_pred ceeeccc--CceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 200 ANLIGAG--NFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 200 ~~~iG~G--~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
..+||+| +||+||++.. .+|+.||||+++.... ...+.+.+|++++..++|||||+++++|.. ....++|
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~lv 77 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWVV 77 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEEE
Confidence 4679999 7899999985 5688999999864322 223567789999999999999999998764 2467999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++..... ..+++.....|+.|++.||.||| +.+|+||||||+|||++.++.++++|||.
T Consensus 78 ~e~~~~~~l~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~ 147 (327)
T cd08227 78 TSFMAYGSAKDLICTHFM-------DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRS 147 (327)
T ss_pred EeccCCCcHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccch
Confidence 999999999999964321 24678888999999999999999 67899999999999999999999999986
Q ss_pred cc
Q 041230 355 AR 356 (485)
Q Consensus 355 a~ 356 (485)
..
T Consensus 148 ~~ 149 (327)
T cd08227 148 NL 149 (327)
T ss_pred hh
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=208.45 Aligned_cols=147 Identities=24% Similarity=0.363 Sum_probs=125.9
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||+|.. .+|+.||||++.... ......|.+|+.++.+++||||+++++++.. ....++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 76 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFVL 76 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeEE
Confidence 55678899999999999985 468899999987543 2335679999999999999999999988653 346799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+ +++|.+++.... ..+++..+..++.+++.||.||| ..+++|+||||+||+++.++.++|+|||
T Consensus 77 v~e~~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg 144 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFG 144 (286)
T ss_pred Eeccc-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeee
Confidence 99999 999999987533 24788889999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
++.....
T Consensus 145 ~~~~~~~ 151 (286)
T cd07832 145 LARLFSE 151 (286)
T ss_pred ecccccC
Confidence 9886543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=207.23 Aligned_cols=147 Identities=22% Similarity=0.416 Sum_probs=123.5
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|++++.+++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeEE
Confidence 56778899999999999999864 678999999864322 223457789999999999999999998753 34689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||++ |+|.+++.... ..+.+.....++.+++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 80 lv~e~~~-~~L~~~~~~~~--------~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 147 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCG--------GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADF 147 (291)
T ss_pred EEEecCC-CCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcc
Confidence 9999998 49999987543 24567777889999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 148 g~~~~~ 153 (291)
T cd07844 148 GLARAK 153 (291)
T ss_pred cccccc
Confidence 998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-24 Score=205.04 Aligned_cols=147 Identities=24% Similarity=0.389 Sum_probs=124.0
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+|+..+.||+|+||.||+|.. .+++.||+|.++..... ..+.|.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence 467778999999999999974 56889999998643311 23578899999999999999999998754 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IG 347 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~ 347 (485)
...++|+||+++|+|.+++.... .+++.....++.+++.||.||| ..+++|+||||+||+++.++ .+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~ 143 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL 143 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 45789999999999999987432 4677888899999999999999 67999999999999998775 69
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||++....
T Consensus 144 ~l~dfg~~~~~~ 155 (268)
T cd06630 144 RIADFGAAARLA 155 (268)
T ss_pred EEcccccccccc
Confidence 999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-24 Score=208.52 Aligned_cols=151 Identities=25% Similarity=0.350 Sum_probs=126.2
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++.+.+ ....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 46778889999999999999864 578999999864332 22346778999999999999999999876431 2468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||++ ++|.+++.... ..+++.....|+.+++.||.||| ..+++||||||+||+++.++.+||+|
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMK--------QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred EEEehhcC-cCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEee
Confidence 99999998 59999887533 24788899999999999999999 67899999999999999999999999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||+++....
T Consensus 150 ~g~~~~~~~ 158 (293)
T cd07843 150 FGLAREYGS 158 (293)
T ss_pred cCceeeccC
Confidence 999886543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-23 Score=200.82 Aligned_cols=232 Identities=18% Similarity=0.282 Sum_probs=162.3
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||+|... +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 3666789999999999999865 688999999865432 34567899999999999999999998876421 24678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++++|.+++.... .++|..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 78 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred EEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 9999999999999997532 5788899999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCc---c-----------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCCC
Q 041230 353 SMARFLPDTDE---Q-----------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 353 Gla~~~~~~~~---~-----------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
|.+........ . .......++++++...+.--.... .+... ........ ........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~-~~~~~~~~ 223 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYK-IGSSGEPP 223 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHh-ccccCCCc
Confidence 99887654321 0 001233456666543322111000 00000 00000000 00000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.........+.++...|++.+|++||++.+++.
T Consensus 224 ------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000112345678889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-24 Score=213.33 Aligned_cols=149 Identities=23% Similarity=0.346 Sum_probs=124.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeecc--CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI--RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||+|... +|+.+|||++... .......+.+|+.++.++ +||||++++++|... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---NDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CCc
Confidence 457788889999999999999854 5788999988532 122345677899999999 999999999987532 234
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||++ ++|.+++... .+.|..+..++.+++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEE
Confidence 5799999998 5999988642 3567788889999999999999 679999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 149 ~d~g~~~~~~ 158 (337)
T cd07852 149 ADFGLARSLS 158 (337)
T ss_pred eeccchhccc
Confidence 9999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=220.83 Aligned_cols=149 Identities=26% Similarity=0.436 Sum_probs=127.6
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|.....||+|+||.||||+- .+.+.||+|.+.+.... ..+...+|++++.+++|||||.++.++. .....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence 4566678899999999999984 55788999998654322 3456899999999999999999998754 34678
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|.||+.+ +|..+|...+ .+.......|+.++..||.||| +.+|+|||+||.||||+..+.+|++|
T Consensus 77 ~vVte~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klcd 143 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCD 143 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeech
Confidence 999999987 9999998643 5777888899999999999999 78999999999999999999999999
Q ss_pred cccccccCCC
Q 041230 352 FSMARFLPDT 361 (485)
Q Consensus 352 FGla~~~~~~ 361 (485)
||+||.....
T Consensus 144 Fg~Ar~m~~~ 153 (808)
T KOG0597|consen 144 FGLARAMSTN 153 (808)
T ss_pred hhhhhhcccC
Confidence 9999987554
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=214.36 Aligned_cols=141 Identities=28% Similarity=0.338 Sum_probs=114.7
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECK-AAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||.||++.. .+|+.||+|++.... ......+..|.. ++..++|||||++++++.. ....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 3699999999999985 457899999986422 122334555554 6788999999999987653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+.......++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 143 (321)
T cd05603 76 DYVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC 143 (321)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCC
Confidence 9999999998886432 3556677779999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (321)
T cd05603 144 KEG 146 (321)
T ss_pred ccC
Confidence 753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=205.90 Aligned_cols=228 Identities=18% Similarity=0.216 Sum_probs=158.3
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
.|...+.||+|+||.||++.. .+++.+++|+++.......+.+.+|+.++..++|+||+++++++.. ....++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence 344457999999999999984 4688999999865444445678899999999999999999998653 2457999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++++|.+++... .+++.....++.+++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 95 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 95 MEFLEGGALTDIVTHT----------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGF 161 (285)
T ss_pred EeccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEccccc
Confidence 9999999999998752 3567788899999999999999 67899999999999999999999999998
Q ss_pred ccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhc--cccchhhhhhhhhhhcccCCCCCCc
Q 041230 355 ARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 355 a~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
+......... ..+....++++++...+.--..... +........... .... . ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~----~~~~-~-~~ 235 (285)
T cd06648 162 CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR----DNLP-P-KL 235 (285)
T ss_pred chhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH----hcCC-C-CC
Confidence 8754322110 1122334666665433321110000 000000000000 0000 0 00
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.........+.++...|++.+|++||++.++++
T Consensus 236 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 ---KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ---cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000112345778999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=203.34 Aligned_cols=150 Identities=24% Similarity=0.355 Sum_probs=127.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|.....||.|+||+|...+. .+|.-+|+|+++... ....+...+|..+|..+.||++|+|++.|.+ ..+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-----~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-----NSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-----CCe
Confidence 4677778999999999999885 457788999997532 2234567789999999999999999987543 457
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.+|||||+++|.|.++|+..+ .|+.+...-+|.+|+.||+||| +..|++||+||+|||||.+|..||+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~---------rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKit 186 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG---------RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKIT 186 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC---------CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEE
Confidence 899999999999999998754 4566666779999999999999 7899999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||+|+...+.
T Consensus 187 DFGFAK~v~~r 197 (355)
T KOG0616|consen 187 DFGFAKRVSGR 197 (355)
T ss_pred eccceEEecCc
Confidence 99999987544
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=205.49 Aligned_cols=146 Identities=25% Similarity=0.400 Sum_probs=123.9
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|++|.||+|.. .+|+.||||++.... ....+.|.+|++++.+++|+||+++++++.. ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 45567899999999999985 468999999986433 2234678899999999999999999998764 246899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||++ ++|.+++..... ..+.+..+..++.+++.||.||| ..+++||||+|+||+++.++.++|+|||
T Consensus 76 v~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~ 144 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFG 144 (283)
T ss_pred EEeccC-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecc
Confidence 999995 799999875432 25788999999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 145 ~~~~~ 149 (283)
T cd07835 145 LARAF 149 (283)
T ss_pred ccccc
Confidence 98754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=231.80 Aligned_cols=154 Identities=25% Similarity=0.359 Sum_probs=117.3
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccc------
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVD------ 264 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~------ 264 (485)
..++|.+..+||+||||.|||++. -||+.+|||++.... ........+|+..+++|+|||||+.+..+.+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456788889999999999999983 589999999986432 222345778999999999999998863221100
Q ss_pred ----------------------------------------------------------------------c---------
Q 041230 265 ----------------------------------------------------------------------Y--------- 265 (485)
Q Consensus 265 ----------------------------------------------------------------------~--------- 265 (485)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred CC---------------------c--------eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHH
Q 041230 266 QG---------------------A--------RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316 (485)
Q Consensus 266 ~~---------------------~--------~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~ 316 (485)
.+ . ...|+=||||+.-.|.++++.+.-.. ..... .++..+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~----wrLFreIlE 708 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEA----WRLFREILE 708 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHH----HHHHHHHHH
Confidence 00 0 23456688999888888887643211 12233 358999999
Q ss_pred HHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 317 gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
||.|+| ..+||||||||.||+||++..+||+|||+|..
T Consensus 709 GLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 709 GLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence 999999 67899999999999999999999999999987
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=205.72 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=124.9
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||+|... +|+.+|+|.+.... ....+.+.+|++++.+++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 345678999999999999864 47899999987542 334567889999999999999999999876421 246899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++ +|.+++.... ..+.+.....++.+++.||.||| ..+++|+||||+||++++++.+||+|||
T Consensus 78 v~e~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred Eeccccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 9999985 8998887542 25778889999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
++.....
T Consensus 146 ~~~~~~~ 152 (287)
T cd07840 146 LARPYTK 152 (287)
T ss_pred ceeeccC
Confidence 9886543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=216.46 Aligned_cols=140 Identities=20% Similarity=0.224 Sum_probs=118.5
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||++.. .+++.||||+++... ....+.+..|+.++.++ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 3699999999999985 457889999987432 12345678899999888 69999999987643 34689999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+++..+..++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~ 143 (327)
T cd05617 76 EYVNGGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMC 143 (327)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccc
Confidence 9999999998886432 4778889999999999999999 678999999999999999999999999998
Q ss_pred cc
Q 041230 356 RF 357 (485)
Q Consensus 356 ~~ 357 (485)
+.
T Consensus 144 ~~ 145 (327)
T cd05617 144 KE 145 (327)
T ss_pred ee
Confidence 75
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=208.42 Aligned_cols=155 Identities=25% Similarity=0.342 Sum_probs=127.3
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccc-----
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVD----- 264 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~----- 264 (485)
..++|...+.||+|+||.||+|... +|+.||||.++... ......+.+|++++.+++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888899999999999999964 58899999986432 223456788999999999999999999876432
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
..+....++|+||+++ +|...+.... ..+++.....|+.+++.||.||| ..+|+||||||+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 0112367899999986 7777776432 25788899999999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccC
Q 041230 345 MIGHVGDFSMARFLP 359 (485)
Q Consensus 345 ~~~ki~DFGla~~~~ 359 (485)
+.+||+|||++....
T Consensus 153 ~~~kl~dfg~~~~~~ 167 (302)
T cd07864 153 GQIKLADFGLARLYN 167 (302)
T ss_pred CcEEeCccccccccc
Confidence 999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=202.54 Aligned_cols=152 Identities=21% Similarity=0.335 Sum_probs=127.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||.|+||+||+|.. .++..+|+|+++... ......+.+|++.+..++|+||+++++.+.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 3677889999999999999985 467889999986432 2245678999999999999999999987653 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++++|.++++..... ..+.+.....++.+++.||.||| ..+|+||||||+||++++++.+||+||
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df 146 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPR------GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADF 146 (267)
T ss_pred EEEeccCCCcHHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence 999999999999999754221 24677888889999999999999 678999999999999999999999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|++..+..
T Consensus 147 ~~~~~~~~ 154 (267)
T cd06610 147 GVSASLAD 154 (267)
T ss_pred chHHHhcc
Confidence 99876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=200.06 Aligned_cols=147 Identities=27% Similarity=0.428 Sum_probs=126.3
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||++... +++.|++|.+..... ...+.+.+|++++.+++|+|++++++++.. ....++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 76 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLYI 76 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEEE
Confidence 566789999999999999854 578999999875433 344678999999999999999999988753 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++++|.+++... ..+++..+..++.+++.||.||| ..+|+||||||+||+++.++.++|+|||
T Consensus 77 v~e~~~~~~L~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~ 144 (254)
T cd06627 77 ILEYAENGSLRQIIKKF---------GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFG 144 (254)
T ss_pred EEecCCCCcHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccc
Confidence 99999999999998753 24678889999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
++.....
T Consensus 145 ~~~~~~~ 151 (254)
T cd06627 145 VATKLND 151 (254)
T ss_pred cceecCC
Confidence 9987643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-23 Score=197.91 Aligned_cols=229 Identities=19% Similarity=0.286 Sum_probs=161.6
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
|...+.||+|+||.||++... +++.+++|++..........+.+|++.+.+++|+||+++++++... ...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEE
Confidence 566788999999999999864 6889999998754444557899999999999999999999987542 4578999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++++|.+++.... ..+.+.....++.+++.||.||| ..+++||||+|+||++++++.++|+|||++
T Consensus 77 e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 77 EFCSGGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred ecCCCCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccc
Confidence 9999999999987642 24788889999999999999999 688999999999999999999999999998
Q ss_pred cccCCCC--cc---------------eeeeccccHHHHHHHHhhhhhhhh-cccc-chhhhhhhhhhhcccCCCCCCcch
Q 041230 356 RFLPDTD--EQ---------------TRFIGKLNVRNFVKMALSQRVEEI-LNDF-NLQEIEEDRTMCMHASSSSSTSTH 416 (485)
Q Consensus 356 ~~~~~~~--~~---------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~-~~~~~~~~~~~~~~~~~~~~~~~~ 416 (485)
....... .. .......++++++...+..-.... .+.. ...... ............
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~-- 219 (253)
T cd05122 146 AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF----KIATNGPPGLRN-- 219 (253)
T ss_pred ccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH----HHHhcCCCCcCc--
Confidence 8765432 00 011223566666543332111100 0000 000000 000000000000
Q ss_pred hhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 417 VSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 417 ~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.......+.++...|++.+|++|||+.||++
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0011345678889999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=205.35 Aligned_cols=148 Identities=22% Similarity=0.400 Sum_probs=125.0
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+|...+.||+|+||.||+|... +|..||||.++.... .....+.+|++++.+++|+||+++++++... ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 4777889999999999999864 588999999865432 2346778899999999999999999987642 35799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++ +|.+++...... ..+.+.....++.+++.||.||| ..+++||||||+||++++++.+|++|||
T Consensus 76 v~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g 145 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFG 145 (284)
T ss_pred EEecCCc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecc
Confidence 9999984 898888654321 35788999999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 146 ~~~~~ 150 (284)
T cd07836 146 LARAF 150 (284)
T ss_pred hhhhh
Confidence 98754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=203.89 Aligned_cols=147 Identities=25% Similarity=0.298 Sum_probs=124.4
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+|...+.||+|+||.||++... +++.||+|.+..... ...+.|.+|++++.+++||||+++++.+.. ....++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence 4666788999999999999864 588999999865432 334678999999999999999999988754 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCC-CCeeeeccCCCceEecCCCcEEEeec
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQ-PRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~-~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
|+||+++++|.+++.... ..+.......++.+++.||.||| . .+++|+||||+||+++.++.+||+||
T Consensus 77 v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~ 145 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDF 145 (265)
T ss_pred EEEecCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999997542 24566777889999999999999 5 78999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|++...
T Consensus 146 g~~~~~ 151 (265)
T cd06605 146 GVSGQL 151 (265)
T ss_pred ccchhh
Confidence 998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=207.70 Aligned_cols=148 Identities=22% Similarity=0.312 Sum_probs=124.2
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++++++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 5777889999999999999864 57899999886432 2234678999999999999999999998764 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||++++.|..++... ..+.+.....++.+++.||.||| ..+++||||||+||++++++.+||+||
T Consensus 77 iv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~ 144 (288)
T cd07833 77 LVFEYVERTLLELLEASP---------GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDF 144 (288)
T ss_pred EEEecCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEee
Confidence 999999998887665432 23677888899999999999999 678999999999999999999999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|++.....
T Consensus 145 g~~~~~~~ 152 (288)
T cd07833 145 GFARALRA 152 (288)
T ss_pred ecccccCC
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=219.02 Aligned_cols=146 Identities=21% Similarity=0.299 Sum_probs=123.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+|+.||||++.... ....+.+.+|++++.+++|||||++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 3677789999999999999974 568899999986422 2234568889999999999999999988754 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~ 143 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLS 143 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEe
Confidence 899999999999999997532 3566677779999999999999 6789999999999999999999999
Q ss_pred ecccccc
Q 041230 351 DFSMARF 357 (485)
Q Consensus 351 DFGla~~ 357 (485)
|||+++.
T Consensus 144 DfGla~~ 150 (377)
T cd05629 144 DFGLSTG 150 (377)
T ss_pred ecccccc
Confidence 9999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=212.21 Aligned_cols=153 Identities=22% Similarity=0.305 Sum_probs=125.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|...+.||+|+||+||++.. .+|+.||||.+... .......+.+|+.++..++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45688889999999999999984 46889999988642 2223456778999999999999999998876433222235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+. ++|.+++.... .+.+.....++.+++.||.||| ..+++||||||+||+++.++.+||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEC
Confidence 799999996 78998886432 4677888899999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 151 Dfg~~~~~~ 159 (337)
T cd07858 151 DFGLARTTS 159 (337)
T ss_pred cCccccccC
Confidence 999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=208.07 Aligned_cols=148 Identities=23% Similarity=0.320 Sum_probs=126.2
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+|...+.||+|+||.||++... +++.||+|.+...... ..+.+..|++++..+.|+||+++++.+.. ....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCEE
Confidence 5777889999999999999864 4889999998653322 34568899999999999999999988653 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++..... ..+.+.....++.+++.||.||| ..+++|+||||+||+++.++.++|+|
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~d 146 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSD 146 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEee
Confidence 999999999999999975322 25778888899999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||++...
T Consensus 147 fg~~~~~ 153 (316)
T cd05574 147 FDLSKQS 153 (316)
T ss_pred cchhhcc
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=211.98 Aligned_cols=141 Identities=28% Similarity=0.327 Sum_probs=113.5
Q ss_pred eeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECK-AAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||++... +++.||+|++.... ......+..|.. ++..++|+||+++++++.. ....++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 36999999999999854 57789999986422 122234444444 5678999999999887653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... .+.......++.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a 143 (325)
T cd05602 76 DYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 143 (325)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCC
Confidence 9999999999997532 3455666779999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (325)
T cd05602 144 KEN 146 (325)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=216.42 Aligned_cols=152 Identities=23% Similarity=0.290 Sum_probs=127.0
Q ss_pred hhhhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
+....++|...+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++..++||||+++++++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--- 114 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--- 114 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc---
Confidence 3445678899999999999999999854 57889999986321 2234567889999999999999999988653
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
....++||||+++|+|.+++... .++......++.+++.||.||| +.+|+||||||+|||++.++
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 115 --DRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCC
Confidence 34689999999999999998642 2455667778999999999999 78999999999999999999
Q ss_pred cEEEeecccccccC
Q 041230 346 IGHVGDFSMARFLP 359 (485)
Q Consensus 346 ~~ki~DFGla~~~~ 359 (485)
.+||+|||+++...
T Consensus 180 ~ikL~DfG~a~~~~ 193 (371)
T cd05622 180 HLKLADFGTCMKMN 193 (371)
T ss_pred CEEEEeCCceeEcC
Confidence 99999999997653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=202.76 Aligned_cols=148 Identities=26% Similarity=0.367 Sum_probs=126.3
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+|...+.||.|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-----EENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-----CCeE
Confidence 4677889999999999999864 58899999986432 2345678999999999999999999877643 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++++|.+++... ..+.+.....++.+++.||.||| ..+++|+||||+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d 143 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK---------VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITD 143 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc---------CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEee
Confidence 9999999999999999754 24667788899999999999999 67899999999999999999999999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||++.....
T Consensus 144 ~~~~~~~~~ 152 (258)
T cd05578 144 FNIATKVTP 152 (258)
T ss_pred cccccccCC
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-23 Score=200.92 Aligned_cols=152 Identities=24% Similarity=0.388 Sum_probs=122.6
Q ss_pred cccceeecccCceEEEEeEeeC-CcEEEEEEeeccCC--cchHHHHHHHHHHHhc---CCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRP--GGARSFKSECKAAINI---RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||.||+|+..+ ++.||||.++.... .....+.+|+.++.++ .|+||+++++++...+..+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4556889999999999999754 88999999864322 2234567788776655 6999999999987644333334
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.+++|||++ ++|.+++..... ..++|.....++.+++.||.||| ..+++|+||||+||+++.++.+||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEe
Confidence 789999997 589998875332 24788999999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||++....
T Consensus 150 dfg~~~~~~ 158 (287)
T cd07838 150 DFGLARIYS 158 (287)
T ss_pred ccCcceecc
Confidence 999987753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=204.10 Aligned_cols=149 Identities=26% Similarity=0.350 Sum_probs=126.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|.....||+|+||.||++... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 35777889999999999999854 58899999986432 2234668899999999999999999988653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|.+++.... .+++..+..++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~ 143 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKIT 143 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEe
Confidence 799999999999999997542 4667788889999999999999 6889999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 144 dfg~~~~~~~ 153 (290)
T cd05580 144 DFGFAKRVKG 153 (290)
T ss_pred eCCCccccCC
Confidence 9999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=206.61 Aligned_cols=150 Identities=21% Similarity=0.276 Sum_probs=121.4
Q ss_pred ccccccceeecccCceEEEEeEeeC-CcEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR-PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 270 (485)
-++|...+.||+|+||.||+|...+ ++.||||.++... ......+..|+.++.+.+ |+||++++++|.. ...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence 3567778999999999999999754 8899999986432 223456677887777775 9999999999764 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||++ ++|.+++.... ..+++..+..|+.+++.||.|||. ..+|+||||+|+||++++++.+||+
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~ 157 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQ--------GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLC 157 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEEC
Confidence 899999985 47777665422 257888899999999999999994 2589999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||++..+.
T Consensus 158 dfg~~~~~~ 166 (296)
T cd06618 158 DFGISGRLV 166 (296)
T ss_pred ccccchhcc
Confidence 999987653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=203.37 Aligned_cols=139 Identities=22% Similarity=0.358 Sum_probs=119.6
Q ss_pred ecccCceEEEEeEeeC-CcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTLFD-GTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||.||++...+ |+.+++|.+..... ...+.+.+|++++.+++|+||+++++.+.. ....++|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 6899999999999754 88999999864332 334678899999999999999999877543 34679999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++.... .+++..+..++.+++.||.||| ..+++||||+|+||++++++.+||+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 76 PGGDLASLLENVG---------SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 9999999997532 4677889999999999999999 678999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=204.95 Aligned_cols=156 Identities=22% Similarity=0.374 Sum_probs=124.5
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCc-ceeEeeeecccc-cCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRN-IVRVFTAVSGVD-YQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~n-iv~l~~~~~~~~-~~~~~ 269 (485)
.+|...++||+|+||+||+|+ ..+|+.||+|++..... +....-.+|+.++.+++|+| ||+|.+.+.... +....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345566789999999999998 46789999999875433 34566789999999999999 999999876432 11223
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+.. +|..++....... ..++-...-.+..|+.+||+||| +++|+||||||.|||+++++..||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEee
Confidence 67899999975 9999998644210 12233455678999999999999 789999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+|+...
T Consensus 162 aDFGlAra~~ 171 (323)
T KOG0594|consen 162 ADFGLARAFS 171 (323)
T ss_pred eccchHHHhc
Confidence 9999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=218.29 Aligned_cols=148 Identities=22% Similarity=0.339 Sum_probs=127.0
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..|.....||+|+-|.|-.|+ ..+|+.+|||++.... ........+|+-+|+-|.||||++|++.+ ....+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence 346667889999999999997 5779999999986431 22345677899999999999999999874 34567
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.|||.||+++|-|.++|-.++ .|..++..+...||..|+.|+| ..+|+|||+||+|+|||.+++.||+
T Consensus 87 lylvlEyv~gGELFdylv~kG---------~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG---------PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeee
Confidence 899999999999999998664 4667788999999999999999 7899999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+|.+-.
T Consensus 155 DFGMAsLe~ 163 (786)
T KOG0588|consen 155 DFGMASLEV 163 (786)
T ss_pred ccceeeccc
Confidence 999998643
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-23 Score=202.66 Aligned_cols=147 Identities=23% Similarity=0.342 Sum_probs=122.5
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc-chHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-GARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||+||+|... +++.|+||++...... ....+.+|+..+.+++ |+||+++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 445678999999999999975 4788999998643221 2234567999999999 9999999998754 346799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+ +|+|.+++..... ..+.|.....++.+++.||.||| ..+++|+||||+||++++++.++|+|||
T Consensus 76 v~e~~-~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred EEecC-CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecc
Confidence 99999 8999999876431 25788999999999999999999 6789999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
+++...
T Consensus 145 ~~~~~~ 150 (283)
T cd07830 145 LAREIR 150 (283)
T ss_pred cceecc
Confidence 998654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=204.89 Aligned_cols=145 Identities=21% Similarity=0.381 Sum_probs=121.4
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||++.. .+|+.||+|.++... ......+.+|++++.+++|+||+++++++.. ....++
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLTL 76 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceEE
Confidence 55668899999999999985 468899999986432 2223567889999999999999999988643 346799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||++ |+|.+++.... ..+++.....++.++++||.||| ..+|+||||||+||+++.++.+||+|||
T Consensus 77 v~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg 144 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN--------GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFG 144 (284)
T ss_pred EEecCC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccc
Confidence 999997 58888876432 24778888999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 145 ~~~~~ 149 (284)
T cd07839 145 LARAF 149 (284)
T ss_pred hhhcc
Confidence 98764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=210.48 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=125.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||+|.. .+|..||+|+++... ......+.+|+.++.+++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 36788889999999999999985 458899999986432 223456788999999999999999988765432 22346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+. |+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+||++++++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEec
Confidence 799999996 69999987532 3678888999999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 150 dfg~~~~~ 157 (334)
T cd07855 150 DFGMARGL 157 (334)
T ss_pred ccccceee
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=205.28 Aligned_cols=147 Identities=22% Similarity=0.272 Sum_probs=121.6
Q ss_pred ccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccC
Q 041230 196 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 266 (485)
+|...+.||+|+||.||++.. .+++.||||.++... ....+.|.+|++++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 356678899999999999874 356889999986422 12345688999999999 59999999877542
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++||||+++|+|.+++.... .+.+.....++.++++||.||| ..+++||||||+||+++.++.
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGH 143 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCC
Confidence 346789999999999999987432 3667778889999999999999 678999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
++|+|||+++...
T Consensus 144 ~~l~dfg~~~~~~ 156 (288)
T cd05583 144 VVLTDFGLSKEFL 156 (288)
T ss_pred EEEEECccccccc
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=210.13 Aligned_cols=148 Identities=22% Similarity=0.262 Sum_probs=124.3
Q ss_pred cccccceeecccCceEEEEeEeeC-CcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||++.... ++.+|+|++... .......|.+|+.++..++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 367778999999999999998644 678999998632 12233458889999999999999999988653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|+... ..+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~ 144 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE--------DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 144 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEe
Confidence 899999999999999997532 24677778889999999999999 6889999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 145 DfG~a~~~ 152 (332)
T cd05623 145 DFGSCLKL 152 (332)
T ss_pred ecchheec
Confidence 99998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-23 Score=203.43 Aligned_cols=153 Identities=22% Similarity=0.330 Sum_probs=124.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccC---C
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ---G 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~---~ 267 (485)
.++|.....||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++||||++++++|...... .
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35688889999999999999985 468899999886432 22234567899999999999999999988653211 1
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++|+||+. ++|.+++.... ..+++.....++.+++.||.||| ..+++|+||||+||+++.++.+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--------VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGIL 158 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcE
Confidence 234689999997 48888886432 24678888999999999999999 6789999999999999999999
Q ss_pred EEeeccccccc
Q 041230 348 HVGDFSMARFL 358 (485)
Q Consensus 348 ki~DFGla~~~ 358 (485)
||+|||++...
T Consensus 159 kl~dfg~~~~~ 169 (310)
T cd07865 159 KLADFGLARAF 169 (310)
T ss_pred EECcCCCcccc
Confidence 99999999765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-23 Score=205.56 Aligned_cols=151 Identities=21% Similarity=0.362 Sum_probs=122.2
Q ss_pred cccceeecccCceEEEEeEee---CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++... ....
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 78 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADKS 78 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCce
Confidence 566788999999999999854 47899999987532 33346778899999999999999999998642 2246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC----CCc
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD----EMI 346 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~----~~~ 346 (485)
.++||||+++ +|.+++....... ...+.......|+.|++.||.||| ..+|+||||||+||+++. ++.
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccce
Confidence 8999999985 6777664322110 124677778889999999999999 678999999999999999 999
Q ss_pred EEEeeccccccc
Q 041230 347 GHVGDFSMARFL 358 (485)
Q Consensus 347 ~ki~DFGla~~~ 358 (485)
+||+|||+++..
T Consensus 151 ~kl~Dfg~~~~~ 162 (316)
T cd07842 151 VKIGDLGLARLF 162 (316)
T ss_pred EEECCCcccccc
Confidence 999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=196.83 Aligned_cols=151 Identities=25% Similarity=0.392 Sum_probs=125.7
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc----ch----HHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG----GA----RSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~----~~----~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
-++|....+||.|..+.|-++.. ..|+..|+|++...... .. +.-.+|+.+|.++ .||||+.+.+.+.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-- 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-- 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc--
Confidence 34566778999999999887763 56889999998654321 12 3346799999986 7999999998744
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
.+.+.++|+|.|+.|.|.++|.+. ..++.+...+|..++..|++||| ...||||||||+|||+|+
T Consensus 94 ---s~sF~FlVFdl~prGELFDyLts~---------VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 94 ---SDAFVFLVFDLMPRGELFDYLTSK---------VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDD 158 (411)
T ss_pred ---CcchhhhhhhhcccchHHHHhhhh---------eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeecc
Confidence 456789999999999999999865 35777888899999999999999 889999999999999999
Q ss_pred CCcEEEeecccccccCCC
Q 041230 344 EMIGHVGDFSMARFLPDT 361 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~ 361 (485)
+++.||+|||+|..+...
T Consensus 159 n~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPG 176 (411)
T ss_pred ccceEEeccceeeccCCc
Confidence 999999999999887554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-23 Score=196.79 Aligned_cols=152 Identities=25% Similarity=0.426 Sum_probs=127.7
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||++... ++..+++|++..... .....+.+|++++.+++|+|++++.+.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 3666788999999999999854 588999999875432 345678899999999999999999987653 24678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++++|.+++...... ...+++.....|+.+++.||.||| ..+++|+||+|+||++++++.++|+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~ 147 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE-----GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDF 147 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc-----CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCc
Confidence 999999999999999764210 135788999999999999999999 679999999999999999999999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|++.....
T Consensus 148 ~~~~~~~~ 155 (258)
T cd08215 148 GISKVLSS 155 (258)
T ss_pred cceeeccc
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=213.45 Aligned_cols=142 Identities=22% Similarity=0.257 Sum_probs=119.1
Q ss_pred cccccceeecccCceEEEEeEee---CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
..|.....||+|+||.||++... .+..||||.+... ..+.+|++++.+++|||||++++++.. ....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~ 161 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-----KSTV 161 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-----CCEE
Confidence 46788899999999999998743 3567999987532 345689999999999999999987643 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+. ++|.+++... ..+.|..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 162 ~lv~e~~~-~~l~~~l~~~---------~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~D 228 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRS---------GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGD 228 (392)
T ss_pred EEEehhcC-CCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcc
Confidence 89999986 6898888432 25788999999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++.+.
T Consensus 229 fG~a~~~~ 236 (392)
T PHA03207 229 FGAACKLD 236 (392)
T ss_pred CccccccC
Confidence 99997653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=200.25 Aligned_cols=148 Identities=26% Similarity=0.407 Sum_probs=120.8
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||.||+|... +|+.||+|.+..... ...+.|.+|++++.+++|+||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 46777889999999999999854 688999998754322 234678899999999999999999998753 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEe
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVG 350 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~ 350 (485)
++|+||++ ++|.+++..... ..+.+.....++.+++.||.||| ..+++||||||+||+++. +..+||+
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~ 145 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLA 145 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCC-------CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEc
Confidence 99999996 588888754322 23466667789999999999999 678999999999999985 5679999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||++...
T Consensus 146 dfg~~~~~ 153 (294)
T PLN00009 146 DFGLARAF 153 (294)
T ss_pred cccccccc
Confidence 99999754
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-23 Score=199.84 Aligned_cols=146 Identities=23% Similarity=0.314 Sum_probs=118.9
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|+||.||+|.. .+++.||+|.++... ........+|+..+.++. |+||+++++++... .....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 34567899999999999984 468899999986432 222234557888898885 99999999987642 1145799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||++ |+|.+++.... ..+.|.....++.+++.||.||| ..+++||||||+||+++. +.+||+|||
T Consensus 78 v~e~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 78 VFELMD-MNLYELIKGRK--------RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred EEecCC-ccHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 999997 68888886532 24788899999999999999999 678999999999999999 999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 145 ~~~~~ 149 (282)
T cd07831 145 SCRGI 149 (282)
T ss_pred ccccc
Confidence 99765
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=203.34 Aligned_cols=141 Identities=22% Similarity=0.320 Sum_probs=120.9
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecC
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMP 279 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~ 279 (485)
..||+|+||.||++.. .+|..||||.+..........|.+|+.++++++|+||+++++++.. .+..++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEecCC
Confidence 5799999999999986 4688999998864444445678999999999999999999988754 346799999999
Q ss_pred CCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccC
Q 041230 280 NGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 280 ~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
+++|.+++... .+.+.....++.+++.||.||| ..+++||||||+||++++++.++|+|||++....
T Consensus 101 ~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 101 GGALTDIVTHT----------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred CCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 99999987532 3567788889999999999999 6789999999999999999999999999887553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-24 Score=218.75 Aligned_cols=174 Identities=26% Similarity=0.400 Sum_probs=137.8
Q ss_pred cceeecccCceEEEEeE-eeCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccc-cCCceeeEEEE
Q 041230 199 SANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVD-YQGARFKAVVY 275 (485)
Q Consensus 199 ~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~~lV~ 275 (485)
....||+|+||.||+|+ -.+|..||||.++... ....+.+.+|+++|++++|+|||++++.-.+.. +.......+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 35689999999999998 5679999999987533 334567889999999999999999987643211 11134578999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec----CCCcEEEee
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD----DEMIGHVGD 351 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld----~~~~~ki~D 351 (485)
|||++|||...|...++. ..|+...-+.+..+++.||.||| ..+|+||||||.||++- ....-||+|
T Consensus 97 EyC~gGsL~~~L~~PEN~------~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENA------YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eecCCCcHHHHhcCcccc------cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 999999999999987654 46788888999999999999999 78999999999999983 334689999
Q ss_pred cccccccCCCCcc------------------eeeeccccHHHHHHHHh
Q 041230 352 FSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMAL 381 (485)
Q Consensus 352 FGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~ 381 (485)
||.||.++++..- ..|+..+++.+|+..++
T Consensus 168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY 215 (732)
T KOG4250|consen 168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLY 215 (732)
T ss_pred ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHH
Confidence 9999998765421 23445667777765544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=202.07 Aligned_cols=159 Identities=24% Similarity=0.373 Sum_probs=127.6
Q ss_pred chhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeec--cCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
+.......|...+.||+|+||.|+++.. .+|..||||++.. ...-..+.-.+|+.+|..++|+|||.++........
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3344555666678899999999999974 5689999998862 222344667889999999999999999887654333
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
...+..|+|+|+| .-+|.+.|+.+. .|.....--+..|+.+||.|+| +-+|+|||+||+|+|++.+.
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADC 162 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCC
Confidence 3445689999999 469999998654 2444555558899999999999 67899999999999999999
Q ss_pred cEEEeecccccccCC
Q 041230 346 IGHVGDFSMARFLPD 360 (485)
Q Consensus 346 ~~ki~DFGla~~~~~ 360 (485)
..||+|||+||....
T Consensus 163 ~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 163 DLKICDFGLARYLDK 177 (359)
T ss_pred CEEeccccceeeccc
Confidence 999999999998854
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-23 Score=206.14 Aligned_cols=150 Identities=21% Similarity=0.302 Sum_probs=122.1
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 269 (485)
.+.|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++.+++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46788889999999999999985 468999999886421 2223568899999999999999999998754321 1123
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+.+ +|..++. ..+.+.....++.+++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 46899999974 7776653 13667788889999999999999 678999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 159 ~dfg~~~~~ 167 (342)
T cd07879 159 LDFGLARHA 167 (342)
T ss_pred eeCCCCcCC
Confidence 999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=206.35 Aligned_cols=153 Identities=24% Similarity=0.356 Sum_probs=126.8
Q ss_pred cchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
.++...+++|...+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++.+++|||||++.+++...
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 81 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP- 81 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-
Confidence 45667889999999999999999999974 46889999987532 222346788999999999999999999887531
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
....++|+||+ +++|.+++... .+.+.....++.+++.||.||| ..+|+||||||+||+++++
T Consensus 82 ---~~~~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 82 ---LEDIYFVTELL-GTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINEN 144 (328)
T ss_pred ---CCcEEEEeehh-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCC
Confidence 23578999998 56999888642 2455666779999999999999 6789999999999999999
Q ss_pred CcEEEeeccccccc
Q 041230 345 MIGHVGDFSMARFL 358 (485)
Q Consensus 345 ~~~ki~DFGla~~~ 358 (485)
+.+||+|||+++..
T Consensus 145 ~~~~l~dfg~~~~~ 158 (328)
T cd07856 145 CDLKICDFGLARIQ 158 (328)
T ss_pred CCEEeCcccccccc
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=197.52 Aligned_cols=232 Identities=18% Similarity=0.237 Sum_probs=159.6
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 366678999999999999874 467899999986432 2234578889999999999999999887653 24679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++++|.+++...... ...+.+.....++.+++.||.||| +.+++|+||+|+||++++++.+|++||
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~ 147 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDL 147 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeec
Confidence 999999999999998752210 135788888999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCCCCCcc
Q 041230 353 SMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 353 Gla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
|++......... ..++...++++++...+....... .+........ ..........
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~---- 220 (256)
T cd08530 148 GISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---YKVQRGKYPP---- 220 (256)
T ss_pred cchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcCCCCC----
Confidence 999776432110 111223455555433322111100 0000000000 0000000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
........+..+...|++.+|++||++.++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00123345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=202.24 Aligned_cols=142 Identities=28% Similarity=0.324 Sum_probs=119.8
Q ss_pred ecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||+||++.. .+|+.||+|.+.... ....+.|..|++++..++||||+++++++.. ....++|+||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 69999999999974 468899999986422 2234567889999999999999999887653 24679999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++..... ..+++.....++.+++.||.||| ..+++||||||+||++++++.+||+|||++...
T Consensus 76 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 76 NGGDLKYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred CCCcHHHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 99999999975432 24678888999999999999999 678999999999999999999999999998765
Q ss_pred C
Q 041230 359 P 359 (485)
Q Consensus 359 ~ 359 (485)
.
T Consensus 146 ~ 146 (277)
T cd05577 146 K 146 (277)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.87 Aligned_cols=145 Identities=19% Similarity=0.238 Sum_probs=122.3
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.|...+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++.+++|+|||++++++.. ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCEE
Confidence 477789999999999999984 457889999986422 2234568899999999999999999988753 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+.......++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~D 144 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTD 144 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeE
Confidence 99999999999999997542 2455566678999999999999 67899999999999999999999999
Q ss_pred cccccc
Q 041230 352 FSMARF 357 (485)
Q Consensus 352 FGla~~ 357 (485)
||+++.
T Consensus 145 FGla~~ 150 (382)
T cd05625 145 FGLCTG 150 (382)
T ss_pred CCCCcc
Confidence 999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=216.21 Aligned_cols=163 Identities=22% Similarity=0.290 Sum_probs=123.7
Q ss_pred hccccccceeecccCceEEEEeEe-----------------eCCcEEEEEEeeccCCcchHHH--------------HHH
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-----------------FDGTTIAVKVFNLIRPGGARSF--------------KSE 241 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-----------------~~~~~vavK~~~~~~~~~~~~f--------------~~E 241 (485)
.+++|...++||+|+||.||+|.. .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999964 2356799999875433333333 447
Q ss_pred HHHHHhcCCCcc-----eeEeeeecccccC---CceeeEEEEEecCCCCHHHhhcCCCCc---------------ccccc
Q 041230 242 CKAAINIRHRNI-----VRVFTAVSGVDYQ---GARFKAVVYKFMPNGSLEEWLHGKDDT---------------HWRLL 298 (485)
Q Consensus 242 ~~~l~~l~H~ni-----v~l~~~~~~~~~~---~~~~~~lV~ey~~~GsL~~~L~~~~~~---------------~~~~~ 298 (485)
+..+.+++|.|+ ++++++|...... .....+|||||+++|+|.++|++.... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877665 6778887532111 123479999999999999999864211 01111
Q ss_pred cccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 299 NFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 299 ~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
...++|.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~ 359 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence 234678888899999999999999 678999999999999999999999999999754
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=211.92 Aligned_cols=139 Identities=24% Similarity=0.230 Sum_probs=113.9
Q ss_pred ecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhc---CCCcceeEeeeecccccCCceeeEEEE
Q 041230 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINI---RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 203 iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
||+|+||+||+|.. .+|+.||||++..... .....+..|..++... +||||+++++++.. ....++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 69999999999985 4588999999864221 1223455677777655 79999999887653 34679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|..++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a 143 (330)
T cd05586 76 DYMSGGELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLS 143 (330)
T ss_pred cCCCCChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcC
Confidence 9999999999987532 4667788889999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 144 ~~~ 146 (330)
T cd05586 144 KAN 146 (330)
T ss_pred cCC
Confidence 754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=211.56 Aligned_cols=149 Identities=25% Similarity=0.316 Sum_probs=125.0
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 267 (485)
..++|....+||+|+||+|+++.+. +++.+|||++++.. ....+..+.|.+++.-. +||.|++|+.+ ++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 4568999999999999999999864 46788999998643 34567777888877655 69999999865 566
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....+.||||+.+|++..+.+. ..|+..+..-+|..|+.||.||| ..+||+||||-.|||||.+|.+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~----------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~ 507 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHT----------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHV 507 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEec----------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcE
Confidence 6789999999999996555543 25777777779999999999999 7899999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+||||++...
T Consensus 508 kiADFGlcKe~m 519 (694)
T KOG0694|consen 508 KIADFGLCKEGM 519 (694)
T ss_pred EecccccccccC
Confidence 999999999754
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=203.17 Aligned_cols=148 Identities=24% Similarity=0.260 Sum_probs=117.3
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|.....||+|+||.||++.. .+++.||||.+..... .....|.+|+.++.++. |+|||++++++.. ....+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence 455567899999999999985 4578999999864322 23457889999999996 9999999998653 23568
Q ss_pred EEEEecCCCCHHHhh---cCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 273 VVYKFMPNGSLEEWL---HGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 273 lV~ey~~~GsL~~~L---~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
+++||+.. +|.++. .... ...+++.....++.+++.||+|||+ ..+|+||||||+||+++.++.+||
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVL-------KSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEE
Confidence 99999874 555433 2211 1357788889999999999999994 357999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 150 ~dfg~~~~~ 158 (288)
T cd06616 150 CDFGISGQL 158 (288)
T ss_pred eecchhHHh
Confidence 999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-23 Score=202.62 Aligned_cols=151 Identities=29% Similarity=0.382 Sum_probs=125.5
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|+.++.+++|+||+++++++.+.. ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 45788889999999999999985 4588999999864322 22345678999999999999999999875421 235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+. ++|.+++.... ..+++.....++.+++.||.||| ..+++||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence 789999997 58988887432 35788899999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 151 dfg~~~~~~ 159 (309)
T cd07845 151 DFGLARTYG 159 (309)
T ss_pred ccceeeecC
Confidence 999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=206.24 Aligned_cols=152 Identities=20% Similarity=0.261 Sum_probs=123.6
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccc-cCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVD-YQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~ 268 (485)
..+.|...+.||+|+||.||++.. .+|+.||||.+... .......+.+|+.++.+++|+||+++++++.... +...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 346788889999999999999984 46889999998532 2223456778999999999999999998875321 1122
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+. |+|.+++.. .+++.....++.+++.||.||| ..+|+||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 35789999996 588888753 2566677889999999999999 67899999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 159 L~Dfg~~~~~~ 169 (353)
T cd07850 159 ILDFGLARTAG 169 (353)
T ss_pred EccCccceeCC
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-23 Score=202.77 Aligned_cols=148 Identities=22% Similarity=0.308 Sum_probs=122.2
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+.|...+.||+|+||.||+|.. .++..+|+|.+.... ....+.|.+|++++.+++|+|++++++++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 3466678899999999999985 457889999886422 1223568889999999999999999998764 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+. |+|.+++.... ..+.+.....++.+++.||.||| ..+++||||||+|||++.++.+||+
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~--------~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~ 157 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEEC
Confidence 789999997 68888775322 24677888999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||++....
T Consensus 158 dfg~~~~~~ 166 (308)
T cd06634 158 DFGSASIMA 166 (308)
T ss_pred Ccccceeec
Confidence 999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=200.31 Aligned_cols=140 Identities=24% Similarity=0.258 Sum_probs=112.4
Q ss_pred eecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHH---HhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 202 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAA---INIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l---~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+||+|+||.||++.. .+++.+|||.+..... .....+.+|..++ ...+||||+.+.+++.. .+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 489999999999985 4588999998864321 1123344454333 34479999999887653 2357899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++.... .+.|.....|+.|++.||.||| ..+|+||||||+|||+++++.+||+|||+
T Consensus 76 ~e~~~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~ 143 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (279)
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999987432 4788889999999999999999 67899999999999999999999999999
Q ss_pred cccc
Q 041230 355 ARFL 358 (485)
Q Consensus 355 a~~~ 358 (485)
+...
T Consensus 144 ~~~~ 147 (279)
T cd05633 144 ACDF 147 (279)
T ss_pred ceec
Confidence 8654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=212.76 Aligned_cols=154 Identities=24% Similarity=0.377 Sum_probs=128.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||.++.... .+++.+++|.+...... ..+.-.+|+.++++++|||||...+.+.. +....
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCceE
Confidence 4566678999999999986552 45678999998754432 33467889999999999999999877543 23348
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||+|++||+|.+.|....+ ..|..++-.++..|+..|+.||| ...|+|||||++||+|..+..+||+|
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~-------~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKG-------VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhh-------ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecc
Confidence 999999999999999986553 46777888899999999999999 78999999999999999999999999
Q ss_pred cccccccCCCC
Q 041230 352 FSMARFLPDTD 362 (485)
Q Consensus 352 FGla~~~~~~~ 362 (485)
||+|+.+....
T Consensus 150 fGlaK~l~~~~ 160 (426)
T KOG0589|consen 150 FGLAKILNPED 160 (426)
T ss_pred hhhhhhcCCch
Confidence 99999986654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=209.47 Aligned_cols=149 Identities=21% Similarity=0.265 Sum_probs=125.4
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++... +++.||||.++.. .......|.+|..++..++|+||+++++++.. ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 46778899999999999999854 5788999998642 12234558889999999999999999988653 356
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... ..+.+.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~ 144 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE--------DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLA 144 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEE
Confidence 899999999999999997532 24667778889999999999999 7899999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 145 DfG~a~~~~ 153 (331)
T cd05624 145 DFGSCLKMN 153 (331)
T ss_pred eccceeecc
Confidence 999987653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=197.44 Aligned_cols=141 Identities=25% Similarity=0.298 Sum_probs=120.5
Q ss_pred ecccCceEEEEeEee-CCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||.||++... +++.||+|.+..... ...+.|.+|+.++.+++||||+++++++.. ....++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 699999999999864 488999999864321 234678999999999999999999988653 24579999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++.... .+.+.....++.+++.||.||| ..+++|+||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 76 LGGELWTILRDRG---------LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred CCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 9999999997642 3667788889999999999999 688999999999999999999999999999876
Q ss_pred CC
Q 041230 359 PD 360 (485)
Q Consensus 359 ~~ 360 (485)
..
T Consensus 144 ~~ 145 (262)
T cd05572 144 KS 145 (262)
T ss_pred Cc
Confidence 44
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=213.28 Aligned_cols=145 Identities=19% Similarity=0.239 Sum_probs=122.3
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+|...+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.++.+++|+||+++++.+.. ....
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCEE
Confidence 577789999999999999984 458899999985321 2234568899999999999999999988653 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+.......++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~D 144 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTD 144 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999997543 3455566678999999999999 67899999999999999999999999
Q ss_pred cccccc
Q 041230 352 FSMARF 357 (485)
Q Consensus 352 FGla~~ 357 (485)
||++..
T Consensus 145 FG~a~~ 150 (376)
T cd05598 145 FGLCTG 150 (376)
T ss_pred CCCCcc
Confidence 999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=198.97 Aligned_cols=147 Identities=23% Similarity=0.381 Sum_probs=123.0
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|...+.||+|++|.||++.. .+|+.+++|.++.... .....+.+|++++.+++|+||+++++++.. ....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 34457899999999999985 4688899999864322 235678899999999999999999988653 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++ +|.+++.... ..+++..+..++.+++.||.||| ..+|+|+||||+||+++.++.+||+|||
T Consensus 76 v~e~~~~-~l~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~ 143 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQ--------RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFG 143 (283)
T ss_pred EEeccCC-CHHHHHHhhc--------ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeee
Confidence 9999985 8888887532 25788889999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
.+.....
T Consensus 144 ~~~~~~~ 150 (283)
T cd05118 144 LARSFGS 150 (283)
T ss_pred eeEecCC
Confidence 9876643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-23 Score=200.89 Aligned_cols=147 Identities=20% Similarity=0.269 Sum_probs=122.2
Q ss_pred ccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccC
Q 041230 196 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 266 (485)
+|...+.||+|+||.||.+.. .+|..||+|+++... ....+.+.+|+.++.++ +|+||+++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 466678999999999999875 368899999986432 12346688899999999 58999999877542
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++|+||+++|+|.++|.... .+.+.....++.+++.||.||| ..+++||||||+|||++.++.
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGH 143 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCC
Confidence 346789999999999999997532 3566777778889999999999 688999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 144 ~kl~dfg~~~~~~ 156 (290)
T cd05613 144 VVLTDFGLSKEFH 156 (290)
T ss_pred EEEeeCccceecc
Confidence 9999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=216.63 Aligned_cols=149 Identities=21% Similarity=0.296 Sum_probs=119.9
Q ss_pred ccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcc---hHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
-|+..+.||.|+||.||.+. ..+...||||++...-.+. .++++.|+..|.+++|||+|...||+.. ....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence 46667889999999999997 3557789999986433222 3567889999999999999999988653 3457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
+||||||- ||-.++|.-.. ..+-.-....|+.|+..||+||| +...||||||..||||.+.+.+|++|
T Consensus 102 WLVMEYCl-GSAsDlleVhk--------KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaD 169 (948)
T KOG0577|consen 102 WLVMEYCL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLAD 169 (948)
T ss_pred HHHHHHHh-ccHHHHHHHHh--------ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeecc
Confidence 89999996 57777775322 23444556678899999999999 67899999999999999999999999
Q ss_pred cccccccCCC
Q 041230 352 FSMARFLPDT 361 (485)
Q Consensus 352 FGla~~~~~~ 361 (485)
||.|.+..+.
T Consensus 170 FGSAsi~~PA 179 (948)
T KOG0577|consen 170 FGSASIMAPA 179 (948)
T ss_pred ccchhhcCch
Confidence 9999876443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-23 Score=214.53 Aligned_cols=154 Identities=21% Similarity=0.286 Sum_probs=119.9
Q ss_pred ccchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCC------cceeEeee
Q 041230 187 FKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHR------NIVRVFTA 259 (485)
Q Consensus 187 ~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~~~ 259 (485)
.+++...+++|...+.||+|+||+||+|.. ..++.||||+++... ...+.+..|++++.+++|. ||++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344555678899999999999999999985 457889999986432 2234566788887777655 47888877
Q ss_pred ecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 260 ~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
+.. .....++|+|++ +++|.+++.... .+.+.....|+.||+.||.|||. ..+||||||||+||
T Consensus 200 ~~~----~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NI 263 (467)
T PTZ00284 200 FQN----ETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENI 263 (467)
T ss_pred EEc----CCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHE
Confidence 643 124578999987 778999886532 46778888999999999999993 25899999999999
Q ss_pred EecCCC----------------cEEEeecccccc
Q 041230 340 LLDDEM----------------IGHVGDFSMARF 357 (485)
Q Consensus 340 Lld~~~----------------~~ki~DFGla~~ 357 (485)
|++.++ .+||+|||++..
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~ 297 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCcccc
Confidence 998765 499999998764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=204.09 Aligned_cols=155 Identities=19% Similarity=0.292 Sum_probs=126.1
Q ss_pred hhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-C
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-Q 266 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~ 266 (485)
+...+.|...+.||+|+||.||++.. .+|..||||+++... ......+.+|+.++.+++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 44567788889999999999999974 468899999985322 1223568899999999999999999988753221 1
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
.....++|+||+ +++|.+++... .+++.....|+.+++.||.||| ..+|+||||||+||+++.++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCC
Confidence 112458999999 77998887532 4677888999999999999999 678999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 157 ~kl~dfg~~~~~~ 169 (343)
T cd07880 157 LKILDFGLARQTD 169 (343)
T ss_pred EEEeecccccccc
Confidence 9999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-22 Score=200.25 Aligned_cols=145 Identities=23% Similarity=0.279 Sum_probs=120.3
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
|...+.||+|+||+||+|.. .+|..|++|.+..... ...+.+.+|++++.+++|||++++++++.+ ....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 44456799999999999985 4588999999864322 223568889999999999999999998764 24679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||++ |+|.+++.... ..+.|..+..++.+++.||.||| ..+|+||||||+||+++.++.+||+||
T Consensus 98 lv~e~~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred EEEecCC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeec
Confidence 9999996 68888775432 24778889999999999999999 678999999999999999999999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|++...
T Consensus 166 g~~~~~ 171 (313)
T cd06633 166 GSASKS 171 (313)
T ss_pred CCCccc
Confidence 998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=210.79 Aligned_cols=147 Identities=23% Similarity=0.342 Sum_probs=125.1
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++... +++.||||+++... ......+..|+.++.+++|+||+++++++.. ...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 36777899999999999999854 58899999986421 2234568889999999999999999987653 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~ 143 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLS 143 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEe
Confidence 899999999999999997542 3566777889999999999999 7899999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++.+
T Consensus 144 DfG~~~~~ 151 (360)
T cd05627 144 DFGLCTGL 151 (360)
T ss_pred eccCCccc
Confidence 99998755
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=203.15 Aligned_cols=151 Identities=23% Similarity=0.327 Sum_probs=125.9
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|.....||+|+||.||+|... +|+.||||++.... ....+.|.+|+.++..++|+||+++.+++...........++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 566789999999999999864 48899999986533 334567899999999999999999999876532122235799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||++ ++|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.++|+|||
T Consensus 82 v~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg 148 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFG 148 (330)
T ss_pred Eecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccC
Confidence 999998 58999887532 4778888999999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
++.....
T Consensus 149 ~~~~~~~ 155 (330)
T cd07834 149 LARGVDP 155 (330)
T ss_pred ceEeecc
Confidence 9987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-22 Score=200.68 Aligned_cols=153 Identities=22% Similarity=0.335 Sum_probs=125.1
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc---CC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY---QG 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 267 (485)
+++|...+.||+|+||.||+|.. .+++.+|||++.... ......+.+|++++.+++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57888899999999999999985 458899999885432 2223567889999999999999999887653221 12
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++|+||+.. +|...+.... ..+++.....++.++++||.||| ..+|+||||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 3357899999975 7777776432 35788889999999999999999 6789999999999999999999
Q ss_pred EEeeccccccc
Q 041230 348 HVGDFSMARFL 358 (485)
Q Consensus 348 ki~DFGla~~~ 358 (485)
||+|||+++..
T Consensus 155 ~l~dfg~~~~~ 165 (311)
T cd07866 155 KIADFGLARPY 165 (311)
T ss_pred EECcCccchhc
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=196.84 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=126.2
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||++... +|+.||+|++.... ....+.+.+|..++.+++ |+||+++++++.. ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 35777789999999999999864 68999999986422 223456888999999998 9999999887643 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... .+.+.....|+.+++.||.||| ..+++|+||||+||+++.++.+++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l 143 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKI 143 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEe
Confidence 6799999999999999997532 4788899999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||++....
T Consensus 144 ~df~~~~~~~ 153 (280)
T cd05581 144 TDFGTAKVLD 153 (280)
T ss_pred cCCccccccC
Confidence 9999988654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=199.53 Aligned_cols=142 Identities=21% Similarity=0.160 Sum_probs=116.5
Q ss_pred eeecccCceEEEEeEeeCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|+.+++.++|+||+++++++.. ....+++|||+
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~ 81 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLM 81 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEecc
Confidence 3455667777777764 7899999998653 22344679999999999999999999987653 34679999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++|+|.+++..... ..+.+.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|||.+...
T Consensus 82 ~~~~l~~~l~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 82 AYGSCEDLLKTHFP-------EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred CCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence 99999999975422 23566777889999999999999 678999999999999999999999999988644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=202.36 Aligned_cols=158 Identities=21% Similarity=0.319 Sum_probs=128.9
Q ss_pred cchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
.++...+++|.....||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+.++.+++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45667889999999999999999999974 568899999986422 122456888999999999999999998875321
Q ss_pred c-CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 265 Y-QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 265 ~-~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
. ......+++++++ +++|.+++... .+.+..+..++.++++||.||| ..+|+||||||+||++++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 155 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcC
Confidence 1 1223467788776 78998887642 3678888999999999999999 678999999999999999
Q ss_pred CCcEEEeecccccccC
Q 041230 344 EMIGHVGDFSMARFLP 359 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~ 359 (485)
++.+||+|||+++...
T Consensus 156 ~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 156 DCELKILDFGLARHTD 171 (345)
T ss_pred CCCEEEeccccccccc
Confidence 9999999999987653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=210.32 Aligned_cols=151 Identities=24% Similarity=0.390 Sum_probs=126.8
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcc--hHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
-+.+|.....||+|.|+.|..+.. .+|..||||.+++..... .+.+.+|+++|..+.|||||+|+.+... ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence 356788889999999999999984 458999999997654332 3568899999999999999999987543 35
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+.+|.+++||...+.. .. ...-.+..|+.++++||| ...|+|||||.+|||||.+++.||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~--------~e-~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikI 196 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRM--------KE-KEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKI 196 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccc--------hh-hhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceee
Confidence 689999999999999999876532 11 344457889999999999 788999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||++.++..
T Consensus 197 aDfgfS~~~~~ 207 (596)
T KOG0586|consen 197 ADFGFSTFFDY 207 (596)
T ss_pred eccccceeecc
Confidence 99999998754
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=194.65 Aligned_cols=141 Identities=21% Similarity=0.291 Sum_probs=113.5
Q ss_pred eeecccCceEEEEeEe-eCCcEEEEEEeeccCCc---chHHHHHHHHHH-HhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GARSFKSECKAA-INIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
..||+|+||.||+|.. .+|+.||||.+...... ....+..|..++ ...+|+||+++++++.. ....++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 3589999999999985 45889999998643211 123344555443 45689999999988753 34689999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++.... .+++.....++.+++.||.||| ..+++||||+|+||+++.++.+||+|||++
T Consensus 77 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 144 (260)
T cd05611 77 EYLNGGDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144 (260)
T ss_pred eccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccc
Confidence 9999999999997532 3566777889999999999999 678999999999999999999999999998
Q ss_pred ccc
Q 041230 356 RFL 358 (485)
Q Consensus 356 ~~~ 358 (485)
+..
T Consensus 145 ~~~ 147 (260)
T cd05611 145 RNG 147 (260)
T ss_pred eec
Confidence 764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-22 Score=191.87 Aligned_cols=149 Identities=23% Similarity=0.382 Sum_probs=124.5
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-----CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-----PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ......|.+|++++.+++|+||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 4678889999999999999985 458899999875321 122357889999999999999999999875321 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+++++|.+++.... .+.+....+++.+++.||.||| ..+++|+||||+||+++.++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 35689999999999999987532 3566778889999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 147 l~dfg~~~~~ 156 (264)
T cd06653 147 LGDFGASKRI 156 (264)
T ss_pred ECcccccccc
Confidence 9999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=211.65 Aligned_cols=148 Identities=34% Similarity=0.588 Sum_probs=116.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeec-ccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDV-MGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||||.++.+||+|||+|+..+. ....... .||.+|+||||...+..+.|+|||||||+++|++||+.|.+
T Consensus 200 HrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 200 HRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred cCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 999999999999999999999999987765 4444444 89999999999998899999999999999999999998876
Q ss_pred CCC-CCCCChhHHHhhhchh-hHHhhhchhhhh-hhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 79 GMF-KDDLNLPNLVKSALPA-RAEQILDVAFFQ-EIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 79 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
... ....++..|....+.. ...+++|+.+.. ... ..+++..+..+|++|++.+|..||+
T Consensus 280 ~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~------------------~~~~~~~~~~~a~~C~~~~~~~RP~ 341 (361)
T KOG1187|consen 280 QSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP------------------DEKEVKKLAELALRCLRPDPKERPT 341 (361)
T ss_pred CCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCC------------------hHHHHHHHHHHHHHHcCcCCCcCcC
Confidence 543 3344567776555543 466777766531 110 0034556789999999999999999
Q ss_pred cchhhHHHHHH
Q 041230 156 INDVESRLRSI 166 (485)
Q Consensus 156 m~~v~~~L~~i 166 (485)
|.+|.+.|+.+
T Consensus 342 m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 342 MSQVVKELEGI 352 (361)
T ss_pred HHHHHHHHHhh
Confidence 99998887443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=196.95 Aligned_cols=146 Identities=25% Similarity=0.408 Sum_probs=123.7
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
|+....||+|+||.||+|+.. +++.||+|.++... ....+.+..|+.++.+++|+||+++++++... ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 344578999999999999865 48899999987542 33346788899999999999999999887542 46799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||++ ++|.+++.... ..+++..+..++.+++.||.||| ..+|+||||+|+||++++++.+||+|||
T Consensus 76 v~e~~~-~~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g 143 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFG 143 (282)
T ss_pred EecCcC-cCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCC
Confidence 999998 59999997542 24778899999999999999999 6789999999999999999999999999
Q ss_pred cccccC
Q 041230 354 MARFLP 359 (485)
Q Consensus 354 la~~~~ 359 (485)
+++...
T Consensus 144 ~~~~~~ 149 (282)
T cd07829 144 LARAFG 149 (282)
T ss_pred cccccC
Confidence 987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=199.85 Aligned_cols=139 Identities=26% Similarity=0.320 Sum_probs=116.2
Q ss_pred eeccc--CceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 202 LIGAG--NFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 202 ~iG~G--~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.||+| +||+||++.. .+|+.||||.++.... ...+.|.+|+.++..++|||||++++++.. ....++|+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~e 79 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVISP 79 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEEe
Confidence 46666 9999999984 4789999999864322 234678899999999999999999998764 245799999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
|+++|+|.+++..... ..+++.....++.+++.||.||| +.+|+||||||+|||++.++.+|++|||.+
T Consensus 80 ~~~~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 80 FMAYGSANSLLKTYFP-------EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred cccCCCHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 9999999999875422 23677788899999999999999 678999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=209.87 Aligned_cols=146 Identities=27% Similarity=0.438 Sum_probs=116.8
Q ss_pred eeecccCceEEEEeEeeC-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecC
Q 041230 201 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMP 279 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~ 279 (485)
-+||+|.||+||-|+-.+ ...+|||-+........+-...|+.+.+.++|+|||+.+|.|+. +.+.-+.||-+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCC
Confidence 368999999999998444 45789998865444445567789999999999999999999864 236789999999
Q ss_pred CCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEeeccccccc
Q 041230 280 NGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVGDFSMARFL 358 (485)
Q Consensus 280 ~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~DFGla~~~ 358 (485)
||||.++|+.+ |.. ..=...+.--+..||..||.||| ...|||||||-.|||++- .|.+||+|||.++.+
T Consensus 656 GGSLSsLLrsk----WGP--lKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 656 GGSLSSLLRSK----WGP--LKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred CCcHHHHHHhc----cCC--CccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhh
Confidence 99999999864 211 11133444457899999999999 788999999999999975 589999999998876
Q ss_pred CC
Q 041230 359 PD 360 (485)
Q Consensus 359 ~~ 360 (485)
..
T Consensus 727 Ag 728 (1226)
T KOG4279|consen 727 AG 728 (1226)
T ss_pred cc
Confidence 43
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=195.36 Aligned_cols=140 Identities=24% Similarity=0.238 Sum_probs=112.7
Q ss_pred eecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHH---HHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 202 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECK---AAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~---~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
+||+|+||.||++.. .+++.||+|.+..... .....+..|.. .+....||||+++.+++.. ....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 489999999999985 4578999998864321 11223444443 4445689999999877653 3467899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++|+|.+++... ..+.|..+..++.+++.||.||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 76 ~e~~~g~~L~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~ 143 (278)
T cd05606 76 LDLMNGGDLHYHLSQH---------GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (278)
T ss_pred EecCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcC
Confidence 9999999999988643 24788999999999999999999 67899999999999999999999999999
Q ss_pred cccc
Q 041230 355 ARFL 358 (485)
Q Consensus 355 a~~~ 358 (485)
++..
T Consensus 144 ~~~~ 147 (278)
T cd05606 144 ACDF 147 (278)
T ss_pred cccc
Confidence 8754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=193.92 Aligned_cols=148 Identities=22% Similarity=0.342 Sum_probs=117.7
Q ss_pred cccceeecccCceEEEEeEeeC-CcEEEEEEeeccC-----CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR-----PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||.||++.... +..+++|.++... ......+..|+.++.+++||||+++++++.. ...
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RDA 76 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CCc
Confidence 4556789999999999997533 4456666665322 2233457789999999999999999988653 235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++++|.++++..... ...+++.....++.+++.||.||| ..+++|+||||+||+++. ..+||+
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeec
Confidence 78999999999999998642111 135788999999999999999999 689999999999999986 569999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 148 d~g~~~~~ 155 (260)
T cd08222 148 DFGVSRLL 155 (260)
T ss_pred ccCceeec
Confidence 99998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=198.61 Aligned_cols=150 Identities=22% Similarity=0.279 Sum_probs=106.4
Q ss_pred cccccceeecccCceEEEEeEeeCC----cEEEEEEeeccCCcc-h----------HHHHHHHHHHHhcCCCcceeEeee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGG-A----------RSFKSECKAAINIRHRNIVRVFTA 259 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~----~~vavK~~~~~~~~~-~----------~~f~~E~~~l~~l~H~niv~l~~~ 259 (485)
+.|...++||+|+||+||+|...++ ..+|+|......... . .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4678889999999999999986543 456666533221111 0 112233345567799999999987
Q ss_pred ecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 260 ~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
+.... ....+.++++|++.. ++.+.+... ..+.+.....|+.+++.||.||| ..+|+||||||+||
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Ni 157 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVE-NTKEIFKRI---------KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENI 157 (294)
T ss_pred eeEec-CCceEEEEEEehhcc-CHHHHHHhh---------ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence 54321 112245677777643 565555432 12456677889999999999999 67899999999999
Q ss_pred EecCCCcEEEeeccccccc
Q 041230 340 LLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 340 Lld~~~~~ki~DFGla~~~ 358 (485)
|++.++.+||+|||+|+.+
T Consensus 158 ll~~~~~~~l~DFGla~~~ 176 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHF 176 (294)
T ss_pred EEcCCCcEEEEEcCCceee
Confidence 9999999999999999865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=201.69 Aligned_cols=142 Identities=23% Similarity=0.361 Sum_probs=118.6
Q ss_pred ceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcc--------------hHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 200 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG--------------ARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
.+.||+|+||+||+|.. .+++.||||.++...... ...+.+|++++.+++|+||+++++++..
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 91 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE-- 91 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec--
Confidence 46799999999999984 468899999886432111 1247789999999999999999998753
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
....++|+||+. |+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+||+++.+
T Consensus 92 ---~~~~~lv~e~~~-~~l~~~l~~~---------~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 92 ---GDFINLVMDIMA-SDLKKVVDRK---------IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSK 155 (335)
T ss_pred ---CCcEEEEEeccc-cCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCC
Confidence 246799999997 6999998643 24677788899999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccC
Q 041230 345 MIGHVGDFSMARFLP 359 (485)
Q Consensus 345 ~~~ki~DFGla~~~~ 359 (485)
+.+||+|||+++...
T Consensus 156 ~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 156 GICKIADFGLARRYG 170 (335)
T ss_pred CCEEECCccceeecc
Confidence 999999999987654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=205.00 Aligned_cols=230 Identities=19% Similarity=0.249 Sum_probs=156.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.-|+....||+|+||.||||.. ..++.||+|++..... ...++.++|+.+++..+++||.+.+|.+.. ....+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-----g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-----GTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-----cccHH
Confidence 3466668999999999999983 5578999999976443 346788999999999999999999887643 34578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
++||||.+|++.+.|...... ....-.-|..++..||.||| ..+.+|||||+.|||+..++.+|++||
T Consensus 88 iiMey~~gGsv~~lL~~~~~~---------~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNIL---------DEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred HHHHHhcCcchhhhhccCCCC---------ccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEec
Confidence 999999999999999864431 11222237889999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc-e-----------------eeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 353 SMARFLPDTDEQ-T-----------------RFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 353 Gla~~~~~~~~~-~-----------------~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
|.+..+..+... . .|..+.++.+++..+++....+- |. ......+.+...-+..+ +
T Consensus 156 gVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP--P~--s~~hPmrvlflIpk~~P--P 229 (467)
T KOG0201|consen 156 GVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP--PH--SKLHPMRVLFLIPKSAP--P 229 (467)
T ss_pred ceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC--CC--cccCcceEEEeccCCCC--C
Confidence 999887655331 1 12233455555444333111110 00 00000000001111111 1
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. .. ..+-..+.+..-.|...+|+.||+..+.++
T Consensus 230 ~-L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 R-LD--GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c-cc--cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 0 00 023334566777999999999999998764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-22 Score=198.93 Aligned_cols=150 Identities=19% Similarity=0.242 Sum_probs=120.3
Q ss_pred ccccceeecccCceEEEEeEee-C--CcEEEEEEeeccC--CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-D--GTTIAVKVFNLIR--PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~--~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
+|...+.||+|+||.||++... + +..||||++.... ....+.+.+|+.++.++ .|||||++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 3566788999999999999853 3 6789999886422 12245678899999999 599999999875432 12224
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++++||+. ++|.+++.... .+.+.....++.|++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEe
Confidence 5678888886 69999986432 4678888999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++.+.
T Consensus 147 ~Dfg~a~~~~ 156 (332)
T cd07857 147 CDFGLARGFS 156 (332)
T ss_pred CcCCCceecc
Confidence 9999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=202.64 Aligned_cols=150 Identities=24% Similarity=0.398 Sum_probs=122.5
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc--------
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-------- 265 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-------- 265 (485)
..|...+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++.+++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5678889999999999999985 4588999999876555556778899999999999999999876543211
Q ss_pred -CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec-C
Q 041230 266 -QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD-D 343 (485)
Q Consensus 266 -~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld-~ 343 (485)
......++|+||++ ++|.+++... .+.+.....++.|++.||.||| ..+|+||||||+||+++ +
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~ 150 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTE 150 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCC
Confidence 11234689999998 5998887532 3567778889999999999999 67899999999999998 4
Q ss_pred CCcEEEeeccccccc
Q 041230 344 EMIGHVGDFSMARFL 358 (485)
Q Consensus 344 ~~~~ki~DFGla~~~ 358 (485)
+..+|++|||+++.+
T Consensus 151 ~~~~kl~dfg~~~~~ 165 (342)
T cd07854 151 DLVLKIGDFGLARIV 165 (342)
T ss_pred CceEEECCcccceec
Confidence 568999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=202.64 Aligned_cols=154 Identities=19% Similarity=0.309 Sum_probs=125.6
Q ss_pred hhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CC
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QG 267 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~ 267 (485)
...++|.....||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++|+||+++.+++...+. ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 44678888999999999999999864 57899999876421 2234567789999999999999999876543221 11
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++|+||+ +++|.+++.. ..+++.....++.+++.||.||| ..+|+||||||+||+++.++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCE
Confidence 23478999998 5799998864 24678888999999999999999 6789999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||++....
T Consensus 158 kL~dfg~~~~~~ 169 (343)
T cd07851 158 KILDFGLARHTD 169 (343)
T ss_pred EEcccccccccc
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=210.56 Aligned_cols=149 Identities=24% Similarity=0.435 Sum_probs=118.0
Q ss_pred ceeecccCceEEEEeEe-eCCcEEE---EEEeecc-CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 200 ANLIGAGNFGSVYNGTL-FDGTTIA---VKVFNLI-RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~-~~~~~va---vK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
..+||+|+|-+||||.- .+|.+|| ||.-+.. .+...+.|..|+.+|+.|+|||||+++.++.+.+ .+..-+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~i 121 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINFI 121 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeeee
Confidence 46799999999999973 3366665 2221211 2334578999999999999999999998876543 2456789
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-CcEEEeecc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MIGHVGDFS 353 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-~~~ki~DFG 353 (485)
+|.|..|+|..|+...+. .+.+--.+++.||.+||.|||++ .|||||||||..||+++.+ |.+||+|+|
T Consensus 122 TEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred eecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence 999999999999986542 23344456899999999999976 7899999999999999876 899999999
Q ss_pred cccccCCC
Q 041230 354 MARFLPDT 361 (485)
Q Consensus 354 la~~~~~~ 361 (485)
||+.+...
T Consensus 192 LAtl~r~s 199 (632)
T KOG0584|consen 192 LATLLRKS 199 (632)
T ss_pred HHHHhhcc
Confidence 99987543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=179.50 Aligned_cols=147 Identities=22% Similarity=0.376 Sum_probs=120.4
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+|..-+.||+|.||+||||+. .++..||.|+.... ..+....-.+|+.++..++|+|||+++...- .++..-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 344556899999999999985 45778999988643 3445677899999999999999999987632 345678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+|||.. +|..+..+-. ..++.........|+.+||.|.| ++.++|||+||.|.|++.+++.|++||
T Consensus 78 lvfe~cdq-dlkkyfdsln--------g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladf 145 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSLN--------GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADF 145 (292)
T ss_pred EeHHHhhH-HHHHHHHhcC--------CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEeccc
Confidence 99999964 7777765433 34566666778999999999999 789999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++.+.
T Consensus 146 glarafg 152 (292)
T KOG0662|consen 146 GLARAFG 152 (292)
T ss_pred chhhhcC
Confidence 9998754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-22 Score=198.85 Aligned_cols=149 Identities=26% Similarity=0.382 Sum_probs=126.9
Q ss_pred ccccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcc---hHHHHHHHHHHHhcC-CCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGG---ARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 268 (485)
...|...+.||.|.||.||+++... |+.+|+|.+++..... .+.+.+|+.+|.++. |||||.+.+.+.. .
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-----~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-----P 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-----C
Confidence 3456666899999999999998654 8999999997554433 357899999999998 9999999998654 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC----
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE---- 344 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~---- 344 (485)
...++|||++.+|.|.+.|... .++......++.+++.++.||| ..+|+||||||+|+|+...
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCC
Confidence 4689999999999999998753 2677888999999999999999 6899999999999999643
Q ss_pred CcEEEeecccccccCC
Q 041230 345 MIGHVGDFSMARFLPD 360 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~ 360 (485)
+..|++|||+|.....
T Consensus 176 ~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKP 191 (382)
T ss_pred CcEEEeeCCCceEccC
Confidence 4799999999998765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=190.91 Aligned_cols=144 Identities=17% Similarity=0.215 Sum_probs=113.4
Q ss_pred ccccccceee--cccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLI--GAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~i--G~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.+ |+|+||.||++.. .++..+|+|.+........ |+..... .+||||+++++++.. ..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-----~~ 82 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-----LK 82 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-----CC
Confidence 3455555555 9999999999984 4578899998864322111 2222221 279999999988754 23
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGH 348 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~k 348 (485)
..++||||+++|+|.+++.... .+.|.....++.++++||.||| ..+++||||||+||+++.++ .++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEE
Confidence 6899999999999999997532 4788899999999999999999 67899999999999999998 999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 151 l~dfg~~~~~~ 161 (267)
T PHA03390 151 LCDYGLCKIIG 161 (267)
T ss_pred EecCccceecC
Confidence 99999987654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=207.60 Aligned_cols=154 Identities=19% Similarity=0.252 Sum_probs=114.0
Q ss_pred hccccccceeecccCceEEEEeEeeC--CcEEEEEEee---------------cc--CCcchHHHHHHHHHHHhcCCCcc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFN---------------LI--RPGGARSFKSECKAAINIRHRNI 253 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~--~~~vavK~~~---------------~~--~~~~~~~f~~E~~~l~~l~H~ni 253 (485)
..+.|...+.||+|+||+||++.... +...++|.++ .. .......|.+|+.++.+++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35679999999999999999987533 2222222110 00 11123468899999999999999
Q ss_pred eeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 041230 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCN 333 (485)
Q Consensus 254 v~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrd 333 (485)
|++++++... ...++|+||+. ++|.+++...... +. ..........|+.|++.||.||| ..+|+|||
T Consensus 226 v~l~~~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~~~-~~---~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrD 292 (501)
T PHA03210 226 LKIEEILRSE-----ANTYMITQKYD-FDLYSFMYDEAFD-WK---DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRD 292 (501)
T ss_pred CcEeEEEEEC-----CeeEEEEeccc-cCHHHHHhhcccc-cc---ccccHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 9999987642 35689999885 6788877643211 10 11233455679999999999999 67899999
Q ss_pred cCCCceEecCCCcEEEeecccccccC
Q 041230 334 LKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 334 lK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
|||+||||+.++.+||+|||+++.+.
T Consensus 293 LKP~NILl~~~~~vkL~DFGla~~~~ 318 (501)
T PHA03210 293 IKLENIFLNCDGKIVLGDFGTAMPFE 318 (501)
T ss_pred CCHHHEEECCCCCEEEEeCCCceecC
Confidence 99999999999999999999998654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=198.93 Aligned_cols=141 Identities=23% Similarity=0.237 Sum_probs=111.1
Q ss_pred hccccccceeecccCceEEEEeEee--CCcEEEEEEeecc-----CCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLI-----RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~--~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
..++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|.+++|+|+|..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 3457888999999999999999854 5777899986422 111245689999999999999999643221
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc-CCCceEecCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL-KPSNVLLDDE 344 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl-K~~NILld~~ 344 (485)
...++||||+++++|.. +.... ...++.++++||.||| ..+|+|||| ||+|||++.+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~~~---------------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARPHG---------------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPD 148 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCccc---------------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCC
Confidence 13589999999999963 21100 1346788999999999 689999999 9999999999
Q ss_pred CcEEEeecccccccCC
Q 041230 345 MIGHVGDFSMARFLPD 360 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~ 360 (485)
+.+||+|||+|+.+..
T Consensus 149 ~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 149 GEAAVIDFQLASVFRR 164 (365)
T ss_pred CCEEEEECccceeccc
Confidence 9999999999997654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=195.47 Aligned_cols=149 Identities=21% Similarity=0.307 Sum_probs=125.1
Q ss_pred cccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+.|...+.||.|.-|+||.+.+.+ +...|+|++.+... ......+.|-+||+.+.||.++.|++.+. .+++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-----t~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-----TDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-----ccce
Confidence 456677899999999999999765 47899999965332 22344567889999999999999998754 4578
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.+||||||+||+|...++.+.. ..|+.....-+|.+|..||+||| ..+||+|||||+||||-++|++-++
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~-------~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPG-------KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCC-------CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEee
Confidence 8999999999999999987654 35666666668999999999999 8999999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
||-|+...
T Consensus 222 DFDLS~~~ 229 (459)
T KOG0610|consen 222 DFDLSLRC 229 (459)
T ss_pred eccccccC
Confidence 99998654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=215.74 Aligned_cols=148 Identities=26% Similarity=0.347 Sum_probs=125.5
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|... +++.||||+++.... .....|..|+.++..++|+|||++++++.. ...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----ANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CCE
Confidence 56778899999999999999864 588999999864322 223568889999999999999999977653 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... .+.+.....|+.+|+.||.||| ..+|+||||||+||||+.++.+||+
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~ 146 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLT 146 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEE
Confidence 899999999999999997432 3566778889999999999999 5789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 147 DFGls~~~~ 155 (669)
T cd05610 147 DFGLSKVTL 155 (669)
T ss_pred eCCCCcccc
Confidence 999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-23 Score=196.48 Aligned_cols=249 Identities=16% Similarity=0.217 Sum_probs=176.8
Q ss_pred chhhhccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeec
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVS 261 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~ 261 (485)
++.-..+.|....++-+|.||.||+|.+.+ .+.|-||.++... +-....|+.|...+..+.|||+..+.+.|.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 343444557778889999999999997643 3456677665332 223456889999999999999999999987
Q ss_pred ccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe
Q 041230 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341 (485)
Q Consensus 262 ~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl 341 (485)
.. ....+++|.|+.-|+|..+|.--.+..... ...+.-.+-+.+|.|+|.|++||| +.+|||.||..+|+++
T Consensus 358 e~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~-aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 358 ED----YATPFVLYPATGVGNLKSFLQICRGDDPSY-AQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVI 429 (563)
T ss_pred ec----cCcceEEEeccCcchHHHHHHHhccCCCcc-ccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhccee
Confidence 52 246789999999999999998211110000 124555677889999999999999 7899999999999999
Q ss_pred cCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhh----hhh-hhhccccchhh
Q 041230 342 DDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALS----QRV-EEILNDFNLQE 396 (485)
Q Consensus 342 d~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~----~~~-~~~~d~~~~~~ 396 (485)
|+...+||+|=.++|.+-..+.+ ..|....++.+|+...++ ++. .--+||.-...
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 99999999999999987554432 234445556566544332 111 11124432222
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
+-. -+. +...+.+|+.++..|+..||+..|++||+++|++.-|.+...-
T Consensus 510 ylk------dGy-------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 YLK------DGY-------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHh------ccc-------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 110 000 1112346999999999999999999999999999988877543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=184.52 Aligned_cols=141 Identities=28% Similarity=0.345 Sum_probs=120.0
Q ss_pred ecccCceEEEEeEee-CCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEec
Q 041230 203 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFM 278 (485)
Q Consensus 203 iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~ 278 (485)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++.+++|+||+++++.+.. ....++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-----EEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-----CCeeEEEEecC
Confidence 699999999999864 488999999864322 234578899999999999999999877543 35689999999
Q ss_pred CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 279 PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 279 ~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
++++|.+++.... .+++.....++.+++.||.||| ..+++|+||||+||+++.++.++|+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 76 PGGELFSHLSKEG---------RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 9999999997542 4677888899999999999999 688999999999999999999999999998765
Q ss_pred CC
Q 041230 359 PD 360 (485)
Q Consensus 359 ~~ 360 (485)
..
T Consensus 144 ~~ 145 (250)
T cd05123 144 SS 145 (250)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=180.78 Aligned_cols=220 Identities=20% Similarity=0.235 Sum_probs=152.5
Q ss_pred CceEEEEeEee-CCcEEEEEEeeccCCcc-hHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecCCCCHH
Q 041230 207 NFGSVYNGTLF-DGTTIAVKVFNLIRPGG-ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLE 284 (485)
Q Consensus 207 ~fg~Vy~g~~~-~~~~vavK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~ 284 (485)
+||.||+|... +|..+|+|++....... .+.|.+|++.+.+++|+||+++++++... ...++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 58999999975 48899999987544433 67899999999999999999999987642 4579999999999999
Q ss_pred HhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc
Q 041230 285 EWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364 (485)
Q Consensus 285 ~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~ 364 (485)
+++.... .+++.....++.+++.+|.||| ..+++|+||+|+||++++++.++|+|||++.........
T Consensus 76 ~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~ 143 (244)
T smart00220 76 DLLKKRG---------RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLL 143 (244)
T ss_pred HHHHhcc---------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccccc
Confidence 9987532 2677888999999999999999 679999999999999999999999999999876542110
Q ss_pred -----------------eeeeccccHHHHHHHHhhhhhhhhccccch-hhhhhhhhhhcccCCCCCCcchhhhHHHHHHH
Q 041230 365 -----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNL-QEIEEDRTMCMHASSSSSTSTHVSIILECVNS 426 (485)
Q Consensus 365 -----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (485)
..++...++++++...+.-.... .+... .......... ........ .........
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~--~p~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~ 216 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK--PPFPGDDQLLELFKKI--GKPKPPFP---PPEWKISPE 216 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC--CCCCCCCcHHHHHHHH--hccCCCCc---cccccCCHH
Confidence 11223445666554332211000 00000 0000000000 00000000 000003356
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHH
Q 041230 427 ICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 427 ~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+.++...|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 778999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=208.45 Aligned_cols=159 Identities=18% Similarity=0.192 Sum_probs=105.9
Q ss_pred hccccccceeecccCceEEEEeEeeC-----CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecc-cccC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSG-VDYQ 266 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 266 (485)
..++|...+.||+|+||.||+|...+ +..||||+++... ..+.+..| .+....+.+++.++..+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999998644 6889999875321 22222222 1222233333333222111 1012
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcc-----------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTH-----------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~-----------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
.....++||||+++|+|.++++...... ...............|+.|++.||.||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 3346799999999999999997543100 0000001112233468999999999999 6789999999
Q ss_pred CCceEecC-CCcEEEeeccccccc
Q 041230 336 PSNVLLDD-EMIGHVGDFSMARFL 358 (485)
Q Consensus 336 ~~NILld~-~~~~ki~DFGla~~~ 358 (485)
|+||||+. ++.+||+|||+|+.+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l 306 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADL 306 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccc
Confidence 99999996 589999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=187.12 Aligned_cols=80 Identities=40% Similarity=0.627 Sum_probs=74.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce-eecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF-IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||.||+|+.+|.+||+|||+++++...... .+.+|||.||+||.+.+..|+.++||||+||++|||+.-++||.+
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 9999999999999999999999999998765543 457999999999999999999999999999999999999999976
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 231 ~ 231 (375)
T KOG0591|consen 231 D 231 (375)
T ss_pred c
Confidence 3
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-20 Score=171.71 Aligned_cols=142 Identities=26% Similarity=0.457 Sum_probs=121.2
Q ss_pred ecccCceEEEEeEeeC-CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecCC
Q 041230 203 IGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPN 280 (485)
Q Consensus 203 iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~ 280 (485)
||+|.+|.||++...+ ++.+++|++...... ..+.|.+|++.+..++|++|+++++++... ...++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 6899999999998654 889999998754322 246789999999999999999999887642 457899999999
Q ss_pred CCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEeecccccccC
Q 041230 281 GSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVGDFSMARFLP 359 (485)
Q Consensus 281 GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~DFGla~~~~ 359 (485)
++|.+++.... ..+++..+..++.+++++|.||| ..+++|+||+|.||+++. +..++|+|||.+....
T Consensus 76 ~~l~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 76 GSLKDLLKENE--------GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred CcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 99999987542 24678889999999999999999 669999999999999999 8999999999998764
Q ss_pred C
Q 041230 360 D 360 (485)
Q Consensus 360 ~ 360 (485)
.
T Consensus 145 ~ 145 (215)
T cd00180 145 S 145 (215)
T ss_pred C
Confidence 4
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-22 Score=200.12 Aligned_cols=144 Identities=21% Similarity=0.243 Sum_probs=120.0
Q ss_pred cceeecccCceEEEEeEeeCCc-EEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEe
Q 041230 199 SANLIGAGNFGSVYNGTLFDGT-TIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKF 277 (485)
Q Consensus 199 ~~~~iG~G~fg~Vy~g~~~~~~-~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey 277 (485)
..-.||.|+||+|||+...+.. .-|.|++........++|+-|+++|+...|||||+|++.+. -.+..++..||
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwiliEF 110 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWILIEF 110 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEEEee
Confidence 3456899999999999866544 34678887666667789999999999999999999998753 23467899999
Q ss_pred cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 278 MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 278 ~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
|.||-.+..+-..+ ..|...+..-|+.+++.||.||| +..|||||||..|||+.-+|.++++|||.+..
T Consensus 111 C~GGAVDaimlEL~--------r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELG--------RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred cCCchHhHHHHHhc--------cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeeccccccc
Confidence 99999988765433 35666777779999999999999 78899999999999999999999999998764
Q ss_pred c
Q 041230 358 L 358 (485)
Q Consensus 358 ~ 358 (485)
.
T Consensus 180 n 180 (1187)
T KOG0579|consen 180 N 180 (1187)
T ss_pred c
Confidence 3
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=182.32 Aligned_cols=131 Identities=20% Similarity=0.118 Sum_probs=109.5
Q ss_pred cCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecCCCCHH
Q 041230 206 GNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLE 284 (485)
Q Consensus 206 G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~ 284 (485)
|.||.||++.. .+++.+|+|++.... .+.+|...+....||||+++++++.. ....++|+||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHH
Confidence 88999999984 568899999986432 34456666667789999999988653 34679999999999999
Q ss_pred HhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 285 EWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 285 ~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
+++.... .+.+.....++.+++.||.||| ..+|+||||||+||+++.++.++++|||++...
T Consensus 74 ~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~ 135 (237)
T cd05576 74 SHISKFL---------NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV 135 (237)
T ss_pred HHHHHhc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence 9986432 3678888999999999999999 688999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-22 Score=185.83 Aligned_cols=154 Identities=18% Similarity=0.285 Sum_probs=122.0
Q ss_pred cccccceeecccCceEEEEeEeeC-----CcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
..|.....||+|.||.|||+.-.+ .+.+|||+++..+ .+....-.+|+.+++.++|||||.|...+...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 345666789999999999996322 2368999997543 34467788999999999999999998776542
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC---
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE--- 344 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~--- 344 (485)
+...+|+|||.+. +|...++-...... ..+.-..--.|.-||..|+.||| +.-|+||||||+|||+..+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCc
Confidence 3568999999987 88888875433211 24454555678999999999999 6779999999999999887
Q ss_pred -CcEEEeecccccccCC
Q 041230 345 -MIGHVGDFSMARFLPD 360 (485)
Q Consensus 345 -~~~ki~DFGla~~~~~ 360 (485)
|.+||+||||+|.+.+
T Consensus 172 rG~VKIaDlGlaR~~~~ 188 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNN 188 (438)
T ss_pred cCeeEeecccHHHHhhc
Confidence 8999999999998744
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=196.45 Aligned_cols=138 Identities=30% Similarity=0.424 Sum_probs=102.4
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCCC-CceeecccccCcccccccC--CCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGM--GSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++ ++||+|||+++..... ...+...||+.|||||++. ...|+.|+||||||+++||++||+.|
T Consensus 166 HrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred ecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 999999999999997 9999999999876543 2334478999999999998 56899999999999999999999999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+... .+...... ..-. ....... +...+..++.+||+.+|..||++
T Consensus 246 f~~~~~-----~~~~~~v~----~~~~--------------Rp~~p~~---------~~~~l~~l~~~CW~~dp~~RP~f 293 (362)
T KOG0192|consen 246 FEDLAP-----VQVASAVV----VGGL--------------RPPIPKE---------CPPHLSSLMERCWLVDPSRRPSF 293 (362)
T ss_pred CCCCCH-----HHHHHHHH----hcCC--------------CCCCCcc---------CCHHHHHHHHHhCCCCCCcCCCH
Confidence 976432 01100000 0000 0000111 22235567778999999999999
Q ss_pred chhhHHHHHHhhhh
Q 041230 157 NDVESRLRSIKMKL 170 (485)
Q Consensus 157 ~~v~~~L~~i~~~~ 170 (485)
.++...++.+....
T Consensus 294 ~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 294 LEIVSRLESIMSHI 307 (362)
T ss_pred HHHHHHHHHHHHhh
Confidence 99999998876644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-22 Score=189.55 Aligned_cols=132 Identities=26% Similarity=0.344 Sum_probs=96.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++..|.+||||||+++.+... ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+-|+...
T Consensus 202 HRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 202 HRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred eccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 9999999999999999999999999976544 456789999999999999999999999999999999999999998653
Q ss_pred CCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchhh
Q 041230 81 FKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVE 160 (485)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v~ 160 (485)
.........++ ..|++.+. ...+.. .+-..++.+.-.|.+.+|.+||+..+..
T Consensus 281 ~~~~~~~~~Ll--------~~Iv~~pp----------------P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl 333 (364)
T KOG0581|consen 281 NPPYLDIFELL--------CAIVDEPP----------------PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLL 333 (364)
T ss_pred CCCCCCHHHHH--------HHHhcCCC----------------CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 11111222221 12222110 000110 0111235566789999999999887753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=188.53 Aligned_cols=146 Identities=29% Similarity=0.452 Sum_probs=114.9
Q ss_pred ceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 200 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.+.||+|-||+||-|+. .+|+.||||++.+.+ .......++|+.+|.+++||.||.|--.|.. .+..++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceEEEEeh
Confidence 57899999999999984 579999999997543 3345678999999999999999999765543 345789999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC---CcEEEeecc
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE---MIGHVGDFS 353 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~---~~~ki~DFG 353 (485)
-+.+--|.-.|....+ .|+.+..--++.||..||.||| ..+|+|+||||+||||... -.+||+|||
T Consensus 644 Kl~GDMLEMILSsEkg--------RL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKG--------RLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred hhcchHHHHHHHhhcc--------cchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccc
Confidence 8865445444544332 2444434447889999999999 6899999999999999754 479999999
Q ss_pred cccccCCC
Q 041230 354 MARFLPDT 361 (485)
Q Consensus 354 la~~~~~~ 361 (485)
+||++.+.
T Consensus 713 fARiIgEk 720 (888)
T KOG4236|consen 713 FARIIGEK 720 (888)
T ss_pred ceeecchh
Confidence 99998654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-22 Score=185.13 Aligned_cols=148 Identities=21% Similarity=0.335 Sum_probs=125.7
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
-|.....||+|+||.|||+.. .+|+.||||.+... ...++...|+.+|.+-..|.+|+.+|.+- .....++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEee
Confidence 466677899999999999974 56999999987543 35678899999999999999999987642 23457999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
||||--||..+.++.+. ..|.......|..+..+||+||| ...-||||||..||||+-++.+|++|||.
T Consensus 107 MEYCGAGSiSDI~R~R~--------K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARR--------KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhhcCCCcHHHHHHHhc--------CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccc
Confidence 99999999999987543 35777777889999999999999 56779999999999999999999999999
Q ss_pred ccccCCC
Q 041230 355 ARFLPDT 361 (485)
Q Consensus 355 a~~~~~~ 361 (485)
|..+.++
T Consensus 176 AGQLTDT 182 (502)
T KOG0574|consen 176 AGQLTDT 182 (502)
T ss_pred cchhhhh
Confidence 9887654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.5e-20 Score=192.73 Aligned_cols=165 Identities=22% Similarity=0.333 Sum_probs=138.5
Q ss_pred CccchhhhccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 186 ~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
.++.+-+.++-|.....||+|.+|.||+++ .++++.+|||++.... ...++...|.+++... .|||++.++|++.-.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 445556778888889999999999999998 5778999999887543 3445666778888766 799999999998755
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
+.-..+..+||||||.+||.-+++.+..+ ..+.|..-.-|+.++.+||.+|| +..++|||||-.||||+.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTE 158 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEec
Confidence 55456679999999999999999986542 46778888889999999999999 788999999999999999
Q ss_pred CCcEEEeecccccccCCC
Q 041230 344 EMIGHVGDFSMARFLPDT 361 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~ 361 (485)
++.+|+.|||++..+..+
T Consensus 159 e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 159 NAEVKLVDFGVSAQLDST 176 (953)
T ss_pred cCcEEEeeeeeeeeeecc
Confidence 999999999999877543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-22 Score=182.22 Aligned_cols=150 Identities=23% Similarity=0.373 Sum_probs=122.3
Q ss_pred ccccccceeecccCceEEEEeE-eeCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+++|+.-..||+|.|+.||+.. ..+|+.+|+|.++.. ...+.++..+|+.+..+++|||||+|..... ...+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence 4567777889999999999876 467888999987543 3345678889999999999999999987643 4567
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC---CcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE---MIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~---~~~ 347 (485)
.++|+|+|.+|+|..-+-.+ ..++....-..+.||..+|.|.| ..+|||||+||.|+||... --+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R---------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~v 152 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR---------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAV 152 (355)
T ss_pred eEEEEecccchHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCce
Confidence 89999999999998765432 34555556678899999999999 7899999999999999644 358
Q ss_pred EEeecccccccCC
Q 041230 348 HVGDFSMARFLPD 360 (485)
Q Consensus 348 ki~DFGla~~~~~ 360 (485)
|++|||+|..+.+
T Consensus 153 KL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 153 KLADFGLAIEVND 165 (355)
T ss_pred eecccceEEEeCC
Confidence 9999999998763
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=174.03 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=104.3
Q ss_pred eeecccCceEEEEeEeeCCcEEEEEEeeccCCc--c-------hHHH-----------------HHHHHHHHhcCCCcce
Q 041230 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--G-------ARSF-----------------KSECKAAINIRHRNIV 254 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~niv 254 (485)
..||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999778999999998753211 1 1122 2499999999887764
Q ss_pred eEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 255 ~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
....+.. ...++||||+++++|...+... ..+++.....++.+++.+|.|+|+ ..+|+||||
T Consensus 83 ~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~---------~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDl 144 (190)
T cd05147 83 CPEPILL-------KSHVLVMEFIGDDGWAAPRLKD---------APLSESKARELYLQVIQIMRILYQ--DCRLVHADL 144 (190)
T ss_pred CCcEEEe-------cCCEEEEEEeCCCCCcchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCC
Confidence 3322110 1237999999998776442211 245677888999999999999942 568999999
Q ss_pred CCCceEecCCCcEEEeeccccccc
Q 041230 335 KPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 335 K~~NILld~~~~~ki~DFGla~~~ 358 (485)
||+|||++ ++.++|.|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-21 Score=186.64 Aligned_cols=123 Identities=35% Similarity=0.423 Sum_probs=94.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||||.+|+++|+|||+++... .+....++|||+.|||||++....|+..+|+||+|+++|||++|.+||.+
T Consensus 148 yRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 148 YRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred eccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 89999999999999999999999999543 33444568999999999999999999999999999999999999999976
Q ss_pred CCC---------CC-C--------ChhHHHhhhch----------hhHHhhhchhhhhhhHHHHHHHhhhhc
Q 041230 80 MFK---------DD-L--------NLPNLVKSALP----------ARAEQILDVAFFQEIEEEETLYKKASS 123 (485)
Q Consensus 80 ~~~---------~~-~--------~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 123 (485)
... .. . ...++++..+. ..++++-.++|+..++|+....++..+
T Consensus 228 ~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~P 299 (357)
T KOG0598|consen 228 EDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSP 299 (357)
T ss_pred ccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCC
Confidence 321 11 1 11222322221 234566677888888888877776654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-21 Score=188.53 Aligned_cols=155 Identities=24% Similarity=0.310 Sum_probs=129.4
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|+.-++||+|+||.||-++.. +|+.+|.|++.+. +..+...-++|-.+|.+++.+.||.|-.++ ...+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 346888899999999999988754 5899999988532 223444567899999999999999986553 3345
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..+||+..|.+|+|.-+|...+. ..|+..+.+-+|.+|+.||++|| +..||+||+||+|||||++|+++|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEe
Confidence 68999999999999999986543 35788888889999999999999 789999999999999999999999
Q ss_pred eecccccccCCCCc
Q 041230 350 GDFSMARFLPDTDE 363 (485)
Q Consensus 350 ~DFGla~~~~~~~~ 363 (485)
||.|||..+++...
T Consensus 329 SDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP 342 (591)
T ss_pred eccceEEecCCCCc
Confidence 99999998876543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=179.73 Aligned_cols=150 Identities=25% Similarity=0.395 Sum_probs=126.8
Q ss_pred CccchhhhccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 186 ~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
.|+++++-|+ .+||+|+|+.|-.++ +.+|.++|||++.+..........+|++++..- .|+||+.|+.++.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-- 146 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE-- 146 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--
Confidence 4677777774 689999999999877 788999999999876555556778899998876 6999999999865
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
++..+|||||-|.+|+|..+|+.+ ..|+....-+++.+||.||.||| .++|.|||+||+|||-.+
T Consensus 147 ---dd~~FYLVfEKm~GGplLshI~~~---------~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 147 ---DDTRFYLVFEKMRGGPLLSHIQKR---------KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCES 211 (463)
T ss_pred ---ccceEEEEEecccCchHHHHHHHh---------hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecC
Confidence 345689999999999999999865 36788888899999999999999 789999999999999865
Q ss_pred C---CcEEEeecccccc
Q 041230 344 E---MIGHVGDFSMARF 357 (485)
Q Consensus 344 ~---~~~ki~DFGla~~ 357 (485)
- --+||+||.|+.-
T Consensus 212 pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSG 228 (463)
T ss_pred CCCcCceeeeccccccc
Confidence 4 3589999988754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=169.53 Aligned_cols=140 Identities=16% Similarity=0.158 Sum_probs=107.2
Q ss_pred eeecccCceEEEEeEeeCCcEEEEEEeeccCCc--c------------------------hHHHHHHHHHHHhcCCCcce
Q 041230 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--G------------------------ARSFKSECKAAINIRHRNIV 254 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--~------------------------~~~f~~E~~~l~~l~H~niv 254 (485)
..||+|+||+||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999778999999998753211 0 11235788999999999875
Q ss_pred eEeeeecccccCCceeeEEEEEecCCCCHHHh-hcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 041230 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEW-LHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCN 333 (485)
Q Consensus 255 ~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~-L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrd 333 (485)
....+... ..++||||++++++... +.. ..++......|+.+++.+|.|+|+ ..+|+|||
T Consensus 83 ~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~----------~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrD 143 (190)
T cd05145 83 VPEPILLK-------KNVLVMEFIGDDGSPAPRLKD----------VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGD 143 (190)
T ss_pred CceEEEec-------CCEEEEEEecCCCchhhhhhh----------ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCC
Confidence 44333211 23799999998865433 322 134556778899999999999993 17999999
Q ss_pred cCCCceEecCCCcEEEeecccccccCC
Q 041230 334 LKPSNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 334 lK~~NILld~~~~~ki~DFGla~~~~~ 360 (485)
|||+|||++ ++.++|+|||+++..+.
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999 89999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-21 Score=202.63 Aligned_cols=308 Identities=23% Similarity=0.283 Sum_probs=188.4
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCC-CC---ceeeccc-ccCcccccccCCCCC-CCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPV-ET---SFIDVMG-TIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~-~~---~~~~~~g-t~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G 73 (485)
|||+||+|.+++..+ ..+++|||+|..+.. .. .....+| ++.|+|||...+..+ ....|+||.|+++..+++|
T Consensus 147 h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g 226 (601)
T KOG0590|consen 147 HRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTG 226 (601)
T ss_pred cCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccC
Confidence 899999999999999 999999999987654 22 2345688 999999999877544 5678999999999999999
Q ss_pred CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 74 LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 74 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
..|.............|..... ......+..+ .. ....+-..+...+|..|
T Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~--------------------~~---~~~~~l~k~l~~~~~~r 277 (601)
T KOG0590|consen 227 ELPWDFPSRKDGRYSSWKSNKG------RFTQLPWNSI--------------------SD---QAHDLLHKILKENPSNR 277 (601)
T ss_pred CCCccccccccccceeeccccc------ccccCccccC--------------------Ch---hhhhcccccccCCchhc
Confidence 9886543222111111111100 0000000000 00 01122233344677888
Q ss_pred cccchhhHHHHHHh-h-hhccCccccccccccccCccchhhhcccc-ccceeecccCceEEEEeEe-eCCcEEEEEEeec
Q 041230 154 MDINDVESRLRSIK-M-KLLKTPVYEEKQTINNLSFKDLYDATNGF-SSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL 229 (485)
Q Consensus 154 P~m~~v~~~L~~i~-~-~~~~~~~~~~~~~~~~~~~~~l~~~t~~f-~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~ 229 (485)
.+..++...---.. . .............+... ...-...| ....++|.|++|.|+.... ...+..+.|.+..
T Consensus 278 ~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~----~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~ 353 (601)
T KOG0590|consen 278 LSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKS----PIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRV 353 (601)
T ss_pred cccccccccccccccccccccccccccccccccC----ccccccccCCccceeeecccCceEEEEecCCCccchhhhhhc
Confidence 87776543211100 0 00000000000000000 00001112 3467899999997776552 3344444443321
Q ss_pred c--CCcchH----HHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCccccccccccc
Q 041230 230 I--RPGGAR----SFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303 (485)
Q Consensus 230 ~--~~~~~~----~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~ 303 (485)
. .....+ .+..|..+-..++|+|++..+..+...+ ...-+|||+++ +|..++.... .+.
T Consensus 354 ~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~~~~~mE~~~~-Dlf~~~~~~~---------~~~ 418 (601)
T KOG0590|consen 354 RVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----GILQSMEYCPY-DLFSLVMSNG---------KLT 418 (601)
T ss_pred ccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----cchhhhhcccH-HHHHHHhccc---------ccc
Confidence 0 111122 2456777888899999988765544321 12334999999 9999987642 233
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccC
Q 041230 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 304 ~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
-..+..+..|+..|+.|+| ..+|.|||+|++|+++..++.+||+|||.+....
T Consensus 419 ~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 419 PLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 4456668899999999999 7889999999999999999999999999987653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=180.41 Aligned_cols=151 Identities=20% Similarity=0.341 Sum_probs=123.5
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcc--hHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.-|..++.||+|-|..|-.++ ...|..||||++.+.+... ...+.+|++.|.-++|||||+|+.... . .-..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD---T--QTKl 92 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID---T--QTKL 92 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc---c--cceE
Confidence 346667889999999998876 5789999999997665433 346778999999999999999987643 2 2357
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEe
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVG 350 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~ 350 (485)
|||.|.=.+|+|++||-..+. .+.....-++..||..|+.|+| ...+|||||||+||.+-+ -|.+|++
T Consensus 93 yLiLELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEee
Confidence 999999999999999976542 3555666779999999999999 789999999999997765 5899999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||++-.+...
T Consensus 162 DFGFSNkf~PG 172 (864)
T KOG4717|consen 162 DFGFSNKFQPG 172 (864)
T ss_pred eccccccCCCc
Confidence 99999765443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.3e-21 Score=207.08 Aligned_cols=151 Identities=26% Similarity=0.357 Sum_probs=120.1
Q ss_pred ccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+-.+...+.||.|.||.||.|. +.+|...|||-++... ......+.+|+.++..|.|||+|+.+|.-.+ .+.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Rek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----REK 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HHH
Confidence 3355667899999999999998 5668888999775332 2234567789999999999999999887432 345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++.||||.+|+|.+.+...... +..---.+..|++.|+.||| ..+||||||||.||+||.++..|.+
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~---------dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIE---------DEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchh---------hhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEee
Confidence 78999999999999998754322 11111236789999999999 7899999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||.|+.+...
T Consensus 1377 DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1377 DFGSAVKIKNN 1387 (1509)
T ss_pred cccceeEecCc
Confidence 99999876443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=180.69 Aligned_cols=152 Identities=25% Similarity=0.394 Sum_probs=122.8
Q ss_pred cccceeecccCceEEEEeE-eeCCcEEEEEEeeccCC-------cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-------GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~-------~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
|-..++||+|+|+.|||+. +...+-||||+-...+. ...+...+|.++...+.||.||++++|++- +.
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl----Dt 540 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL----DT 540 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee----cc
Confidence 4456889999999999997 55677899997543221 112335678999999999999999999763 23
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CC
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EM 345 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~ 345 (485)
+.+|-|.|||++-+|+-||.... ..+......|+.+|+.||.||.. ..+||||-||||.||||-. .|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccc
Confidence 45799999999999999997643 45677888999999999999984 4799999999999999953 47
Q ss_pred cEEEeecccccccCCCC
Q 041230 346 IGHVGDFSMARFLPDTD 362 (485)
Q Consensus 346 ~~ki~DFGla~~~~~~~ 362 (485)
..||+||||++++.++.
T Consensus 611 eIKITDFGLSKIMdddS 627 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDS 627 (775)
T ss_pred eeEeeecchhhhccCCc
Confidence 89999999999986654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-20 Score=200.82 Aligned_cols=152 Identities=26% Similarity=0.324 Sum_probs=126.4
Q ss_pred hhhhccccccceeecccCceEEEEeEee-CCcEEEEEEeec---cCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNL---IRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
+....++|...++||+|+||.|...+.. +++.+|+|++++ .+.....-|..|-.+|..-..+-||+|..+ |
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----F 144 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----F 144 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----h
Confidence 3444568888999999999999998864 477889999975 445566789999999999999999999644 6
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
++..+.|+||||||||+|-.+|...+. ++..-..-++..|..||.-|| +.++|||||||.|||||..|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccC
Confidence 777899999999999999999986542 222223447788999999999 89999999999999999999
Q ss_pred cEEEeeccccccc
Q 041230 346 IGHVGDFSMARFL 358 (485)
Q Consensus 346 ~~ki~DFGla~~~ 358 (485)
++|++|||..-.+
T Consensus 213 HikLADFGsClkm 225 (1317)
T KOG0612|consen 213 HIKLADFGSCLKM 225 (1317)
T ss_pred cEeeccchhHHhc
Confidence 9999999976544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-21 Score=176.48 Aligned_cols=153 Identities=22% Similarity=0.363 Sum_probs=122.0
Q ss_pred ccccceeecccCceEEEEeEee-CCcEEEEEEe--eccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccC---Cce
Q 041230 196 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVF--NLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ---GAR 269 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~--~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~---~~~ 269 (485)
.|....+||+|.||.||++... .|+.||+|+. ...+.+-...-.+|+.+|..++|+|++.++..|...... ...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445578999999999999854 4778898864 233445556678899999999999999999998754321 123
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..+|||++|+. +|.-.|.... ..++..+.-++..++..||.|+| ...|+|||+|++|+|++.++..||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--------vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--------VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--------ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEe
Confidence 47999999986 8888886543 24555666778999999999999 678999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||++|.+..
T Consensus 166 ADFGlar~fs~ 176 (376)
T KOG0669|consen 166 ADFGLARAFST 176 (376)
T ss_pred eccccccceec
Confidence 99999987644
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=184.46 Aligned_cols=148 Identities=26% Similarity=0.375 Sum_probs=119.8
Q ss_pred ccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-C-----CcceeEeeeecccccCCc
Q 041230 196 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-H-----RNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~~ 268 (485)
.|.....||+|+||.|-|+. ..+++.||||++++.+. -..+-..|+.+|..|+ | -|+|++++|+.. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----R 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----c
Confidence 45668899999999999998 45588999999986432 2234456899999886 3 489999998653 4
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC--Cc
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE--MI 346 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~--~~ 346 (485)
+..|||+|.+. -+|+++|..+.-. .|+...-..|+.||+.||.+|| ..+|||+||||+||||.+- ..
T Consensus 261 ~HlciVfELL~-~NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCc
Confidence 57899999886 4999999876532 3666677789999999999999 7899999999999999754 47
Q ss_pred EEEeecccccccCC
Q 041230 347 GHVGDFSMARFLPD 360 (485)
Q Consensus 347 ~ki~DFGla~~~~~ 360 (485)
+||+|||.|.+...
T Consensus 330 vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQ 343 (586)
T ss_pred eeEEecccccccCC
Confidence 99999999987544
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-20 Score=172.50 Aligned_cols=149 Identities=21% Similarity=0.264 Sum_probs=108.7
Q ss_pred ccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeEEE
Q 041230 198 SSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
.....||.|+.|.|++.... .|..+|||.+.... ....+..+..+.++.+-+ .|.||+.+||+... ...++.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~Ic 169 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVFIC 169 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHHHH
Confidence 33456999999999999854 48899999986432 223345666777766655 79999999998742 235677
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
||.|.- -++.+|..-. ..+...-.-++...+..||.||-. .++|+|||+||+|||||+.|++|++|||+
T Consensus 170 MelMs~-C~ekLlkrik--------~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIK--------GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHH-HHHHHHHHhc--------CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccc
Confidence 887752 4444444211 123333333578889999999975 67899999999999999999999999999
Q ss_pred ccccCCCC
Q 041230 355 ARFLPDTD 362 (485)
Q Consensus 355 a~~~~~~~ 362 (485)
+..+.++.
T Consensus 239 sGrlvdSk 246 (391)
T KOG0983|consen 239 SGRLVDSK 246 (391)
T ss_pred cceeeccc
Confidence 98875543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=180.03 Aligned_cols=150 Identities=21% Similarity=0.209 Sum_probs=121.7
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.|.....||+||.+.||+....+.+.+|+|++.... ......|.+|+.+|.++ .|.+||+|++|-.+ +.+.|
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~~lY 436 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DGYLY 436 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----CceEE
Confidence 467778999999999999988788889998765332 23456799999999999 48999999988554 46789
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||= .-+|..+|...... ...| -+..+..++..++.++| ..+|||.||||.|+||- .|..||.||
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~-------~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDF 503 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSI-------DPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDF 503 (677)
T ss_pred EEeecc-cccHHHHHHhccCC-------CchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeee
Confidence 999975 46999999876532 2334 34568899999999999 78999999999999986 567999999
Q ss_pred ccccccCCCCc
Q 041230 353 SMARFLPDTDE 363 (485)
Q Consensus 353 Gla~~~~~~~~ 363 (485)
|+|..+..+..
T Consensus 504 GIA~aI~~DTT 514 (677)
T KOG0596|consen 504 GIANAIQPDTT 514 (677)
T ss_pred chhcccCcccc
Confidence 99998765543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=168.44 Aligned_cols=151 Identities=26% Similarity=0.375 Sum_probs=123.0
Q ss_pred hccccccc-eeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~-~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.|++|+.. .+||-|-.|.|-.+.. .+++.+|.|++. +...-++|+++.-. -.|||||.++..+.. .|++..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCce
Confidence 45556543 5789999999987763 457789999874 23456788887644 479999999988753 366777
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCc
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMI 346 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~ 346 (485)
..++|||+|++|.|.+.+..++. ..|..++.-.|..+|+.|+.||| ..+|.||||||+|+|... |-.
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~-------~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD-------QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc-------ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcc
Confidence 88999999999999999987653 36888899999999999999999 789999999999999964 568
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
.|++|||+|+.-.
T Consensus 203 lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 203 LKLTDFGFAKETQ 215 (400)
T ss_pred eEecccccccccC
Confidence 9999999999754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-20 Score=171.47 Aligned_cols=78 Identities=31% Similarity=0.460 Sum_probs=71.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
+|||||+|||||.+|++||+|||+|+..... .-+.||||.|+|||.+.+..+...+|+|||||++|||+.|.+||...
T Consensus 167 YRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 167 YRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred eccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 5999999999999999999999999976544 45689999999999999999999999999999999999999999653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=162.40 Aligned_cols=140 Identities=24% Similarity=0.337 Sum_probs=104.3
Q ss_pred cccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-----CCCcceeEeeeecccccCCcee-
Q 041230 197 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-----RHRNIVRVFTAVSGVDYQGARF- 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~~~~~~~~~~~~~~- 270 (485)
++....||+|+||.||. .-.++.. +||++........+.+.+|+.++.++ .||||++++|+..... +...
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 34567899999999996 3233444 68887654444567899999999999 5799999999976421 2223
Q ss_pred eEEEEEe--cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHH-HHhhcCCCCCeeeeccCCCceEecC----
Q 041230 271 KAVVYKF--MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL-KYLHCDCQPRIAHCNLKPSNVLLDD---- 343 (485)
Q Consensus 271 ~~lV~ey--~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL-~yLH~~~~~~ivHrdlK~~NILld~---- 343 (485)
..+|+|| +++|+|.+++.... +... ..++.++..++ .||| ..+|+||||||+|||++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISES 144 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCC
Confidence 3478999 66899999996421 2222 34577888788 9999 788999999999999974
Q ss_pred CCcEEEeecccc
Q 041230 344 EMIGHVGDFSMA 355 (485)
Q Consensus 344 ~~~~ki~DFGla 355 (485)
+..++|+||+.+
T Consensus 145 ~~~~~LiDg~G~ 156 (210)
T PRK10345 145 EVIPVVCDNIGE 156 (210)
T ss_pred CCcEEEEECCCC
Confidence 348999995444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.5e-20 Score=178.60 Aligned_cols=79 Identities=34% Similarity=0.568 Sum_probs=73.5
Q ss_pred CCCCCCCcEEECCC------CcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDE------MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~------~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+||||+.. -.+||+|||+|+.+..+....+.||||.|||||++...+|+.|+|+||.|+++|++++|+
T Consensus 132 HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 132 HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred eccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCC
Confidence 99999999999875 458999999999998777777899999999999999999999999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||..
T Consensus 212 ~Pf~a 216 (429)
T KOG0595|consen 212 PPFDA 216 (429)
T ss_pred CCccc
Confidence 99974
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-19 Score=168.19 Aligned_cols=80 Identities=38% Similarity=0.541 Sum_probs=71.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC---CCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG---SEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
|||+||+|||||..|.+|++|||++..+......+...|.+.|||||.+.- ..|+-++||||||+.++||.||+-|+
T Consensus 215 HRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy 294 (391)
T KOG0983|consen 215 HRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY 294 (391)
T ss_pred ecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence 999999999999999999999999988776655566789999999998753 46788999999999999999999999
Q ss_pred CCC
Q 041230 78 NGM 80 (485)
Q Consensus 78 ~~~ 80 (485)
.+.
T Consensus 295 ~~c 297 (391)
T KOG0983|consen 295 KGC 297 (391)
T ss_pred CCC
Confidence 763
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=171.03 Aligned_cols=148 Identities=22% Similarity=0.268 Sum_probs=120.1
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...++||+|.||+|-.++- .+|+.+|||++++.- ......-+.|-++|.+-+||.+..|.. +++..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY-----sFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY-----SFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh-----hhccCc
Confidence 35788889999999999998873 468899999987432 222334566889999999999998853 355566
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..|.||||..+|.|.-+|.... .|+..+..-+-..|..||.||| +.+||.||+|-+|.|||.+++.||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEe
Confidence 7899999999999998887543 3454444457789999999999 688999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+||||.+.-
T Consensus 310 tDFGLCKE~ 318 (516)
T KOG0690|consen 310 TDFGLCKEE 318 (516)
T ss_pred eecccchhc
Confidence 999998853
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=180.42 Aligned_cols=148 Identities=20% Similarity=0.261 Sum_probs=121.2
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.-|...+.||-|+||.|.++. .++...+|.|.|.+. ..+.......|-.||+....+-||+|+.. |++.+.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence 357778899999999999986 445667899988542 23344567789999999999999999744 566778
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.|+||||+++|++-.+|-..+. |......-++.++++|+++.| ..++|||||||.|||||.+|++||+
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeee
Confidence 9999999999999999876542 344444446778999999999 8999999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
||||..-+.
T Consensus 772 DFGLCTGfR 780 (1034)
T KOG0608|consen 772 DFGLCTGFR 780 (1034)
T ss_pred eccccccce
Confidence 999987653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-20 Score=178.17 Aligned_cols=82 Identities=30% Similarity=0.521 Sum_probs=71.5
Q ss_pred CCCCCCCcEEECCC---CcEEEEeccCccccCCCCceeecccccCcccccccCCCCC---CCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDE---MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV---SSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~---~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+||||..+ ..+||+|||+|++.....-..+.||||.|.|||++.+..+ ..+.|+||+||+||-+++|.
T Consensus 299 HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 299 HRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred cccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 99999999999776 7799999999999876666778999999999999876543 34789999999999999999
Q ss_pred CCCCCCCC
Q 041230 75 RPNNGMFK 82 (485)
Q Consensus 75 ~p~~~~~~ 82 (485)
.||.....
T Consensus 379 pPFS~~~~ 386 (475)
T KOG0615|consen 379 PPFSEEYT 386 (475)
T ss_pred CCcccccC
Confidence 99976543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-19 Score=162.70 Aligned_cols=150 Identities=19% Similarity=0.397 Sum_probs=123.2
Q ss_pred hhccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCce
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 269 (485)
..+++|...+.+|+|.|+.||.|. ..++..++||+++.. ..+...+|+.+|.+++ |||||+|+....+.. .+
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---cc
Confidence 456788889999999999999998 567788999999754 3467889999999997 999999998866432 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-CcEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MIGH 348 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-~~~k 348 (485)
...||+||+.|.+....... |+-........++.+||.|+| +.+|+|||+||.|+++|.. -..+
T Consensus 109 tpaLiFE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred CchhHhhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceee
Confidence 57899999999998776542 222233447889999999999 7899999999999999976 5799
Q ss_pred EeecccccccCCCC
Q 041230 349 VGDFSMARFLPDTD 362 (485)
Q Consensus 349 i~DFGla~~~~~~~ 362 (485)
+.|+|||.+.....
T Consensus 174 lIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGK 187 (338)
T ss_pred eeecchHhhcCCCc
Confidence 99999999875543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=159.43 Aligned_cols=149 Identities=27% Similarity=0.438 Sum_probs=126.8
Q ss_pred cccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
|...+.||+|+||.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 4456789999999999999765 789999998754443 567889999999999999999999886542 457899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
+||+++++|.+++..... .+++.....++.+++.+|.||| ..+++|+||+++||+++.++.++|+|||+
T Consensus 76 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~ 144 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGL 144 (225)
T ss_pred EeccCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCce
Confidence 999999999999975421 1677888899999999999999 56999999999999999999999999999
Q ss_pred ccccCCC
Q 041230 355 ARFLPDT 361 (485)
Q Consensus 355 a~~~~~~ 361 (485)
+......
T Consensus 145 ~~~~~~~ 151 (225)
T smart00221 145 ARFIHRD 151 (225)
T ss_pred eeEecCc
Confidence 9876543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-19 Score=185.32 Aligned_cols=81 Identities=30% Similarity=0.367 Sum_probs=74.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
+||||.+|||||.+|++||+|||+++-.. .+....++||||.|||||++.+..|+..+|+|||||++|||+.|+.||.+
T Consensus 491 YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 491 YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred eeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 69999999999999999999999999643 44556789999999999999999999999999999999999999999987
Q ss_pred CC
Q 041230 80 MF 81 (485)
Q Consensus 80 ~~ 81 (485)
..
T Consensus 571 dd 572 (694)
T KOG0694|consen 571 DD 572 (694)
T ss_pred CC
Confidence 43
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.2e-19 Score=177.53 Aligned_cols=134 Identities=28% Similarity=0.465 Sum_probs=97.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce--eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF--IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||-+.|||++.+..+||+|||+|+....+... ....-...|.|||.+....++.|+|||||||+|+|++| |+.|+
T Consensus 326 HRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py 405 (468)
T KOG0197|consen 326 HRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPY 405 (468)
T ss_pred chhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCC
Confidence 9999999999999999999999999954332211 11233568999999999999999999999999999998 88887
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.++.. .+++. .++ .-..+.. ... |...+.+++..||+.+|++||++.
T Consensus 406 ~~msn-----~ev~~---------~le--------~GyRlp~--P~~---------CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 406 PGMSN-----EEVLE---------LLE--------RGYRLPR--PEG---------CPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred CCCCH-----HHHHH---------HHh--------ccCcCCC--CCC---------CCHHHHHHHHHHhhCCcccCCCHH
Confidence 66532 11111 111 1111111 112 333567899999999999999999
Q ss_pred hhhHHHHHHh
Q 041230 158 DVESRLRSIK 167 (485)
Q Consensus 158 ~v~~~L~~i~ 167 (485)
.....+..+.
T Consensus 453 ~L~~~l~~~~ 462 (468)
T KOG0197|consen 453 TLREVLEDFF 462 (468)
T ss_pred HHHHHHHHhh
Confidence 8777776643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-19 Score=166.94 Aligned_cols=145 Identities=27% Similarity=0.417 Sum_probs=100.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||||||+|+.+. .+...+..+.|.+|.|||.+.+ .+|+...||||.||++.||++|.+-++
T Consensus 124 HRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 124 HRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred cccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 99999999999999999999999999887 4455677889999999999887 689999999999999999999988776
Q ss_pred CCCCCCCChhHHHh--hh---chhhHHhhhc-hhhhhh-----hHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 79 GMFKDDLNLPNLVK--SA---LPARAEQILD-VAFFQE-----IEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 79 ~~~~~~~~~~~~~~--~~---~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|.. ++.++.. .. +.++..+++. .++|.. .+..+.+.++... ...-+.+++..|.+
T Consensus 204 G~S----DiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~----------~s~~~ld~~k~cL~ 269 (396)
T KOG0593|consen 204 GRS----DIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK----------ISNVLLDLLKKCLK 269 (396)
T ss_pred Ccc----hHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhccc----------chHHHHHHHHHHhc
Confidence 532 2333321 11 2233333332 122111 1111111111110 01134688899999
Q ss_pred cCCCcccccchh
Q 041230 148 ELPDERMDINDV 159 (485)
Q Consensus 148 ~~p~~RP~m~~v 159 (485)
.+|++|++-.+.
T Consensus 270 ~dP~~R~sc~ql 281 (396)
T KOG0593|consen 270 MDPDDRLSCEQL 281 (396)
T ss_pred CCccccccHHHH
Confidence 999999987764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-19 Score=179.56 Aligned_cols=137 Identities=24% Similarity=0.363 Sum_probs=100.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
|||||+=||||+.+..+||+|||.++.+........++||..|||||+++..+.+.|+||||||||||||+||..|+...
T Consensus 235 HRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 235 HRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 99999999999999999999999998776555455689999999999999999999999999999999999999998643
Q ss_pred CCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchhh
Q 041230 81 FKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVE 160 (485)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v~ 160 (485)
..... -+.+... . +--.+..+|. ..+.-+..+||+..|..||++.++.
T Consensus 315 dssAI------IwGVGsN---s--------------L~LpvPstcP---------~GfklL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 315 DSSAI------IWGVGSN---S--------------LHLPVPSTCP---------DGFKLLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred chhee------EEeccCC---c--------------ccccCcccCc---------hHHHHHHHHHHhcCCCCCccHHHHH
Confidence 22110 0000000 0 0001122232 2234467789999999999999987
Q ss_pred HHHHHHhhh
Q 041230 161 SRLRSIKMK 169 (485)
Q Consensus 161 ~~L~~i~~~ 169 (485)
.-|.-....
T Consensus 363 ~HldIa~pe 371 (904)
T KOG4721|consen 363 LHLDIASPE 371 (904)
T ss_pred HHHhhcCHH
Confidence 665444333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-19 Score=181.32 Aligned_cols=79 Identities=33% Similarity=0.523 Sum_probs=74.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|+|||..+.+||+|||+|.....++.+.+.||+|.|.+||++.+.+| +.++||||+||+||.|++|+.||+.
T Consensus 135 HRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred eccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999998778888889999999999999999998 5789999999999999999999974
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=171.24 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=96.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG--SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ....|+..|+|||+..+ ..++.++|||||||++|||++|+.||.
T Consensus 146 Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred CCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999998654321 23568899999999865 678999999999999999999999996
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccch
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIND 158 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~ 158 (485)
+.. ...+....... ... ...... +...+..+..+|++.+|+.||++.+
T Consensus 224 ~~~-----~~~~~~~i~~~------~~~------------~~~~~~---------~~~~l~~li~~cl~~dp~~Rps~~e 271 (283)
T PHA02988 224 NLT-----TKEIYDLIINK------NNS------------LKLPLD---------CPLEIKCIVEACTSHDSIKRPNIKE 271 (283)
T ss_pred CCC-----HHHHHHHHHhc------CCC------------CCCCCc---------CcHHHHHHHHHHhcCCcccCcCHHH
Confidence 431 11111100000 000 000000 1123567888999999999999999
Q ss_pred hhHHHHHHh
Q 041230 159 VESRLRSIK 167 (485)
Q Consensus 159 v~~~L~~i~ 167 (485)
+...++..+
T Consensus 272 ll~~l~~~~ 280 (283)
T PHA02988 272 ILYNLSLYK 280 (283)
T ss_pred HHHHHHHHH
Confidence 998887654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-19 Score=166.97 Aligned_cols=152 Identities=23% Similarity=0.261 Sum_probs=111.0
Q ss_pred ccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCC-cchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+......||.|+||+|+|-. -+.|+.+|||++..... ...++|+.|.+...+ -.-||||+++|.+-. ....+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCcee
Confidence 34445679999999999876 46799999999964433 345678888876554 478999999998642 22468
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+.||.|. -||+.+...- ...+...++..---.|+.-+..||.||-. ...|||||+||||||||..|.+|++||
T Consensus 140 iCMELMd-~SlDklYk~v----y~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRV----YSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred eeHHHHh-hhHHHHHHHH----HHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecc
Confidence 9999996 4776554310 00111233333334577788999999975 567999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|++..+.
T Consensus 213 GIcGqLv 219 (361)
T KOG1006|consen 213 GICGQLV 219 (361)
T ss_pred cchHhHH
Confidence 9987653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.3e-19 Score=176.08 Aligned_cols=79 Identities=34% Similarity=0.576 Sum_probs=70.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC------------c--eeecccccCcccccccCCCCCCCccchhhHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET------------S--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGIL 66 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~------------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~ 66 (485)
||||||+|||||.++++||+|||-|+.++... . ..+++||-.|.+||++.....+..+|+|+|||+
T Consensus 197 HRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCi 276 (604)
T KOG0592|consen 197 HRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCI 276 (604)
T ss_pred eccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHH
Confidence 99999999999999999999999999774311 1 135899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCC
Q 041230 67 LLEMFTGLRPNNG 79 (485)
Q Consensus 67 l~el~~G~~p~~~ 79 (485)
+|+|+.|++||.+
T Consensus 277 lyQmlaG~PPFra 289 (604)
T KOG0592|consen 277 LYQMLAGQPPFRA 289 (604)
T ss_pred HHHHhcCCCCCcc
Confidence 9999999999976
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.1e-18 Score=179.38 Aligned_cols=149 Identities=23% Similarity=0.392 Sum_probs=112.5
Q ss_pred ccccceeecccCceE-EEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGS-VYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~-Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
-|+...++|.|+-|+ ||+|. .+|+.||||++-.. ...-..+|+..|..- .|||||+.+ |.+ ++.++.|+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyy--c~E---~d~qF~YI 580 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGV-YEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYY--CSE---QDRQFLYI 580 (903)
T ss_pred eeccHHHcccCCCCcEEEEEe-eCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEE--eec---cCCceEEE
Confidence 467778899998875 68997 47899999987421 122346799988766 699999986 443 34678999
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-----CCcEE
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-----EMIGH 348 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-----~~~~k 348 (485)
..|.|. -||.+++...... .... .. -.-+.+..|++.||++|| ...||||||||.||||+. ...++
T Consensus 581 alELC~-~sL~dlie~~~~d-~~~~-~~---i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~ 651 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLD-VEMQ-SD---IDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAK 651 (903)
T ss_pred EehHhh-hhHHHHHhccccc-hhhc-cc---ccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEE
Confidence 999996 5999999874111 0000 01 123557889999999999 678999999999999976 36899
Q ss_pred EeecccccccCCCC
Q 041230 349 VGDFSMARFLPDTD 362 (485)
Q Consensus 349 i~DFGla~~~~~~~ 362 (485)
|+|||+++.+..+.
T Consensus 652 iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 652 ISDFGLSKKLAGGK 665 (903)
T ss_pred ecccccccccCCCc
Confidence 99999999886554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=154.89 Aligned_cols=137 Identities=20% Similarity=0.156 Sum_probs=106.0
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc----------------------chHHHHHHHHHHHhcCCCc-
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----------------------GARSFKSECKAAINIRHRN- 252 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~----------------------~~~~f~~E~~~l~~l~H~n- 252 (485)
.++..+.||+|+||.||++...+|+.||||++...... ....+..|..++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 35667889999999999999878999999987542210 0113567888999998884
Q ss_pred -ceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 041230 253 -IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAH 331 (485)
Q Consensus 253 -iv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivH 331 (485)
+..+++. ...++||||+++++|...... .....++.+++.++.++| ..+|+|
T Consensus 96 ~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh---~~gi~H 148 (198)
T cd05144 96 PVPKPIDW---------NRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAY---KHGIIH 148 (198)
T ss_pred CCCceeec---------CCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHH---HCCCCc
Confidence 4444332 134899999999999765431 112458889999999999 688999
Q ss_pred eccCCCceEecCCCcEEEeecccccccC
Q 041230 332 CNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 332 rdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
|||||+||++++++.++|+|||++....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=177.98 Aligned_cols=79 Identities=34% Similarity=0.533 Sum_probs=72.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|||||..|++|+.+.++||+|||+|..+... ..-.+.||||-|+|||++....++..+||||+||++|.|+.|++||..
T Consensus 141 HRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 141 HRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 9999999999999999999999999877533 445679999999999999988899999999999999999999999964
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.8e-18 Score=170.70 Aligned_cols=162 Identities=18% Similarity=0.241 Sum_probs=125.9
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC---cc-----hHHHHHHHHHHHhcC---CCcceeEeeee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GG-----ARSFKSECKAAINIR---HRNIVRVFTAV 260 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~-----~~~f~~E~~~l~~l~---H~niv~l~~~~ 260 (485)
...+|+....+|+|+||.|..+... +..+|+||.+.+.+- .+ ....-.|+++|+.++ |+||++++.++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3446788889999999999999854 456899998864321 11 113456999999997 99999999986
Q ss_pred cccccCCceeeEEEEEec-CCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 261 SGVDYQGARFKAVVYKFM-PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 261 ~~~~~~~~~~~~lV~ey~-~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
.. +++.+|++|-. ++-+|.+++.-+. .++.+..--|..||+.|+++|| ..+|||||||-+||
T Consensus 639 Ed-----dd~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenv 701 (772)
T KOG1152|consen 639 ED-----DDYYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENV 701 (772)
T ss_pred ec-----CCeeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhcccccc---ccCceecccccccE
Confidence 53 45778999855 6779999997553 3555666679999999999999 78999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCcceeeecccc
Q 041230 340 LLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLN 372 (485)
Q Consensus 340 Lld~~~~~ki~DFGla~~~~~~~~~~~~~~~~~ 372 (485)
.+|.+|-+||.|||.|....... -+.|.|.++
T Consensus 702 ivd~~g~~klidfgsaa~~ksgp-fd~f~gtv~ 733 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKSGP-FDVFVGTVD 733 (772)
T ss_pred EEecCCeEEEeeccchhhhcCCC-cceeeeecc
Confidence 99999999999999887643322 245666554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=170.76 Aligned_cols=82 Identities=29% Similarity=0.450 Sum_probs=73.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|||||+.|||+..+|.+||+|||++..+..... ..+++|||+|||||++....|+.|+||||+|++.+||++|.+|+..
T Consensus 134 HrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 134 HRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred cccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 999999999999999999999999987765432 3678999999999999988999999999999999999999999876
Q ss_pred CCC
Q 041230 80 MFK 82 (485)
Q Consensus 80 ~~~ 82 (485)
..+
T Consensus 214 ~hP 216 (467)
T KOG0201|consen 214 LHP 216 (467)
T ss_pred cCc
Confidence 544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=158.21 Aligned_cols=141 Identities=16% Similarity=0.135 Sum_probs=106.3
Q ss_pred cccceeecccCceEEEEeE--eeCCcEEEEEEeeccCCc-------------------c-----hHHHHHHHHHHHhcCC
Q 041230 197 FSSANLIGAGNFGSVYNGT--LFDGTTIAVKVFNLIRPG-------------------G-----ARSFKSECKAAINIRH 250 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~--~~~~~~vavK~~~~~~~~-------------------~-----~~~f~~E~~~l~~l~H 250 (485)
|...+.||+|+||.||+|. ..+|+.||||+++..... . ...+..|.+.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5566789999999999998 578999999998643210 0 0235679999999976
Q ss_pred Cc--ceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCC
Q 041230 251 RN--IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPR 328 (485)
Q Consensus 251 ~n--iv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ 328 (485)
.+ +.+++++ ...++||||+++++|..++.... .+.......++.+++.+|.||| ..+
T Consensus 110 ~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 110 AGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred cCCCCCeeeEe---------cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 43 3344432 12479999999999876543211 2233445679999999999999 677
Q ss_pred -eeeeccCCCceEecCCCcEEEeecccccccC
Q 041230 329 -IAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 329 -ivHrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
|+||||||+||+++ ++.++|.|||++....
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999999 8899999999988643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=154.35 Aligned_cols=135 Identities=19% Similarity=0.268 Sum_probs=108.8
Q ss_pred eeecccCceEEEEeEeeCCcEEEEEEeeccCCc--------chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.||+|++|.||+|.. +|..|+||+....... ....+.+|+.++..++|+||.....++.. ....+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCCE
Confidence 4689999999999986 7788999976532211 12357789999999999998776655432 12468
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++++|.+++.... + .+..++.+++.+|.++| ..+++|||++|.|||++ ++.++|+||
T Consensus 76 lv~e~~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG------------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence 9999999999999886321 1 67889999999999999 67899999999999999 788999999
Q ss_pred cccccc
Q 041230 353 SMARFL 358 (485)
Q Consensus 353 Gla~~~ 358 (485)
|+++..
T Consensus 139 ~~a~~~ 144 (211)
T PRK14879 139 GLAEFS 144 (211)
T ss_pred CcccCC
Confidence 998763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-19 Score=165.20 Aligned_cols=151 Identities=23% Similarity=0.343 Sum_probs=114.1
Q ss_pred cccceeecccCceEEEEeE-eeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
....+-||-|+||.||..+ -++|+.||.|++...-. ...+.|.+|+.+|.-++|.|++..++...-....-.+..|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3456789999999999877 36799999998854322 23467888999999999999998876543221111234678
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
+.|.|.. +|+..+-+... ++-...--...||.+||.||| +-+|+||||||.|.|++.|...||+|||
T Consensus 135 ~TELmQS-DLHKIIVSPQ~---------Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFG 201 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQA---------LTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFG 201 (449)
T ss_pred HHHHHHh-hhhheeccCCC---------CCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccc
Confidence 8888864 78777765432 232222336789999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
++|.-..
T Consensus 202 LARvee~ 208 (449)
T KOG0664|consen 202 LARTWDQ 208 (449)
T ss_pred cccccch
Confidence 9997543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-18 Score=171.84 Aligned_cols=135 Identities=27% Similarity=0.408 Sum_probs=95.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 197 HrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~p 276 (338)
T cd05102 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276 (338)
T ss_pred CCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986533221 123346788999999988889999999999999999997 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+.. .+.+... ...... ....+..+...|++.+|..||++
T Consensus 277 f~~~~~~----~~~~~--------~~~~~~~-----------~~~~~~---------~~~~l~~li~~cl~~dp~~RPs~ 324 (338)
T cd05102 277 YPGVQIN----EEFCQ--------RLKDGTR-----------MRAPEN---------ATPEIYRIMLACWQGDPKERPTF 324 (338)
T ss_pred CCCCCcc----HHHHH--------HHhcCCC-----------CCCCCC---------CCHHHHHHHHHHccCChhhCcCH
Confidence 8653211 00000 0000000 000000 01134678899999999999999
Q ss_pred chhhHHHHHHh
Q 041230 157 NDVESRLRSIK 167 (485)
Q Consensus 157 ~~v~~~L~~i~ 167 (485)
.++.+.|+.+.
T Consensus 325 ~el~~~l~~~~ 335 (338)
T cd05102 325 SALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHHH
Confidence 99999887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.2e-18 Score=151.95 Aligned_cols=153 Identities=20% Similarity=0.295 Sum_probs=113.4
Q ss_pred cccccceeecccCceEEEEeE-eeCCcEEEEEEeeccC-CcchHHHHHHHHHHH-hcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAI-NIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+.......||+|+||.|-+-+ ..+|+..|||++...- .+..+..+.|+.+.. ....|.+|+++|... .....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----ccccE
Confidence 344455679999999986655 4689999999987433 233456677887654 457899999998642 23457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++.||.|.- ||+.+...--.. +......---+||..|..||.|||+ ...|||||+||+|||+|.++.+||+|
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcc
Confidence 899999964 887765421000 0122333345699999999999996 67899999999999999999999999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||.+..+.+
T Consensus 193 FGIsG~L~d 201 (282)
T KOG0984|consen 193 FGISGYLVD 201 (282)
T ss_pred cccceeehh
Confidence 999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-18 Score=172.79 Aligned_cols=127 Identities=27% Similarity=0.387 Sum_probs=94.5
Q ss_pred CCCCCCCcEEECCC-CcEEEEeccCcccc-CCCCceeecccccCcccccccCCCC-CC-CccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFL-PVETSFIDVMGTIGYVAPEYGMGSE-VS-SYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~-~~~kl~dfG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||||.+ +.+||+|||++... .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.|
T Consensus 143 HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 143 HRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred eCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 99999999999999 99999999999977 3445677899999999999999877 85 678999999999999999999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|+. .+.+.+....... .+ . ....+ + -..+..+..+|...+|..|+++
T Consensus 223 F~d-----~~~~~l~~ki~~~--------~~---------~---~p~~~-~-------S~~~~~Li~~mL~~~P~~R~t~ 269 (370)
T KOG0583|consen 223 FDD-----SNVPNLYRKIRKG--------EF---------K---IPSYL-L-------SPEARSLIEKMLVPDPSTRITL 269 (370)
T ss_pred CCC-----ccHHHHHHHHhcC--------Cc---------c---CCCCc-C-------CHHHHHHHHHHcCCCcccCCCH
Confidence 974 2223222221100 00 0 00000 0 1123456678899999999999
Q ss_pred chhh
Q 041230 157 NDVE 160 (485)
Q Consensus 157 ~~v~ 160 (485)
.++.
T Consensus 270 ~~i~ 273 (370)
T KOG0583|consen 270 LEIL 273 (370)
T ss_pred HHHh
Confidence 9886
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=175.96 Aligned_cols=140 Identities=16% Similarity=0.216 Sum_probs=108.8
Q ss_pred hhccccccceeecccCceEEEEeEeeCCcEEEEEEe-ecc-CC------cchHHHHHHHHHHHhcCCCcceeEeeeeccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVF-NLI-RP------GGARSFKSECKAAINIRHRNIVRVFTAVSGV 263 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~-~~~-~~------~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~ 263 (485)
.....|...+.||+|+||+||+|.+... .+++|+. ... .. ...+.+.+|++++.+++|+|++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3344556788999999999999986544 4444432 211 11 1124688999999999999998876665431
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
...++||||+++++|.+++. .+..++.+++.+|.||| ..+++||||||+|||+ .
T Consensus 409 -----~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~ 462 (535)
T PRK09605 409 -----EEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-R 462 (535)
T ss_pred -----CCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-E
Confidence 24589999999999998874 24568999999999999 6889999999999999 6
Q ss_pred CCcEEEeeccccccc
Q 041230 344 EMIGHVGDFSMARFL 358 (485)
Q Consensus 344 ~~~~ki~DFGla~~~ 358 (485)
++.++|+|||+++..
T Consensus 463 ~~~~~liDFGla~~~ 477 (535)
T PRK09605 463 DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCcEEEEeCcccccC
Confidence 788999999999874
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.7e-18 Score=156.37 Aligned_cols=78 Identities=35% Similarity=0.557 Sum_probs=71.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccC------CCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM------GSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||+|.+..+||+|||++..+..+......||||+|+|||.+. ...|+...|.|++||++|.++.|.
T Consensus 146 HRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 146 HRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred hcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999998888888899999999999753 235778899999999999999999
Q ss_pred CCCC
Q 041230 75 RPNN 78 (485)
Q Consensus 75 ~p~~ 78 (485)
+||-
T Consensus 226 pPFw 229 (411)
T KOG0599|consen 226 PPFW 229 (411)
T ss_pred Cchh
Confidence 9984
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-18 Score=166.57 Aligned_cols=137 Identities=22% Similarity=0.265 Sum_probs=94.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--------ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT 72 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~ 72 (485)
||||||+|||++.++.++|+|||+++.+.... ......||+.|+|||...+..++.++|||||||+++||++
T Consensus 149 HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 149 HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999998653211 1122469999999999988889999999999999999999
Q ss_pred CCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCc
Q 041230 73 GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDE 152 (485)
Q Consensus 73 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~ 152 (485)
|+.||.+..... ..+.... ..+...+..... ....| ...+.++...|+..+|++
T Consensus 229 g~~P~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~~~~~~~ 282 (294)
T PHA02882 229 IKLPWKGFGHNG----NLIHAAK---------CDFIKRLHEGKI----KIKNA---------NKFIYDFIECVTKLSYEE 282 (294)
T ss_pred CCCCCCccccch----HHHHHhH---------HHHHHHhhhhhh----ccCCC---------CHHHHHHHHHHHhCCCCC
Confidence 999997542111 1111000 001111110000 00011 123457888999999999
Q ss_pred ccccchhhHHH
Q 041230 153 RMDINDVESRL 163 (485)
Q Consensus 153 RP~m~~v~~~L 163 (485)
||++.++.+.+
T Consensus 283 rp~~~~l~~~~ 293 (294)
T PHA02882 283 KPDYDALIKIF 293 (294)
T ss_pred CCCHHHHHHhh
Confidence 99998887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=153.44 Aligned_cols=144 Identities=13% Similarity=0.090 Sum_probs=112.0
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchH---H------HHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGAR---S------FKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~---~------f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
.+.|...+++|+|+||.||.... ++..+|||.+........+ . |.+|++.+.++.|++|..+..+.....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 56788999999999999998654 5778999998643322222 2 578999999999999999877644221
Q ss_pred cC---CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe
Q 041230 265 YQ---GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341 (485)
Q Consensus 265 ~~---~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl 341 (485)
+. .....++||||+++.+|.++.. ++ .....+++.+|..+| ..+++|||+||+||++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~----~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili 168 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------------IS----EDVKAKIKASIESLH---QHGMVSGDPHKGNFIV 168 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------------cc----HHHHHHHHHHHHHHH---HcCCccCCCChHHEEE
Confidence 11 1234789999999999987732 11 124568999999999 7899999999999999
Q ss_pred cCCCcEEEeecccccccC
Q 041230 342 DDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 342 d~~~~~ki~DFGla~~~~ 359 (485)
++++ ++|.|||..+...
T Consensus 169 ~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred eCCC-EEEEECCCccccc
Confidence 9998 9999999887653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-17 Score=148.67 Aligned_cols=133 Identities=15% Similarity=0.075 Sum_probs=103.5
Q ss_pred ccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc---c-hHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeE
Q 041230 198 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG---G-ARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~---~-~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.....|++|+||+||...- .+..++.+.++....- . ...|.+|+++|.++. |+++.+++++. ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 4467899999999996653 6777877777643321 1 124789999999995 58899998751 258
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc-CCCceEecCCCcEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL-KPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl-K~~NILld~~~~~ki~D 351 (485)
++|||+.+.+|.+.+.. ....+..+++.+|.|+| ..+|+|||| ||+|||+++++.++|+|
T Consensus 75 lvmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LID 135 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVID 135 (218)
T ss_pred EEEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEE
Confidence 99999999999754321 01346788999999999 789999999 79999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+|....
T Consensus 136 FG~A~~~~ 143 (218)
T PRK12274 136 FQLAVRGN 143 (218)
T ss_pred CCCceecC
Confidence 99998543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=151.47 Aligned_cols=131 Identities=18% Similarity=0.255 Sum_probs=103.1
Q ss_pred eecccCceEEEEeEeeCCcEEEEEEeeccCC--c------chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--G------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 202 ~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+||+|+||.||+|. .+|..|++|....... . ....+.+|++++..++|+++.....++.. ....++
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKTI 74 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCEE
Confidence 48999999999998 4678899998643211 1 12457789999999998876544333322 123589
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++++|.+++.... ..++.+++.+|.+|| ..+++|||++|.||+++ ++.+++.|||
T Consensus 75 v~e~~~g~~l~~~~~~~~----------------~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN----------------DELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred EEEEECCccHHHHHhhcH----------------HHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence 999999999998875321 068999999999999 78999999999999999 8899999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+++..
T Consensus 135 ~a~~~ 139 (199)
T TIGR03724 135 LGKYS 139 (199)
T ss_pred CCcCC
Confidence 98764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-18 Score=163.28 Aligned_cols=157 Identities=23% Similarity=0.247 Sum_probs=120.2
Q ss_pred ccCccchhhhccccccceeecccCceEEEEeEeeC-CcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEee
Q 041230 184 NLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFT 258 (485)
Q Consensus 184 ~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~ 258 (485)
..+-.+...+| +|+...+||+|+||+|..+.-.. ...+|||++++.- ....+--+.|-++|+-. +-|.+|.|..
T Consensus 339 ~~~~~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 339 NSSKRDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred CCCcccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 33444444444 68888999999999999987433 3468999997532 22333345566666654 5678888865
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
+ ++..+-.|.||||+.+|+|--+++.-+ .|-.+..+-+|.+||-||-||| +.+||.||||-.|
T Consensus 418 c-----FQTmDRLyFVMEyvnGGDLMyhiQQ~G---------kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDN 480 (683)
T KOG0696|consen 418 C-----FQTMDRLYFVMEYVNGGDLMYHIQQVG---------KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDN 480 (683)
T ss_pred H-----hhhhhheeeEEEEecCchhhhHHHHhc---------ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccc
Confidence 5 444456899999999999998887543 3444566779999999999999 7899999999999
Q ss_pred eEecCCCcEEEeeccccccc
Q 041230 339 VLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 339 ILld~~~~~ki~DFGla~~~ 358 (485)
||||.++++||+|||+.+.-
T Consensus 481 vmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEeccCCceEeeeccccccc
Confidence 99999999999999999863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-18 Score=171.32 Aligned_cols=139 Identities=28% Similarity=0.396 Sum_probs=97.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC---CCceeecccccCcccccccCCC---CCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV---ETSFIDVMGTIGYVAPEYGMGS---EVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
|||||+.||+|.+++.+||+|||++..-.. ........|...|||||+++.. +|+..+||||||||+|||++|.
T Consensus 511 HrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 511 HRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred hhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 999999999999999999999999864322 2233456789999999998643 6889999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.|+.....+. +-.+.... .+.++. -+... .|-..+.+|...||..++++||
T Consensus 591 lPysi~~~dq------IifmVGrG---~l~pd~-----------s~~~s---------~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 591 LPYSIQNRDQ------IIFMVGRG---YLMPDL-----------SKIRS---------NCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred CCcCCCChhh------eEEEeccc---ccCccc-----------hhhhc---------cCHHHHHHHHHHHHhcCcccCc
Confidence 9986321111 00000000 000000 00111 2233456788999999999999
Q ss_pred ccchhhHHHHHHhh
Q 041230 155 DINDVESRLRSIKM 168 (485)
Q Consensus 155 ~m~~v~~~L~~i~~ 168 (485)
.+.++...+..+..
T Consensus 642 ~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 642 LFPQLLSKLEELLP 655 (678)
T ss_pred cHHHHHHHHHHhhh
Confidence 99999987766554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-18 Score=170.21 Aligned_cols=79 Identities=35% Similarity=0.587 Sum_probs=73.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|||+||.||||+..+++|++|||+|+....++. .....|||.|||||...+..|+..+|.||+||++||+.+|++||..
T Consensus 123 hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 123 HRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred cccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 899999999999999999999999998877654 4567899999999999999999999999999999999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-17 Score=168.09 Aligned_cols=78 Identities=29% Similarity=0.446 Sum_probs=71.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
|||||++||||+.++.+||+|||++..+.... ...+.+|||+|||||+.....|+.+.||||+|++++||+-|.+||-
T Consensus 392 HrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 392 HRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred eeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 99999999999999999999999998776443 4567899999999999999999999999999999999999999984
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=164.28 Aligned_cols=80 Identities=33% Similarity=0.495 Sum_probs=70.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||......++.++|||||||++|||++|+.||.+.
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 133 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred eCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 99999999999999999999999998665443334567999999999988888899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-18 Score=156.87 Aligned_cols=79 Identities=38% Similarity=0.430 Sum_probs=67.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCC--CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS--EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
|||+||+||||+..|.+||||||++..+...-..+.-.|...|||||.+... .|+-++||||+|+.|||+.||.-|+.
T Consensus 191 HRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 191 HRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred hccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 9999999999999999999999999876544333344688999999987533 47889999999999999999999975
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 271 ~ 271 (361)
T KOG1006|consen 271 K 271 (361)
T ss_pred h
Confidence 3
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-17 Score=161.50 Aligned_cols=81 Identities=32% Similarity=0.447 Sum_probs=68.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-Cc----eeecccccCcccccccC--CCCCCCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TS----FIDVMGTIGYVAPEYGM--GSEVSSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~----~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~~G 73 (485)
|||||+.||||+.+|.+||+|||++-.+..+ .. ..+++||++|||||++. ...|+.|+||||||+...|+.+|
T Consensus 149 HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G 228 (516)
T KOG0582|consen 149 HRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG 228 (516)
T ss_pred ecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence 9999999999999999999999988755332 21 24578999999999843 34689999999999999999999
Q ss_pred CCCCCCCC
Q 041230 74 LRPNNGMF 81 (485)
Q Consensus 74 ~~p~~~~~ 81 (485)
..||....
T Consensus 229 ~aPf~k~p 236 (516)
T KOG0582|consen 229 HAPFSKYP 236 (516)
T ss_pred CCCcccCC
Confidence 99997654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.9e-18 Score=173.23 Aligned_cols=150 Identities=24% Similarity=0.337 Sum_probs=126.8
Q ss_pred hccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
..++|.....+|+|.||.|||++ ...++..|||+++........-.++|+-++..-+|+|||.++|.+.. .+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCc
Confidence 34567777899999999999998 45688999999987766666777889999999999999999887543 3457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++.||||-+|+|.+..|..+ .++..+...++....+||.||| +.+-+|||||-.||||.+.+.+|++|
T Consensus 88 wicMEycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEEecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecc
Confidence 99999999999999988754 3455555667889999999999 67779999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||.+..+.
T Consensus 156 fgvsaqit 163 (829)
T KOG0576|consen 156 FGVSAQIT 163 (829)
T ss_pred cCchhhhh
Confidence 99987653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.7e-18 Score=166.87 Aligned_cols=79 Identities=38% Similarity=0.629 Sum_probs=66.2
Q ss_pred CCCCCCCcEEECC-CCcEEEEeccCccccCC----CCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDD-EMTAHLGDFGIARFLPV----ETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~-~~~~kl~dfG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++. ++.+||+|||+++.... ........||+.|||||++..+ .....+||||+||++.||+||+
T Consensus 140 H~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~ 219 (313)
T KOG0198|consen 140 HCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGK 219 (313)
T ss_pred ccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCC
Confidence 9999999999999 79999999999986553 1123357899999999998853 2335899999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.|+..
T Consensus 220 ~PW~~ 224 (313)
T KOG0198|consen 220 PPWSE 224 (313)
T ss_pred Ccchh
Confidence 99864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.2e-17 Score=161.01 Aligned_cols=80 Identities=33% Similarity=0.518 Sum_probs=71.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 125 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998765444344567999999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4e-17 Score=161.76 Aligned_cols=80 Identities=28% Similarity=0.421 Sum_probs=71.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCccccccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG-MGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|||+||+|||+..+..+||+|||+||.......++..+.|.+|.|||++ +++-|+.+.|+|++||+++|+.+-++-|.|
T Consensus 133 HRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 133 HRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred cccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 9999999999999999999999999987766677788999999999985 456789999999999999999998877766
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 213 ~ 213 (538)
T KOG0661|consen 213 A 213 (538)
T ss_pred C
Confidence 4
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-17 Score=162.01 Aligned_cols=132 Identities=25% Similarity=0.517 Sum_probs=95.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+||+++.++.+||+|||+++...... ......+++.|+|||+.....++.++|||||||++|||++ |..|
T Consensus 147 H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p 226 (283)
T cd05048 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226 (283)
T ss_pred ccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999997543221 1223456889999999888889999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+... ..+... +..... ..... .+...+..+...|++.+|.+||++
T Consensus 227 ~~~~~~-----~~~~~~--------i~~~~~-----------~~~~~---------~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 227 YYGFSN-----QEVIEM--------IRSRQL-----------LPCPE---------DCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred CCCCCH-----HHHHHH--------HHcCCc-----------CCCcc---------cCCHHHHHHHHHHccCChhhCcCH
Confidence 865321 111100 000000 00000 112235678899999999999999
Q ss_pred chhhHHHHH
Q 041230 157 NDVESRLRS 165 (485)
Q Consensus 157 ~~v~~~L~~ 165 (485)
.++.+.|++
T Consensus 274 ~~i~~~l~~ 282 (283)
T cd05048 274 KDIHTRLRS 282 (283)
T ss_pred HHHHHHHhc
Confidence 999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-17 Score=166.99 Aligned_cols=134 Identities=27% Similarity=0.435 Sum_probs=94.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++........ ....++..|+|||+.....++.++|||||||++|||++ |+.|
T Consensus 235 HrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~P 314 (374)
T cd05106 235 HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314 (374)
T ss_pred eccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999865433211 12335678999999888889999999999999999997 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|....... .+...+. .. ........ . ...+..+...|++.+|.+||++
T Consensus 315 f~~~~~~~-~~~~~~~------------~~-----------~~~~~~~~-----~---~~~l~~li~~cl~~dp~~RPs~ 362 (374)
T cd05106 315 YPGILVNS-KFYKMVK------------RG-----------YQMSRPDF-----A---PPEIYSIMKMCWNLEPTERPTF 362 (374)
T ss_pred CccccccH-HHHHHHH------------cc-----------cCccCCCC-----C---CHHHHHHHHHHcCCChhhCcCH
Confidence 86432110 0000000 00 00000000 0 1124567889999999999999
Q ss_pred chhhHHHHHH
Q 041230 157 NDVESRLRSI 166 (485)
Q Consensus 157 ~~v~~~L~~i 166 (485)
.++.+.++++
T Consensus 363 ~~l~~~l~~~ 372 (374)
T cd05106 363 SQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHH
Confidence 9999888764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8e-18 Score=150.21 Aligned_cols=80 Identities=31% Similarity=0.410 Sum_probs=67.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC----CCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG----SEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
|||+||+||||+.+|.+|+||||++..+......+--.|...|||||.+.. ..|+-++||||+|+.+.||.+++.|
T Consensus 172 HRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 172 HRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred hccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence 999999999999999999999999987754432222468889999998643 3688999999999999999999999
Q ss_pred CCCC
Q 041230 77 NNGM 80 (485)
Q Consensus 77 ~~~~ 80 (485)
++.-
T Consensus 252 Y~~w 255 (282)
T KOG0984|consen 252 YESW 255 (282)
T ss_pred cccc
Confidence 8653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-17 Score=156.41 Aligned_cols=124 Identities=28% Similarity=0.426 Sum_probs=96.7
Q ss_pred CCCCCCcEEECCCCcEEEEeccCcccc-CCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 2 CDLKPSNVFLDDEMTAHLGDFGIARFL-PVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 2 rDlk~~NiLl~~~~~~kl~dfG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||.+|+|||.+|++||+|||+++-- ..+....++||||.|+|||++....|+...|+|.+||++|||++|+.||...
T Consensus 292 RDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 292 RDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred eechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 899999999999999999999999843 3344566799999999999999999999999999999999999999999753
Q ss_pred CCC---------CCChhH--------HHhhhc-----------hhhHHhhhchhhhhhhHHHHHHHhhhhccc
Q 041230 81 FKD---------DLNLPN--------LVKSAL-----------PARAEQILDVAFFQEIEEEETLYKKASSTC 125 (485)
Q Consensus 81 ~~~---------~~~~~~--------~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 125 (485)
..+ +..+|. ++...+ +..+.++..++|+..++|+.+..+++.+..
T Consensus 372 dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred chhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 221 111111 111111 335678888889999999988887765543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.3e-18 Score=168.11 Aligned_cols=157 Identities=23% Similarity=0.306 Sum_probs=125.2
Q ss_pred ccccceeecccCceEEEEeEeeCCc-EEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGT-TIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~-~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++.....||-|+||.|-.....+.. .+|+|++++. .....+....|-.+|...+.|.||+|+.. |.++++.
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhh
Confidence 4445567999999999887754433 3788887643 23345667889999999999999999865 4456788
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
|+.||-|-+|.|...|+.++. |+..+..-++..|..|++||| +++||+|||||+|.+||.+|-+||-|
T Consensus 496 YmLmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEee
Confidence 999999999999999997653 344444558899999999999 78999999999999999999999999
Q ss_pred cccccccCCCCcceeeec
Q 041230 352 FSMARFLPDTDEQTRFIG 369 (485)
Q Consensus 352 FGla~~~~~~~~~~~~~~ 369 (485)
||+|+.+......-.|.|
T Consensus 564 FGFAKki~~g~KTwTFcG 581 (732)
T KOG0614|consen 564 FGFAKKIGSGRKTWTFCG 581 (732)
T ss_pred hhhHHHhccCCceeeecC
Confidence 999999866544333443
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.5e-17 Score=164.09 Aligned_cols=135 Identities=25% Similarity=0.385 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++.+..... .....++..|+|||++.+..++.++|||||||++||+++ |..|
T Consensus 196 HrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p 275 (337)
T cd05054 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275 (337)
T ss_pred cCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986543221 123456778999999988889999999999999999998 9989
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+....+ .....+... . ...... .....+.+++.+|++.+|++||++
T Consensus 276 ~~~~~~~~-----~~~~~~~~~----~----------------~~~~~~-------~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 276 YPGVQIDE-----EFCRRLKEG----T----------------RMRAPE-------YATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred CCCCCccH-----HHHHHHhcc----C----------------CCCCCc-------cCCHHHHHHHHHHccCChhhCcCH
Confidence 86422110 000000000 0 000000 011235678899999999999999
Q ss_pred chhhHHHHHHh
Q 041230 157 NDVESRLRSIK 167 (485)
Q Consensus 157 ~~v~~~L~~i~ 167 (485)
.++.+.|+.+.
T Consensus 324 ~ell~~l~~~~ 334 (337)
T cd05054 324 SELVEILGDLL 334 (337)
T ss_pred HHHHHHHHHHH
Confidence 99998887643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-17 Score=166.40 Aligned_cols=129 Identities=26% Similarity=0.321 Sum_probs=99.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|||||+.||+++.+..+||+|||+|+.+.... ...+..||+.||+||.+.+.+|..|+|+||+||++|||++-+++|.+
T Consensus 129 HRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 129 HRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred cccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 99999999999999999999999999887655 44568899999999999999999999999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.++..++....+.. .+ +.....+. .+..+...|++.+|+.||+..++
T Consensus 209 -----~~m~~Li~ki~~~~----~~------------------Plp~~ys~------el~~lv~~~l~~~P~~RPsa~~L 255 (426)
T KOG0589|consen 209 -----SNMSELILKINRGL----YS------------------PLPSMYSS------ELRSLVKSMLRKNPEHRPSALEL 255 (426)
T ss_pred -----cchHHHHHHHhhcc----CC------------------CCCccccH------HHHHHHHHHhhcCCccCCCHHHH
Confidence 34444444333211 00 00011111 22345668899999999999887
Q ss_pred hHH
Q 041230 160 ESR 162 (485)
Q Consensus 160 ~~~ 162 (485)
...
T Consensus 256 L~~ 258 (426)
T KOG0589|consen 256 LRR 258 (426)
T ss_pred hhC
Confidence 655
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.8e-17 Score=163.00 Aligned_cols=79 Identities=32% Similarity=0.378 Sum_probs=70.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||...+..++.++|+|||||++|+|++|+.||.+
T Consensus 142 HrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999865444333456799999999999888899999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.7e-17 Score=149.76 Aligned_cols=148 Identities=19% Similarity=0.321 Sum_probs=114.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.+.|.....+|+|.||.+-.+.. .+.+.+++|.+... ....++|.+|...--.| .|.|||.-+.. -++..++.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v----aFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV----AFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH----HhhcCceE
Confidence 34677788999999999999875 34678999987532 23457899998765555 68999976543 24555677
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec--CCCcEEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD--DEMIGHV 349 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld--~~~~~ki 349 (485)
..++||+|.|+|.+-+...+ +.....-+|+.|++.|+.|+| +..+||||||.+|||+- +...+|+
T Consensus 98 vF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEe
Confidence 89999999999998876533 223344568999999999999 78999999999999993 3458999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 165 cDFG~t~k~g 174 (378)
T KOG1345|consen 165 CDFGLTRKVG 174 (378)
T ss_pred eecccccccC
Confidence 9999987643
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-17 Score=162.31 Aligned_cols=79 Identities=35% Similarity=0.537 Sum_probs=73.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
.|||||+|||||..|+++|+|+|+|--++.+......+||.+|||||++....|+...|+||+||++|||+.|+.||..
T Consensus 310 YRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 310 YRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 3899999999999999999999999988877777677999999999999999999999999999999999999999853
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4e-17 Score=172.65 Aligned_cols=128 Identities=27% Similarity=0.390 Sum_probs=92.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC---CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++.+... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999865432 1223468999999999998888999999999999999999999998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+. +...++...+.. . +......+ ...+..+...|++.+|..||++.
T Consensus 246 ~~~-----~~~~~~~~~~~~--------~-----------~~~~~~~~---------~~~l~~li~~~L~~dP~~RPs~~ 292 (496)
T PTZ00283 246 DGE-----NMEEVMHKTLAG--------R-----------YDPLPPSI---------SPEMQEIVTALLSSDPKRRPSSS 292 (496)
T ss_pred CCC-----CHHHHHHHHhcC--------C-----------CCCCCCCC---------CHHHHHHHHHHcccChhhCcCHH
Confidence 642 111111111000 0 00000000 11245677899999999999998
Q ss_pred hhhH
Q 041230 158 DVES 161 (485)
Q Consensus 158 ~v~~ 161 (485)
++..
T Consensus 293 ell~ 296 (496)
T PTZ00283 293 KLLN 296 (496)
T ss_pred HHHh
Confidence 8754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.67 E-value=7e-17 Score=164.36 Aligned_cols=80 Identities=33% Similarity=0.402 Sum_probs=70.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 149 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred cCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998654433334567899999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.2e-17 Score=160.37 Aligned_cols=138 Identities=20% Similarity=0.322 Sum_probs=92.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhC--CC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTG--LR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G--~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....++..|+|||+.....++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986533221 1234567889999998888899999999999999999974 45
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
|+.... ........ .+.+... . ..........| ...+.++..+|++.+|..||+
T Consensus 241 p~~~~~-----~~~~~~~~-----~~~~~~~-----~--~~~~~~~~~~~---------~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 241 PYGELT-----DEQVIENA-----GEFFRDQ-----G--RQVYLFRPPPC---------PQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred CCCcCC-----HHHHHHHH-----HHHhhhc-----c--ccccccCCCCC---------CHHHHHHHHHHccCCchhCcC
Confidence 654321 11111000 0000000 0 00000000111 124567889999999999999
Q ss_pred cchhhHHHH
Q 041230 156 INDVESRLR 164 (485)
Q Consensus 156 m~~v~~~L~ 164 (485)
+.++...++
T Consensus 295 ~~~i~~~l~ 303 (304)
T cd05096 295 FSDIHAFLT 303 (304)
T ss_pred HHHHHHHHh
Confidence 999987764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.6e-17 Score=158.74 Aligned_cols=131 Identities=27% Similarity=0.477 Sum_probs=93.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....+++.|+|||...+..++.++|||||||++|||++ |..|
T Consensus 147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 226 (283)
T cd05091 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226 (283)
T ss_pred ccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999886533221 123446789999999888888999999999999999998 7777
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+.. ...+.. .+.+... ..... .+...+..+...|++.+|.+||++
T Consensus 227 ~~~~~-----~~~~~~--------~i~~~~~-----------~~~~~---------~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 227 YCGYS-----NQDVIE--------MIRNRQV-----------LPCPD---------DCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred CCCCC-----HHHHHH--------HHHcCCc-----------CCCCC---------CCCHHHHHHHHHHhCCCcccCCCH
Confidence 75421 111111 0100000 00000 112235678899999999999999
Q ss_pred chhhHHHH
Q 041230 157 NDVESRLR 164 (485)
Q Consensus 157 ~~v~~~L~ 164 (485)
.++.+.++
T Consensus 274 ~~i~~~l~ 281 (283)
T cd05091 274 KDIHSRLR 281 (283)
T ss_pred HHHHHHhh
Confidence 99988875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.7e-17 Score=163.00 Aligned_cols=80 Identities=31% Similarity=0.403 Sum_probs=70.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||.+.+..++.++||||+||++|+|++|+.||.+.
T Consensus 146 HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998654433334567899999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.67 E-value=9.3e-17 Score=157.15 Aligned_cols=135 Identities=21% Similarity=0.398 Sum_probs=96.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......|+..|++||...+..++.++||||||+++||+++ |+.|
T Consensus 132 H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998654322 1223457788999999988889999999999999999998 9989
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+.... ...+++.... .......| ...+..+..+|+..+|..||++
T Consensus 212 ~~~~~~~--~~~~~~~~~~----------------------~~~~~~~~---------~~~~~~li~~c~~~~p~~Rps~ 258 (279)
T cd05111 212 YAGMRPH--EVPDLLEKGE----------------------RLAQPQIC---------TIDVYMVMVKCWMIDENVRPTF 258 (279)
T ss_pred CCCCCHH--HHHHHHHCCC----------------------cCCCCCCC---------CHHHHHHHHHHcCCCcccCcCH
Confidence 8643210 0111110000 00000001 1224567789999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.+..+..
T Consensus 259 ~el~~~l~~~~~ 270 (279)
T cd05111 259 KELANEFTRMAR 270 (279)
T ss_pred HHHHHHHHHHHh
Confidence 999888766544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-17 Score=172.14 Aligned_cols=135 Identities=24% Similarity=0.493 Sum_probs=100.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCcccc-CCC--CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL-PVE--TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~-~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||-..|+|+.++..+||+|||+++-. +.+ .......-...||+||.+..++|+.++|||||||+|||+++ |+.|
T Consensus 626 HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QP 705 (774)
T KOG1026|consen 626 HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQP 705 (774)
T ss_pred ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCc
Confidence 9999999999999999999999999843 211 11112334678999999999999999999999999999998 8889
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+...++ .+ +.+-+.. + ..|. ..|...+..|+..||+..|.+||++
T Consensus 706 y~glSn~E-----VI--------e~i~~g~--------------l-L~~P-----e~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 706 YYGLSNQE-----VI--------ECIRAGQ--------------L-LSCP-----ENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred ccccchHH-----HH--------HHHHcCC--------------c-ccCC-----CCCCHHHHHHHHHHhhcCcccCCCH
Confidence 87643221 11 1110000 0 1111 1244567899999999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
+++..+|+....
T Consensus 753 ~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 753 KEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHHHHHh
Confidence 999999987544
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.7e-17 Score=161.54 Aligned_cols=79 Identities=33% Similarity=0.478 Sum_probs=67.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC----ceeecccccCcccccccCC--CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGMG--SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 126 H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~ 205 (338)
T cd07859 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205 (338)
T ss_pred cCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999998543211 1234579999999998765 56788999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 206 ~pf~~ 210 (338)
T cd07859 206 PLFPG 210 (338)
T ss_pred CCCCC
Confidence 99865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-16 Score=144.37 Aligned_cols=136 Identities=22% Similarity=0.241 Sum_probs=90.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
|..-||+|||++.++.+|+ ||+++...... ..||+.|||||++.+..++.++|||||||++|||++|+.|+...
T Consensus 34 H~~~kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 34 HRQAKSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred HhcCCcccEeEcCccceee--ccceEeecccc----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 4444999999999999999 99988654322 36899999999999989999999999999999999999998542
Q ss_pred CCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchhh
Q 041230 81 FKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVE 160 (485)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v~ 160 (485)
.. ....+..... ..... ................+.++..+|+..+|..||++.++.
T Consensus 108 ~~----~~~~~~~~~~----~~~~~----------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll 163 (176)
T smart00750 108 RE----LSAILEILLN----GMPAD----------------DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYL 163 (176)
T ss_pred ch----hcHHHHHHHH----HhccC----------------CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHH
Confidence 21 1111111000 00000 000000000001112356788999999999999999987
Q ss_pred HHHHHH
Q 041230 161 SRLRSI 166 (485)
Q Consensus 161 ~~L~~i 166 (485)
..+...
T Consensus 164 ~~~~~~ 169 (176)
T smart00750 164 AHCRAL 169 (176)
T ss_pred HHHHHH
Confidence 765443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-17 Score=163.95 Aligned_cols=80 Identities=31% Similarity=0.512 Sum_probs=68.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-------------------------CC---ce------------------
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-------------------------ET---SF------------------ 34 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-------------------------~~---~~------------------ 34 (485)
||||||+|+|||..|++||+||||+.-+.. .. ..
T Consensus 264 HRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~ 343 (550)
T KOG0605|consen 264 HRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQ 343 (550)
T ss_pred cccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhh
Confidence 999999999999999999999999853210 00 00
Q ss_pred --eecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 35 --IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 35 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
.+.+|||-|||||++.+..|+..+|+||+||++|||+.|.+||.+.
T Consensus 344 ~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 344 LAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred hhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 0257999999999999999999999999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.4e-17 Score=169.35 Aligned_cols=78 Identities=26% Similarity=0.368 Sum_probs=66.9
Q ss_pred CCCCCCCcEEECCCC----------------cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHH
Q 041230 1 HCDLKPSNVFLDDEM----------------TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFG 64 (485)
Q Consensus 1 HrDlk~~NiLl~~~~----------------~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G 64 (485)
||||||+|||++.++ .+||+|||.+..... .....+||+.|+|||++.+..++.++||||||
T Consensus 255 HrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlG 332 (467)
T PTZ00284 255 HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332 (467)
T ss_pred cCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHH
Confidence 999999999998765 499999998764322 22356899999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 041230 65 ILLLEMFTGLRPNNGM 80 (485)
Q Consensus 65 v~l~el~~G~~p~~~~ 80 (485)
|++|||++|+.||.+.
T Consensus 333 vil~elltG~~pf~~~ 348 (467)
T PTZ00284 333 CIIYELYTGKLLYDTH 348 (467)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.4e-17 Score=158.22 Aligned_cols=80 Identities=30% Similarity=0.454 Sum_probs=69.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+||+++.++.+||+|||+++...... ......|++.|+|||+..+..++.++|+|||||++|||++|+.||.
T Consensus 123 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred cCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998754322 2234578999999999988889999999999999999999999987
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 203 ~~ 204 (287)
T cd07848 203 GE 204 (287)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=160.82 Aligned_cols=78 Identities=32% Similarity=0.491 Sum_probs=68.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ......|++.|+|||+..+..++.++|+|||||++|||++|+.||..
T Consensus 127 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred cCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999765332 22345799999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=159.52 Aligned_cols=135 Identities=23% Similarity=0.360 Sum_probs=95.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCcee---ecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++......... ...++..|++||+.....++.++||||||+++||+++ |+.|
T Consensus 132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p 211 (316)
T cd05108 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211 (316)
T ss_pred ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998765332211 2234678999999988889999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+.. ...+ ..++.... ....... +...+..+...|+..+|+.||++
T Consensus 212 ~~~~~-----~~~~---------~~~~~~~~----------~~~~~~~---------~~~~~~~li~~cl~~~p~~Rps~ 258 (316)
T cd05108 212 YDGIP-----ASEI---------SSILEKGE----------RLPQPPI---------CTIDVYMIMVKCWMIDADSRPKF 258 (316)
T ss_pred CCCCC-----HHHH---------HHHHhCCC----------CCCCCCC---------CCHHHHHHHHHHccCChhhCcCH
Confidence 86421 1110 00000000 0000001 11235678899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...+..+..
T Consensus 259 ~~l~~~l~~~~~ 270 (316)
T cd05108 259 RELIIEFSKMAR 270 (316)
T ss_pred HHHHHHHHHHHc
Confidence 999888766544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-16 Score=159.23 Aligned_cols=79 Identities=35% Similarity=0.529 Sum_probs=69.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||...+..++.++||||+||++|||++|+.||.+
T Consensus 116 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred eCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 9999999999999999999999999854322 223346799999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7e-17 Score=176.33 Aligned_cols=139 Identities=26% Similarity=0.415 Sum_probs=100.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||-..|+||+....+||+|||+|+-+-..... ....-...|||||.+..+.++.|+|||||||++||++| |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999943221111 11233468999999999999999999999999999998 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+....+ ++...+... .++ ....| -..+.+++..||+.+|++||++
T Consensus 905 Y~~~~n~~-----v~~~~~~gg---RL~----------------~P~~C---------P~~ly~lM~~CW~~~pe~RP~F 951 (1025)
T KOG1095|consen 905 YPSRSNFE-----VLLDVLEGG---RLD----------------PPSYC---------PEKLYQLMLQCWKHDPEDRPSF 951 (1025)
T ss_pred CCCcchHH-----HHHHHHhCC---ccC----------------CCCCC---------ChHHHHHHHHHccCChhhCccH
Confidence 86542211 111000000 111 11223 3346789999999999999999
Q ss_pred chhhHHHHHHhhhhcc
Q 041230 157 NDVESRLRSIKMKLLK 172 (485)
Q Consensus 157 ~~v~~~L~~i~~~~~~ 172 (485)
..+..++..+......
T Consensus 952 ~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 952 RTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHHhhhhhhhhhhcc
Confidence 9999988777665443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-16 Score=156.57 Aligned_cols=148 Identities=23% Similarity=0.333 Sum_probs=96.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....++..|+|||......++.++||||||++++||++|..|
T Consensus 130 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p 209 (283)
T cd05080 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209 (283)
T ss_pred ccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986543221 1123456779999998888889999999999999999999998
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+...... +......... ......+.+. ........+.. .....+..+...|++.+|..||++
T Consensus 210 ~~~~~~~---~~~~~~~~~~----~~~~~~~~~~------~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~ 271 (283)
T cd05080 210 KQSPPKK---FEEMIGPKQG----QMTVVRLIEL------LERGMRLPCPK-----NCPQEVYILMKNCWETEAKFRPTF 271 (283)
T ss_pred CCCCcch---hhhhhccccc----ccchhhhhhh------hhcCCCCCCCC-----CCCHHHHHHHHHHhccChhhCCCH
Confidence 7532111 1111110000 0000000000 00000000000 112245678999999999999999
Q ss_pred chhhHHHHHH
Q 041230 157 NDVESRLRSI 166 (485)
Q Consensus 157 ~~v~~~L~~i 166 (485)
.++...++++
T Consensus 272 ~~i~~~l~~~ 281 (283)
T cd05080 272 RSLIPILKEM 281 (283)
T ss_pred HHHHHHHHHh
Confidence 9999888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-16 Score=154.93 Aligned_cols=80 Identities=29% Similarity=0.485 Sum_probs=75.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|||||.+|||||.++++||+|||++.++....-+.++||+|.|.+||++.+.+| ++..|.||+||+||.|+.|..||+|
T Consensus 176 HRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 176 HRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 999999999999999999999999998887777788999999999999999988 5789999999999999999999987
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 256 ~ 256 (668)
T KOG0611|consen 256 R 256 (668)
T ss_pred c
Confidence 3
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-17 Score=168.51 Aligned_cols=80 Identities=33% Similarity=0.488 Sum_probs=67.9
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++ .+||+|||+++.+..........||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 193 HrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 193 HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred cCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999665 6999999999876544434456789999999987654 68899999999999999999999987
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 273 ~~ 274 (440)
T PTZ00036 273 GQ 274 (440)
T ss_pred CC
Confidence 53
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.8e-16 Score=162.14 Aligned_cols=133 Identities=25% Similarity=0.431 Sum_probs=93.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++........ ....++..|+|||...+..++.++|||||||++|||++ |..|
T Consensus 237 H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p 316 (375)
T cd05104 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316 (375)
T ss_pred ccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999865432211 12345678999999988889999999999999999998 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|....... .+... +...+ ........ ...+.++...|++.+|++||++
T Consensus 317 ~~~~~~~~-~~~~~------------~~~~~-----------~~~~~~~~--------~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 317 YPGMPVDS-KFYKM------------IKEGY-----------RMLSPECA--------PSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred CCCCCchH-HHHHH------------HHhCc-----------cCCCCCCC--------CHHHHHHHHHHccCChhHCcCH
Confidence 75432110 00000 00000 00000000 1134578889999999999999
Q ss_pred chhhHHHHH
Q 041230 157 NDVESRLRS 165 (485)
Q Consensus 157 ~~v~~~L~~ 165 (485)
.++.+.+++
T Consensus 365 ~eil~~l~~ 373 (375)
T cd05104 365 KQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHh
Confidence 999988764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.2e-17 Score=160.63 Aligned_cols=81 Identities=35% Similarity=0.482 Sum_probs=75.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
.|||||+|.|||.+|.+||.|||+|+.+..+....++||||.|.|||++....++..+|.||+|+++|||++|.+||.+.
T Consensus 543 YRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 543 YRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred eccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 38999999999999999999999999988777777899999999999999999999999999999999999999999875
Q ss_pred C
Q 041230 81 F 81 (485)
Q Consensus 81 ~ 81 (485)
.
T Consensus 623 d 623 (732)
T KOG0614|consen 623 D 623 (732)
T ss_pred c
Confidence 3
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.4e-17 Score=147.45 Aligned_cols=135 Identities=28% Similarity=0.373 Sum_probs=95.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--c--------eeecccccCcccccccC---CCCCCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--S--------FIDVMGTIGYVAPEYGM---GSEVSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l 67 (485)
||||||.|||+..++.+++.|||-+...+... . ...-..|..|.|||.+. +...+.++|||||||++
T Consensus 152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 99999999999999999999999887543211 0 01134689999999864 34568899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 68 LEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 68 ~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|+|+.|..||+.....+.++.-.+... ++ .+.+ .+. -...++++...|.+
T Consensus 232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~------q~---s~P~------------------~~~---yse~l~~lik~mlq 281 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSLALAVQNA------QI---SIPN------------------SSR---YSEALHQLIKSMLQ 281 (302)
T ss_pred HHHHHcCCcchHHhhcCCeEEEeeecc------cc---ccCC------------------CCC---ccHHHHHHHHHHhc
Confidence 999999999987655444432111110 00 0000 000 01234677788999
Q ss_pred cCCCcccccchhhHHHHH
Q 041230 148 ELPDERMDINDVESRLRS 165 (485)
Q Consensus 148 ~~p~~RP~m~~v~~~L~~ 165 (485)
.+|.+||++.++...+..
T Consensus 282 vdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 282 VDPNQRPTIPELLSKLDD 299 (302)
T ss_pred CCcccCCCHHHHHHHHHh
Confidence 999999999998877654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-16 Score=168.47 Aligned_cols=79 Identities=35% Similarity=0.513 Sum_probs=69.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++.+.... .....+||+.|+|||+..+..++.++|||||||++|||++|+.||
T Consensus 192 HrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf 271 (478)
T PTZ00267 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271 (478)
T ss_pred ECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654332 123467999999999998888999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 272 ~~ 273 (478)
T PTZ00267 272 KG 273 (478)
T ss_pred CC
Confidence 54
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-16 Score=156.21 Aligned_cols=135 Identities=24% Similarity=0.429 Sum_probs=97.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.++|+|||++........ .....|+..|+|||+..+..++.++|+||||+++|||++ |+.|
T Consensus 146 H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 146 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543221 123456788999999888888999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+..... ...+.. +....+. .... .....+.++..+|++.+|.+||++
T Consensus 226 ~~~~~~-----~~~~~~--------~~~~~~~-----------~~~~---------~~~~~~~~li~~~l~~~P~~Rpt~ 272 (291)
T cd05094 226 WFQLSN-----TEVIEC--------ITQGRVL-----------ERPR---------VCPKEVYDIMLGCWQREPQQRLNI 272 (291)
T ss_pred CCCCCH-----HHHHHH--------HhCCCCC-----------CCCc---------cCCHHHHHHHHHHcccChhhCcCH
Confidence 754211 111110 0000000 0000 011234578899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.+.++..
T Consensus 273 ~~v~~~l~~~~~ 284 (291)
T cd05094 273 KEIYKILHALGK 284 (291)
T ss_pred HHHHHHHHHHHh
Confidence 999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.7e-16 Score=159.16 Aligned_cols=79 Identities=33% Similarity=0.403 Sum_probs=68.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC--CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 205 HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 205 HRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999999999999999999999999753221 22334689999999999988889999999999999999999998864
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
.
T Consensus 285 ~ 285 (391)
T PHA03212 285 E 285 (391)
T ss_pred C
Confidence 3
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-16 Score=154.63 Aligned_cols=135 Identities=24% Similarity=0.438 Sum_probs=96.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....++..|+|||...+..++.++|+|||||++|+|++ |..|
T Consensus 143 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p 222 (288)
T cd05093 143 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222 (288)
T ss_pred ecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986533221 122345778999999988888999999999999999998 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|..... ...... +....+. .....+ ...+..+..+|++.+|.+||++
T Consensus 223 ~~~~~~-----~~~~~~--------i~~~~~~-----------~~~~~~---------~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 223 WYQLSN-----NEVIEC--------ITQGRVL-----------QRPRTC---------PKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred CCCCCH-----HHHHHH--------HHcCCcC-----------CCCCCC---------CHHHHHHHHHHccCChhhCCCH
Confidence 754211 111100 0000000 000000 1135678899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...++.+..
T Consensus 270 ~~v~~~l~~~~~ 281 (288)
T cd05093 270 KEIHSLLQNLAK 281 (288)
T ss_pred HHHHHHHHHHHH
Confidence 999999887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=158.14 Aligned_cols=80 Identities=29% Similarity=0.496 Sum_probs=67.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC------CceeecccccCcccccccCCCC---C-CCccchhhHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE------TSFIDVMGTIGYVAPEYGMGSE---V-SSYGDVYSFGILLLEM 70 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~-~~~~Dv~s~Gv~l~el 70 (485)
||||||+|+||+.+|++||+|||++...+.+ ..+....|||.|||||.+.++. + +.+.||||+||.||.+
T Consensus 233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl 312 (576)
T KOG0585|consen 233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL 312 (576)
T ss_pred ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence 9999999999999999999999999765322 2234578999999999987732 3 4677999999999999
Q ss_pred HhCCCCCCCC
Q 041230 71 FTGLRPNNGM 80 (485)
Q Consensus 71 ~~G~~p~~~~ 80 (485)
+.|+-||.+.
T Consensus 313 lfG~~PF~~~ 322 (576)
T KOG0585|consen 313 LFGQLPFFDD 322 (576)
T ss_pred hhccCCcccc
Confidence 9999999653
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-16 Score=155.84 Aligned_cols=137 Identities=23% Similarity=0.310 Sum_probs=94.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++..............+..|+|||+.....++.++|||||||++|||++ |..||.+
T Consensus 142 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 142 HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred cCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999999864322111111223557999999888888999999999999999997 9889854
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ..++.... . ..+. ...... ....+..+..+|++.+|.+||++.++
T Consensus 222 ~~-----~~~~~~~~--------~-~~~~----------~~~~~~---------~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 222 MT-----CAELYEKL--------P-QGYR----------MEKPRN---------CDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred CC-----HHHHHHHH--------h-cCCC----------CCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 21 11111100 0 0000 000000 01234578889999999999999999
Q ss_pred hHHHHHHhhhh
Q 041230 160 ESRLRSIKMKL 170 (485)
Q Consensus 160 ~~~L~~i~~~~ 170 (485)
.+.+..+....
T Consensus 269 ~~~l~~~~~~~ 279 (297)
T cd05089 269 SVQLSRMLEAR 279 (297)
T ss_pred HHHHHHHHHhh
Confidence 88887765543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=154.60 Aligned_cols=80 Identities=30% Similarity=0.445 Sum_probs=71.1
Q ss_pred CCCCCCCcEEECCC-CcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~-~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|+|+|.+ +.+||||||-|+.+..+....+...|..|.|||.+.+. .|+.+.||||.|||+.||+.|+.-|.
T Consensus 148 HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 148 HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred cCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 99999999999987 88999999999988766655666779999999998765 58999999999999999999998887
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
|.
T Consensus 228 G~ 229 (364)
T KOG0658|consen 228 GD 229 (364)
T ss_pred CC
Confidence 63
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-16 Score=156.35 Aligned_cols=79 Identities=33% Similarity=0.490 Sum_probs=69.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++............|+..|+|||...+..++.++|+||+||++|+|++|+.||.+
T Consensus 131 H~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred cCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 9999999999999999999999999876543333446789999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=154.85 Aligned_cols=80 Identities=34% Similarity=0.446 Sum_probs=71.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
.||||..|||||.+|++||+|||+++--- ......++||||-|+|||++...+|+..+|+|||||+||||+.|+.||++
T Consensus 473 YRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 473 YRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred eeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 38999999999999999999999998532 23345679999999999999999999999999999999999999999987
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 553 e 553 (683)
T KOG0696|consen 553 E 553 (683)
T ss_pred C
Confidence 4
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-16 Score=152.50 Aligned_cols=132 Identities=29% Similarity=0.422 Sum_probs=93.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce----eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF----IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||.|||++.++.+||+|||+++........ ....++..|+|||......++.++|+|||||++||+++ |+.
T Consensus 118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 197 (257)
T cd05116 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQK 197 (257)
T ss_pred ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999866433221 12234578999999887788889999999999999998 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||..... ..+... +.... ....... ....+.++...|++.+|+.||+
T Consensus 198 p~~~~~~-----~~~~~~---------i~~~~----------~~~~~~~---------~~~~l~~li~~~~~~~p~~Rp~ 244 (257)
T cd05116 198 PYKGMKG-----NEVTQM---------IESGE----------RMECPQR---------CPPEMYDLMKLCWTYGVDERPG 244 (257)
T ss_pred CCCCCCH-----HHHHHH---------HHCCC----------CCCCCCC---------CCHHHHHHHHHHhccCchhCcC
Confidence 9864211 011000 00000 0000000 1123457888999999999999
Q ss_pred cchhhHHHHH
Q 041230 156 INDVESRLRS 165 (485)
Q Consensus 156 m~~v~~~L~~ 165 (485)
+.+|...|+.
T Consensus 245 ~~~i~~~l~~ 254 (257)
T cd05116 245 FAVVELRLRN 254 (257)
T ss_pred HHHHHHHHhc
Confidence 9999888754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.64 E-value=3e-16 Score=151.99 Aligned_cols=137 Identities=29% Similarity=0.379 Sum_probs=97.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|+||||+||+++.++.++++|||++....... ......|++.|+|||...+..++.++|+||||+++|||++|..|+..
T Consensus 129 H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 99999999999999999999999988654332 12235688999999998888888999999999999999999999753
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. .+...+.... .....++ .. . ......+.++...|+..+|++||++.++
T Consensus 209 ~~---~~~~~~~~~~-----~~~~~~~-----------------~~--~---~~~~~~~~~li~~cl~~~p~~Rp~~~~v 258 (267)
T cd08228 209 DK---MNLFSLCQKI-----EQCDYPP-----------------LP--T---EHYSEKLRELVSMCIYPDPDQRPDIGYV 258 (267)
T ss_pred cc---ccHHHHHHHH-----hcCCCCC-----------------CC--h---hhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence 21 1111111100 0000000 00 0 0011234577889999999999999999
Q ss_pred hHHHHHHh
Q 041230 160 ESRLRSIK 167 (485)
Q Consensus 160 ~~~L~~i~ 167 (485)
.+.++.++
T Consensus 259 l~~~~~~~ 266 (267)
T cd08228 259 HQIAKQMH 266 (267)
T ss_pred HHHHHHhc
Confidence 99887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=139.21 Aligned_cols=136 Identities=18% Similarity=0.242 Sum_probs=94.3
Q ss_pred ceeecccCceEEEEeEeeCCcEEEEEEeeccCCcc--hHHH----------------------HHHHHHHHhcCCCc--c
Q 041230 200 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--ARSF----------------------KSECKAAINIRHRN--I 253 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~--~~~f----------------------~~E~~~l~~l~H~n--i 253 (485)
.+.||+|+||+||+|...+|+.||||++....... ...+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999997789999999986432111 1111 23444555544332 2
Q ss_pred eeEeeeecccccCCceeeEEEEEecCCCCHHHh-hcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCC-CCeee
Q 041230 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEW-LHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQ-PRIAH 331 (485)
Q Consensus 254 v~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~-L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~-~~ivH 331 (485)
.+.+++ ...++||||+++|++... |... ... .....++.+++.++.++| . .+|+|
T Consensus 82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~----------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH 138 (187)
T cd05119 82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV----------RLL-EDPEELYDQILELMRKLY---REAGLVH 138 (187)
T ss_pred CceEec---------CCCEEEEEEeCCCCccChhhhhh----------hhc-ccHHHHHHHHHHHHHHHh---hccCcCc
Confidence 233321 135899999999654321 1110 000 345678999999999999 5 78999
Q ss_pred eccCCCceEecCCCcEEEeecccccccC
Q 041230 332 CNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 332 rdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
|||||+||+++ ++.++++|||.+....
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999 9999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.9e-16 Score=153.48 Aligned_cols=135 Identities=23% Similarity=0.394 Sum_probs=94.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++........ ....+++.|++||...+..++.++|||||||++||+++ |..|
T Consensus 132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999876433221 11234678999999888889999999999999999998 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+...... .+..++.... . ..... .+...+..+...|+..+|+.||++
T Consensus 212 ~~~~~~~--~~~~~~~~~~--------~--------------~~~~~---------~~~~~~~~li~~~l~~dp~~Rp~~ 258 (279)
T cd05109 212 YDGIPAR--EIPDLLEKGE--------R--------------LPQPP---------ICTIDVYMIMVKCWMIDSECRPRF 258 (279)
T ss_pred CCCCCHH--HHHHHHHCCC--------c--------------CCCCc---------cCCHHHHHHHHHHcCCChhhCcCH
Confidence 7542110 0111110000 0 00000 011234577889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...+..+..
T Consensus 259 ~~l~~~l~~~~~ 270 (279)
T cd05109 259 RELVDEFSRMAR 270 (279)
T ss_pred HHHHHHHHHhhc
Confidence 999888766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.7e-16 Score=154.92 Aligned_cols=80 Identities=26% Similarity=0.420 Sum_probs=66.5
Q ss_pred CCCCCCCcEEE----CCCCcEEEEeccCccccCCCC----ceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHH
Q 041230 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMF 71 (485)
Q Consensus 1 HrDlk~~NiLl----~~~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~ 71 (485)
||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+. .++.++|+||+||++|||+
T Consensus 131 HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (317)
T cd07868 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH
Confidence 99999999999 456789999999998654321 22346789999999988764 5788999999999999999
Q ss_pred hCCCCCCCC
Q 041230 72 TGLRPNNGM 80 (485)
Q Consensus 72 ~G~~p~~~~ 80 (485)
+|+.||.+.
T Consensus 211 ~g~~~f~~~ 219 (317)
T cd07868 211 TSEPIFHCR 219 (317)
T ss_pred hCCCCccCC
Confidence 999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=159.81 Aligned_cols=79 Identities=32% Similarity=0.430 Sum_probs=69.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 119 H~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 999999999999999999999999975322 2223456899999999999888899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=158.61 Aligned_cols=77 Identities=34% Similarity=0.538 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 124 H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred ccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 999999999999999999999999976533 22346799999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-16 Score=158.39 Aligned_cols=79 Identities=27% Similarity=0.385 Sum_probs=69.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 118 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred eCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 999999999999999999999999975322 2233456899999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.4e-16 Score=157.39 Aligned_cols=78 Identities=33% Similarity=0.497 Sum_probs=68.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++...... ......|+..|+|||...+..++.++|+|||||++|++++|+.||..
T Consensus 127 H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999998754322 12345789999999999888889999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-16 Score=151.92 Aligned_cols=133 Identities=24% Similarity=0.420 Sum_probs=93.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce--eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF--IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||++......... ....++..|+|||+..+..++.++|||||||++|||++ |..|+
T Consensus 127 H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred ecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999999865432211 12234668999999888889999999999999999998 88887
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ...+... +...+. ...... ....+..+..+|+..+|++||++.
T Consensus 207 ~~~~-----~~~~~~~---------~~~~~~----------~~~~~~---------~~~~~~~li~~cl~~~p~~Rp~~~ 253 (263)
T cd05052 207 PGID-----LSQVYEL---------LEKGYR----------MERPEG---------CPPKVYELMRACWQWNPSDRPSFA 253 (263)
T ss_pred CCCC-----HHHHHHH---------HHCCCC----------CCCCCC---------CCHHHHHHHHHHccCCcccCCCHH
Confidence 6421 1111000 000000 000000 112356788899999999999999
Q ss_pred hhhHHHHHH
Q 041230 158 DVESRLRSI 166 (485)
Q Consensus 158 ~v~~~L~~i 166 (485)
++.+.++.+
T Consensus 254 ~l~~~l~~~ 262 (263)
T cd05052 254 EIHQAFETM 262 (263)
T ss_pred HHHHHHHhh
Confidence 998887653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=9e-17 Score=159.19 Aligned_cols=80 Identities=34% Similarity=0.595 Sum_probs=67.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+ ..++.++|+||+||++|||++|+.||.
T Consensus 126 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 205 (303)
T cd07869 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205 (303)
T ss_pred cCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987543222 2234578999999998765 357888999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 206 ~~ 207 (303)
T cd07869 206 GM 207 (303)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-16 Score=157.01 Aligned_cols=79 Identities=34% Similarity=0.458 Sum_probs=69.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+
T Consensus 124 HrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred ecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 999999999999999999999999975432 2223456799999999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.9e-16 Score=150.86 Aligned_cols=132 Identities=30% Similarity=0.503 Sum_probs=93.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce--eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF--IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+||+++.++.+||+|||+++........ ....++..|+|||+..+..++.++|+||||+++||+++ |+.|+
T Consensus 126 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred eccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 8999999999999999999999999876432211 11223457999999988888999999999999999999 88888
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+... ...... ....+ . .... ......+.++..+|++.+|.+||++.
T Consensus 206 ~~~~~-----~~~~~~---------~~~~~-----------~---~~~~-----~~~~~~~~~li~~~l~~~P~~Rp~~~ 252 (261)
T cd05068 206 PGMTN-----AEVLQQ---------VDQGY-----------R---MPCP-----PGCPKELYDIMLDCWKEDPDDRPTFE 252 (261)
T ss_pred CCCCH-----HHHHHH---------HHcCC-----------C---CCCC-----CcCCHHHHHHHHHHhhcCcccCCCHH
Confidence 64211 110000 00000 0 0000 00112356788999999999999999
Q ss_pred hhhHHHHH
Q 041230 158 DVESRLRS 165 (485)
Q Consensus 158 ~v~~~L~~ 165 (485)
++.+.++.
T Consensus 253 ~l~~~l~~ 260 (261)
T cd05068 253 TLQWKLED 260 (261)
T ss_pred HHHHHHhc
Confidence 99988764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.2e-16 Score=151.78 Aligned_cols=79 Identities=34% Similarity=0.460 Sum_probs=70.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||+++.++.++|+|||++.............|+..|+|||+..+..++.++|+||+||++|||++|+.||..
T Consensus 118 H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred EccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999876544444456799999999998888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-16 Score=152.85 Aligned_cols=133 Identities=25% Similarity=0.325 Sum_probs=92.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+|||++.++.+|++|||++..............+..|+|||+.....++.++|+||||++++||++ |..||.+
T Consensus 135 H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 135 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred ecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999999863221111112234567999999888888999999999999999997 9889854
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ........ . ..+..+ ... .....+..+..+|+..+|..||++.++
T Consensus 215 ~~-----~~~~~~~~--------~-~~~~~~----------~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 215 MT-----CAELYEKL--------P-QGYRLE----------KPL---------NCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred cC-----HHHHHHHH--------h-CCCCCC----------CCC---------cCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 21 11111100 0 000000 000 011234678899999999999999999
Q ss_pred hHHHHHH
Q 041230 160 ESRLRSI 166 (485)
Q Consensus 160 ~~~L~~i 166 (485)
...|+.+
T Consensus 262 l~~l~~~ 268 (270)
T cd05047 262 LVSLNRM 268 (270)
T ss_pred HHHHHHh
Confidence 9888664
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-16 Score=152.02 Aligned_cols=132 Identities=21% Similarity=0.354 Sum_probs=93.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++........ ....+++.|++||+..+..++.++|+||||+++||+++ |+.|
T Consensus 135 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 135 HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred ccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999865432211 12345678999999888888999999999999999999 7888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+... ..... .+..... ..... .....+..+..+|+..+|++||++
T Consensus 215 ~~~~~~-----~~~~~--------~~~~~~~-----------~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~ 261 (272)
T cd05075 215 YPGVEN-----SEIYD--------YLRQGNR-----------LKQPP---------DCLDGLYSLMSSCWLLNPKDRPSF 261 (272)
T ss_pred CCCCCH-----HHHHH--------HHHcCCC-----------CCCCC---------CCCHHHHHHHHHHcCCCcccCcCH
Confidence 754211 11100 0000000 00000 011235678899999999999999
Q ss_pred chhhHHHHH
Q 041230 157 NDVESRLRS 165 (485)
Q Consensus 157 ~~v~~~L~~ 165 (485)
.++.+.++.
T Consensus 262 ~~l~~~l~~ 270 (272)
T cd05075 262 ETLRCELEK 270 (272)
T ss_pred HHHHHHHHh
Confidence 999888765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.7e-16 Score=150.06 Aligned_cols=136 Identities=30% Similarity=0.378 Sum_probs=95.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
|+||||+||+++.++.++++|||++........ .....|+..|+|||...+..++.++|+||||+++|+|++|..|+.+
T Consensus 129 H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred cCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999999999886644322 2345789999999999888889999999999999999999999854
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
... ....+.... .....+ .. .... ....+..+..+|+..+|.+||++.+|
T Consensus 209 ~~~---~~~~~~~~~-----~~~~~~--------------~~-----~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~i 258 (267)
T cd08229 209 DKM---NLYSLCKKI-----EQCDYP--------------PL-----PSDH---YSEELRQLVNMCINPDPEKRPDITYV 258 (267)
T ss_pred ccc---hHHHHhhhh-----hcCCCC--------------CC-----Cccc---ccHHHHHHHHHhcCCCcccCCCHHHH
Confidence 211 111110000 000000 00 0000 11124567789999999999999998
Q ss_pred hHHHHHH
Q 041230 160 ESRLRSI 166 (485)
Q Consensus 160 ~~~L~~i 166 (485)
.+.+++.
T Consensus 259 ~~~~~~~ 265 (267)
T cd08229 259 YDVAKRM 265 (267)
T ss_pred HHHHhhh
Confidence 8877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-16 Score=149.47 Aligned_cols=133 Identities=23% Similarity=0.371 Sum_probs=93.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+||+++.++.+||+|||+++........ ....++..|+|||+.....++.++|||||||++|||++ |..|
T Consensus 136 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p 215 (273)
T cd05035 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215 (273)
T ss_pred ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999865432211 11235678999999888888999999999999999999 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+... ..+.. .+...... .... .....+.++..+|++.+|.+||++
T Consensus 216 ~~~~~~-----~~~~~--------~~~~~~~~-----------~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~ 262 (273)
T cd05035 216 YPGVEN-----HEIYD--------YLRHGNRL-----------KQPE---------DCLDELYDLMYSCWRADPKDRPTF 262 (273)
T ss_pred CCCCCH-----HHHHH--------HHHcCCCC-----------CCCc---------CCCHHHHHHHHHHcCCChhhCcCH
Confidence 754211 11110 00000000 0000 111235677889999999999999
Q ss_pred chhhHHHHHH
Q 041230 157 NDVESRLRSI 166 (485)
Q Consensus 157 ~~v~~~L~~i 166 (485)
.++...++.+
T Consensus 263 ~e~~~~l~~~ 272 (273)
T cd05035 263 TKLREVLENI 272 (273)
T ss_pred HHHHHHHHhh
Confidence 9998887653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.7e-16 Score=155.20 Aligned_cols=79 Identities=35% Similarity=0.502 Sum_probs=69.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||.+
T Consensus 119 H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999864322 223456799999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=5e-16 Score=156.36 Aligned_cols=130 Identities=29% Similarity=0.420 Sum_probs=89.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCC-----------CCCCccchhhHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGS-----------EVSSYGDVYSFGIL 66 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~ 66 (485)
|.||||.|.|+-. |.+||.|||+|..+...+. ..+.+||+-||+||.+... +.++++||||+||+
T Consensus 483 HSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCI 561 (677)
T KOG0596|consen 483 HSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCI 561 (677)
T ss_pred ecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhH
Confidence 8999999999864 7899999999998765542 2357899999999976432 25678999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhh
Q 041230 67 LLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACS 146 (485)
Q Consensus 67 l~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~ 146 (485)
||+|+.|+.||.. +.+... ....+.|+.- ++ -|+.. +..- .+..++..|.
T Consensus 562 LYqMvYgktPf~~-------~~n~~a-----Kl~aI~~P~~--~I-----efp~~-------~~~~----~li~~mK~CL 611 (677)
T KOG0596|consen 562 LYQMVYGKTPFGQ-------IINQIA-----KLHAITDPNH--EI-----EFPDI-------PEND----ELIDVMKCCL 611 (677)
T ss_pred HHHHHhcCCchHH-------HHHHHH-----HHHhhcCCCc--cc-----cccCC-------CCch----HHHHHHHHHH
Confidence 9999999999852 222111 1112222210 00 00000 0001 1467889999
Q ss_pred ccCCCcccccchhhH
Q 041230 147 AELPDERMDINDVES 161 (485)
Q Consensus 147 ~~~p~~RP~m~~v~~ 161 (485)
..+|.+||++.++.+
T Consensus 612 ~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 612 ARDPKKRWSIPELLQ 626 (677)
T ss_pred hcCcccCCCcHHHhc
Confidence 999999999987653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-16 Score=150.19 Aligned_cols=130 Identities=24% Similarity=0.369 Sum_probs=92.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+||+++.++.+|++|||+++...... ....++..|+|||+..+..++.++|||||||++|||++ |+.|+..
T Consensus 125 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999987543221 22345678999999888888999999999999999998 8888753
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
. .+..+.... ...+.. .... .+...+..+..+|++.+|++||++.++
T Consensus 203 ~-----~~~~~~~~~---------~~~~~~----------~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l 249 (256)
T cd05082 203 I-----PLKDVVPRV---------EKGYKM----------DAPD---------GCPPVVYDVMKQCWHLDAATRPSFLQL 249 (256)
T ss_pred C-----CHHHHHHHH---------hcCCCC----------CCCC---------CCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 2 121111110 000000 0000 011234567889999999999999999
Q ss_pred hHHHHH
Q 041230 160 ESRLRS 165 (485)
Q Consensus 160 ~~~L~~ 165 (485)
.+.|+.
T Consensus 250 ~~~l~~ 255 (256)
T cd05082 250 REQLEH 255 (256)
T ss_pred HHHHhc
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 485 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-22 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-51
Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 17/189 (8%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL-IRPGGARSFKSECKA 244
S ++L A++ FS+ N++G G FG VY G L DGT +AVK GG F++E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 245 AINIRHRNIVRVFTAVSGVDY--QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
HRN++R+ + + +VY +M NGS+ L + ++ L D+
Sbjct: 81 ISMAVHRNLLRL------RGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPL---DW 130
Query: 303 LIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+++ IA+ AR L YLH C P+I H ++K +N+LLD+E VGDF +A+ + D
Sbjct: 131 PKRQR--IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 363 E--QTRFIG 369
T G
Sbjct: 189 THVTTAVRG 197
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 9/137 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI--DVMGTIGYVAPEYGMGSEVSSYG 58
H D+K +N+ LD+E A +GDFG+A+ + + + + V GTIG++APEY + S
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 216
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPA----RAEQILDVAFFQEIEEE 114
DV+ +G++LLE+ TG R + + + L+ + E ++DV ++E
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE 276
Query: 115 ETLYK--KASSTCTQSS 129
E + + + + CTQSS
Sbjct: 277 E-VEQLIQVALLCTQSS 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 13/178 (7%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAA 245
DL +ATN F LIG G FG VY G L DG +A+K G F++E +
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 246 INIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIK 305
RH ++V + G + ++YK+M NG+L+ L+G D + + +
Sbjct: 90 SFCRHPHLVSLI----GFCDERNE-MILIYKYMENGNLKRHLYGSDLPTMSM---SW--E 139
Query: 306 KKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
++L+I I AR L YLH I H ++K N+LLD+ + + DF +++ + D+
Sbjct: 140 QRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP------VETSFIDVMGTIGYVAPEYGMGSEV 54
H D+K N+ LD+ + DFGI++ + T V GT+GY+ PEY + +
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST---VVKGTLGYIDPEYFIKGRL 218
Query: 55 SSYGDVYSFGILLLEMFTGLRP-NNGMFKDDLNLPNLVKSALPAR-AEQILDVAFFQEIE 112
+ DVYSFG++L E+ + ++ +NL + EQI+D
Sbjct: 219 TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD-------- 270
Query: 113 EEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159
L I E L V C A ++R + DV
Sbjct: 271 --PNL---------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 4e-36
Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 34/200 (17%)
Query: 186 SFKDLYDATNGFSS------ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----GA 235
SF +L + TN F N +G G FG VY G + + TT+AVK +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 236 RSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTH- 294
+ F E K +H N+V + G G +VY +MPNGSL + L D T
Sbjct: 75 QQFDQEIKVMAKCQHENLVELL----GFSSDGDD-LCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 295 --WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352
W + IA A + +LH + I H ++K +N+LLD+ + DF
Sbjct: 130 LSW---------HMRCKIAQGAANGINFLHENH--HI-HRDIKSANILLDEAFTAKISDF 177
Query: 353 SMARFLPDTDEQ---TRFIG 369
+AR + +R +G
Sbjct: 178 GLARASEKFAQTVMTSRIVG 197
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFID--VMGTIGYVAPEYGMGSEVSSY 57
H D+K +N+ LD+ TA + DFG+AR + + ++GT Y+APE + E++
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPK 214
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDLNLP--NLVKSALP 96
D+YSFG++LLE+ TGL D + L+
Sbjct: 215 SDIYSFGVVLLEIITGLPAV------DEHREPQLLLDIKEE 249
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 43/187 (22%), Positives = 78/187 (41%), Gaps = 24/187 (12%)
Query: 184 NLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECK 243
+L ++LY + + G FG V+ +AVK+F +S+++E +
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP---IQDKQSWQNEYE 68
Query: 244 AAI--NIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFD 301
++H NI++ F ++ F GSL ++L +++++
Sbjct: 69 VYSLPGMKHENILQ-FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWN 121
Query: 302 FLIKKKLDIAIDVARALKYLHCD-------CQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
L IA +AR L YLH D +P I+H ++K NVLL + + + DF +
Sbjct: 122 ELCH----IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 355 ARFLPDT 361
A
Sbjct: 178 ALKFEAG 184
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 19/174 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID---VMGTIGYVAPEY---GMGSEV 54
H D+K NV L + +TA + DFG+A S D +GT Y+APE + +
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213
Query: 55 SSY--GDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIE 112
++ D+Y+ G++L E+ + +G D+ LP + E + +V ++
Sbjct: 214 DAFLRIDMYAMGLVLWELASRCTAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKR 272
Query: 113 EEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+ + +C C + R+ V R+ +
Sbjct: 273 PVL------RDYWQKH----AGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 22/178 (12%)
Query: 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRH 250
+ LIG G +G+VY G+L D +AVKVF ++F +E + H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEH 66
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
NI R V G +V ++ PNGSL ++L +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----------WVSSCRL 116
Query: 311 AIDVARALKYLHCD------CQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
A V R L YLH + +P I+H +L NVL+ ++ + DF ++ L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 36/197 (18%), Positives = 70/197 (35%), Gaps = 38/197 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL---------PVETSFIDVMGTIGYVAPEYGMG 51
H DL NV + ++ T + DFG++ L + + I +GTI Y+APE G
Sbjct: 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
Query: 52 S-------EVSSYGDVYSFGILLLEMF---TGLRPNNGMFKDDLNLPNLVKSALPARAEQ 101
+ D+Y+ G++ E+F T L P + + + + E
Sbjct: 203 AVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV--PEYQMAFQTEVGNHPTFED 260
Query: 102 ILDVAFFQ----EIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157
+ + + + E ++S+ + L C + + R+
Sbjct: 261 MQVLVSREKQRPKFPE----------AWKENSLAVRSLKETIE---DCWDQDAEARLTAQ 307
Query: 158 DVESRLRSIKMKLLKTP 174
E R+ + M +
Sbjct: 308 XAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 15/165 (9%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVFTAV 260
IGAG+FG+V+ + G+ +AVK+ F E +RH NIV AV
Sbjct: 45 IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+ Q ++V +++ GSL LH +++L +A DVA+ + Y
Sbjct: 104 T----QPPNL-SIVTEYLSRGSLYRLLHKSGA------REQLDERRRLSMAYDVAKGMNY 152
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
LH P I H NLK N+L+D + V DF ++R T +
Sbjct: 153 LHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS 196
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM---GTIGYVAPEYGMGSEVSSY 57
H +LK N+ +D + T + DFG++R ++F+ GT ++APE +
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 58 GDVYSFGILLLEMFTGLRPNNGM 80
DVYSFG++L E+ T +P +
Sbjct: 220 SDVYSFGVILWELATLQQPWGNL 242
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 14/161 (8%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVFTAV 260
+ + G ++ G + G I VKV + R F EC H N++ V A
Sbjct: 18 LNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
A ++ +MP GSL LH + + + A+D+AR + +
Sbjct: 77 QS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ-------SQAVKFALDMARGMAF 126
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
LH +P I L +V++D++M + +
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 19/83 (22%), Positives = 32/83 (38%), Gaps = 7/83 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
L +V +D++MTA + + M +VAPE +
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF-QSPG---RMYAPAWVAPEALQKKPEDTNRRS 191
Query: 59 -DVYSFGILLLEMFTGLRPNNGM 80
D++SF +LL E+ T P +
Sbjct: 192 ADMWSFAVLLWELVTREVPFADL 214
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 21/162 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSG 262
+G G FG V + +A+K ++F E + + H NIV+++
Sbjct: 16 VGRGAFGVVCKAK-WRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLY----- 67
Query: 263 VDYQGARFKA--VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GA +V ++ GSL LHG + L + + + ++ + Y
Sbjct: 68 ----GACLNPVCLVMEYAEGGSLYNVLHGAE----PLPYYTA--AHAMSWCLQCSQGVAY 117
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEM-IGHVGDFSMARFLPDT 361
LH + H +LKP N+LL + + DF A +
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 1 HCDLKPSNVFLDDEMT-AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H DLKP N+ L T + DFG A ++T + G+ ++APE GS S D
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 60 VYSFGILLLEMFTGLRPNNGM 80
V+S+GI+L E+ T +P + +
Sbjct: 186 VFSWGIILWEVITRRKPFDEI 206
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 42/172 (24%), Positives = 67/172 (38%), Gaps = 28/172 (16%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRP----GGARSFKSECKAAINIRHRNIVRVFT 258
IG G FG VY + G +AVK + + E K ++H NI+ +
Sbjct: 15 IGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+ +V +F G L L GK +L ++ A+ +AR +
Sbjct: 74 VCL----KEPNL-CLVMEFARGGPLNRVLSGKR-IPPDIL---------VNWAVQIARGM 118
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGH--------VGDFSMARFLPDTD 362
YLH + I H +LK SN+L+ ++ + DF +AR T
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT 170
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 9/88 (10%)
Query: 1 HCDLKPSNVFLDDEMTAH--------LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS 52
H DLK SN+ + ++ + DFG+AR T+ + G ++APE S
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAAGAYAWMAPEVIRAS 189
Query: 53 EVSSYGDVYSFGILLLEMFTGLRPNNGM 80
S DV+S+G+LL E+ TG P G+
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 41/172 (23%), Positives = 65/172 (37%), Gaps = 22/172 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRNIVRVFT 258
IG G +G V+ G + G +AVKVF S+ E + +RH NI+
Sbjct: 43 KQIGKGRYGEVWMGK-WRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
A + ++ + NGSL ++L D K L +A L
Sbjct: 99 ADIKGTGSWTQL-YLITDYHENGSLYDYLKST--------TLDA--KSMLKLAYSSVSGL 147
Query: 319 KYLHCD-----CQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
+LH + +P IAH +LK N+L+ + D +A +
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 35/182 (19%), Positives = 62/182 (34%), Gaps = 31/182 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPE------YG 49
H DLK N+ + T + D G+A +T+ +D+ GT Y+ PE
Sbjct: 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
Query: 50 MGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQ 109
+ D+YSFG++L E+ + ++ LP E + ++ +
Sbjct: 225 NHFQSYIMADMYSFGLILWEVARRCVSGGIV--EEYQLPYHDLVPSDPSYEDMREIVCIK 282
Query: 110 ----EIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRS 165
ECL + ++ C A P R+ V+ L
Sbjct: 283 KLRPSFPN--------------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 166 IK 167
+
Sbjct: 329 MS 330
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 43/179 (24%)
Query: 203 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGA-------RSFKSECKAAINIRHRNIV 254
IG G FG V+ G L D + +A+K L G + F+ E N+ H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 255 RVFTAVSGVDYQGARFKAVVYK-------FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
+ +++ F+P G L L K + K
Sbjct: 87 K--------------LYGLMHNPPRMVMEFVPCGDLYHRLLDKAH------PIKW--SVK 124
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD-----DEMIGHVGDFSMARFLPDT 361
L + +D+A ++Y+ P I H +L+ N+ L + V DF +++ +
Sbjct: 125 LRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 9/87 (10%)
Query: 1 HCDLKPSNVFLD-----DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE--YGMGSE 53
H DL+ N+FL + A + DFG+++ S ++G ++APE
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMAPETIGAEEES 204
Query: 54 VSSYGDVYSFGILLLEMFTGLRPNNGM 80
+ D YSF ++L + TG P +
Sbjct: 205 YTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 22/172 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRNIVRVFT 258
IG G FG V+ G + G +AVK+F RS+ E + +RH NI+
Sbjct: 48 ESIGKGRFGEVWRGK-WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
A + + + +V + +GSL ++L+ T ++ +A+ A L
Sbjct: 104 ADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVEGMIK----------LALSTASGL 152
Query: 319 KYLHCD-----CQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
+LH + +P IAH +LK N+L+ + D +A +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 36/182 (19%), Positives = 57/182 (31%), Gaps = 31/182 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVS 55
H DLK N+ + T + D G+A T ID+ GT Y+APE S
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 56 SYG------DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQ 109
+ D+Y+ G++ E+ +D LP E++ V Q
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
Query: 110 ----EIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRS 165
I E L + +I C R+ ++ L
Sbjct: 288 KLRPNIPNRWQSC--------------EALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 166 IK 167
+
Sbjct: 334 LS 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 37/169 (21%), Positives = 68/169 (40%), Gaps = 22/169 (13%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRNIVRVFT 258
+G G +G V+ G+ + G +AVK+F +S+ E + +RH NI+
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+ + + ++ + GSL ++L D L I + +A L
Sbjct: 70 SDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT--------TLDT--VSCLRIVLSIASGL 118
Query: 319 KYLHCD-----CQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+LH + +P IAH +LK N+L+ + D +A +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 35/181 (19%), Positives = 61/181 (33%), Gaps = 31/181 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV-----MGTIGYVAPE------YG 49
H DLK N+ + + D G+A T+ +DV +GT Y+APE
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 50 MGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQ 109
+ D+++FG++L E+ + N + +D P E + V
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKPPFYDVVPNDPSFEDMRKVVCVD 253
Query: 110 ----EIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRS 165
I L S+ ++ C + P R+ ++ L
Sbjct: 254 QQRPNIPNRWFSD--------------PTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 166 I 166
I
Sbjct: 300 I 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 21/169 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVFTAV 260
IG+G+FG+VY G +AVK+ N+ P ++FK+E RH NI+
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+ A+V ++ SL LH + F +KK +DIA AR + Y
Sbjct: 90 TAPQL------AIVTQWCEGSSLYHHLHASETK--------FEMKKLIDIARQTARGMDY 135
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG 369
LH I H +LK +N+ L ++ +GDF +A +F
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 6/86 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF---LPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLK +N+FL ++ T +GDFG+A F + G+I ++APE + + Y
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 58 G---DVYSFGILLLEMFTGLRPNNGM 80
DVY+FGI+L E+ TG P + +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 42/188 (22%), Positives = 68/188 (36%), Gaps = 37/188 (19%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG T T + + LIR R+F E K + H N+++
Sbjct: 18 LGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----- 71
Query: 261 SGVDYQGARFKAVVYK---------FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311
F V+YK ++ G+L + D + +++ A
Sbjct: 72 ---------FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--------YPWSQRVSFA 114
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKL 371
D+A + YLH I H +L N L+ + V DF +AR + D Q + L
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 372 NVRNFVKM 379
+ K
Sbjct: 172 KKPDRKKR 179
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 15/95 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL---------------PVETSFIDVMGTIGYVA 45
H DL N + + + DFG+AR + P V+G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 46 PEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80
PE G DV+SFGI+L E+ + +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 21/168 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGA--RSFKSECKAAINIRHRNIVRVFT 258
LIG G FG VY+G +A+++ ++ R ++FK E A RH N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM- 95
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
G A++ +L + + K IA ++ + +
Sbjct: 96 ---GACMSPPHL-AIITSLCKGRTLYSVVRDAKIV--------LDVNKTRQIAQEIVKGM 143
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
YLH I H +LK NV D+ + + DF + R
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRR 187
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 22/95 (23%), Positives = 34/95 (35%), Gaps = 16/95 (16%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV------ETSFIDVMGTIGYVAPE------Y 48
H DLK NVF D+ + DFG+ V E G + ++APE
Sbjct: 153 HKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 49 GMGSEVSSYG---DVYSFGILLLEMFTGLRPNNGM 80
+ + DV++ G + E+ P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 40/176 (22%), Positives = 80/176 (45%), Gaps = 21/176 (11%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFT 258
+GAG FG V+ T T +AVK ++PG +F +E ++H +V++
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLH- 249
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
V + + ++ +FM GSL ++L + + L K +D + +A +
Sbjct: 250 ---AVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPL-------PKLIDFSAQIAEGM 297
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
++ Q H +L+ +N+L+ ++ + DF +AR + D + R K ++
Sbjct: 298 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL+ +N+ + + + DFG+AR + + + G I + APE +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL+E+ T G P GM
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGM 389
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 33/180 (18%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVFTAV 260
+GAG FG V+ G T +AVK ++ G +F +E ++H+ +VR++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLY--- 74
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
V Q + ++ ++M NGSL ++L L + L+ D+A +A + +
Sbjct: 75 -AVVTQEPIY--IITEYMENGSLVDFLKTPSGIK---LTINKLL----DMAAQIAEGMAF 124
Query: 321 L------HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+ H D + N+L+ D + + DF +AR + D + R K ++
Sbjct: 125 IEERNYIHRDLRAA---------NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 11/87 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPE---YGMGSEV 54
H DL+ +N+ + D ++ + DFG+AR + + + G I + APE YG
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT---F 187
Query: 55 SSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ DV+SFGILL E+ T G P GM
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFT 258
+G G FG V+ GT T +A+K ++PG +F E + +RH +V+++
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
VS +V ++M GSL ++L G+ + RL + +D+A +A +
Sbjct: 330 VVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRL-------PQLVDMAAQIASGM 376
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
Y+ + H +L+ +N+L+ + ++ V DF +AR + D + R K ++
Sbjct: 377 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT--IGYVAPEYGMGSEVSSYG 58
H DL+ +N+ + + + + DFG+AR + I + APE + +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 59 DVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGM 468
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFT 258
+G G FG V+ GT T +A+K ++PG +F E + +RH +V+++
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
VS +V ++M GSL ++L G+ + RL + +D+A +A +
Sbjct: 247 VVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRL-------PQLVDMAAQIASGM 293
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
Y+ + H +L+ +N+L+ + ++ V DF +AR + D + R K ++
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT--IGYVAPEYGMGSEVSSYG 58
H DL+ +N+ + + + + DFG+AR + I + APE + +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 59 DVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+ T G P GM
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGM 385
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 19/166 (11%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-ARSFKSECKAAINIRHRNIVRVFTAVS 261
IG G FG V G + G +AVK I+ A++F +E +RH N+V++
Sbjct: 201 IGKGEFGDVMLGD-YRGNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL---- 252
Query: 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYL 321
GV + +V ++M GSL ++L + + L ++DV A++YL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-------DCLLKFSLDVCEAMEYL 305
Query: 322 HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
H +L NVL+ ++ + V DF + + T + +
Sbjct: 306 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 9/84 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL NV + ++ A + DFG+ + + + APE + S+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTK 366
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+++ G P +
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRI 390
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 21/177 (11%)
Query: 201 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVF 257
+ +G G +G VY G T+AVK ++ F E I+H N+V++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
GV + F ++ +FM G+L ++L + L +A ++ A
Sbjct: 283 ----GVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSA-------VVLLYMATQISSA 330
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
++YL + H NL N L+ + + V DF ++R + K ++
Sbjct: 331 MEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 24/83 (28%), Positives = 42/83 (50%), Gaps = 3/83 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H +L N + + + DFG++R + + T+ I + APE ++ S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 59 DVYSFGILLLEMFT-GLRPNNGM 80
DV++FG+LL E+ T G+ P G+
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGI 423
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 6e-19
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 21/174 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVFTAV 260
+G+G FG V G +AVK+ I+ G F E + + + H +V+ +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFY--- 69
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV + +V +++ NG L +L + L++ DV + +
Sbjct: 70 -GVCSKEYPI-YIVTEYISNGCLLNYLRSHGKG--------LEPSQLLEMCYDVCEGMAF 119
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
L + H +L N L+D ++ V DF M R++ D + K V+
Sbjct: 120 LE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 3e-07
Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N +D ++ + DFG+ R++ + ++ +GT + + APE + SS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV++FGIL+ E+F+ G P +
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLY 209
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-ARSFKSECKAAINIRHRNIVRVFTA 259
IG G FG V G G +AVK I+ A++F +E +RH N+V++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL-- 80
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
GV + +V ++M GSL ++L + + L D L+ ++DV A++
Sbjct: 81 --GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLL----KFSLDVCEAME 131
Query: 320 YL------HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
YL H D R NVL+ ++ + V DF + + T + +
Sbjct: 132 YLEGNNFVHRDLAAR---------NVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 9/84 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL NV + ++ A + DFG+ + + + APE + S+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTK 194
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFGILL E+++ G P +
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPRI 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 43/181 (23%), Positives = 69/181 (38%), Gaps = 26/181 (14%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTA 259
LIG+G FG V+ DG T +K + E KA + H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72
Query: 260 VSGVDYQGARFKAVVYK-----------FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL 308
G DY + F G+LE+W+ + L
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLAL 125
Query: 309 DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFI 368
++ + + + Y+H ++ + +LKPSN+ L D +GDF + L + ++TR
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 369 G 369
G
Sbjct: 183 G 183
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 19/134 (14%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
+ DLKPSN+FL D +GDFG+ L + GT+ Y++PE + D+
Sbjct: 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDL 204
Query: 61 YSFGILLLEMFTGLRP-----------NNGMFKDDL--NLPNLVKSAL---PAR---AEQ 101
Y+ G++L E+ +G+ D L++ L P +
Sbjct: 205 YALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSE 264
Query: 102 ILDVAFFQEIEEEE 115
IL + E+
Sbjct: 265 ILRTLTVWKKSPEK 278
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 25/176 (14%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
IG+G FG V+ G + +A+K IR G F E + + + H +V+++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 261 SGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+V +FM +G L ++L + F + L + +DV +
Sbjct: 73 LEQAPIC-------LVTEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGM 117
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
YL + + H +L N L+ + + V DF M RF+ D + K V+
Sbjct: 118 AYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 170
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 9e-07
Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + + + DFG+ RF+ + + GT + + +PE S SS
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+SFG+L+ E+F+ G P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENR 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ + + A+L DFGIA E T + +GT+ Y+APE S +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216
Query: 59 DVYSFGILLLEMFTGLRP 76
D+Y+ +L E TG P
Sbjct: 217 DIYALTCVLYECLTGSPP 234
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 31/169 (18%), Positives = 58/169 (34%), Gaps = 31/169 (18%)
Query: 202 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGARS------FKSECKAAINIRHRN 252
L+G G G VY D +A+K+ + + + E + A ++ +
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKL---MSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+V + G G + V + + L L L + + I
Sbjct: 96 VVPIHD--FGEI-DGQLY--VDMRLINGVDLAAMLR----RQGPLA-----PPRAVAIVR 141
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
+ AL H H ++KP N+L+ + ++ DF +A D
Sbjct: 142 QIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 25/176 (14%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V G +A+K+ I+ G F E K +N+ H +V+++
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 261 SGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+ + ++ ++M NG L +L F ++ L++ DV A+
Sbjct: 89 TKQRPIF-------IITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAM 133
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+YL + H +L N L++D+ + V DF ++R++ D + + K VR
Sbjct: 134 EYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 23/84 (27%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N ++D+ + DFG++R++ + + +G+ + + PE M S+ SS
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
D+++FG+L+ E+++ G P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERF 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 5e-18
Identities = 33/81 (40%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ +D T + DFGIA+ L T V+GT+ Y +PE G
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 59 DVYSFGILLLEMFTGLRPNNG 79
D+YS GI+L EM G P NG
Sbjct: 194 DIYSIGIVLYEMLVGEPPFNG 214
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 34/172 (19%), Positives = 62/172 (36%), Gaps = 37/172 (21%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARS------FKSECKAAINIRHRNIV 254
+G G +VY +A+K I F+ E + + H+NIV
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKA---IFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD-----DTHWRLLNFDFLIKKKLD 309
+ + Y M E++ G ++H L + ++
Sbjct: 75 SMID--VDEE------DDCYYLVM------EYIEGPTLSEYIESHGPLS-----VDTAIN 115
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
+ +K+ H RI H ++KP N+L+D + DF +A+ L +T
Sbjct: 116 FTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 30/83 (36%), Positives = 44/83 (53%), Gaps = 4/83 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI----DVMGTIGYVAPEYGMGSEVSS 56
H D+KP+N+ + + DFGIAR + + + V+GT Y++PE G V +
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 198
Query: 57 YGDVYSFGILLLEMFTGLRPNNG 79
DVYS G +L E+ TG P G
Sbjct: 199 RSDVYSLGCVLYEVLTGEPPFTG 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 33/172 (19%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARS------FKSECKAAINIRHRNIV 254
++G G V+ L D +AVKV +R AR F+ E + A + H IV
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKV---LRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD-----DTHWRLLNFDFLIKKKLD 309
V+ +G A + Y M E++ G T + K+ ++
Sbjct: 76 AVY--DTGEAETPAG--PLPYIVM------EYVDGVTLRDIVHTEGPM-----TPKRAIE 120
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
+ D +AL + H Q I H ++KP+N+++ V DF +AR + D+
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 203 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGA-----RSFKSECKAAINIRHRNI 253
+G G FGSV G L +AVK ++ + F SE + H N+
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKT---MKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL-HGKDDTHWRLLNFDFLIKKKLDIAI 312
+R+ + QG V+ FM G L +L + + +T + + ++ L +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP----LQTLLKFMV 154
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE-QTRFIGKL 371
D+A ++YL H +L N +L D+M V DF +++ + D + I K+
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 372 NVR 374
V+
Sbjct: 212 PVK 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL N L D+MT + DFG+++ + Y A E
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSK---------KIYSGDYYRQGRIAKMPVKWIAIES 220
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ +S DV++FG+ + E+ T G+ P G+
Sbjct: 221 LADRV---YTSKSDVWAFGVTMWEIATRGMTPYPGV 253
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 22/144 (15%), Positives = 48/144 (33%), Gaps = 33/144 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H L+P ++ LD L F + + + + G+ PE SY
Sbjct: 229 HTYLRPVDIVLDQRGGVFLTGFEHLVR---DGARVVSSVSRGFEPPELEARRATISYHRD 285
Query: 59 ---------DVYSFGILLLEMFTGLRPNNG---------MFKDDLNLPNLVKSAL----- 95
D ++ G+++ ++ P +F+ N+P V++ L
Sbjct: 286 RRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLR 345
Query: 96 --PAR---AEQILDVAFFQEIEEE 114
Q ++ ++++ E
Sbjct: 346 YPKEDRLLPLQAMETPEYEQLRTE 369
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 25/180 (13%), Positives = 53/180 (29%), Gaps = 30/180 (16%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGA----------------RSFKSECKA 244
++G + + T G + V V + R K++ +A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 245 AINIRHRNIVRVFTA------VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLL 298
+++R + + + + + P G+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 299 NFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMAR 356
+ + +L + + V R L LH + H L+P +++LD G V F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR--GGVFLTGFEHLV 254
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+IG G+FG VY+GTL D AVK N I G S F +E + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ +G+ VV +M +G L ++ + + +K + + VA
Sbjct: 91 LLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVA 138
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD---EQTRFIGKLN 372
+ +KYL + H +L N +LD++ V DF +AR + D + + KL
Sbjct: 139 KGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 373 VR 374
V+
Sbjct: 196 VK 197
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 27/89 (30%), Positives = 40/89 (44%), Gaps = 12/89 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YGMGS 52
H DL N LD++ T + DFG+AR + + + T + A E +
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+SFG+LL E+ T G P +
Sbjct: 211 TKS---DVWSFGVLLWELMTRGAPPYPDV 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 19/140 (13%), Positives = 41/140 (29%), Gaps = 26/140 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPE--YGMGSEVSS 56
H L+P ++ LD L F + A +
Sbjct: 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTL 293
Query: 57 YG---DVYSFGILLLEMFTGLRPNNG---------MFKDDLNLP----NLVKSAL---PA 97
D ++ G+ + ++ PN +F+ N+P L++ L
Sbjct: 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353
Query: 98 R---AEQILDVAFFQEIEEE 114
Q ++ ++++ E
Sbjct: 354 DRLLPLQAMETPEYEQLRTE 373
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 23/185 (12%), Positives = 51/185 (27%), Gaps = 30/185 (16%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVR----- 255
++G + + T G + V V + + K + + +R ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 256 -----------------VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLL 298
+ + + + P G+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 299 NFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMAR 356
+ + +L + + V R L LH + H L+P +++LD G V F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR--GGVFLTGFEHLV 259
Query: 357 FLPDT 361
+
Sbjct: 260 RDGAS 264
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 28/97 (28%), Positives = 41/97 (42%), Gaps = 5/97 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
+ DLKP N+ L +E L D G + SF + GT G+ APE + D+
Sbjct: 205 YNDLKPENIMLTEE-QLKLIDLGAVSRI---NSFGYLYGTPGFQAPEIVRT-GPTVATDI 259
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPA 97
Y+ G L + L NG + D L + V +
Sbjct: 260 YTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDS 296
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 30/163 (18%), Positives = 60/163 (36%), Gaps = 18/163 (11%)
Query: 202 LIGAGNFGSVYNG--TLFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFT 258
I G G +Y +G + +K +E + + H +IV++F
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
V D G +V +++ SL+ K + + + +++ AL
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILPAL 195
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
YLH + + +LKP N++L +E + + D +
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSF 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 23/182 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+IG G+FG VY+GTL D AVK N I G S F +E + H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ +G+ VV +M +G L ++ + +K + + VA
Sbjct: 155 LLGICL--RSEGSPL--VVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVA 202
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE---QTRFIGKLN 372
+ +K+L + H +L N +LD++ V DF +AR + D + + KL
Sbjct: 203 KGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 373 VR 374
V+
Sbjct: 260 VK 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 12/89 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YGMGS 52
H DL N LD++ T + DFG+AR + + T + A E
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-- 272
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
++ DV+SFG+LL E+ T G P +
Sbjct: 273 -FTTKSDVWSFGVLLWELMTRGAPPYPDV 300
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 23/182 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+IG G+FG VY+G D A+K + I F E + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ + +G V+ +M +G L +++ + +K + + VA
Sbjct: 87 LIGIML--PPEGLPH--VLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVA 134
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD---EQTRFIGKLN 372
R ++YL + + H +L N +LD+ V DF +AR + D + Q +L
Sbjct: 135 RGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 373 VR 374
V+
Sbjct: 192 VK 193
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 12/89 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YGMGS 52
H DL N LD+ T + DFG+AR + + + A E
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-- 204
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
++ DV+SFG+LL E+ T G P +
Sbjct: 205 -FTTKSDVWSFGVLLWELLTRGAPPYRHI 232
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 25/178 (14%)
Query: 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG----GARSFKSECKAAINIRHRNIVRVF 257
IG GNFG V++G L D T +AVK R F E + H NIVR+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
GV Q +V + + G +L + +K L + D A
Sbjct: 179 ----GVCTQKQPI-YIVMELVQGGDFLTFLRTEGAR--------LRVKTLLQMVGDAAAG 225
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD-EQTRFIGKLNVR 374
++YL H +L N L+ ++ + + DF M+R D + + ++ V+
Sbjct: 226 MEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 27/86 (31%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APEYGMGSEVS 55
H DL N + ++ + DFG++R G + V APE S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 56 SYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+SFGILL E F+ G P +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNL 319
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 18/180 (10%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVRVFTA 259
+G G FG V+ D A+K L AR E KA + H IVR F A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 260 ----VSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+ Q + K +Y M +L++W++G+ + L I +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFL 125
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLN 372
+A A+++LH + H +LKPSN+ + + VGDF + + +E+ + +
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 39/149 (26%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-------------GTIGYVAPE 47
H DLKPSN+F + +GDFG+ + + V+ GT Y++PE
Sbjct: 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200
Query: 48 YGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDL------------------NLPN 89
G+ S D++S G++L E+ + M +
Sbjct: 201 QIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYV 258
Query: 90 LVKSAL---PAR---AEQILDVAFFQEIE 112
+V+ L P A I++ A F++++
Sbjct: 259 MVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 19/166 (11%)
Query: 203 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G GNFGSV G +AVK P R F+ E + + IV+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
G Q R +V +++P+G L ++L + L + + +
Sbjct: 91 GVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRAR--------LDASRLLLYSSQICKG 139
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
++YL R H +L N+L++ E + DF +A+ LP +
Sbjct: 140 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 21/89 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL N+ ++ E + DFG+A+ LP++ + YV E G E
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--------YVVREPGQSPIFWYAPES 201
Query: 55 SSYG------DVYSFGILLLEMFT-GLRP 76
S DV+SFG++L E+FT +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 19/166 (11%)
Query: 203 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G GNFGSV G +AVK R F+ E + +++H NIV+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+ + ++ +++P GSL ++L + K L + +
Sbjct: 78 GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKG 126
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
++YL R H +L N+L+++E +GDF + + LP E
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 24/84 (28%), Positives = 38/84 (45%), Gaps = 20/84 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL N+ +++E +GDFG+ + LP + F + E G E
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--------FKVKEPGESPIFWYAPES 188
Query: 55 SSYG------DVYSFGILLLEMFT 72
+ DV+SFG++L E+FT
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 35/177 (19%), Positives = 71/177 (40%), Gaps = 25/177 (14%)
Query: 203 IGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPGG--ARSFKSECKAAINIRHRNIVRVFTA 259
+G G +G VY G + +AVK ++ F E I+H N+V++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 260 VSGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+ Y ++ +FM G+L ++L + ++ L+ +A ++ A
Sbjct: 78 CTREPPFY-------IITEFMTYGNLLDYLRECNRQE---VSAVVLL----YMATQISSA 123
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
++YL + H +L N L+ + + V DF ++R + K ++
Sbjct: 124 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL N + + + DFG++R + ++ G I + APE ++ S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV++FG+LL E+ T G+ P G+
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGI 216
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 203 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGG---ARSFKSECKAAINIRHRNIV 254
+G GNFGSV G +AVK ++ R F+ E + +++H NIV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
+ + + ++ +++P GSL ++L + K L +
Sbjct: 106 KYKGVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQI 154
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ ++YL R H +L N+L+++E +GDF + + LP E
Sbjct: 155 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 24/84 (28%), Positives = 38/84 (45%), Gaps = 20/84 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL N+ +++E +GDFG+ + LP + + Y E G E
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--------YKVKEPGESPIFWYAPES 219
Query: 55 SSYG------DVYSFGILLLEMFT 72
+ DV+SFG++L E+FT
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 36/182 (19%), Positives = 65/182 (35%), Gaps = 32/182 (17%)
Query: 203 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPG----GARSFKSECKAAI--NIRHRN 252
IG G FG V+ G +A+K + F E A H +
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQE--ALTMRQFDHPH 77
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
IV++ ++ ++ + G L +L + + + A
Sbjct: 78 IVKLIGVITENPVW------IIMELCTLGELRSFLQVRKY--------SLDLASLILYAY 123
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLN 372
++ AL YL R H ++ NVL+ +GDF ++R++ D+ GKL
Sbjct: 124 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 373 VR 374
++
Sbjct: 181 IK 182
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 23/87 (26%), Positives = 44/87 (50%), Gaps = 11/87 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPE---YGMGSEV 54
H D+ NV + LGDFG++R++ ++++ I ++APE +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR---F 194
Query: 55 SSYGDVYSFGILLLEMFT-GLRPNNGM 80
+S DV+ FG+ + E+ G++P G+
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 48/181 (26%), Positives = 73/181 (40%), Gaps = 26/181 (14%)
Query: 203 IGAGNFGSVYNGTL--FDGTTI--AVKVFN---LIRPGGARSFKSECKAAINIRHRNIVR 255
+G G+FG V G G T+ AVK L +P F E A ++ HRN++R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
++ V + +V + P GSL + L FL+ A+ VA
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVA 131
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--TRFIGKLNV 373
+ YL R H +L N+LL + +GDF + R LP D+ + K+
Sbjct: 132 EGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 374 R 374
Sbjct: 189 A 189
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 27/93 (29%), Positives = 34/93 (36%), Gaps = 21/93 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL N+ L +GDFG+ R LP YV E+ E
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--------YVMQEHRKVPFAWCAPES 195
Query: 55 SSYG------DVYSFGILLLEMFT-GLRPNNGM 80
D + FG+ L EMFT G P G+
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 34/146 (23%), Positives = 55/146 (37%), Gaps = 35/146 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-------------GTIGYVAPE 47
H DLKPSN+F + +GDFG+ + + V+ GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 48 YGMGSEVSSYGDVYSFGILLLEMFTGLRPN-----------NGMFKDDL-----NLPNLV 91
G+ S D++S G++L E+ N F +V
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 92 KSAL---PAR---AEQILDVAFFQEI 111
+ L P A I++ A F+ +
Sbjct: 307 QDMLSPSPTERPEATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 41/219 (18%), Positives = 67/219 (30%), Gaps = 51/219 (23%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR-SFKSECKAAINIRHRNIVRVFTA 259
+G G FG V+ D A+K L AR E KA + H IVR F A
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLE----------------------------------- 284
+ + + +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 285 --------EWLHGKDDTHW---RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCN 333
+ ++ W R D L I I +A A+++LH + H +
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRD 189
Query: 334 LKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLN 372
LKPSN+ + + VGDF + + +E+ + +
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 203 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGA----RSFKSECKAAINIRHRNI 253
+G G+FG V G +AVK ++P K E + N+ H NI
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
V+ + G + ++ +F+P+GSL+E+L + +K++L A+
Sbjct: 86 VKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQ 134
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ + + YL + H +L NVL++ E +GDF + + + E
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 10/79 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPE---YGMGSE 53
H DL NV ++ E +GDFG+ + + + + V + + APE
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYI 208
Query: 54 VSSYGDVYSFGILLLEMFT 72
S DV+SFG+ L E+ T
Sbjct: 209 AS---DVWSFGVTLHELLT 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 36/182 (19%), Positives = 73/182 (40%), Gaps = 30/182 (16%)
Query: 203 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGARSFKSE--CKAAI--NIRHRNI 253
+G+G FG+VY G +A+K +R + E +A + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
R+ Q ++ + MP G L +++ D + L+ +
Sbjct: 80 CRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQ 125
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD-EQTRFIGKLN 372
+A+ + YL R+ H +L NVL+ + DF +A+ L + E GK+
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 373 VR 374
++
Sbjct: 183 IK 184
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 10/87 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPE---YGMGSEV 54
H DL NV + + DFG+A+ L E G I ++A E + + +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 55 SSYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+S+G+ + E+ T G +P +G+
Sbjct: 200 S---DVWSYGVTVWELMTFGSKPYDGI 223
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 33/137 (24%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-----YGMGSEVS 55
H D+KP+N+FL LGDFG+ L + G Y+APE YG +
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAA--- 236
Query: 56 SYGDVYSFGILLLEMFTGLR-PNNG-----MFKDDLNLP----------NLVKSAL---P 96
DV+S G+ +LE+ + P+ G + + L +++ L P
Sbjct: 237 ---DVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293
Query: 97 AR---AEQILDVAFFQE 110
AE +L + ++
Sbjct: 294 KLRATAEALLALPVLRQ 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 33/184 (17%), Positives = 52/184 (28%), Gaps = 45/184 (24%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAIN--------IRHRN 252
+G G++G V+ DG AVK G + + +H
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-----PKDRARKLAEVGSHEKVGQHPC 118
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSL---EEWLHGKDDTHWRLLNFDFLIKKK-- 307
VR + A + G L E + + +
Sbjct: 119 CVR---------LEQA--------WEEGGILYLQTELCGP--SLQQHCEAWGASLPEAQV 159
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQT 365
D AL +LH + H ++KP+N+ L G GDF + L
Sbjct: 160 WGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPR--GRCKLGDFGLLVELGTAGAGE 214
Query: 366 RFIG 369
G
Sbjct: 215 VQEG 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 40/179 (22%), Positives = 69/179 (38%), Gaps = 24/179 (13%)
Query: 203 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
+G+G FG+V+ G + +KV + A ++ H +IVR+
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
G Q +V +++P GSL + + + L+ + +A+
Sbjct: 81 LGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAK 126
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT-RFIGKLNVR 374
+ YL + + H NL NVLL V DF +A LP D+Q K ++
Sbjct: 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 4/84 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H +L NV L + DFG+A LP + + I ++A E + +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+S+G+ + E+ T G P G+
Sbjct: 198 SDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 39/182 (21%), Positives = 68/182 (37%), Gaps = 18/182 (9%)
Query: 203 IGAGNFGSVYNGTLFDG----TTIAVKVF--NLIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FGSV L +AVK+ ++I F E H ++ ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 257 FTAVSGVDYQGARFKA-VVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKKLDIAID 313
+G V+ FM +G L +L + + L + +D
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL-----VRFMVD 145
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE-QTRFIGKLN 372
+A ++YL H +L N +L ++M V DF ++R + D + KL
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 373 VR 374
V+
Sbjct: 203 VK 204
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL N L ++MT + DFG++R + Y A E
Sbjct: 160 HRDLAARNCMLAEDMTVCVADFGLSR---------KIYSGDYYRQGCASKLPVKWLALES 210
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ + + DV++FG+ + E+ T G P G+
Sbjct: 211 LADNL---YTVHSDVWAFGVTMWEIMTRGQTPYAGI 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 22/167 (13%)
Query: 203 IGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
+G G+FG V G +AVK RS +K E + H +I++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
+ +V +++P GSL ++L +LL F A +
Sbjct: 99 KGCCEDAGAASLQ---LVMEYVPLGSLRDYLPRHSIGLAQLLLF----------AQQICE 145
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ YLH H +L NVLLD++ + +GDF +A+ +P+ E
Sbjct: 146 GMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 25/84 (29%), Positives = 35/84 (41%), Gaps = 20/84 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL NV LD++ +GDFG+A+ +P + Y E G E
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--------YRVREDGDSPVFWYAPEC 208
Query: 55 SSYG------DVYSFGILLLEMFT 72
DV+SFG+ L E+ T
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPEYGMGSEVSSYGD 59
H D+KP+NVF+ LGD G+ RF +T+ ++GT Y++PE + + D
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
++S G LL EM P G D +NL +L K
Sbjct: 219 IWSLGCLLYEMAALQSPFYG---DKMNLYSLCK 248
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 36/181 (19%), Positives = 68/181 (37%), Gaps = 34/181 (18%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHRNIVRV 256
IG G F VY L DG +A+K + A++ +++C I++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA-RADCIKEIDLLKQLNHPNVIK- 96
Query: 257 FTAVSGVDYQGARFKA-----VVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKKLD 309
Y + F +V + G L + K +
Sbjct: 97 --------YYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRL-------IPERTVWK 140
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR-FI 368
+ + AL+++H R+ H ++KP+NV + + +GD + RF +
Sbjct: 141 YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 369 G 369
G
Sbjct: 198 G 198
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 31/174 (17%)
Query: 203 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGG----ARSFKSECKAAI--NIRHRN 252
IG+G+ G V G L +A+K ++ G R F SE A+I H N
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSE--ASIMGQFDHPN 111
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
I+R+ GV +G +V ++M NGSL+ +L D F I + + +
Sbjct: 112 IIRLE----GVVTRGRLA-MIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLR 158
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
V ++YL H +L NVL+D ++ V DF ++R L D +
Sbjct: 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 28/88 (31%), Positives = 41/88 (46%), Gaps = 11/88 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV-MGT---IGYVAPE---YGMGSE 53
H DL NV +D + + DFG++R L + G I + APE + S
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 54 VSSYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+SFG+++ E+ G RP M
Sbjct: 234 AS---DVWSFGVVMWEVLAYGERPYWNM 258
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 26/179 (14%)
Query: 203 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGARS-FKSECKAAI--NIRHRNIVR 255
+G G FG VY G + +AVK + F SE A I N+ H +IV+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE--AVIMKNLDHPHIVK 77
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ G+ + + ++ + P G L +L ++ + + ++ +
Sbjct: 78 LI----GIIEEEPTW--IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQIC 123
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+A+ YL H ++ N+L+ +GDF ++R++ D D + +L ++
Sbjct: 124 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 19/87 (21%), Positives = 41/87 (47%), Gaps = 11/87 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPE---YGMGSEV 54
H D+ N+ + LGDFG++R++ + + T I +++PE +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRR---F 191
Query: 55 SSYGDVYSFGILLLEMFT-GLRPNNGM 80
++ DV+ F + + E+ + G +P +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 47/250 (18%), Positives = 85/250 (34%), Gaps = 32/250 (12%)
Query: 137 SICRIGVACSAELPDERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNG 196
I R LP N+ + +RS + + +T Y E ++
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIID-EEDTYTMPSTRDYE 386
Query: 197 FSSANL-----IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGARS-FKSECKAAI 246
+ IG G FG V+ G +A+K R F E A
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE--ALT 444
Query: 247 --NIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
H +IV++ ++ ++ + G L +L + + +
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW------IIMELCTLGELRSFLQVRKFS--------LDL 490
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364
+ A ++ AL YL R H ++ NVL+ +GDF ++R++ D+
Sbjct: 491 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 365 TRFIGKLNVR 374
GKL ++
Sbjct: 548 KASKGKLPIK 557
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 23/84 (27%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H D+ NV + LGDFG++R++ ++++ I ++APE +S
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+ FG+ + E+ G++P G+
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGV 596
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 39/181 (21%), Positives = 67/181 (37%), Gaps = 29/181 (16%)
Query: 203 IGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPG----GARSFKSECKAAINIRHRNIVR 255
+G GNFGSV G +A+KV ++ G E + + + IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ +V + G L ++L GK + + ++ V+
Sbjct: 75 LIGVCQAEALM------LVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVS 120
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE--QTRFIGKLNV 373
+KYL + H +L NVLL + + DF +++ L D R GK +
Sbjct: 121 MGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 374 R 374
+
Sbjct: 178 K 178
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 13/89 (14%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YGMGS 52
H DL NV L + A + DFG+++ L + S+ + G APE +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR--- 188
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ SS DV+S+G+ + E + G +P M
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 203 IGAGNFGSVYNGTLFDGT-----TIAVKVFNLIRPGG----ARSFKSECKAAI--NIRHR 251
IGAG FG VY G L + +A+K ++ G F E A I H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGE--AGIMGQFSHH 106
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311
NI+R+ GV + ++ ++M NG+L+++L KD F + + + +
Sbjct: 107 NIIRLE----GVISKYKPM-MIITEYMENGALDKFLREKDGE--------FSVLQLVGML 153
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--TRFIG 369
+A +KYL H +L N+L++ ++ V DF ++R L D E T G
Sbjct: 154 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 370 KLNVR 374
K+ +R
Sbjct: 211 KIPIR 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 11/88 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGT---IGYVAPE---YGMGSE 53
H DL N+ ++ + + DFG++R L + G I + APE Y +
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR---K 226
Query: 54 VSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+S DV+SFGI++ E+ T G RP +
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 21/149 (14%), Positives = 45/149 (30%), Gaps = 38/149 (25%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H P N+F+ + LGD V T + Y E+ + + +++
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPVTYAPREF-LNASTATFTHA 273
Query: 59 -DVYSFGILLLEMFTGLRPNNGM----------------------FKDDLNLP----NLV 91
+ + G+ + ++ P + F LP L+
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI 333
Query: 92 KSAL---PAR---AEQILDVAFFQEIEEE 114
L R + ++ F +++ E
Sbjct: 334 GRFLNFDRRRRLLPLEAMETPEFLQLQNE 362
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 25/179 (13%), Positives = 42/179 (23%), Gaps = 29/179 (16%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+ G+ V+ + A+KVF AA + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 258 TA------------------VSGVDYQGARFKAVVYKFMP--NGSLEEWLHGKDDTHWRL 297
Q A MP + LE D +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF- 187
Query: 298 LNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
D I + + R L + H + P N+ + + +GD S
Sbjct: 188 -RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 24/179 (13%)
Query: 203 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
+G+G FG+VY G +A+K A E ++ + ++ R+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
Q ++ + MP G L +++ D + L+ + +A+
Sbjct: 83 LGICLTSTVQ------LITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAK 128
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD-EQTRFIGKLNVR 374
+ YL R+ H +L NVL+ + DF +A+ L + E GK+ ++
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 24/84 (28%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT---IGYVAPEYGMGSEVSSY 57
H DL NV + + DFG+A+ L E G I ++A E + +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 58 GDVYSFGILLLEMFT-GLRPNNGM 80
DV+S+G+ + E+ T G +P +G+
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGI 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 29/181 (16%)
Query: 203 IGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPG----GARSFKSECKAAINIRHRNIVR 255
+G GNFGSV G +A+KV ++ G E + + + IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ +V + G L ++L GK + + ++ V+
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVS 446
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE--QTRFIGKLNV 373
+KYL + H NL NVLL + + DF +++ L D R GK +
Sbjct: 447 MGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 374 R 374
+
Sbjct: 504 K 504
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APEYGMGSEVS 55
H +L NV L + A + DFG+++ L + S+ + G APE + S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKFS 517
Query: 56 SYGDVYSFGILLLEMFT-GLRPNNGM 80
S DV+S+G+ + E + G +P M
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 45/190 (23%)
Query: 203 IGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGG----ARSFKSECKAAI--NIRHRN 252
+GAG FG V +G L ++A+K ++ G R F E A+I H N
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGE--ASIMGQFDHPN 107
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
I+R+ GV + +V ++M NGSL+ +L D F + + + +
Sbjct: 108 IIRLE----GVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLR 154
Query: 313 DVARALKYL------HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE--Q 364
+A +KYL H D R N+L++ ++ V DF + R L D E
Sbjct: 155 GIASGMKYLSDMGYVHRDLAAR---------NILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 365 TRFIGKLNVR 374
T GK+ +R
Sbjct: 206 TTRGGKIPIR 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 25/85 (29%), Positives = 41/85 (48%), Gaps = 5/85 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDV-MGT---IGYVAPEYGMGSEVSS 56
H DL N+ ++ + + DFG+ R L + G I + +PE + +S
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGM 80
DV+S+GI+L E+ + G RP M
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 38/176 (21%), Positives = 64/176 (36%), Gaps = 24/176 (13%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVFT 258
IG G+F +VY G +A + + FK E + ++H NIVR +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGK-DDTHWRLLNFDFLIKKKLDIAIDVA 315
+ +V + M +G+L+ +L R +
Sbjct: 93 SWESTVKGKKCI-VLVTELMTSGTLKTYLKRFKVMKIKVLRS------------WCRQIL 139
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+ L++LH P I H +LK N+ + G V GD +A + + IG
Sbjct: 140 KGLQFLH-TRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFAKA-VIG 192
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 3/77 (3%)
Query: 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H DLK N+F+ + +GD G+A + V+GT ++APE + D
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYE-EKYDESVD 211
Query: 60 VYSFGILLLEMFTGLRP 76
VY+FG+ +LEM T P
Sbjct: 212 VYAFGMCMLEMATSEYP 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 19/172 (11%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
++G G +G VY G L + IA+K ++ E +++H+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
G + K + + +P GSL L K L + + I + LKY
Sbjct: 86 -GSFSENGFIK-IFMEQVPGGSLSALLRSK---WGPLKDNEQTIGF---YTKQILEGLKY 137
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR-FIG 369
LH +I H ++K NVL++ G + DF ++ L + T F G
Sbjct: 138 LH---DNQIVHRDIKGDNVLINTYS-GVLKISDFGTSKRLAGINPCTETFTG 185
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 6/81 (7%)
Query: 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFL-PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+K NV ++ + DFG ++ L + GT+ Y+APE YG
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP-RGYG 203
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D++S G ++EM TG P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 36/179 (20%), Positives = 68/179 (37%), Gaps = 25/179 (13%)
Query: 203 IGAGNFGSVYNGTL---FDGTTIAVKVF--NLIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G+GNFG+V G T+AVK+ P +E + + IVR+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+ +V + G L ++L + + +++ V+
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVSMG 129
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE--QTRFIGKLNVR 374
+KYL + H +L NVLL + + DF +++ L + + + GK V+
Sbjct: 130 MKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 21/93 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL NV L + A + DFG+++ L + ++ Y A +G E
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENY--------YKAQTHGKWPVKWYAPEC 191
Query: 55 SSYG------DVYSFGILLLEMFT-GLRPNNGM 80
+Y DV+SFG+L+ E F+ G +P GM
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 36/178 (20%), Positives = 69/178 (38%), Gaps = 36/178 (20%)
Query: 203 IGAGNFGSVYNGTL--------FDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRN 252
+G G F ++ G T + +KV + + SF A++ + H++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA--ASMMSKLSHKH 73
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+V + GV G +V +F+ GSL+ +L + I KL++A
Sbjct: 74 LVLNY----GVCVCGDEN-ILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAK 120
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH--------VGDFSMARFLPDTD 362
+A A+ +L + + H N+ N+LL E + D ++ + D
Sbjct: 121 QLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 25/96 (26%)
Query: 1 HCDLKPSNVFLDDEMTAH--------LGDFGIARFLPVETSFIDVMGTIGY------VAP 46
H ++ N+ L E L D GI+ V+ V P
Sbjct: 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI---------TVLPKDILQERIPWVPP 186
Query: 47 E-YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
E ++ D +SFG L E+ + G +P + +
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 16/168 (9%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
+G G+FG VY G T +A+K N R F +E ++VR
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL-DIAIDV 314
+ GV QG V+ + M G L+ +L K+ +A ++
Sbjct: 93 LL----GVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
A + YL+ + H +L N ++ ++ +GDF M R + +TD
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 14/89 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YGMGS 52
H DL N + ++ T +GDFG+ R + + G G + +PE G+
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMSPESLKDGV-- 216
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
++Y DV+SFG++L E+ T +P G+
Sbjct: 217 -FTTYSDVWSFGVVLWEIATLAEQPYQGL 244
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 37/99 (37%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPE------YGMGSE 53
H DLKP+NVFLD + LGDFG+AR L +TSF +GT Y++PE Y S
Sbjct: 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS- 197
Query: 54 VSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
D++S G LL E+ + P F + L
Sbjct: 198 -----DIWSLGCLLYELCALMPP----FTAF-SQKELAG 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 14/174 (8%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFT 258
IG G++G DG + K + + SE ++H NIVR +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+ +D +V ++ G L + T + L + + AL
Sbjct: 73 RI--IDRTNTTLY-IVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 319 KYLH--CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR-FIG 369
K H D + H +LKP+NV LD + +GDF +AR L + F+G
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+FL + T LGDFGIAR L +GT Y++PE ++ D
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSD 207
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
+++ G +L E+ T F + ++ NLV
Sbjct: 208 IWALGCVLYELCTLKHA----F-EAGSMKNLVL 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 29/177 (16%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFT 258
IG G+FG DG +K N+ R + E N++H NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ--- 87
Query: 259 AVSGVDYQGARFKA-----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
Y+ + F+ +V + G L + ++ + F + LD +
Sbjct: 88 ------YRES-FEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQ 133
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR-FIG 369
+ ALK++H +I H ++K N+ L + +GDF +AR L T E R IG
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG 187
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 42/178 (23%), Positives = 70/178 (39%), Gaps = 32/178 (17%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG V+ + +AVK + F+ E + ++H++IVR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL------DI 310
F GV +G +V+++M +G L +L L + + L +
Sbjct: 109 F----GVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 311 AIDVARALKYL------HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
A VA + YL H D R N L+ ++ +GDF M+R + TD
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATR---------NCLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 12/88 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGT----IGYVAPE---YGMGSE 53
H DL N + + +GDFG++R + T + V G I ++ PE Y
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTMLPIRWMPPESILYRK--- 236
Query: 54 VSSYGDVYSFGILLLEMFT-GLRPNNGM 80
++ DV+SFG++L E+FT G +P +
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQL 264
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 46/174 (26%), Positives = 64/174 (36%), Gaps = 28/174 (16%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS-FKSECKAAI--NIRHRNI 253
+G G FG VY G + +AVK + F E A I H+NI
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME--ALIISKFNHQNI 95
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKKLDIA 311
VR GV Q ++ + M G L+ +L + L L L +A
Sbjct: 96 VRCI----GVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL----LHVA 146
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV---GDFSMARFLPDTD 362
D+A +YL + H ++ N LL G V GDF MAR +
Sbjct: 147 RDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 26/92 (28%), Positives = 38/92 (41%), Gaps = 17/92 (18%)
Query: 1 HCDLKPSNVFLD---DEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YG 49
H D+ N L A +GDFG+AR + + G + PE G
Sbjct: 163 HRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWMPPEAFMEG 220
Query: 50 MGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ +S D +SFG+LL E+F+ G P
Sbjct: 221 I---FTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 41/195 (21%), Positives = 72/195 (36%), Gaps = 39/195 (20%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS-FKSECKAAI--NIRHRNI 253
+G FG VY G LF +A+K G R F+ E A + ++H N+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE--AMLRARLQHPNV 74
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK------ 307
V + GV + ++++ + +G L E+L + D K
Sbjct: 75 VCLL----GVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 308 -LDIAIDVARALKYL------HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
+ + +A ++YL H D R NVL+ D++ + D + R +
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATR---------NVLVYDKLNVKISDLGLFREVYA 180
Query: 361 TDE-QTRFIGKLNVR 374
D + L +R
Sbjct: 181 ADYYKLLGNSLLPIR 195
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 22/93 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL NV + D++ + D G+ R +V Y M E
Sbjct: 151 HKDLATRNVLVYDKLNVKISDLGLFR---------EVYAADYYKLLGNSLLPIRWMAPEA 201
Query: 55 SSYG------DVYSFGILLLEMFT-GLRPNNGM 80
YG D++S+G++L E+F+ GL+P G
Sbjct: 202 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 46/177 (25%), Positives = 63/177 (35%), Gaps = 34/177 (19%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS-FKSECKAAI--NIRHRNI 253
+G G FG VY G + +AVK + F E A I H+NI
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME--ALIISKFNHQNI 136
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKKLDIA 311
VR GV Q ++ + M G L+ +L + L L +A
Sbjct: 137 VRCI----GVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAM----LDLLHVA 187
Query: 312 IDVARALKYL---HCDCQPRIAHCNLKPSNVLLDDEMIGHV---GDFSMARFLPDTD 362
D+A +YL H H ++ N LL G V GDF MAR +
Sbjct: 188 RDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 26/92 (28%), Positives = 38/92 (41%), Gaps = 17/92 (18%)
Query: 1 HCDLKPSNVFLD---DEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YG 49
H D+ N L A +GDFG+AR + + G + PE G
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKWMPPEAFMEG 261
Query: 50 MGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ +S D +SFG+LL E+F+ G P
Sbjct: 262 I---FTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 30/150 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H D+KP N+ LD+ H+ DF IA LP ET + GT Y+APE + + Y
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 59 -DVYSFGILLLEMFTGLRP--------NNGMF----KDDLNLP--------NLVKSAL-- 95
D +S G+ E+ G RP + + + P +L+K L
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEP 257
Query: 96 -PAR----AEQILDVAFFQEIEEEETLYKK 120
P + + + + +I + K+
Sbjct: 258 NPDQRFSQLSDVQNFPYMNDINWDAVFQKR 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 23/58 (39%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG--DFSMARFLPDTDEQTRFIG 369
+ AL YL RI H ++KP N+LLD+ GHV DF++A LP + T G
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTMAG 176
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 31/178 (17%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS---FKSECKAAI--NIRHR 251
+G G FG V+ ++ +AVK ++ + F+ E A + N++H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA---LKDPTLAARKDFQRE--AELLTNLQHE 77
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK---- 307
+IV+ + GV G +V+++M +G L ++L L++ K
Sbjct: 78 HIVKFY----GVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 308 ---LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
L IA +A + YL H +L N L+ ++ +GDF M+R + TD
Sbjct: 133 SQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 27/93 (29%), Positives = 39/93 (41%), Gaps = 22/93 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG------MGSEV 54
H DL N + + +GDFG++R DV T Y + M E
Sbjct: 156 HRDLATRNCLVGANLLVKIGDFGMSR---------DVYSTDYYRVGGHTMLPIRWMPPES 206
Query: 55 SSYG------DVYSFGILLLEMFT-GLRPNNGM 80
Y DV+SFG++L E+FT G +P +
Sbjct: 207 IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 37/171 (21%), Positives = 60/171 (35%), Gaps = 31/171 (18%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTA 259
++ G F VY + G A+K R+ E + H NIV+ +A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 260 VSGVDYQGARFKAVVYKFM--PNGSLEEWLHGKDDTHWRLLNFDFLIKKK---------- 307
S + +A G L +FL K +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQL----------------VEFLKKMESRGPLSCDTV 138
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
L I RA++++H +P I H +LK N+LL ++ + DF A +
Sbjct: 139 LKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 25/108 (23%), Positives = 38/108 (35%), Gaps = 30/108 (27%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF-------------IDVMGTIGYVAPE 47
H DLK N+ L ++ T L DFG A + + I T Y PE
Sbjct: 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
Query: 48 YGMGSEVSSYG--------DVYSFGILLLEMFTGLRPNNGMFKDDLNL 87
+ + Y D+++ G +L + P F+D L
Sbjct: 221 --I---IDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 40/179 (22%), Positives = 68/179 (37%), Gaps = 27/179 (15%)
Query: 201 NLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGARS----FKSECKAAINI-R 249
+GAG FG V T F +AVK +++ SE K ++ +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL-----I 304
H NIV + A + + G V+ ++ G L +L K F
Sbjct: 109 HENIVNLLGACT---HGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ L + VA+ + +L H ++ NVLL + + +GDF +AR + +
Sbjct: 164 RDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 30/89 (33%), Positives = 41/89 (46%), Gaps = 22/89 (24%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APEY 48
H D+ NV L + A +GDFG+AR D+M Y+ APE
Sbjct: 187 HRDVAARNVLLTNGHVAKIGDFGLAR---------DIMNDSNYIVKGNARLPVKWMAPES 237
Query: 49 GMGSEVSSYGDVYSFGILLLEMFT-GLRP 76
+ DV+S+GILL E+F+ GL P
Sbjct: 238 IFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 37/187 (19%), Positives = 70/187 (37%), Gaps = 21/187 (11%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
++G G FG V D A+K + SE ++ H+ +VR + A
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 261 SGVDYQGARFKAVVYK--------FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
AV K + NG+L + +H + N + + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--------NLNQQRDEYWRLFR 123
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLN 372
+ AL Y+H I H +LKP N+ +D+ +GDF +A+ + + + + +
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 373 VRNFVKM 379
+ +
Sbjct: 181 PGSSDNL 187
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 33/160 (20%), Positives = 58/160 (36%), Gaps = 45/160 (28%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM---------------GTIGYVA 45
H DLKP N+F+D+ +GDFG+A+ + + + GT YVA
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 46 PEYGMGSEVSSYG---DVYSFGILLLEMFTGLRPNN---GMFKD----DLNLP------- 88
E + Y D+YS GI+ EM + K + P
Sbjct: 199 TE--VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNK 256
Query: 89 -----NLVKSAL---PAR---AEQILDVAFFQEIEEEETL 117
+++ + P + A +L+ + ++E +
Sbjct: 257 MKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 36/182 (19%), Positives = 58/182 (31%), Gaps = 32/182 (17%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G F V L DG A+K + E H NI+R+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-----------LD 309
++ F G+L ++ + + K L
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTL----------------WNEIERLKDKGNFLTEDQILW 138
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG 369
+ + + R L+ +H AH +LKP+N+LL DE + D E +R
Sbjct: 139 LLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 370 KL 371
L
Sbjct: 196 TL 197
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 27/92 (29%), Positives = 36/92 (39%), Gaps = 19/92 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----------FIDVMGTIGYVAPE--- 47
H DLKP+N+ L DE L D G + + TI Y APE
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 48 ---YGMGSEVSSYGDVYSFGILLLEMFTGLRP 76
+ + E + DV+S G +L M G P
Sbjct: 217 VQSHCVIDERT---DVWSLGCVLYAMMFGEGP 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 41/181 (22%), Positives = 69/181 (38%), Gaps = 31/181 (17%)
Query: 203 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGARS----FKSECKAAINI-RHR 251
+GAG FG V T + T+AVK +++P + SE K + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK---- 307
NIV + A + G V+ ++ G L +L K D+ +++
Sbjct: 88 NIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 308 -----LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
L + VA+ + +L H +L N+LL I + DF +AR + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 363 E 363
Sbjct: 200 N 200
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 28/93 (30%), Positives = 37/93 (39%), Gaps = 22/93 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APEY 48
H DL N+ L + DFG+AR D+ YV APE
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLAR---------DIKNDSNYVVKGNARLPVKWMAPES 218
Query: 49 GMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ DV+S+GI L E+F+ G P GM
Sbjct: 219 IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 37/172 (21%), Positives = 61/172 (35%), Gaps = 39/172 (22%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRH--RNIVRV 256
IG+G V+ A+K NL S+++E ++ I+R+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 257 FTAVSGVDYQGARFKAVVYKFM--PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD----- 309
+ Y +Y M N L WL K K +D
Sbjct: 122 YDYEITDQY--------IYMVMECGNIDLNSWLKKK---------------KSIDPWERK 158
Query: 310 -IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
++ A+ +H Q I H +LKP+N L+ D M+ + DF +A +
Sbjct: 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQP 206
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 29/90 (32%), Positives = 40/90 (44%), Gaps = 15/90 (16%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID---VMGTIGYVAPE--------YG 49
H DLKP+N FL + L DFGIA + +T+ + +G + Y+ PE
Sbjct: 178 HSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 50 MGSEVSSYG---DVYSFGILLLEMFTGLRP 76
G S DV+S G +L M G P
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 40/191 (20%), Positives = 68/191 (35%), Gaps = 41/191 (21%)
Query: 183 NNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGARSFKS 240
NL F+ + +S IG+G V+ A+K NL S+++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 241 ECKAAINIRHRN--IVRVFTAVSGVDYQGARFKAVVYKFM--PNGSLEEWLHGKDDTHWR 296
E ++ + I+R++ Y +Y M N L
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY--------IYMVMECGNIDL------------- 114
Query: 297 LLNFDFLIKKK-------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349
+L KKK ++ A+ +H Q I H +LKP+N L+ D M+ +
Sbjct: 115 ---NSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KL 167
Query: 350 GDFSMARFLPD 360
DF +A +
Sbjct: 168 IDFGIANQMQP 178
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 30/90 (33%), Positives = 41/90 (45%), Gaps = 15/90 (16%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID---VMGTIGYVAPE--------YG 49
H DLKP+N FL + L DFGIA + +T+ + +GT+ Y+ PE
Sbjct: 150 HSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 50 MGSEVSSYG---DVYSFGILLLEMFTGLRP 76
G S DV+S G +L M G P
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 42/193 (21%), Positives = 73/193 (37%), Gaps = 32/193 (16%)
Query: 203 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGARS----FKSECKAAINI-R 249
+G G FG V T +AVK +++ SE + I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFL---- 303
H+NI+ + A + Q V+ ++ G+L E+L +
Sbjct: 134 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 304 -IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
K + A VAR ++YL + H +L NVL+ ++ + + DF +AR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 363 EQT-RFIGKLNVR 374
G+L V+
Sbjct: 246 YYKKTTNGRLPVK 258
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 28/93 (30%), Positives = 39/93 (41%), Gaps = 22/93 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APEY 48
H DL NV + ++ + DFG+AR D+ Y APE
Sbjct: 214 HRDLAARNVLVTEDNVMKIADFGLAR---------DIHHIDYYKKTTNGRLPVKWMAPEA 264
Query: 49 GMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ DV+SFG+LL E+FT G P G+
Sbjct: 265 LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 38/184 (20%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTA 259
++G G +V+ G G A+KVFN I E + + H+NIV++F
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK----------LD 309
+ R K ++ +F P GSL + L + L
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSL----------------YTVLEEPSNAYGLPESEFLI 116
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGHVGDFSMARFLPDTDEQT 365
+ DV + +L + I H N+KP N++ D + + + DF AR L D ++
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 366 RFIG 369
G
Sbjct: 174 SLYG 177
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 12/88 (13%)
Query: 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-----YGMG 51
H ++KP N+ D + L DFG AR L + F+ + GT Y+ P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194
Query: 52 SEVSSYG---DVYSFGILLLEMFTGLRP 76
YG D++S G+ TG P
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 40/182 (21%), Positives = 71/182 (39%), Gaps = 34/182 (18%)
Query: 203 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGARS----FKSECKAAINI-RHR 251
+G G FG V F T+AVK +++ G S SE K I+I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 252 NIVRVFTAVSGVD---YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK- 307
N+V + A + V+ +F G+L +L K + + K
Sbjct: 92 NVVNLLGACTKPGGPLM-------VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 308 ------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
+ + VA+ +++L + H +L N+LL ++ + + DF +AR +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 362 DE 363
+
Sbjct: 202 PD 203
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 28/96 (29%), Positives = 41/96 (42%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL N+ L ++ + DFG+AR D+ YV APE
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGLAR---------DIYKDPDYVRKGDARLPLKWMAPET 221
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ + DV+SFG+LL E+F+ G P G+
Sbjct: 222 IFDRV---YTIQSDVWSFGVLLWEIFSLGASPYPGV 254
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 41/188 (21%), Positives = 68/188 (36%), Gaps = 44/188 (23%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRH--RNIVRV 256
IG+G V+ A+K NL S+++E ++ I+R+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 257 FTAVSGVDYQGARFKAVVYKFM--PNGSLEEWLHGKDDTHWRLLNFDFLIKKK------- 307
+ Y +Y M N L +L KKK
Sbjct: 75 YDYEITDQY--------IYMVMECGNIDL----------------NSWLKKKKSIDPWER 110
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL-PDTDEQTR 366
++ A+ +H Q I H +LKP+N L+ D M+ + DF +A + PDT +
Sbjct: 111 KSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVK 166
Query: 367 --FIGKLN 372
+G +N
Sbjct: 167 DSQVGTVN 174
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 30/90 (33%), Positives = 41/90 (45%), Gaps = 15/90 (16%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID---VMGTIGYVAPE--------YG 49
H DLKP+N FL + L DFGIA + +T+ + +GT+ Y+ PE
Sbjct: 131 HSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 50 MGSEVSSYG---DVYSFGILLLEMFTGLRP 76
G S DV+S G +L M G P
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 33/238 (13%), Positives = 75/238 (31%), Gaps = 36/238 (15%)
Query: 156 INDVESRLRSIKMKLLKTPV------YEEKQTINNLSFK-DLYDATNGFSSANLIGAGNF 208
N + +L + L PV +E + + + K + + +L+G G F
Sbjct: 19 GNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAF 78
Query: 209 GSVY------NGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSG 262
VY + +KV P + ++ ++A
Sbjct: 79 AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA--- 135
Query: 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLH 322
+ +V + G+L ++ +T +++ +I A+ + ++ +H
Sbjct: 136 --HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS----FAMRMLYMIEQVH 189
Query: 323 CDCQPRIAHCNLKPSNVLLDDEMIGHVG-----------DFSMARFLPDTDEQTRFIG 369
I H ++KP N +L + + D + + + T F
Sbjct: 190 ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 19/109 (17%), Positives = 29/109 (26%), Gaps = 20/109 (18%)
Query: 1 HCDLKPSNVFLDDEMTAH-----------LGDFGIARFL---PVETSFIDVMGTIGYVAP 46
H D+KP N L + L D G + + P T F T G+
Sbjct: 195 HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254
Query: 47 EYGMGSEVSSYG---DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
E + D + + M G + L +
Sbjct: 255 EMLSNK---PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 28/166 (16%), Positives = 55/166 (33%), Gaps = 43/166 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G F + + A K+ L++P E ++ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 258 TAVSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
V+ + SL + ++K +
Sbjct: 108 GFFE--------DNDFVFVVLELCRRRSL----------------LELHKRRKA-LTEPE 142
Query: 315 AR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352
AR +YLH + R+ H +LK N+ L++++ +GDF
Sbjct: 143 ARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDF 185
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 14/95 (14%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEY----GMGSEVS 55
H DLK N+FL++++ +GDFG+A + + V+ GT Y+APE G EV
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV- 222
Query: 56 SYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNL 90
DV+S G ++ + G P F + L
Sbjct: 223 ---DVWSIGCIMYTLLVGKPP----F-ETSCLKET 249
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 38/184 (20%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTA 259
++G G +V+ G G A+KVFN I E + + H+NIV++F
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK----------LD 309
+ R K ++ +F P GSL + L + L
Sbjct: 76 ---EEETTTRHKVLIMEFCPCGSL----------------YTVLEEPSNAYGLPESEFLI 116
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGHVGDFSMARFLPDTDEQT 365
+ DV + +L + I H N+KP N++ D + + + DF AR L D ++
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 366 RFIG 369
G
Sbjct: 174 SLYG 177
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 16/104 (15%)
Query: 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-----YGMG 51
H ++KP N+ D + L DFG AR L + F+ + GT Y+ P+
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194
Query: 52 SEVSSYG---DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
YG D++S G+ TG P F+ +
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKE 234
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/203 (20%), Positives = 68/203 (33%), Gaps = 47/203 (23%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVR 255
IG G FG V+ T +AVK+ ++ F+ E + NIV+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKK------ 307
+ GV G +++++M G L E+L + +
Sbjct: 115 LL----GVCAVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 308 -------LDIAIDVARALKYL------HCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
L IA VA + YL H D R N L+ + M+ + DF +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR---------NCLVGENMVVKIADFGL 220
Query: 355 ARFLPDTDE---QTRFIGKLNVR 374
+R + D + +R
Sbjct: 221 SRNIYSADYYKADGN--DAIPIR 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL N + + M + DFG++R ++ Y PE
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSR---------NIYSADYYKADGNDAIPIRWMPPES 247
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
Y ++ DV+++G++L E+F+ GL+P GM
Sbjct: 248 IFYNR---YTTESDVWAYGVVLWEIFSYGLQPYYGM 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 28/166 (16%), Positives = 55/166 (33%), Gaps = 43/166 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G F + + A K+ L++P E ++ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 258 TAVSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
V+ + SL + ++K +
Sbjct: 82 GFFE--------DNDFVFVVLELCRRRSL----------------LELHKRRKA-LTEPE 116
Query: 315 AR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352
AR +YLH + R+ H +LK N+ L++++ +GDF
Sbjct: 117 ARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDF 159
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 9e-11
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H DLK N+FL++++ +GDFG+A + + V+ GT Y+APE S D
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 197
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNL 90
V+S G ++ + G P F + L
Sbjct: 198 VWSIGCIMYTLLVGKPP----F-ETSCLKET 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 33/179 (18%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-----RHRNIVRV 256
IG G +GSV G +AVK IR + + +++ IV+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKR---IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ- 85
Query: 257 FTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+ GA F+ + + M + S +++ ++ + L K I +
Sbjct: 86 --------FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK----ITL 132
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+AL +L +I H ++KPSN+LLD G++ DF ++ L D+ +TR G
Sbjct: 133 ATVKALNHLKE--NLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTRDAG 187
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 33/92 (35%), Positives = 41/92 (44%), Gaps = 13/92 (14%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP---VETSFIDVMGTIGYVAPEYGMGSEV-SS 56
H D+KPSN+ LD L DFGI+ L +T G Y+APE S
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMAPERIDPSASRQG 205
Query: 57 YG---DVYSFGILLLEMFTG---LRPNNGMFK 82
Y DV+S GI L E+ TG N +F
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 35/186 (18%), Positives = 72/186 (38%), Gaps = 36/186 (19%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS----FKSECKAAINIRHRN 252
+G G FG V T F TT+AVK +++ + S SE + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNFDFLIKKK--- 307
+++++ A S Q ++ ++ GSL +L K +
Sbjct: 88 VIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 308 ----------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
+ A +++ ++YL + ++ H +L N+L+ + + DF ++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 358 LPDTDE 363
+ + D
Sbjct: 200 VYEEDS 205
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 26/96 (27%), Positives = 39/96 (40%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL N+ + + + DFG++R DV YV A E
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSR---------DVYEEDSYVKRSQGRIPVKWMAIES 223
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ ++ DV+SFG+LL E+ T G P G+
Sbjct: 224 LFDHI---YTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 38/181 (20%), Positives = 68/181 (37%), Gaps = 31/181 (17%)
Query: 203 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGARS----FKSECKAAINI-R 249
+G G FG V T+AVK+ ++ SE + I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL-------HGKDDTHWRLLNFDF 302
H+NI+ + A + Q V+ ++ G+L E+L R+
Sbjct: 100 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 303 LIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
K + +AR ++YL + H +L NVL+ + + + DF +AR + + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 363 E 363
Sbjct: 212 Y 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/96 (28%), Positives = 39/96 (40%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL NV + + + DFG+AR D+ Y APE
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLAR---------DINNIDYYKKTTNGRLPVKWMAPEA 230
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ + DV+SFG+L+ E+FT G P G+
Sbjct: 231 LFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 40/187 (21%), Positives = 69/187 (36%), Gaps = 24/187 (12%)
Query: 201 NLIGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGARS-FKSECKAAINI-RHRNIVR 255
++IG GNFG V + A+K F E + + H NI+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-------L 308
+ A Y + ++ P+G+L ++L L
Sbjct: 91 LLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 309 DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE-QTRF 367
A DVAR + YL Q + H +L N+L+ + + + DF ++R + +
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 368 IGKLNVR 374
+G+L VR
Sbjct: 200 MGRLPVR 206
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 17/89 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV-----APE---YGMGS 52
H DL N+ + + A + DFG++R V T+G + A E Y +
Sbjct: 165 HRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSV-- 217
Query: 53 EVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
++ DV+S+G+LL E+ + G P GM
Sbjct: 218 -YTTNSDVWSYGVLLWEIVSLGGTPYCGM 245
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 28/73 (38%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE---YGMGSEVSSY 57
H DLKP N+ LDD+M L DFG + L +V GT Y+APE M Y
Sbjct: 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 58 G---DVYSFGILL 67
G D++S G+++
Sbjct: 207 GKEVDMWSTGVIM 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-09
Identities = 40/202 (19%), Positives = 68/202 (33%), Gaps = 48/202 (23%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN-----LIRPGGARSFK 239
F + Y+ ++G G V AVK+ + + +
Sbjct: 14 GFYENYEP------KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67
Query: 240 SECKAAINI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTH 294
++I H NI+++ Y+ F +V+ M G L
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGEL----------- 111
Query: 295 WRLLNFDFLIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347
FD+L +K I + + LH + I H +LKP N+LLDD+M
Sbjct: 112 -----FDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNI 163
Query: 348 HVGDFSMARFLPDTDEQTRFIG 369
+ DF + L ++ G
Sbjct: 164 KLTDFGFSCQLDPGEKLREVCG 185
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 28/175 (16%), Positives = 46/175 (26%), Gaps = 40/175 (22%)
Query: 202 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGARS------FKSECKAAINIRHRN 252
G + D +A+ + P G S I
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTF---VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+ RV V + VV +++ GSL+E +
Sbjct: 93 VARVLDV---VHTRAGGL--VVAEWIRGGSLQEVADTSPSPVGA-----------IRAMQ 136
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQT 365
+A A H + +A PS V + + G V +PD + Q
Sbjct: 137 SLAAAADAAH---RAGVALSIDHPSRVRVSID--GDVVLAYP---ATMPDANPQD 183
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 8/76 (10%), Positives = 14/76 (18%), Gaps = 26/76 (34%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
PS V + + L + + D+
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPAT--------------------------MPDANPQDDI 185
Query: 61 YSFGILLLEMFTGLRP 76
G L + P
Sbjct: 186 RGIGASLYALLVNRWP 201
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 36/186 (19%)
Query: 203 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGARS----FKSECKAAINI-RHR 251
+G+G FG V N T + +AVK +++ S SE K + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK---- 307
NIV + A + G + +++++ G L +L K + K+
Sbjct: 110 NIVNLLGACTL---SGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 308 ----------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
L A VA+ +++L H +L NVL+ + + DF +AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 358 LPDTDE 363
+
Sbjct: 222 IMSDSN 227
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 30/96 (31%), Positives = 42/96 (43%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL NV + + DFG+AR D+M YV APE
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLAR---------DIMSDSNYVVRGNARLPVKWMAPES 245
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
G+ + DV+S+GILL E+F+ G+ P G+
Sbjct: 246 LFEGI---YTIKSDVWSYGILLWEIFSLGVNPYPGI 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 37/183 (20%), Positives = 63/183 (34%), Gaps = 35/183 (19%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V G +A+K P + E + + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 261 -SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK----------LD 309
+ ++ G L +L + +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDL----------------RKYLNQFENCCGLKEGPIRT 125
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD---DEMIGHVGDFSMARFLPDTDEQTR 366
+ D++ AL+YLH + RI H +LKP N++L +I + D A+ L + T
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 367 FIG 369
F+G
Sbjct: 183 FVG 185
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 27/82 (32%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 1 HCDLKPSNVFLD---DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N+ L + + D G A+ L + +GT+ Y+APE + +
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 58 GDVYSFGILLLEMFTGLRPNNG 79
D +SFG L E TG RP
Sbjct: 204 VDYWSFGTLAFECITGFRPFLP 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 35/176 (19%), Positives = 65/176 (36%), Gaps = 38/176 (21%)
Query: 197 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-----RHR 251
F +++G G G++ +FD +AVK S + + H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEHP 78
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMP--NGSLEEWLHGKDDTHWRLLNFDFLIKKKLD 309
N++R F + +F Y + +L+E++ KD F L + +
Sbjct: 79 NVIRYFCT-----EKDRQF---QYIAIELCAATLQEYVEQKD--------FAHLGLEPIT 122
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLL-----DDEMIGHVGDFSMARFLPD 360
+ L +LH I H +LKP N+L+ ++ + DF + + L
Sbjct: 123 LLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 12/88 (13%)
Query: 1 HCDLKPSNVFL-----DDEMTAHLGDFGIARFLPVETSFIDVM----GTIGYVAPEYGMG 51
H DLKP N+ + ++ A + DFG+ + L V GT G++APE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 52 SEVSSYG---DVYSFGILLLEMFTGLRP 76
+ D++S G + + +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 21/101 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP---VETSFIDVMGTIGYVAPE------YGMG 51
H D+KPSN+ +D L DFG + ++ ++ S GT ++ PE G
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----RGTYEFMPPEFFSNESSYNG 230
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
++V D++S GI L MF + P F ++L L
Sbjct: 231 AKV----DIWSLGICLYVMFYNVVP----FSLKISLVELFN 263
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 32/185 (17%), Positives = 67/185 (36%), Gaps = 36/185 (19%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAIN------------ 247
+ G F + D A+K + L + ++ + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 248 --IRHRNIVR---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL--HGKDDTHWRLLNF 300
I++ + + T V Y ++Y++M N S+ ++ D ++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEV-Y-------IIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 301 DFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
+IK I V + Y+H + I H ++KPSN+L+D + DF + ++ D
Sbjct: 150 IQVIKC---IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 361 TDEQT 365
+
Sbjct: 205 KKIKG 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 27/93 (29%), Positives = 39/93 (41%), Gaps = 6/93 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H DL SN+ L M + DFG+A L + + GT Y++PE S D
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESD 194
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
V+S G + + G P F D + N +
Sbjct: 195 VWSLGCMFYTLLIGRPP----F-DTDTVKNTLN 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 38/177 (21%), Positives = 68/177 (38%), Gaps = 42/177 (23%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
L+G G+F VY + G +A+K+ + + + G + ++E K ++H +I+ ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 258 TAVSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
+Y VY + NG + +L + + +
Sbjct: 78 NYFEDSNY--------VYLVLEMCHNGEM----------------NRYLKNRVKPFSENE 113
Query: 315 AR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
AR + YLH I H +L SN+LL M + DF +A L E
Sbjct: 114 ARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 31/181 (17%)
Query: 203 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGARS----FKSECKAAINI-R 249
+G G FG V T+AVK+ ++ SE + I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-- 307
H+NI+ + A + Q V+ ++ G+L E+L + + ++
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 308 -----LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+ +AR ++YL + H +L NVL+ + + + DF +AR + + D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 363 E 363
Sbjct: 258 Y 258
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 27/96 (28%), Positives = 39/96 (40%), Gaps = 28/96 (29%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APE- 47
H DL NV + + + DFG+AR D+ Y APE
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLAR---------DINNIDYYKKTTNGRLPVKWMAPEA 276
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGM 80
+ + DV+SFG+L+ E+FT G P G+
Sbjct: 277 LFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPGI 309
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 36/181 (19%), Positives = 66/181 (36%), Gaps = 33/181 (18%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAIN-------- 247
F IG+G FGSV+ DG A+K G + + A+
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-----SVDEQNALREVYAHAVL 67
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLI 304
+H ++VR F+A + D+ + GSL + + ++ L
Sbjct: 68 GQHSHVVRYFSAWAEDDH--------MLIQNEYCNGGSLADAIS-ENYRIMSYFKEAEL- 117
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364
D+ + V R L+Y+H + H ++KPSN+ + I + +++
Sbjct: 118 ---KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 365 T 365
Sbjct: 172 M 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 15/107 (14%), Positives = 34/107 (31%), Gaps = 30/107 (28%)
Query: 1 HCDLKPSNVFLDDE-------------------MTAHLGDFGIARFLPVETSFIDVMGTI 41
H D+KPSN+F+ + +GD G + G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDS 194
Query: 42 GYVAPEYGMGSEVSSYG---DVYSFGILLLEMFTGLRP---NNGMFK 82
++A E + E ++ D+++ + ++ + +
Sbjct: 195 RFLANE--VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 26/83 (31%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFL------PVETSFIDVMGTIGYVAPEYGMGSE 53
H D+K NV L + A L DFG A L + + GT ++APE MG
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 54 VSSYGDVYSFGILLLEMFTGLRP 76
+ D++S ++L M G P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 41/209 (19%), Positives = 67/209 (32%), Gaps = 32/209 (15%)
Query: 160 ESRLRSIKMKLLKTPVYEEKQTINNLSFK----DLYDATNGFSSANLIGAGNFGSVYNGT 215
S K++ L + + + K + + + + +G G+FG V+
Sbjct: 19 TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK 78
Query: 216 -LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274
G AVK L E A + IV ++ G +G +
Sbjct: 79 DKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLY----GAVREGPWVN-IF 128
Query: 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334
+ + GSL + + L + L+YLH RI H ++
Sbjct: 129 MELLEGGSLGQLI-----KQMGCLP-EDRALY---YLGQALEGLEYLH---TRRILHGDV 176
Query: 335 KPSNVLLDDEMIGHV---GDFSMARFLPD 360
K NVLL + G DF A L
Sbjct: 177 KADNVLLSSD--GSRAALCDFGHALCLQP 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 31/93 (33%), Positives = 43/93 (46%), Gaps = 11/93 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE---YGMGSEVSSY 57
H DLKP N+ LDD M L DFG + L ++ GT GY+APE M Y
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 58 G---DVYSFGILLLEMFTGLRP-----NNGMFK 82
G D+++ G++L + G P M +
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 52/234 (22%), Positives = 80/234 (34%), Gaps = 47/234 (20%)
Query: 146 SAELPDERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGA 205
SA L E +ND + + P E F YD ++IG
Sbjct: 51 SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP------KDVIGR 104
Query: 206 GNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAA----INI-----RHRNIVR 255
G V G AVK+ + + E + A +I H +I+
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL------- 308
+ + Y+ + F +V+ M G L FD+L +K
Sbjct: 165 LIDS-----YESSSFMFLVFDLMRKGEL----------------FDYLTEKVALSEKETR 203
Query: 309 DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
I + A+ +LH I H +LKP N+LLDD M + DF + L +
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 48/207 (23%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAA 245
S K+L S ++G G+ G+V F G +AVK + E
Sbjct: 12 SLKNLVV------SEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALME---- 58
Query: 246 INI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMP--NGSLEEWLHGKDDTHWRLL 298
I + H N++R + + RF +Y + N +L++ + K+ + L
Sbjct: 59 IKLLTESDDHPNVIRYYCS-----ETTDRF---LYIALELCNLNLQDLVESKNVSDENLK 110
Query: 299 NFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG-------- 350
+ + +A + +LH +I H +LKP N+L+
Sbjct: 111 LQK--EYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165
Query: 351 -----DFSMARFLPDTDEQTRFIGKLN 372
DF + + L Q+ F LN
Sbjct: 166 RILISDFGLCKKL--DSGQSSFRTNLN 190
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 30/176 (17%), Positives = 57/176 (32%), Gaps = 54/176 (30%)
Query: 1 HCDLKPSNVFLDDEMTAH-------------LGDFGIARFL-PVETSFIDVM----GTIG 42
H DLKP N+ + + DFG+ + L ++SF + GT G
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 43 YVAPEYGMGSEVSS----YG---DVYSFGILLLEMFTGLRP--------NNGMFKDDLNL 87
+ APE S D++S G + + + + + + + +L
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL 257
Query: 88 P---------------NLVKSAL---PAR---AEQILDVAFFQEIEEEETLYKKAS 122
+L+ + P + A ++L F ++ K S
Sbjct: 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVS 313
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 28/79 (35%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSY 57
H D+KPSN+ ++ L DFG++ L +++ SF+ GT Y++PE G+ S
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV---GTRSYMSPERLQGTHYSVQ 210
Query: 58 GDVYSFGILLLEMFTGLRP 76
D++S G+ L+EM G P
Sbjct: 211 SDIWSMGLSLVEMAVGRYP 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 37/178 (20%)
Query: 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHRNIVRVF 257
+GAGN G V+ + G +A K+ I + +++ + + IV
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKL---IHLEIKPAIRNQIIRELQVLHECNSPYIVG-- 95
Query: 258 TAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
+ GA + + + M GSL++ L + L K ++I
Sbjct: 96 -------FYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGK----VSIA 139
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
V + L YL +I H ++KPSN+L++ G + DF ++ L D+ + F+G
Sbjct: 140 VIKGLTYLREKH--KIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLIDSMANS-FVG 192
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 9e-10
Identities = 79/529 (14%), Positives = 159/529 (30%), Gaps = 161/529 (30%)
Query: 5 KPSNV---FLDDEMTAHLGDFGIARFL--PVETSFID-VMGTIGYVA---PEYGMGSEVS 55
K + F+++ + ++ FL P++T M T Y+ Y +
Sbjct: 74 KQEEMVQKFVEEVLRI---NYK---FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 56 SYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLV--------KSALPA---RAEQILD 104
Y +V L+ + LR + + N++ K+ + + ++
Sbjct: 128 KY-NVSR-----LQPYLKLR--QALLELRPA-KNVLIDGVLGSGKTWVALDVCLSYKVQC 178
Query: 105 VAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPD----ERMDINDVE 160
F+ ++ C +LE L + D ++ I+ ++
Sbjct: 179 KMDFK-------IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 161 SRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGT 220
+ LR +LLK+ YE + L ++ +A
Sbjct: 232 AELR----RLLKSKPYENCLLV--LL--NVQNAK-------------------------- 257
Query: 221 TIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPN 280
A FNL CK + R + V +S P+
Sbjct: 258 --AWNAFNL-----------SCKILLTTRFKQ---VTDFLSAATTTHISLDHHSMTLTPD 301
Query: 281 GSLE---EWLHGKDD--------THWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329
++L + T+ R L+ +I + + + K+++CD I
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESIRDGLATWDNWKHVNCDKLTTI 358
Query: 330 AHCNLKPS-NVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNFVKMALSQRVEEI 388
++ S NVL E S+ F P T + + + + + V +
Sbjct: 359 ----IESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLSLI----WFDV-IKSDVMVV 407
Query: 389 LNDFN----LQEIEEDRTMCMH-------ASSSSSTSTHVSIILECVNSICE-------- 429
+N + +++ ++ T+ + + + H SI+ + N
Sbjct: 408 VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV-DHYNIPKTFDSDDLIP 466
Query: 430 ----------IG----VACSAERPRE-RMKLNDVESRLRLIRKKILETS 463
IG ER RM D R + +KI S
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD----FRFLEQKIRHDS 511
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 3e-04
Identities = 51/319 (15%), Positives = 96/319 (30%), Gaps = 110/319 (34%)
Query: 152 ERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSV 211
+ D DV+ +SI L EE + + + S +
Sbjct: 31 DNFDCKDVQDMPKSI----LSK---EE--------IDHIIMSKDAVSGTLRL-------- 67
Query: 212 YNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271
F + +V+ F V V +F
Sbjct: 68 ---------------FWTLLSKQE----------------EMVQKF--VEEVLRINYKFL 94
Query: 272 AVVYKFMPNG-SLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIA 330
K S+ ++ + RL N + + K +V+R YL + R A
Sbjct: 95 MSPIKTEQRQPSMMTRMY--IEQRDRLYNDNQVFAKY-----NVSRLQPYL----KLRQA 143
Query: 331 HCNLKPS-NVLLDDEMIGHVGDFSMA-RFLPDTDEQTRFIGK---LNVRNFVKMALSQRV 385
L+P+ NVL+D ++G G +A Q + K LN++N
Sbjct: 144 LLELRPAKNVLIDG-VLG-SGKTWVALDVCLSYKVQCKMDFKIFWLNLKN------CNSP 195
Query: 386 EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKL 445
E +L LQ + + ++ + S ++++
Sbjct: 196 ETVLE--MLQ------KLLYQIDPNWTSRSDHS--------------------SNIKLRI 227
Query: 446 NDVESRLR-LIRKKILETS 463
+ +++ LR L++ K E
Sbjct: 228 HSIQAELRRLLKSKPYENC 246
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 34/179 (18%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHR-----NIVRV 256
+G G +G V + G +AVK IR + ++I R V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKR---IRATVNSQEQKRLLMDLDISMRTVDCPFTVT- 70
Query: 257 FTAVSGVDYQGARFK----AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+ GA F+ + + M + SL+++ D + D L K IA+
Sbjct: 71 --------FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTI-PEDILGK----IAV 116
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+ +AL++LH + + H ++KPSNVL++ G V DF ++ +L D + G
Sbjct: 117 SIVKALEHLHS--KLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLVDDVAKDIDAG 171
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 23/80 (28%), Positives = 36/80 (45%), Gaps = 10/80 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP---VETSFIDVMGTIGYVAPE----YGMGSE 53
H D+KPSNV ++ + DFGI+ +L + G Y+APE
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQKG 189
Query: 54 VSSYGDVYSFGILLLEMFTG 73
S D++S GI ++E+
Sbjct: 190 YSVKSDIWSLGITMIELAIL 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 52/218 (23%), Positives = 81/218 (37%), Gaps = 57/218 (26%)
Query: 177 EEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGA 235
++++ + L D F L+G G +G VY G + G A+KV ++
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----- 60
Query: 236 RSFKSECKAAINI-----RHRNIVRVFTAVSGVDYQGARFKA----------VVYKFMPN 280
+ E K IN+ HRNI Y GA K +V +F
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIAT---------YYGAFIKKNPPGMDDQLWLVMEFCGA 111
Query: 281 GSLEEWLHGKDDTHWRLLNFDFLIKKKLD---IAI---DVARALKYLHCDCQPRIAHCNL 334
GS+ + + L IA ++ R L +LH Q ++ H ++
Sbjct: 112 GSVTDLIKNTKG-------------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDI 155
Query: 335 KPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR-FIG 369
K NVLL + V DF ++ L T + FIG
Sbjct: 156 KGQNVLLTEN--AEVKLVDFGVSAQLDRTVGRRNTFIG 191
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 12/89 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPE--YGMGSEV 54
H D+K NV L + L DFG++ L +FI GT ++APE +
Sbjct: 152 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIACDENPD 208
Query: 55 SSYG---DVYSFGILLLEMFTGLRPNNGM 80
++Y D++S GI +EM G P M
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 38/144 (26%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVET------SFIDVMGTIGYVAPEYGMGSEVSS 56
DLKP N+ L+++M + DFG A+ L E+ SF+ GT YV+PE
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV---GTAQYVSPELLTEKSACK 211
Query: 57 YGDVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKSAL---P 96
D+++ G ++ ++ GL P +F K + + P +LV+ L
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDA 271
Query: 97 AR---------AEQILDVAFFQEI 111
+ + FF+ +
Sbjct: 272 TKRLGCEEMEGYGPLKAHPFFESV 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 44/232 (18%), Positives = 75/232 (32%), Gaps = 63/232 (27%)
Query: 154 MDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVY- 212
MD E R + ++ + P K+ + F ++G G+F +V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPED------------FKFGKILGEGSFSTVVL 48
Query: 213 -----NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264
+ A+K+ +I+ E + H V+++
Sbjct: 49 ARELATSREY-----AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT----- 98
Query: 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR-------- 316
+Q + NG L I+K R
Sbjct: 99 FQDDEKLYFGLSYAKNGEL----------------L-KYIRKIGSFDETCTRFYTAEIVS 141
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR 366
AL+YLH I H +LKP N+LL+++ H+ DF A+ L +Q R
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQAR 188
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 29/109 (26%), Positives = 47/109 (43%), Gaps = 18/109 (16%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP NV L +++ + DFG ++ L + + GT Y+APE + + Y
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 58 G---DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQIL 103
D +S G++L +G P F + +L +QI
Sbjct: 322 NRAVDCWSLGVILFICLSGYPP----FSEHRTQVSL--------KDQIT 358
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 39/212 (18%), Positives = 77/212 (36%), Gaps = 50/212 (23%)
Query: 177 EEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN------- 228
+ Q++ + +D Y + +G+G G V +A+++ +
Sbjct: 123 VDDQSVYPKALRDEYIMSK------TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 229 -LIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWL 287
A + ++E + + H I+++ DY +V + M G L
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGEL---- 226
Query: 288 HGKDDTHWRLLNFDFLIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340
FD ++ K + A++YLH + I H +LKP NVL
Sbjct: 227 ------------FDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVL 271
Query: 341 L---DDEMIGHVGDFSMARFLPDTDEQTRFIG 369
L +++ + + DF ++ L +T G
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 26/93 (27%), Positives = 39/93 (41%), Gaps = 8/93 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H D+KP N+ L + DFG + P +S + GT+ Y+ PE G D
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
++S G+L E G P F+ + K
Sbjct: 190 LWSLGVLCYEFLVGKPP----FEAN-TYQETYK 217
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 39/176 (22%), Positives = 68/176 (38%), Gaps = 35/176 (19%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG+VY +A+KV L + G + E + ++RH NI+R+
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIK-KKLD------ 309
+ + A ++ ++ P G++ + L K K D
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTV----------------YRELQKLSKFDEQRTAT 113
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
++A AL Y H R+ H ++KP N+LL + DF + P +
Sbjct: 114 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD 166
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 25/77 (32%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG---D 59
DLKP+N+ LD+ + D G+A + V GT GY+APE + + +Y D
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPE--VLQKGVAYDSSAD 373
Query: 60 VYSFGILLLEMFTGLRP 76
+S G +L ++ G P
Sbjct: 374 WFSLGCMLFKLLRGHSP 390
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 25/73 (34%), Positives = 36/73 (49%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 61 YSFGILLLEMFTG 73
+S G ++ EM G
Sbjct: 210 WSVGCIMGEMIKG 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 29/124 (23%), Positives = 51/124 (41%), Gaps = 26/124 (20%)
Query: 248 IRHRNIVR---VFTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGK-DDTHWRLLNFD 301
+ H+NI+ VFT ++ F+ V V + M +L + + + D L +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135
Query: 302 FLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
L +K+LH I H +LKPSN+++ + + DF +AR +
Sbjct: 136 ML------------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 362 DEQT 365
T
Sbjct: 181 FMMT 184
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 37/173 (21%), Positives = 64/173 (36%), Gaps = 37/173 (21%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN----LIRPGGARSFKSECKAAINIRHRNIVRV 256
L+G G++G V AVK+ P G + K E + +RH+N++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 257 FTAVSGVDYQGARFKA-VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
V Y + K +V ++ G E + D + +K+ + A
Sbjct: 72 VD----VLYNEEKQKMYMVMEYCVCGMQE-------------M-LDSVPEKRFPV--CQA 111
Query: 316 R--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
L+YLH I H ++KP N+LL + +A L
Sbjct: 112 HGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 24/104 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPE-------Y 48
H D+KP N+ L T + G+A L + D G+ + PE +
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAA--DDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 49 GMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
G +V D++S G+ L + TGL P F + N+ L +
Sbjct: 190 S-GFKV----DIWSAGVTLYNITTGLYP----F-EGDNIYKLFE 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 23/84 (27%), Positives = 38/84 (45%), Gaps = 14/84 (16%)
Query: 1 HCDLKPSN-VFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPE-----YGMGS 52
H D+KP N + + ++ DFG++ F + D +GT Y+APE Y
Sbjct: 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKC 228
Query: 53 EVSSYGDVYSFGILLLEMFTGLRP 76
DV+S G+++ + G P
Sbjct: 229 ------DVWSCGVIMYILLCGYPP 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 34/193 (17%), Positives = 69/193 (35%), Gaps = 48/193 (24%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAA---------INI-- 248
+G+G +G V + A+KV + R I++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 249 --RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKK 306
H NI+++F ++ ++ +V +F G L F+ +I +
Sbjct: 102 SLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGEL----------------FEQIINR 140
Query: 307 K-------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---VGDFSMAR 356
+I + + YLH + I H ++KP N+LL+++ + DF ++
Sbjct: 141 HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 357 FLPDTDEQTRFIG 369
F + +G
Sbjct: 198 FFSKDYKLRDRLG 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 44/231 (19%), Positives = 78/231 (33%), Gaps = 46/231 (19%)
Query: 150 PDERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFG 209
+ IND + I K + PV + S D YD +G+G FG
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPV-----EVKQGSVYDYYDI------LEELGSGAFG 65
Query: 210 SVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268
V+ G K N P + K+E + H ++ + A ++
Sbjct: 66 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDK 120
Query: 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI----AIDVAR----ALKY 320
++ +F+ G L FD + + + I+ R LK+
Sbjct: 121 YEMVLILEFLSGGEL----------------FDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+H + I H ++KP N++ + + V DF +A L +
Sbjct: 165 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 22/78 (28%), Positives = 37/78 (47%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ + + + + DFG+A L + T + APE V Y
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 231
Query: 59 DVYSFGILLLEMFTGLRP 76
D+++ G+L + +GL P
Sbjct: 232 DMWAIGVLGYVLLSGLSP 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 22/78 (28%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D++P N+ ++ + +FG AR L +F + Y APE VS+
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G L+ + +G+ P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 31/194 (15%), Positives = 61/194 (31%), Gaps = 42/194 (21%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAA 245
+ Y A +G G FG V+ T K ++ K E
Sbjct: 3 LYEKYMI------AEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISIL 55
Query: 246 INIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIK 305
RHRNI+ + + ++ ++++F+ + F+ +
Sbjct: 56 NIARHRNILHLHES-----FESMEELVMIFEFISGLDI----------------FERINT 94
Query: 306 KKLDI----AIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMA 355
++ + AL++LH I H +++P N++ + +F A
Sbjct: 95 SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
Query: 356 RFLPDTDEQTRFIG 369
R L D
Sbjct: 152 RQLKPGDNFRLLFT 165
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 10/82 (12%)
Query: 1 HCDLKPSN-VFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N + E A + DFG++ + + +GT Y+APE Y
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK----KY 214
Query: 58 G---DVYSFGILLLEMFTGLRP 76
DV+S G++L + G P
Sbjct: 215 DEKCDVWSIGVILFILLAGYPP 236
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 34/197 (17%), Positives = 65/197 (32%), Gaps = 43/197 (21%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR--SFKSEC 242
++Y +G+G +G V A+K+ + E
Sbjct: 34 HLSEMYQR------VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ H NI++++ ++ R +V + G L FD
Sbjct: 88 AVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGEL----------------FDE 126
Query: 303 LIKKK-------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---VGDF 352
+I + I V + YLH + I H +LKP N+LL+ + + DF
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 353 SMARFLPDTDEQTRFIG 369
++ + + +G
Sbjct: 184 GLSAVFENQKKMKERLG 200
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 28/78 (35%), Positives = 37/78 (47%), Gaps = 15/78 (19%)
Query: 1 HCDLKPSNV-FLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPE----YGMGSE 53
H DLKP N+ + A L DFG+++ + + V GT GY APE G E
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 54 VSSYGDVYSFG----ILL 67
V D++S G ILL
Sbjct: 231 V----DMWSVGIITYILL 244
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 33/195 (16%), Positives = 68/195 (34%), Gaps = 43/195 (22%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKA 244
+ D ++ + +G G VY A+KV + + ++E
Sbjct: 50 ALSDFFEV------ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGV 101
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
+ + H NI+++ ++ ++V + + G L FD ++
Sbjct: 102 LLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGEL----------------FDRIV 140
Query: 305 KKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHVGDFSM 354
+K D + A+ YLH + I H +LKP N+L + + DF +
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGL 197
Query: 355 ARFLPDTDEQTRFIG 369
++ + G
Sbjct: 198 SKIVEHQVLMKTVCG 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 23/79 (29%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 1 HCDLKPSNVFLDDEMTAH---LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N+ L + DFG++R + ++MGT Y+APE +++
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213
Query: 58 GDVYSFGILLLEMFTGLRP 76
D+++ GI+ + T P
Sbjct: 214 TDMWNIGIIAYMLLTHTSP 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 39/228 (17%), Positives = 71/228 (31%), Gaps = 61/228 (26%)
Query: 164 RSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTI 222
S + L +Y + +F + Y T+ +G G F V G
Sbjct: 7 HSSGVDLGTENLYFQSME----NFNNFYILTS-----KELGRGKFAVVRQCISKSTGQEY 57
Query: 223 AVKVFNLIRPGGARSFKSECKAA----INI-----RHRNIVRVFTAVSGVDYQGARFKAV 273
A K R +C+A I + ++ + Y+ +
Sbjct: 58 AAKFLK------KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-----YENTSEIIL 106
Query: 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI-----AIDVAR----ALKYLHCD 324
+ ++ G + F + + ++ I + + + YLH
Sbjct: 107 ILEYAAGGEI----------------FSLCLPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 325 CQPRIAHCNLKPSNVLLDDEMIGH---VGDFSMARFLPDTDEQTRFIG 369
Q I H +LKP N+LL + DF M+R + E +G
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 8/93 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGD 59
H D+KP N+ + + + DFG + P + M GT+ Y+ PE G D
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
++ G+L E G+ P F D + +
Sbjct: 195 LWCAGVLCYEFLVGMPP----F-DSPSHTETHR 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 41/178 (23%)
Query: 202 LIGAGNFGSVYNG-TLFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G FG+VY + +A+KV L + G + E + ++RH NI+R++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 258 TAVSGVDYQGARFKAVVY---KFMPNGSLEEWLHGKDDTHWRLLNFDFLIK-KKLD---- 309
+ R +Y +F P G L + L K + D
Sbjct: 81 ----NYFHDRKR----IYLMLEFAPRGEL----------------YKELQKHGRFDEQRS 116
Query: 310 --IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
++A AL Y H + ++ H ++KP N+L+ + + DF + P +T
Sbjct: 117 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 27/74 (36%), Positives = 38/74 (51%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYS 62
DLKP N+ LDD + D G+A +P + +GT+GY+APE + D ++
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWA 370
Query: 63 FGILLLEMFTGLRP 76
G LL EM G P
Sbjct: 371 LGCLLYEMIAGQSP 384
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 40/184 (21%), Positives = 71/184 (38%), Gaps = 33/184 (17%)
Query: 197 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAIN 247
F ++G G FG V G ++ A K + + G +E +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMY-----ACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
+ R +V + A Y+ +V M G L+ ++ + F +
Sbjct: 241 VNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY-------HMGQAGFPEARA 288
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQT 365
+ A ++ L+ LH + RI + +LKP N+LLDD GH+ D +A +P+
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIK 343
Query: 366 RFIG 369
+G
Sbjct: 344 GRVG 347
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 43/190 (22%), Positives = 69/190 (36%), Gaps = 47/190 (24%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHRNIVRVF 257
IG+G V +A+K NL + ++ E I H NIV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMSQCHHPNIVS-- 77
Query: 258 TAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD---I 310
Y + +V K + GS+ + + ++ LD I
Sbjct: 78 -------YYTSFVVKDELWLVMKLLSGGSVLDIIKH-------IVAKGEHKSGVLDESTI 123
Query: 311 AI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQT 365
A +V L+YLH + H ++K N+LL ++ G V DF ++ FL + T
Sbjct: 124 ATILREVLEGLEYLHKN---GQIHRDVKAGNILLGED--GSVQIADFGVSAFLATGGDIT 178
Query: 366 R------FIG 369
R F+G
Sbjct: 179 RNKVRKTFVG 188
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 17/89 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL---------PVETSFIDVMGTIGYVAPEYGMG 51
H D+K N+ L ++ + + DFG++ FL V +F+ GT ++APE +
Sbjct: 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV---GTPCWMAPE--VM 198
Query: 52 SEVSSYG---DVYSFGILLLEMFTGLRPN 77
+V Y D++SFGI +E+ TG P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 27/78 (34%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ + + L DFG+ L + S GT + APE G V Y
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G+L + +GL P
Sbjct: 338 DMWSVGVLSYILLSGLSP 355
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 38/207 (18%), Positives = 68/207 (32%), Gaps = 41/207 (19%)
Query: 174 PVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP 232
Y + I + D YD +G G FG V+ T G A K
Sbjct: 142 QYYPQPVEIKHDHVLDHYDI------HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 233 GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDD 292
+ + E + +RH +V + A ++ ++Y+FM G L
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGEL--------- 241
Query: 293 THWRLLNFDFLIKKKLDI----AIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDDE 344
F+ + + + A++ R L ++H + H +LKP N++ +
Sbjct: 242 -------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTK 291
Query: 345 MIGHV--GDFSMARFLPDTDEQTRFIG 369
+ DF + L G
Sbjct: 292 RSNELKLIDFGLTAHLDPKQSVKVTTG 318
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 1/75 (1%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYGDVY 61
DLKP NV LDD+ + D G+A L + GT G++APE +G E D +
Sbjct: 314 DLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373
Query: 62 SFGILLLEMFTGLRP 76
+ G+ L EM P
Sbjct: 374 ALGVTLYEMIAARGP 388
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 21/56 (37%), Positives = 31/56 (55%), Gaps = 8/56 (14%)
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR-FIG 369
L++LH Q I + +LKP NVLLDD+ G+V D +A L +T+ + G
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAG 351
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 43/232 (18%), Positives = 83/232 (35%), Gaps = 41/232 (17%)
Query: 150 PDERMDINDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFG 209
ERM + + ++ + P T + Y S ++G G FG
Sbjct: 48 LTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT----VSKTEILGGGRFG 103
Query: 210 SVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268
V+ G +A K+ K+E + H N+++++ A ++
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----FESK 158
Query: 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI----AIDVAR----ALKY 320
+V +++ G L FD +I + ++ I + +++
Sbjct: 159 NDIVLVMEYVDGGEL----------------FDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 321 LHCDCQPRIAHCNLKPSNVLL---DDEMIGHVGDFSMARFLPDTDEQTRFIG 369
+H Q I H +LKP N+L D + I + DF +AR ++ G
Sbjct: 203 MH---QMYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFG 250
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ + + DFG+AR GT ++APE VS
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G++ + +GL P
Sbjct: 270 DMWSVGVIAYMLLSGLSP 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 10/82 (12%)
Query: 1 HCDLKPSN-VFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N + A++ DFG++ D +GT Y+APE G +Y
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG----TY 204
Query: 58 G---DVYSFGILLLEMFTGLRP 76
DV+S G++L + +G P
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP 226
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 38/181 (20%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVFT 258
+G G+FG V G AVKV + + + S E + + H NI++++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL-------DIA 311
++ + +V + G L FD +I +K I
Sbjct: 94 F-----FEDKGYFYLVGEVYTGGEL----------------FDEIISRKRFSEVDAARII 132
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---VGDFSMARFLPDTDEQTRFI 368
V + Y+H + +I H +LKP N+LL+ + + DF ++ + + I
Sbjct: 133 RQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 369 G 369
G
Sbjct: 190 G 190
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 6/73 (8%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP NV L +++ + DFG ++ L + + GT Y+APE + + Y
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 58 G---DVYSFGILL 67
D +S G++L
Sbjct: 197 NRAVDCWSLGVIL 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 35/186 (18%), Positives = 68/186 (36%), Gaps = 44/186 (23%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAI--------NIRHRNI 253
+G+G G V +A+K+ + + + +++ + + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL----- 308
+++ DY +V + M G L FD ++ K
Sbjct: 78 IKIKNFFDAEDYY------IVLELMEGGEL----------------FDKVVGNKRLKEAT 115
Query: 309 --DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHVGDFSMARFLPDTDE 363
+ A++YLH + I H +LKP NVLL +++ + + DF ++ L +T
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 364 QTRFIG 369
G
Sbjct: 173 MRTLCG 178
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 10/82 (12%)
Query: 1 HCDLKPSN-VFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N + E + DFG++ T D +GT Y+APE G +Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG----TY 199
Query: 58 G---DVYSFGILLLEMFTGLRP 76
DV+S G++L + +G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 41/197 (20%), Positives = 71/197 (36%), Gaps = 43/197 (21%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSEC 242
+F + Y+ ++G G+FG V AVKV N + + E
Sbjct: 19 TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ + H NI+++F + + +V + G L FD
Sbjct: 73 ELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGEL----------------FDE 111
Query: 303 LIKKK-------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---VGDF 352
+IK+K I V + Y+H + I H +LKP N+LL+ + + DF
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 353 SMARFLPDTDEQTRFIG 369
++ + IG
Sbjct: 169 GLSTCFQQNTKMKDRIG 185
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 24/73 (32%), Positives = 35/73 (47%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 61 YSFGILLLEMFTG 73
+S G ++ EM
Sbjct: 247 WSVGCIMGEMVRH 259
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 29/123 (23%), Positives = 52/123 (42%), Gaps = 26/123 (21%)
Query: 249 RHRNIVR---VFTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGK-DDTHWRLLNFDF 302
H+NI+ VFT ++ F+ V V + M +L + + + D +
Sbjct: 119 NHKNIISLLNVFTPQKTLE----EFQDVYLVMELMDA-NLCQVIQMELDHERMS-----Y 168
Query: 303 LIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
L+ + L +K+LH I H +LKPSN+++ + + DF +AR +
Sbjct: 169 LLYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 363 EQT 365
T
Sbjct: 219 MMT 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 30/84 (35%), Positives = 39/84 (46%), Gaps = 11/84 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP---VETSFIDVMGTIGYVAPE--YGMGSEVS 55
H D+KPSN+ LD+ L DFGI+ L + G Y+APE
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPDPTKP 204
Query: 56 SYG---DVYSFGILLLEMFTGLRP 76
Y DV+S GI L+E+ TG P
Sbjct: 205 DYDIRADVWSLGISLVELATGQFP 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 38/178 (21%), Positives = 64/178 (35%), Gaps = 35/178 (19%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-----RHRNIVRV 256
+G+G G V+ G IAVK +R G + +++ IV+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQ---MRRSGNKEENKRILMDLDVVLKSHDCPYIVQ- 88
Query: 257 FTAVSGVDYQGARFK-AVVYKFMP--NGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
G V+ M E+ + L K + +
Sbjct: 89 --------CFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----IPERILGK----MTVA 132
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+ +AL YL + + H ++KPSN+LLD+ G + DF ++ L D + R G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAG 186
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 3e-08
Identities = 42/175 (24%), Positives = 65/175 (37%), Gaps = 45/175 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G FG V G G +AVK+ N + K E + RH +I+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 258 TAVSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLDIAID 313
YQ + M G L FD++ K +++
Sbjct: 77 -------YQVISTPTDFFMVMEYVSGGEL----------------FDYICKHGRVEE--M 111
Query: 314 VAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
AR A+ Y H + + H +LKP NVLLD M + DF ++ + D
Sbjct: 112 EARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 18/99 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPE------YGMGSE 53
H DLKP NV LD M A + DFG++ + + F+ G+ Y APE Y G E
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISGRLYA-GPE 191
Query: 54 VSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
V D++S G++L + G P F DD ++P L K
Sbjct: 192 V----DIWSCGVILYALLCGTLP----F-DDEHVPTLFK 221
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 27/83 (32%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA-RFLPVETSFIDVM-GTIGYVAPE--YGMGSEVSS 56
H D+KP N+ +D L DFG + + T V GT Y++PE M
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 57 YG---DVYSFGILLLEMFTGLRP 76
YG D +S G+ + EM G P
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETP 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 40/194 (20%), Positives = 69/194 (35%), Gaps = 52/194 (26%)
Query: 197 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAIN 247
F +IG G FG V +F A+K+ N +++ F+ E +N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVF-----AMKILNKWEMLKRAETACFREERDVLVN 130
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
+ I + A +Q +V + G L L K +
Sbjct: 131 GDSKWITTLHYA-----FQDDNNLYLVMDYYVGGDL----------------LTLLSKFE 169
Query: 308 LDIAIDVAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMA-R 356
+ ++AR A+ +H Q H ++KP N+L+D GH+ DF +
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLK 224
Query: 357 FLPDTDEQTR-FIG 369
+ D Q+ +G
Sbjct: 225 LMEDGTVQSSVAVG 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 32/175 (18%), Positives = 55/175 (31%), Gaps = 41/175 (23%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFN--------LIRPGGARSFKSECKAAINIRHRNI 253
+G+G FG V+ + VK I E + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
++V + M E+ G D L F F+ + +
Sbjct: 92 IKVLDIFENQGF--------FQLVM-----EKHGSGLD------L-FAFIDRHP-RLDEP 130
Query: 314 VAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
+A A+ YL I H ++K N+++ ++ + DF A +L
Sbjct: 131 LASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 11/82 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE------YGMGSEV 54
H D+K N+ + ++ T L DFG A +L F GTI Y APE Y G E+
Sbjct: 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR-GPEL 211
Query: 55 SSYGDVYSFGILLLEMFTGLRP 76
+++S G+ L + P
Sbjct: 212 ----EMWSLGVTLYTLVFEENP 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 31/106 (29%), Positives = 44/106 (41%), Gaps = 23/106 (21%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------------APEY 48
H DL N+ L ++ + DFG+AR D+ YV APE
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLAR---------DIYKDPDYVRKGDARLPLKWMAPET 266
Query: 49 GMGSEVSSYGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKS 93
+ DV+SFG+LL E+F+ G P G+ K D +K
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 31/190 (16%), Positives = 64/190 (33%), Gaps = 30/190 (15%)
Query: 203 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGARSFKSECKAAINI-----RHR 251
+G G FG V F T+AVK +++ G S + + I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311
N+V + A + + V+ +F G+L +L K + ++ D
Sbjct: 87 NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY- 141
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKL 371
+ + D + R+ S+ G V + S++ + + + L
Sbjct: 142 ------VGAIPVDLKRRLDSITSSQSS-----ASSGFVEEKSLSDVEEEEAPEDLYKDFL 190
Query: 372 NVRNFVKMAL 381
+ + + +
Sbjct: 191 TLEHLICYSF 200
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 51/196 (26%)
Query: 192 DATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-- 248
D F+ IG G+FG V+ G +A+K+ +L A + + I +
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLS 75
Query: 249 --RHRNIVRVFTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ + Y G+ K ++ +++ GS D
Sbjct: 76 QCDSPYVTK---------YYGSYLKDTKLWIIMEYLGGGSA----------------LDL 110
Query: 303 LIKKKLD---IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSM 354
L LD IA ++ + L YLH + + H ++K +NVLL + G V DF +
Sbjct: 111 LEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH--GEVKLADFGV 165
Query: 355 ARFLPDT-DEQTRFIG 369
A L DT ++ F+G
Sbjct: 166 AGQLTDTQIKRNTFVG 181
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 7/84 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K +NV L + L DFG+A L +F+ GT ++APE S S
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQSAYDS 198
Query: 57 YGDVYSFGILLLEMFTGLRPNNGM 80
D++S GI +E+ G P++ +
Sbjct: 199 KADIWSLGITAIELARGEPPHSEL 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 39/194 (20%), Positives = 73/194 (37%), Gaps = 42/194 (21%)
Query: 194 TNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGARSFK----SECKAAIN 247
+ F + G G FG+V G G ++A+K V F+ +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAV 75
Query: 248 IRHRNIVR---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
+ H NIV+ F + D + + VV +++P D H R
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRD-IYLNVVMEYVP-----------DTLH-RCC--RNYY 120
Query: 305 KKKLDIAID--------VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH--VGDFSM 354
++++ + R++ LH + H ++KP NVL+++ G + DF
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEAD-GTLKLCDFGS 178
Query: 355 ARFLPDTDEQTRFI 368
A+ L ++ +I
Sbjct: 179 AKKLSPSEPNVAYI 192
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/88 (29%), Positives = 38/88 (43%), Gaps = 23/88 (26%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIAR-FLPVETSFIDVMGTIGYV------APEYGMG 51
H D+KP NV +++ L DFG A+ P E + + Y+ APE G
Sbjct: 154 HRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSEPN-------VAYICSRYYRAPELIFG 205
Query: 52 SEVSSYG---DVYSFGILLLEMFTGLRP 76
+ Y D++S G + EM G P
Sbjct: 206 N--QHYTTAVDIWSVGCIFAEMMLG-EP 230
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAH----LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKP N+ L D+ L DFG+A + F ++ GT +VAPE +
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL 197
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D++S G++ + +G P
Sbjct: 198 EADMWSIGVITYILLSGASP 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 43/202 (21%), Positives = 73/202 (36%), Gaps = 48/202 (23%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSF--KSEC 242
+D YD +G+G F V G A K + +R + E
Sbjct: 9 KVEDFYDI------GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 243 KAAINI----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLL 298
+ ++I H N++ + Y+ ++ + + G L
Sbjct: 63 EREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGEL--------------- 102
Query: 299 NFDFLIKKKL---DIAIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH--- 348
FDFL +K+ + A + + YLH +IAH +LKP N++L D+ I
Sbjct: 103 -FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 349 -VGDFSMARFLPDTDEQTRFIG 369
+ DF +A + D E G
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFG 180
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 37/169 (21%), Positives = 62/169 (36%), Gaps = 43/169 (25%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVR 255
S IG G+ G V G +AVK+ +L + +E + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 256 VFTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD-- 309
+ V+ +F+ G+L D + + +L+
Sbjct: 107 ---------MYKSYLVGEELWVLMEFLQGGALT----------------DIVSQVRLNEE 141
Query: 310 -IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDF 352
IA V +AL YLH + H ++K ++LL + G V DF
Sbjct: 142 QIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD--GRVKLSDF 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 7/81 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA----RFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K ++ L + L DFG + +P S + GT ++APE S ++
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEVISRSLYAT 220
Query: 57 YGDVYSFGILLLEMFTGLRPN 77
D++S GI+++EM G P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPY 241
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAH----LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKP N+ L D + DFG+A + F ++ GT +VAPE +
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 196
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D++S G++ + +G P
Sbjct: 197 EADMWSIGVITYILLSGASP 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 42/204 (20%), Positives = 72/204 (35%), Gaps = 52/204 (25%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKA 244
+ D YD +G+G F V G A K R +R + +
Sbjct: 8 NVDDYYDT------GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSRE 59
Query: 245 AI--------NIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWR 296
I I+H N++ + Y+ ++ + + G L
Sbjct: 60 DIEREVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGEL------------- 101
Query: 297 LLNFDFLIKKKL---DIAIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH- 348
FDFL +K+ + A + + + YLH +IAH +LKP N++L D +
Sbjct: 102 ---FDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 155
Query: 349 ---VGDFSMARFLPDTDEQTRFIG 369
+ DF +A + +E G
Sbjct: 156 RIKIIDFGLAHKIDFGNEFKNIFG 179
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 38/201 (18%), Positives = 65/201 (32%), Gaps = 67/201 (33%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN------------LIRPGGARSFKSECKAAIN- 247
IG G++G V D T A+KV + P G R C
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 248 -------------IRHRNIVRVF----TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGK 290
+ H N+V++ Y +V++ + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPV------- 125
Query: 291 DDTHWRLLNFDFLIKKKLDIAIDVAR--------ALKYLHCDCQPRIAHCNLKPSNVLLD 342
+ K L D AR ++YLH +I H ++KPSN+L+
Sbjct: 126 ---------MEVPTLKPLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVG 171
Query: 343 DEMIGHVGDFSMARFLPDTDE 363
++ + DF ++ +D
Sbjct: 172 EDGHIKIADFGVSNEFKGSDA 192
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 24/94 (25%), Positives = 42/94 (44%), Gaps = 9/94 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPEYGMGSEVSSYG- 58
H D+KPSN+ + ++ + DFG++ + + +GT ++APE + G
Sbjct: 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGK 219
Query: 59 --DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNL 90
DV++ G+ L G P F D + L
Sbjct: 220 ALDVWAMGVTLYCFVFGQCP----F-MDERIMCL 248
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 43/191 (22%), Positives = 67/191 (35%), Gaps = 50/191 (26%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHR 251
+ +G G FG VY G A KV + E I I H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE----IEILATCDHP 76
Query: 252 NIVRVFTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
IV+ GA + ++ +F P G+++ + + +
Sbjct: 77 YIVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIML--------------ELDRG 113
Query: 308 LD---IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLP 359
L I + + AL +LH RI H +LK NVL+ E G + DF ++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLE--GDIRLADFGVSAKNL 168
Query: 360 DTDEQ-TRFIG 369
T ++ FIG
Sbjct: 169 KTLQKRDSFIG 179
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 12/89 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPE--YGMGSEV 54
H DLK NV + E L DFG++ SFI GT ++APE +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMAPEVVMCETMKD 196
Query: 55 SSYG---DVYSFGILLLEMFTGLRPNNGM 80
+ Y D++S GI L+EM P++ +
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 5e-08
Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAH----LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKP N+ L D+ + L DFGIA + F ++ GT +VAPE +
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL 190
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D++S G++ + +G P
Sbjct: 191 EADMWSIGVITYILLSGASP 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 45/202 (22%), Positives = 75/202 (37%), Gaps = 48/202 (23%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSF--KSEC 242
+D Y+ +G+G F V G A K R +R + E
Sbjct: 2 MVEDHYEMGE------ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 55
Query: 243 KAAINI----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLL 298
+ +NI RH NI+ + ++ ++ + + G L
Sbjct: 56 EREVNILREIRHPNIITLHDI-----FENKTDVVLILELVSGGEL--------------- 95
Query: 299 NFDFLIKKKL---DIAIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH--- 348
FDFL +K+ D A + + YLH RIAH +LKP N++L D+ + +
Sbjct: 96 -FDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRI 151
Query: 349 -VGDFSMARFLPDTDEQTRFIG 369
+ DF +A + +E G
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFG 173
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 25/80 (31%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 1 HCDLKPSNVFLDDEMTAH----LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKP N+ L D+ L DFG+A + F ++ GT +VAPE +
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL 197
Query: 57 YGDVYSFGILLLEMFTGLRP 76
D++S G++ + +G P
Sbjct: 198 EADMWSIGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 45/208 (21%), Positives = 75/208 (36%), Gaps = 48/208 (23%)
Query: 180 QTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSF 238
+T +D YD +G+G F V G A K + +R
Sbjct: 3 ETFKQQKVEDFYDI------GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG 56
Query: 239 --KSECKAAINI----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDD 292
+ E + ++I H NI+ + Y+ ++ + + G L
Sbjct: 57 VCREEIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGEL--------- 102
Query: 293 THWRLLNFDFLIKKKL---DIAIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345
FDFL +K+ + A + + YLH +IAH +LKP N++L D+
Sbjct: 103 -------FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152
Query: 346 IGH----VGDFSMARFLPDTDEQTRFIG 369
I + DF +A + D E G
Sbjct: 153 IPIPHIKLIDFGLAHEIEDGVEFKNIFG 180
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 6e-08
Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 8/81 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ L +FG+AR +PV +V+ T+ Y P+ G++ Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK--LYS 180
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D++S G + E+ RP
Sbjct: 181 TSIDMWSAGCIFAELANAGRP 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 36/183 (19%), Positives = 59/183 (32%), Gaps = 70/183 (38%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGARSFKSECKAAINIRH 250
IG G +G+V+ +A+K L +R E ++H
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICLLKELKH 60
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL---IKKK 307
+NIVR L + LH L F+F +KK
Sbjct: 61 KNIVR---------------------------LHDVLHSDKKLT---LVFEFCDQDLKKY 90
Query: 308 LD---IAIDVA----------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
D +D + L + H + H +LKP N+L++ + +F +
Sbjct: 91 FDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGL 147
Query: 355 ARF 357
AR
Sbjct: 148 ARA 150
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 32/102 (31%), Positives = 44/102 (43%), Gaps = 24/102 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL----PVETSFIDVMGTIGYVAPE------YGM 50
H DLK N+ LD +M + DFG + ++ G Y APE Y
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQGKKY-D 191
Query: 51 GSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
G EV DV+S G++L + +G P F D NL L +
Sbjct: 192 GPEV----DVWSLGVILYTLVSGSLP----F-DGQNLKELRE 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 38/178 (21%), Positives = 63/178 (35%), Gaps = 43/178 (24%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSECKAAINIRHRNIVRVFTA 259
IG GNF V + G +A+K+ + + P + E + + H NIV++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 260 VSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
++ + +Y M G + FD+L+ + AR
Sbjct: 80 -----FEVIETEKTLYLIMEYASGGEV----------------FDYLVAHG-RMKEKEAR 117
Query: 317 --------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM-ARFLPDTDEQT 365
A++Y H I H +LK N+LLD +M + DF F
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 29/91 (31%), Positives = 37/91 (40%), Gaps = 17/91 (18%)
Query: 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVETSFIDVMGTIGYVAPE------YGMGSE 53
H D+K N+ +D A L DFG L + + D GT Y PE Y
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEWISRHQY-HALP 219
Query: 54 VSSYGDVYSFGILLLEMFTGLRPNNGMFKDD 84
V+S GILL +M G P F+ D
Sbjct: 220 A----TVWSLGILLYDMVCGDIP----FERD 242
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 37/182 (20%), Positives = 63/182 (34%), Gaps = 48/182 (26%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSECKAAINI--------RH 250
L+G G FG+V+ G L D +A+KV + S C + + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLD 309
++R+ + + E L +D L FD++ +K L
Sbjct: 98 PGVIRL--------LDWFETQEGFMLVL-----ERPLPAQD------L-FDYITEKGPLG 137
Query: 310 IAIDVAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLP 359
+R A+++ H + H ++K N+L+D G DF L
Sbjct: 138 E--GPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRR-GCAKLIDFGSGALLH 191
Query: 360 DT 361
D
Sbjct: 192 DE 193
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 43/169 (25%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVR 255
++ IG G G+VY + G +A++ NL + +E ++ NIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 256 VFTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD-- 309
Y + VV +++ GSL D + + +D
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLT----------------DVVTETCMDEG 116
Query: 310 -IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDF 352
IA + +AL++LH + ++ H ++K N+LL + G V DF
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD--GSVKLTDF 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 7/81 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA----RFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K N+ L + + L DFG ++ + GT ++APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGP 195
Query: 57 YGDVYSFGILLLEMFTGLRPN 77
D++S GI+ +EM G P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPY 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/77 (29%), Positives = 34/77 (44%), Gaps = 13/77 (16%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H +LKP N+ L L DFG+A + ++ GT GY++PE Y
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK---DPY 207
Query: 58 G---DVYSFG----ILL 67
D+++ G ILL
Sbjct: 208 SKPVDIWACGVILYILL 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 42/197 (21%), Positives = 70/197 (35%), Gaps = 43/197 (21%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSEC 242
F D YD +G G F V G A K+ N + + + E
Sbjct: 26 KFSDNYDV------KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ ++H NIVR+ + Q F +V+ + G L F+
Sbjct: 80 RICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGEL----------------FED 118
Query: 303 LIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---VGDF 352
++ ++ + ++ Y H I H NLKP N+LL + G + DF
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 353 SMARFLPDTDEQTRFIG 369
+A + D++ F G
Sbjct: 176 GLAIEVNDSEAWHGFAG 192
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 30/91 (32%), Positives = 39/91 (42%), Gaps = 17/91 (18%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE------YGMGSE 53
H D+K N+ +D + L DFG L +T + D GT Y PE Y G
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRY-HGRS 229
Query: 54 VSSYGDVYSFGILLLEMFTGLRPNNGMFKDD 84
V+S GILL +M G P F+ D
Sbjct: 230 A----AVWSLGILLYDMVCGDIP----FEHD 252
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 35/184 (19%), Positives = 60/184 (32%), Gaps = 54/184 (29%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN------LIRPGGARSFKSECKAAINIRHR--N 252
L+G+G FGSVY+G + D +A+K E +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFM----PNGSLEEWLHGKDDTHWRLLNFDFLIKK-K 307
++R+ + P L FDF+ ++
Sbjct: 110 VIRL--------LDWFERPDSFVLILERPEPVQDL----------------FDFITERGA 145
Query: 308 LDIAIDVAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARF 357
L ++AR A+++ H + H ++K N+L+D G + DF
Sbjct: 146 LQE--ELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL 199
Query: 358 LPDT 361
L DT
Sbjct: 200 LKDT 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 33/180 (18%), Positives = 60/180 (33%), Gaps = 46/180 (25%)
Query: 204 GAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHRNIVRVFT 258
G + +V G + V+ NL + + + +++ H NIV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVP--- 90
Query: 259 AVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD---IA 311
Y+ VV FM GS ++ L+ F ++ IA
Sbjct: 91 ------YRATFIADNELWVVTSFMAYGSAKD-----------LICTHF--MDGMNELAIA 131
Query: 312 I---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR 366
V +AL Y+H H ++K S++L+ + G V + ++ R
Sbjct: 132 YILQGVLKALDYIH---HMGYVHRSVKASHILISVD--GKVYLSGLRSNLSMISHGQRQR 186
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 12/91 (13%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--------PVETSFIDVMGTIGYVAPEYGMGS 52
H +K S++ + + +L + V + + +++PE +
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-LQQ 209
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRPNNGM 80
+ Y D+YS GI E+ G P M
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 45/175 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G FG V G G +AVK+ N + + E + RH +I++++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 258 TAVSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLDIAID 313
+S + ++ M G L FD++ K +LD
Sbjct: 83 QVIST--------PSDIFMVMEYVSGGEL----------------FDYICKNGRLDE--K 116
Query: 314 VAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
+R + Y H + H +LKP NVLLD M + DF ++ + D
Sbjct: 117 ESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 39/104 (37%), Positives = 50/104 (48%), Gaps = 28/104 (26%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA------RFLPVETSFIDVMGTIGYVAPE------Y 48
H DLKP NV LD M A + DFG++ FL TS G+ Y APE Y
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTS----CGSPNYAAPEVISGRLY 192
Query: 49 GMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
G EV D++S G++L + G P F DD ++P L K
Sbjct: 193 A-GPEV----DIWSSGVILYALLCGTLP----F-DDDHVPTLFK 226
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 25/94 (26%), Positives = 38/94 (40%), Gaps = 15/94 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETS-----FIDVMGTIGYVAPEYGMGSE 53
H D+KP N + + DFG+++ + GT +VAPE + +
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTT 249
Query: 54 VSSYG---DVYSFGILLLEMFTGLRPNNGMFKDD 84
SYG D +S G+LL + G P F
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVP----FPGV 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 38/199 (19%), Positives = 61/199 (30%), Gaps = 37/199 (18%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFN-----LIRPGGARSFKSECKAAINIRHRNIVRV 256
IG G++G V A+K+ N I P K+E + + H NI R+
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 257 FTA-------------VSG-------------VDYQGARFKAVVYKFMPNGSLEEWLHGK 290
+ G + A EE ++G
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 291 DDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV- 349
L+F K +I + AL YLH I H ++KP N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 350 -GDFSMARFLPDTDEQTRF 367
DF +++ + +
Sbjct: 211 LVDFGLSKEFYKLNNGEYY 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 9/85 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA-RFLPVETSFIDVM-GTIGYVAPE----YGMGSEV 54
H D+KP N+ LD L DFG + T V GT Y++PE G G
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 55 SSYG---DVYSFGILLLEMFTGLRP 76
SYG D ++ G+ EMF G P
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 52/194 (26%)
Query: 197 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAIN 247
F +IG G F V G ++ A+K+ N +++ G F+ E +N
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVY-----AMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
R I ++ A +Q + +V ++ G L L K
Sbjct: 118 GDRRWITQLHFA-----FQDENYLYLVMEYYVGGDL----------------LTLLSKFG 156
Query: 308 LDIAIDVAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMA-R 356
I ++AR A+ +H + H ++KP N+LLD GH+ DF +
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLK 211
Query: 357 FLPDTDEQTR-FIG 369
D ++ +G
Sbjct: 212 LRADGTVRSLVAVG 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 37/174 (21%), Positives = 67/174 (38%), Gaps = 44/174 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
+G G+FG V T +A+K + L + + E +RH +I+++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 258 TAVSGVDYQGARFKAVVYKFM--PNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLDIAIDV 314
Y + + G L FD++++K ++ D
Sbjct: 75 -------YDVITTPTDIVMVIEYAGGEL----------------FDYIVEKKRMTE--DE 109
Query: 315 AR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360
R A++Y H +I H +LKP N+LLDD + + DF ++ + D
Sbjct: 110 GRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 39/102 (38%), Positives = 51/102 (50%), Gaps = 24/102 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP----VETSFIDVMGTIGYVAPE------YGM 50
H DLKP N+ LDD + + DFG++ + ++TS G+ Y APE Y
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----CGSPNYAAPEVINGKLYA- 185
Query: 51 GSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
G EV DV+S GI+L M G P F DD +PNL K
Sbjct: 186 GPEV----DVWSCGIVLYVMLVGRLP----F-DDEFIPNLFK 218
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 25/85 (29%), Positives = 35/85 (41%), Gaps = 15/85 (17%)
Query: 1 HCDLKPSN-VFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV--- 54
H D+KP N ++ A L DFG A+ S T YVAP EV
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP------EVLGP 237
Query: 55 SSYG---DVYSFGILLLEMFTGLRP 76
Y D++S G+++ + G P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 40/151 (26%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPE----YGMGSEVSSY 57
DLKP N+ LD + DFG A+++P T + GT Y+APE +
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---GTPDYIAPEVVSTKPYNKSI--- 184
Query: 58 GDVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKS------- 93
D +SFGIL+ EM G P + +L P +L+
Sbjct: 185 -DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 243
Query: 94 ----ALPARAEQILDVAFFQEIEEEETLYKK 120
L E + + +F+E+ E+ L +
Sbjct: 244 QRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 25/73 (34%), Positives = 38/73 (52%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ + L DFG+AR + + V+ T+ Y APE + S ++ D+
Sbjct: 143 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 202
Query: 61 YSFGILLLEMFTG 73
+S G + EMF
Sbjct: 203 WSVGCIFAEMFRR 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 15/41 (36%), Positives = 22/41 (53%), Gaps = 3/41 (7%)
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356
R L +LH R+ H +LKP N+L+ + DF +AR
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 23/80 (28%), Positives = 35/80 (43%), Gaps = 19/80 (23%)
Query: 1 HCDLKPSNV-FLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPE------YGMG 51
H +LKP N+ A + DFG+A + ++ GT GY++PE Y
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK- 186
Query: 52 SEVSSYGDVYSFG----ILL 67
V D+++ G ILL
Sbjct: 187 -PV----DIWACGVILYILL 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 4e-07
Identities = 42/197 (21%), Positives = 70/197 (35%), Gaps = 43/197 (21%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSEC 242
F D YD +G G F V G A K+ N + + + E
Sbjct: 3 KFSDNYDV------KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 56
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ ++H NIVR+ + Q F +V+ + G L F+
Sbjct: 57 RICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGEL----------------FED 95
Query: 303 LIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---VGDF 352
++ ++ + ++ Y H I H NLKP N+LL + G + DF
Sbjct: 96 IVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADF 152
Query: 353 SMARFLPDTDEQTRFIG 369
+A + D++ F G
Sbjct: 153 GLAIEVNDSEAWHGFAG 169
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 9/81 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ + L DFG+AR +PV + +V+ T+ Y AP+ MGS+ Y
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSK--KYS 198
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D++S G + EM TG +P
Sbjct: 199 TSVDIWSIGCIFAEMITG-KP 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 40/182 (21%), Positives = 62/182 (34%), Gaps = 69/182 (37%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----------IRPGGARSFKSECKAAINIRHR 251
+G G +G VY G +A+K L IR E + H
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---------EISLLKELHHP 79
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL---IKKKL 308
NIV L + +H + L F+F+ +KK L
Sbjct: 80 NIVS---------------------------LIDVIHSERCLT---LVFEFMEKDLKKVL 109
Query: 309 D---IAIDVA----------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355
D + + R + + H Q RI H +LKP N+L++ + + DF +A
Sbjct: 110 DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLA 166
Query: 356 RF 357
R
Sbjct: 167 RA 168
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 31/151 (20%), Positives = 54/151 (35%), Gaps = 40/151 (26%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPE----YGMGSEVSSY 57
DLKP N+ +D + + DFG A+ + T + GT +APE G V
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---GTPEALAPEIILSKGYNKAV--- 219
Query: 58 GDVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKS------- 93
D ++ G+L+ EM G P ++ + P +L+++
Sbjct: 220 -DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 94 ----ALPARAEQILDVAFFQEIEEEETLYKK 120
L I + +F + +K
Sbjct: 279 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 27/86 (31%), Positives = 39/86 (45%), Gaps = 16/86 (18%)
Query: 1 HCDLKPSNV-FLDDEMTAHL--GDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEV-- 54
H DLKP N+ F D+ + DFG AR P + T+ Y AP E+
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP------ELLN 182
Query: 55 -SSYG---DVYSFGILLLEMFTGLRP 76
+ Y D++S G++L M +G P
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 38/201 (18%), Positives = 65/201 (32%), Gaps = 56/201 (27%)
Query: 182 INNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKS 240
+ + F YD +G G+F AVK+ + + ++
Sbjct: 1 MKDSPFYQHYDL---DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEA 50
Query: 241 ECKAAINI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW 295
+ I H NIV++ + +V + + G L
Sbjct: 51 NTQKEITALKLCEGHPNIVKLHEV-----FHDQLHTFLVMELLNGGEL------------ 93
Query: 296 RLLNFDFLIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE---- 344
F+ + KKK I + A+ ++H + H +LKP N+L DE
Sbjct: 94 ----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNL 146
Query: 345 --MIGHVGDFSMARFLPDTDE 363
I DF AR P ++
Sbjct: 147 EIKI---IDFGFARLKPPDNQ 164
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 24/84 (28%), Positives = 34/84 (40%), Gaps = 14/84 (16%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-----YGMGS 52
H DLKP N + L DFG+A +GT YV+P+ Y G
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY--GP 186
Query: 53 EVSSYGDVYSFGILLLEMFTGLRP 76
E D +S G+++ + G P
Sbjct: 187 EC----DEWSAGVMMYVLLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 36/178 (20%), Positives = 60/178 (33%), Gaps = 35/178 (19%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVS 261
IG G++G V A K FK E + ++ H NI+R++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-------LDIAIDV 314
++ +V + G L F+ ++ K+ I DV
Sbjct: 75 ---FEDNTDIYLVMELCTGGEL----------------FERVVHKRVFRESDAARIMKDV 115
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHVGDFSMARFLPDTDEQTRFIG 369
A+ Y H + +AH +LKP N L + + DF +A +G
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 35/150 (23%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-GTIGYVAPEYGMGSEVSSYG--- 58
DLK N+ LD + + DFG+ + + + + GT Y+APE + YG
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED---NDYGRAV 330
Query: 59 DVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKSAL---PAR 98
D + G+++ EM G P + +F +++ P +L+ L P +
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 99 --------AEQILDVAFFQEIEEEETLYKK 120
A++I+ FF I + KK
Sbjct: 391 RLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 30/94 (31%), Positives = 40/94 (42%), Gaps = 18/94 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-----TSFIDVMGTIGYVAPE--YGMGSE 53
H D+KP N+ LD L DFG + E + + GT Y++PE G +
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV---GTPDYISPEVLKSQGGD 247
Query: 54 VSSYG---DVYSFGILLLEMFTGLRPNNGMFKDD 84
YG D +S G+ L EM G P F D
Sbjct: 248 -GYYGRECDWWSVGVFLYEMLVGDTP----FYAD 276
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 38/188 (20%), Positives = 64/188 (34%), Gaps = 52/188 (27%)
Query: 197 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGARSFKSECKAAIN 247
+ +IG G FG V ++ A+K+ + +I+ + F E
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVY-----AMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
+V++F A +Q R+ +V ++MP G L +
Sbjct: 126 ANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL------------------VNLMSN 162
Query: 308 LDIAIDVAR--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARF 357
D+ AR AL +H H ++KP N+LLD GH+ DF
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMK 217
Query: 358 LPDTDEQT 365
+
Sbjct: 218 MNKEGMVR 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 26/73 (35%), Positives = 39/73 (53%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ + T L DFG+AR + + V+ T+ Y APE + S ++ D+
Sbjct: 143 HRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDM 202
Query: 61 YSFGILLLEMFTG 73
+S G + EMF
Sbjct: 203 WSVGCIFAEMFRR 215
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 1e-04
Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 26/169 (15%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGARSFKS----------ECKAAINI 248
IG G +G+VY G +A+K + GG +A
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--- 71
Query: 249 RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL 308
H N+VR+ + +V++ + L +L D L + IK
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAE-TIKD-- 124
Query: 309 DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
+ R L +LH I H +LKP N+L+ + DF +AR
Sbjct: 125 -LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 26/77 (33%), Positives = 34/77 (44%), Gaps = 14/77 (18%)
Query: 1 HCDLKPSNV-FLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N+ +L E + + DFG+++ GT GYVAPE Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQ---KPY 184
Query: 58 G---DVYSFG----ILL 67
D +S G ILL
Sbjct: 185 SKAVDCWSIGVITYILL 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 36/187 (19%), Positives = 69/187 (36%), Gaps = 43/187 (22%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKA 244
+ + + ++G+G F V+ G A+K S ++E
Sbjct: 6 NIRKTFI------FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
I+H NIV + Y+ +V + + G L FD ++
Sbjct: 60 LKKIKHENIVTLEDI-----YESTTHYYLVMQLVSGGEL----------------FDRIL 98
Query: 305 KKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGHVGDFS 353
++ + + V A+KYLH + I H +LKP N+L ++ I + DF
Sbjct: 99 ERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKI-MITDFG 154
Query: 354 MARFLPD 360
+++ +
Sbjct: 155 LSKMEQN 161
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 8/79 (10%)
Query: 1 HCDLKPSNVFLDDEMTAH------LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV 54
H D+KP NV ++ + + D G A + + + + + T Y +PE +G+
Sbjct: 155 HTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPW 212
Query: 55 SSYGDVYSFGILLLEMFTG 73
D++S L+ E+ TG
Sbjct: 213 GCGADIWSTACLIFELITG 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 14/74 (18%)
Query: 303 LIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH------VGDFSMAR 356
+K+ I+ + L Y+H C I H ++KP NVL++ + D A
Sbjct: 132 YVKQ---ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 357 FLPD---TDEQTRF 367
+ + QTR
Sbjct: 187 WYDEHYTNSIQTRE 200
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 14/93 (15%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+KP V L ++ LG FG+A L +GT ++APE
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR---EP 209
Query: 57 YG---DVYSFGILLLEMFTGLRP----NNGMFK 82
YG DV+ G++L + +G P +F+
Sbjct: 210 YGKPVDVWGCGVILFILLSGCLPFYGTKERLFE 242
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 43/203 (21%), Positives = 70/203 (34%), Gaps = 54/203 (26%)
Query: 183 NNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-----FNLIRPGGAR 236
+++ F+D+Y+ +IG G F V G AVK+ F
Sbjct: 18 DDVLFEDVYEL------CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE 71
Query: 237 SFKSECKAAI--NIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTH 294
K E A+I ++H +IV + Y +V++FM L
Sbjct: 72 DLKRE--ASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGADL----------- 113
Query: 295 WRLLNFDFLIKKKLDI-------AIDVAR----ALKYLHCDCQPRIAHCNLKPSNVLLDD 343
++K+ A R AL+Y H I H ++KP VLL
Sbjct: 114 -----CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLAS 165
Query: 344 EMIGH---VGDFSMARFLPDTDE 363
+ +G F +A L ++
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGL 188
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 37/199 (18%), Positives = 66/199 (33%), Gaps = 55/199 (27%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKA 244
F+D+Y +++G G V L AVK+ E
Sbjct: 9 RFEDVYQLQE-----DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE--- 60
Query: 245 AINI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLN 299
+ + HRN++ + ++ +V++ M GS+
Sbjct: 61 -VEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSI---------------- 98
Query: 300 FDFLIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE------MI 346
+ K++ + DVA AL +LH IAH +LKP N+L + I
Sbjct: 99 LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKI 155
Query: 347 GHVGDFSMARFLPDTDEQT 365
DF + + + +
Sbjct: 156 ---CDFDLGSGIKLNGDCS 171
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 18/84 (21%)
Query: 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVETSFIDVM--------GTIGYVAPE- 47
H DLKP N L + + DF + + + + G+ Y+APE
Sbjct: 134 HRDLKPEN-ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 48 -YGMGSEVSSYG---DVYSFGILL 67
E S Y D++S G++L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 14/78 (17%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSS 56
H +LKP N+ L L DFG+A + E + GT GY++PE
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK---DP 189
Query: 57 YG---DVYSFG----ILL 67
YG D+++ G ILL
Sbjct: 190 YGKPVDLWACGVILYILL 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 35/196 (17%), Positives = 67/196 (34%), Gaps = 43/196 (21%)
Query: 181 TINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARS 237
TI F + Y +G G F V + G A + N + +
Sbjct: 3 TITCTRFTEEYQL------FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK 56
Query: 238 FKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRL 297
+ E + ++H NIVR+ + +++ + G L
Sbjct: 57 LEREARICRLLKHPNIVRLHDS-----ISEEGHHYLIFDLVTGGEL-------------- 97
Query: 298 LNFDFLIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH-- 348
F+ ++ ++ + A+ + H Q + H NLKP N+LL ++ G
Sbjct: 98 --FEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAV 152
Query: 349 -VGDFSMARFLPDTDE 363
+ DF +A + +
Sbjct: 153 KLADFGLAIEVEGEQQ 168
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 38/152 (25%), Positives = 57/152 (37%), Gaps = 50/152 (32%)
Query: 3 DLKPSNVFLDDEMTAHLGDFG-----IARFLPVETSFIDVMGTIGYVAPE------YGMG 51
D+K N+ LD L DFG +A F GTI Y+AP+ G
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---GTIEYMAPDIVRGGDSGHD 240
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRP---------NNGMF----KDDLNLP--------NL 90
V D +S G+L+ E+ TG P + K + P +L
Sbjct: 241 KAV----DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 91 VKSAL---PAR--------AEQILDVAFFQEI 111
++ L P + A++I + FFQ+I
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 14/84 (16%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE-----YGMGS 52
H DLKP N+ L + + + DFG++ T D +GT Y+APE Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY--DE 201
Query: 53 EVSSYGDVYSFGILLLEMFTGLRP 76
+ DV+S G++L + +G P
Sbjct: 202 KC----DVWSAGVILYILLSGTPP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 41/197 (20%), Positives = 71/197 (36%), Gaps = 43/197 (21%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSEC 242
+F + Y+ ++G G+FG V AVKV N + + E
Sbjct: 19 TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ + H NI+++F + + +V + G L FD
Sbjct: 73 ELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGEL----------------FDE 111
Query: 303 LIKKK-------LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHVGDF 352
+IK+K I V + Y+H + I H +LKP N+LL + + + DF
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 353 SMARFLPDTDEQTRFIG 369
++ + IG
Sbjct: 169 GLSTCFQQNTKMKDRIG 185
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 14/87 (16%)
Query: 1 HCDLKPSNVFLDDEMTAH----LGDFGIARF--LPVE--TSFIDVMGTIGYVAPEYGMGS 52
H DLKP+N+ + E + D G AR P++ V+ T Y APE +G+
Sbjct: 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRP 76
Y D+++ G + E+ T P
Sbjct: 211 R--HYTKAIDIWAIGCIFAELLTS-EP 234
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 28/164 (17%), Positives = 59/164 (35%), Gaps = 20/164 (12%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAI--NIRHRNIVRVFTAV 260
+G G +G VY DG I G S + + A+ ++H N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 87
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF---LIKKKLDIAIDVARA 317
+ + + +++ + + L + + ++K + +
Sbjct: 88 --LSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS---LLYQILDG 140
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH----VGDFSMARF 357
+ YLH + H +LKP+N+L+ E + D AR
Sbjct: 141 IHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 23/83 (27%), Positives = 42/83 (50%), Gaps = 14/83 (16%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYV------APEYGMGSE 53
H DLKP+N+F++ E + +GDFG+AR + S + + + +P +
Sbjct: 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL-S-EGLVTKWYRSPRLLLSP- 199
Query: 54 VSSYG---DVYSFGILLLEMFTG 73
++Y D+++ G + EM TG
Sbjct: 200 -NNYTKAIDMWAAGCIFAEMLTG 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 27/82 (32%), Positives = 38/82 (46%), Gaps = 13/82 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYV------APEYGMGSEV 54
H DLKPSN+ L+ + DFG+AR + + T YV APE + S
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-T-EYVATRWYRAPEIMLNS-- 206
Query: 55 SSYG---DVYSFGILLLEMFTG 73
Y D++S G +L EM +
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSN 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/53 (35%), Positives = 28/53 (52%), Gaps = 3/53 (5%)
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFI 368
R LKY+H + H +LKPSN+LL+ + DF +AR + T F+
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 22/82 (26%), Positives = 36/82 (43%), Gaps = 10/82 (12%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPE---YGMGSEV 54
H DLKP N+ + DFG+A + + GT Y+APE + +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKC 206
Query: 55 SSYGDVYSFGILLLEMFTGLRP 76
D++S G+++ + TG P
Sbjct: 207 ----DIWSAGVVMYFLLTGCLP 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 32/183 (17%), Positives = 61/183 (33%), Gaps = 40/183 (21%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G+G FG V+ G +K N R ++E + ++ H NI+++F
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKL-----------D 309
++ +V + G L + ++ + +
Sbjct: 89 ----FEDYHNMYIVMETCEGGEL----------------LERIVSAQARGKALSEGYVAE 128
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHVGDFSMARFLPDTDEQTR 366
+ + AL Y H + H +LKP N+L + DF +A + T
Sbjct: 129 LMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 367 FIG 369
G
Sbjct: 186 AAG 188
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 12/83 (14%)
Query: 1 HCDLKPSN-VFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPE----YGMGSE 53
H D+KP N ++ E A L DFG A+ + + T YVAPE
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPEKYDKS 209
Query: 54 VSSYGDVYSFGILLLEMFTGLRP 76
D++S G+++ + G P
Sbjct: 210 C----DMWSLGVIMYILLCGFPP 228
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 33/200 (16%), Positives = 63/200 (31%), Gaps = 54/200 (27%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSE-CK 243
+ D Y + ++G G G V G A+K+ S +
Sbjct: 25 AVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKCALKLLY----------DSPKAR 69
Query: 244 AAINI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLL 298
++ +IV + + + ++ + M G L
Sbjct: 70 QEVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGEL--------------- 113
Query: 299 NFDFLIKKKL---------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH- 348
F + ++ +I D+ A+++LH IAH ++KP N+L +
Sbjct: 114 -FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAV 169
Query: 349 --VGDFSMARFLPDTDEQTR 366
+ DF A+ QT
Sbjct: 170 LKLTDFGFAKETTQNALQTP 189
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 43/154 (27%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVE-----TSFIDVMGTIGYVAPEYGMGSEVSSY 57
DLKP N+ LD+E L DFG+++ ++ SF GT+ Y+APE +
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC---GTVEYMAPEVVNRR---GH 203
Query: 58 G---DVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKSAL-- 95
D +SFG+L+ EM TG P K L +P +L++
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKR 263
Query: 96 -PAR--------AEQILDVAFFQEIEEEETLYKK 120
PA E+I +FF I+ + ++
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRRE 297
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 40/147 (27%), Positives = 58/147 (39%), Gaps = 33/147 (22%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVSSY 57
DLK N+ LD + + DFG+ + E D GT Y+APE +G + +
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 198
Query: 58 GDVYSFGILLLEMFTGLRP-----NNGMFK----DDLNLP--------NLVKSAL---PA 97
D +SFG+LL EM G P +F D+ P +L+ P
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPE 258
Query: 98 R----AEQILDVAFFQEIEEEETLYKK 120
+ I F+EI EE K+
Sbjct: 259 KRLGVRGDIRQHPLFREINWEELERKE 285
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 34/81 (41%), Positives = 48/81 (59%), Gaps = 9/81 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ LGDFG+AR +PV T +V+ T+ Y AP+ MGS +Y
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSR--TYS 187
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D++S G +L EM TG +P
Sbjct: 188 TSIDIWSCGCILAEMITG-KP 207
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 42/171 (24%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNL----------IRPGGARSFKSECKAAINIRHR 251
+G G + +VY G G +A+K L IR E ++H
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---------EISLMKELKHE 63
Query: 252 NIVRVFTAVSGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF---LIKK 306
NIVR++ + + +V++FM N L++++ D L+K
Sbjct: 64 NIVRLYDVIHTENKLT-------LVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKY 112
Query: 307 KLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
+ + L + H + +I H +LKP N+L++ +GDF +AR
Sbjct: 113 ---FQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 39/145 (26%), Positives = 57/145 (39%), Gaps = 43/145 (29%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVSSY 57
DLK NV LD E + DFG+ + E + V GT Y+APE Y
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQ---PY 198
Query: 58 G---DVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKSAL-- 95
G D ++FG+LL EM G P + +F + ++ P + K +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 258
Query: 96 -PAR--------AEQILDVAFFQEI 111
P + I + AFF+ I
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 45/153 (29%), Positives = 63/153 (41%), Gaps = 41/153 (26%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
DLKP N+ L+ + L DFG+ + + +F GTI Y+APE M S +
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAPEILMRS---GHN 199
Query: 59 ---DVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKSAL--- 95
D +S G L+ +M TG P K LNLP +L+K L
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 96 PAR--------AEQILDVAFFQEIEEEETLYKK 120
A A ++ FF+ I EE L +K
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ +++ L DFG+AR +P +T +V+ T+ Y P+ +GS Y
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST--DYS 179
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D++ G + EM TG RP
Sbjct: 180 TQIDMWGVGCIFYEMATG-RP 199
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 38/188 (20%), Positives = 67/188 (35%), Gaps = 69/188 (36%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL----------IRPGGARSFKSECKAA 245
+ + +G G + +VY G +A+K L IR E
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---------EVSLL 54
Query: 246 INIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL-- 303
+++H NIV L + +H + L F++L
Sbjct: 55 KDLKHANIVT---------------------------LHDIIHTEKSLT---LVFEYLDK 84
Query: 304 -IKKKLD---IAIDVA----------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349
+K+ LD I++ R L Y H + ++ H +LKP N+L+++ +
Sbjct: 85 DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKL 141
Query: 350 GDFSMARF 357
DF +AR
Sbjct: 142 ADFGLARA 149
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+KP NV +D E L D+G+A F + + + + PE + ++ Y
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 212
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G +L M P
Sbjct: 213 DMWSLGCMLASMIFRKEP 230
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 39/187 (20%), Positives = 70/187 (37%), Gaps = 32/187 (17%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKA 244
S + + + +G G + V+ + + + VK+ ++P + K E K
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKI 83
Query: 245 AINIR-HRNIVR----VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLN 299
N+R NI+ V VS +V++ + N ++ D R
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPA-------LVFEHVNNTDFKQLYQTLTDYDIR--- 133
Query: 300 FDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MIGHVGDFSMARFL 358
F + + L +AL Y H I H ++KP NV++D E + D+ +A F
Sbjct: 134 --FYMYEIL-------KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
Query: 359 PDTDEQT 365
E
Sbjct: 182 HPGQEYN 188
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 17/78 (21%)
Query: 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVETSFI-DVMGTIGYVAPE------YG 49
H DLKPSN+ + + + DFG A+ L E + T +VAPE Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198
Query: 50 MGSEVSSYGDVYSFGILL 67
D++S G+LL
Sbjct: 199 A--AC----DIWSLGVLL 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 40/195 (20%), Positives = 68/195 (34%), Gaps = 55/195 (28%)
Query: 186 SFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKA 244
F D Y+ IG G++ AVK+ + +S K +
Sbjct: 19 QFTDGYEVKE------DIGVGSYSVCKRCIHKATNMEFAVKIID-------KS-KRDPTE 64
Query: 245 AINI-----RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLN 299
I I +H NI+ + Y ++ VV + M G L
Sbjct: 65 EIEILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGEL---------------- 103
Query: 300 FDFLIKKKL-------DIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH---- 348
D ++++K + + + ++YLH + H +LKPSN+L DE
Sbjct: 104 LDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIR 160
Query: 349 VGDFSMARFLPDTDE 363
+ DF A+ L +
Sbjct: 161 ICDFGFAKQLRAENG 175
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 38/185 (20%), Positives = 60/185 (32%), Gaps = 71/185 (38%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGARSFKSECKAAINI 248
IG G +G VY G +A+K L IR E +
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---------EISLLKEL 59
Query: 249 RHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL----- 303
H NIV+ L + +H ++ + L F+FL
Sbjct: 60 NHPNIVK---------------------------LLDVIHTENKLY---LVFEFLHQDLK 89
Query: 304 --IKKKLDIAIDVA----------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351
+ I + + L + H R+ H +LKP N+L++ E + D
Sbjct: 90 KFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 146
Query: 352 FSMAR 356
F +AR
Sbjct: 147 FGLAR 151
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.0 bits (118), Expect = 1e-06
Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 9/81 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ E + DFG+AR +PV +++ T+ Y AP+ MGS+ Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSK--KYS 179
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D++S G + EM G P
Sbjct: 180 TTIDIWSVGCIFAEMVNG-TP 199
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 1e-04
Identities = 42/181 (23%), Positives = 61/181 (33%), Gaps = 69/181 (38%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----------IRPGGARSFKSECKAAINIRHR 251
IG G +G VY G T A+K L IR E ++H
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------EISILKELKHS 60
Query: 252 NIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL---IKKKL 308
NIV+ L + +H K L F+ L +KK L
Sbjct: 61 NIVK---------------------------LYDVIHTKKRLV---LVFEHLDQDLKKLL 90
Query: 309 D---IAIDVA----------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355
D ++ + Y H R+ H +LKP N+L++ E + DF +A
Sbjct: 91 DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLA 147
Query: 356 R 356
R
Sbjct: 148 R 148
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 39/144 (27%), Positives = 57/144 (39%), Gaps = 41/144 (28%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYG 58
DLK NV LD E + DFG+ + T +F GT Y+APE YG
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEIIAYQ---PYG 520
Query: 59 ---DVYSFGILLLEMFTGLRP-----NNGMF----KDDLNLP--------NLVKSAL--- 95
D ++FG+LL EM G P + +F + ++ P + K +
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 580
Query: 96 PAR--------AEQILDVAFFQEI 111
P + I + AFF+ I
Sbjct: 581 PGKRLGCGPEGERDIKEHAFFRYI 604
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 54/223 (24%)
Query: 165 SIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIA 223
S++ L+ P + + ++ S F +G G++GSVY G +A
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTK--QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVA 58
Query: 224 VKVFNLIRPGGARSFKSECKAAINI----RHRNIVRVFTAVSGVDYQGARFKA----VVY 275
+K + S E I+I ++V+ Y G+ FK +V
Sbjct: 59 IKQVPV------ESDLQEIIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVM 103
Query: 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD---IAI---DVARALKYLHCDCQPRI 329
++ GS+ + + L K L IA + L+YLH R
Sbjct: 104 EYCGAGSVSDIIR--------------LRNKTLTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 330 AHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQ-TRFIG 369
H ++K N+LL+ E GH DF +A L DT + IG
Sbjct: 147 IHRDIKAGNILLNTE--GHAKLADFGVAGQLTDTMAKRNTVIG 187
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/84 (32%), Positives = 39/84 (46%), Gaps = 7/84 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+K N+ L+ E A L DFG+A L + I GT ++APE +
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI---GTPFWMAPEVIQEIGYNC 204
Query: 57 YGDVYSFGILLLEMFTGLRPNNGM 80
D++S GI +EM G P +
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADI 228
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 34/168 (20%), Positives = 57/168 (33%), Gaps = 43/168 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTA 259
+G G +G V +AVK+ ++ R + K E + H N+V+ +
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 260 VSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLDIAIDVA 315
+ Y F+ G L FD + + A
Sbjct: 74 RRE--------GNIQYLFLEYCSGGEL----------------FDRIEPDIGMPE--PDA 107
Query: 316 R--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355
+ + YLH I H ++KP N+LLD+ + DF +A
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 30/107 (28%), Positives = 41/107 (38%), Gaps = 30/107 (28%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA---------RFLPVETSFIDVMGTIGYVAPE---- 47
H D+KP N+ LD+ + DFG+A R L GT+ YVAPE
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKM----CGTLPYVAPELLKR 181
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
+ V DV+S GI+L M G P + +
Sbjct: 182 REF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDSCQEYS 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 6/83 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H D+K N+ L + LGDFG A + SF+ GT ++APE + + Y
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTPYWMAPEVILAMDEGQYDGK 233
Query: 59 -DVYSFGILLLEMFTGLRPNNGM 80
DV+S GI +E+ P M
Sbjct: 234 VDVWSLGITCIELAERKPPLFNM 256
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 39/173 (22%), Positives = 64/173 (36%), Gaps = 47/173 (27%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI----RHR 251
FS IG G+FG+VY + + +A+K + + + + RH
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-SGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 252 NIVRVFTAVSGVDYQGARFKA----VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
N ++ Y+G + +V ++ GS + L + KK
Sbjct: 115 NTIQ---------YRGCYLREHTAWLVMEYCL-GSASDLLE--------------VHKKP 150
Query: 308 LD---IAI---DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDF 352
L IA + L YLH + H ++K N+LL + G V GDF
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEP--GLVKLGDF 198
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 37/113 (32%), Positives = 48/113 (42%), Gaps = 18/113 (15%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIA--RFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYG 58
DLK NV LD E L DFG+ T +F GT Y+APE YG
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIAPEILQEM---LYG 202
Query: 59 ---DVYSFGILLLEMFTGLRP-----NNGMFKDDLNLPNLVKSALPARAEQIL 103
D ++ G+LL EM G P + +F+ LN + + L A IL
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 37/197 (18%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVK--VFNLIRPGGARSFKS---- 240
+L+ + ++ I +G++G+V G +G +A+K +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 241 -----ECKAAINIRHRNIVR---VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD- 291
E + + H NI+ +F +V + M L + +H +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKL---YLVTELMRT-DLAQVIHDQRI 129
Query: 292 ---DTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348
H + + L L LH + + H +L P N+LL D
Sbjct: 130 VISPQHIQYFMYHIL------------LGLHVLH---EAGVVHRDLHPGNILLADNNDIT 174
Query: 349 VGDFSMARFLPDTDEQT 365
+ DF++AR +T
Sbjct: 175 ICDFNLAREDTADANKT 191
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 22/76 (28%), Positives = 33/76 (43%), Gaps = 5/76 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H DL P N+ L D + DF +AR + + + Y APE M +
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQF--KGFTKL 214
Query: 59 -DVYSFGILLLEMFTG 73
D++S G ++ EMF
Sbjct: 215 VDMWSAGCVMAEMFNR 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 39/152 (25%), Positives = 56/152 (36%), Gaps = 40/152 (26%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYG 58
DLKP N+ LD + L DFG+ + T +F GT Y+APE Y
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPEYLAPEVLHKQ---PYD 217
Query: 59 ---DVYSFGILLLEMFTGLRP-----NNGMFK----DDLNLP--------NLVKSAL--- 95
D + G +L EM GL P M+ L L +L++ L
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 96 PAR-------AEQILDVAFFQEIEEEETLYKK 120
+ +I FF I ++ + KK
Sbjct: 278 RTKRLGAKDDFMEIKSHVFFSLINWDDLINKK 309
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 29/77 (37%), Positives = 38/77 (49%), Gaps = 6/77 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+KP N+ + L DFG AR L + D + T Y APE +G YG
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV--KYGK 204
Query: 59 --DVYSFGILLLEMFTG 73
DV++ G L+ EMF G
Sbjct: 205 AVDVWAIGCLVTEMFMG 221
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 41/153 (26%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIAR--FLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYG 58
D+K N+ LD + + DFG+ + T +F GT Y+APE + YG
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDN---DYG 183
Query: 59 ---DVYSFGILLLEMFTGLRP-----NNGMFK----DDLNLP--------NLVKSAL--- 95
D + G+++ EM G P + +F+ +++ P +L+ L
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 96 PAR--------AEQILDVAFFQEIEEEETLYKK 120
P + A+++++ FF I ++ + KK
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 26/85 (30%), Positives = 40/85 (47%), Gaps = 13/85 (15%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFID----VMGTIGYVAPEYGMGSEV 54
H D+K +NV + + L DFG+AR L + V+ T+ Y PE +G
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGER- 204
Query: 55 SSYG---DVYSFGILLLEMFTGLRP 76
YG D++ G ++ EM+T P
Sbjct: 205 -DYGPPIDLWGAGCIMAEMWTR-SP 227
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 36/177 (20%), Positives = 61/177 (34%), Gaps = 50/177 (28%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR-SFKS----ECKAAINIRHRNIVRV 256
IG G FG V+ G +A+K + + F E K ++H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL---IKKKLD---I 310
R K +Y L FDF + L +
Sbjct: 82 IEICRTKASPYNRCKGSIY----------------------LVFDFCEHDLAGLLSNVLV 119
Query: 311 AIDVA----------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
++ L Y+H + +I H ++K +NVL+ + + + DF +AR
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 7/80 (8%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+KP N+ + L DFG AR L + + D + T Y +PE +G YG
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT--QYGP 182
Query: 59 --DVYSFGILLLEMFTGLRP 76
DV++ G + E+ +G P
Sbjct: 183 PVDVWAIGCVFAELLSG-VP 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 26/86 (30%), Positives = 40/86 (46%), Gaps = 14/86 (16%)
Query: 1 HCDLKPSNVFLDDEMTAH-----LGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSE 53
H DLKP N+ L + +GDFG+AR +P+ +++ T+ Y PE +GS
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSR 213
Query: 54 VSSYG---DVYSFGILLLEMFTGLRP 76
Y D++S + EM P
Sbjct: 214 --HYSTSVDIWSIACIWAEMLMK-TP 236
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 39/187 (20%), Positives = 58/187 (31%), Gaps = 74/187 (39%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGARSFKSECKAAINIRH 250
+G G +G VY T+A+K L IR E ++H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EVSLLKELQH 92
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL---IKKK 307
RNI+ L+ +H H L F++ +KK
Sbjct: 93 RNIIE---------------------------LKSVIHHNHRLH---LIFEYAENDLKKY 122
Query: 308 LDIAIDVA------------RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG----- 350
+D DV+ + + H R H +LKP N+LL
Sbjct: 123 MDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIG 179
Query: 351 DFSMARF 357
DF +AR
Sbjct: 180 DFGLARA 186
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 34/168 (20%), Positives = 57/168 (33%), Gaps = 43/168 (25%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTA 259
+G G +G V +AVK+ ++ R + K E + H N+V+ +
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 260 VSGVDYQGARFKAVVYKFM---PNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLDIAIDVA 315
+ Y F+ G L FD + + A
Sbjct: 74 RRE--------GNIQYLFLEYCSGGEL----------------FDRIEPDIGMPE--PDA 107
Query: 316 R--------ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355
+ + YLH I H ++KP N+LLD+ + DF +A
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 30/105 (28%), Positives = 41/105 (39%), Gaps = 30/105 (28%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIA---------RFLPVETSFIDVMGTIGYVAPE---- 47
H D+KP N+ LD+ + DFG+A R L GT+ YVAPE
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKM----CGTLPYVAPELLKR 181
Query: 48 --YGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNL 90
+ V DV+S GI+L M G P + +
Sbjct: 182 REF-HAEPV----DVWSCGIVLTAMLAGELP----WDQPSDSCQE 217
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 1 HCDLKPSNVFLDDEMTAH--LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
HCDLKP N+ L + + + DFG + L + Y +PE +G
Sbjct: 182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ--SRFYRSPEVLLGMPYDLAI 239
Query: 59 DVYSFGILLLEMFTGL 74
D++S G +L+EM TG
Sbjct: 240 DMWSLGCILVEMHTGE 255
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 7/76 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H DLKP N+ ++++ + DFG+AR ++ + T Y APE + Y
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEVILNW--MRYTQT 206
Query: 59 -DVYSFGILLLEMFTG 73
D++S G ++ EM TG
Sbjct: 207 VDIWSVGCIMAEMITG 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 38/183 (20%), Positives = 76/183 (41%), Gaps = 36/183 (19%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVK----VF-NLIRPGGARSFKS 240
K ++ + +G+G +G+V + G +A+K F + + R+++
Sbjct: 17 TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF--AKRAYR- 73
Query: 241 ECKAAINIRHRNIVR---VFTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGKD--DT 293
E + ++RH N++ VFT +D F V FM L + + + +
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLD----DFTDFYLVMPFMGT-DLGKLMKHEKLGED 128
Query: 294 HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353
+ L + L + L+Y+H I H +LKP N+ ++++ + DF
Sbjct: 129 RIQFLVYQML------------KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173
Query: 354 MAR 356
+AR
Sbjct: 174 LAR 176
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 7/76 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H DLKP N+ ++++ + DFG+AR + + T Y APE + Y
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSW--MHYNQT 204
Query: 59 -DVYSFGILLLEMFTG 73
D++S G ++ EM TG
Sbjct: 205 VDIWSVGCIMAEMLTG 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 35/182 (19%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVK----VF-NLIRPGGARSFKS 240
K ++ + S +G+G +GSV + G +A+K F + I R+++
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF--AKRAYR- 72
Query: 241 ECKAAINIRHRNIVR---VFTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGK-DDTH 294
E +++H N++ VFT S + F V FM L++ + K +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLR----NFYDFYLVMPFMQT-DLQKIMGLKFSEEK 127
Query: 295 WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354
+ L + L + LKY+H + H +LKP N+ ++++ + DF +
Sbjct: 128 IQYLVYQML------------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGL 172
Query: 355 AR 356
AR
Sbjct: 173 AR 174
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 38/180 (21%)
Query: 203 IGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGARSFKS-ECKAAINIRHRNIVR---V 256
IG G+FG VY L D G +A+K V R FK+ E + + H NIVR
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYF 115
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI---- 312
F S + + + +V ++P + + R+ K+ L +
Sbjct: 116 FY--SSGEKKDEVYLNLVLDYVP-----------ETVY-RVARHYSRAKQTLPVIYVKLY 161
Query: 313 --DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFI 368
+ R+L Y+H I H ++KP N+LLD + + DF A+ L + +I
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRGEPNVSYI 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 21/87 (24%)
Query: 1 HCDLKPSNVFLDDEMTA-HLGDFGIAR-FLPVETSFIDVMGTIGYV------APEYGMGS 52
H D+KP N+ LD + L DFG A+ + E + + Y+ APE G+
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-------VSYICSRYYRAPELIFGA 231
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRP 76
+ Y DV+S G +L E+ G +P
Sbjct: 232 --TDYTSSIDVWSAGCVLAELLLG-QP 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 24/76 (31%), Positives = 38/76 (50%), Gaps = 7/76 (9%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H DLKPSN+ ++++ + DFG+AR + T Y APE + Y
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNW--MHYNQT 210
Query: 59 -DVYSFGILLLEMFTG 73
D++S G ++ E+ TG
Sbjct: 211 VDIWSVGCIMAELLTG 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 44/187 (23%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKS----- 240
K +++ + + + +G+G +GSV G +AVK L RP F+S
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRP-----FQSIIHAK 73
Query: 241 ----ECKAAINIRHRNIVR---VFTAVSGVDYQGARFKAV--VYKFMPNGSLEEWLHGKD 291
E + +++H N++ VFT ++ F V V M L + +
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLE----EFNDVYLVTHLMGA-DLNNIVKCQK 128
Query: 292 --DTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349
D H + L + L R LKY+H I H +LKPSN+ ++++ +
Sbjct: 129 LTDDHVQFLIYQIL------------RGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173
Query: 350 GDFSMAR 356
DF +AR
Sbjct: 174 LDFGLAR 180
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 28/82 (34%), Positives = 36/82 (43%), Gaps = 15/82 (18%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVSSY 57
DLK NV LD E L D+G+ + E GT Y+APE G Y
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGE---DY 187
Query: 58 G---DVYSFGILLLEMFTGLRP 76
G D ++ G+L+ EM G P
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSP 209
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 17/90 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTI-----GYV------APEYG 49
H DLKPSN+ ++ + DFG+AR + + +V APE
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194
Query: 50 MGSEVSSYG---DVYSFGILLLEMFTGLRP 76
+ S + Y DV+S G +L E+F RP
Sbjct: 195 LTS--AKYSRAMDVWSCGCILAELFLR-RP 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
RA+K LH + H +LKPSN+L++ V DF +AR + ++
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 28/82 (34%), Positives = 36/82 (43%), Gaps = 15/82 (18%)
Query: 3 DLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVM-----GTIGYVAPEYGMGSEVSSY 57
DLK NV LD E L D+G+ + E GT Y+APE G Y
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCGTPNYIAPEILRGE---DY 230
Query: 58 G---DVYSFGILLLEMFTGLRP 76
G D ++ G+L+ EM G P
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSP 252
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 16/82 (19%)
Query: 1 HCDLKPSNVFLDDEMTAH--LGDFGIARFLP------VETSFIDVMGTIGYVAPEYGMGS 52
HCDLKP N+ L + + + DFG + + +++ F Y APE +G+
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--------YRAPEVILGA 274
Query: 53 EVSSYGDVYSFGILLLEMFTGL 74
D++S G +L E+ TG
Sbjct: 275 RYGMPIDMWSLGCILAELLTGY 296
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 9/81 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARF--LPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP+N+ LD+ L DFG+A+ P V+ T Y APE G+ YG
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGAR--MYG 191
Query: 59 ---DVYSFGILLLEMFTGLRP 76
D+++ G +L E+ P
Sbjct: 192 VGVDMWAVGCILAELLLR-VP 211
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 42/166 (25%), Positives = 64/166 (38%), Gaps = 33/166 (19%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKS--------ECKAAINIRHRNI 253
+G G F +VY +A+K I+ G K E K + H NI
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK---IKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 254 VRVFTAVSGVD--YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311
+ + A +V+ FM LE + D L IK
Sbjct: 75 IGLLDAFGHKSNIS-------LVFDFMET-DLEVII---KDNSLVLTPSH--IKA---YM 118
Query: 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
+ + L+YLH Q I H +LKP+N+LLD+ + + DF +A+
Sbjct: 119 LMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 21/87 (24%)
Query: 1 HCDLKPSNVFLDDEMTA-HLGDFGIAR-FLPVETSFIDVMGTIGYV------APEYGMGS 52
H D+KP N+ LD L DFG A+ + E + + Y+ APE G+
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-------VSYICSRYYRAPELIFGA 216
Query: 53 EVSSYG---DVYSFGILLLEMFTGLRP 76
++Y D++S G ++ E+ G +P
Sbjct: 217 --TNYTTNIDIWSTGCVMAELMQG-QP 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVK-VFNLIRPGGARSFKS-ECKAAINIRHRNIVRVFTAV 260
IG G+FG V+ L + +A+K V R FK+ E + ++H N+V +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFF 101
Query: 261 -SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI------D 313
S D + F +V +++P E ++ R +K+ + + +
Sbjct: 102 YSNGDKKDEVFLNLVLEYVP-----ETVY-------RASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFI 368
+ R+L Y+H I H ++KP N+LLD G + DF A+ L + +I
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPS-GVLKLIDFGSAKILIAGEPNVSYI 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 32/201 (15%), Positives = 64/201 (31%), Gaps = 48/201 (23%)
Query: 203 IGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGARSFKSECKAAINI----RHRNIVRV 256
+G G+FG V + G A+K V ++I H NI+++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ---------DPRYKNRELDIMKVLDHVNIIKL 65
Query: 257 FTAV-SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL------------ 303
+ D + + G + +L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 304 ------IKKKLDIAID--------VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349
I+ I ++ + RA+ ++H I H ++KP N+L++ + +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD-NTL 181
Query: 350 --GDFSMARFLPDTDEQTRFI 368
DF A+ L ++ +I
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYI 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 22/78 (28%), Positives = 38/78 (48%), Gaps = 8/78 (10%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ ++ + L DFG A+ L + + + Y APE +G+ + Y
Sbjct: 164 HRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA--TEYT 220
Query: 59 ---DVYSFGILLLEMFTG 73
D++S G + E+ G
Sbjct: 221 PSIDLWSIGCVFGELILG 238
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 35/116 (30%), Positives = 47/116 (40%), Gaps = 24/116 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHL--GDFGIARFLPVETSFID-VMGTIGYVAPE------YGMG 51
H DLK N LD L DFG ++ V S +GT Y+APE Y G
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRQEYD-G 196
Query: 52 SEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAF 107
DV+S G+ L M G P F +D P + + ++IL V +
Sbjct: 197 KIA----DVWSCGVTLYVMLVGAYP----F-EDPEEPRDYRKTI----QRILSVKY 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 34/171 (19%), Positives = 56/171 (32%), Gaps = 39/171 (22%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG+GNFG +AVK + + E ++RH NIVR +
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKK-KLDIAIDVAR--- 316
+ A++ ++ G L ++ + + D AR
Sbjct: 86 LTPTHL-----AIIMEYASGGEL----------------YERICNAGRFSE--DEARFFF 122
Query: 317 -----ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH--VGDFSMARFLPD 360
+ Y H +I H +LK N LLD + DF ++
Sbjct: 123 QQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 28/101 (27%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTI----------------GYV 44
H D+KPSN+ L+ E + DFG++R + + YV
Sbjct: 132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 45 ------APEYGMGSEVSSYG---DVYSFGILLLEMFTGLRP 76
APE +GS + Y D++S G +L E+ G +P
Sbjct: 192 ATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCG-KP 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 29/174 (16%), Positives = 61/174 (35%), Gaps = 32/174 (18%)
Query: 202 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTA 259
IG G FG +Y + ++ +++ P +E K ++ +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 260 VSGVDYQG---------ARFKAVVYKFM------PNGSLEEWLHGKDDTHWRLLNFDFLI 304
+ Y G Y+FM L++ + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK--------IYEANAKRFSR 151
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD--DEMIGHVGDFSMAR 356
K L +++ + L+Y+H + H ++K SN+LL+ + ++ D+ +A
Sbjct: 152 KTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 3/50 (6%)
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
+KY+H I H +LKP+N L++ + V DF +AR + +
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 24/109 (22%), Positives = 41/109 (37%), Gaps = 28/109 (25%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTI-----------------GY 43
H DLKP+N L+ + + + DFG+AR + E V +
Sbjct: 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH 211
Query: 44 V------APEYGMGSEVSSYG---DVYSFGILLLEMFTGLRPNNGMFKD 83
V APE + +Y D++S G + E+ L+ + +
Sbjct: 212 VVTRWYRAPELILLQ--ENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 5e-04
Identities = 32/204 (15%), Positives = 54/204 (26%), Gaps = 36/204 (17%)
Query: 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV--------FNLIRPGGAR 236
+ F T IG G FG V+ D T +A+K+ N
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 237 SFKSEC---------KAAINIRHRNIVRVFTA--VSGVDYQGARFKAVVYKFMPNGSLEE 285
E + R + + + V G Y + +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 286 WLHGKDDTHWRLLNFDFL-------------IKKKLDIAIDVARALKYLHCDCQPRIAHC 332
KDD + +L F+F + I + +L + H
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHR 186
Query: 333 NLKPSNVLLDDEMIGHVGDFSMAR 356
+L NVLL + + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 485 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.98 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.98 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.96 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.95 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.95 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.94 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.94 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.94 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.93 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.93 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.93 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.93 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.92 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.91 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.89 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.89 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.89 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.89 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.89 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.88 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.87 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.86 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.86 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.86 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.8 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.79 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.79 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.79 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.78 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.78 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.77 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.77 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.76 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.76 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.76 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.75 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.75 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.75 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.75 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.75 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.75 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.75 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.74 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.74 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.74 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.74 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.73 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.73 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.73 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.73 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.72 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.72 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.72 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.72 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.72 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.72 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.72 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.72 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.71 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.71 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.71 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.71 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.71 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.71 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.71 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.71 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.71 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.71 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.71 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.71 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.71 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.7 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.7 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.7 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.7 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.7 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.7 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.7 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.7 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.7 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.7 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.7 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.7 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.7 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.7 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.7 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.7 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.7 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.7 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.7 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.69 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.69 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.69 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.69 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.69 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.69 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.69 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.69 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.69 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.69 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.69 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.69 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.69 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.69 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.69 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.69 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.69 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.68 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.68 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.68 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.68 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.68 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.68 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.68 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.68 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.68 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.68 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.68 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.68 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.68 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.68 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.68 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.68 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.68 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.68 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.68 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.68 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.68 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.68 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.68 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.68 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.68 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.68 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.68 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.68 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.67 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.67 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.67 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.67 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.67 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.67 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.67 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.67 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.67 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.67 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.67 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.67 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.67 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.67 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.67 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.67 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.67 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.67 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.67 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.67 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.67 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.67 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.66 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.66 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.66 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.66 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.66 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.66 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.66 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.66 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.66 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.66 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.66 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.66 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.66 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.66 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.66 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.66 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.66 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.66 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.66 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.66 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.66 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.66 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.66 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.65 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.65 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.65 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.65 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.65 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.65 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.65 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.65 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.65 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.65 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.65 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.65 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.65 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.65 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.65 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.65 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.65 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.65 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.64 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.64 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.64 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.64 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.64 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.64 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.64 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.64 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.64 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.64 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.64 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.64 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.64 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.64 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.64 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.64 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.63 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.63 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.63 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.63 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.63 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.63 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.63 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.63 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.63 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.63 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.63 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.63 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.63 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.62 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.62 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.62 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.62 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.62 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.62 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.61 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.61 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.61 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.61 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.61 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.61 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.6 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.6 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.6 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.6 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.6 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.6 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.6 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.59 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.59 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.58 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.57 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.56 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.56 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.55 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=344.16 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=170.9
Q ss_pred cccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG----- 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 45667789999999999999864 4788999999765555567899999999999999999999998742
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcc------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTH------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
...+||||||++|||.++|+...... .......++|.++++|+.|||+||.||| ..+||||||||+|||||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 45799999999999999998643210 0112246899999999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDR 401 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~ 401 (485)
+++.+||+|||+|+.....+.. ..++...++++|+...++--. ... |+......+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~--Pf~~~~~~~~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ--PWYQLSNTEAI 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC--TTCSSCHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCC--CCCCCCHHHHH
Confidence 9999999999999876433211 113334567777654432111 010 00000000000
Q ss_pred hhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 402 TMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.....+.. .. .+..|...+.+|+..||+.+|++||||.||+++|+.+.+
T Consensus 271 ~~i~~g~~-~~------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQGRE-LE------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHTCC-CC------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCC-CC------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 00011110 00 011245567799999999999999999999999998865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.21 Aligned_cols=239 Identities=19% Similarity=0.310 Sum_probs=171.5
Q ss_pred cccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 197 FSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
+...+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|... .
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----~ 102 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-----Q 102 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----S
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-----C
Confidence 444578999999999999863 467899999974432 3457899999999999999999999998742 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCc-------ccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDT-------HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~-------~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
..+||||||++|||.++|+..... ..+.....++|..+++|+.|||+||.||| +.+||||||||+|||||
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence 579999999999999999754321 01122346899999999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhcc----ccchhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILN----DFNLQEIE 398 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d----~~~~~~~~ 398 (485)
+++.+||+|||+|+.+...+.. ..++...++++|+...++ ++. |+......
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~E-----l~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE-----VFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH-----HHTTTCCTTTTCCHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHH-----HHhCCCCCCCCCCHH
Confidence 9999999999999875332210 123345567777654432 221 11100000
Q ss_pred hhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 399 EDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
+...........+ .+.+|...+.+|+..||+.+|++||||.||+++|+..
T Consensus 255 ~~~~~i~~~~~~~-------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNRQVLP-------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCCCC-------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111111111 1123566778999999999999999999999999753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.45 Aligned_cols=246 Identities=19% Similarity=0.315 Sum_probs=174.6
Q ss_pred cccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|...
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 46777889999999999999864 4678999999865555567899999999999999999999998742
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcc----cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTH----WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~----~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
+..++|||||++|||.++|+...... .......++|..+++|+.|||+||.||| +.+||||||||+|||||++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 35799999999999999998543100 0111246899999999999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhh
Q 041230 345 MIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTM 403 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~ 403 (485)
+.+||+|||+|+.....+.. ..++...++++|+...++--. ... |+......+....
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~--Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ--PWYQLSNNEVIEC 242 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC--TTTTSCHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Confidence 99999999999875433211 123344566676654332110 010 1100000000000
Q ss_pred hcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
...+.... . +..|...+.+++..||+.+|++||||.+|++.|+.+.+
T Consensus 243 i~~~~~~~-~------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRVLQ-R------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCCCC-C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC-C------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 01111000 0 11245567799999999999999999999999998765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=338.21 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=171.3
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|++. ..||||+++.... ...+.|.+|+.+|++++|||||+++|+|.. ...
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~~ 106 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DNL 106 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------CeE
Confidence 356677789999999999999864 4699999875432 234679999999999999999999999853 246
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
+||||||++|||.++|+... ..++|..+++|+.|||+||.||| +.+||||||||+|||||+++.+||+|
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~--------~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~D 175 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE--------TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGD 175 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECC
T ss_pred EEEEEcCCCCCHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEee
Confidence 89999999999999998643 35889999999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc-----------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccC
Q 041230 352 FSMARFLPDTDEQ-----------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 352 FGla~~~~~~~~~-----------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 408 (485)
||+|+........ ..++...++++|+...++--.....-..... ............
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~~ 254 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRGY 254 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTTC
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCC
Confidence 9999876432110 1133345777776554431111110000000 000000000111
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..+... ....+|...+.+++..||+.+|++||||.||++.|+.++..
T Consensus 255 ~~p~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 255 ASPDLS---KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCST---TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCcc---cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111000 01123456677899999999999999999999999988653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=326.92 Aligned_cols=246 Identities=20% Similarity=0.272 Sum_probs=169.1
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHH--HHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFK--SECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~--~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
++...+.||+|+||+||+|++ +|+.||||+++.. ..+.+. .|+..+.+++|||||+++|+|...+. .....+|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~l 78 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL 78 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEE
Confidence 355668899999999999986 6899999998642 233444 45555678999999999999975321 1235799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeeccCCCceEecCCCcEE
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC-----QPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~-----~~~ivHrdlK~~NILld~~~~~k 348 (485)
|||||++|||.++|+.. .++|..+++|+.|+|+||+|||+.+ .++||||||||+|||||.++++|
T Consensus 79 V~Ey~~~gsL~~~l~~~----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K 148 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred EecCCCCCcHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence 99999999999999742 4789999999999999999999642 45899999999999999999999
Q ss_pred EeecccccccCCCCcce----------------------------eeeccccHHHHHHHHhhhhhhhhc--------ccc
Q 041230 349 VGDFSMARFLPDTDEQT----------------------------RFIGKLNVRNFVKMALSQRVEEIL--------NDF 392 (485)
Q Consensus 349 i~DFGla~~~~~~~~~~----------------------------~~~~~~~l~~~~~~~~~~~~~~~~--------d~~ 392 (485)
|+|||+|+......... .++...++++|+...++--..... .+.
T Consensus 149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 99999998764332110 011234666666544331110000 000
Q ss_pred c----h-hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 393 N----L-QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 393 ~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
. . ...............++..+..+ ...++...+.+|+..||+.+|++||||.+|+++|+.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0 0 00000011111111111111111 112466778899999999999999999999999998865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=321.89 Aligned_cols=247 Identities=19% Similarity=0.276 Sum_probs=174.7
Q ss_pred hhccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCC-CcceeEeeeeccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGARSFKSECKAAINIRH-RNIVRVFTAVSGV 263 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H-~niv~l~~~~~~~ 263 (485)
...++|...+.||+|+||+||+|.... ++.||||+++.... ...+.|.+|+.+|.+++| ||||+++|+|...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345678888999999999999998543 35799999975433 234679999999999965 8999999998642
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
....++|||||++|||.++|+...... .......++|..++.|+.|||+||.||| +.+||||||||
T Consensus 141 ----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~ 213 (353)
T 4ase_A 141 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 213 (353)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred ----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence 235789999999999999998543210 0111235899999999999999999999 67899999999
Q ss_pred CceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhcc----cc
Q 041230 337 SNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILN----DF 392 (485)
Q Consensus 337 ~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d----~~ 392 (485)
+||||++++.+||+|||+|+.+..+... ..++...++++|+...++ ++. |+
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~E-----l~t~G~~Pf 288 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-----IFSLGASPY 288 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH-----HTTTSCCSS
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHH-----HHhCCCCCC
Confidence 9999999999999999999976543321 112334566666654332 221 11
Q ss_pred chhhhh-hhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 393 NLQEIE-EDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 393 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
...... ........+ .+...+ ..+...+.+++..||+.+|++||||.||++.|+.+.+
T Consensus 289 ~~~~~~~~~~~~i~~g-~~~~~p------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 289 PGVKIDEEFCRRLKEG-TRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp TTCCCSHHHHHHHHHT-CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcC-CCCCCC------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 000000 000000000 001011 1234567789999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.57 Aligned_cols=233 Identities=21% Similarity=0.287 Sum_probs=160.3
Q ss_pred ccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 198 SSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
.....||+|+||+||+|.. .++..||||++.... ....+.|.+|+++|++++|||||++++++... ..+....++|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 3456799999999999985 458899999986432 22346799999999999999999999987542 1234567999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEeecc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVGDFS 353 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~DFG 353 (485)
||||++|+|.++|... ..+++.....|+.||+.||.|||+. .++||||||||+||||+. ++.+||+|||
T Consensus 108 mEy~~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred EeCCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCc
Confidence 9999999999999753 2578888899999999999999943 245999999999999984 7999999999
Q ss_pred cccccCCCCcc---------------eeeeccccHHHHHHHHhhhhhhhhc--cccchhhhhhhhhhhcccCCCCCCcch
Q 041230 354 MARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFNLQEIEEDRTMCMHASSSSSTSTH 416 (485)
Q Consensus 354 la~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (485)
+|+........ ..++...++++++...+..-..... +....... ....... .... .
T Consensus 178 la~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~---~~~i~~~---~~~~-~ 250 (290)
T 3fpq_A 178 LATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSG---VKPA-S 250 (290)
T ss_dssp GGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTT---CCCG-G
T ss_pred CCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH---HHHHHcC---CCCC-C
Confidence 99875433221 1133345677766544331111110 00000000 0000000 0000 0
Q ss_pred hhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 417 VSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 417 ~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.+ ..+...+.++...|++.+|++|||+.|+++
T Consensus 251 ~~--~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC--ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 012234567889999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=300.17 Aligned_cols=231 Identities=16% Similarity=0.191 Sum_probs=164.0
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
..|.....||+|+||+||+|.. .+|+.||||+++.......+.|.+|+.+|++++|||||++++++.. .+..+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 3466678899999999999985 4689999999976555566779999999999999999999998764 346899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|||||++|+|.+++... .+++.....|+.||+.||.||| +.+||||||||+||||+.++.+||+|||
T Consensus 149 vmEy~~gg~L~~~l~~~----------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFG 215 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 215 (346)
T ss_dssp EECCCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCc
Confidence 99999999999999642 4778888999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcc
Q 041230 354 MARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 354 la~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
+|+.+...... ..++...++++++...+..-.... |+......+..............
T Consensus 216 la~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~--PF~~~~~~~~~~~i~~~~~~~~~-- 291 (346)
T 4fih_A 216 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP--PYFNEPPLKAMKMIRDNLPPRLK-- 291 (346)
T ss_dssp TCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC--TTTTSCHHHHHHHHHHSSCCCCS--
T ss_pred CceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC--CCCCcCHHHHHHHHHcCCCCCCC--
Confidence 99976443211 123344566666544333111110 00000000000000000000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.+. ..-..+.++...|++.||++|||+.|+++
T Consensus 292 ~~~---~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLH---KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001 11223457888999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.29 Aligned_cols=232 Identities=20% Similarity=0.268 Sum_probs=158.7
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|+++|++++|||||++++++.. ....
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEE
Confidence 5788899999999999999984 5689999999975432 234679999999999999999999998754 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|||||++|+|.++|..... ..+++.....|+.||+.||.||| +.+||||||||+||||++++.+||+|
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~-------~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~D 168 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKG-------VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGD 168 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECS
T ss_pred EEEEeCCCCCcHHHHHHHcCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcc
Confidence 999999999999999975432 24677788889999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 352 FSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 352 FGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
||+|+.+...... ..++...++++++...+..-.... |+......+.......... ...
T Consensus 169 FGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~--PF~~~~~~~~~~~i~~~~~-~~~ 245 (350)
T 4b9d_A 169 FGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH--AFEAGSMKNLVLKIISGSF-PPV 245 (350)
T ss_dssp TTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC--SCCCSSHHHHHHHHHHTCC-CCC
T ss_pred cccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC--CCCCcCHHHHHHHHHcCCC-CCC
Confidence 9999876432110 123344566666544433111110 0000000000000000000 000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+. ..-..+.++...|++.||++|||+.|+++
T Consensus 246 ~~------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SL------HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 11223557888999999999999999865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.78 Aligned_cols=157 Identities=24% Similarity=0.417 Sum_probs=124.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeeccccc-------
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDY------- 265 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~------- 265 (485)
++|...+.||+|+||+||+|.. .+|+.||||+++..... ..+.|.+|+++|++++|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688889999999999999984 56899999999754332 34678999999999999999999998754321
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
....+.++|||||++|+|.++|...... ....+.....|+.|++.||.||| +.+||||||||+||||+.++
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI------EERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG------GGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC------ChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCC
Confidence 1233578999999999999999875432 23456667889999999999999 67899999999999999999
Q ss_pred cEEEeecccccccCC
Q 041230 346 IGHVGDFSMARFLPD 360 (485)
Q Consensus 346 ~~ki~DFGla~~~~~ 360 (485)
.+||+|||+|+.+..
T Consensus 156 ~vKl~DFGla~~~~~ 170 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQ 170 (299)
T ss_dssp CEEECCCCCC-----
T ss_pred cEEEccCccceecCC
Confidence 999999999987643
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=296.43 Aligned_cols=232 Identities=19% Similarity=0.185 Sum_probs=164.5
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||+++... .+.+|+.+|++++|||||++++++.. ....+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVRE-----GPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 45677888999999999999985 568999999997532 22479999999999999999998764 34689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~ki~D 351 (485)
||||||++|+|.++|+.. ..+++.....|+.||+.||.||| +.+||||||||+||||+.++ .+||+|
T Consensus 127 ivmEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~D 194 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM---------GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCD 194 (336)
T ss_dssp EEECCCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECC
T ss_pred EEEeccCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEee
Confidence 999999999999999743 24788899999999999999999 78999999999999999987 699999
Q ss_pred cccccccCCCCcc-----------------------eeeeccccHHHHHHHHhhhhhhhhc--ccc---chhhhhhhhhh
Q 041230 352 FSMARFLPDTDEQ-----------------------TRFIGKLNVRNFVKMALSQRVEEIL--NDF---NLQEIEEDRTM 403 (485)
Q Consensus 352 FGla~~~~~~~~~-----------------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~---~~~~~~~~~~~ 403 (485)
||+|+.+...... ..++...++++++...+..-..... +.. +...+..
T Consensus 195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---- 270 (336)
T 4g3f_A 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS---- 270 (336)
T ss_dssp CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----
T ss_pred CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----
Confidence 9999876432110 1122344566665443321111000 000 0000000
Q ss_pred hcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 404 CMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
. .. .. ...+..+-..+.++...|++.+|++|||+.|+++.|..+....
T Consensus 271 ---~--~~-~~--~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 271 ---E--PP-PI--REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ---S--CC-GG--GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---C--CC-Cc--hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0 00 00 0000112334567889999999999999999999988776543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.83 Aligned_cols=231 Identities=16% Similarity=0.183 Sum_probs=165.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||+++.......+.|.+|+.+|++++|||||++++++.. .+..|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEE
Confidence 45677888999999999999985 4689999999986665666789999999999999999999998764 34689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
||||||++|+|.+++... .+.+.....|+.||+.||.||| +.+||||||||+||||+.++.+||+||
T Consensus 225 iVmEy~~gG~L~~~i~~~----------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEEECCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecC
Confidence 999999999999999642 4677888899999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCC-CCCC
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASS-SSST 413 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~-~~~~ 413 (485)
|+|+.+...... ..++...++++++...+..-.... ++......+.......... ....
T Consensus 292 Gla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~--PF~~~~~~~~~~~i~~~~~~~~~~ 369 (423)
T 4fie_A 292 GFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP--PYFNEPPLKAMKMIRDNLPPRLKN 369 (423)
T ss_dssp TTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC--TTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred ccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC--CCCCcCHHHHHHHHHcCCCCCCcc
Confidence 999876443211 123344566666544433111110 0000000000000000000 0000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+ . ..-..+.++...|++.||++|||+.|+++
T Consensus 370 ~---~---~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 L---H---KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp T---T---SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---c---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 01123457888999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=285.71 Aligned_cols=149 Identities=21% Similarity=0.331 Sum_probs=129.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+++. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. ...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 5688889999999999999984 56899999999642 23445679999999999999999999988653 456
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|... ..+++.....|+.||+.||.||| +.+|+||||||+||||+.++.+||+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~---------~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~ 174 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKI---------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 174 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEE
Confidence 89999999999999999753 24677888889999999999999 6789999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+|+.+..
T Consensus 175 DFGla~~~~~ 184 (311)
T 4aw0_A 175 DFGTAKVLSP 184 (311)
T ss_dssp CCTTCEECCT
T ss_pred EcCCceecCC
Confidence 9999998643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=277.04 Aligned_cols=148 Identities=21% Similarity=0.405 Sum_probs=120.6
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.|.+|+++|++++|||||++++++.. ...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 5788889999999999999984 568999999996432 2334679999999999999999999998653 356
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+ +|+|.++|.... .+++.....++.|++.||.||| +.+|+||||||+||||++++.+||+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~ 154 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 154 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred EEEEEeCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEe
Confidence 89999999 689999997542 4778888999999999999999 6789999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+|+...+
T Consensus 155 DFGla~~~~~ 164 (275)
T 3hyh_A 155 DFGLSNIMTD 164 (275)
T ss_dssp CSSCC-----
T ss_pred ecCCCeecCC
Confidence 9999987644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=278.92 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=185.3
Q ss_pred ccCccchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccc
Q 041230 184 NLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGV 263 (485)
Q Consensus 184 ~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~ 263 (485)
.+++.++..++++|...+.||+|+||+||+|...+|+.||||++........+.|.+|+.++.+++|||||+++++|..
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE- 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 4566777889999999999999999999999987899999999876555566789999999999999999999999754
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
....++||||+++|+|.+++...... ...++|..++.|+.+++.||.||| ..+|+||||||+|||++.
T Consensus 107 ----~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~ 174 (321)
T 2qkw_B 107 ----RNEMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDE 174 (321)
T ss_dssp ----TTCCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECT
T ss_pred ----CCeEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECC
Confidence 23578999999999999999764321 135889999999999999999999 678999999999999999
Q ss_pred CCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhh-hcccc----chhhhh
Q 041230 344 EMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEE-ILNDF----NLQEIE 398 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~-~~d~~----~~~~~~ 398 (485)
++.+||+|||+++........ ..++...++++++...+.--... ..... ......
T Consensus 175 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~ 254 (321)
T 2qkw_B 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254 (321)
T ss_dssp TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH
T ss_pred CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH
Confidence 999999999999865322110 11223345666654433211000 00000 000000
Q ss_pred hhhhhhcccCCCC--CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 399 EDRTMCMHASSSS--STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 399 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
............. ..........++...+.+++..|++.+|++||||.||++.|+.+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 0000000000000 0000001123567788899999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.29 Aligned_cols=264 Identities=29% Similarity=0.462 Sum_probs=186.5
Q ss_pred cccccCccchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeee
Q 041230 181 TINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTA 259 (485)
Q Consensus 181 ~~~~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~ 259 (485)
.++.+++.++..++++|...+.||+|+||+||+|...+|+.||||+++.... .....|.+|+.++.+++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4677899999999999999999999999999999987899999999865432 233478999999999999999999999
Q ss_pred ecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 260 ~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
|... ...++||||+++|+|.+++...... ...++|..+..|+.+++.||.|||..+.++|+||||||+||
T Consensus 96 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 96 CMTP-----TERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp ECCS-----SCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred EecC-----CceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 8642 3568999999999999999865422 13588999999999999999999965555999999999999
Q ss_pred EecCCCcEEEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhh-------hccccc
Q 041230 340 LLDDEMIGHVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEE-------ILNDFN 393 (485)
Q Consensus 340 Lld~~~~~ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~-------~~d~~~ 393 (485)
|++.++.+||+|||+++........ ..++...++++++...+.--... ..+...
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred EECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 9999999999999999876432211 11222345666554333211000 000000
Q ss_pred hhhhhhhhhhhcccCCCC--CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 394 LQEIEEDRTMCMHASSSS--STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
.................. ..........++...+.+++..|++.+|.+|||+.+|+++|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000000000000000000 0000001123466788899999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=283.43 Aligned_cols=148 Identities=24% Similarity=0.272 Sum_probs=121.1
Q ss_pred cccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||+++. .+++.||||+++... ......|.+|+++|++++|||||++++++.. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 5788999999999999999974 246789999986432 2233468899999999999999999998754 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|||||++|||.++|... ..+++.....|+.|++.||.||| +.+|+||||||+|||+++++.+|
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vK 166 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKE---------VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIK 166 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEE
Confidence 4689999999999999999753 24777888899999999999999 67899999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+|+...
T Consensus 167 l~DFGla~~~~ 177 (304)
T 3ubd_A 167 LTDFGLSKESI 177 (304)
T ss_dssp EESSEEEEC--
T ss_pred ecccccceecc
Confidence 99999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-32 Score=267.54 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=183.7
Q ss_pred cccccCccchhhhccccccc------eeecccCceEEEEeEeeCCcEEEEEEeeccC----CcchHHHHHHHHHHHhcCC
Q 041230 181 TINNLSFKDLYDATNGFSSA------NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR----PGGARSFKSECKAAINIRH 250 (485)
Q Consensus 181 ~~~~~~~~~l~~~t~~f~~~------~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~H 250 (485)
....|++.++..+|++|+.. +.||+|+||.||+|.. +++.||||++.... ....+.|.+|+.++.+++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678999999999999988 8999999999999985 68899999986432 2234678999999999999
Q ss_pred CcceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 041230 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIA 330 (485)
Q Consensus 251 ~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~iv 330 (485)
|||+++++++.. ....++||||+++|+|.+++...... ..++|..+..|+.+++.||.||| ..+|+
T Consensus 90 ~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~ 155 (307)
T 2nru_A 90 ENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLH---ENHHI 155 (307)
T ss_dssp TTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred CCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHh---cCCee
Confidence 999999999764 23578999999999999999753211 35889999999999999999999 67899
Q ss_pred eeccCCCceEecCCCcEEEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhhh-cc
Q 041230 331 HCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEI-LN 390 (485)
Q Consensus 331 HrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~-~d 390 (485)
||||||+|||++.++.+||+|||+++........ ..+....++++++...+.--.... .+
T Consensus 156 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcc
Confidence 9999999999999999999999999865432111 012233456666543332111000 00
Q ss_pred ----ccchhhhhhhhh-----hhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 391 ----DFNLQEIEEDRT-----MCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 391 ----~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
............ .......... .....+...+.++...|++.+|.+||++.+|++.|+.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS-----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred cCcchHHHHHHHHHhhhhhhhhhhhcccccc-----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 000000000000 0000000000 0112355678899999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=276.73 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=173.0
Q ss_pred hhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
...++|...+.||+|+||.||+|... +++.||||.++.... ...+.|.+|++++.+++|||||+++++|.. ..
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQ 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CC
Confidence 34567888899999999999999975 688999999864322 223578899999999999999999999864 23
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.++|.... ..+++...+.++.+++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG--------ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEE
Confidence 5799999999999999997432 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhcc----ccchhhhhhhhhhhc
Q 041230 350 GDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILN----DFNLQEIEEDRTMCM 405 (485)
Q Consensus 350 ~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d----~~~~~~~~~~~~~~~ 405 (485)
+|||+++........ ..++...++++++...+. ++. +..............
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~e-----l~t~g~~p~~~~~~~~~~~~~~ 329 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE-----TFSLGASPYPNLSNQQTREFVE 329 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHH-----HHTTSCCSSTTSCHHHHHHHHH
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHH-----HHhCCCCCCCCCCHHHHHHHHH
Confidence 999999865332110 112234456665543322 211 000000000000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
... ....+ ..+...+.++...||+.+|++||||.+|++.|+.++++
T Consensus 330 ~~~-~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGG-RLPCP------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTC-CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC-CCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 000 00000 12345677899999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=270.95 Aligned_cols=240 Identities=20% Similarity=0.291 Sum_probs=173.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.++|...+.||+|+||+||++.. .+++.||+|++........+.|.+|++++.+++|||||++++++.. ....+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence 35677889999999999999985 4588999999865444556789999999999999999999999864 24578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++.... ..++|..+..|+.+++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD--------SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADF 152 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC--------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCC
T ss_pred EEEEecCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeec
Confidence 9999999999999997533 35788999999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc--------------------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhh
Q 041230 353 SMARFLPDTDEQ--------------------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEED 400 (485)
Q Consensus 353 Gla~~~~~~~~~--------------------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~ 400 (485)
|+++........ ..++...++++++...+.--......+.......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~-- 230 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-- 230 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--
Confidence 999875332210 0112234555555433321100000000000000
Q ss_pred hhhhcccCCCCCCcchhh-----hHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHhh
Q 041230 401 RTMCMHASSSSSTSTHVS-----IILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKILE 461 (485)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~~ 461 (485)
........ ....+...+.++...|++.+|++|||+.++++.|+.++.....
T Consensus 231 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 231 ----------DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp ----------TSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ----------HHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00000000 0011233567899999999999999999999999999887643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=266.93 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=169.0
Q ss_pred cccccceeecccCceEEEEeEe-----eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
+.|...+.||+|+||+||++.+ .+++.||||++........+.|.+|+.++.+++|||||+++++|...+ ..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 86 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 86 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---HT
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---CC
Confidence 4677789999999999999974 357899999987554444578999999999999999999999875422 23
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK--------ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEE
T ss_pred ceEEEEEeCCCCCHHHHHHhcc--------cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEE
Confidence 4689999999999999997542 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhh---------hh---cccc-chh
Q 041230 350 GDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVE---------EI---LNDF-NLQ 395 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~---------~~---~d~~-~~~ 395 (485)
+|||+++........ ..++...++++++...+.--.. +. .... ...
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence 999999876432210 1112234555555433221000 00 0000 000
Q ss_pred h-hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 396 E-IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 396 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
. ............... . ...+...+.++...|++.+|++|||+.+|+++|+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~-~------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLP-R------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHTTCCCC-C------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhHHHHHHHHhccCcCC-C------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 000000000000000 0 0123456778999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-32 Score=276.03 Aligned_cols=240 Identities=22% Similarity=0.367 Sum_probs=164.0
Q ss_pred ccccccceeecccCceEEEEeEee----CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||.||+|... ++..||||+++.... ...+.|.+|+.++.+++|||||+++++|.. .
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence 357888999999999999999864 467899999875432 234679999999999999999999999864 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.++|+... ..+++..++.|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 187 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred CceEEEEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEE
Confidence 35799999999999999998643 35788999999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..+....++++++...+.--. ... +...............
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~--P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER--PYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C--TTTTCCHHHHHHHHHT
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHc
Confidence 9999999876432211 011223455555543322000 000 0000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... . ...+...+.+++..|++.+|++||+|.+|+++|+.+...
T Consensus 266 ~~~~~-~------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLP-P------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECC-C------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCC-C------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 00000 0 012345677899999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=266.78 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=171.9
Q ss_pred hhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.-..++|...+.||+|+||+||+|.. .++.||||+++... .....+..|+.++.+++|||||++++++..... ....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~ 96 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVD 96 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEE
T ss_pred ccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCce
Confidence 34456788899999999999999985 48899999986432 223456678889999999999999999875321 1234
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC-------CCCeeeeccCCCceEecC
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC-------QPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~-------~~~ivHrdlK~~NILld~ 343 (485)
.++||||+++|+|.+++... .++|..+..|+.+++.||.|||..+ .++|+||||||+|||++.
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN----------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred EEEEEecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 78999999999999999742 4788999999999999999999321 129999999999999999
Q ss_pred CCcEEEeecccccccCCCCcce-------------------------eeeccccHHHHHHHHhhhhhhhh-ccc----cc
Q 041230 344 EMIGHVGDFSMARFLPDTDEQT-------------------------RFIGKLNVRNFVKMALSQRVEEI-LND----FN 393 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~~~~~-------------------------~~~~~~~l~~~~~~~~~~~~~~~-~d~----~~ 393 (485)
++.+||+|||+++......... .++...++++++...+.--.... .+. ..
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 9999999999997654322110 00112255555543332110000 000 00
Q ss_pred h---------hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 394 L---------QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 394 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
. ......................+. ...+...+.++...|++.+|++|||+.+|+++|+.+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ-KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGG-SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCCcccccc-ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000000000111111111110011 113456688999999999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-31 Score=260.73 Aligned_cols=246 Identities=20% Similarity=0.301 Sum_probs=168.2
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHh--cCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAIN--IRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|.. +|+.||||++.. .....+..|.+++.. ++||||+++++++... .......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCcee
Confidence 45788889999999999999985 789999999864 244567777777776 8999999999987643 2234567
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeeccCCCceEecCCCc
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC-----QPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~-----~~~ivHrdlK~~NILld~~~~ 346 (485)
++||||+++|+|.++++.. .+++..+..|+.+++.||.|||... ..+|+||||||+|||++.++.
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 8999999999999999642 4788899999999999999999422 578999999999999999999
Q ss_pred EEEeecccccccCCCCcce----------------------------eeeccccHHHHHHHHhhhhhh----hh----cc
Q 041230 347 GHVGDFSMARFLPDTDEQT----------------------------RFIGKLNVRNFVKMALSQRVE----EI----LN 390 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~~----------------------------~~~~~~~l~~~~~~~~~~~~~----~~----~d 390 (485)
+||+|||+++......... .++...++++++...+.--.. .+ -.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997653322110 001123455554433221100 00 00
Q ss_pred ccch-----hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 391 DFNL-----QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 391 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
|... ...................+.. .....+...+.++...|++.+|++|||+.+|+++|+.|
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR-WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChh-hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 0000 0000000000001111111100 01123566788999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-31 Score=266.23 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=168.7
Q ss_pred ccccccceeecccCceEEEEeEee----CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~----~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.+.|...+.||+|+||+||+|... .+..||||+++.... ...+.|.+|+.++.+++|||||++++++.. .
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 122 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-----G 122 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-----G
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 346778899999999999999863 344699999875432 234679999999999999999999999764 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD--------GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEE
Confidence 45789999999999999997543 25788999999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..++...++++++...+.--. ... +...............
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~--p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER--PYWNMTNRDVISSVEE 269 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC--TTTTSCHHHHHHHHHT
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC--CcccCCHHHHHHHHHc
Confidence 9999999876443211 111223355555443322100 000 0000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... . ...+...+.++...|++.+|++||+|.+|++.|+.+.+.
T Consensus 270 ~~~~~-~------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 270 GYRLP-A------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp TCCCC-C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCC-C------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 00000 0 012334567899999999999999999999999988654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=273.24 Aligned_cols=153 Identities=25% Similarity=0.396 Sum_probs=129.5
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccc-cCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVD-YQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 269 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.... +....
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35688889999999999999984 5689999999964332 23457889999999999999999999876432 33445
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|||||+ |+|.++|.... .+++.....|+.||+.||.||| +.+||||||||+|||++.++.+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEE
Confidence 6899999996 78999997543 4778888899999999999999 679999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+|+.+.
T Consensus 200 ~DFGla~~~~ 209 (398)
T 4b99_A 200 GDFGMARGLC 209 (398)
T ss_dssp CCCTTCBCC-
T ss_pred eecceeeecc
Confidence 9999998763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=281.03 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=174.0
Q ss_pred cchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.+.....++|...+.||+|+||+||+|...++..||||+++... ...+.|.+|+.+|.+++|||||+++++|..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----- 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK----- 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-----
Confidence 33445567888899999999999999998888899999987533 346789999999999999999999998752
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++||||+++|+|.++|+.... ..+++...+.|+.++|.||.||| +.+|+||||||+|||++.++.+
T Consensus 255 -~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~ 323 (454)
T 1qcf_A 255 -EPIYIITEFMAKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVC 323 (454)
T ss_dssp -SSCEEEECCCTTCBHHHHHHSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCE
T ss_pred -CccEEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcE
Confidence 346899999999999999975321 24678889999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
||+|||+++........ ..++...++++++...+.--. ... |.......+........
T Consensus 324 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~--P~~~~~~~~~~~~i~~~ 401 (454)
T 1qcf_A 324 KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI--PYPGMSNPEVIRALERG 401 (454)
T ss_dssp EECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC--SSTTCCHHHHHHHHHHT
T ss_pred EEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHcC
Confidence 99999999876432100 112233456666543332110 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
. .... +..+...+.++...|++.+|++||||.+|++.|+.+
T Consensus 402 ~-~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 402 Y-RMPR------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp C-CCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred C-CCCC------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 0000 112445677899999999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=261.01 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=166.8
Q ss_pred hhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
+....++|...+.||+|+||+||+|.. +|+.||||++..... ...+.|.+|+.++.+++|||||++++++...
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 106 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP---- 106 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST----
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----
Confidence 334456788899999999999999975 788999999864432 2245789999999999999999999997642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeeccCCCceEecCCC
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPR--IAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~--ivHrdlK~~NILld~~~ 345 (485)
...++||||+++|+|.+++...... ..+++..++.|+.+++.||.||| ..+ |+||||||+|||++.++
T Consensus 107 -~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 107 -PNLSIVTEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp -TCCEEEEECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTC
T ss_pred -CceEEEEecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCC
Confidence 3478999999999999999864321 24788999999999999999999 455 99999999999999999
Q ss_pred cEEEeecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhc-cccchhhhhhhhhhhcc
Q 041230 346 IGHVGDFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEIL-NDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 346 ~~ki~DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~ 406 (485)
.+||+|||+++........ ..+....++++++...+.--..... +........ .... .
T Consensus 177 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--~~~~-~ 253 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AAVG-F 253 (309)
T ss_dssp CEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--HHHH-H
T ss_pred cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-h
Confidence 9999999999764332110 1122345666665443321111000 000000000 0000 0
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
.......+ ..+-..+.++...|++.+|++|||+.+|++.|+.+.+.
T Consensus 254 ~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 KCKRLEIP------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCCCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000000 01223466889999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=275.61 Aligned_cols=240 Identities=20% Similarity=0.310 Sum_probs=171.6
Q ss_pred hccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
..++|...+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.+|.+++|||||+++++|... ....+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence 456788889999999999999986 57899999987532 457899999999999999999999997642 23578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.++|..... ..+++..++.++.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 264 iv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence 99999999999999985432 23678889999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcch
Q 041230 353 SMARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTH 416 (485)
Q Consensus 353 Gla~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (485)
|+++........ ..++...++++++...+.--. ....-+.. ...+......... ....
T Consensus 334 G~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--~~~~~~~~i~~~~-~~~~--- 407 (450)
T 1k9a_A 334 GLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY-KMDA--- 407 (450)
T ss_dssp TTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS--CTTTHHHHHHTTC-CCCC---
T ss_pred CCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHHHcCC-CCCC---
Confidence 999865332111 112334456666544332110 00000000 0000000000000 0000
Q ss_pred hhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 417 VSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 417 ~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
+..+...+.++...||+.+|++|||+.++++.|+.++..
T Consensus 408 ---p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 ---PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 112445677899999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=265.54 Aligned_cols=237 Identities=17% Similarity=0.328 Sum_probs=163.5
Q ss_pred cccccceeecccCceEEEEeEe-eCCcE----EEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~----vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||+|.. .+++. ||+|.+.... ....+.|.+|+.++.+++|||||+++++|...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 4688889999999999999984 34444 5777775322 33457899999999999999999999998642
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
..++|+||+++|+|.+++.... ..+++..++.|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHK--------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHST--------TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEE
T ss_pred -CeEEEEEecCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEE
Confidence 3679999999999999997543 25788899999999999999999 57899999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..++...++++++...+.--. ... .+........ .....
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~ 234 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK 234 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHc
Confidence 9999999876433211 011223455555543332111 000 0000000000 00000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
....... ..+...+..++..|++.+|++||+|.+|++.|+.+...
T Consensus 235 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 GERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCCCCC-------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCC-------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0000000 11334567899999999999999999999999988653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=267.58 Aligned_cols=255 Identities=18% Similarity=0.217 Sum_probs=174.2
Q ss_pred ccchhhhccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEee
Q 041230 187 FKDLYDATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFT 258 (485)
Q Consensus 187 ~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~ 258 (485)
..+.....++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.|.+|++++.++ +|||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 334455678899999999999999999974 2357899999975332 2346799999999999 8999999999
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCccc-------------------------------------------
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW------------------------------------------- 295 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~------------------------------------------- 295 (485)
+|... ....++||||+++|+|.++++.......
T Consensus 94 ~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 94 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 98642 2347899999999999999986532100
Q ss_pred --------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCC
Q 041230 296 --------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361 (485)
Q Consensus 296 --------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~ 361 (485)
......+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 000122889999999999999999999 678999999999999999999999999999865332
Q ss_pred Ccc--------------------eeeeccccHHHHHHHHhhhhh-hhhc--cccchhhhhhhhhhhcccCCCCCCcchhh
Q 041230 362 DEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEIL--NDFNLQEIEEDRTMCMHASSSSSTSTHVS 418 (485)
Q Consensus 362 ~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (485)
... ..++...++++++...+.--. .... ........... ...... ...+
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~~-~~~~---- 318 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKEGTR-MRAP---- 318 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH---HHHTCC-CCCC----
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH---HHcCCC-CCCC----
Confidence 211 011223455555543322110 0000 00000000000 000000 0000
Q ss_pred hHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 419 IILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 419 ~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..+...+.++...|++.+|++||||.+|++.|+.+...
T Consensus 319 --~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 319 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 01223567889999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=279.95 Aligned_cols=242 Identities=19% Similarity=0.292 Sum_probs=173.5
Q ss_pred chhhhccccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
......++|...+.||+|+||.||+|.... +..||||.++... ...+.|.+|+.+|.+++|||||+++++|...
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---- 288 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---- 288 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC----
Confidence 334456678889999999999999999754 7899999987532 3467899999999999999999999998642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++||||+++|+|.++|..... ..+++..++.|+.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 289 -~~~~lv~E~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~ 357 (495)
T 1opk_A 289 -PPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLV 357 (495)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred -CcEEEEEEccCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcE
Confidence 357999999999999999975332 24788899999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
||+|||+++........ ..++...++++++...+.--. ... +................
T Consensus 358 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~--p~~~~~~~~~~~~~~~~ 435 (495)
T 1opk_A 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEKD 435 (495)
T ss_dssp EECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC--SSTTCCGGGHHHHHHTT
T ss_pred EEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHcC
Confidence 99999999876432210 112233456666544332110 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
. .... ...+...+.+|...|++.+|++||||.+|++.|+.+
T Consensus 436 ~-~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 436 Y-RMER------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp C-CCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred C-CCCC------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 0 0000 112345677899999999999999999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=265.91 Aligned_cols=248 Identities=19% Similarity=0.284 Sum_probs=171.3
Q ss_pred ccccccceeecccCceEEEEeEee--------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~--------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
.++|...+.||+|+||+||+|... ++..||||+++.... ...+.|.+|+.++.++ +|||||+++++|..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 467888899999999999999753 345799999875432 2346789999999999 89999999999764
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
....++||||+++|+|.++|....... .......+++...+.|+.+++.||.||| ..+|+||||||
T Consensus 159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 231 (370)
T 2psq_A 159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA 231 (370)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence 235799999999999999998543210 0111235789999999999999999999 67899999999
Q ss_pred CceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchh
Q 041230 337 SNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQ 395 (485)
Q Consensus 337 ~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~ 395 (485)
+|||++.++.+||+|||+++........ ..++...++++++...+.--. ... +....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~--p~~~~ 309 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS--PYPGI 309 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCC--SSTTC
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC--CCCCC
Confidence 9999999999999999999865432110 112223455665543332110 000 00000
Q ss_pred hhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 396 EIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...+.......... ... ...+...+.++...|++.+|++||++.|+++.|+.+...
T Consensus 310 ~~~~~~~~~~~~~~-~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 310 PVEELFKLLKEGHR-MDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp CGGGHHHHHHTTCC-CCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHhcCCC-CCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00000000000000 000 012344567899999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-31 Score=252.73 Aligned_cols=238 Identities=20% Similarity=0.314 Sum_probs=171.1
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|++++.+++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceEE
Confidence 45788889999999999999998888899999987533 345679999999999999999999999753 245799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||
T Consensus 81 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg 149 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG--------KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFG 149 (268)
T ss_dssp EEECCTTCBHHHHHHHHG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTT
T ss_pred EEEccCCCcHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCc
Confidence 999999999999997432 34788999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhc-cccchhhhhhhhhhhcccCCCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEIL-NDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~-d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
+++........ ..++...++++++...+.--. .... +........ ....... ...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~-~~~ 225 (268)
T 3sxs_A 150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV---LKVSQGH-RLY 225 (268)
T ss_dssp CEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTC-CCC
T ss_pred cceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH---HHHHcCC-CCC
Confidence 99876433211 112334556665543322110 0000 000000000 0000000 000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
.+ . .+...+.++...|++.+|++|||+.++++.|+.++++
T Consensus 226 ~~---~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 226 RP---H---LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CC---T---TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CC---C---cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00 0 0123466889999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=259.25 Aligned_cols=146 Identities=21% Similarity=0.285 Sum_probs=129.1
Q ss_pred cccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
|.....||+|+||.||+|... +|+.||||++........+.|.+|+.++.+++|||||++++++... ...++||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~ 121 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVLM 121 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEE
Confidence 566678999999999999865 6999999999866556667899999999999999999999987642 3579999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.+++... .++|..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||++
T Consensus 122 e~~~~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 122 EFLQGGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp CCCCSCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 999999999998642 4788999999999999999999 578999999999999999999999999999
Q ss_pred cccCC
Q 041230 356 RFLPD 360 (485)
Q Consensus 356 ~~~~~ 360 (485)
+....
T Consensus 189 ~~~~~ 193 (321)
T 2c30_A 189 AQISK 193 (321)
T ss_dssp EECCS
T ss_pred eeccc
Confidence 87643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=258.24 Aligned_cols=241 Identities=17% Similarity=0.270 Sum_probs=165.1
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||+||+|.. .++.||||++.. ....+.|.+|++++.+++|||||++++++.. ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEEE
Confidence 4677789999999999999985 578899999853 2345789999999999999999999998752 25899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc-EEEeecc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI-GHVGDFS 353 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~-~ki~DFG 353 (485)
|||+++|+|.+++...... ..+.+...+.++.++++||.|||.....+|+||||||+|||++.++. +||+|||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp EECCTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred EEcCCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 9999999999999865432 24678888999999999999999543378999999999999998876 8999999
Q ss_pred cccccCCCCcc---------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCCCCCcchh
Q 041230 354 MARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSSSSTSTHV 417 (485)
Q Consensus 354 la~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (485)
+++........ ..++...++++++...+.--.... .+........ ..... .........
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~--- 226 (307)
T 2eva_A 152 TACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAV-HNGTRPPLI--- 226 (307)
T ss_dssp C------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHH-HTTCCCCCB---
T ss_pred cccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHH-hcCCCCCcc---
Confidence 99765322110 112334566666544332111110 0000000000 00000 000000000
Q ss_pred hhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 418 SIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 418 ~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
..+...+.++...|++.+|++|||+.+|++.|+.+...+
T Consensus 227 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 227 ---KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ---cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 012345668999999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=252.00 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=169.7
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++|...+.||+|+||+||+|...++..||||++.... ...+.|.+|+.++.+++||||+++++++.. ....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceEE
Confidence 35677889999999999999998788899999987432 345679999999999999999999998764 235799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+|||
T Consensus 83 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp EEECCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred EEEeCCCCcHHHHHHhcC--------cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccc
Confidence 999999999999997543 24788889999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
+++........ ..++...++++++...+.--. ... .+......... ..... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~---~~~~~-~~~~ 227 (269)
T 4hcu_A 152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTG-FRLY 227 (269)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHHTT-CCCC
T ss_pred ccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHhcC-ccCC
Confidence 99865322100 112223455555543322100 000 00000000000 00000 0000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.+ ......+.++...|++.+|++||++.++++.|+.+.+
T Consensus 228 ~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KP------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 00 0112345688999999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=275.48 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=168.6
Q ss_pred hhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.....++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|+.+|.+++|||||+++++|.. .
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------C
Confidence 344556788889999999999999998777889999987533 345789999999999999999999998753 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.++|..... ..+++...+.|+.+++.||.||| ..+|+||||||+|||+++++.+||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ceEEEehhhcCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEE
Confidence 46899999999999999974211 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCC
Q 041230 350 GDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 350 ~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~ 409 (485)
+|||+++........ ..++...++++++...+.--. ... +.......+.........
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~--P~~~~~~~~~~~~i~~~~- 398 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGY- 398 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC--SSTTCCHHHHHHHHHTTC-
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHcCC-
Confidence 999999876432110 112223455555543322110 000 000000000000000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
.... +..+...+.++...|++.+|++|||+.++++.|+.+
T Consensus 399 ~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 399 RMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 012445677899999999999999999999998865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=257.03 Aligned_cols=244 Identities=22% Similarity=0.335 Sum_probs=172.1
Q ss_pred cccccceeecccCceEEEEeEe-----eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||++.. .+|+.||||++........+.|.+|+.++.+++||||+++++++... +..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CCC
Confidence 4577788999999999999974 35889999998765555567899999999999999999999987642 223
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK--------ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST--------TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEE
T ss_pred ceEEEEECCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEE
Confidence 5789999999999999997543 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhh---------hhc---cccchhh
Q 041230 350 GDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVE---------EIL---NDFNLQE 396 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~---------~~~---d~~~~~~ 396 (485)
+|||+++........ ..++...++++++...+.--.. +.. .......
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence 999999876443210 0122234555555433221000 000 0000000
Q ss_pred h--hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 397 I--EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 397 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
. ............... ...+...+.++...|++.+|++||++.+|+++|+.+++.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCC-------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 000000000000000 0123356778999999999999999999999999998865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=250.77 Aligned_cols=241 Identities=20% Similarity=0.324 Sum_probs=168.8
Q ss_pred hhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
....++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|++++.+++||||+++++++.. ...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCC
Confidence 34456788889999999999999998888899999987432 345779999999999999999999998753 345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~ 162 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMR--------HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVS 162 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGG--------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEc
Confidence 799999999999999997532 35788899999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhc-cccchhhhhhhhhhhcccCC
Q 041230 351 DFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEIL-NDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 351 DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~-d~~~~~~~~~~~~~~~~~~~ 409 (485)
|||+++........ ..+....++++++...+.--. .... +........ .......
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~- 238 (283)
T 3gen_A 163 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQGL- 238 (283)
T ss_dssp STTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTC-
T ss_pred cccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---HHHhccc-
Confidence 99999865321100 112223455555443322100 0000 000000000 0000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
....+ . .+...+.++...|++.+|++|||+.++++.|+.+.+.
T Consensus 239 ~~~~~---~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RLYRP---H---LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCC---T---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---C---cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00000 0 1123466899999999999999999999999988653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=279.30 Aligned_cols=235 Identities=21% Similarity=0.305 Sum_probs=167.6
Q ss_pred ccccce-eecccCceEEEEeEee---CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 196 GFSSAN-LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~-~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++.... .||+|+||.||+|... ++..||||+++... ....+.|.+|+++|.+++|||||+++++|.. +.
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence 333333 7999999999999864 45679999997543 2356789999999999999999999999863 24
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|.... ..+++..+..|+.+|+.||.||| ..+|+||||||+||||+.++.+||+
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~ 478 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKIS 478 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEe
Confidence 789999999999999997543 35788999999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhhhhcc-ccc---hhhhhhhhhhhc
Q 041230 351 DFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVEEILN-DFN---LQEIEEDRTMCM 405 (485)
Q Consensus 351 DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~~~~d-~~~---~~~~~~~~~~~~ 405 (485)
|||+++........ ..++...++++++...+. ++. ... .....+......
T Consensus 479 DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~e-----llt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE-----ALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp CCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHH-----HHTTSCCTTTTCCSHHHHHHHH
T ss_pred eccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHH-----HHHCCCCCCCCCCHHHHHHHHH
Confidence 99999876432210 112223455555543322 221 100 000000000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
.... ... +..+...+.+|+..||+.+|++||+|.+|++.|+.+....
T Consensus 554 ~~~~-~~~------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 554 QGKR-MEC------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TTCC-CCC------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCC-CCC------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0000 000 1124456779999999999999999999999999886654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=258.61 Aligned_cols=257 Identities=19% Similarity=0.309 Sum_probs=162.9
Q ss_pred cchhhhccccccceeecccCceEEEEeEeeCC----cEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeec
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFDG----TTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVS 261 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~----~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~ 261 (485)
+++....++|...+.||+|+||+||+|..... ..||||+++.. .....+.|.+|++++.+++|||||++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34445567899999999999999999985433 27999998643 2334578999999999999999999999976
Q ss_pred ccccCC-ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceE
Q 041230 262 GVDYQG-ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340 (485)
Q Consensus 262 ~~~~~~-~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NIL 340 (485)
.....+ ....++|+||+++|+|.+++...... .....+++..+..|+.+++.||.||| ..+|+||||||+|||
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG---ENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCM 169 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhcc---ccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEE
Confidence 432211 11248999999999999999642211 01135788999999999999999999 678999999999999
Q ss_pred ecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhh
Q 041230 341 LDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIE 398 (485)
Q Consensus 341 ld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~ 398 (485)
++.++.+||+|||+++........ ..++...++++++...+.--. ... .+........
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 249 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence 999999999999999865332210 011223455555543322110 000 0000000000
Q ss_pred hhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHh
Q 041230 399 EDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460 (485)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~ 460 (485)
.......... .. ..+...+.++...|++.+|++|||+.++++.|+.+....+
T Consensus 250 ---~~~~~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 250 ---NYLIGGNRLK-QP------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ---HHHHTTCCCC-CC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ---HHHhcCCCCC-CC------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 0000000000 00 1123456789999999999999999999999999977543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=256.72 Aligned_cols=152 Identities=31% Similarity=0.497 Sum_probs=124.5
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHH--HHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKA--AINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||+|.. +++.||||+++.. ....+..|.++ +..++||||+++++++......+....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788889999999999999975 7899999998642 33455555555 445899999999987665444555667
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC------CCCeeeeccCCCceEecCCC
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC------QPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~------~~~ivHrdlK~~NILld~~~ 345 (485)
++||||+++|+|.+++... .++|..+..|+.+++.||.|||+.+ .++|+||||||+|||++.++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred EEEEecCCCCcHHHHHhhc----------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 8999999999999999643 3467888999999999999999431 12999999999999999999
Q ss_pred cEEEeecccccccC
Q 041230 346 IGHVGDFSMARFLP 359 (485)
Q Consensus 346 ~~ki~DFGla~~~~ 359 (485)
.+||+|||+++.+.
T Consensus 158 ~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 158 TCVISDFGLSMRLT 171 (336)
T ss_dssp CEEECCCTTCEECS
T ss_pred cEEEeeccceeecc
Confidence 99999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=255.13 Aligned_cols=159 Identities=25% Similarity=0.378 Sum_probs=131.2
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc------
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY------ 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~------ 265 (485)
.++|...+.||+|+||.||+|... +|+.||||+++... ....+.|.+|+.++.+++|||||++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888899999999999999864 78999999997543 2345779999999999999999999998753211
Q ss_pred ----------------------------------------------CCceeeEEEEEecCCCCHHHhhcCCCCccccccc
Q 041230 266 ----------------------------------------------QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLN 299 (485)
Q Consensus 266 ----------------------------------------------~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~ 299 (485)
....+.++||||+++|+|.+++......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------ 158 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL------ 158 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc------
Confidence 1122478999999999999999875432
Q ss_pred ccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccccccCCC
Q 041230 300 FDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361 (485)
Q Consensus 300 ~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~ 361 (485)
....+.....|+.+++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 34567778899999999999999 678999999999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=257.89 Aligned_cols=243 Identities=21% Similarity=0.327 Sum_probs=170.1
Q ss_pred cccccceeecccCceEEEEeEe-----eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||++.. .+++.||||++........+.|.+|++++.+++||||+++++++... +..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence 5778889999999999999984 45788999998765444556799999999999999999999987632 245
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR--------ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEE
T ss_pred eEEEEEeecCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEE
Confidence 6789999999999999997422 24788999999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhh---------hhccc----cchh
Q 041230 350 GDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVE---------EILND----FNLQ 395 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~---------~~~d~----~~~~ 395 (485)
+|||+++........ ..++...++++++...+.--.. +.... ....
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence 999999876433211 1122234555555433221000 00000 0000
Q ss_pred hhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 396 EIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
................. ...+...+.++...|++.+|++|||+.+|++.|+.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPA-------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred cHHHHHHHhhcccCCCC-------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 00000000000000000 011234567899999999999999999999999988654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=275.81 Aligned_cols=153 Identities=20% Similarity=0.322 Sum_probs=132.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.++|...+.||+|+||+||++.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.. ....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 35788899999999999999985 4689999999976544455678999999999999999999998653 35689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC--CcEEEe
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE--MIGHVG 350 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~--~~~ki~ 350 (485)
+|||||++|+|.++|.... ..+++.....|+.||+.||.||| ..+|+||||||+||||+.+ +.+||+
T Consensus 231 iv~E~~~gg~L~~~i~~~~--------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~ 299 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 299 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT--------SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEeecCCCcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEe
Confidence 9999999999999997543 24778888999999999999999 6789999999999999854 899999
Q ss_pred ecccccccCCCC
Q 041230 351 DFSMARFLPDTD 362 (485)
Q Consensus 351 DFGla~~~~~~~ 362 (485)
|||+|+.+....
T Consensus 300 DFG~a~~~~~~~ 311 (573)
T 3uto_A 300 DFGLTAHLDPKQ 311 (573)
T ss_dssp CCSSCEECCTTS
T ss_pred eccceeEccCCC
Confidence 999999875543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-30 Score=247.39 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=171.7
Q ss_pred hhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
...+.|...+.||+|+||.||+|...++..||||.++... ...+.|.+|++++.+++||||+++++++.. ...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCc
Confidence 3456788889999999999999998778899999986432 345789999999999999999999998752 246
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++|+|.+++..... ..+++..+..|+.+++.||.||| ..+|+||||||+|||+++++.+||+|
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECC
Confidence 899999999999999975321 25788899999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCC
Q 041230 352 FSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 352 FGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
||+++........ ..++...++++++...+.--. ... +.......+............
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~--p~~~~~~~~~~~~~~~~~~~~ 230 (279)
T 1qpc_A 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMV 230 (279)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC--SSTTCCHHHHHHHHHTTCCCC
T ss_pred CcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC--CCcccCHHHHHHHHhcccCCC
Confidence 9999876432210 112223455555543322110 000 000000000000000000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
.. ..+...+.++...|++.+|++|||+.++++.|+.+...
T Consensus 231 -~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 -RP------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -Cc------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 00 01234567899999999999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-30 Score=251.49 Aligned_cols=231 Identities=16% Similarity=0.205 Sum_probs=163.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++.+++|||||++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence 45688889999999999999983 5688999999976555566789999999999999999999998764 23579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df 160 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (297)
T ss_dssp EEEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEECCCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999742 3677888999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhh-hhhhhhhhcccCCCCCC
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQE-IEEDRTMCMHASSSSST 413 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~~~~~~ 413 (485)
|+++........ ..++...++++++...+.--.... +..... .................
T Consensus 161 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~--pf~~~~~~~~~~~~~~~~~~~~~~ 238 (297)
T 3fxz_A 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--PYLNENPLRALYLIATNGTPELQN 238 (297)
T ss_dssp TTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC--TTTTSCHHHHHHHHHHHCSCCCSC
T ss_pred CCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC--CCCCCCHHHHHHHHHhCCCCCCCC
Confidence 999876433211 112233456666544332111100 000000 00000000000000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+ ......+.++...|++.+|++|||+.|+++
T Consensus 239 ~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 P------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 112234568889999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=263.04 Aligned_cols=240 Identities=23% Similarity=0.365 Sum_probs=160.5
Q ss_pred ccccceeecccCceEEEEeEeeC--C--cEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD--G--TTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~--~--~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.|...+.||+|+||+||+|...+ + ..||||.++... ....+.|.+|+.++.+++|||||+++++|... ...
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence 45567899999999999998643 2 358999886432 23457899999999999999999999987532 235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~ 234 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVA 234 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEECCCCCCHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEe
Confidence 689999999999999997543 24678889999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc----------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 351 DFSMARFLPDTDEQ----------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 351 DFGla~~~~~~~~~----------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
|||+++........ ..++...++++++...+.--. ... +.......+........
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~--p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQG 312 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC--SCTTSCSSCHHHHHHTT
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC--CCCCCCHHHHHHHHHcC
Confidence 99999865322110 011223455555543322110 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
. ....+ ..+...+.++...|++.+|++||++.+|++.|+.+...+
T Consensus 313 ~-~~~~p------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 313 R-RLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp C-CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C-CCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 00000 113345678999999999999999999999999987754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=251.24 Aligned_cols=241 Identities=20% Similarity=0.303 Sum_probs=166.3
Q ss_pred cccccceeecccCceEEEEeEe-----eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.|...+.||+|+||.||++.+ .+++.||||+++... ....+.+.+|+.++.+++||||+++++++... +.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 3577788999999999999983 468899999987433 23457899999999999999999999998642 22
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k 166 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK--------NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 166 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT--------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEE
Confidence 45789999999999999996432 24788899999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhh------------hhccccchh
Q 041230 349 VGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVE------------EILNDFNLQ 395 (485)
Q Consensus 349 i~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~------------~~~d~~~~~ 395 (485)
|+|||+++........ ..+....++++++...+.--.. ....+....
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246 (302)
T ss_dssp ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence 9999999876443211 1122234555555433221000 000010000
Q ss_pred h-hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 396 E-IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 396 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
. ................ + ..+...+.++...|++.+|++|||+.+|+++|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPC-P------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTCCCCC-C------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCC-C------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 0000000000000000 0 012345678999999999999999999999999764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=251.22 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=166.7
Q ss_pred cchhhhccccccceeecccCceEEEEeEeeC----CcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeec
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVS 261 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~ 261 (485)
.++....++|...+.||+|+||.||+|.... +..||||.++.... ...+.|.+|+.++.+++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444456788889999999999999998542 44799999864432 23467899999999999999999999987
Q ss_pred ccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe
Q 041230 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341 (485)
Q Consensus 262 ~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl 341 (485)
..+..+....++|+||+++|+|.+++...... .....+++.....|+.+++.||.||| ..+|+||||||+|||+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli 180 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE---TGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCML 180 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBT---TSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhh---cCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEE
Confidence 54333333569999999999999998532210 01135888999999999999999999 6789999999999999
Q ss_pred cCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhh
Q 041230 342 DDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEED 400 (485)
Q Consensus 342 d~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~ 400 (485)
+.++.+||+|||+++........ ..+....++++++...+.--. ... +.........
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~--p~~~~~~~~~ 258 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT--PYPGVQNHEM 258 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCC--SSTTCCGGGH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCC--CCccCCHHHH
Confidence 99999999999999865332110 011223355555543322111 000 0000000000
Q ss_pred hhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 401 RTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
........... .+ ..+...+.++...|++.+|.+||++.++++.|+.+.+.
T Consensus 259 ~~~~~~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 YDYLLHGHRLK-QP------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHHTTCCCC-CB------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-CC------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00000000000 00 11334567899999999999999999999999998765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=260.41 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=171.2
Q ss_pred hccccccceeecccCceEEEEeEee--------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSG 262 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~--------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~ 262 (485)
..+.|...+.||+|+||+||+|... ++..||||+++.... ...+.|.+|++++.++ +|||||+++++|..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888899999999999999852 235799999875432 2346789999999999 99999999999864
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
....++||||+++|+|.+++........ ......+++..+..|+.+++.||.||| +.+|+|||||
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 218 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA 218 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCC
Confidence 2357999999999999999975432100 011135899999999999999999999 6789999999
Q ss_pred CCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccch
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNL 394 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~ 394 (485)
|+|||++.++.+||+|||+++........ ..++...++++++...+.--. ... +...
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~--p~~~ 296 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPG 296 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC--SSTT
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC--CCCC
Confidence 99999999999999999999865432110 011223455555543322110 000 0000
Q ss_pred hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 395 QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
....+............. + ..+...+.++...|++.+|++||++.+|++.|+.+...
T Consensus 297 ~~~~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRMDK-P------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp CCHHHHHHHHHTTCCCCC-C------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCC-C------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000000000000 0 01234567899999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-29 Score=250.80 Aligned_cols=242 Identities=19% Similarity=0.280 Sum_probs=169.9
Q ss_pred cccceeecccCceEEEEeEe-----eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 197 FSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-----~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
|...+.||+|+||+||++.+ .+|+.||||+++.... ...+.|.+|++++.+++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 47778999999999988764 2578899999975432 2346789999999999999999999998642 2346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++... .+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecccCCcHHHHHhhC----------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEEC
Confidence 78999999999999999753 3678889999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhhhhc--cc---------cchhh--
Q 041230 351 DFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVEEIL--ND---------FNLQE-- 396 (485)
Q Consensus 351 DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~---------~~~~~-- 396 (485)
|||+++........ ..+....++++++...+.--..... .+ .....
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 99999876543211 0122234555555433221000000 00 00000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHhh
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKILE 461 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~~ 461 (485)
................ ...+...+.++...|++.+|++|||+.++++.|+.+.+.+..
T Consensus 257 ~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 257 VLRLTELLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCC-------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 0000000000000000 011334577899999999999999999999999999988743
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-30 Score=247.36 Aligned_cols=238 Identities=21% Similarity=0.271 Sum_probs=156.4
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC----cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP----GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||+|.. .|+.||||+++.... ...+.|.+|+.++.+++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----EP 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C-
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----CC
Confidence 35788889999999999999985 588999999864322 234678999999999999999999999764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC------
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD------ 343 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~------ 343 (485)
..++||||+++|+|.+++... .+++.....++.+++.||.|||.....+|+||||||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred ceEEEEEcCCCCCHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 579999999999999999642 4678889999999999999999543334999999999999986
Q ss_pred --CCcEEEeecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhc
Q 041230 344 --EMIGHVGDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 344 --~~~~ki~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 405 (485)
++.+||+|||+++........ ..++...++++++...+.--.....-...... .......
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~- 227 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-AVAYGVA- 227 (271)
T ss_dssp CSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-HHHHHHH-
T ss_pred ccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHhhh-
Confidence 778999999999865432211 01122345555544332211000000000000 0000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
......... ..+...+.++...|++.+|++|||+.||++.|+.|
T Consensus 228 ~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 MNKLALPIP------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSCCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCCCCCCCC------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000000000 11234567899999999999999999999999754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=278.49 Aligned_cols=242 Identities=21% Similarity=0.352 Sum_probs=172.6
Q ss_pred cchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.......++|...+.||+|+||.||+|...++..||||+++... ...+.|.+|+++|.+++|+|||+++++|..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence 33444566788899999999999999998777889999987533 345789999999999999999999998753
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++||||+++|+|.++|..... ..+++...+.|+.+|+.||.||| ..+|+||||||+|||++.++.+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~ 402 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVC 402 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred -ccceEeeehhcCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcE
Confidence 346899999999999999974211 24788899999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
||+|||+++........ ..+....++++++...+.--. ... +.......+........
T Consensus 403 kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~--P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERG 480 (535)
T ss_dssp EECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCC--SSTTCCHHHHHHHHHTT
T ss_pred EEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHcC
Confidence 99999999875431100 112234456666544332111 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
. ..... ..+...+.+|...||+.+|++||||.+|++.|+.+
T Consensus 481 ~-~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 481 Y-RMPCP------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp C-CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred C-CCCCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 00000 12345567899999999999999999999998865
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-30 Score=249.37 Aligned_cols=240 Identities=24% Similarity=0.381 Sum_probs=165.5
Q ss_pred cccccceeecccCceEEEEeEeeCC----cEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~----~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..|...+.||+|+||+||+|...++ ..||||.++.... ...+.|.+|+.++.+++||||++++++|... ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----CC
Confidence 3566778999999999999985332 2589998864332 2346789999999999999999999987532 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl 169 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKV 169 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEeCCCCCCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEE
Confidence 5789999999999999997543 24678889999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc----------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhc
Q 041230 350 GDFSMARFLPDTDEQ----------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 350 ~DFGla~~~~~~~~~----------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~ 405 (485)
+|||+++........ ..++...++++++...+.--. ... .......... ....
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~ 246 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLL 246 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHH
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHh
Confidence 999999865432210 011122345555433222100 000 0000000000 0000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
... ....+ ..+...+.++...|++.+|++||++.+++++|+.+...+
T Consensus 247 ~~~-~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 247 QGR-RLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TTC-CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred cCC-CCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 00000 012345678999999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=247.47 Aligned_cols=242 Identities=19% Similarity=0.310 Sum_probs=167.9
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||.||+|.. +|+.||||+++.... ...+.|.+|+.++.+++|||||++++++... .....+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPHPT 85 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSSCE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCCeE
Confidence 4677889999999999999986 588999999875432 2346799999999999999999999998642 124578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.+++..... ..+++..+..|+.+++.||.|||+. .++|+||||||+|||++.++.++|+||
T Consensus 86 lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred eeecccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEec
Confidence 99999999999999986432 2578899999999999999999932 233999999999999999999999999
Q ss_pred ccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhc-cccchhhhhhhhhhhcccCCCCCCcc
Q 041230 353 SMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEIL-NDFNLQEIEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 353 Gla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (485)
|++......... ..++...++++++...+.--..... +........ .... ........+
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~~- 233 (271)
T 3kmu_A 158 DVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG--MKVA-LEGLRPTIP- 233 (271)
T ss_dssp GSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH--HHHH-HSCCCCCCC-
T ss_pred cceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH--HHHH-hcCCCCCCC-
Confidence 987654322110 0001124666665443321111000 000000000 0000 000000000
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
..+...+.++...|++.+|++|||+.+|++.|+.+++
T Consensus 234 -----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 234 -----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0123346688899999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=257.71 Aligned_cols=237 Identities=19% Similarity=0.305 Sum_probs=163.7
Q ss_pred cccccceeecccCceEEEEeEe-eCCcE----EEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~----vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||+|.. .+++. ||+|.+.... ....+.|.+|+.++.+++|||||+++++|.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------ 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence 4677889999999999999985 34554 7777765332 2334567889999999999999999998753
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR--------GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG--------GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEE
T ss_pred CccEEEEEeCCCCCHHHHHHHcc--------ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEE
Confidence 34789999999999999997542 25677888999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcce--------------------eeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 349 VGDFSMARFLPDTDEQT--------------------RFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 349 i~DFGla~~~~~~~~~~--------------------~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
|+|||+++......... .++...++++++...+.--. ... +................
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~--p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE--PYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC--TTTTSCTTHHHHHHHTT
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCC--CccccCHHHHHHHHHcC
Confidence 99999998764432210 11223355555443322110 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.... .+ ..+...+.++...|++.+|++||++.+|++.|+.+..
T Consensus 234 ~~~~-~~------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ERLA-QP------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CBCC-CC------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCC-CC------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 00 0122245578899999999999999999999998854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=250.12 Aligned_cols=240 Identities=18% Similarity=0.308 Sum_probs=160.0
Q ss_pred hccccccceeecccCceEEEEeEeeC----CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
..+.|...+.||+|+||.||+|.... +..||||.++.... ...+.|.+|+.++.+++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 34578888999999999999998533 45699998764332 234678999999999999999999998742
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++||||+++|+|.+++.... ..+++..+..++.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTT--------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred -CccEEEEecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCE
Confidence 34689999999999999997543 25788899999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
||+|||+++........ ..++...++++++...+.--. .. -+................
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~--~pf~~~~~~~~~~~i~~~ 233 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRIENG 233 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC--CTTTTCCGGGHHHHHHTT
T ss_pred EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC--CCCCcCCHHHHHHHHHcC
Confidence 99999999876432210 011123455555433222100 00 000000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... + ..+...+.++...|++.+|++||++.++++.|+.+.+.
T Consensus 234 ~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 ERLPM-P------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-C------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 0 11334567899999999999999999999999998664
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-30 Score=249.30 Aligned_cols=236 Identities=21% Similarity=0.347 Sum_probs=164.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcc-------hHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG-------ARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||+||+|.. .+++.||||++....... .+.|.+|+.++.+++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 45788889999999999999986 468899999986433221 16789999999999999999999987532
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeeccCCCceEecC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPR--IAHCNLKPSNVLLDD 343 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~--ivHrdlK~~NILld~ 343 (485)
.++||||+++|+|.+++.... ..+++..+..++.+++.||.||| ..+ |+||||||+|||++.
T Consensus 96 -----~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~ 159 (287)
T 4f0f_A 96 -----PRMVMEFVPCGDLYHRLLDKA--------HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQS 159 (287)
T ss_dssp -----TEEEEECCTTCBHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESC
T ss_pred -----CeEEEEecCCCCHHHHHhccc--------CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEec
Confidence 269999999999999987543 25788999999999999999999 456 999999999999988
Q ss_pred CCc-----EEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhh
Q 041230 344 EMI-----GHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEED 400 (485)
Q Consensus 344 ~~~-----~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~ 400 (485)
++. +||+|||+++........ ..++...++++++...+.--.... .+..........
T Consensus 160 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 239 (287)
T 4f0f_A 160 LDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239 (287)
T ss_dssp CCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred cCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence 776 999999999754332110 112234466666544332111100 000000000000
Q ss_pred hhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 401 RTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
....... .....+ ..+...+.++...|++.+|++|||+.+|++.|++
T Consensus 240 ~~~~~~~-~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEG-LRPTIP------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSC-CCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccC-CCCCCC------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0000000 000000 1133456789999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-30 Score=251.93 Aligned_cols=248 Identities=16% Similarity=0.261 Sum_probs=170.5
Q ss_pred hhccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
...++|...+.||+|+||.||++.. .++..||||+++.... ...+.|.+|+.++.+++|||||++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--
Confidence 3456788889999999999999975 2347899999864322 234678999999999999999999998754
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCccc---------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHW---------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~---------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~i 329 (485)
....++||||+++|+|.+++........ ......+++.....|+.+++.||.||| ..+|
T Consensus 98 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i 171 (314)
T 2ivs_A 98 ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKL 171 (314)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred ---CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence 2357999999999999999975432100 001134788999999999999999999 6789
Q ss_pred eeeccCCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh
Q 041230 330 AHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI 388 (485)
Q Consensus 330 vHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~ 388 (485)
+||||||+|||++.++.+||+|||+++........ ..++...++++++...+.--. ...
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876432211 012223455555443322110 000
Q ss_pred -ccccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 389 -LNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 389 -~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.......... .......... .+ ..+...+.++...|++.+|++||++.+|++.|+.+..
T Consensus 252 p~~~~~~~~~~---~~~~~~~~~~-~~------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 252 PYPGIPPERLF---NLLKTGHRME-RP------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SSTTCCGGGHH---HHHHTTCCCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHH---HHhhcCCcCC-CC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000000000 0000000000 00 1123456789999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=263.44 Aligned_cols=247 Identities=19% Similarity=0.294 Sum_probs=168.5
Q ss_pred ccccccceeecccCceEEEEeEee------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.++|...+.||+|+||+||+|... ++..||||+++... ......|.+|+.++.+++|||||++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 357888899999999999999843 45689999986432 2334578999999999999999999999754
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC--
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-- 344 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-- 344 (485)
....++||||+++|+|.+++....... .....+.+..++.|+.+++.||.||| ..+|+||||||+|||++.+
T Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 146 -SLPRFILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred -CCCCEEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCC
Confidence 234689999999999999997543211 11135889999999999999999999 6789999999999999954
Q ss_pred -CcEEEeecccccccCCCC---c-----------------ceeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhh
Q 041230 345 -MIGHVGDFSMARFLPDTD---E-----------------QTRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRT 402 (485)
Q Consensus 345 -~~~ki~DFGla~~~~~~~---~-----------------~~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~ 402 (485)
..+||+|||+++...... . ...+....++++++...+.--. ... +...........
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~--pf~~~~~~~~~~ 297 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM--PYPSKSNQEVLE 297 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC--SSTTCCHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCC--CCCCCCHHHHHH
Confidence 469999999997531110 0 0112233455555543322110 000 000000000000
Q ss_pred hhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 403 MCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
......... .. ..+...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 298 ~i~~~~~~~-~~------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 298 FVTSGGRMD-PP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHTTCCCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHcCCCCC-CC------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 000000000 00 113345678999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=258.65 Aligned_cols=251 Identities=18% Similarity=0.259 Sum_probs=171.1
Q ss_pred hhccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
...++|...+.||+|+||.||+|... +++.||||+++.... ...+.|.+|+.++.+++||||++++++|..
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 34678888999999999999999864 347899999875432 234679999999999999999999999764
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCccc---------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHW---------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~---------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~i 329 (485)
....++||||+++|+|.++|........ ......+++..++.|+.+++.||.||| ..+|
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~i 195 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 195 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 2457999999999999999975321100 000135889999999999999999999 6789
Q ss_pred eeeccCCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh
Q 041230 330 AHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI 388 (485)
Q Consensus 330 vHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~ 388 (485)
+||||||+|||++.++.+||+|||+++........ ..+....++++++...+.--. ..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~- 274 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL- 274 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC-
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC-
Confidence 99999999999999999999999999764322100 111223455555443322110 00
Q ss_pred ccccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 389 LNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 389 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
.+.......+............. + ..+...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 275 -~p~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 275 -QPYYGMAHEEVIYYVRDGNILAC-P------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -CTTTTSCHHHHHHHHHTTCCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -CcCCCCChHHHHHHHhCCCcCCC-C------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 00000000000000000000000 0 113345678999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-29 Score=250.20 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=167.4
Q ss_pred hccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc--CCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI--RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..++|...+.||+|+||.||+|.. .|+.||||++... ....+..|.+++..+ +||||+++++++.... .....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCc
Confidence 346788899999999999999985 5899999998632 334555666666554 9999999999876431 11246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeeccCCCceEecCCC
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC-----QPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~-----~~~ivHrdlK~~NILld~~~ 345 (485)
.++||||+++|+|.+++... .+++..+..|+.+++.||.|||..+ .++|+||||||+|||++.++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred eEEEEeccCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 79999999999999999642 4778899999999999999999421 23899999999999999999
Q ss_pred cEEEeecccccccCCCCcc-----------eee-----------ecc------ccHHHHHHHHhhhhhhhhc--------
Q 041230 346 IGHVGDFSMARFLPDTDEQ-----------TRF-----------IGK------LNVRNFVKMALSQRVEEIL-------- 389 (485)
Q Consensus 346 ~~ki~DFGla~~~~~~~~~-----------~~~-----------~~~------~~l~~~~~~~~~~~~~~~~-------- 389 (485)
.+||+|||+++........ ..| ... .++++++...+.--.....
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999999765332211 000 011 4566665443321111000
Q ss_pred ccc--c---hhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 390 NDF--N---LQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 390 d~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
-+. . ....................+... ...++...+.++...|++.+|++|||+.+|++.|+.+.+.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW-SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccc-hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 000 0 000000001111111111111101 1125677788999999999999999999999999998763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=247.79 Aligned_cols=239 Identities=21% Similarity=0.338 Sum_probs=166.5
Q ss_pred ccccceeecccCceEEEEeEeeC-Cc---EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFD-GT---TIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~-~~---~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.|...+.||+|+||+||+|...+ +. .||||.++.... ...+.|.+|+.++.+++|||||++++++... ...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence 34556899999999999998533 32 699999865332 2346789999999999999999999997642 234
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+.+|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~ 166 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQ--------RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVA 166 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred cEEEEecccCCCHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeC
Confidence 589999999999999997643 35678889999999999999999 5789999999999999999999999
Q ss_pred ecccccccCCCCcc----------------------eeeeccccHHHHHHHHhhhhhhh-h-ccccchhhhhhhhhhhcc
Q 041230 351 DFSMARFLPDTDEQ----------------------TRFIGKLNVRNFVKMALSQRVEE-I-LNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 351 DFGla~~~~~~~~~----------------------~~~~~~~~l~~~~~~~~~~~~~~-~-~d~~~~~~~~~~~~~~~~ 406 (485)
|||+++........ ..++...++++++...+.--... . .......... .....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~ 243 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFLAQ 243 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHHHT
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHhhc
Confidence 99999865332100 01122345556554333211100 0 0000000000 00000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
...... . ..+...+.++...|++.+|.+|||+.+++++|+.+.+.+
T Consensus 244 ~~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 244 GRRLPQ-P------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp TCCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCC-C------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 000000 0 012235668999999999999999999999999998765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-30 Score=253.09 Aligned_cols=227 Identities=17% Similarity=0.152 Sum_probs=156.3
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc--chHHHHHHHHHHHhc-CCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--GARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|... +|+.||||++...... ....+..|+..+.++ +|||||+++++|.. ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 57888999999999999999865 6899999997643222 223455666666555 99999999999864 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+ +|+|.+++.... ..++|..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG--------ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEEC
T ss_pred EEEEEecc-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEc
Confidence 79999999 779999887532 35889999999999999999999 5689999999999999999999999
Q ss_pred ecccccccCCCCcce----------------eeeccccHHHHHHHHhhhhhh-hhccccchhhhhhhhhhhcccCCCCCC
Q 041230 351 DFSMARFLPDTDEQT----------------RFIGKLNVRNFVKMALSQRVE-EILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 351 DFGla~~~~~~~~~~----------------~~~~~~~l~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|||+++......... .++...++++++...+.-... ..... ....... .. ...
T Consensus 200 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~--~~~~~~~----~~----~~~ 269 (311)
T 3p1a_A 200 DFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG--GEGWQQL----RQ----GYL 269 (311)
T ss_dssp CCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS--HHHHHHH----TT----TCC
T ss_pred cceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC--ccHHHHH----hc----cCC
Confidence 999998764322111 122234566665443321100 00000 0000000 00 000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. ..........+.++...|++.+|++|||+.++++
T Consensus 270 ~--~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 P--PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp C--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 0001112345678999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=253.61 Aligned_cols=250 Identities=18% Similarity=0.214 Sum_probs=167.8
Q ss_pred hhccccccceeecccCceEEEEeEee------CCcEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
...++|...+.||+|+||.||+|... ++..||||+++... ....+.|.+|+.++.++ +||||+++++++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 45578889999999999999999852 35579999986432 23456899999999999 99999999999764
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCccc--------------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW--------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRI 329 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~--------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~i 329 (485)
....++||||+++|+|.+++........ ......+++..+..|+.+++.||.||| ..+|
T Consensus 121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 193 (344)
T 1rjb_A 121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSC 193 (344)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 2357999999999999999986432100 000124789999999999999999999 6789
Q ss_pred eeeccCCCceEecCCCcEEEeecccccccCCCCcce--------------------eeeccccHHHHHHHHhhhhh-hhh
Q 041230 330 AHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT--------------------RFIGKLNVRNFVKMALSQRV-EEI 388 (485)
Q Consensus 330 vHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~~--------------------~~~~~~~l~~~~~~~~~~~~-~~~ 388 (485)
+||||||+|||++.++.+||+|||+++......... .++...++++++...+.--. ...
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999998654332110 11122345555443322110 000
Q ss_pred ccccchhhh-hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 389 LNDFNLQEI-EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 389 ~d~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
+...... .............. .+ ..+...+..+...|++.+|.+||++.+|++.|+.+...
T Consensus 274 --p~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 274 --PYPGIPVDANFYKLIQNGFKMD-QP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp --SSTTCCCSHHHHHHHHTTCCCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --CcccCCcHHHHHHHHhcCCCCC-CC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 0000000 00000000000000 00 01234567899999999999999999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=276.71 Aligned_cols=232 Identities=20% Similarity=0.272 Sum_probs=163.5
Q ss_pred eeecccCceEEEEeEee---CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||.||+|.+. .++.||||+++.... ...+.|.+|++++.+++|||||+++++|.. +..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 47999999999999753 357899999975322 235789999999999999999999999853 2368999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.++|... ..+++..+..|+.+|+.||.||| ..+|+||||||+||||+.++.+||+|||++
T Consensus 449 E~~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 449 EMAELGPLNKYLQQN---------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp ECCTTEEHHHHHHHC---------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred EccCCCCHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 999999999999743 24788899999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 356 RFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 356 ~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+.+...... ..++...++++++...+.--. ... +.......+............ .
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~--Pf~~~~~~~~~~~i~~~~~~~-~ 593 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGERMG-C 593 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC--SSTTCCHHHHHHHHHTTCCCC-C
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHcCCCCC-C
Confidence 876433210 012223455555543322110 000 000000000000000000000 0
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
+..+...+.++...||+.+|++||+|.+|+++|+.+...+
T Consensus 594 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 594 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0123456778999999999999999999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=249.66 Aligned_cols=248 Identities=19% Similarity=0.212 Sum_probs=170.5
Q ss_pred hccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVD 264 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~ 264 (485)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.|.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 346788889999999999999974 2467899999875432 2346799999999999 999999999997642
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCccc---------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHW---------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~---------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
...++|+||+++|+|.+++........ ......+++.....++.+++.||.||| ..+|+|||||
T Consensus 100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 172 (313)
T 1t46_A 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 172 (313)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred ----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCc
Confidence 356899999999999999975432100 001124889999999999999999999 6789999999
Q ss_pred CCceEecCCCcEEEeecccccccCCCCcce--------------------eeeccccHHHHHHHHhhhhh-hhhcc-c-c
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQT--------------------RFIGKLNVRNFVKMALSQRV-EEILN-D-F 392 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~~~~~~~~--------------------~~~~~~~l~~~~~~~~~~~~-~~~~d-~-~ 392 (485)
|+|||++.++.+||+|||+++......... .++...++++++...+.--. ..... . .
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999999998764432210 01122345555433222100 00000 0 0
Q ss_pred chhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 393 NLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...... .......... .. ..+...+.++...|++.+|.+|||+.+|++.|+.+...
T Consensus 253 ~~~~~~---~~~~~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFY---KMIKEGFRML-SP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHH---HHHHHTCCCC-CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHH---HHhccCCCCC-Cc------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 000000 0000000000 00 01234567899999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=244.49 Aligned_cols=236 Identities=22% Similarity=0.344 Sum_probs=168.9
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||.||++...++..||||.++... ...+.|.+|++++.+++||||+++++++.. ....++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEEE
Confidence 5677889999999999999998788899999987533 234689999999999999999999999764 2357899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|||+
T Consensus 82 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp ECCCTTCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred EeCCCCCcHHHHHhhCc--------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccc
Confidence 99999999999997543 24678889999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
++........ ..++...++++++...+.--. ... ........... .. ..... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~i-~~~~~-~~~ 226 (267)
T 3t9t_A 151 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE--DI-STGFR-LYK 226 (267)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--HH-HTTCC-CCC
T ss_pred ccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH--HH-hcCCc-CCC
Confidence 9865321100 111223455555543322110 000 00000000000 00 00000 000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+ ..+...+.++...|++.+|++||++.++++.|+.+.+
T Consensus 227 ~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 P------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 0122346689999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=250.43 Aligned_cols=236 Identities=17% Similarity=0.204 Sum_probs=166.0
Q ss_pred ccccccceeecccCceEEEEeEeeC-C-------cEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD-G-------TTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~-~-------~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||+||+|.... + ..||+|.+........+.|.+|+.++.+++|||||++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence 3567888999999999999998543 3 46999998765555667899999999999999999999997642
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
...++||||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++
T Consensus 85 ---~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 150 (289)
T 4fvq_A 85 ---DENILVQEFVKFGSLDTYLKKNK--------NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREE 150 (289)
T ss_dssp ---TCCEEEEECCTTCBHHHHHHHTG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECC
T ss_pred ---CCCEEEEECCCCCCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCC
Confidence 34689999999999999997542 24788889999999999999999 67899999999999999888
Q ss_pred c--------EEEeecccccccCCCCcc---------------eeeeccccHHHHHHHHhhhhhh-hh-ccccchhhhhhh
Q 041230 346 I--------GHVGDFSMARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRVE-EI-LNDFNLQEIEED 400 (485)
Q Consensus 346 ~--------~ki~DFGla~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~~-~~-~d~~~~~~~~~~ 400 (485)
. +||+|||+++........ ..++...++++++...+.--.. .. ............
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred cccccccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 7 999999999765322100 1122334566655433321100 00 000000000000
Q ss_pred hhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 401 RTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.. ....... .....+.++...|++.+|++|||+.++++.|+.+-.
T Consensus 231 ---~~--~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 ---YE--DRHQLPA-------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ---HH--TTCCCCC-------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ---hh--ccCCCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 0000000 011235578899999999999999999999987744
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-29 Score=246.48 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=173.9
Q ss_pred cchhhhccccccceeecccCceEEEEeEeeC-CcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
++.....++|...+.||+|+||.||+|.... +..||||.++.. ....+.|.+|+.++.+++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 80 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 80 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 3444556788889999999999999998654 788999998643 3345789999999999999999999998753
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++||||+++|+|.+++..... ..+++..+..|+.+++.||.||| ..+|+||||||+||+++.++.
T Consensus 81 -~~~~~~v~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~ 149 (288)
T 3kfa_A 81 -EPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHL 149 (288)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGC
T ss_pred -CCCEEEEEEcCCCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCC
Confidence 2457999999999999999975332 35788899999999999999999 678999999999999999999
Q ss_pred EEEeecccccccCCCCcce-------------------eeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 347 GHVGDFSMARFLPDTDEQT-------------------RFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~~-------------------~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
+||+|||+++......... .++...++++++...+.--. ... +...............
T Consensus 150 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~--p~~~~~~~~~~~~~~~ 227 (288)
T 3kfa_A 150 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEK 227 (288)
T ss_dssp EEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC--SSTTCCGGGHHHHHHT
T ss_pred EEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHhc
Confidence 9999999998765432110 01122345555433322110 000 0000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
... ...+ ..+...+.++...|++.+|.+||++.+|++.|+.+...
T Consensus 228 ~~~-~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 228 DYR-MERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TCC-CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC-CCCC------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0000 11234567899999999999999999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=254.59 Aligned_cols=145 Identities=23% Similarity=0.284 Sum_probs=123.3
Q ss_pred hccccccceeecccCceEEEEeEee----CCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~----~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 267 (485)
..+.|...+.||+|+||+||+|+.. +++.||||++... .....+.+|+++|..+ +|||||++++++..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~----- 91 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK----- 91 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----
Confidence 3567888999999999999999742 3678999988543 3456788999999988 69999999988653
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-Cc
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MI 346 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-~~ 346 (485)
.+..++||||+++|+|.+++. .+++.....++.|++.||.||| +.+|+||||||+||||+.+ +.
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~------------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~ 156 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN------------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKK 156 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTE
T ss_pred CCEEEEEEeCCCcccHHHHHc------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCe
Confidence 346899999999999999984 2566777889999999999999 6899999999999999987 79
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+|+...
T Consensus 157 ~kl~DFGla~~~~ 169 (361)
T 4f9c_A 157 YALVDFGLAQGTH 169 (361)
T ss_dssp EEECCCTTCEECT
T ss_pred EEECcCCCCcccC
Confidence 9999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=252.68 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=162.6
Q ss_pred cccccceeecccCceEEEEeEeeC-----CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.|...+.||+|+||+||+|.... +..||||.++.... .....|.+|+.++.+++||||+++++++.. .
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence 456667899999999999998643 23599999874332 234578999999999999999999999754 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++.... ..+++..++.|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~k 187 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCK 187 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEE
Confidence 45799999999999999997542 25788899999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+++........ ..+....++++++...+.--. .. .+...............
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~--~pf~~~~~~~~~~~~~~ 265 (333)
T 1mqb_A 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--RPYWELSNHEVMKAIND 265 (333)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC--CTTTTCCHHHHHHHHHT
T ss_pred ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC--CCcccCCHHHHHHHHHC
Confidence 9999999876432110 011122355555433222000 00 00000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
...... . ..+...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 266 ~~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 266 GFRLPT-P------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TCCCCC-C------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCcCCC-c------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000 0 113345678999999999999999999999999887643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=243.93 Aligned_cols=241 Identities=20% Similarity=0.300 Sum_probs=169.0
Q ss_pred cccccce-eecccCceEEEEeEee---CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSAN-LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~-~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|.... .||+|+||.||+|... ++..||||+++.... ...+.|.+|++++.+++||||+++++++.. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence 3454444 8999999999999753 577899999875432 335679999999999999999999999742 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..+++..+..++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl 151 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKI 151 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCC--------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEE
Confidence 4789999999999999997543 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 350 GDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
+|||+++........ ..++...++++++...+.--. ... +................
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~--p~~~~~~~~~~~~i~~~ 229 (287)
T 1u59_A 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQG 229 (287)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC--TTTTCCTHHHHHHHHTT
T ss_pred CcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC--CcccCCHHHHHHHHhcC
Confidence 999999876432211 111223455555443322110 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHHhh
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKILE 461 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~~~ 461 (485)
..... + ..+...+.++...|++.+|++||++.+|++.|+.+......
T Consensus 230 ~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 230 KRMEC-P------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp CCCCC-C------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CcCCC-C------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 00000 0 11334567899999999999999999999999999776543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=258.03 Aligned_cols=247 Identities=14% Similarity=0.138 Sum_probs=166.1
Q ss_pred hccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCCcc-----------hHHHHHHHHHHHhcCCCccee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGG-----------ARSFKSECKAAINIRHRNIVR 255 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~ 255 (485)
..++|...+.||+|+||.||+|...+ ++.||||++....... ...+..|+..+.+++|||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998654 4789999986432110 122445666777889999999
Q ss_pred EeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 256 l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
+++++... ..+....++||||+ +|+|.+++.... ..+++..++.|+.+++.||.||| ..+|+|||||
T Consensus 113 ~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlk 179 (364)
T 3op5_A 113 YWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANA--------KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIK 179 (364)
T ss_dssp EEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred EEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCC
Confidence 99998642 22335689999999 999999997532 35889999999999999999999 5799999999
Q ss_pred CCceEec--CCCcEEEeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhh
Q 041230 336 PSNVLLD--DEMIGHVGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEI 388 (485)
Q Consensus 336 ~~NILld--~~~~~ki~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~ 388 (485)
|+|||++ .++.+||+|||+++.+...... ..++...++++++...+.--....
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999 8899999999999765322110 012223456666544332111100
Q ss_pred c-cccc-hhhhhhhhhhhcccCCCCCCcchhhhHHHH------HHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 389 L-NDFN-LQEIEEDRTMCMHASSSSSTSTHVSIILEC------VNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 389 ~-d~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
. +... ............ ..........| ...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 260 Pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 260 PWEDNLKDPKYVRDSKIRY-------RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp TTGGGTTCHHHHHHHHHHH-------HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CccccccCHHHHHHHHHHh-------hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0 0000 000000000000 00000001111 456778999999999999999999999999887654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=247.57 Aligned_cols=240 Identities=24% Similarity=0.346 Sum_probs=160.0
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.+.|...+.||+|+||+||+|.. ...||||+++.... ...+.|.+|+.++.+++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~ 94 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQL 94 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred ccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------Ccc
Confidence 45788889999999999999974 44699999875432 234679999999999999999999997642 346
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASE--------TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred EEEEEecCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEcc
Confidence 89999999999999997543 35788899999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc-----------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccC
Q 041230 352 FSMARFLPDTDEQ-----------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 352 FGla~~~~~~~~~-----------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 408 (485)
||+++........ ..++...++++++...+.--........... ............
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~ 242 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEMVGRGS 242 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHHHHHTS
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHHhcccc
Confidence 9999765321110 0111234566665443321111100000000 000000000000
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
...... .....+...+.++...|++.+|++||++.+++++|+.+.
T Consensus 243 ~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 243 LSPDLS---KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCCTT---SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCcchh---hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 000000 000123456778999999999999999999999998763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=250.30 Aligned_cols=250 Identities=19% Similarity=0.287 Sum_probs=170.2
Q ss_pred hccccccceeecccCceEEEEeEe--------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL--------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSG 262 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~--------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~ 262 (485)
..++|...+.||+|+||.||+|.. .++..||||+++.... ...+.|.+|+.++.++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 346788889999999999999985 3467899999874332 2346789999999999 99999999999764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
....++||||+++|+|.+++........ ......+++..++.|+.+++.||.||| ..+|+|||||
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 184 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCc
Confidence 2357999999999999999986432100 011134789999999999999999999 6789999999
Q ss_pred CCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccch
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNL 394 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~ 394 (485)
|+|||++.++.+||+|||+++........ ..++...++++++...+.--. ... +...
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~--p~~~ 262 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS--PYPG 262 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC--SSTT
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC--CcCc
Confidence 99999999999999999999876432210 112223455555543322110 000 0000
Q ss_pred hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 395 QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
....+............. . ..+...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 263 IPVEELFKLLKEGHRMDK-P------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CCHHHHHHHHHHTCCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCC-C------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000000000000000 0 112345678999999999999999999999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=248.96 Aligned_cols=252 Identities=18% Similarity=0.219 Sum_probs=171.9
Q ss_pred hhhhccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeec
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVS 261 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~ 261 (485)
.....++|...+.||+|+||+||+|.. .+++.||||+++.... ...+.|.+|+.++.++ +||||++++++|.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 334567888999999999999999974 3457899999875432 2345789999999999 7999999999976
Q ss_pred ccccCCceeeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 262 ~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
.. ....++|+||+++|+|.+++........ ......+++..+..++.+++.||.||| ..+|+||||
T Consensus 102 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di 174 (316)
T 2xir_A 102 KP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 174 (316)
T ss_dssp CT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred cC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence 42 2347899999999999999986543110 000123788999999999999999999 678999999
Q ss_pred CCCceEecCCCcEEEeecccccccCCCCcce--------------------eeeccccHHHHHHHHhhhhh-hhhcc--c
Q 041230 335 KPSNVLLDDEMIGHVGDFSMARFLPDTDEQT--------------------RFIGKLNVRNFVKMALSQRV-EEILN--D 391 (485)
Q Consensus 335 K~~NILld~~~~~ki~DFGla~~~~~~~~~~--------------------~~~~~~~l~~~~~~~~~~~~-~~~~d--~ 391 (485)
||+|||++.++.+||+|||+++......... .++...++++++...+.--. ..... .
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999998764332110 11123345555433322100 00000 0
Q ss_pred cchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 392 FNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
......... ........ .. ..+...+.++...|++.+|.+|||+.+|++.|+.+...
T Consensus 255 ~~~~~~~~~---~~~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 255 KIDEEFCRR---LKEGTRMR-AP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCSHHHHHH---HHHTCCCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHH---hccCccCC-CC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 000000000 00000000 00 01223466888999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=251.96 Aligned_cols=151 Identities=23% Similarity=0.382 Sum_probs=130.2
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++..++|||||++++++.. ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 456788899999999999999985 5789999999875422 234678899999999999999999998753 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++.... .+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl 155 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKI 155 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEEEEECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEE
Confidence 6799999999999999996432 4677888999999999999999 678999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 156 ~DFG~a~~~~~ 166 (328)
T 3fe3_A 156 ADFGFSNEFTV 166 (328)
T ss_dssp CSTTCCGGGSS
T ss_pred eeccCceecCC
Confidence 99999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=246.73 Aligned_cols=154 Identities=27% Similarity=0.421 Sum_probs=130.3
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.|...+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++.+++|||||++++++... .....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence 46788899999999999999864 48899999987433 23456788999999999999999999987642 233578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe----cCCCcEE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGH 348 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl----d~~~~~k 348 (485)
+||||+++|+|.+++...... ..+++.....|+.+++.||.||| ..+|+||||||+|||+ +.++.+|
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred EEEeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEE
Confidence 999999999999999864321 23888999999999999999999 6789999999999999 8888999
Q ss_pred EeecccccccCC
Q 041230 349 VGDFSMARFLPD 360 (485)
Q Consensus 349 i~DFGla~~~~~ 360 (485)
|+|||+++....
T Consensus 157 L~Dfg~a~~~~~ 168 (319)
T 4euu_A 157 LTDFGAARELED 168 (319)
T ss_dssp ECCCTTCEECCT
T ss_pred EccCCCceecCC
Confidence 999999987644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=246.33 Aligned_cols=235 Identities=21% Similarity=0.334 Sum_probs=167.7
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc--------
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-------- 265 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-------- 265 (485)
++|...+.||+|+||.||+|... +|+.||||.++.. .+.+.+|++++.+++||||+++++++...++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46888899999999999999864 6899999998743 2467889999999999999999998754222
Q ss_pred ---CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 266 ---QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 266 ---~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
......++||||+++|+|.+++..... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLV 156 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEc
Confidence 113457899999999999999974321 35788899999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchh-hhhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQ-EIEEDRTMC 404 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~ 404 (485)
.++.+||+|||+++........ ..+....++++++...+. ++...... .........
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~-----l~~~~~~~~~~~~~~~~~ 231 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE-----LLHVCDTAFETSKFFTDL 231 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHH-----HHSCCSSHHHHHHHHHHH
T ss_pred CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHH-----HHhcCCcchhHHHHHHHh
Confidence 9999999999999876443211 112233456665543322 11110000 000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
....... .....+.++...|++.+|++||++.++++.|..+++.
T Consensus 232 ~~~~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 232 RDGIISD----------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HTTCCCT----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred hcccccc----------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0000000 0112345788899999999999999999999988654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=269.98 Aligned_cols=151 Identities=23% Similarity=0.244 Sum_probs=125.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHH---HHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKS---ECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.++|...++||+|+||+||+++. .+|+.||||+++... ......+.+ ++.++..++|||||++++++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 46799999999999999999985 468999999996421 222233333 4667778899999999988653
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++|||||++|+|.++|... ..+++.....|+.+|+.||.||| +.+||||||||+|||||.++.
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~---------~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQH---------GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCC
Confidence 45689999999999999999753 24777888889999999999999 789999999999999999999
Q ss_pred EEEeecccccccCCC
Q 041230 347 GHVGDFSMARFLPDT 361 (485)
Q Consensus 347 ~ki~DFGla~~~~~~ 361 (485)
+||+|||+|+.+...
T Consensus 331 vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 331 VRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCTTCEECSSC
T ss_pred EEecccceeeecCCC
Confidence 999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=244.35 Aligned_cols=238 Identities=20% Similarity=0.268 Sum_probs=165.4
Q ss_pred ccccccce-eecccCceEEEEeEee---CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 194 TNGFSSAN-LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 194 t~~f~~~~-~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.+.|.... .||+|+||.||+|... +++.||||+++.... ...+.|.+|+.++.+++||||+++++++..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----- 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----
Confidence 34566666 8999999999999643 367899999865332 225679999999999999999999999732
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++|+||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 90 -~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 90 -ESWMLVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcE
Confidence 34689999999999999997532 4678889999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhc
Q 041230 348 HVGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~ 405 (485)
||+|||+++........ ..++...++++++...+.--. ... +..............
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~--p~~~~~~~~~~~~~~ 234 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLE 234 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC--SSTTCCHHHHHHHHH
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC--CCCCCCHHHHHHHHH
Confidence 99999999876443211 011223455555443322110 000 000000000000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...... .+ ..+...+.++...|++.+|++||++.+|++.|+.+-..
T Consensus 235 ~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 235 KGERMG-CP------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TTCCCC-CC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCCCCC-CC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000000 00 11234567899999999999999999999999988664
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=245.02 Aligned_cols=240 Identities=19% Similarity=0.299 Sum_probs=165.7
Q ss_pred hccccccceeecccCceEEEEeEeeC----CcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
..++|...+.||+|+||+||+|...+ +..||||.++... ....+.|.+|+.++.+++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 45678888999999999999998643 2359999986542 2345679999999999999999999998653
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++|+||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK--------NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT--------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEE
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc--------ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcE
Confidence 23589999999999999997432 24778889999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
||+|||+++........ ..++...++++++...+.--. ... +................
T Consensus 153 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~--p~~~~~~~~~~~~~~~~ 230 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ--PFFWLENKDVIGVLEKG 230 (281)
T ss_dssp EECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC--TTTTSCGGGHHHHHHHT
T ss_pred EeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC--CcccCChHHHHHHHhcC
Confidence 99999999865432210 011223455555443322110 000 00000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... + ..+...+.++...|++.+|++||++.++++.|+.+...
T Consensus 231 ~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 231 DRLPK-P------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-C------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00000 0 01223466899999999999999999999999988653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-29 Score=247.59 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=171.3
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHh--cCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAIN--IRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||+|.. +|+.||||+++. ...+.+.+|.+++.. ++||||+++++++..... .....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-cccee
Confidence 45788889999999999999986 689999999863 245678889998887 799999999999764321 11257
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeeccCCCceEecCCCc
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC-----QPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~-----~~~ivHrdlK~~NILld~~~~ 346 (485)
++|+||+++|+|.+++... .+++..+..++.+++.||.|||... ..+|+||||||+|||++.++.
T Consensus 116 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred EEEEeecCCCcHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 9999999999999999642 4788899999999999999999421 468999999999999999999
Q ss_pred EEEeecccccccCCCCcc-----------eee-----------------eccccHHHHHHHHhhhhhhhh--------cc
Q 041230 347 GHVGDFSMARFLPDTDEQ-----------TRF-----------------IGKLNVRNFVKMALSQRVEEI--------LN 390 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~-----------~~~-----------------~~~~~l~~~~~~~~~~~~~~~--------~d 390 (485)
+||+|||+++........ ..| ....++++++...+.--.... --
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999765433210 000 012355555443322110000 00
Q ss_pred ccch-----hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 391 DFNL-----QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 391 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
+... ...................+..+ ...++...+.++...|++.+|++|||+.+|++.|+.+.+.
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 0000 00000001111111111111111 1124667788999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=244.86 Aligned_cols=151 Identities=21% Similarity=0.307 Sum_probs=124.1
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--------------------------cchHHHHHHHHHHH
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--------------------------GGARSFKSECKAAI 246 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--------------------------~~~~~f~~E~~~l~ 246 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35788889999999999999985 4588999999864321 11356899999999
Q ss_pred hcCCCcceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCC
Q 041230 247 NIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQ 326 (485)
Q Consensus 247 ~l~H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~ 326 (485)
+++|||||++++++... .....++||||+++|+|.+++.. ..+++.....++.+++.||.||| .
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH---~ 155 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTL----------KPLSEDQARFYFQDLIKGIEYLH---Y 155 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCS----------SCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 99999999999987642 23467999999999999876542 24788899999999999999999 6
Q ss_pred CCeeeeccCCCceEecCCCcEEEeecccccccCC
Q 041230 327 PRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 327 ~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~ 360 (485)
.+|+||||||+|||++.++.+||+|||+++....
T Consensus 156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 189 (298)
T 2zv2_A 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189 (298)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCeeccCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 7899999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=249.22 Aligned_cols=148 Identities=20% Similarity=0.334 Sum_probs=126.5
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++..++|||||++++++.. ....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence 357888899999999999999854 688999999864332 234678999999999999999999998764 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~D 148 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 148 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEE
Confidence 99999999999999997542 4778899999999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||+++.+
T Consensus 149 fg~a~~~ 155 (323)
T 3tki_A 149 FGLATVF 155 (323)
T ss_dssp CTTCEEC
T ss_pred eecccee
Confidence 9999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=244.92 Aligned_cols=238 Identities=21% Similarity=0.335 Sum_probs=163.0
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++|...+.||+|+||+||++.. +|+.||||+++.. ...+.|.+|+.++.+++||||+++++++... ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEE
Confidence 45788889999999999999975 5889999998643 3457899999999999999999999986532 235789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
|+||+++|+|.+++..... ..+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp EECCCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEecCCCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecc
Confidence 9999999999999974321 23678889999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhc-cccchhhhhhhhhhhcccCCCCCCcch
Q 041230 354 MARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEIL-NDFNLQEIEEDRTMCMHASSSSSTSTH 416 (485)
Q Consensus 354 la~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (485)
+++........ ..+....++++++...+.--. .... ......... .......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~~~~~~~-~~-- 236 (278)
T 1byg_A 163 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEKGYKMD-AP-- 236 (278)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHTTTCCCC-CC--
T ss_pred ccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhcCCCCC-Cc--
Confidence 99765332111 112223455555543322110 0000 000000000 0000000000 00
Q ss_pred hhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 417 VSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 417 ~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..+...+.++...|++.+|++||++.++++.|+.++..
T Consensus 237 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 ----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11234566888999999999999999999999999764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=250.49 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=170.0
Q ss_pred hhhccccccceeecccCceEEEEeEeeC------CcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecc
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSG 262 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~~~------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~ 262 (485)
....++|...+.||+|+||.||+|.... +..||||.++.... ...+.|.+|+.++.++ +|||||+++++|..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3456788899999999999999998532 24799999875432 2346789999999999 89999999999764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCc-----ccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCC
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDT-----HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPS 337 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~-----~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~ 337 (485)
. ...++||||+++|+|.+++...... ........+++.....++.+++.||.||| ..+|+||||||+
T Consensus 122 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 122 G-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAAR 193 (333)
T ss_dssp S-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred C-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccc
Confidence 2 3578999999999999999743210 00011235788999999999999999999 678999999999
Q ss_pred ceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhcc----ccc
Q 041230 338 NVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILN----DFN 393 (485)
Q Consensus 338 NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d----~~~ 393 (485)
|||++.++.+||+|||+++........ ..++...++++++...+. ++. +..
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e-----l~t~g~~p~~ 268 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE-----IFSLGLNPYP 268 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHH-----HTTTSCCSST
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHH-----HHcCCCCCCc
Confidence 999999999999999999865332211 011223345555433322 111 000
Q ss_pred hhhh-hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 394 LQEI-EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 394 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
.... .............. .+ ..+...+.++...|++.+|.+|||+.+|++.|+.+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~-~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 269 GILVNSKFYKLVKDGYQMA-QP------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp TCCSSHHHHHHHHHTCCCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHhcCCCCC-CC------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 00000000000000 00 012345668999999999999999999999999886643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=245.94 Aligned_cols=247 Identities=17% Similarity=0.129 Sum_probs=169.1
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.++|...+.||+|+||.||++.. .+|+.||||++........+.|.+|+.++.+++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 45788899999999999999985 578999999987554445678999999999999999999999986321 1234678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|.+++..... ....+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 107 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKD-----KGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCCCcHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 99999999999999974211 0135788999999999999999999 578999999999999999999999999
Q ss_pred ccccccCCCC------------------------c------ceeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhh
Q 041230 353 SMARFLPDTD------------------------E------QTRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRT 402 (485)
Q Consensus 353 Gla~~~~~~~------------------------~------~~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 402 (485)
|+++...... + ...+....++++++...+.--.....-............
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 9876542110 0 011233456666654433211100000000000000000
Q ss_pred hhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 403 MCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
........... ..+...+.++...|++.+|.+||++.+|++.|+.+.
T Consensus 259 ~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQNQLSIPQS-------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHCC--CCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HhhccCCCCcc-------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00000000000 012235678999999999999999999999998763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=248.65 Aligned_cols=237 Identities=17% Similarity=0.320 Sum_probs=161.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcE----EEEEEeecc-CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLI-RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~----vavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.++|...+.||+|+||+||+|.. .+++. ||+|.+... .....+.|.+|+.++.+++||||++++++|...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 35688889999999999999984 34554 466666432 234567899999999999999999999998642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
..++|+||+++|+|.+++.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 156 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHK--------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred --CceEEEEecCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCE
Confidence 3689999999999999997543 24778889999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhc
Q 041230 348 HVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~ 405 (485)
||+|||+++........ ..+....++++++...+.--. ... .+........ ....
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~ 233 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILE 233 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHH
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHH
Confidence 99999999875332211 011223455555443322110 000 0000000000 0000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
....... . ..+...+.++...|++.+|.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~-~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGERLPQ-P------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTCCCCC-C------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCCCCCC-C------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0000000 0 0123356789999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=247.30 Aligned_cols=234 Identities=17% Similarity=0.196 Sum_probs=163.0
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||++... +|+.||+|.++.. ......+.+|+.++..++|||||++++++.. ....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEE
Confidence 467888899999999999999854 5788999998643 3344678899999999999999999998754 24679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC--CCcEEEe
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD--EMIGHVG 350 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~--~~~~ki~ 350 (485)
+||||+++|+|.+++.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++. ++.+||+
T Consensus 78 lv~e~~~g~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~ 146 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKII 146 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEEeCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEE
Confidence 9999999999999997543 25788899999999999999999 679999999999999997 7899999
Q ss_pred ecccccccCCCCcce-----------------eeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 351 DFSMARFLPDTDEQT-----------------RFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 351 DFGla~~~~~~~~~~-----------------~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|||+++......... .++...++++++...+.--... .|.................. ...
T Consensus 147 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~--~pf~~~~~~~~~~~i~~~~~-~~~ 223 (321)
T 1tki_A 147 EFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI--NPFLAETNQQIIENIMNAEY-TFD 223 (321)
T ss_dssp CCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS--CTTCCSSHHHHHHHHHHTCC-CCC
T ss_pred ECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC--CCCcCCCHHHHHHHHHcCCC-CCC
Confidence 999998765433211 1223345555554332211000 00000000000000000000 000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. ....+....+.++...|++.+|++|||+.|+++
T Consensus 224 ~---~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 E---EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h---hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000012334568899999999999999999976
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=245.79 Aligned_cols=240 Identities=16% Similarity=0.253 Sum_probs=164.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||.||++.. .+++.||||.+...... ..+.|.+|+.++.+++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence 34688889999999999999984 46889999998643322 23578999999999999999999998753 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl 152 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH---------GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKI 152 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 679999999999999999743 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCC
Q 041230 350 GDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 350 ~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
+|||+++........ ..+....++++++...+.--.... +.......... ........
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~--pf~~~~~~~~~-~~~~~~~~ 229 (294)
T 4eqm_A 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP--PFNGETAVSIA-IKHIQDSV 229 (294)
T ss_dssp CCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC--SSCSSCHHHHH-HHHHSSCC
T ss_pred EeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC--CCCCCChHHHH-HHHhhccC
Confidence 999999865432110 011223456666544332111110 00000000000 00000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCC-CHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERM-KLNDVESRLRLI 455 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP-~m~~V~~~L~~i 455 (485)
.........+....+.++...|++.+|++|| ++.++.+.|+.+
T Consensus 230 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 230 --PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0000000011234567899999999999999 888888888765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=241.97 Aligned_cols=150 Identities=24% Similarity=0.367 Sum_probs=127.5
Q ss_pred hccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..+.|...+.||+|+||+||+|...+|+.||||++..... ...+.+.+|+.++.+++|||||++++++.. ...
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 93 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----ERC 93 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----SSC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----CCE
Confidence 4567888999999999999999987899999999864322 234678899999999999999999998753 345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||++ |+|.+++.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENK--------TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcCCC-CCHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEc
Confidence 799999998 58888887543 24778888999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 162 Dfg~a~~~~ 170 (311)
T 3niz_A 162 DFGLARAFG 170 (311)
T ss_dssp CCTTCEETT
T ss_pred cCcCceecC
Confidence 999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=246.35 Aligned_cols=246 Identities=15% Similarity=0.223 Sum_probs=162.3
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||+|.. .+|+.||||+++.... ...+.|.+|+.++.+++||||+++++++.. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 35788889999999999999985 5689999999875322 234578899999999999999999998764 23
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++..... ....+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl 177 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKK-----QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 177 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred cEEEEEecCCCCCHHHHHHHhcc-----cccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEE
Confidence 67899999999999999864110 0134778889999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCC
Q 041230 350 GDFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 350 ~DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
+|||+++........ ..+....++++++...+.--.... ........ .............
T Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYP 256 (310)
T ss_dssp CCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHTTCSC
T ss_pred EeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhcccCC
Confidence 999999765432110 112223456666543332110000 00000000 0000000000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
.... ..+...+.++...|++.+|++||++.+|++.|+.++...
T Consensus 257 ~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 PLPS------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CCCT------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcc------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 0000 012234668899999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=248.81 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=173.0
Q ss_pred cCccchhhhccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEe
Q 041230 185 LSFKDLYDATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVF 257 (485)
Q Consensus 185 ~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~ 257 (485)
+..+++....++|...+.||+|+||.||+|... +++.||||.++.... .....|.+|+.++.+++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344555666788999999999999999999754 367899999864332 2345689999999999999999999
Q ss_pred eeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcc-cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTH-WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 258 ~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
+++.. ....++||||+++|+|.+++....... .......+++..++.|+.+++.||.||| ..+|+||||||
T Consensus 95 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp 166 (322)
T 1p4o_A 95 GVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAA 166 (322)
T ss_dssp EEECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSG
T ss_pred EEEcc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCcc
Confidence 99754 235789999999999999997432100 0000124678899999999999999999 67899999999
Q ss_pred CceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchh
Q 041230 337 SNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQ 395 (485)
Q Consensus 337 ~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~ 395 (485)
+|||++.++.+||+|||+++........ ..++...++++++...+.--. ... +....
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~--p~~~~ 244 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGL 244 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC--TTTTS
T ss_pred ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCC--ccccC
Confidence 9999999999999999999865332110 011223455555443322110 000 00000
Q ss_pred hhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 396 EIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
................. . ..+...+.++...|++.+|++|||+.++++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 245 SNEQVLRFVMEGGLLDK-P------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CHHHHHHHHHTTCCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CHHHHHHHHHcCCcCCC-C------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00000000000000000 0 1123456689999999999999999999999987633
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=250.06 Aligned_cols=238 Identities=17% Similarity=0.215 Sum_probs=167.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|.. .+|+.||||++.... ..+.|.+|+.++.++ +||||+++++++.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCcc
Confidence 35788899999999999999984 568899999986432 335688999999999 99999999998754 2467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc-----
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI----- 346 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~----- 346 (485)
++||||+ +|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~ 148 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCD--------RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQV 148 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTS
T ss_pred EEEEEeC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCce
Confidence 9999999 999999997532 25788999999999999999999 678999999999999999887
Q ss_pred EEEeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhc----c-ccchhh
Q 041230 347 GHVGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEIL----N-DFNLQE 396 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~----d-~~~~~~ 396 (485)
+||+|||+++........ ..++...++++++...+.--..... + ......
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~ 228 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence 999999999875432210 0112234555655433321111000 0 000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhH-HHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSII-LECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
+...... .. ... .... ..+. .+.++...|++.+|.+||++.+|++.|+.+.+..
T Consensus 229 ~~~i~~~----~~--~~~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 229 YQKIGDT----KR--ATP--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHH----HH--HSC--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhh----hc--cCC--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000 00 000 0000 0122 7789999999999999999999999999887654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=244.07 Aligned_cols=234 Identities=16% Similarity=0.193 Sum_probs=162.5
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.+.|...+.||+|+||.||++... +|+.||||+++..... ..+.|.+|+.++.+++|||||++++++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 456788899999999999999854 5889999998754321 34679999999999999999999998753
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM- 345 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~- 345 (485)
....++||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++
T Consensus 86 -~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 86 -KTDVILILELVAGGELFDFLAEK---------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp -SSEEEEEEECCCSCBHHHHHTTS---------SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSS
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhc---------CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCC
Confidence 34679999999999999999753 24778899999999999999999 67899999999999999887
Q ss_pred ---cEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhc
Q 041230 346 ---IGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 346 ---~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 405 (485)
.+||+|||+++........ ..++...++++++...+.--.... +..............
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~--pf~~~~~~~~~~~~~ 230 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVS 230 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC--SSCCSSHHHHHHHHH
T ss_pred CCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcC--CCCCCCHHHHHHHHH
Confidence 8999999999876432211 112233456666543332111100 000000000000000
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.... .... .........+.++...|++.+|++|||+.|+++
T Consensus 231 ~~~~-~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 AVNY-EFED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HTCC-CCCH---HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCC-CcCc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 000012234568889999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=252.03 Aligned_cols=231 Identities=16% Similarity=0.188 Sum_probs=156.0
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
|...+.||+|+||.||+|.. .+|+.||||+++.......+.|.+|+.++.+++|||||++++++.. ....++||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence 34457899999999999985 4688999999976544456789999999999999999999999764 24679999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe--cCCCcEEEeecc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL--DDEMIGHVGDFS 353 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl--d~~~~~ki~DFG 353 (485)
||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||+ +.++.+||+|||
T Consensus 166 E~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG 234 (373)
T 2x4f_A 166 EYVDGGELFDRIIDES--------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFG 234 (373)
T ss_dssp ECCTTCEEHHHHHHTG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred eCCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCC
Confidence 9999999999986432 35788899999999999999999 6789999999999999 677899999999
Q ss_pred cccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhh-hhhhhhhhcccCCCCCCcc
Q 041230 354 MARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQE-IEEDRTMCMHASSSSSTST 415 (485)
Q Consensus 354 la~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~~~~~~~~ 415 (485)
+++........ ..+....++++++...+.--.... +..... ......+....+... ..
T Consensus 235 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~--pf~~~~~~~~~~~i~~~~~~~~--~~ 310 (373)
T 2x4f_A 235 LARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS--PFLGDNDAETLNNILACRWDLE--DE 310 (373)
T ss_dssp SCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC--TTCCSSHHHHHHHHHHTCCCSC--SG
T ss_pred CceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC--CCCCCCHHHHHHHHHhccCCCC--hh
Confidence 99876443211 111223456666543332111000 000000 000000000000000 00
Q ss_pred hhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 416 HVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 416 ~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.+. ..-..+.++...|++.+|++||++.|+++
T Consensus 311 ~~~---~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 EFQ---DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc---cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 12234568899999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-29 Score=241.08 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=159.3
Q ss_pred ccccccceeecccCceEEEEeEeeC--Cc--EEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD--GT--TIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~--~~--~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.++|...+.||+|+||+||+|.... ++ .||||+++... ....+.|.+|+.++.+++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3578888999999999999998532 33 58999886432 23456789999999999999999999987632
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
..++|+||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~ 159 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQ--------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDL 159 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHG--------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred ---CceeeEecccCCCHHHHHHhcc--------CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCC
Confidence 3689999999999999997432 35788899999999999999999 678999999999999999999
Q ss_pred EEEeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhh
Q 041230 347 GHVGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMC 404 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~ 404 (485)
+||+|||+++........ ..++...++++++...+.--. ... +.............
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~--p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKI 237 (291)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC--TTTTCCHHHHHHHH
T ss_pred EEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC--CcccCCHHHHHHHH
Confidence 999999999876443221 011223455555443322110 000 00000000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.......... ..+...+.++...|++.+|++||++.++++.|+++..
T Consensus 238 ~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 238 DKEGERLPRP------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HTSCCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HccCCCCCCC------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0000000000 1133456789999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=241.05 Aligned_cols=240 Identities=15% Similarity=0.156 Sum_probs=168.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+.++.++ +|+|++++++++.. ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Ccee
Confidence 34688889999999999999984 67899999998643 2345688999999999 89999999988653 2467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc-----
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI----- 346 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~----- 346 (485)
++|+||+ +|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCG--------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred EEEEEec-CCCHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCe
Confidence 8999999 999999997542 24788899999999999999999 679999999999999987776
Q ss_pred EEEeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhcccc-----chhh
Q 041230 347 GHVGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEILNDF-----NLQE 396 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~-----~~~~ 396 (485)
+||+|||+++........ ..++...++++++...+.--.....-.. ....
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 999999999876443210 0112234556655433321111000000 0000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
+...... ... .. .......+...+.++...|++.+|++||++.+|++.|+.+.+..
T Consensus 230 ~~~~~~~----~~~--~~-~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 230 YERIGEK----KQS--TP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHHHH----HHH--SC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhh----ccC--cc-HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 0000000 000 00 00000012346778999999999999999999999999987754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=247.35 Aligned_cols=160 Identities=22% Similarity=0.235 Sum_probs=130.9
Q ss_pred hhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccc---c
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVD---Y 265 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~---~ 265 (485)
.....+|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++.++. |||||++++++.... .
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 33445788899999999999999985 468899999986554445567899999999996 999999999884221 1
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeeccCCCceEecC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPR--IAHCNLKPSNVLLDD 343 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~--ivHrdlK~~NILld~ 343 (485)
......++|+||+. |+|.+++..... ...+++..+..|+.+++.||.||| ..+ |+||||||+|||++.
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMES------RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHT------TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECT
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECC
Confidence 23456799999996 899999864211 135788999999999999999999 455 999999999999999
Q ss_pred CCcEEEeecccccccCC
Q 041230 344 EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~ 360 (485)
++.+||+|||+++....
T Consensus 174 ~~~~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISH 190 (337)
T ss_dssp TSCEEBCCCTTCBCCSS
T ss_pred CCCEEEecCccceeccc
Confidence 99999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=250.05 Aligned_cols=152 Identities=19% Similarity=0.322 Sum_probs=130.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||+|.. .+|+.||+|++..........+.+|+.++.+++|||||++++++.. ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence 45788889999999999999985 4588999999875443445678999999999999999999998754 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC--CCcEEEe
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD--EMIGHVG 350 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~--~~~~ki~ 350 (485)
+||||+++|+|.+++.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++. ++.+||+
T Consensus 125 lv~E~~~gg~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193 (387)
T ss_dssp EEEECCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEcCCCCcHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEE
Confidence 9999999999999997543 35788899999999999999999 678999999999999974 5789999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||+++.....
T Consensus 194 DFG~a~~~~~~ 204 (387)
T 1kob_A 194 DFGLATKLNPD 204 (387)
T ss_dssp CCTTCEECCTT
T ss_pred ecccceecCCC
Confidence 99999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=239.04 Aligned_cols=151 Identities=24% Similarity=0.352 Sum_probs=126.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.|....+||+|+||.||+|.. .+++.||||.++.......+.|.+|+.++.+++|||||++++++.. ....++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence 3455567999999999999984 5678999999976555556789999999999999999999998764 235789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCcEEEeec
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMIGHVGDF 352 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~~ki~DF 352 (485)
|+||+++|+|.+++...... ..+.+.....++.+++.||.||| ..+|+||||||+|||++. ++.+||+||
T Consensus 97 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEEeCCCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeec
Confidence 99999999999999754221 34567788889999999999999 678999999999999998 899999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 168 g~~~~~~ 174 (295)
T 2clq_A 168 GTSKRLA 174 (295)
T ss_dssp TTCEESC
T ss_pred ccccccC
Confidence 9998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=251.09 Aligned_cols=154 Identities=27% Similarity=0.421 Sum_probs=130.0
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.|...+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++.+++|||||++++++... +....+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence 46788899999999999999864 48899999987433 23356788999999999999999999987642 233578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe----cCCCcEE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGH 348 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl----d~~~~~k 348 (485)
+||||+++|+|.+++...... ..+++..+..|+.+++.||.||| ..+|+||||||+|||+ +.++.+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred EEEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEE
Confidence 999999999999999764321 23788999999999999999999 6789999999999999 8888999
Q ss_pred EeecccccccCC
Q 041230 349 VGDFSMARFLPD 360 (485)
Q Consensus 349 i~DFGla~~~~~ 360 (485)
|+|||+++....
T Consensus 157 L~DFG~a~~~~~ 168 (396)
T 4eut_A 157 LTDFGAARELED 168 (396)
T ss_dssp ECCGGGCEECCC
T ss_pred EecCCCceEccC
Confidence 999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=247.85 Aligned_cols=230 Identities=18% Similarity=0.251 Sum_probs=160.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||++...... ..+.|.+|+.++.+++|||||++++++.. ..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 34577888999999999999984 57889999998754322 23568899999999999999999998764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||++ |+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEE
T ss_pred eEEEEEecCC-CCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEE
Confidence 6799999998 78888885322 35788899999999999999999 578999999999999999999999
Q ss_pred eecccccccCCCCc-----------------ceeeeccccHHHHHHHHhhhhhhhh--ccccchhhhhhhhhhhcccCCC
Q 041230 350 GDFSMARFLPDTDE-----------------QTRFIGKLNVRNFVKMALSQRVEEI--LNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 350 ~DFGla~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~~~~~--~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
+|||+++....... ...++...++++++...+.--.... .+....... ...... ...
T Consensus 196 ~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~---~~~~~~-~~~ 271 (348)
T 1u5q_A 196 GDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQN-ESP 271 (348)
T ss_dssp CCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHS-CCC
T ss_pred eeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhc-CCC
Confidence 99999987543221 0122334566666644332111100 000000000 000000 000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
..... .+...+.++...|++.+|++|||+.++++
T Consensus 272 ~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 272 ALQSG------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC------CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000 01233557888999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=246.79 Aligned_cols=160 Identities=20% Similarity=0.285 Sum_probs=132.2
Q ss_pred ccchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcc-----------hHHHHHHHHHHHhcCCCccee
Q 041230 187 FKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-----------ARSFKSECKAAINIRHRNIVR 255 (485)
Q Consensus 187 ~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~ 255 (485)
..++....++|...+.||+|+||.||+|...+|..||||++....... .+.|.+|+.++.+++|||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 345566788999999999999999999987789999999985432211 267899999999999999999
Q ss_pred EeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 256 l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
+++++...+.......++||||++ |+|.+++.... ..+++..+..|+.+++.||.||| ..+|+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--------IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCC
Confidence 999986533333456799999998 78988887543 35788899999999999999999 5789999999
Q ss_pred CCceEecCCCcEEEeeccccccc
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~ 358 (485)
|+|||++.++.+||+|||+++..
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp GGGEEECTTCCEEECCTTC----
T ss_pred hHHEEEcCCCCEEEEecCccccc
Confidence 99999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=244.44 Aligned_cols=162 Identities=23% Similarity=0.347 Sum_probs=129.9
Q ss_pred chhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc-----CCcchHHHHHHHHHHHhcCCCcceeEeeeecc
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI-----RPGGARSFKSECKAAINIRHRNIVRVFTAVSG 262 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~ 262 (485)
++....+.|...+.||+|+||.||+|.. .++..||||++... .....+.|.+|+.++.+++|||||++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4556678899999999999999999985 45788999998643 23345789999999999999999999999764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCc-------------------------------ccccccccccHHHHHHHH
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDT-------------------------------HWRLLNFDFLIKKKLDIA 311 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~-------------------------------~~~~~~~~l~~~~r~~ia 311 (485)
....++||||+++|+|.+++...... ........+++.....|+
T Consensus 100 -----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 174 (345)
T 3hko_A 100 -----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM 174 (345)
T ss_dssp -----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred -----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence 34689999999999999999521000 000112334667778899
Q ss_pred HHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC--cEEEeeccccccc
Q 041230 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM--IGHVGDFSMARFL 358 (485)
Q Consensus 312 ~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~--~~ki~DFGla~~~ 358 (485)
.+++.||.||| ..+|+||||||+|||++.++ .+||+|||+++.+
T Consensus 175 ~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~ 220 (345)
T 3hko_A 175 RQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220 (345)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred HHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence 99999999999 57899999999999998776 8999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-28 Score=245.35 Aligned_cols=151 Identities=21% Similarity=0.322 Sum_probs=129.5
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG------GARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
..+.|...+.||+|+||+||++... +|+.||||+++..... ..+.+.+|+.++.+++|||||++++++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--- 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--- 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe---
Confidence 3457888899999999999999854 5889999999754321 24678999999999999999999998753
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
....++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++
T Consensus 87 --~~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 87 --RTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCC
Confidence 346799999999999999997532 4788899999999999999999 67899999999999998877
Q ss_pred ----cEEEeecccccccCC
Q 041230 346 ----IGHVGDFSMARFLPD 360 (485)
Q Consensus 346 ----~~ki~DFGla~~~~~ 360 (485)
.+||+|||+++....
T Consensus 153 ~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp SSSCCEEECCCSSCEECCT
T ss_pred CCccCEEEEecCCceEcCC
Confidence 799999999987644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=238.97 Aligned_cols=233 Identities=21% Similarity=0.277 Sum_probs=160.1
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.|.....||+|+||+||+|.. .++..||+|.+.... ....+.|.+|+.++.+++|||||++++++... ..+....+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence 356677899999999999985 457789999987433 22346789999999999999999999987643 22345689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCC--eeeeccCCCceEec-CCCcEEE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPR--IAHCNLKPSNVLLD-DEMIGHV 349 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~--ivHrdlK~~NILld-~~~~~ki 349 (485)
+||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+ |+||||||+|||++ +++.+||
T Consensus 106 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl 173 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---------KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred EEEEecCCCCHHHHHHHc---------cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEE
Confidence 999999999999999742 24678889999999999999999 445 99999999999998 7899999
Q ss_pred eecccccccCCCCcc---------------eeeeccccHHHHHHHHhhhhhhhhc-cc-cchhhhhhhhhhhcccCCCCC
Q 041230 350 GDFSMARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRVEEIL-ND-FNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 350 ~DFGla~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~-~~~~~~~~~~~~~~~~~~~~~ 412 (485)
+|||++......... ..+....++++++...+.--..... .. ....... ...... ...
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~-~~~- 248 (290)
T 1t4h_A 174 GDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSG-VKP- 248 (290)
T ss_dssp CCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTT-CCC-
T ss_pred eeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH---HHHhcc-CCc-
Confidence 999999765433211 1122344566665443321111000 00 0000000 000000 000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. .........+.++...|++.+|++|||+.||++
T Consensus 249 -~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 -A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -c---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 000012235678999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=265.55 Aligned_cols=240 Identities=19% Similarity=0.311 Sum_probs=167.1
Q ss_pred hccccccceeecccCceEEEEeEeeC----CcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
..+.|...+.||+|+||+||+|.... +..||||.++.... ...+.|.+|+.++.+++|||||++++++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 34567788999999999999998632 45799998864332 234679999999999999999999998742
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++||||+++|+|.+++.... ..+++..++.++.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTT--------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred -CceEEEEEcCCCCcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCE
Confidence 24689999999999999997543 35788899999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhccc
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHA 407 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 407 (485)
||+|||+++........ ..++...++++++...+.--. .. .+.......+........
T Consensus 531 kL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~--~Pf~~~~~~~~~~~i~~~ 608 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRIENG 608 (656)
T ss_dssp EECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC--CTTTTCCHHHHHHHHHHT
T ss_pred EEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCC--CCCCCCCHHHHHHHHHcC
Confidence 99999999876433211 011223455555433222100 00 000000000000000000
Q ss_pred CCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 408 SSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
..... + ..+...+.++...|++.+|++||++.+|+++|+.+.+.
T Consensus 609 ~~~~~-~------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ERLPM-P------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCCCC-C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-C------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00000 0 12334567899999999999999999999999988653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-28 Score=241.66 Aligned_cols=247 Identities=20% Similarity=0.319 Sum_probs=166.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcE--EEEEEeeccC-CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTT--IAVKVFNLIR-PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~--vavK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||.||+|... +|.. ||||.++... ....+.|.+|+.++.++ +||||+++++++.. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----CC
Confidence 57888899999999999999854 4654 4999886432 23456789999999999 99999999999764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCccc-------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHW-------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~-------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
..++||||+++|+|.+++........ ......+++..+..|+.+++.||.||| ..+|+||||||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence 67999999999999999986531000 001135788999999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMC 404 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~ 404 (485)
.++.+||+|||+++........ ..+....++++++...+.--. ... +.............
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~--pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKL 254 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC--TTTTCCHHHHHHHG
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCC--CCCCCcHHHHHHHh
Confidence 9999999999999743211100 112233455555543322110 000 00000000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
........ + ..+...+.++...|++.+|++||++.++++.|+.+...
T Consensus 255 ~~~~~~~~-~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 255 PQGYRLEK-P------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp GGTCCCCC-C------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCC-C------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00000000 0 01224566889999999999999999999999988654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=250.80 Aligned_cols=240 Identities=14% Similarity=0.156 Sum_probs=159.1
Q ss_pred ccccccceeecccCceEEEEeEee----CCcEEEEEEeeccCCc-----------chHHHHHHHHHHHhcCCCcceeEee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPG-----------GARSFKSECKAAINIRHRNIVRVFT 258 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~----~~~~vavK~~~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~~ 258 (485)
.++|...+.||+|+||+||+|... ++..||||++...... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999864 5678999998654321 1234677888999999999999999
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
++... +.+....++||||+ +|+|.+++.... .+++..+..|+.+++.||.||| +.+|+||||||+|
T Consensus 116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 181 (345)
T 2v62_A 116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAAN 181 (345)
T ss_dssp EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHH
Confidence 98642 23356789999999 999999997532 5788999999999999999999 6789999999999
Q ss_pred eEecCCC--cEEEeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhc-c
Q 041230 339 VLLDDEM--IGHVGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEIL-N 390 (485)
Q Consensus 339 ILld~~~--~~ki~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~-d 390 (485)
||++.++ .+||+|||+++.+...... ..++...++++++...+.--..... +
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999887 9999999999865321100 0122234566665433321111000 0
Q ss_pred ccchhh--hhhhhhhhcccCCCCCCcchhhhHH------HHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 391 DFNLQE--IEEDRTMCMHASSSSSTSTHVSIIL------ECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 391 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
...... ........ . ...+ .... .+...+.++...|++.+|++||++.+|++.|+.+
T Consensus 262 ~~~~~~~~~~~~~~~~----~-~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNL----L-DELP---QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp GGTTCHHHHHHHHHHH----H-HTTT---HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccccHHHHHHHHhh----c-cccc---HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 000000 00000000 0 0000 0000 1233677899999999999999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=245.92 Aligned_cols=147 Identities=22% Similarity=0.293 Sum_probs=125.4
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCC--CcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRH--RNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||.||++...+++.||||++..... ...+.|.+|+.++.+++| +||+++++++.. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~~ 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----CC
Confidence 456888899999999999999988899999999875432 234678999999999977 999999999764 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||| +.+|+|.+++.... .+++..+..|+.+++.||.||| ..+|+||||||+|||++ ++.+||
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred EEEEEEe-CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEE
Confidence 6799999 57899999997542 4678889999999999999999 67899999999999997 678999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 149 ~DFG~a~~~~ 158 (343)
T 3dbq_A 149 IDFGIANQMQ 158 (343)
T ss_dssp CCCSSSCCC-
T ss_pred eecccccccC
Confidence 9999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=246.13 Aligned_cols=233 Identities=15% Similarity=0.188 Sum_probs=150.9
Q ss_pred hhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
...+.|...+.||+|+||+||+|... +++.||||+++... ..+.+.+|+.++.+++|||||++++++.. ...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 122 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTE 122 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCe
Confidence 34567888999999999999999864 47889999987432 34678899999999999999999999764 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~~ 347 (485)
.++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++. ++.+
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~ 190 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPL 190 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCE
Confidence 799999999999999997542 4678889999999999999999 678999999999999975 8999
Q ss_pred EEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhh--hccccchhhhhhhhhhhcccC
Q 041230 348 HVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEE--ILNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~--~~d~~~~~~~~~~~~~~~~~~ 408 (485)
||+|||+++........ ..++...++++++...+.--... ..+........ ..... .
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~i~~-~- 266 (349)
T 2w4o_A 191 KIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF--RRILN-C- 266 (349)
T ss_dssp EECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH--HHHHT-T-
T ss_pred EEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH--HHHHh-C-
Confidence 99999999865432110 11233456666654433211100 00000000000 00000 0
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
........+. +....+.++...|++.+|++|||+.|+++
T Consensus 267 ~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 267 EYYFISPWWD---EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCCCCTTTTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCccCCchhh---hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000001 12234568899999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=257.57 Aligned_cols=247 Identities=11% Similarity=0.072 Sum_probs=162.3
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHH---HHHHhcCCCcceeEeeeecccc
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSEC---KAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~~~~~~~~ 264 (485)
...++|...+.||+|+||+||+|.. .+|+.||||+++.. .....+.|.+|+ +.+++++|||||++++.+....
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457888899999999999999985 56899999999743 233457789999 5666678999999985443110
Q ss_pred --cC------------Cc-----eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC
Q 041230 265 --YQ------------GA-----RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC 325 (485)
Q Consensus 265 --~~------------~~-----~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~ 325 (485)
+. +. ...++||||+ +|+|.+++....... .....++|..+..|+.|++.||.|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH--- 223 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLH--- 223 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHHH---
Confidence 00 00 0268999999 689999997532110 01135667889999999999999999
Q ss_pred CCCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc--------------e-----------eeeccccHHHHHHHH
Q 041230 326 QPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------T-----------RFIGKLNVRNFVKMA 380 (485)
Q Consensus 326 ~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~--------------~-----------~~~~~~~l~~~~~~~ 380 (485)
..+|+||||||+|||++.++.+||+|||+++........ . .++...++++++...
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 578999999999999999999999999999864321100 1 233344555555433
Q ss_pred hhhhhhhhccccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH--HHHHHHHH
Q 041230 381 LSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES--RLRLIRKK 458 (485)
Q Consensus 381 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~--~L~~i~~~ 458 (485)
+.--.... +............ .. . .. ..+...+.++...|++.+|++||++.++++ -++.+++.
T Consensus 304 ~elltg~~--Pf~~~~~~~~~~~--~~---~-~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 304 YWIWCADL--PITKDAALGGSEW--IF---R-SC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHHHSSC--CC------CCSGG--GG---S-SC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHHHHCCC--CCcccccccchhh--hh---h-hc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 32111000 0000000000000 00 0 00 012234568899999999999999999985 45555554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-28 Score=237.34 Aligned_cols=157 Identities=24% Similarity=0.352 Sum_probs=126.9
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-----cchHHHHHHHHHHHhc---CCCcceeEeeeeccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-----GGARSFKSECKAAINI---RHRNIVRVFTAVSGV 263 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~ 263 (485)
.++.|...+.||+|+||+||+|.. .+|+.||||+++.... .....+.+|+.++.++ +|||||+++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356888899999999999999984 5688999999864321 1235677788777766 499999999998754
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
........++||||+. |+|.+++..... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-------PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence 3333345789999997 699999986542 24788999999999999999999 578999999999999999
Q ss_pred CCcEEEeecccccccCC
Q 041230 344 EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~ 360 (485)
++.+||+|||+++....
T Consensus 156 ~~~~kl~Dfg~a~~~~~ 172 (308)
T 3g33_A 156 GGTVKLADFGLARIYSY 172 (308)
T ss_dssp TSCEEECSCSCTTTSTT
T ss_pred CCCEEEeeCccccccCC
Confidence 99999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-28 Score=243.67 Aligned_cols=147 Identities=22% Similarity=0.256 Sum_probs=127.5
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++... +|+.||||+++.. .....+.+.+|+.++.+++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CCE
Confidence 57888899999999999999854 5889999999643 23345678899999999999999999988754 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|..++... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~ 147 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRE---------RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKIT 147 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEe
Confidence 89999999999999998743 24677888899999999999999 6789999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 148 DFG~a~~~ 155 (337)
T 1o6l_A 148 DFGLCKEG 155 (337)
T ss_dssp CCTTCBCS
T ss_pred eccchhhc
Confidence 99999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=238.67 Aligned_cols=154 Identities=22% Similarity=0.381 Sum_probs=129.3
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccc--------
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVD-------- 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-------- 264 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++.+++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788889999999999999985 46899999998642 223467899999999999999999999875421
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
.......++|+||+++|+|.+++.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--------LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--------GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--------cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCC
Confidence 122456799999999999999997532 34677888899999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccC
Q 041230 345 MIGHVGDFSMARFLP 359 (485)
Q Consensus 345 ~~~ki~DFGla~~~~ 359 (485)
+.+||+|||+++...
T Consensus 153 ~~~kl~dfg~~~~~~ 167 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVH 167 (303)
T ss_dssp SCEEECCCCCCSCTT
T ss_pred CCEEEeeCcchhhcc
Confidence 999999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=244.22 Aligned_cols=246 Identities=19% Similarity=0.288 Sum_probs=165.0
Q ss_pred ccccccceeecccCceEEEEeEe------eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~------~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.++|...+.||+|+||.||+|.. .++..||||.+.... ......|.+|+.++.+++||||+++++++...
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--- 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC---
Confidence 45788899999999999999973 346789999986432 23346789999999999999999999997642
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec---C
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD---D 343 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld---~ 343 (485)
...++||||+++|+|.+++....... .....+++..++.|+.+++.||.||| ..+|+||||||+|||++ .
T Consensus 106 --~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 106 --LPRFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred --CCcEEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCC
Confidence 34689999999999999998643211 11135788999999999999999999 67899999999999999 4
Q ss_pred CCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhh
Q 041230 344 EMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRT 402 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~ 402 (485)
+..+||+|||+++........ ..+....++++++...+.--. ... +...........
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~--p~~~~~~~~~~~ 256 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM--PYPSKSNQEVLE 256 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC--SSTTCCHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCC--CCCCcCHHHHHH
Confidence 557999999998754221100 111223455555433322100 000 000000000000
Q ss_pred hhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 403 MCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
......... .. ..+...+.++...|++.+|.+||++.+|++.|+.+...
T Consensus 257 ~~~~~~~~~-~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 FVTSGGRMD-PP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHTTCCCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCCCC-CC------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 000000000 00 01234567899999999999999999999999988764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-28 Score=235.31 Aligned_cols=232 Identities=20% Similarity=0.280 Sum_probs=160.7
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.++|...+.||+|+||+||+|... ++..||||++.... ......+.+|+.++.+++||||+++++++.. .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----A 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----C
Confidence 4567888999999999999999854 46789999986422 1234678899999999999999999999764 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~ 149 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKL---------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELK 149 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEE
Confidence 4579999999999999998643 24678889999999999999999 67999999999999999999999
Q ss_pred EeecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCC
Q 041230 349 VGDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 349 i~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
|+|||++......... ..+....++++++...+.--.... +...................
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~--p~~~~~~~~~~~~~~~~~~~-- 225 (279)
T 3fdn_A 150 IADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP--PFEANTYQETYKRISRVEFT-- 225 (279)
T ss_dssp ECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC--TTCCSSHHHHHHHHHHTCCC--
T ss_pred EEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCC--CCCCCcHHHHHHHHHhCCCC--
Confidence 9999998654332210 112234566666544332111100 00000000000000000000
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.+ . .....+.++...|++.+|++||++.||++.
T Consensus 226 ~~---~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 FP---D---FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CC---T---TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CC---C---cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0 012345688999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-28 Score=236.37 Aligned_cols=234 Identities=18% Similarity=0.146 Sum_probs=164.2
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||.||+|... ++..||+|++........+.|.+|++++.+++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeEE
Confidence 456888899999999999999854 467899999876555567889999999999999999999999764 34579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCcEEE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHV 349 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~~ki 349 (485)
+||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||+ +.++.+||
T Consensus 83 lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK---------RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp EEEECCCSCBHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEeccCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEE
Confidence 999999999999998643 24778889999999999999999 6789999999999999 88899999
Q ss_pred eecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 350 GDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 350 ~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+|||++......... ..++...++++++...+.--.... +.................. ...
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~--p~~~~~~~~~~~~~~~~~~-~~~ 227 (277)
T 3f3z_A 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYP--PFSAPTDSEVMLKIREGTF-TFP 227 (277)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSC--SSCCSSHHHHHHHHHHCCC-CCC
T ss_pred EecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCC--CCCCCCHHHHHHHHHhCCC-CCC
Confidence 999999865433211 112334456666544332111100 0000000000000000000 000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. .........+.++...|++.+|++||++.++++
T Consensus 228 ~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 E---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp H---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000012345668899999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=237.75 Aligned_cols=233 Identities=18% Similarity=0.247 Sum_probs=160.8
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 268 (485)
.+++|...+.||+|+||+||+|... +++.||||+++.... .....+.+|+..+.++ +||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----D 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----T
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----C
Confidence 3467888899999999999999864 689999999875332 2346788999999999 99999999998764 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-----
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD----- 343 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~----- 343 (485)
...++||||+++|+|.+++..... ....+++.....|+.+++.||.||| ..+|+||||||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~ 155 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYR-----IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPN 155 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcc-----cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCc
Confidence 467999999999999999974311 0124788899999999999999999 678999999999999984
Q ss_pred --------------CCcEEEeecccccccCCCCcce---------------eeeccccHHHHHHHHhhhhhhhhccccch
Q 041230 344 --------------EMIGHVGDFSMARFLPDTDEQT---------------RFIGKLNVRNFVKMALSQRVEEILNDFNL 394 (485)
Q Consensus 344 --------------~~~~ki~DFGla~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~~~~~~~d~~~~ 394 (485)
...+||+|||+++......... .+....++++++...+. ++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~-----l~~~~~~ 230 (289)
T 1x8b_A 156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC-----AAGAEPL 230 (289)
T ss_dssp --------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH-----HTTCCCC
T ss_pred ccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH-----HhcCCCC
Confidence 4479999999998764432110 11123455555543322 1111100
Q ss_pred hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 395 QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.................... .+...+.++...|++.+|++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 231 PRNGDQWHEIRQGRLPRIPQ-------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CSSSHHHHHHHTTCCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcchhHHHHHHcCCCCCCCc-------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00000000000000000000 12234568899999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=238.12 Aligned_cols=148 Identities=23% Similarity=0.393 Sum_probs=126.7
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||+||+|...+|+.||||++..... ...+.+.+|+.++.+++|||||++++++.. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeEE
Confidence 45777889999999999999987799999999864332 234678899999999999999999998764 24579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++ +|.+++.... ..+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 144 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCE--------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (288)
T ss_dssp EEEECCSE-EHHHHHHTST--------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred EEEEecCC-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeEC
Confidence 99999985 9999987543 24677888999999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 145 g~~~~~~ 151 (288)
T 1ob3_A 145 GLARAFG 151 (288)
T ss_dssp THHHHHC
T ss_pred ccccccC
Confidence 9997653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=243.23 Aligned_cols=163 Identities=29% Similarity=0.338 Sum_probs=137.5
Q ss_pred cccccCccchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-----CCcce
Q 041230 181 TINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-----HRNIV 254 (485)
Q Consensus 181 ~~~~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----H~niv 254 (485)
....+++.+.....+.|...+.||+|+||+||+|.. .+++.||||+++.. ....+.+..|+.++.+++ |||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 456677887777889999999999999999999985 46889999998632 223456788999999986 99999
Q ss_pred eEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 255 ~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
++++++... ...++||||+ +|+|.+++..... ..+++.....|+.+++.||.||| +.+|+||||
T Consensus 100 ~~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDl 163 (360)
T 3llt_A 100 KYHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNY-------NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDL 163 (360)
T ss_dssp CEEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred cccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCC
Confidence 999987642 3579999999 9999999975432 24778889999999999999999 678999999
Q ss_pred CCCceEecC-------------------------CCcEEEeecccccccCC
Q 041230 335 KPSNVLLDD-------------------------EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 335 K~~NILld~-------------------------~~~~ki~DFGla~~~~~ 360 (485)
||+|||++. ++.+||+|||+++....
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 999999986 78999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=234.10 Aligned_cols=150 Identities=24% Similarity=0.436 Sum_probs=129.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.+++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 45788889999999999999985 578999999986432 2234678999999999999999999999764 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... ..+++..+..++.+++.||.||| ..+|+||||||+||+++.++.+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl 153 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV--------KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKI 153 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 6799999999999999998543 24788899999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||++....
T Consensus 154 ~dfg~~~~~~ 163 (278)
T 3cok_A 154 ADFGLATQLK 163 (278)
T ss_dssp CCCTTCEECC
T ss_pred Eeecceeecc
Confidence 9999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=238.36 Aligned_cols=154 Identities=21% Similarity=0.287 Sum_probs=127.3
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.+.|...+.||+|+||.||++.. .++..||||++.... ....+.+.+|++++.+++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeE
Confidence 35688889999999999999985 458899999987543 2345789999999999999999999999763 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCcEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGH 348 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~~k 348 (485)
++||||+++|+|.+++..... ....+++.....|+.+++.||.||| ..+|+||||||+|||+ +.++.+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQA-----RGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHhhhh-----cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEE
Confidence 999999999999999864211 0135788889999999999999999 6789999999999999 5568899
Q ss_pred EeecccccccCC
Q 041230 349 VGDFSMARFLPD 360 (485)
Q Consensus 349 i~DFGla~~~~~ 360 (485)
|+|||+++....
T Consensus 168 l~Dfg~a~~~~~ 179 (285)
T 3is5_A 168 IIDFGLAELFKS 179 (285)
T ss_dssp ECCCCCCCC---
T ss_pred EEeeecceecCC
Confidence 999999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=236.11 Aligned_cols=148 Identities=20% Similarity=0.325 Sum_probs=126.9
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.. ....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 46778899999999999999864 4889999998643322 24568899999999999999999999764 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 145 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCD 145 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEee
Confidence 89999999999999887532 4678888999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 146 fg~~~~~~ 153 (311)
T 4agu_A 146 FGFARLLT 153 (311)
T ss_dssp CTTCEECC
T ss_pred CCCchhcc
Confidence 99998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=244.07 Aligned_cols=234 Identities=17% Similarity=0.238 Sum_probs=161.7
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||++.. .+|+.||||+++.... ...+.+.+|+.++.+++|||||++++++.. ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 45788889999999999999985 4588999999975432 234578899999999999999999998764 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC---CcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE---MIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~---~~~ 347 (485)
.++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.+ +.+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 799999999999999997542 4678889999999999999999 6789999999999999865 459
Q ss_pred EEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCC
Q 041230 348 HVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
||+|||+++........ ..+....++++++...+.--.... +...................
T Consensus 171 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~--Pf~~~~~~~~~~~i~~~~~~ 248 (362)
T 2bdw_A 171 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQIKAGAYD 248 (362)
T ss_dssp EECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC--SSCCSSHHHHHHHHHHTCCC
T ss_pred EEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC--CCCCCCHHHHHHHHHhCCCC
Confidence 99999999876533211 112334566666544332111100 00000000000000000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.....+. .....+.++...|++.+|++||++.++++
T Consensus 249 -~~~~~~~---~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 -YPSPEWD---TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCTTGGG---GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCccccc---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000011 12234568889999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=248.45 Aligned_cols=243 Identities=12% Similarity=0.085 Sum_probs=162.7
Q ss_pred cccccceeecccCceEEEEeEee---------CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeE---------
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF---------DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRV--------- 256 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~---------~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l--------- 256 (485)
++|...+.||+|+||.||+|... +++.||||.+... +.+.+|+.++.+++|||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57888999999999999999865 3789999998643 468899999999999999984
Q ss_pred ------eeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 041230 257 ------FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIA 330 (485)
Q Consensus 257 ------~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~iv 330 (485)
++++.. .....++||||+ +|+|.+++..... ..+++..+..|+.+++.||.||| ..+|+
T Consensus 117 ~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~iv 181 (352)
T 2jii_A 117 LAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLH---ENEYV 181 (352)
T ss_dssp CSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHH---HTTCB
T ss_pred cCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 334321 235679999999 9999999985421 35889999999999999999999 67899
Q ss_pred eeccCCCceEecCCC--cEEEeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhh
Q 041230 331 HCNLKPSNVLLDDEM--IGHVGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQ 383 (485)
Q Consensus 331 HrdlK~~NILld~~~--~~ki~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~ 383 (485)
||||||+|||++.++ .+||+|||+++.+...... ..++...++++++...+.-
T Consensus 182 H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 261 (352)
T 2jii_A 182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261 (352)
T ss_dssp CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 999999999999998 9999999999765322110 0122234566665443321
Q ss_pred hhhhhc-ccc--chhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 384 RVEEIL-NDF--NLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 384 ~~~~~~-d~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
-..... ... ............ ......... ...........+.++...|++.+|++||++.+|+++|+.+.+..
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVG-PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEEC-TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhh-hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 110000 000 000000000000 000000000 00000001245678899999999999999999999999987764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=239.21 Aligned_cols=167 Identities=24% Similarity=0.354 Sum_probs=135.6
Q ss_pred ccccCccchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeee
Q 041230 182 INNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTA 259 (485)
Q Consensus 182 ~~~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~ 259 (485)
+..+++.++....+.|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++.++ +||||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 44567777888889999999999999999999985 46889999998743 23457889999999999 89999999999
Q ss_pred ecccccC-CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 260 VSGVDYQ-GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 260 ~~~~~~~-~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
+...... .....++||||+++|+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~N 159 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQN 159 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGG
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHH
Confidence 8642211 13467999999999999999975321 35777888999999999999999 6789999999999
Q ss_pred eEecCCCcEEEeecccccccC
Q 041230 339 VLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 339 ILld~~~~~ki~DFGla~~~~ 359 (485)
||++.++.+||+|||++....
T Consensus 160 Il~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 160 VLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEECTTCCEEECCCTTTC---
T ss_pred EEEcCCCCEEEeeCcCceecC
Confidence 999999999999999987653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=250.74 Aligned_cols=234 Identities=16% Similarity=0.186 Sum_probs=160.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++.|...+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|+.++.+++|||||++++++.. ...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CCE
Confidence 46788889999999999999974 5688999999875432 234578999999999999999999998753 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec---CCCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD---DEMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld---~~~~~ 347 (485)
.++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++ .++.+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcE
Confidence 799999999999999987542 4778888999999999999999 67899999999999998 56789
Q ss_pred EEeecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCC
Q 041230 348 HVGDFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 409 (485)
||+|||+++........ ..++...++++++...+.--.... |..................
T Consensus 153 kL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~--Pf~~~~~~~~~~~i~~~~~ 230 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQIKAGAY 230 (444)
T ss_dssp EECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC--SCCCSSHHHHHHHHHHTCC
T ss_pred EEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCC--CCCCccHHHHHHHHHhCCC
Confidence 99999999876433211 112334466666544332111000 0000000000000000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. .....+. ..-..+.++...|++.+|++|||+.|+++
T Consensus 231 ~-~~~~~~~---~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 D-FPSPEWD---TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp C-CCTTTTT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C-CCccccc---cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000001 11234568889999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=244.56 Aligned_cols=226 Identities=16% Similarity=0.178 Sum_probs=161.5
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc--------chHHHHHHHHHHHhcCCCcceeEeeeeccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--------GARSFKSECKAAINIRHRNIVRVFTAVSGV 263 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~ 263 (485)
..+.|...+.||+|+||+||+|.. .+|+.||||+++..... ..+.|.+|+.++.+++|||||++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 346788889999999999999984 56889999998754311 23467889999999999999999998753
Q ss_pred ccCCceeeEEEEEecCCC-CHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 264 DYQGARFKAVVYKFMPNG-SLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~G-sL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
....++||||+.+| +|.+++.... .+++..+..|+.+++.||.||| ..+|+||||||+|||++
T Consensus 101 ----~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 101 ----QGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIA 164 (335)
T ss_dssp ----SSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ----CCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEc
Confidence 34678999999887 9999997543 4778889999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCccee-----------------e-eccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhh
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQTR-----------------F-IGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMC 404 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~~~-----------------~-~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 404 (485)
.++.+||+|||+++.......... + ....++++++...+.--.....-........
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------ 238 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE------ 238 (335)
T ss_dssp TTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT------
T ss_pred CCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh------
Confidence 999999999999987654332111 1 1223555555433321111000000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.....+ . ..-..+.++...|++.+|++|||+.++++.
T Consensus 239 ----~~~~~~---~---~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ----AAIHPP---Y---LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TCCCCS---S---CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hccCCC---c---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0 012345688899999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=247.07 Aligned_cols=149 Identities=26% Similarity=0.357 Sum_probs=129.0
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||++... +|+.||||+++.. .....+.+.+|+.++.+++|||||++++++.. ...
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EED 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CCE
Confidence 57888899999999999999854 5788999998643 23345678899999999999999999988753 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|..++.... .+++.....++.+++.||.||| ..+|+||||||+||||+.++.+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~ 157 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHIT 157 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEe
Confidence 799999999999999997542 4778888999999999999999 6789999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 158 DFG~a~~~~~ 167 (384)
T 4fr4_A 158 DFNIAAMLPR 167 (384)
T ss_dssp CCTTCEECCT
T ss_pred ccceeeeccC
Confidence 9999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=246.84 Aligned_cols=153 Identities=24% Similarity=0.341 Sum_probs=126.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-----CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-----PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
+.|...+.||+|+||+||++.. .+|+.||||+++... ....+.|.+|+.++.+++|||||++++++.. .
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----D 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 4677889999999999999985 468999999986321 1235779999999999999999999998764 2
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc--
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI-- 346 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~-- 346 (485)
...++||||+++|+|.+++..... ....+++.....|+.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRAD-----AGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcc-----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCC
Confidence 467999999999999988864211 0134788889999999999999999 678999999999999987654
Q ss_pred -EEEeecccccccCC
Q 041230 347 -GHVGDFSMARFLPD 360 (485)
Q Consensus 347 -~ki~DFGla~~~~~ 360 (485)
+||+|||+++....
T Consensus 171 ~vkl~Dfg~a~~~~~ 185 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGE 185 (351)
T ss_dssp CEEECCCTTCEECCT
T ss_pred cEEEecCcceeEecC
Confidence 99999999987644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=239.84 Aligned_cols=239 Identities=14% Similarity=0.153 Sum_probs=162.0
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||++... +++.||||+++..... ..+.|.+|+.++.+++||||+++++++.. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence 356888899999999999999854 6889999998643222 23678899999999999999999998764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ---------GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEE
Confidence 679999999999999999743 24778889999999999999999 678999999999999999999999
Q ss_pred eecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCC
Q 041230 350 GDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 350 ~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
+|||+++........ ..+....++++++...+.--.... +...................
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~--pf~~~~~~~~~~~~~~~~~~ 253 (309)
T 2h34_A 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP--PYQGDQLSVMGAHINQAIPR 253 (309)
T ss_dssp CSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC--SSCSCHHHHHHHHHHSCCCC
T ss_pred ecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC--CCCCchHHHHHHHhccCCCC
Confidence 999998765332110 112234566666544332111110 00000000000000000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCC-CHHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERM-KLNDVESRLRLIR 456 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP-~m~~V~~~L~~i~ 456 (485)
. . .....+...+.++...|++.+|++|| ++.++++.|+.+.
T Consensus 254 ~--~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 P--S---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp G--G---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred c--c---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0 0 00001223456889999999999999 8999999988763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-29 Score=244.62 Aligned_cols=153 Identities=22% Similarity=0.357 Sum_probs=126.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcc---hHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG---ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||.||++.. .+++.||||+++...... ...|.+|+.++.+++|||||++++++..... ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence 45788889999999999999984 568899999997543222 3568899999999999999999998764321 123
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.++++.. ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEE
T ss_pred ccEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEE
Confidence 458999999999999999743 24778889999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 158 ~Dfg~a~~~~ 167 (311)
T 3ork_A 158 MDFGIARAIA 167 (311)
T ss_dssp CCCSCC----
T ss_pred eeccCccccc
Confidence 9999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=249.05 Aligned_cols=150 Identities=23% Similarity=0.430 Sum_probs=129.8
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++..++|||||++++++.. ..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence 356788899999999999999854 68999999986432 2234678999999999999999999998764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEE
Confidence 6799999999999999997532 4778889999999999999999 679999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 158 ~DFG~a~~~~~ 168 (476)
T 2y94_A 158 ADFGLSNMMSD 168 (476)
T ss_dssp CCCSSCEECCT
T ss_pred Eeccchhhccc
Confidence 99999987644
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=236.35 Aligned_cols=149 Identities=27% Similarity=0.371 Sum_probs=128.7
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+|+.||||+++.. .....+.+.+|..++..++|||||++++++.. ...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CCE
Confidence 5688889999999999999985 46899999998643 12345678899999999999999999998753 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|.... .+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~ 148 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 148 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEe
Confidence 899999999999999997532 4677888899999999999999 7799999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 149 Dfg~a~~~~~ 158 (318)
T 1fot_A 149 DFGFAKYVPD 158 (318)
T ss_dssp CCSSCEECSS
T ss_pred ecCcceecCC
Confidence 9999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=233.99 Aligned_cols=242 Identities=17% Similarity=0.213 Sum_probs=164.5
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
..+.|...+.||+|+||+||+|.. .+++.||||++.... ..+.+.+|+.++..++|+|++..+++|.. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence 356788899999999999999984 568899999875432 23468899999999999999888877643 23467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCcEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGH 348 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~~k 348 (485)
++||||+ +|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEE
Confidence 9999999 999999997432 24788999999999999999999 6789999999999999 7899999
Q ss_pred EeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhc----ccc-chhhhh
Q 041230 349 VGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEIL----NDF-NLQEIE 398 (485)
Q Consensus 349 i~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~----d~~-~~~~~~ 398 (485)
|+|||+++........ ..++...++++++...+.--..... +.. ....+.
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999876443210 0112233555555433321100000 000 000000
Q ss_pred hhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 399 EDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
....... . .+ .......+...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 229 ~~~~~~~---~---~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 229 RISEKKM---S---TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHH---H---SC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhcccc---c---ch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0000000 0 00 00000012346778999999999999999999999999987764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=236.45 Aligned_cols=234 Identities=16% Similarity=0.190 Sum_probs=162.7
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
.+.|...+.||+|+||.||++... +|+.||||.++..... ..+.|.+|+.++.+++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 456888899999999999999854 5889999998754321 24679999999999999999999998754
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM- 345 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~- 345 (485)
....++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 87 -RTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTS
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCC
Confidence 346799999999999999997532 4778889999999999999999 67899999999999999888
Q ss_pred ---cEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhc
Q 041230 346 ---IGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 346 ---~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 405 (485)
.+||+|||+++........ ..++...++++++...+.--.... +........... .
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~--pf~~~~~~~~~~--~ 229 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLA--N 229 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC--SSCCSSHHHHHH--H
T ss_pred CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCC--CCCCCCHHHHHH--H
Confidence 7999999999876443211 112233456666543332111100 000000000000 0
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
......... ..........+.++...|++.+|++|||+.++++
T Consensus 230 i~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 230 ITSVSYDFD--EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHTTCCCCC--HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHhcccccC--hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 0000012234568899999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=250.40 Aligned_cols=158 Identities=21% Similarity=0.242 Sum_probs=134.1
Q ss_pred ccchhhhccccccceeecccCceEEEEeEeeC-CcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecc
Q 041230 187 FKDLYDATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSG 262 (485)
Q Consensus 187 ~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~ 262 (485)
+.++...+++|...+.||+|+||+||+|...+ ++.||||+++... ......|.+|..++.+++|||||+++++|..
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34455667899999999999999999999654 7889999986421 2233458999999999999999999998764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
....++|||||++|+|.++|.... ..+++.....++.+++.||.||| ..+|+||||||+|||||
T Consensus 146 -----~~~~~lV~Ey~~gg~L~~~l~~~~--------~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 146 -----DNNLYLVMDYYVGGDLLTLLSKFE--------DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMD 209 (437)
T ss_dssp -----SSEEEEEECCCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred -----CCEEEEEEecCCCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEc
Confidence 346899999999999999998632 24778888999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCC
Q 041230 343 DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~ 360 (485)
.++.+||+|||+++....
T Consensus 210 ~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 210 MNGHIRLADFGSCLKLME 227 (437)
T ss_dssp TTSCEEECCCTTCEECCT
T ss_pred CCCCEEEcchhhhhhccc
Confidence 999999999999976543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=245.28 Aligned_cols=146 Identities=22% Similarity=0.294 Sum_probs=123.9
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcC--CCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIR--HRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~~ 270 (485)
..|...+.||+|+||+||++...+++.||||++..... ...+.|.+|+.++.+++ |||||++++++.. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CCE
Confidence 45888899999999999999877799999999875432 23467999999999996 5999999998764 235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||| +.+|+|.+++.... .+++..+..|+.+|+.||.||| ..+|+||||||+|||++ ++.+||+
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EEEEEe-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 899999 67899999997542 4677788999999999999999 67899999999999996 5789999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++.+.
T Consensus 197 DFG~a~~~~ 205 (390)
T 2zmd_A 197 DFGIANQMQ 205 (390)
T ss_dssp CCSSSCCC-
T ss_pred ecCcccccc
Confidence 999998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=250.00 Aligned_cols=150 Identities=20% Similarity=0.296 Sum_probs=124.6
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--------cchHHHHHHHHHHHhcCCCcceeEeeeeccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--------GGARSFKSECKAAINIRHRNIVRVFTAVSGV 263 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~ 263 (485)
..++|...+.||+|+||+||+|.. .+++.||||++..... .....|.+|+.++.+++|||||++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 456788899999999999999985 4578999999864321 112358899999999999999999998643
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
...++||||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.
T Consensus 212 -----~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 212 -----EDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp -----SEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESS
T ss_pred -----CceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEec
Confidence 24689999999999999987542 4778889999999999999999 578999999999999965
Q ss_pred ---CCcEEEeecccccccCC
Q 041230 344 ---EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 344 ---~~~~ki~DFGla~~~~~ 360 (485)
++.+||+|||+++....
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC-
T ss_pred CCCcceEEEeecccceecCC
Confidence 45699999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=238.02 Aligned_cols=241 Identities=17% Similarity=0.204 Sum_probs=161.7
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||++... +|+.||+|.+..... ...+.|.+|+.++.+++||||+++++++... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 357888899999999999999854 688999999875432 2345789999999999999999999987532 1346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC--CCCeeeeccCCCceEecCCCcEE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC--QPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~--~~~ivHrdlK~~NILld~~~~~k 348 (485)
.++||||+++|+|.+++...... ...+++.....|+.+++.||.|||... ..+|+||||||+|||++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence 79999999999999999742210 124788999999999999999999432 12399999999999999999999
Q ss_pred EeecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhc-cccchhhhhhhhhhhcccCC
Q 041230 349 VGDFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEIL-NDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 349 i~DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~ 409 (485)
|+|||+++........ ..++...++++++...+.--..... +......... .......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~i~~~~~ 233 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---KIREGKF 233 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCC
T ss_pred EecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH---HHhhccc
Confidence 9999999875432210 1122334566655433321110000 0000000000 0000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
... + ..+...+.++...|++.+|++||++.||++.+
T Consensus 234 ~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 234 RRI-P------YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCC-C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ccC-C------cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 000 0 01224566889999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=232.12 Aligned_cols=240 Identities=18% Similarity=0.220 Sum_probs=163.9
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC------cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP------GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|...+.||+|+||.||++... +|+.||||.++.... ...+.|.+|+.++.+++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 46778899999999999999864 588999999875322 135679999999999999999999998764
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC--
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-- 345 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-- 345 (485)
....++||||+++|+|.+++... ..+++..+..++.+++.||.||| ..+|+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK---------ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSS
T ss_pred CCeEEEEEeecCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCC
Confidence 24579999999999999999642 24788899999999999999999 67899999999999999877
Q ss_pred --cEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcc
Q 041230 346 --IGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 346 --~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 406 (485)
.+||+|||+++........ ..+....++++++...+.-..... +............ .
T Consensus 148 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~--p~~~~~~~~~~~~--~ 223 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTN--I 223 (283)
T ss_dssp SCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC--TTCCSSHHHHHHH--H
T ss_pred CCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCC--CCCCcchHHHHHH--h
Confidence 8999999999875432211 112223456665543332111000 0000000000000 0
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH--HHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES--RLRLIRK 457 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~--~L~~i~~ 457 (485)
........ ..........+.++...|++.+|++||++.++++ -++.++.
T Consensus 224 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 224 SAVNYDFD--EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HTTCCCCC--HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HhcccCCc--chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00000000 0000112334668999999999999999999986 3454443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=236.60 Aligned_cols=242 Identities=17% Similarity=0.206 Sum_probs=167.9
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
..++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.++..++|+|++..++++.. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCce
Confidence 356788899999999999999985 678999999986432 33568999999999999998888776643 23467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCcEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGH 348 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~~k 348 (485)
++||||+ +|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence 9999999 999999997432 24788899999999999999999 6789999999999999 5889999
Q ss_pred EeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhc-cc----cchhhhh
Q 041230 349 VGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEIL-ND----FNLQEIE 398 (485)
Q Consensus 349 i~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~----~~~~~~~ 398 (485)
|+|||+++........ ..++...++++++...+.--..... +. .....+.
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 9999999876443210 0112234556655433321111000 00 0000000
Q ss_pred hhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 399 EDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
...... .. .. .......+...+.++...|++.+|++||++.+|++.|+.+....
T Consensus 229 ~~~~~~----~~--~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 229 RISEKK----MS--TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHH----HH--SC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhcccc----cC--Cc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 000000 00 00 00000012345778999999999999999999999999987654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=252.76 Aligned_cols=149 Identities=21% Similarity=0.243 Sum_probs=119.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++.+++|||||+++++|... .
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence 45788889999999999999984 46889999998742 233446688899999999999999999987642 3
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++... ..+++.....|+.+++.||.|||+ ..+|+||||||+||||+.++.+||
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl 290 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE---------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKI 290 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEE
T ss_pred EEEEEEeeCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEE
Confidence 579999999999999999643 247788899999999999999993 168999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 291 ~DFG~a~~~ 299 (446)
T 4ejn_A 291 TDFGLCKEG 299 (446)
T ss_dssp CCCCCCCTT
T ss_pred ccCCCceec
Confidence 999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=233.35 Aligned_cols=232 Identities=17% Similarity=0.229 Sum_probs=163.5
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.+.|...+.||+|+||.||+|.. .+++.||||+++... ....+.|.+|+.++.+++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 34577889999999999999984 468899999987543 2345789999999999999999999998764 2357
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~D 162 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLAD 162 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEee
Confidence 9999999999999999642 4678899999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 352 FSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 352 FGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
||+++........ ..+....++++++...+.--........... ................
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 240 (303)
T 3a7i_A 163 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVLFLIPKNNPPTLE 240 (303)
T ss_dssp CTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCCC
T ss_pred cccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHHHHhhcCCCCCCc
Confidence 9999775432210 1122334566665433321111000000000 0000000000000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRL 452 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L 452 (485)
. .+...+.++...|++.+|++|||+.++++..
T Consensus 241 ~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 241 G-------NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp S-------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred c-------ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 0 1223466889999999999999999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=237.93 Aligned_cols=148 Identities=22% Similarity=0.288 Sum_probs=119.8
Q ss_pred ccccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||.||++.. .+|+.||||+++... ......+.+|+.++.+++|||||++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 35788889999999999999986 468899999987432 1234567889999999999999999998754
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
....++||||+++|+|.+++... ..+.+.....++.+++.||.||| ..+|+||||||+|||++.++
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 93 --GGKLYLILEYLSGGELFMQLERE---------GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQG 158 (327)
T ss_dssp --SSCEEEEEECCTTEEHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTS
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCC
Confidence 24579999999999999999743 24677788899999999999999 67899999999999999999
Q ss_pred cEEEeeccccccc
Q 041230 346 IGHVGDFSMARFL 358 (485)
Q Consensus 346 ~~ki~DFGla~~~ 358 (485)
.+||+|||+++..
T Consensus 159 ~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 159 HVKLTDFGLCKES 171 (327)
T ss_dssp CEEECCCSCC---
T ss_pred cEEEEeCCccccc
Confidence 9999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=233.16 Aligned_cols=233 Identities=17% Similarity=0.230 Sum_probs=160.7
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++.+++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence 46788899999999999999985 4588999999865332 234678899999999999999999998753 345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc---E
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI---G 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~---~ 347 (485)
.++|+||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++. +
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~ 147 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAR---------EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 147 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcE
Confidence 78999999999999988643 24778889999999999999999 678999999999999986655 9
Q ss_pred EEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhc-cccchhhhhhhhhhhcccCC
Q 041230 348 HVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEIL-NDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~ 409 (485)
||+|||++......... ..++...++++++...+.--..... ........... . .....
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~-~~~~~ 224 (284)
T 3kk8_A 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ--I-KAGAY 224 (284)
T ss_dssp EECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--H-HHTCC
T ss_pred EEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH--H-Hhccc
Confidence 99999999765433221 1122334566655433321110000 00000000000 0 00000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. .....+ ......+.++...|++.+|++|||+.|+++
T Consensus 225 ~-~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 D-YPSPEW---DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C-CCTTTT---TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-CCchhh---cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 000000 012234568889999999999999999976
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=243.57 Aligned_cols=147 Identities=22% Similarity=0.253 Sum_probs=125.0
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||++... +|+.||||++.... ...+.+.+|+.++.+++|||||++++++.. ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence 457888899999999999999854 68899999987532 234678899999999999999999999764 24579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc--EEEe
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI--GHVG 350 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~--~ki~ 350 (485)
+||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++. +||+
T Consensus 93 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~ 160 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA---------GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKIC 160 (361)
T ss_dssp EEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred EEEEeCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEe
Confidence 999999999999998643 24778889999999999999999 678999999999999988765 9999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+++..
T Consensus 161 Dfg~a~~~ 168 (361)
T 3uc3_A 161 DFGYSKSS 168 (361)
T ss_dssp CCCCC---
T ss_pred ecCccccc
Confidence 99999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=234.81 Aligned_cols=234 Identities=17% Similarity=0.209 Sum_probs=160.3
Q ss_pred ccccccc-eeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHH-HhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAA-INIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~-~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|... +.||+|+||.||++.. .+++.||||+++. ...+.+|+.++ ..++||||+++++++... +.+...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 3456555 7899999999999985 5688999999863 35678899888 566999999999987542 223456
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~~ 347 (485)
.++||||+++|+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|||++. ++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcE
Confidence 8999999999999999986432 25788899999999999999999 678999999999999998 7899
Q ss_pred EEeecccccccCCCCcceeeeccccHHHHHHHHhhhhhhhhc-cccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHH
Q 041230 348 HVGDFSMARFLPDTDEQTRFIGKLNVRNFVKMALSQRVEEIL-NDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNS 426 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (485)
||+|||+++..... .+....++++++...+.--..... ......... ..+........... .......+...
T Consensus 160 kl~Dfg~a~~~~~~----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (299)
T 3m2w_A 160 KLTDFGFAKETTGE----KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQYEF-PNPEWSEVSEE 232 (299)
T ss_dssp EECCCTTCEECTTC----GGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCCSSCTTCCSS-CHHHHTTSCHH
T ss_pred EEeccccccccccc----cCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--HHHHHHHhhccccC-CchhcccCCHH
Confidence 99999999876543 234455666665443321111000 000000000 00000000000000 00000112345
Q ss_pred HHHHHHhccCCCcCCCCCHHHHHH
Q 041230 427 ICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 427 ~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+.++...|++.+|++|||+.|+++
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcccChhhCCCHHHHhc
Confidence 678899999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=242.14 Aligned_cols=149 Identities=21% Similarity=0.363 Sum_probs=127.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++..++|||||++++++.. ..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 35788889999999999999985 568899999986421 2234678999999999999999999999764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+ +|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl 149 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEK---------KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKI 149 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEE
T ss_pred EEEEEEECC-CCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEE
Confidence 579999999 78999998643 24778889999999999999999 578999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 150 ~DFG~s~~~~~ 160 (336)
T 3h4j_B 150 ADFGLSNIMTD 160 (336)
T ss_dssp CCSSCTBTTTT
T ss_pred EEeccceeccC
Confidence 99999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=232.43 Aligned_cols=148 Identities=21% Similarity=0.358 Sum_probs=124.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.++.+++|||||++++++.. ....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 4677789999999999999985 4588999999875432 234678899999999999999999999764 2467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++ +|.+++.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~D 144 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCN--------GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCC-CHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 999999986 5555554322 24788889999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 145 fg~~~~~~ 152 (292)
T 3o0g_A 145 FGLARAFG 152 (292)
T ss_dssp CTTCEECC
T ss_pred cccceecC
Confidence 99998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=231.70 Aligned_cols=148 Identities=20% Similarity=0.340 Sum_probs=128.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 356778899999999999999864 68899999987433 2345678999999999999999999998764 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 148 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 148 (276)
T ss_dssp EEEEECCTTEEGGGGSBTT---------TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCcHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEee
Confidence 8999999999999998753 24778889999999999999999 67899999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||++...
T Consensus 149 fg~~~~~ 155 (276)
T 2yex_A 149 FGLATVF 155 (276)
T ss_dssp CTTCEEC
T ss_pred CCCcccc
Confidence 9999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=247.93 Aligned_cols=154 Identities=23% Similarity=0.303 Sum_probs=131.3
Q ss_pred chhhhccccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
++....++|...+.||+|+||+||++... +++.||||+++.. .....+.+.+|+.++..++|||||++++++..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-- 140 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-- 140 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--
Confidence 44556778999999999999999999864 5789999998642 12334568899999999999999999998764
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
....++||||+++|+|.+++... .+++.....++.+++.||.||| ..+|+||||||+||||+.+
T Consensus 141 ---~~~~~lV~E~~~gg~L~~~l~~~----------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 141 ---DRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp ---SSEEEEEECCCTTEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCC
Confidence 34689999999999999999642 3667778889999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccCC
Q 041230 345 MIGHVGDFSMARFLPD 360 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~ 360 (485)
+.+||+|||+++....
T Consensus 205 g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 205 GHLKLADFGTCMKMNK 220 (410)
T ss_dssp SCEEECCCTTCEECCT
T ss_pred CCEEEeccceeEeecc
Confidence 9999999999987643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=251.18 Aligned_cols=154 Identities=20% Similarity=0.294 Sum_probs=122.2
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..+.|...+.||+|+||+||+|.. .+|+.||||++..... ...+.|.+|+.+|.+++|||||++++++...+.....
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 346788899999999999999984 4688999999864322 2346789999999999999999999998654444445
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+. |+|.+++.... .+++.....|+.+|+.||.||| ..+|+||||||+||||+.++.+||
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEeccc-cchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEee
Confidence 6899999984 79999987532 4778889999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 198 ~DFGla~~~~ 207 (458)
T 3rp9_A 198 CDFGLARTVD 207 (458)
T ss_dssp CCCTTCBCTT
T ss_pred cccccchhcc
Confidence 9999998753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=236.53 Aligned_cols=231 Identities=11% Similarity=-0.033 Sum_probs=160.4
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+.|...+.||+|+||.||+|... +|+.||||+++..... ..+.|.+|+..+.+++|||||++++++.. ...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence 46888899999999999999864 4889999998754322 23678999999999999999999998764 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++... ....+..+|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEE
Confidence 79999999999999999542 123456889999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcceeeeccccHHHHHHHHhhhhhhhhc-cc-cchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHH
Q 041230 351 DFSMARFLPDTDEQTRFIGKLNVRNFVKMALSQRVEEIL-ND-FNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSIC 428 (485)
Q Consensus 351 DFGla~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-d~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (485)
++|.... ++...++++++...+.--..... +. ....... ....+........ ......+...+.
T Consensus 172 ~~~~~~~---------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~l~ 237 (286)
T 3uqc_A 172 YPATMPD---------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQPIEP--ADIDRDIPFQIS 237 (286)
T ss_dssp SCCCCTT---------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSCBCCH--HHHCTTSCHHHH
T ss_pred eccccCC---------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccCCCCh--hhcccCCCHHHH
Confidence 8775431 23445666665443321111100 00 0000000 0000000000000 000011334567
Q ss_pred HHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 429 EIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 429 ~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
++...|++.+|++| |+.++++.|+.+....
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 89999999999999 9999999999886543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=233.67 Aligned_cols=149 Identities=19% Similarity=0.281 Sum_probs=127.7
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||.||++... +++.||+|++.... ....+.|.+|+.++.+++||||+++++++.. ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence 356778899999999999999864 47889999986432 2234678899999999999999999999764 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 156 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRR---------KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 156 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEE
Confidence 679999999999999988642 24778899999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 157 ~dfg~~~~~~ 166 (294)
T 2rku_A 157 GDFGLATKVE 166 (294)
T ss_dssp CCCTTCEECC
T ss_pred EeccCceecc
Confidence 9999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=236.49 Aligned_cols=154 Identities=23% Similarity=0.410 Sum_probs=115.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.++.+++|||||++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence 45788889999999999999985 458899999987543 2345678999999999999999999998753 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||++ |+|.+++...... .....+.+.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVG---NTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSS---SCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEecC-CCHHHHHHhcccc---ccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECc
Confidence 99999998 6999998643211 00124778888999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 152 fg~~~~~~ 159 (317)
T 2pmi_A 152 FGLARAFG 159 (317)
T ss_dssp CSSCEETT
T ss_pred CccceecC
Confidence 99998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=241.98 Aligned_cols=148 Identities=24% Similarity=0.286 Sum_probs=126.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||+||++.. .+|+.||||+++.. .....+.+..|..++..+ +|||||++++++.. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-----P 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-----C
Confidence 45788889999999999999985 45889999998743 123346688899999988 79999999988753 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+||||+.++.+|
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ik 164 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS---------RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCK 164 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEE
Confidence 4689999999999999999753 24778888999999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 165 L~DFG~a~~~ 174 (353)
T 3txo_A 165 LADFGMCKEG 174 (353)
T ss_dssp ECCCTTCBCS
T ss_pred Eccccceeec
Confidence 9999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.37 Aligned_cols=237 Identities=17% Similarity=0.229 Sum_probs=157.0
Q ss_pred cccccc-eeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHH-hcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAI-NIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~-~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|... +.||+|+||+||++.. .+|+.||||+++. ...+.+|+.++. ..+|||||++++++... +.+....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence 455554 6899999999999985 4588999999863 256788998874 45899999999987532 2334568
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCcEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMIGH 348 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~~k 348 (485)
++||||+++|+|.++|..... ..+++.....|+.+++.||.||| ..+|+||||||+|||++. ++.+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEE
Confidence 999999999999999986432 25788999999999999999999 578999999999999998 78999
Q ss_pred EeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhh-hhhhhhhcccCC
Q 041230 349 VGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEI-EEDRTMCMHASS 409 (485)
Q Consensus 349 i~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~-~~~~~~~~~~~~ 409 (485)
|+|||+++........ ..++...++++++...+.--.... .+....... ............
T Consensus 205 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 205 LTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp ECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred EEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 9999999875432110 112334566666654332111100 000000000 000000000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
. .....+. .+-..+.++...|++.+|++|||+.||++.
T Consensus 285 ~-~~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E-FPNPEWS---EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-CCTTTTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-CCCcccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000001 122345688999999999999999999763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=240.67 Aligned_cols=150 Identities=19% Similarity=0.256 Sum_probs=129.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.++.+++|||||++++++.. ..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 357888899999999999999854 68899999986432 2345678899999999999999999988753 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.++|... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI---------GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEE
Confidence 689999999999999999743 24677888999999999999999 678999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 183 ~DFg~a~~~~~ 193 (350)
T 1rdq_E 183 TDFGFAKRVKG 193 (350)
T ss_dssp CCCTTCEECSS
T ss_pred cccccceeccC
Confidence 99999987644
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=230.11 Aligned_cols=228 Identities=19% Similarity=0.278 Sum_probs=161.0
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++.+++||||+++++++.. ...
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RKR 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CCE
Confidence 56888899999999999999864 57789999986421 2334678999999999999999999999764 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 156 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIA 156 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEe
Confidence 799999999999999997432 4678889999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 351 DFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 351 DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|||++......... ..+....++++++...+.--.... .+........ ..... ... ..
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-~~~-~~- 231 (284)
T 2vgo_A 157 DFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--RRIVN-VDL-KF- 231 (284)
T ss_dssp CCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHT-TCC-CC-
T ss_pred cccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH--HHHhc-ccc-CC-
Confidence 99998765432111 112334566666544332111100 0000000000 00000 000 00
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+ . ..-..+.++...|++.+|++||++.++++
T Consensus 232 ~---~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 P---P---FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C---T---TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---C---cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 0 01234567889999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=243.20 Aligned_cols=151 Identities=19% Similarity=0.160 Sum_probs=129.1
Q ss_pred hccccccceeeccc--CceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAG--NFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G--~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
..+.|...+.||+| +||+||++... +|+.||||+++.... ...+.+.+|+.++.+++|||||++++++..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----- 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence 45678889999999 99999999864 689999999975432 234568889999999999999999999764
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+++|+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFM-------DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKV 167 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCT-------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 2467999999999999999975422 24778889999999999999999 6789999999999999999999
Q ss_pred EEeeccccccc
Q 041230 348 HVGDFSMARFL 358 (485)
Q Consensus 348 ki~DFGla~~~ 358 (485)
||+|||++...
T Consensus 168 kl~dfg~~~~~ 178 (389)
T 3gni_B 168 YLSGLRSNLSM 178 (389)
T ss_dssp EECCGGGCEEC
T ss_pred EEcccccceee
Confidence 99999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=237.86 Aligned_cols=149 Identities=23% Similarity=0.300 Sum_probs=127.0
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
..+.|...+.||+|+||.||+|... +|+.||+|++........+.|.+|+.++.+++||||+++++++.. ....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeE
Confidence 4567888899999999999999864 488999999876555566789999999999999999999998764 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|+||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 160 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD--------RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLAD 160 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEE
Confidence 99999999999999986422 24788899999999999999999 67899999999999999999999999
Q ss_pred cccccc
Q 041230 352 FSMARF 357 (485)
Q Consensus 352 FGla~~ 357 (485)
||++..
T Consensus 161 fg~~~~ 166 (302)
T 2j7t_A 161 FGVSAK 166 (302)
T ss_dssp CHHHHH
T ss_pred CCCCcc
Confidence 998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=238.36 Aligned_cols=149 Identities=19% Similarity=0.281 Sum_probs=128.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||.||++... +++.||+|++.... ....+.|.+|+.++.+++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence 456888899999999999999864 47789999986432 2234678899999999999999999999764 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl 182 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR---------KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 182 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEE
Confidence 679999999999999988642 24778899999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 183 ~Dfg~~~~~~ 192 (335)
T 2owb_A 183 GDFGLATKVE 192 (335)
T ss_dssp CCCTTCEECC
T ss_pred eeccCceecc
Confidence 9999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=236.61 Aligned_cols=149 Identities=21% Similarity=0.284 Sum_probs=122.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--------cchHHHHHHHHHHHhcCCCcceeEeeeecccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--------GGARSFKSECKAAINIRHRNIVRVFTAVSGVD 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~ 264 (485)
.++|...+.||+|+||.||+|.. .+++.||||+++.... .....|.+|++++.+++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 35688889999999999999985 4578999999864321 123458899999999999999999998753
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
...++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||++.+
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSS
T ss_pred ----CceEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecC
Confidence 23689999999999999997542 4677888999999999999999 6789999999999999876
Q ss_pred Cc---EEEeecccccccCC
Q 041230 345 MI---GHVGDFSMARFLPD 360 (485)
Q Consensus 345 ~~---~ki~DFGla~~~~~ 360 (485)
+. +||+|||+++....
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp SSSCCEEECCCTTCEECCC
T ss_pred CCCCeEEEccCccceeccc
Confidence 54 99999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=239.24 Aligned_cols=157 Identities=22% Similarity=0.352 Sum_probs=131.7
Q ss_pred chhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
++....+.|...+.||+|+||.||++.. .+++.||||++..... ...+.|.+|++++.+++|||||++++++...+..
T Consensus 21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 3344556899999999999999999984 4678899999874332 2236789999999999999999999998654434
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
.....++|+||+. |+|.+++... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~ 166 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCD 166 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCC
T ss_pred ccceEEEEEcccC-cCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCC
Confidence 4456799999998 6999998642 4778889999999999999999 678999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 167 ~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 167 LKICDFGLARVAD 179 (364)
T ss_dssp EEECCCTTCEECC
T ss_pred EEEEeCcceEecC
Confidence 9999999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=228.57 Aligned_cols=150 Identities=24% Similarity=0.410 Sum_probs=128.9
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++.+++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 357888899999999999999864 68999999986432 2335678999999999999999999998764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|+||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l 152 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH---------GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKI 152 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeccCCCcHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEE
Confidence 679999999999999999743 24677889999999999999999 578999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||++.....
T Consensus 153 ~dfg~~~~~~~ 163 (276)
T 2h6d_A 153 ADFGLSNMMSD 163 (276)
T ss_dssp CCCCGGGCCCC
T ss_pred eecccccccCC
Confidence 99999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=242.54 Aligned_cols=149 Identities=19% Similarity=0.279 Sum_probs=127.3
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 267 (485)
..++|...+.||+|+||+||++... +|+.||||+++... ....+.+..|..++..+ +|||||++++++..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----- 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----- 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence 3467888899999999999999864 58899999997432 23456678899999876 99999999988753
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+++|+|.+++... ..+++.....++.+++.||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~v 157 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC---------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHI 157 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCE
Confidence 34689999999999999999743 24678888999999999999999 6789999999999999999999
Q ss_pred EEeeccccccc
Q 041230 348 HVGDFSMARFL 358 (485)
Q Consensus 348 ki~DFGla~~~ 358 (485)
||+|||+++..
T Consensus 158 kL~DFG~a~~~ 168 (345)
T 1xjd_A 158 KIADFGMCKEN 168 (345)
T ss_dssp EECCCTTCBCC
T ss_pred EEeEChhhhhc
Confidence 99999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=232.35 Aligned_cols=150 Identities=24% Similarity=0.336 Sum_probs=128.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc---------chHHHHHHHHHHHhcC-CCcceeEeeeecc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG---------GARSFKSECKAAINIR-HRNIVRVFTAVSG 262 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~---------~~~~f~~E~~~l~~l~-H~niv~l~~~~~~ 262 (485)
.++|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+.++.+++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888899999999999999864 5889999998754311 1346789999999996 9999999998753
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
....++||||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+||+++
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 96 -----NTFFFLVFDLMKKGELFDYLTEK---------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLD 158 (298)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred -----CCeEEEEEeccCCCcHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEc
Confidence 34679999999999999999742 24778889999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCC
Q 041230 343 DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~ 360 (485)
.++.+||+|||++.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp TTCCEEECCCTTCEECCT
T ss_pred CCCcEEEecccchhhcCC
Confidence 999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=242.29 Aligned_cols=243 Identities=21% Similarity=0.264 Sum_probs=161.4
Q ss_pred chhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
+.....++|...+.||+|+||.||+|... ..||||+++... ....+.|.+|+.++.+++||||+++++++...
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 101 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP--- 101 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS---
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC---
Confidence 33444577888999999999999999753 359999986432 22345688899999999999999999997642
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
...++|+||+++|+|.+++.... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++ ++.
T Consensus 102 --~~~~iv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 102 --PHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp --SCEEEECBCCCSEEHHHHTTSSC--------CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---C
T ss_pred --CceEEEeecccCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCC
Confidence 35789999999999999997643 24677889999999999999999 67899999999999998 679
Q ss_pred EEEeecccccccCCCCcc--------------------------------eeeeccccHHHHHHHHhhhhhhhhc-cccc
Q 041230 347 GHVGDFSMARFLPDTDEQ--------------------------------TRFIGKLNVRNFVKMALSQRVEEIL-NDFN 393 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~--------------------------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~ 393 (485)
+||+|||+++........ ..++...++++++...+.--..... +...
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998754211000 0012234566665433321111000 0000
Q ss_pred hhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 394 LQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
..... ..+.. ........ ..+...+.++...|++.+|++|||+.+|+++|+.+..+.
T Consensus 248 ~~~~~--~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 248 AEAII--WQMGT-GMKPNLSQ------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHH--HHHHT-TCCCCCCC------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHH--HHhcc-CCCCCCCc------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00000 00000 00000000 001234568999999999999999999999999987653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=239.68 Aligned_cols=151 Identities=20% Similarity=0.306 Sum_probs=129.0
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc---ch--------------HHHHHHHHHHHhcCCCcceeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG---GA--------------RSFKSECKAAINIRHRNIVRV 256 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~---~~--------------~~f~~E~~~l~~l~H~niv~l 256 (485)
.++|...+.||+|+||.||+|.. +|+.||||++...... .. +.|.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999999997 8999999998643211 11 789999999999999999999
Q ss_pred eeeecccccCCceeeEEEEEecCCCCHHHh------hcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 041230 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEW------LHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIA 330 (485)
Q Consensus 257 ~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~------L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~iv 330 (485)
++++.. ....++||||+++|+|.++ +.... ...+++..+..|+.+++.||.|||. ..+|+
T Consensus 109 ~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~ 174 (348)
T 2pml_X 109 EGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHN--EKNIC 174 (348)
T ss_dssp SEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEE
T ss_pred EEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEe
Confidence 999764 2467999999999999999 54321 1367889999999999999999993 27899
Q ss_pred eeccCCCceEecCCCcEEEeecccccccC
Q 041230 331 HCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 331 HrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
||||||+|||++.++.+||+|||+++...
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 203 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMV 203 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECB
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccc
Confidence 99999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=238.49 Aligned_cols=141 Identities=24% Similarity=0.314 Sum_probs=120.3
Q ss_pred ceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeEEEEEe
Q 041230 200 ANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKAVVYKF 277 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lV~ey 277 (485)
.+.||+|+||+||++... +|+.||||++... ....+.+|+.++.++. |||||++++++.. ....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEEEEEEc
Confidence 478999999999999864 5889999998642 3467889999999997 9999999999763 3467999999
Q ss_pred cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC---cEEEeeccc
Q 041230 278 MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM---IGHVGDFSM 354 (485)
Q Consensus 278 ~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~---~~ki~DFGl 354 (485)
+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 88 LNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp CCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 99999999997542 4788899999999999999999 67899999999999997665 899999999
Q ss_pred ccccCC
Q 041230 355 ARFLPD 360 (485)
Q Consensus 355 a~~~~~ 360 (485)
++....
T Consensus 156 a~~~~~ 161 (325)
T 3kn6_A 156 ARLKPP 161 (325)
T ss_dssp CEECCC
T ss_pred ceecCC
Confidence 986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=234.35 Aligned_cols=148 Identities=22% Similarity=0.291 Sum_probs=123.9
Q ss_pred ccccc-ceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHh-cCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSS-ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAIN-IRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~-~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+.|.. .+.||+|+||+||++.. .+++.||||+++.......+.+.+|++++.+ .+||||+++++++.. ....
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCEE
Confidence 34554 36799999999999984 5689999999976555556789999999998 479999999999764 2467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc---EE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI---GH 348 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~---~k 348 (485)
++||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++. +|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~k 154 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR---------RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVK 154 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEE
T ss_pred EEEEEcCCCCcHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceE
Confidence 9999999999999999753 24677888999999999999999 578999999999999998776 99
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 155 l~Dfg~~~~~~ 165 (316)
T 2ac3_A 155 ICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCCC---
T ss_pred EEEccCccccc
Confidence 99999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=236.00 Aligned_cols=162 Identities=19% Similarity=0.216 Sum_probs=130.7
Q ss_pred ccCccchhhhccccccc-eeecccCceEEEEeEee-CCcEEEEEEeeccCC--cchHHHHHHHHHHHhc-CCCcceeEee
Q 041230 184 NLSFKDLYDATNGFSSA-NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGARSFKSECKAAINI-RHRNIVRVFT 258 (485)
Q Consensus 184 ~~~~~~l~~~t~~f~~~-~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~~ 258 (485)
++.|.......+.|... +.||+|+||.||+|... +|+.||||+++.... .....+.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34444444445555555 78999999999999854 589999999874332 2356789999999998 5699999999
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
++.. ....++||||+++|+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|
T Consensus 97 ~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~N 161 (327)
T 3lm5_A 97 VYEN-----TSEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQN 161 (327)
T ss_dssp EEEC-----SSEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGG
T ss_pred EEEe-----CCeEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHH
Confidence 8753 3457999999999999999865322 35788899999999999999999 6789999999999
Q ss_pred eEecC---CCcEEEeecccccccCC
Q 041230 339 VLLDD---EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 339 ILld~---~~~~ki~DFGla~~~~~ 360 (485)
||++. ++.+||+|||+++....
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCCCcEEEeeCccccccCC
Confidence 99998 78999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-27 Score=237.61 Aligned_cols=155 Identities=15% Similarity=0.177 Sum_probs=129.0
Q ss_pred chhhhccccccceeecccCceEEEEeE------eeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC---CCcceeEeee
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGT------LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIR---HRNIVRVFTA 259 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~------~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~~~ 259 (485)
++....+.|...+.||+|+||+||+|. ..+++.||||+++. ....+|..|++++..++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 444556789999999999999999993 45688999999864 34567888999988887 9999999998
Q ss_pred ecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 260 ~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
+... ...++||||+++|+|.++|...... ....++|..+..|+.+++.||.||| ..+|+||||||+||
T Consensus 136 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NI 203 (365)
T 3e7e_A 136 HLFQ-----NGSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNF 203 (365)
T ss_dssp EECS-----SCEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGE
T ss_pred eecC-----CCcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHE
Confidence 7642 3578999999999999999742110 0135889999999999999999999 67899999999999
Q ss_pred EecC-----------CCcEEEeeccccccc
Q 041230 340 LLDD-----------EMIGHVGDFSMARFL 358 (485)
Q Consensus 340 Lld~-----------~~~~ki~DFGla~~~ 358 (485)
||+. ++.+||+|||+|+.+
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEG
T ss_pred EecccccCccccccccCCEEEeeCchhhhh
Confidence 9998 899999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-27 Score=232.82 Aligned_cols=146 Identities=22% Similarity=0.349 Sum_probs=125.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|.. .+++.||||+++. ...+.+.+|+.++.+++ ||||+++++++... .....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCce
Confidence 46788899999999999999974 5688999999863 34578999999999997 99999999987642 13457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEEEe
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGHVG 350 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~ki~ 350 (485)
++||||+++|+|.+++. .+++.....|+.+++.||.||| ..+|+||||||+|||++.++ .+||+
T Consensus 109 ~lv~e~~~~~~l~~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp EEEEECCCCCCHHHHGG------------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEeccCchhHHHHHH------------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 89999999999999885 2566778889999999999999 67899999999999999776 89999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 174 Dfg~a~~~~~ 183 (330)
T 3nsz_A 174 DWGLAEFYHP 183 (330)
T ss_dssp CCTTCEECCT
T ss_pred eCCCceEcCC
Confidence 9999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=244.41 Aligned_cols=153 Identities=20% Similarity=0.284 Sum_probs=129.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.++.+++|||||++++++...++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46788899999999999999985 4578899999864322 23467899999999999999999999986544333356
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+. |+|.+++.... .+++.....|+.++++||.||| +.+|+||||||+|||++.++.+||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEc
Confidence 899999987 69999997532 4788889999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 172 DFGla~~~~ 180 (432)
T 3n9x_A 172 DFGLARTIN 180 (432)
T ss_dssp CCTTCEEC-
T ss_pred cCCCccccc
Confidence 999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=248.64 Aligned_cols=157 Identities=22% Similarity=0.273 Sum_probs=132.9
Q ss_pred cchhhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeeccc
Q 041230 188 KDLYDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGV 263 (485)
Q Consensus 188 ~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~ 263 (485)
.+....+++|...+.||+|+||+||++.. .+|+.||||+++... ....+.+.+|..++.+++|||||++++++..
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD- 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-
Confidence 34445678899999999999999999986 468999999986421 2233568899999999999999999988753
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
....++||||+++|+|.++|.... ..+++.....++.+++.||.||| +.+|+||||||+|||||.
T Consensus 133 ----~~~~~lVmE~~~gg~L~~~l~~~~--------~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~ 197 (412)
T 2vd5_A 133 ----ENYLYLVMEYYVGGDLLTLLSKFG--------ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDR 197 (412)
T ss_dssp ----SSEEEEEECCCCSCBHHHHHHHHS--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred ----CCEEEEEEcCCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecC
Confidence 346899999999999999997432 24778888899999999999999 678999999999999999
Q ss_pred CCcEEEeecccccccCC
Q 041230 344 EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~ 360 (485)
++.+||+|||+++....
T Consensus 198 ~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 198 CGHIRLADFGSCLKLRA 214 (412)
T ss_dssp TSCEEECCCTTCEECCT
T ss_pred CCCEEEeechhheeccC
Confidence 99999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=241.68 Aligned_cols=147 Identities=20% Similarity=0.217 Sum_probs=125.1
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||+||+++.. +++.||||+++... ....+.+..|..++.++ +|||||++++++.. ..
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~~ 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ES 126 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----CC
Confidence 56888899999999999999864 47789999997532 22335688899999887 89999999998753 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|..++... ..+++.....++.+++.||.||| ..+|+||||||+||||+.++.+||
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL 194 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ---------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKL 194 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEE
Confidence 689999999999999998743 24778889999999999999999 678999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 195 ~DFGla~~~ 203 (396)
T 4dc2_A 195 TDYGMCKEG 203 (396)
T ss_dssp CCCTTCBCC
T ss_pred eecceeeec
Confidence 999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=230.79 Aligned_cols=152 Identities=22% Similarity=0.343 Sum_probs=125.7
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR----PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||.||++.. .+++.||||+++... ....+.|.+|+.++.+++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 35788889999999999999985 457899999986432 23456799999999999999999999987431 23
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++| |.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred CeEEEEehhccCC-HHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEE
Confidence 4679999999987 7777764321 35788899999999999999999 67899999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||++....
T Consensus 150 l~dfg~~~~~~ 160 (305)
T 2wtk_C 150 ISALGVAEALH 160 (305)
T ss_dssp ECCCTTCEECC
T ss_pred eeccccccccC
Confidence 99999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=239.65 Aligned_cols=152 Identities=24% Similarity=0.394 Sum_probs=129.4
Q ss_pred hhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc--------chHHHHHHHHHHHhc-CCCcceeEeeeec
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--------GARSFKSECKAAINI-RHRNIVRVFTAVS 261 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l-~H~niv~l~~~~~ 261 (485)
...++|...+.||+|+||.||+|... +|+.||||++...... ..+.|.+|+.++.++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34467888899999999999999874 6999999998754321 134678899999999 7999999999875
Q ss_pred ccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe
Q 041230 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341 (485)
Q Consensus 262 ~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl 341 (485)
. ....++||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||+
T Consensus 171 ~-----~~~~~lv~e~~~g~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~ 233 (365)
T 2y7j_A 171 S-----SSFMFLVFDLMRKGELFDYLTEK---------VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILL 233 (365)
T ss_dssp B-----SSEEEEEECCCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred e-----CCEEEEEEEeCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 3 24679999999999999999742 24788889999999999999999 5789999999999999
Q ss_pred cCCCcEEEeecccccccCC
Q 041230 342 DDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 342 d~~~~~ki~DFGla~~~~~ 360 (485)
+.++.+||+|||++..+..
T Consensus 234 ~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 234 DDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp CTTCCEEECCCTTCEECCT
T ss_pred CCCCCEEEEecCcccccCC
Confidence 9999999999999987643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-27 Score=231.92 Aligned_cols=232 Identities=16% Similarity=0.212 Sum_probs=157.6
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||.||+|... +|+.||||.+... ...+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 100 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLW 100 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 456888899999999999999864 4889999998753 345789999999999999999999998764 23579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+|+||+++|+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+||
T Consensus 101 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEeecCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeec
Confidence 9999999999999986321 35788899999999999999999 678999999999999999999999999
Q ss_pred ccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 353 SMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 353 Gla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
|+++........ ..+....++++++...+.--.... +.......................
T Consensus 170 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~--p~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T 3com_A 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP--PYADIHPMRAIFMIPTNPPPTFRK 247 (314)
T ss_dssp TTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC--TTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred ccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC--CCCCCChHHHHHHHhcCCCcccCC
Confidence 999765432110 112334566666544332111100 000000000000000000000000
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.......+.++...|++.+|.+|||+.++++
T Consensus 248 -----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 -----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0012234668899999999999999999965
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=237.98 Aligned_cols=157 Identities=22% Similarity=0.268 Sum_probs=114.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DEL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----SCE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CCc
Confidence 46788889999999999999984 468899999886432 23346788999999999999999999987642 357
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++....... ......+++..+..|+.+++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred EEEehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 89999999999999986310000 001135788999999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 165 fg~~~~~~ 172 (303)
T 2vwi_A 165 FGVSAFLA 172 (303)
T ss_dssp CHHHHHCC
T ss_pred ccchheec
Confidence 99987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=244.05 Aligned_cols=148 Identities=20% Similarity=0.252 Sum_probs=126.7
Q ss_pred ccccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCcceeEeeeecccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINI-RHRNIVRVFTAVSGVD 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~ 264 (485)
.++|...+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|++++.++ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 46788899999999999999986 368899999986422 22345678899999999 69999999988754
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
....++||||+++|+|.++|... ..+++.....++.+++.||.||| ..+|+||||||+||||+.+
T Consensus 131 ---~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 131 ---ETKLHLILDYINGGELFTHLSQR---------ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN 195 (355)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred ---CceEEEEeecCCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence 23578999999999999999743 24678888999999999999999 6789999999999999999
Q ss_pred CcEEEeeccccccc
Q 041230 345 MIGHVGDFSMARFL 358 (485)
Q Consensus 345 ~~~ki~DFGla~~~ 358 (485)
+.+||+|||+++..
T Consensus 196 ~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 196 GHVVLTDFGLSKEF 209 (355)
T ss_dssp SCEEESCSSEEEEC
T ss_pred CcEEEeeCCCCeec
Confidence 99999999999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=232.76 Aligned_cols=233 Identities=18% Similarity=0.192 Sum_probs=159.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||++.. .+|+.||||+++.......+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence 35677889999999999999985 3689999999976544445678999999999999999999998753 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCcEEE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHV 349 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~~ki 349 (485)
+|+||+++|+|.+++... ..+++.....++.+++.||.||| ..+|+||||||+|||+ +.++.+||
T Consensus 83 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER---------GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp EEECCCCSCBHHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred EEEEcCCCccHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEE
Confidence 999999999999998643 24677888999999999999999 6789999999999999 78899999
Q ss_pred eecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhc-cccchhhhhhhhhhhcccCCCCC
Q 041230 350 GDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEIL-NDFNLQEIEEDRTMCMHASSSSS 412 (485)
Q Consensus 350 ~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~~~~~~~ 412 (485)
+|||+++........ ..+....++++++...+.--..... .......... ........ .
T Consensus 151 ~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~-~ 226 (304)
T 2jam_A 151 TDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE---KIKEGYYE-F 226 (304)
T ss_dssp CSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHCCCC-C
T ss_pred ccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHcCCCC-C
Confidence 999999764332110 1122345666665433321111000 0000000000 00000000 0
Q ss_pred CcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 413 TSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 413 ~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.. .........+.++...|++.+|++||++.++++
T Consensus 227 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ES---PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CT---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred Cc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 000012234568899999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-27 Score=244.92 Aligned_cols=153 Identities=19% Similarity=0.232 Sum_probs=123.0
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~ 268 (485)
..+.|...+.||+|+||+||++.. .+|+.||||++... .....+.+.+|+.++..++|||||++++++..... ...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 356788899999999999999974 45889999998643 22234678899999999999999999999864321 223
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||++++ |.+.+.. .+++.....|+.|++.||.||| ..+|+||||||+||||+.++.+|
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~-----------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCCC-HHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEE
Confidence 4579999999864 6666642 3677888899999999999999 67899999999999999999999
Q ss_pred EeecccccccCC
Q 041230 349 VGDFSMARFLPD 360 (485)
Q Consensus 349 i~DFGla~~~~~ 360 (485)
|+|||+++....
T Consensus 205 l~DFG~a~~~~~ 216 (464)
T 3ttj_A 205 ILDFGLARTAGT 216 (464)
T ss_dssp ECCCCCC-----
T ss_pred EEEEEeeeecCC
Confidence 999999987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-27 Score=232.23 Aligned_cols=158 Identities=23% Similarity=0.370 Sum_probs=128.9
Q ss_pred hhhccccccceeecccCceEEEEeEe--eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCcceeEeeeeccc
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIR--PGGARSFKSECKAAINI---RHRNIVRVFTAVSGV 263 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~--~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~ 263 (485)
..+.+.|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++..+ +||||++++++|...
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34567899999999999999999986 457889999986432 22334677788777666 899999999998632
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
........++|+||++ |+|.+++..... ..+++.....++.+++.||.||| ..+|+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 155 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcC
Confidence 2223456899999998 799999975432 24788899999999999999999 678999999999999999
Q ss_pred CCcEEEeecccccccC
Q 041230 344 EMIGHVGDFSMARFLP 359 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~ 359 (485)
++.+||+|||+++...
T Consensus 156 ~~~~kl~Dfg~~~~~~ 171 (326)
T 1blx_A 156 SGQIKLADFGLARIYS 171 (326)
T ss_dssp TCCEEECSCCSCCCCC
T ss_pred CCCEEEecCccccccc
Confidence 9999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=252.13 Aligned_cols=154 Identities=24% Similarity=0.325 Sum_probs=132.1
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
..++|...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++.+++|||||++++++.. .
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----K 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----C
Confidence 456788999999999999999986 46899999998642 22345678899999999999999999988753 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++..... ..+++..+..++.+|+.||.||| ..+|+||||||+||||+.++.+|
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeE
Confidence 468999999999999999975432 24788899999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCC
Q 041230 349 VGDFSMARFLPDT 361 (485)
Q Consensus 349 i~DFGla~~~~~~ 361 (485)
|+|||+++.....
T Consensus 327 L~DFGla~~~~~~ 339 (576)
T 2acx_A 327 ISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCTTCEECCTT
T ss_pred EEecccceecccC
Confidence 9999999876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-27 Score=238.80 Aligned_cols=156 Identities=20% Similarity=0.264 Sum_probs=122.8
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-----
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY----- 265 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~----- 265 (485)
...+.|...+.||+|+||+||+|.. .+|+.||||++.... ..+.+|++++..++|||||++++++.....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3466888899999999999999984 568999999986432 223479999999999999999998753211
Q ss_pred ----------------------------CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHH
Q 041230 266 ----------------------------QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317 (485)
Q Consensus 266 ----------------------------~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~g 317 (485)
....+.++||||++ |+|.+.|..... ....+++.....|+.++++|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-----SGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHH
Confidence 22345789999999 688887763110 01357888899999999999
Q ss_pred HHHhhcCCCCCeeeeccCCCceEec-CCCcEEEeecccccccCC
Q 041230 318 LKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 318 L~yLH~~~~~~ivHrdlK~~NILld-~~~~~ki~DFGla~~~~~ 360 (485)
|.||| ..+|+||||||+|||++ .++.+||+|||+++....
T Consensus 154 L~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 194 (383)
T 3eb0_A 154 VGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP 194 (383)
T ss_dssp HHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred HHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC
Confidence 99999 67999999999999998 689999999999987533
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-27 Score=234.10 Aligned_cols=154 Identities=21% Similarity=0.334 Sum_probs=127.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc---CC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY---QG 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 267 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++.+++|||||++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788889999999999999986 568999999985432 2334678899999999999999999999865321 01
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+++ +|.+.+.... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--------VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCE
Confidence 3457899999985 7877776533 24788899999999999999999 6789999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||+++...
T Consensus 164 kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 164 KLADFGLARAFS 175 (351)
T ss_dssp EECCCTTCEECC
T ss_pred EEccchhccccc
Confidence 999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=232.41 Aligned_cols=152 Identities=20% Similarity=0.227 Sum_probs=115.7
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc-c-hHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-G-ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||+||++.. .+|+.||||+++..... . .+.+.++...+..++||||+++++++.. ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 46788889999999999999985 56889999998643222 1 2334455556788999999999999764 235
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeeccCCCceEecCCCcEEE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQP-RIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~-~ivHrdlK~~NILld~~~~~ki 349 (485)
.++||||++ |+|.+++..... ....+++..+..|+.+++.||.||| .. +|+||||||+|||++.++.+||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVID-----KGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEB
T ss_pred EEEEEehhc-cchHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEE
Confidence 799999998 598888753110 0135788999999999999999999 44 8999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 152 ~Dfg~~~~~~ 161 (290)
T 3fme_A 152 CDFGISGYLV 161 (290)
T ss_dssp CCC-------
T ss_pred eecCCccccc
Confidence 9999997653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=236.19 Aligned_cols=150 Identities=25% Similarity=0.407 Sum_probs=120.7
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCcceeEeeeecccccC
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-----GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~ 266 (485)
..+.|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.++.+++|||||++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---- 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----
Confidence 3467888899999999999999854 588999999864322 123568899999999999999999998753
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++||||+++ +|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.
T Consensus 84 -~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 84 -KSNISLVFDFMET-DLEVIIKDNS--------LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp -TTCCEEEEECCSE-EHHHHHTTCC--------SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred -CCceEEEEEcCCC-CHHHHHHhcC--------cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCC
Confidence 2357899999986 8999887543 24666778899999999999999 678999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 151 ~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 151 LKLADFGLAKSFG 163 (346)
T ss_dssp EEECCCGGGSTTT
T ss_pred EEEEecccceecc
Confidence 9999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=235.48 Aligned_cols=149 Identities=20% Similarity=0.325 Sum_probs=124.9
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|.....||+|+||.||++... +|+.||||++...... ..+.+.+|+.++.+++||||++++++|.. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence 356888899999999999999864 4889999998644322 23567899999999999999999999764 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++++|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~ 166 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLC 166 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEE
Confidence 799999999999998876432 4778889999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 167 Dfg~~~~~~ 175 (331)
T 4aaa_A 167 DFGFARTLA 175 (331)
T ss_dssp CCTTC----
T ss_pred eCCCceeec
Confidence 999997653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-27 Score=231.05 Aligned_cols=152 Identities=24% Similarity=0.410 Sum_probs=121.7
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccc--------
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVD-------- 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-------- 264 (485)
.+.|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++.+++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 356788899999999999999865 48899999987654445678999999999999999999998874211
Q ss_pred -cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec-
Q 041230 265 -YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD- 342 (485)
Q Consensus 265 -~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld- 342 (485)
.......++||||++ |+|.+++... .+++.....++.+++.||.||| ..+|+||||||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----------CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcC
Confidence 122356799999998 7999999642 3677888899999999999999 67899999999999997
Q ss_pred CCCcEEEeecccccccC
Q 041230 343 DEMIGHVGDFSMARFLP 359 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~ 359 (485)
+++.+||+|||+++...
T Consensus 156 ~~~~~kl~Dfg~~~~~~ 172 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMD 172 (320)
T ss_dssp TTTEEEECCCTTCBCC-
T ss_pred CCCeEEEccCccccccC
Confidence 56799999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=236.09 Aligned_cols=148 Identities=21% Similarity=0.390 Sum_probs=122.6
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||+||+|... +++.||||+++.... .....+.+|+.++.+++|||||++++++.. ....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence 46778899999999999999864 688999999864332 122345679999999999999999999764 24579
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||++ |+|.+++.... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 144 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCG--------NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADF 144 (324)
T ss_dssp EEEECCS-EEHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSS
T ss_pred EEecccc-cCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccC
Confidence 9999998 69999987543 24778888999999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 145 g~a~~~~ 151 (324)
T 3mtl_A 145 GLARAKS 151 (324)
T ss_dssp SEEECC-
T ss_pred ccccccc
Confidence 9997653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-27 Score=234.59 Aligned_cols=147 Identities=21% Similarity=0.216 Sum_probs=126.2
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC---cchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||+||++... +|+.||||+++.... ...+.+.+|..++.++ +|||||++++++.. ..
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----CC
Confidence 56888899999999999999864 578999999975432 2235678899999987 89999999998753 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.+++... ..+++.....++.+++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~---------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 151 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQ---------RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKL 151 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEE
Confidence 689999999999999999743 24778888999999999999999 678999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+++..
T Consensus 152 ~DFG~a~~~ 160 (345)
T 3a8x_A 152 TDYGMCKEG 160 (345)
T ss_dssp CCGGGCBCS
T ss_pred Eeccccccc
Confidence 999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=233.20 Aligned_cols=158 Identities=23% Similarity=0.302 Sum_probs=129.9
Q ss_pred cccCccchhhhccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcC--CCcceeEee
Q 041230 183 NNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGARSFKSECKAAINIR--HRNIVRVFT 258 (485)
Q Consensus 183 ~~~~~~~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~--H~niv~l~~ 258 (485)
.++.+..+....+.|...+.||+|+||.||++...+++.||||++..... ...+.|.+|+.++.+++ |+||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 45666666666778999999999999999999987899999999875332 23467899999999997 599999999
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
++.. ....++||| +.+|+|.+++.... .+++..+..|+.+++.||.||| ..+|+||||||+|
T Consensus 96 ~~~~-----~~~~~lv~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~N 157 (313)
T 3cek_A 96 YEIT-----DQYIYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPAN 157 (313)
T ss_dssp EEEC-----SSEEEEEEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred Eeec-----CCEEEEEEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCccc
Confidence 8764 245789999 67899999997532 4677889999999999999999 6789999999999
Q ss_pred eEecCCCcEEEeecccccccC
Q 041230 339 VLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 339 ILld~~~~~ki~DFGla~~~~ 359 (485)
||+++ +.+||+|||+++...
T Consensus 158 Il~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 158 FLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEET-TEEEECCCSSSCC--
T ss_pred EEEEC-CeEEEeecccccccc
Confidence 99975 899999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-27 Score=236.02 Aligned_cols=153 Identities=24% Similarity=0.327 Sum_probs=130.4
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..++|...+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.++.+++||||+++++++....+.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578899999999999999999854 588999999864322 23457889999999999999999999886544444466
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+. |+|.+++... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccC-ccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEE
Confidence 899999998 6999998642 4678889999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+++...
T Consensus 155 Dfg~a~~~~ 163 (353)
T 2b9h_A 155 DFGLARIID 163 (353)
T ss_dssp CCTTCEECC
T ss_pred ecccccccc
Confidence 999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=246.36 Aligned_cols=239 Identities=17% Similarity=0.178 Sum_probs=162.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.++|...+.||+|+||.||+|.. .+++.||||+++... ....+..|++++..++|++.+..+.++.. .....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence 35788889999999999999984 568999999876432 23468899999999988655554444321 134679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCcEEE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMIGHV 349 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~~ki 349 (485)
+||||+ +|+|.+++.... ..+++..++.|+.+|+.||.||| ..+|+||||||+|||| +.++.+||
T Consensus 80 lvme~~-g~sL~~ll~~~~--------~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred EEEECC-CCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEE
Confidence 999999 999999997432 35789999999999999999999 6789999999999999 68899999
Q ss_pred eecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhc----cc-cchhhhhh
Q 041230 350 GDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEIL----ND-FNLQEIEE 399 (485)
Q Consensus 350 ~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~----d~-~~~~~~~~ 399 (485)
+|||+++........ ..+....++++++...+.--..... +. .....+..
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 999999876443211 0111233566665443321111000 00 00000000
Q ss_pred hhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 400 DRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.... ... .. .......+...+.++...|++.+|++||+|.+|++.|+.+..
T Consensus 228 i~~~----~~~--~~-~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 228 ISEK----KVA--TS-IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHH----HHH--SC-HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred Hhhc----ccc--cc-HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0000 000 00 000001123467899999999999999999999999998855
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=236.17 Aligned_cols=149 Identities=21% Similarity=0.423 Sum_probs=121.5
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..+.|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.++.+++|||||++++++.. ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----TT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----CC
Confidence 345788889999999999999984 4688999999864332 224567899999999999999999999764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe-----cCC
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL-----DDE 344 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl-----d~~ 344 (485)
..++||||++ |+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||+ +.+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----C
T ss_pred EEEEEEecCC-CCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCcc
Confidence 6799999998 59999997542 4677888999999999999999 6789999999999999 556
Q ss_pred CcEEEeecccccccC
Q 041230 345 MIGHVGDFSMARFLP 359 (485)
Q Consensus 345 ~~~ki~DFGla~~~~ 359 (485)
+.+||+|||+++...
T Consensus 174 ~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 174 PVLKIGDFGLARAFG 188 (329)
T ss_dssp CEEEECCTTHHHHHC
T ss_pred ceEEECcCCCccccC
Confidence 679999999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=244.85 Aligned_cols=155 Identities=14% Similarity=0.095 Sum_probs=109.2
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC---cchHHHHHHHHHHHhc--CCCcceeEeeeec------
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGARSFKSECKAAINI--RHRNIVRVFTAVS------ 261 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l--~H~niv~l~~~~~------ 261 (485)
..+|...+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.++..+ +|||||+++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45688889999999999999985 4688999999976432 2235677785444444 6999888553221
Q ss_pred -cccc------------CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHH------HHHHHHHHHHHHHhh
Q 041230 262 -GVDY------------QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK------LDIAIDVARALKYLH 322 (485)
Q Consensus 262 -~~~~------------~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r------~~ia~~ia~gL~yLH 322 (485)
.... ......++||||++ |+|.+++.... ..+.+..+ ..|+.+++.||.|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--------FVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--------HSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--------cccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 1000 00134799999999 99999997532 12333445 778899999999999
Q ss_pred cCCCCCeeeeccCCCceEecCCCcEEEeecccccccCC
Q 041230 323 CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 323 ~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~ 360 (485)
..+|+||||||+|||++.++.+||+|||+++....
T Consensus 212 ---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp ---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred ---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 67899999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-27 Score=235.21 Aligned_cols=148 Identities=20% Similarity=0.200 Sum_probs=127.0
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||+||++... +|+.||||+++.. .....+.+..|..++..+ +||||+++++++.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----C
Confidence 457888899999999999999864 4788999998743 223456788899999887 89999999988653 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.++|... ..+++.....++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~---------~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vk 161 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV---------GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIK 161 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEE
Confidence 4689999999999999999743 24778888999999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 162 L~DFG~a~~~ 171 (353)
T 2i0e_A 162 IADFGMCKEN 171 (353)
T ss_dssp ECCCTTCBCC
T ss_pred EEeCCccccc
Confidence 9999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=239.59 Aligned_cols=149 Identities=23% Similarity=0.301 Sum_probs=126.9
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||++... +|..||+|+++.... ...+.|.+|+.++.+++|||||++++++.. ....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence 356888899999999999999854 588999999875432 234678999999999999999999998764 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|+|.+++.... .+++.....|+.+++.||.|||+ ..+|+||||||+|||++.++.+||+|
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~D 175 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 175 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEE
Confidence 99999999999999997432 46778889999999999999993 13799999999999999999999999
Q ss_pred ccccccc
Q 041230 352 FSMARFL 358 (485)
Q Consensus 352 FGla~~~ 358 (485)
||+++..
T Consensus 176 fg~~~~~ 182 (360)
T 3eqc_A 176 FGVSGQL 182 (360)
T ss_dssp CCCCHHH
T ss_pred CCCCccc
Confidence 9998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=246.90 Aligned_cols=235 Identities=16% Similarity=0.194 Sum_probs=157.3
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|...+.||+|+||+||+|... ++..||||++.... ......+.+|+.++..++|||||+++++|.. ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 456888899999999999999854 67899999987533 3345778999999999999999999999764 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~~ 347 (485)
.++||||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++. ++.+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHR---------MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred EEEEEecCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcE
Confidence 79999999999999988643 24778888999999999999999 678999999999999976 4569
Q ss_pred EEeecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCC
Q 041230 348 HVGDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
||+|||+++........ ..+....++++++...+.--.... |.......+...........
T Consensus 179 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~--pf~~~~~~~~~~~i~~~~~~- 255 (494)
T 3lij_A 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYP--PFGGQTDQEILRKVEKGKYT- 255 (494)
T ss_dssp EECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSC--SSCCSSHHHHHHHHHHTCCC-
T ss_pred EEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCC--CCCCCCHHHHHHHHHhCCCC-
Confidence 99999999876433211 112233455555543322110000 00000000000000000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESR 451 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~ 451 (485)
.....+. ..-..+.++...|++.+|++|||+.++++.
T Consensus 256 ~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDSPEWK---NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSGGGT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCchhcc---cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000011 112345678899999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=245.87 Aligned_cols=234 Identities=18% Similarity=0.207 Sum_probs=162.4
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||+||++... +|+.||||++.... ....+.+.+|+.++.+++|||||++++++.. ..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 456778899999999999999854 68899999986432 2345779999999999999999999999764 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe---cCCCc
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---DDEMI 346 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---d~~~~ 346 (485)
..++|+||+++|+|.+++.... .+++.....|+.+++.||.||| ..+|+||||||+|||+ +.++.
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCc
Confidence 6799999999999999997543 4778889999999999999999 6789999999999999 56789
Q ss_pred EEEeecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCC
Q 041230 347 GHVGDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 347 ~ki~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
+||+|||+++........ ..+....++++++...+.--.... |..................
T Consensus 168 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~--pf~~~~~~~~~~~i~~~~~- 244 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCP--PFNGANEYDILKKVEKGKY- 244 (484)
T ss_dssp EEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSC--SSCCSSHHHHHHHHHHCCC-
T ss_pred EEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCC--CCCCCCHHHHHHHHHcCCC-
Confidence 999999999876443221 112233455555543322110000 0000000000000000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
......+. ..-..+.++...|++.+|++|||+.++++
T Consensus 245 ~~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 TFELPQWK---KVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCSGGGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00000111 12234568889999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=246.81 Aligned_cols=151 Identities=21% Similarity=0.349 Sum_probs=126.1
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCC-------------cchHHHHHHHHHHHhcCCCcceeEee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-------------GGARSFKSECKAAINIRHRNIVRVFT 258 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~~ 258 (485)
..+.|...+.||+|+||+||+|... +++.||||+++.... ...+.+.+|+.++.+++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4567888999999999999999854 578999999864321 22467899999999999999999999
Q ss_pred eecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCc
Q 041230 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSN 338 (485)
Q Consensus 259 ~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~N 338 (485)
++.. ....++||||+++|+|.+++... ..+++..+..|+.+++.||.||| ..+|+||||||+|
T Consensus 114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 114 VFED-----KKYFYLVTEFYEGGELFEQIINR---------HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPEN 176 (504)
T ss_dssp EEEC-----SSEEEEEEECCTTCBHHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred EEEc-----CCEEEEEEecCCCCcHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHH
Confidence 9764 34679999999999999998643 24788899999999999999999 6789999999999
Q ss_pred eEecCCC---cEEEeecccccccCC
Q 041230 339 VLLDDEM---IGHVGDFSMARFLPD 360 (485)
Q Consensus 339 ILld~~~---~~ki~DFGla~~~~~ 360 (485)
||++.++ .+||+|||+++....
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~ 201 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSK 201 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCT
T ss_pred EEEecCCCCccEEEEECCCCEEcCC
Confidence 9998775 699999999987644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=243.92 Aligned_cols=150 Identities=22% Similarity=0.350 Sum_probs=127.4
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|...+.||+|+||+||++... +|+.||||+++.. .......+.+|+.++.+++|||||++++++.. ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCE
Confidence 356778899999999999999853 6889999998642 23345778999999999999999999999764 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec---CCCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD---DEMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld---~~~~~ 347 (485)
.++|+||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+|||++ .++.+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 163 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKR---------KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCE
T ss_pred EEEEEEcCCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 79999999999999988643 24778889999999999999999 67899999999999995 56789
Q ss_pred EEeecccccccCC
Q 041230 348 HVGDFSMARFLPD 360 (485)
Q Consensus 348 ki~DFGla~~~~~ 360 (485)
||+|||+++....
T Consensus 164 kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 164 KIIDFGLSTCFQQ 176 (486)
T ss_dssp EECSCSCTTTBCC
T ss_pred EEEECCcCeECCC
Confidence 9999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-27 Score=237.27 Aligned_cols=148 Identities=24% Similarity=0.354 Sum_probs=117.6
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 269 (485)
.+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.++. |||||++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 45788889999999999999984 568899999985332 223456788999999997 99999999997642 234
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++|||||+ |+|..++... .+.+..+..++.+++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecccC-cCHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEe
Confidence 5799999998 6999998742 4677788889999999999999 678999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+|+..
T Consensus 151 ~DFG~a~~~ 159 (388)
T 3oz6_A 151 ADFGLSRSF 159 (388)
T ss_dssp CCCTTCEES
T ss_pred cCCcccccc
Confidence 999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-27 Score=237.84 Aligned_cols=148 Identities=27% Similarity=0.323 Sum_probs=117.5
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHH-HHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKA-AINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||+||+++.. +++.||||+++... ....+.+..|..+ +..++|||||++++++.. .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence 457888999999999999999864 47889999997532 2233456667766 567899999999988754 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.++|.... .+++.....++.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ik 179 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIV 179 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEE
Confidence 46899999999999999997432 4667778889999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 180 L~DFG~a~~~ 189 (373)
T 2r5t_A 180 LTDFGLCKEN 189 (373)
T ss_dssp ECCCCBCGGG
T ss_pred EeeCcccccc
Confidence 9999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=235.40 Aligned_cols=146 Identities=23% Similarity=0.376 Sum_probs=122.4
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||.||++... +|+.||||+++.... .+.+|++++.++ +|||||++++++.. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-----GKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEE
Confidence 457888899999999999999854 588999999975432 345688888887 79999999998753 3468
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC----CcE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE----MIG 347 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~----~~~ 347 (485)
++||||+++|+|.+++.... .+++.....++.+++.||.||| ..+|+||||||+|||+.++ +.+
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeE
Confidence 99999999999999997542 4778889999999999999999 6789999999999998443 359
Q ss_pred EEeecccccccCC
Q 041230 348 HVGDFSMARFLPD 360 (485)
Q Consensus 348 ki~DFGla~~~~~ 360 (485)
||+|||+++....
T Consensus 160 kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 160 RICDFGFAKQLRA 172 (342)
T ss_dssp EECCCTTCEECBC
T ss_pred EEEECCCcccCcC
Confidence 9999999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=233.84 Aligned_cols=154 Identities=19% Similarity=0.288 Sum_probs=122.0
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CC
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QG 267 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~ 267 (485)
...+.|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++.+++|||||++++++..... ..
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3456788899999999999999985 4689999999854322 224578899999999999999999998764321 11
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+ +++|.+++... .+++.....++.+++.||.||| +.+|+||||||+|||++.++.+
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred CceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCE
Confidence 23468999999 89999998742 3677788899999999999999 6789999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||+++...
T Consensus 168 kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 168 KILDFGLARQAD 179 (367)
T ss_dssp EECCCTTCEECC
T ss_pred EEEeeecccccc
Confidence 999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=253.04 Aligned_cols=234 Identities=16% Similarity=0.217 Sum_probs=163.0
Q ss_pred ccccccceeecccCceEEEEeEee--CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~--~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|...+.||+|+||+||+|... +|+.||||++..... ...+.|.+|+.++.+++|||||++++++...+..+...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367888999999999999999864 588999999864322 23457889999999999999999999987644333344
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.. .++|..++.|+.+++.||.||| ..+|+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEE
Confidence 6999999999999887653 4788999999999999999999 6789999999999999986 89999
Q ss_pred ecccccccCCCCcc-------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCcchh
Q 041230 351 DFSMARFLPDTDEQ-------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHV 417 (485)
Q Consensus 351 DFGla~~~~~~~~~-------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (485)
|||+++........ ...+...++++++...+. ++....... .. ........
T Consensus 224 DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~-----l~~g~~~~~--~~-----~~~~~~~~---- 287 (681)
T 2pzi_A 224 DLGAVSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAA-----LTLDLPTRN--GR-----YVDGLPED---- 287 (681)
T ss_dssp CCTTCEETTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHH-----HHSCCCEET--TE-----ECSSCCTT----
T ss_pred ecccchhcccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHH-----HHhCCCCCc--cc-----cccccccc----
Confidence 99999876443210 001123455665543322 111100000 00 00000000
Q ss_pred hhHHHHHHHHHHHHHhccCCCcCCCCC-HHHHHHHHHHHHHH
Q 041230 418 SIILECVNSICEIGVACSAERPRERMK-LNDVESRLRLIRKK 458 (485)
Q Consensus 418 ~~~~~~~~~~~~ial~C~~~~p~~RP~-m~~V~~~L~~i~~~ 458 (485)
.........+.++...|++.+|++||+ +.++...|..+...
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 011123345678999999999999996 66677777766543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=226.63 Aligned_cols=149 Identities=23% Similarity=0.392 Sum_probs=124.4
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEec-----CCce
Confidence 56888899999999999999864 68899999986432 2234678899999999999999999999764 2457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||++ |+|.+++..... ..+++.....++.+++.||.||| ..+|+||||||+||+++.++.+||+|
T Consensus 78 ~lv~e~~~-~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d 146 (299)
T 2r3i_A 78 YLVFEFLH-QDLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 146 (299)
T ss_dssp EEEEECCS-EEHHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECS
T ss_pred EEEEEccc-CCHHHHHHhhhc-------cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECc
Confidence 99999998 699999875432 24677888999999999999999 67899999999999999999999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 147 fg~~~~~~ 154 (299)
T 2r3i_A 147 FGLARAFG 154 (299)
T ss_dssp TTHHHHHC
T ss_pred chhhhhcc
Confidence 99987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=231.12 Aligned_cols=162 Identities=19% Similarity=0.233 Sum_probs=116.1
Q ss_pred hhhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc--CC
Q 041230 191 YDATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY--QG 267 (485)
Q Consensus 191 ~~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~--~~ 267 (485)
....++|...+.||+|+||+||+|.. .+|+.||||++.... .....+.+|++.+..++|||||++++++..... ..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 44567888999999999999999986 458899999986432 234567788999999999999999999864322 12
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-CCc
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-EMI 346 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-~~~ 346 (485)
..+.++||||+++ +|...+..... ....+.+.....++.+++.||.|||.+ ..+|+||||||+|||++. ++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYR-----RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 3457899999996 45444331000 013467778888999999999999943 578999999999999997 899
Q ss_pred EEEeecccccccCC
Q 041230 347 GHVGDFSMARFLPD 360 (485)
Q Consensus 347 ~ki~DFGla~~~~~ 360 (485)
+||+|||+++....
T Consensus 171 ~kl~Dfg~a~~~~~ 184 (360)
T 3e3p_A 171 LKLCDFGSAKKLSP 184 (360)
T ss_dssp EEECCCTTCBCCCT
T ss_pred EEEeeCCCceecCC
Confidence 99999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=246.15 Aligned_cols=154 Identities=27% Similarity=0.330 Sum_probs=131.0
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++|...+.||+|+||+||++... +|+.||||+++... ....+.+.+|+.++.+++|||||++++++.. ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 467888899999999999999864 58999999986432 2345678899999999999999999988653 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.++|...... ...+++.....++.+|+.||.||| ..+|+||||||+||||+.++.+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEE
Confidence 689999999999999999754321 135788889999999999999999 678999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 331 ~DFGla~~~~~ 341 (543)
T 3c4z_A 331 SDLGLAVELKA 341 (543)
T ss_dssp CCCTTCEECCT
T ss_pred eecceeeeccC
Confidence 99999987643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=231.85 Aligned_cols=151 Identities=19% Similarity=0.236 Sum_probs=122.5
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccc-cCCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVD-YQGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 269 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++..++|||||++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46788899999999999999974 4588999999874322 23457889999999999999999999876432 11233
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||++ |+|.+++.. .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEcCC-CCHHHHHhh-----------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEE
Confidence 6799999998 578888852 3667788899999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 169 ~Dfg~a~~~~ 178 (371)
T 2xrw_A 169 LDFGLARTAG 178 (371)
T ss_dssp CCCCC-----
T ss_pred EEeecccccc
Confidence 9999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-26 Score=250.24 Aligned_cols=148 Identities=20% Similarity=0.212 Sum_probs=127.3
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||+||++... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.. .
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-----~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----S
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----C
Confidence 457888999999999999999854 5788999999742 233456788899999887 79999999987543 3
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.++|.... .+++.....|+.+|+.||.||| ..+|+||||||+|||||.++.+|
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEE
T ss_pred CEEEEEEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEE
Confidence 56899999999999999997532 4778889999999999999999 67899999999999999999999
Q ss_pred Eeeccccccc
Q 041230 349 VGDFSMARFL 358 (485)
Q Consensus 349 i~DFGla~~~ 358 (485)
|+|||+++..
T Consensus 483 L~DFGla~~~ 492 (674)
T 3pfq_A 483 IADFGMCKEN 492 (674)
T ss_dssp ECCCTTCEEC
T ss_pred Eeecceeecc
Confidence 9999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=235.43 Aligned_cols=153 Identities=22% Similarity=0.327 Sum_probs=121.2
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~ 272 (485)
...|...+.||+|+||+||+|....+..||||++..... ...+|++++..++|||||++++++..... ....+.+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346888899999999999999987777799998754322 22369999999999999999999864322 2344578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec-CCCcEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld-~~~~~ki~D 351 (485)
+||||++++.+....+... ....+++.....++.++++||.||| ..+|+||||||+|||++ .++.+||+|
T Consensus 115 lv~e~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAK------LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEECCSEEHHHHHHHHHH------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeccCccHHHHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 9999999765544332110 0135777888899999999999999 67899999999999999 799999999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++...
T Consensus 186 FG~a~~~~ 193 (394)
T 4e7w_A 186 FGSAKILI 193 (394)
T ss_dssp CTTCEECC
T ss_pred CCCccccc
Confidence 99998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-26 Score=223.05 Aligned_cols=234 Identities=16% Similarity=0.179 Sum_probs=161.1
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|...+.||+|+||.||++... +++.||||++.... ....+.|.+|+.++.+++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 356788899999999999999864 68899999986432 2345789999999999999999999998764 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC---CcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE---MIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~---~~~ 347 (485)
.++|+||+++|+|.+++... ..+++.....|+.+++.||.||| ..+|+||||||+||+++.+ +.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR---------KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred EEEEEEccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccE
Confidence 79999999999999988643 24678889999999999999999 6789999999999999764 479
Q ss_pred EEeecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCC
Q 041230 348 HVGDFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
||+|||+++........ ..+....++++++...+.-..... +...................
T Consensus 164 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~--p~~~~~~~~~~~~~~~~~~~- 240 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTP--PFYGKNEYDILKRVETGKYA- 240 (287)
T ss_dssp EECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSC--SSCCSSHHHHHHHHHHCCCC-
T ss_pred EEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCC--CCCCCCHHHHHHHHHcCCCC-
Confidence 99999999876443211 012233455555543332111000 00000000000000000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.....+ ......+.++...|++.+|++|||+.++++
T Consensus 241 ~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQW---RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGGG---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhh---hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000 012234668999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=231.72 Aligned_cols=152 Identities=20% Similarity=0.265 Sum_probs=121.8
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc------chHHHHHHHHHHHhc----CCCcceeEeeee
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GARSFKSECKAAINI----RHRNIVRVFTAV 260 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l----~H~niv~l~~~~ 260 (485)
...++|...+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3456789999999999999999974 46889999998643321 223466799999998 899999999987
Q ss_pred cccccCCceeeEEEEEe-cCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 261 SGVDYQGARFKAVVYKF-MPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 261 ~~~~~~~~~~~~lV~ey-~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
.. ....++|+|| +++|+|.+++... ..+++..+..|+.+++.||.||| ..+|+||||||+||
T Consensus 108 ~~-----~~~~~~v~e~~~~~~~L~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 170 (312)
T 2iwi_A 108 ET-----QEGFMLVLERPLPAQDLFDYITEK---------GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENI 170 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGE
T ss_pred ec-----CCeEEEEEEecCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhE
Confidence 53 2457899999 8999999999753 24788899999999999999999 57899999999999
Q ss_pred Eec-CCCcEEEeecccccccCC
Q 041230 340 LLD-DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 340 Lld-~~~~~ki~DFGla~~~~~ 360 (485)
|++ .++.+||+|||+++....
T Consensus 171 l~~~~~~~~kl~dfg~~~~~~~ 192 (312)
T 2iwi_A 171 LIDLRRGCAKLIDFGSGALLHD 192 (312)
T ss_dssp EEETTTTEEEECCCSSCEECCS
T ss_pred EEeCCCCeEEEEEcchhhhccc
Confidence 999 889999999999987644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=235.66 Aligned_cols=154 Identities=21% Similarity=0.317 Sum_probs=113.8
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccc-cCC
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVD-YQG 267 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~-~~~ 267 (485)
...+.|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++.+++|||||++++++.... ...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3456788899999999999999984 5688999999864322 23467889999999999999999999875421 112
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++|+||+ +++|.+++... .+++.....++.++++||.||| +.+|+||||||+|||++.++.+
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CCCCEEEEECC-CEECC-----C----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred CCeEEEEeccc-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCE
Confidence 24578999999 78999888642 4778889999999999999999 6789999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||+++...
T Consensus 172 kL~DFG~a~~~~ 183 (367)
T 2fst_X 172 KILDFGLARHTA 183 (367)
T ss_dssp EECC--------
T ss_pred EEeecccccccc
Confidence 999999998653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=239.10 Aligned_cols=150 Identities=22% Similarity=0.298 Sum_probs=115.4
Q ss_pred cccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceeeEEEE
Q 041230 197 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.. ....++||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~lv~ 88 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYIAL 88 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEEEE
Confidence 4456889999999998766678999999998642 345678899999876 89999999988653 34689999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC------------
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD------------ 343 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~------------ 343 (485)
||+. |+|.+++.......... ....+.....|+.+++.||.||| +.+|+||||||+|||++.
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENL--KLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp CCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred ecCC-CCHHHHHhccCCCchhh--hhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCC
Confidence 9995 79999998654221100 01123345679999999999999 678999999999999965
Q ss_pred -CCcEEEeecccccccCC
Q 041230 344 -EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 344 -~~~~ki~DFGla~~~~~ 360 (485)
++.+||+|||+++....
T Consensus 163 ~~~~~kL~DFG~a~~~~~ 180 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDS 180 (434)
T ss_dssp CSCEEEECCCTTCEECCC
T ss_pred CceEEEEcccccceecCC
Confidence 45899999999987643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=229.66 Aligned_cols=151 Identities=22% Similarity=0.352 Sum_probs=119.9
Q ss_pred hccccccc-eeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHH-HHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSA-NLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSEC-KAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~-~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~-~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.+++|... ++||+|+||+||+|... +|+.||||++... ....+|+ ..+..+.||||+++++++.... .+..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCc
Confidence 34567774 57999999999999864 6899999998642 2233333 3466789999999999876421 2245
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCc
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMI 346 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~ 346 (485)
..++||||+++|+|.+++..... ..+++..+..|+.+++.||.||| ..+|+||||||+|||++. ++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCce
Confidence 57999999999999999986432 25788999999999999999999 678999999999999976 456
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 170 ~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 170 LKLTDFGFAKETT 182 (336)
T ss_dssp EEECCCTTCEEC-
T ss_pred EEEeccccceecc
Confidence 9999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-26 Score=229.77 Aligned_cols=152 Identities=21% Similarity=0.313 Sum_probs=123.8
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccC-Cc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ-GA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~-~~ 268 (485)
..+.|...+.||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+.++.+++|||||++++++...+.. ..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 456788889999999999999984 46889999998643222 246788999999999999999999998643211 11
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++|+||+. |+|.+++.. .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+|
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEEcccc-ccHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEE
Confidence 22489999998 689888742 3778889999999999999999 67899999999999999999999
Q ss_pred EeecccccccC
Q 041230 349 VGDFSMARFLP 359 (485)
Q Consensus 349 i~DFGla~~~~ 359 (485)
|+|||+++...
T Consensus 185 L~Dfg~a~~~~ 195 (371)
T 4exu_A 185 ILDFGLARHAD 195 (371)
T ss_dssp ECSTTCC----
T ss_pred EEecCcccccc
Confidence 99999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-26 Score=234.44 Aligned_cols=152 Identities=24% Similarity=0.347 Sum_probs=120.2
Q ss_pred cccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~ 272 (485)
..|...+.||+|+||.||+|... +|+.||||++.... +.+.+|++++.+++|||||++++++..... .+..+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35778899999999999999864 58999999986432 233479999999999999999998754221 2234567
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC-CcEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-MIGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~-~~~ki~D 351 (485)
+||||+++ +|.+.+.... .....+++.....++.|+++||.||| ..+|+||||||+||||+.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS-----RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH-----HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHh-----hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEecc
Confidence 99999986 6666554210 00135788888999999999999999 6899999999999999965 6789999
Q ss_pred cccccccC
Q 041230 352 FSMARFLP 359 (485)
Q Consensus 352 FGla~~~~ 359 (485)
||+++.+.
T Consensus 201 FG~a~~~~ 208 (420)
T 1j1b_A 201 FGSAKQLV 208 (420)
T ss_dssp CTTCEECC
T ss_pred chhhhhcc
Confidence 99998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-26 Score=234.39 Aligned_cols=150 Identities=21% Similarity=0.299 Sum_probs=123.7
Q ss_pred ccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhc------CCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINI------RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~~~~~~~~~~ 266 (485)
...|...+.||+|+||+||+|... +++.||||+++.. ....+.+.+|+.++..+ .|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc----
Confidence 346888899999999999999754 5789999998642 22345677888888877 57799999998764
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
....++||||+. |+|.+++..... ..+++..+..|+.+++.||.||| ..+|+||||||+||||+.++.
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKF-------QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGR 238 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTS
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCC
Confidence 246799999996 799999875432 24788899999999999999999 578999999999999999987
Q ss_pred --EEEeecccccccCC
Q 041230 347 --GHVGDFSMARFLPD 360 (485)
Q Consensus 347 --~ki~DFGla~~~~~ 360 (485)
+||+|||+++....
T Consensus 239 ~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp CCEEECCCTTCEETTC
T ss_pred cceEEeecccceecCC
Confidence 99999999976543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=236.71 Aligned_cols=151 Identities=18% Similarity=0.260 Sum_probs=112.9
Q ss_pred ceeecccCceEEEEeEee---CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEEE
Q 041230 200 ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYK 276 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~e 276 (485)
.++||+|+||+||+|... +++.||||+++.. .....+.+|+.++.+++|||||++++++... .....++|||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~lv~e 100 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 100 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEEEEEe
Confidence 457999999999999865 4778999998642 3346789999999999999999999997532 2346899999
Q ss_pred ecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe----cCCCcEEEeec
Q 041230 277 FMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL----DDEMIGHVGDF 352 (485)
Q Consensus 277 y~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl----d~~~~~ki~DF 352 (485)
|+. |+|.+++..............+++.....|+.+++.||.||| ..+|+||||||+|||| +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 997 588888753211000011134888899999999999999999 6789999999999999 77899999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+++...
T Consensus 177 g~a~~~~ 183 (405)
T 3rgf_A 177 GFARLFN 183 (405)
T ss_dssp TCCC---
T ss_pred CCceecC
Confidence 9998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=231.43 Aligned_cols=139 Identities=19% Similarity=0.296 Sum_probs=110.9
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC--------CCcceeEeeeecccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR--------HRNIVRVFTAVSGVD 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~~~~~~~~ 264 (485)
.+.|...+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+.++..++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 35788899999999999999974 55889999998632 223467889999999886 788999999875321
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeeccCCCceEecC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQP-RIAHCNLKPSNVLLDD 343 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~-~ivHrdlK~~NILld~ 343 (485)
......++||||+ +|+|.+++..... ..+++.....|+.|++.||.||| .. +|+||||||+|||++.
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECC
T ss_pred -CCCceEEEEEecc-CccHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEec
Confidence 1234689999999 5677666654321 24788899999999999999999 45 8999999999999997
Q ss_pred CC
Q 041230 344 EM 345 (485)
Q Consensus 344 ~~ 345 (485)
++
T Consensus 183 ~~ 184 (397)
T 1wak_A 183 NE 184 (397)
T ss_dssp CH
T ss_pred cc
Confidence 75
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=229.68 Aligned_cols=150 Identities=19% Similarity=0.261 Sum_probs=125.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc------chHHHHHHHHHHHhcC--CCcceeEeeeecccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GARSFKSECKAAINIR--HRNIVRVFTAVSGVD 264 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~~~~~~~~ 264 (485)
.+.|...+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.++.+++ |+||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 45688889999999999999984 56889999998753221 2245778999999996 5999999999764
Q ss_pred cCCceeeEEEEEecCC-CCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec-
Q 041230 265 YQGARFKAVVYKFMPN-GSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD- 342 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~-GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld- 342 (485)
....++|+||+.+ |+|.+++... ..+++.....|+.+++.||.||| +.+|+||||||+|||++
T Consensus 120 ---~~~~~lv~e~~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 120 ---PDSFVLILERPEPVQDLFDFITER---------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDL 184 (320)
T ss_dssp ---SSEEEEEEECCSSEEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEET
T ss_pred ---CCcEEEEEEcCCCCccHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeC
Confidence 2457899999986 9999999743 24678888999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCC
Q 041230 343 DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~ 360 (485)
+++.+||+|||+++....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKD 202 (320)
T ss_dssp TTTEEEECCCTTCEECCS
T ss_pred CCCCEEEeeCcccccccc
Confidence 789999999999987644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=227.58 Aligned_cols=153 Identities=21% Similarity=0.236 Sum_probs=120.7
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHH-HHHhcCCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECK-AAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|...+.||+|+||.||+|.. .+|+.||||+++.... .....+..|+. ++..++||||+++++++.. ...
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence 46788889999999999999986 4688999999975432 22345666666 6778899999999999764 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeeccCCCceEecCCCcEEE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQP-RIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~-~ivHrdlK~~NILld~~~~~ki 349 (485)
.++||||+++ +|.+++..... .....+++.....|+.+++.||.||| .. +|+||||||+|||++.++.+||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYS----VLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHH----TTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred eEEEEeecCC-ChHHHHHHHHh----hhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEE
Confidence 7899999985 88887752100 00135778889999999999999999 45 8999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 168 ~Dfg~~~~~~ 177 (327)
T 3aln_A 168 CDFGISGQLV 177 (327)
T ss_dssp CCCSSSCC--
T ss_pred ccCCCceecc
Confidence 9999998654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=235.53 Aligned_cols=147 Identities=22% Similarity=0.376 Sum_probs=117.0
Q ss_pred hccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCceee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
....|...++||+|+||+||.....+|+.||||++... ....+.+|++++.++ +|||||++++++.. ....
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~ 93 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQ 93 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEE
Confidence 34568888999999999966555578999999998642 223467899999999 89999999988753 3467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec-----CCCc
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD-----DEMI 346 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld-----~~~~ 346 (485)
++||||+. |+|.+++..... .+.+.....|+.+++.||.||| ..+|+||||||+|||++ ....
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~ 161 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF--------AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIK 161 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC--------CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCC
T ss_pred EEEEECCC-CCHHHHHHhcCC--------CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCcee
Confidence 99999997 699999986542 1222345679999999999999 67899999999999994 3457
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 162 ~kL~DFG~a~~~~ 174 (432)
T 3p23_A 162 AMISDFGLCKKLA 174 (432)
T ss_dssp EEECCTTEEECC-
T ss_pred EEEecccceeecc
Confidence 8899999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=223.78 Aligned_cols=150 Identities=19% Similarity=0.344 Sum_probs=124.3
Q ss_pred ccccccceeecccCceEEEEeEe--eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCc------ceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRN------IVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~--~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 265 (485)
.+.|...+.||+|+||+||++.. .+|+.||||+++.. ....+.+.+|+.++..++|+| ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence 35788889999999999999975 36789999998642 223467889999999887665 8999988753
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC--
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-- 343 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-- 343 (485)
....++||||+ +|+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKENGF-------LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCC
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhcCC-------CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccc
Confidence 24679999999 8999999975432 24778889999999999999999 678999999999999988
Q ss_pred -----------------CCcEEEeecccccccCC
Q 041230 344 -----------------EMIGHVGDFSMARFLPD 360 (485)
Q Consensus 344 -----------------~~~~ki~DFGla~~~~~ 360 (485)
++.+||+|||+++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred cccccCCccccccccccCCCceEeeCcccccCcc
Confidence 67899999999987543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=225.22 Aligned_cols=151 Identities=21% Similarity=0.311 Sum_probs=124.0
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCcceeEeeeecccccC-Cce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQ-GAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~-~~~ 269 (485)
.++|...+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++.+++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46788889999999999999985 46889999998643222 245788999999999999999999987643211 112
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+. |+|.+++.. .+++.....|+.+++.||.||| ..+|+||||||+|||++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEE
Confidence 3589999998 688877742 3677889999999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 168 ~Dfg~~~~~~ 177 (353)
T 3coi_A 168 LDFGLARHAD 177 (353)
T ss_dssp CSTTCTTC--
T ss_pred eecccccCCC
Confidence 9999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=226.42 Aligned_cols=156 Identities=21% Similarity=0.240 Sum_probs=125.2
Q ss_pred hhhhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CC-----cceeEeeeecc
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HR-----NIVRVFTAVSG 262 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~~~~~~ 262 (485)
.....++|...+.||+|+||+||+|... +++.||||+++.. ......+..|+.++..++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3445678999999999999999999854 5788999998632 223456778888888875 55 38999888753
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
....++||||++ |+|.+++..... ..+++..+..|+.+++.||.|||.+ ..+|+||||||+|||++
T Consensus 128 -----~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 128 -----RNHLCLVFEMLS-YNLYDLLRNTNF-------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193 (382)
T ss_dssp -----TTEEEEEEECCC-CBHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEES
T ss_pred -----CCceEEEEecCC-CCHHHHHhhcCc-------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEe
Confidence 246799999996 699999975432 2478889999999999999999943 46899999999999994
Q ss_pred --CCCcEEEeecccccccCC
Q 041230 343 --DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 343 --~~~~~ki~DFGla~~~~~ 360 (485)
.++.+||+|||+++....
T Consensus 194 ~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 194 NPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp STTSCCEEECCCTTCEETTC
T ss_pred cCCCCcEEEEeccCceeccc
Confidence 578899999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=223.07 Aligned_cols=151 Identities=21% Similarity=0.227 Sum_probs=111.0
Q ss_pred hccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCc-c-hHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-G-ARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..++|...+.||+|+||.||+|... +|+.||||++...... . .+.+.++..++..++||||+++++++.. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence 3567888899999999999999864 6899999998754322 1 2334455567888899999999999764 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+ ++.+..++.... ..+++.....|+.+++.||.|||. ..+|+||||||+|||++.++.+||
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQ--------GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEE
T ss_pred cEEEEEecc-CCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEE
Confidence 679999999 455555443211 357788899999999999999993 138999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 167 ~dfg~~~~~~ 176 (318)
T 2dyl_A 167 CDFGISGRLV 176 (318)
T ss_dssp CCCTTC----
T ss_pred EECCCchhcc
Confidence 9999997653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=226.08 Aligned_cols=153 Identities=16% Similarity=0.270 Sum_probs=124.5
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-----------CCcceeEeeeecc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-----------HRNIVRVFTAVSG 262 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~~~~~~ 262 (485)
+.|...+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688889999999999999984 56889999998632 223467888999998886 8999999998764
Q ss_pred cccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCC-CeeeeccCCCceEe
Q 041230 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQP-RIAHCNLKPSNVLL 341 (485)
Q Consensus 263 ~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~-~ivHrdlK~~NILl 341 (485)
.. ......++||||+ +|+|.+++..... ..+++.....|+.+++.||.||| .. +|+||||||+|||+
T Consensus 98 ~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 98 KG-PNGVHVVMVFEVL-GENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLM 165 (373)
T ss_dssp EE-TTEEEEEEEECCC-CEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEE
T ss_pred cC-CCCceEEEEEecC-CCCHHHHHHHhhc-------cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEE
Confidence 32 1223678999999 9999999975332 24778889999999999999999 55 89999999999999
Q ss_pred c------CCCcEEEeecccccccCC
Q 041230 342 D------DEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 342 d------~~~~~ki~DFGla~~~~~ 360 (485)
+ .++.+||+|||+++....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB
T ss_pred eccCCCcCcceEEEcccccccccCC
Confidence 4 455899999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=219.34 Aligned_cols=150 Identities=19% Similarity=0.331 Sum_probs=121.5
Q ss_pred ccccccceeecccCceEEEEeEee-CC-cEEEEEEeeccCCcchHHHHHHHHHHHhcCCCc------ceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLF-DG-TTIAVKVFNLIRPGGARSFKSECKAAINIRHRN------IVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~-~~-~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~~~~~~~~~ 265 (485)
.+.|...+.||+|+||+||++... ++ +.||||+++.. ....+.+.+|+.++.+++|+| ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence 357888899999999999999853 34 68999998632 223467888999999998776 8888777653
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEe----
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL---- 341 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILl---- 341 (485)
....++||||+ +|+|.+++..... ..+++.....|+.+++.||.||| ..+|+||||||+|||+
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSE 160 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCC
T ss_pred --CCeEEEEEecc-CCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccc
Confidence 24679999999 6777777764321 24788899999999999999999 6799999999999999
Q ss_pred ---------------cCCCcEEEeecccccccCC
Q 041230 342 ---------------DDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 342 ---------------d~~~~~ki~DFGla~~~~~ 360 (485)
+.++.+||+|||+++....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred ccccccccccccccccCCCcEEEeecCccccccc
Confidence 6788999999999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=227.36 Aligned_cols=163 Identities=15% Similarity=0.125 Sum_probs=116.5
Q ss_pred hhhhccccccceeecccCceEEEEeE-eeCCcEEEEEEeeccCC---cchHHHHHHHHHHHhcCC-CcceeEeee-----
Q 041230 190 LYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGARSFKSECKAAINIRH-RNIVRVFTA----- 259 (485)
Q Consensus 190 l~~~t~~f~~~~~iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~---~~~~~f~~E~~~l~~l~H-~niv~l~~~----- 259 (485)
+...+.+|...++||+|+||+||+|. ..+|+.||||+++.... ...+.|.+|+.++..++| +|...+..+
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 44556678888999999999999998 45689999999873322 225779999999999987 433222111
Q ss_pred ----------------ecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhc
Q 041230 260 ----------------VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHC 323 (485)
Q Consensus 260 ----------------~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~ 323 (485)
............+++|+ +.+|+|.+++...... ......++|..++.|+.|++.||.|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~L~~ll~~l~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH- 228 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSH--SSTHKSLVHHARLQLTLQVIRLLASLH- 228 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEE-CCSEEHHHHHHHHHHH--TTTSHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred chhhcccCCCCccccccCCCccccccceEEEee-hhcCCHHHHHHHhhcc--cccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 00000000112355555 4578999988411000 000135788999999999999999999
Q ss_pred CCCCCeeeeccCCCceEecCCCcEEEeeccccccc
Q 041230 324 DCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358 (485)
Q Consensus 324 ~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~ 358 (485)
..+|+||||||+||||+.++.+||+|||+++..
T Consensus 229 --~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~ 261 (413)
T 3dzo_A 229 --HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261 (413)
T ss_dssp --HTTEECSCCCGGGEEECTTCCEEECCGGGCEET
T ss_pred --hCCcccCCcccceEEEecCCeEEEEeccceeec
Confidence 678999999999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=239.55 Aligned_cols=157 Identities=22% Similarity=0.351 Sum_probs=126.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~ 271 (485)
+.|...+.||+|+||.||+|.. .+|+.||||+++... ....+.|.+|++++.+++|||||++++++..... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5788889999999999999985 458899999986432 2334678999999999999999999998764221 224567
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC---cEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM---IGH 348 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~---~~k 348 (485)
++||||+++|+|.+++...... ..+++.....|+.+++.||.||| ..+|+||||||+|||++.++ .+|
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEE
Confidence 8999999999999999864321 24667788899999999999999 57899999999999999665 499
Q ss_pred EeecccccccCC
Q 041230 349 VGDFSMARFLPD 360 (485)
Q Consensus 349 i~DFGla~~~~~ 360 (485)
|+|||+++....
T Consensus 165 L~DFG~a~~~~~ 176 (676)
T 3qa8_A 165 IIDLGYAKELDQ 176 (676)
T ss_dssp ECSCCCCCBTTS
T ss_pred Eccccccccccc
Confidence 999999987543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-25 Score=223.21 Aligned_cols=154 Identities=19% Similarity=0.231 Sum_probs=121.5
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--------cchHHHHHHHHHHHhcC---------CCcceeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--------GGARSFKSECKAAINIR---------HRNIVRV 256 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--------~~~~~f~~E~~~l~~l~---------H~niv~l 256 (485)
.++|...+.||+|+||+||+|.. +|+.||||+++.... ...+.+.+|+.++.+++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999985 789999999975432 22377899999999886 7777776
Q ss_pred eeeeccc-------------------------ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHH
Q 041230 257 FTAVSGV-------------------------DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIA 311 (485)
Q Consensus 257 ~~~~~~~-------------------------~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia 311 (485)
.+.+... ++.+....++||||+++|++.+.+.. ..+++.....|+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----------~~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----------KLSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----------TCCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----------cCCCHHHHHHHH
Confidence 6653210 01124568999999999987776643 136778889999
Q ss_pred HHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC--------------------cEEEeecccccccCC
Q 041230 312 IDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM--------------------IGHVGDFSMARFLPD 360 (485)
Q Consensus 312 ~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~--------------------~~ki~DFGla~~~~~ 360 (485)
.|++.||.|||+ ..+|+||||||+||||+.++ .+||+|||+|+....
T Consensus 168 ~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 168 HQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 999999999992 25799999999999999887 999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-25 Score=218.35 Aligned_cols=141 Identities=25% Similarity=0.397 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCC---CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMG---SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+||||+.++.+||+|||+|+...... .....+||+.|||||++.+ ..|+.++|||||||++|||+||+
T Consensus 155 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~ 234 (307)
T 3omv_A 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234 (307)
T ss_dssp CSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred CCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence 99999999999999999999999998764322 2345789999999999853 35889999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.||.+... ...+...+.. ....+.+ ......| ...+.+++..|++.+|++||
T Consensus 235 ~Pf~~~~~-----~~~~~~~~~~---~~~~p~~-----------~~~~~~~---------~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 235 LPYSHINN-----RDQIIFMVGR---GYASPDL-----------SKLYKNC---------PKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp CTTTTCCC-----HHHHHHHHHT---TCCCCCS-----------TTSCTTS---------CHHHHHHHHHHTCSSSTTSC
T ss_pred CCCCCCCh-----HHHHHHHHhc---CCCCCCc-----------ccccccc---------hHHHHHHHHHHcCCCHhHCc
Confidence 99965321 1111100000 0000000 0000111 12345788999999999999
Q ss_pred ccchhhHHHHHHhhh
Q 041230 155 DINDVESRLRSIKMK 169 (485)
Q Consensus 155 ~m~~v~~~L~~i~~~ 169 (485)
++.++.+.++.++..
T Consensus 287 s~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 287 LFPQILSSIELLQHS 301 (307)
T ss_dssp CHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHhcc
Confidence 999999988776553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-25 Score=218.06 Aligned_cols=154 Identities=21% Similarity=0.232 Sum_probs=99.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-----eeecccccCcccccccCCC------CCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-----FIDVMGTIGYVAPEYGMGS------EVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+||||+.++.+||+|||+|+....... ....+||+.|||||++.+. .++.++|||||||++||
T Consensus 131 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~E 210 (303)
T 3hmm_A 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHH
Confidence 999999999999999999999999987643321 2246899999999998654 36778999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhh--chhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSA--LPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|+||..|+............+.... .......+.+. ...+.........++...+.+++.+||+
T Consensus 211 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------~~rp~~p~~~~~~~~~~~l~~li~~cl~ 276 (303)
T 3hmm_A 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ--------------KLRPNIPNRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS--------------CCCCCCCGGGGSSHHHHHHHHHHHTTCC
T ss_pred HHHCCCCCCccccccccchhcccccchHHHHHHHHhcc--------------cCCCCCCccccchHHHHHHHHHHHHHcc
Confidence 9999887654322111111110000 00000000000 0000011111112334456789999999
Q ss_pred cCCCcccccchhhHHHHHHhh
Q 041230 148 ELPDERMDINDVESRLRSIKM 168 (485)
Q Consensus 148 ~~p~~RP~m~~v~~~L~~i~~ 168 (485)
.+|.+||++.++.+.|+++..
T Consensus 277 ~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 277 ANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred cCHhHCcCHHHHHHHHHHHHH
Confidence 999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.3e-25 Score=216.56 Aligned_cols=133 Identities=27% Similarity=0.459 Sum_probs=99.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+||||+.++.+||+|||+++...... .....+||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 168 HRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 168 HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp CSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654322 2335689999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.. ..+++... ..... ......| ...+.+++.+||+.+|.+||+|
T Consensus 248 f~~~~-----~~~~~~~i--------~~~~~-----------~~~p~~~---------~~~~~~li~~C~~~dP~~RPs~ 294 (308)
T 4gt4_A 248 YCGYS-----NQDVVEMI--------RNRQV-----------LPCPDDC---------PAWVYALMIECWNEFPSRRPRF 294 (308)
T ss_dssp TTTCC-----HHHHHHHH--------HTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCC-----HHHHHHHH--------HcCCC-----------CCCcccc---------hHHHHHHHHHHcCCChhHCcCH
Confidence 86532 11111110 00000 0001111 1235678899999999999999
Q ss_pred chhhHHHHHH
Q 041230 157 NDVESRLRSI 166 (485)
Q Consensus 157 ~~v~~~L~~i 166 (485)
.+|.+.|++.
T Consensus 295 ~ei~~~L~a~ 304 (308)
T 4gt4_A 295 KDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHHHhc
Confidence 9999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-24 Score=213.27 Aligned_cols=135 Identities=23% Similarity=0.413 Sum_probs=100.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+||||+.++.+||+|||+|+........ ...+||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 151 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 151 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999865433221 23579999999999999999999999999999999999 8999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.. ..+++... .... .......| ...+.+++..||+.+|++||++
T Consensus 231 f~~~~-----~~~~~~~i--------~~~~-----------~~~~p~~~---------~~~~~~li~~cl~~dP~~RPs~ 277 (299)
T 4asz_A 231 WYQLS-----NNEVIECI--------TQGR-----------VLQRPRTC---------PQEVYELMLGCWQREPHMRKNI 277 (299)
T ss_dssp TTTSC-----HHHHHHHH--------HHTC-----------CCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCC-----HHHHHHHH--------HcCC-----------CCCCCccc---------hHHHHHHHHHHcCCChhHCcCH
Confidence 96531 11111110 0000 00001111 1235678899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++..+|+++..
T Consensus 278 ~~i~~~L~~~~~ 289 (299)
T 4asz_A 278 KGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999887654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-24 Score=217.77 Aligned_cols=135 Identities=25% Similarity=0.376 Sum_probs=99.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+|+.+.... .....+||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999999765432 2234689999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+...+. . .. .......|. ..+.+++..||+.+|.+||++
T Consensus 288 f~~~~~~-----~~~~~~i~----~----g~----------~~~~p~~~~---------~~~~~li~~c~~~dP~~RPt~ 335 (353)
T 4ase_A 288 YPGVKID-----EEFCRRLK----E----GT----------RMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTF 335 (353)
T ss_dssp STTCCCS-----HHHHHHHH----H----TC----------CCCCCTTCC---------HHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH-----HHHHHHHH----c----CC----------CCCCCccCC---------HHHHHHHHHHcCcChhHCcCH
Confidence 9753211 11110000 0 00 000011111 124577889999999999999
Q ss_pred chhhHHHHHHh
Q 041230 157 NDVESRLRSIK 167 (485)
Q Consensus 157 ~~v~~~L~~i~ 167 (485)
.++.+.|+.+.
T Consensus 336 ~eil~~L~~ll 346 (353)
T 4ase_A 336 SELVEHLGNLL 346 (353)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99998887754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-24 Score=210.97 Aligned_cols=135 Identities=25% Similarity=0.403 Sum_probs=94.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+||||+.++.+||+|||+++...... .....+||+.|||||++.+..++.++|||||||++|||+| |+.|
T Consensus 181 HRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp CSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC
Confidence 99999999999999999999999998664332 2234679999999999999999999999999999999999 8999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.. ..+++... .... .......| ...+.+++..||+.+|++||++
T Consensus 261 f~~~~-----~~~~~~~i--------~~g~-----------~~~~p~~~---------~~~~~~li~~cl~~dP~~RPs~ 307 (329)
T 4aoj_A 261 WYQLS-----NTEAIDCI--------TQGR-----------ELERPRAC---------PPEVYAIMRGCWQREPQQRHSI 307 (329)
T ss_dssp TCSSC-----HHHHHHHH--------HHTC-----------CCCCCTTC---------CHHHHHHHHHHCCSSTTTSCCH
T ss_pred CCCCC-----HHHHHHHH--------HcCC-----------CCCCcccc---------cHHHHHHHHHHcCcChhHCcCH
Confidence 86531 11111110 0000 00001111 1234578899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.|+.+..
T Consensus 308 ~ei~~~L~~l~~ 319 (329)
T 4aoj_A 308 KDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhh
Confidence 999999988654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-24 Score=207.45 Aligned_cols=77 Identities=34% Similarity=0.513 Sum_probs=67.6
Q ss_pred CCCCCCCcEEECC-CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDD-EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~-~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||||+. ++.+||+|||+|+.... ....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+
T Consensus 154 HRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ecccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999984 78999999999986433 33456799999999998864 699999999999999999999999964
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-23 Score=207.52 Aligned_cols=137 Identities=22% Similarity=0.277 Sum_probs=96.7
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCCCC------ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVET------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G 73 (485)
||||||+||||+.++ .+||+|||+|+.+.... .....+||+.|||||++.+..++.++|||||||++|||++|
T Consensus 173 HRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG 252 (336)
T 4g3f_A 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252 (336)
T ss_dssp CSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999987 59999999998764321 11246899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 74 LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 74 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
+.||.+..... .+..+..... ++ ......+. ..+.++...|++.+|.+|
T Consensus 253 ~~Pf~~~~~~~-~~~~i~~~~~----------~~-----------~~~~~~~s---------~~~~~li~~~L~~dP~~R 301 (336)
T 4g3f_A 253 CHPWTQYFRGP-LCLKIASEPP----------PI-----------REIPPSCA---------PLTAQAIQEGLRKEPVHR 301 (336)
T ss_dssp SCSSTTTCCSC-CHHHHHHSCC----------GG-----------GGSCTTSC---------HHHHHHHHHHTCSSGGGS
T ss_pred cCCCCCCCHHH-HHHHHHcCCC----------Cc-----------hhcCccCC---------HHHHHHHHHHccCCHhHC
Confidence 99997643321 1111111000 00 00000110 123456789999999999
Q ss_pred cccchhhHHHHHHhh
Q 041230 154 MDINDVESRLRSIKM 168 (485)
Q Consensus 154 P~m~~v~~~L~~i~~ 168 (485)
|++.++.+.+.....
T Consensus 302 ~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 302 ASAMELRRKVGKALQ 316 (336)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHh
Confidence 999998877665443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=220.51 Aligned_cols=139 Identities=19% Similarity=0.162 Sum_probs=106.2
Q ss_pred ecccCceEEEEeE-eeCCcEEEEEEeeccCC----------cchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCcee
Q 041230 203 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP----------GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 203 iG~G~fg~Vy~g~-~~~~~~vavK~~~~~~~----------~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.+.|++|.++... ..-|+.+|||++..... ...++|.+|+++|.++ .|+||+++++++.+ +..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CCE
Confidence 4566666665543 45689999999864321 1235699999999999 79999999998653 456
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.||||||++||+|.++|...+. ++. .+|+.||+.||.|+| +.+||||||||+||||++++.+||+
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~---------l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEE---------IDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCC---------CCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhCCC---------CCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEe
Confidence 8999999999999999986542 332 248999999999999 7899999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||+|+.....
T Consensus 382 DFGlAr~~~~~ 392 (569)
T 4azs_A 382 DFGSIVTTPQD 392 (569)
T ss_dssp CCTTEESCC--
T ss_pred ecccCeeCCCC
Confidence 99999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=206.99 Aligned_cols=79 Identities=28% Similarity=0.438 Sum_probs=72.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||||+.++.+||+|||+|+.+... ....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 193 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999976543 334568999999999999989999999999999999999999999964
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=194.67 Aligned_cols=139 Identities=17% Similarity=0.140 Sum_probs=109.9
Q ss_pred hccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc------------------chHHHHHHHHHHHhcCCCcce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------------------GARSFKSECKAAINIRHRNIV 254 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~------------------~~~~f~~E~~~l~~l~H~niv 254 (485)
....|+..+.||+|+||.||+|...+|+.||||.++..... ....|.+|+.++.+++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34456667899999999999999867899999998642211 2346889999999999 4 5
Q ss_pred eEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 041230 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334 (485)
Q Consensus 255 ~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdl 334 (485)
++.+++.. ...++||||+++|+|.+ +... ....|+.+++.||.||| ..+|+||||
T Consensus 165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~---------------~~~~i~~qi~~~l~~lH---~~giiHrDl 219 (282)
T 1zar_A 165 AVPKVYAW------EGNAVLMELIDAKELYR-VRVE---------------NPDEVLDMILEEVAKFY---HRGIVHGDL 219 (282)
T ss_dssp SSCCEEEE------ETTEEEEECCCCEEGGG-CCCS---------------CHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred CcCeEEec------cceEEEEEecCCCcHHH-cchh---------------hHHHHHHHHHHHHHHHH---HCCCEeCCC
Confidence 66554321 34589999999999988 5321 12359999999999999 678999999
Q ss_pred CCCceEecCCCcEEEeecccccccCC
Q 041230 335 KPSNVLLDDEMIGHVGDFSMARFLPD 360 (485)
Q Consensus 335 K~~NILld~~~~~ki~DFGla~~~~~ 360 (485)
||+|||++ ++.+||+|||+|+....
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEETTS
T ss_pred CHHHEEEE-CCcEEEEECCCCeECCC
Confidence 99999999 99999999999986543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.8e-23 Score=197.25 Aligned_cols=79 Identities=30% Similarity=0.516 Sum_probs=60.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+.........+.+||+.|||||.+.+..+ +.++||||+||++|||++|+.||.+
T Consensus 135 HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999987665555556899999999999988876 5789999999999999999999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-23 Score=207.49 Aligned_cols=128 Identities=27% Similarity=0.389 Sum_probs=94.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||||+.++.+||+|||+|+.+.... ...+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 148 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp ETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999998764332 23457899999999999999999999999999999999999999965
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
. +...++... +...+ .... ...+ ..+.++...|++.+|.+||+..++
T Consensus 228 ~-----~~~~~~~~i--------~~~~~-----------~~~~---~~~s------~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 228 G-----SMKNLVLKI--------ISGSF-----------PPVS---LHYS------YDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp S-----SHHHHHHHH--------HHTCC-----------CCCC---TTSC------HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred c-----CHHHHHHHH--------HcCCC-----------CCCC---ccCC------HHHHHHHHHHccCChhHCcCHHHH
Confidence 3 222221111 10000 0000 0000 123467789999999999999887
Q ss_pred hH
Q 041230 160 ES 161 (485)
Q Consensus 160 ~~ 161 (485)
.+
T Consensus 275 l~ 276 (350)
T 4b9d_A 275 LE 276 (350)
T ss_dssp HT
T ss_pred hc
Confidence 53
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=199.25 Aligned_cols=79 Identities=32% Similarity=0.616 Sum_probs=71.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC---CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+||||+.++.+||+|||+|+.+... ....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||
T Consensus 155 HRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 234 (311)
T 4aw0_A 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234 (311)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999976432 2345679999999999999889999999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 235 ~~ 236 (311)
T 4aw0_A 235 RA 236 (311)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-22 Score=206.53 Aligned_cols=79 Identities=28% Similarity=0.438 Sum_probs=72.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||||+.++.+||+|||+|+.+... ....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 270 HRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp CCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999876543 334568999999999999999999999999999999999999999964
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.5e-22 Score=209.47 Aligned_cols=134 Identities=16% Similarity=0.200 Sum_probs=103.3
Q ss_pred cceeecccCceEEEEeEeeCCcEEEEEEeeccCCc--------chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 199 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--------GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 199 ~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..++||+|+||+||+|. ..+..+++|+....... ..+.|.+|++++.+++|||||++..++... ..
T Consensus 340 ~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~ 413 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----DN 413 (540)
T ss_dssp --------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----TT
T ss_pred CCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----Cc
Confidence 45789999999999995 56788999986432211 124589999999999999999665554421 23
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++.. +..|+.|++.||.||| +.+|+||||||+|||++. .+||+
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEEC
T ss_pred cEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEE
Confidence 5899999999999999874 2458999999999999 678999999999999999 99999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+++....
T Consensus 472 DFGla~~~~~ 481 (540)
T 3en9_A 472 DFGLGKISNL 481 (540)
T ss_dssp CCTTCEECCC
T ss_pred ECccCEECCC
Confidence 9999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-22 Score=197.62 Aligned_cols=79 Identities=38% Similarity=0.580 Sum_probs=69.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+.... .....+.+||+.|||||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 149 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~ 228 (304)
T 3ubd_A 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228 (304)
T ss_dssp CSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999986543 2334567999999999999999999999999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=191.50 Aligned_cols=75 Identities=33% Similarity=0.603 Sum_probs=59.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-------------ceeecccccCcccccccCCCCCCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-------------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 67 (485)
||||||+||||+.++.+||+|||+|+.+.... ...+.+||+.|||||.+.+..|+.++|||||||++
T Consensus 141 HRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 220 (299)
T 4g31_A 141 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220 (299)
T ss_dssp CCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHH
Confidence 99999999999999999999999998764321 11346899999999999999999999999999999
Q ss_pred HHHHhCCCCCC
Q 041230 68 LEMFTGLRPNN 78 (485)
Q Consensus 68 ~el~~G~~p~~ 78 (485)
|||++ ||.
T Consensus 221 yell~---Pf~ 228 (299)
T 4g31_A 221 FELLY---PFS 228 (299)
T ss_dssp HHHHS---CCS
T ss_pred HHHcc---CCC
Confidence 99996 664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=174.02 Aligned_cols=138 Identities=19% Similarity=0.198 Sum_probs=103.4
Q ss_pred cccceeecccCceEEEEeEe-eCCcE--EEEEEeeccCCcc------------------------hHHHHHHHHHHHhcC
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTT--IAVKVFNLIRPGG------------------------ARSFKSECKAAINIR 249 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~--vavK~~~~~~~~~------------------------~~~f~~E~~~l~~l~ 249 (485)
|...+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999987 78999 9999875321110 125788999999998
Q ss_pred CCcc--eeEeeeecccccCCceeeEEEEEecC-CC----CHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhh
Q 041230 250 HRNI--VRVFTAVSGVDYQGARFKAVVYKFMP-NG----SLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLH 322 (485)
Q Consensus 250 H~ni--v~l~~~~~~~~~~~~~~~~lV~ey~~-~G----sL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH 322 (485)
|+|+ ..++.+ ...+|||||+. +| +|.+++.. ..+.....++.+++.||.|||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHH
Confidence 8865 333322 23589999995 25 66665432 112345679999999999999
Q ss_pred cCCCCCeeeeccCCCceEecCCCcEEEeecccccccC
Q 041230 323 CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 323 ~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~ 359 (485)
. ..+|+||||||+|||+++ .++|+|||+|....
T Consensus 188 ~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 188 Q--EAELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp H--TSCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred H--HCCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 3 357999999999999998 99999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.5e-20 Score=181.22 Aligned_cols=144 Identities=21% Similarity=0.307 Sum_probs=98.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce-----eecccccCcccccccCCC------CCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF-----IDVMGTIGYVAPEYGMGS------EVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||++.++.+||+|||+++........ ....||+.|+|||...+. .++.++|||||||++||
T Consensus 136 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~e 215 (301)
T 3q4u_A 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215 (301)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999865433221 234799999999998766 44578999999999999
Q ss_pred HHhC----------CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHH
Q 041230 70 MFTG----------LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISIC 139 (485)
Q Consensus 70 l~~G----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (485)
|++| +.||.................... ..................+.
T Consensus 216 l~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~l~ 273 (301)
T 3q4u_A 216 VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVD----------------------QQRPNIPNRWFSDPTLTSLA 273 (301)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS----------------------CCCCCCCGGGGGSHHHHHHH
T ss_pred HHhhhcCccccccccccccccCCCCcchhhhhHHHhcc----------------------CCCCCCChhhccCccHHHHH
Confidence 9999 667654433322222111100000 00000000001112233466
Q ss_pred HHHHhhhccCCCcccccchhhHHHHHH
Q 041230 140 RIGVACSAELPDERMDINDVESRLRSI 166 (485)
Q Consensus 140 ~l~~~C~~~~p~~RP~m~~v~~~L~~i 166 (485)
++...|++.+|.+||++.++.+.|+++
T Consensus 274 ~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 274 KLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 889999999999999999999998765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-20 Score=186.49 Aligned_cols=79 Identities=29% Similarity=0.410 Sum_probs=65.3
Q ss_pred CCCCCCCcEEECCC-CcEEEEeccCccccCCCC-----------------------------ceeecccccCcccccccC
Q 041230 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVET-----------------------------SFIDVMGTIGYVAPEYGM 50 (485)
Q Consensus 1 HrDlk~~NiLl~~~-~~~kl~dfG~a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~ 50 (485)
||||||+|||++.+ +.+||+|||+|+...... ...+.+||+.|+|||++.
T Consensus 140 HRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 219 (361)
T 4f9c_A 140 HRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT 219 (361)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred eCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 99999999999877 799999999997543211 122457999999999987
Q ss_pred CC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 51 GS-EVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 51 ~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
+. .++.++||||+||++|||++|+.||..
T Consensus 220 ~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 220 KCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 65 478899999999999999999999854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.2e-20 Score=186.23 Aligned_cols=80 Identities=31% Similarity=0.443 Sum_probs=68.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-----CceeecccccCcccccccCCCC-CCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-----TSFIDVMGTIGYVAPEYGMGSE-VSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+|+.+... ....+.+||+.|||||++.+.. ++.++||||+||++|||++|+
T Consensus 181 HRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~ 260 (398)
T 4b99_A 181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260 (398)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred CCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence 9999999999999999999999999876432 2234579999999999987754 588999999999999999999
Q ss_pred CCCCCC
Q 041230 75 RPNNGM 80 (485)
Q Consensus 75 ~p~~~~ 80 (485)
.||.+.
T Consensus 261 ~pF~g~ 266 (398)
T 4b99_A 261 QLFPGK 266 (398)
T ss_dssp CSSCCS
T ss_pred CCCCCC
Confidence 999763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.1e-20 Score=196.85 Aligned_cols=120 Identities=27% Similarity=0.442 Sum_probs=91.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||||+.++++||+|||+|+.+.... ..+.+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.+
T Consensus 315 HRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred ccCCchHHeEEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998765432 345799999999999864 5789999999999999999999999965
Q ss_pred CCCCC------------C--------ChhHHHhhhch-----------hhHHhhhchhhhhhhHHHHHHHhhh
Q 041230 80 MFKDD------------L--------NLPNLVKSALP-----------ARAEQILDVAFFQEIEEEETLYKKA 121 (485)
Q Consensus 80 ~~~~~------------~--------~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (485)
..... . .+.+++...+. ..++++..++|++.++|.....++.
T Consensus 394 ~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~ 466 (689)
T 3v5w_A 394 HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY 466 (689)
T ss_dssp GGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCS
T ss_pred CChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCC
Confidence 21110 0 11233333321 1357888888998888876655443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=180.20 Aligned_cols=158 Identities=23% Similarity=0.329 Sum_probs=102.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCC-----CCCCCccchhhHHHHHHHHHh
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMG-----SEVSSYGDVYSFGILLLEMFT 72 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~~ 72 (485)
||||||+|||++.++.+||+|||+++....... ....+||+.|+|||.+.+ ..++.++|||||||++|||++
T Consensus 154 H~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t 233 (322)
T 3soc_A 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh
Confidence 999999999999999999999999986543322 223579999999999876 345668899999999999999
Q ss_pred CCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCc
Q 041230 73 GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDE 152 (485)
Q Consensus 73 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~ 152 (485)
|+.||.+...... .+.............+.+. ..................+...+.++...|++.+|.+
T Consensus 234 g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (322)
T 3soc_A 234 RCTAADGPVDEYM-LPFEEEIGQHPSLEDMQEV----------VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302 (322)
T ss_dssp TBTTSSSCCCCCC-CTTHHHHCSSCCHHHHHHH----------HTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCcchhc-cchhhhhccCCchhhhhhh----------hhcccCCCCccccccccchHHHHHHHHHHHccCChhh
Confidence 9999976433211 1110000000000000000 0000000000000111122334678899999999999
Q ss_pred ccccchhhHHHHHHhhh
Q 041230 153 RMDINDVESRLRSIKMK 169 (485)
Q Consensus 153 RP~m~~v~~~L~~i~~~ 169 (485)
||++.++.+.|+.+...
T Consensus 303 Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 303 RLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHH
Confidence 99999999999887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.7e-20 Score=184.12 Aligned_cols=146 Identities=21% Similarity=0.188 Sum_probs=100.5
Q ss_pred CCCCCCCcEEEC--CCCcEEEEeccCccccCCCC--------ceeecccccCcccccccCCCCCCCccchhhHHHHHHHH
Q 041230 1 HCDLKPSNVFLD--DEMTAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEM 70 (485)
Q Consensus 1 HrDlk~~NiLl~--~~~~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el 70 (485)
||||||+|||++ .++.+||+|||+++.+.... .....+||+.|+|||...+..++.++|||||||++|||
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999 88999999999998654221 11235699999999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCC
Q 041230 71 FTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELP 150 (485)
Q Consensus 71 ~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p 150 (485)
++|+.||.+..... ................+++. |.... .+...+..+...|++.+|
T Consensus 255 ~~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~-------------------~~~~~---~~~~~~~~li~~cl~~~p 311 (364)
T 3op5_A 255 LTGHLPWEDNLKDP-KYVRDSKIRYRENIASLMDK-------------------CFPAA---NAPGEIAKYMETVKLLDY 311 (364)
T ss_dssp HHSCCTTGGGTTCH-HHHHHHHHHHHHCHHHHHHH-------------------HSCTT---CCCHHHHHHHHHHHTCCT
T ss_pred HhCCCCccccccCH-HHHHHHHHHhhhhHHHHHHH-------------------hcccc---cCHHHHHHHHHHHhcCCC
Confidence 99999997432110 00000010011111111110 10000 001234577889999999
Q ss_pred CcccccchhhHHHHHHhhh
Q 041230 151 DERMDINDVESRLRSIKMK 169 (485)
Q Consensus 151 ~~RP~m~~v~~~L~~i~~~ 169 (485)
.+||++.++.+.++.+...
T Consensus 312 ~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 312 TEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp TCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHH
Confidence 9999999999998876554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=176.30 Aligned_cols=139 Identities=27% Similarity=0.454 Sum_probs=100.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---------------eecccccCcccccccCCCCCCCccchhhHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---------------IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGI 65 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv 65 (485)
||||||+|||++.++.+||+|||+++........ ...+||+.|+|||.+.+..++.++||||||+
T Consensus 131 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 210 (310)
T 3s95_A 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI 210 (310)
T ss_dssp CSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred CCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence 9999999999999999999999999865432211 1457999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhh
Q 041230 66 LLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVAC 145 (485)
Q Consensus 66 ~l~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 145 (485)
++|||++|..|+............. .....+ ......+. ..+..+...|
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~~~~~--------~~~~~~--------------~~~~~~~~---------~~l~~li~~~ 259 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMDFGLN--------VRGFLD--------------RYCPPNCP---------PSFFPITVRC 259 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTTSSBC--------HHHHHH--------------HTCCTTCC---------TTHHHHHHHH
T ss_pred HHHHHhcCCCCCcchhhhHHHHhhh--------hhcccc--------------ccCCCCCC---------HHHHHHHHHH
Confidence 9999999999876533222111100 000000 00011111 1245678899
Q ss_pred hccCCCcccccchhhHHHHHHhhhh
Q 041230 146 SAELPDERMDINDVESRLRSIKMKL 170 (485)
Q Consensus 146 ~~~~p~~RP~m~~v~~~L~~i~~~~ 170 (485)
++.+|++||++.++.+.++.+....
T Consensus 260 l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 260 CDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999998887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-19 Score=191.45 Aligned_cols=79 Identities=35% Similarity=0.596 Sum_probs=72.8
Q ss_pred CCCCCCCcEEECCC--CcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDE--MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~--~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.+ +.+||+|||+|+.+.........+||+.|||||++.+..|+.++||||+||++|||++|+.||.
T Consensus 278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred eccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999854 8899999999998876666677899999999999999999999999999999999999999997
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 358 ~ 358 (573)
T 3uto_A 358 G 358 (573)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=6.7e-19 Score=174.93 Aligned_cols=147 Identities=25% Similarity=0.350 Sum_probs=97.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-----eeecccccCcccccccCCCCCCCc------cchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-----FIDVMGTIGYVAPEYGMGSEVSSY------GDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gv~l~e 69 (485)
||||||+|||++.++.+||+|||+++....... ....+||+.|+|||.+.+...+.. +|||||||++||
T Consensus 165 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e 244 (337)
T 3mdy_A 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244 (337)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHH
T ss_pred ecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHH
Confidence 999999999999999999999999976543221 124579999999999877666554 899999999999
Q ss_pred HHhCCC----------CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHH
Q 041230 70 MFTGLR----------PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISIC 139 (485)
Q Consensus 70 l~~G~~----------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (485)
|++|.. |+............... ... ................+...+.
T Consensus 245 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---------~~~-------------~~~~~~~~~~~~~~~~~~~~l~ 302 (337)
T 3mdy_A 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE---------IVC-------------IKKLRPSFPNRWSSDECLRQMG 302 (337)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH---------HHT-------------TSCCCCCCCGGGGGSHHHHHHH
T ss_pred HHhccCcccccccccccHhhhcCCCCchhhhHH---------HHh-------------hhccCccccccchhhHHHHHHH
Confidence 999944 44332221111111100 000 0000000000001112344567
Q ss_pred HHHHhhhccCCCcccccchhhHHHHHHhhh
Q 041230 140 RIGVACSAELPDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 140 ~l~~~C~~~~p~~RP~m~~v~~~L~~i~~~ 169 (485)
++...|++.+|.+||++.++.+.|+.+...
T Consensus 303 ~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 303 KLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 889999999999999999999999887653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-19 Score=176.56 Aligned_cols=140 Identities=24% Similarity=0.304 Sum_probs=90.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+
T Consensus 162 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp CTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998644322 23346799999999999988899999999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ........ .. .......... .-..+.++...|++.+|.+||++.++
T Consensus 242 ~~-----~~~~~~~~-----~~----------------~~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~~l 289 (309)
T 3p86_A 242 LN-----PAQVVAAV-----GF----------------KCKRLEIPRN------LNPQVAAIIEGCWTNEPWKRPSFATI 289 (309)
T ss_dssp SC-----HHHHHHHH-----HH----------------SCCCCCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CC-----HHHHHHHH-----Hh----------------cCCCCCCCcc------CCHHHHHHHHHHccCChhhCcCHHHH
Confidence 21 11110000 00 0000000000 01124567889999999999999999
Q ss_pred hHHHHHHhhhhcc
Q 041230 160 ESRLRSIKMKLLK 172 (485)
Q Consensus 160 ~~~L~~i~~~~~~ 172 (485)
.+.++.+.....+
T Consensus 290 l~~L~~~~~~~~p 302 (309)
T 3p86_A 290 MDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHHHC----
T ss_pred HHHHHHHHHhCCC
Confidence 9999887665443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=170.52 Aligned_cols=144 Identities=15% Similarity=0.197 Sum_probs=101.0
Q ss_pred CCCCCCCcEEECCCCc-----EEEEeccCccccCCCCc--------eeecccccCcccccccCCCCCCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDDEMT-----AHLGDFGIARFLPVETS--------FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~-----~kl~dfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 67 (485)
||||||+|||++.++. +||+|||+++....... .....||+.|+|||...+..++.++||||||+++
T Consensus 129 H~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (298)
T 1csn_A 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 208 (298)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHH
Confidence 9999999999987776 99999999986643221 2346799999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 68 LEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 68 ~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|||++|+.||.+.... ......... ......... ......+ ...+..+...|++
T Consensus 209 ~el~~g~~pf~~~~~~--~~~~~~~~~--------~~~~~~~~~-------~~~~~~~---------~~~l~~li~~~l~ 262 (298)
T 1csn_A 209 MYFLRGSLPWQGLKAA--TNKQKYERI--------GEKKQSTPL-------RELCAGF---------PEEFYKYMHYARN 262 (298)
T ss_dssp HHHHHSSCTTSSCCSC--CHHHHHHHH--------HHHHHHSCH-------HHHTTTS---------CHHHHHHHHHHHH
T ss_pred HHHHcCCCCcchhhcc--ccHHHHHHH--------HhhccCccH-------HHHHhhC---------cHHHHHHHHHHhc
Confidence 9999999999753211 111111100 000000000 0000000 1234578889999
Q ss_pred cCCCcccccchhhHHHHHHhhhh
Q 041230 148 ELPDERMDINDVESRLRSIKMKL 170 (485)
Q Consensus 148 ~~p~~RP~m~~v~~~L~~i~~~~ 170 (485)
.+|.+||++.++.+.++++....
T Consensus 263 ~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 263 LAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCcccCCCHHHHHHHHHHHHHhc
Confidence 99999999999999998876644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.9e-19 Score=173.72 Aligned_cols=149 Identities=28% Similarity=0.419 Sum_probs=103.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||||+++|||++|+.||
T Consensus 162 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~ 241 (321)
T 2qkw_B 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241 (321)
T ss_dssp CSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred cCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999998643221 223456999999999988888999999999999999999999998
Q ss_pred CCCCCCCC-ChhHHHhhhc-hhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 78 NGMFKDDL-NLPNLVKSAL-PARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 78 ~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
.+...... ....+..... ......+++..+. .....+....+..+...|++.+|++||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps 302 (321)
T 2qkw_B 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA-------------------DKIRPESLRKFGDTAVKCLALSSEDRPS 302 (321)
T ss_dssp SCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT-------------------TCSCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred cccCcHHHHHHHHHhhhccccccHHHhcChhhc-------------------cccCHHHHHHHHHHHHHHcCCCcccCcC
Confidence 76433221 1111111000 0000011111110 0011123445668889999999999999
Q ss_pred cchhhHHHHHHhh
Q 041230 156 INDVESRLRSIKM 168 (485)
Q Consensus 156 m~~v~~~L~~i~~ 168 (485)
+.++...++.+..
T Consensus 303 ~~ell~~L~~~l~ 315 (321)
T 2qkw_B 303 MGDVLWKLEYALR 315 (321)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhh
Confidence 9999998877643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-19 Score=176.75 Aligned_cols=146 Identities=33% Similarity=0.537 Sum_probs=102.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||||+++|+|++|+.||.
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999999999999999999999998764332 2334569999999999888888999999999999999999999985
Q ss_pred CC---CCCCCChhHHHhhhchh-hHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 79 GM---FKDDLNLPNLVKSALPA-RAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 79 ~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.. .........++...... ....+.+..+. ..........+.++...|++.+|.+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~Rp 297 (326)
T 3uim_A 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-------------------GNYKDEEVEQLIQVALLCTQSSPMERP 297 (326)
T ss_dssp HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT-------------------TSCCHHHHHHHHHHHHHHTCSCGGGSC
T ss_pred ccccccccchhHHHHHHHHhhchhhhhhcChhhc-------------------cccCHHHHHHHHHHHHHHhCcCCccCC
Confidence 31 11112222332222211 01111111110 011122334567889999999999999
Q ss_pred ccchhhHHHHH
Q 041230 155 DINDVESRLRS 165 (485)
Q Consensus 155 ~m~~v~~~L~~ 165 (485)
++.++.+.|+.
T Consensus 298 s~~ell~~L~~ 308 (326)
T 3uim_A 298 KMSEVVRMLEG 308 (326)
T ss_dssp CHHHHHHHHHT
T ss_pred CHHHHHHHhcC
Confidence 99999998865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=168.63 Aligned_cols=145 Identities=20% Similarity=0.225 Sum_probs=101.6
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCc--------eeecccccCcccccccCCCCCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETS--------FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||...+..++.++|||||||++||
T Consensus 128 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred eCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHH
Confidence 99999999999 4788999999999986643321 234679999999999998889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccC
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAEL 149 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 149 (485)
|++|+.||.+....... ..... +....+.... . .....+ ...+..+...|++.+
T Consensus 208 l~~g~~pf~~~~~~~~~--~~~~~--------~~~~~~~~~~---~----~~~~~~---------~~~l~~li~~~l~~d 261 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKR--QKYER--------ISEKKMSTPI---E----VLCKGY---------PSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHSSCTTSSCCCSSSS--SHHHH--------HHHHHHHSCH---H----HHTTTS---------CHHHHHHHHHHHTSC
T ss_pred HHhCCCCCCCcCchhhh--hhhhh--------hcccccCCch---H----HHHhhC---------CHHHHHHHHHHHhcC
Confidence 99999999754321110 00000 0000000000 0 000000 112457788999999
Q ss_pred CCcccccchhhHHHHHHhhhhc
Q 041230 150 PDERMDINDVESRLRSIKMKLL 171 (485)
Q Consensus 150 p~~RP~m~~v~~~L~~i~~~~~ 171 (485)
|.+||++.++.+.++.+.....
T Consensus 262 p~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 262 FDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp TTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCcCCCHHHHHHHHHHHHHhcC
Confidence 9999999999999988766543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=168.34 Aligned_cols=144 Identities=20% Similarity=0.237 Sum_probs=101.6
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCc--------eeecccccCcccccccCCCCCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETS--------FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||...+..++.++|||||||++|+
T Consensus 128 H~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp CSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHH
Confidence 99999999999 7889999999999986543321 224679999999999998889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccC
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAEL 149 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 149 (485)
|++|+.||.+....... ..... +....+.... . .....+ ...+..+...|++.+
T Consensus 208 l~~g~~pf~~~~~~~~~--~~~~~--------~~~~~~~~~~---~----~~~~~~---------~~~l~~li~~~l~~~ 261 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKR--QKYER--------ISEKKMSTPI---E----VLCKGY---------PSEFATYLNFCRSLR 261 (296)
T ss_dssp HHHSSCTTSSCCCSSSS--SHHHH--------HHHHHHHSCH---H----HHTTTS---------CHHHHHHHHHHHTSC
T ss_pred HhcCCCCCcccchhhhh--hhhhh--------hhcccccchh---h----hhhccC---------CHHHHHHHHHHHhcC
Confidence 99999999764322111 11100 0000000000 0 000000 113457788999999
Q ss_pred CCcccccchhhHHHHHHhhhh
Q 041230 150 PDERMDINDVESRLRSIKMKL 170 (485)
Q Consensus 150 p~~RP~m~~v~~~L~~i~~~~ 170 (485)
|++||++.++.+.++++....
T Consensus 262 p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 262 FDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp TTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHh
Confidence 999999999999998876654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9e-19 Score=174.51 Aligned_cols=147 Identities=21% Similarity=0.270 Sum_probs=99.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-----eeecccccCcccccccCCC------CCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-----FIDVMGTIGYVAPEYGMGS------EVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||++.++.+||+|||++........ .....||+.|+|||...+. .++.++||||||+++||
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 249 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHH
Confidence 999999999999999999999999986543321 2345799999999998765 23367999999999999
Q ss_pred HHhC----------CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHH
Q 041230 70 MFTG----------LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISIC 139 (485)
Q Consensus 70 l~~G----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (485)
|++| ..||............+..... ... ............++...+.
T Consensus 250 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--------~~~--------------~~~~~~~~~~~~~~~~~l~ 307 (342)
T 1b6c_B 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC--------EQK--------------LRPNIPNRWQSCEALRVMA 307 (342)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT--------TSC--------------CCCCCCGGGGTSHHHHHHH
T ss_pred HHhccCcCCcccccccCccccCcCcccHHHHHHHHH--------HHH--------------hCCCCcccccchhHHHHHH
Confidence 9999 5565443222222211111100 000 0000000001112334567
Q ss_pred HHHHhhhccCCCcccccchhhHHHHHHhhh
Q 041230 140 RIGVACSAELPDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 140 ~l~~~C~~~~p~~RP~m~~v~~~L~~i~~~ 169 (485)
++...|++.+|.+||++.++.+.++.+...
T Consensus 308 ~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 308 KIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 889999999999999999999999887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=172.07 Aligned_cols=142 Identities=18% Similarity=0.193 Sum_probs=100.8
Q ss_pred CCCCCCCcEEECCCCc-----EEEEeccCccccCCCCc--------eeecccccCcccccccCCCCCCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDDEMT-----AHLGDFGIARFLPVETS--------FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~-----~kl~dfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 67 (485)
||||||+|||++.++. +||+|||+++.+..... ....+||+.|+|||...+..++.++|||||||++
T Consensus 128 HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 207 (330)
T 2izr_A 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMF 207 (330)
T ss_dssp CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHH
Confidence 9999999999999887 99999999986543221 2356899999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 68 LEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 68 ~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|||++|+.||.+.... .....+.... ..... ......+... . .+..+...|++
T Consensus 208 ~ell~g~~Pf~~~~~~--~~~~~~~~i~--------~~~~~----------~~~~~~~~~~------p-~~~~li~~~l~ 260 (330)
T 2izr_A 208 MYFLRGSLPWQGLKAD--TLKERYQKIG--------DTKRA----------TPIEVLCENF------P-EMATYLRYVRR 260 (330)
T ss_dssp HHHHHSSCTTTTCCCS--SHHHHHHHHH--------HHHHH----------SCHHHHTTTC------H-HHHHHHHHHHH
T ss_pred HHHhcCCCCccccccc--cHHHHHHHHH--------hhhcc----------CCHHHHhccC------h-HHHHHHHHHHh
Confidence 9999999999764211 1111111110 00000 0000000000 1 35677889999
Q ss_pred cCCCcccccchhhHHHHHHhhh
Q 041230 148 ELPDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 148 ~~p~~RP~m~~v~~~L~~i~~~ 169 (485)
.+|..||++.++.+.++.+...
T Consensus 261 ~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 261 LDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHHHH
Confidence 9999999999999988876554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.9e-19 Score=176.11 Aligned_cols=157 Identities=21% Similarity=0.307 Sum_probs=98.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---------ceeecccccCcccccccCC-------CCCCCccchhhHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---------SFIDVMGTIGYVAPEYGMG-------SEVSSYGDVYSFG 64 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G 64 (485)
||||||+|||++.++.+||+|||+++.+.... .....+||+.|+|||.+.+ ..++.++||||||
T Consensus 143 H~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 222 (336)
T 3g2f_A 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222 (336)
T ss_dssp CSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred ecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence 99999999999999999999999998654321 1224579999999999876 3456789999999
Q ss_pred HHHHHHHhCCCCCCCCCC-CCCChhHHHhhhchhhHHhhhchhhhhhhHHHHH---HHhhhhccccchhhHHHHHHHHHH
Q 041230 65 ILLLEMFTGLRPNNGMFK-DDLNLPNLVKSALPARAEQILDVAFFQEIEEEET---LYKKASSTCTQSSIILECLISICR 140 (485)
Q Consensus 65 v~l~el~~G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 140 (485)
|++|||++|..|+..... ...... +.. ................ ........+.... .....+.+
T Consensus 223 ~il~ell~g~~p~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~ 290 (336)
T 3g2f_A 223 LIYWEIFMRCTDLFPGESVPEYQMA-FQT--------EVGNHPTFEDMQVLVSREKQRPKFPEAWKENS---LAVRSLKE 290 (336)
T ss_dssp HHHHHHHTTBGGGSTTSCCCCCCCT-THH--------HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCS---HHHHHHHH
T ss_pred HHHHHHHhcCCcCCCccchhHHHHh-hhc--------ccCCCchHHHHHhhhcccccCCCCCccccccc---chHHHHHH
Confidence 999999999776533211 111100 000 0000000000000000 0000000011111 12234668
Q ss_pred HHHhhhccCCCcccccchhhHHHHHHhhh
Q 041230 141 IGVACSAELPDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 141 l~~~C~~~~p~~RP~m~~v~~~L~~i~~~ 169 (485)
+...|++.+|.+||++.++.+.|+.+...
T Consensus 291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 291 TIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 88999999999999999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-18 Score=171.09 Aligned_cols=79 Identities=29% Similarity=0.448 Sum_probs=70.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++....... .....+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 139 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998665332 33456899999999999888999999999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-19 Score=176.78 Aligned_cols=144 Identities=22% Similarity=0.268 Sum_probs=97.3
Q ss_pred CCCCCCCcEEECCCC--cEEEEeccCccccCCCC--------ceeecccccCcccccccCCCCCCCccchhhHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEM--TAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEM 70 (485)
Q Consensus 1 HrDlk~~NiLl~~~~--~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el 70 (485)
||||||+|||++.++ .+||+|||+++.+.... ......||+.|+|||...+..++.++|||||||++|||
T Consensus 174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999887 99999999998653221 11345799999999999888899999999999999999
Q ss_pred HhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCC
Q 041230 71 FTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELP 150 (485)
Q Consensus 71 ~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p 150 (485)
++|+.||.+..... ........ . +...+... ... +.... .....+..+...|++.+|
T Consensus 254 l~g~~pf~~~~~~~----~~~~~~~~-~--------~~~~~~~~--~~~-----~~~~~---~~~~~l~~li~~~l~~dp 310 (345)
T 2v62_A 254 LCGKLPWEQNLKDP----VAVQTAKT-N--------LLDELPQS--VLK-----WAPSG---SSCCEIAQFLVCAHSLAY 310 (345)
T ss_dssp HHSSCTTGGGTTCH----HHHHHHHH-H--------HHHTTTHH--HHH-----HSCTT---SCCHHHHHHHHHHHTCCT
T ss_pred HhCCCCcccccccc----HHHHHHHH-h--------hcccccHH--HHh-----hcccc---ccHHHHHHHHHHHhhcCc
Confidence 99999985421111 00000000 0 00000000 000 00000 001135577889999999
Q ss_pred CcccccchhhHHHHHHh
Q 041230 151 DERMDINDVESRLRSIK 167 (485)
Q Consensus 151 ~~RP~m~~v~~~L~~i~ 167 (485)
.+||++.++.+.++...
T Consensus 311 ~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 311 DEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCCCCHHHHHHHHCTTC
T ss_pred ccCCCHHHHHHHHhccC
Confidence 99999999999887643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-18 Score=170.59 Aligned_cols=77 Identities=32% Similarity=0.492 Sum_probs=64.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|||++|..|+.
T Consensus 180 H~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp CCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred cCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987654444445679999999998875 68999999999999999999977653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-18 Score=171.61 Aligned_cols=135 Identities=23% Similarity=0.426 Sum_probs=96.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 138 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 99999999999999999999999998764332 2234568889999999988889999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... .....+.... .. .....+. ..+..+...|++.+|..||++
T Consensus 218 ~~~~~~~--~~~~~~~~~~--------~~--------------~~~~~~~---------~~~~~li~~~l~~dp~~Rps~ 264 (325)
T 3kex_A 218 YAGLRLA--EVPDLLEKGE--------RL--------------AQPQICT---------IDVYMVMVKCWMIDENIRPTF 264 (325)
T ss_dssp TTTSCTT--HHHHHHHTTC--------BC--------------CCCTTBC---------TTTTHHHHHHTCSCTTTSCCH
T ss_pred ccccCHH--HHHHHHHcCC--------CC--------------CCCCcCc---------HHHHHHHHHHcCCChhhCcCH
Confidence 8653211 1111110000 00 0000010 113457789999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...++.+..
T Consensus 265 ~el~~~l~~~~~ 276 (325)
T 3kex_A 265 KELANEFTRMAR 276 (325)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHHh
Confidence 999998877644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=171.20 Aligned_cols=80 Identities=34% Similarity=0.541 Sum_probs=71.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++............+||+.|+|||.+.+..+ +.++||||+||++|+|++|+.||.+
T Consensus 131 H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp CCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred ecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999987665544556789999999999887776 6789999999999999999999975
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 211 ~ 211 (336)
T 3h4j_B 211 E 211 (336)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.2e-18 Score=176.23 Aligned_cols=80 Identities=31% Similarity=0.367 Sum_probs=66.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 187 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998765544455678999999999999989999999999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.72 E-value=9.8e-19 Score=173.75 Aligned_cols=135 Identities=22% Similarity=0.374 Sum_probs=97.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++|||||||++|||++ |+.|
T Consensus 140 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 999999999999999999999999987643322 223457889999999988889999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... .+...+.... .. .....+ ...+..+...|++.+|.+||++
T Consensus 220 ~~~~~~~--~~~~~~~~~~--------~~--------------~~~~~~---------~~~~~~li~~~l~~~p~~Rps~ 266 (327)
T 3poz_A 220 YDGIPAS--EISSILEKGE--------RL--------------PQPPIC---------TIDVYMIMVKCWMIDADSRPKF 266 (327)
T ss_dssp TTTCCGG--GHHHHHHTTC--------CC--------------CCCTTB---------CHHHHHHHHHHTCSCGGGSCCH
T ss_pred ccCCCHH--HHHHHHHcCC--------CC--------------CCCccC---------CHHHHHHHHHHcCCChhhCCCH
Confidence 8653211 1111110000 00 000001 1134578889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...++.+..
T Consensus 267 ~ell~~l~~~~~ 278 (327)
T 3poz_A 267 RELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 999988877654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-18 Score=173.76 Aligned_cols=135 Identities=24% Similarity=0.377 Sum_probs=98.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 226 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998654322 1223467889999999988889999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+... ..+.... .. ... ......+ ...+..+...|++.+|..||++
T Consensus 306 ~~~~~~-----~~~~~~~--------~~-~~~----------~~~~~~~---------~~~l~~li~~~l~~dP~~Rpt~ 352 (370)
T 2psq_A 306 YPGIPV-----EELFKLL--------KE-GHR----------MDKPANC---------TNELYMMMRDCWHAVPSQRPTF 352 (370)
T ss_dssp STTCCG-----GGHHHHH--------HT-TCC----------CCCCTTS---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCH-----HHHHHHH--------hc-CCC----------CCCCCCC---------CHHHHHHHHHHcCCChhhCcCH
Confidence 865321 1111100 00 000 0000001 1134567889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...|+.+..
T Consensus 353 ~ell~~L~~il~ 364 (370)
T 2psq_A 353 KQLVEDLDRILT 364 (370)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999887654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.72 E-value=4.3e-18 Score=174.10 Aligned_cols=80 Identities=28% Similarity=0.389 Sum_probs=64.6
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++. ++.+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 184 HrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 263 (400)
T 1nxk_A 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 9999999999998 7889999999998765444455678999999999998889999999999999999999999999
Q ss_pred CCC
Q 041230 78 NGM 80 (485)
Q Consensus 78 ~~~ 80 (485)
.+.
T Consensus 264 ~~~ 266 (400)
T 1nxk_A 264 YSN 266 (400)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.2e-18 Score=170.38 Aligned_cols=79 Identities=33% Similarity=0.563 Sum_probs=70.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVS-SYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+..+. .++||||+||++|+|++|+.||.+
T Consensus 137 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp CSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999876655555567899999999998887764 789999999999999999999965
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.72 E-value=9e-18 Score=175.65 Aligned_cols=143 Identities=21% Similarity=0.291 Sum_probs=101.4
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCc--------eeecccccCcccccccCCCCCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETS--------FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||+ +.++.+||+|||+++.+..... ....+||+.|+|||.+.+..++.++|||||||++||
T Consensus 126 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~e 205 (483)
T 3sv0_A 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMY 205 (483)
T ss_dssp CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHH
Confidence 99999999999 6889999999999987643321 125679999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccC
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAEL 149 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 149 (485)
|++|+.||.+.... .....+.. +....+...+. .+. ..+ ...+..+...|++.+
T Consensus 206 lltG~~Pf~~~~~~--~~~~~~~~--------i~~~~~~~~~~---~l~----~~~---------p~~l~~li~~cl~~d 259 (483)
T 3sv0_A 206 FLRGSLPWQGLKAG--TKKQKYEK--------ISEKKVATSIE---ALC----RGY---------PTEFASYFHYCRSLR 259 (483)
T ss_dssp HHHSSCTTSSCCCS--SHHHHHHH--------HHHHHHHSCHH---HHH----TTS---------CHHHHHHHHHHHTCC
T ss_pred HHhCCCCCccccch--hHHHHHHH--------HhhccccccHH---HHh----cCC---------cHHHHHHHHHHhcCC
Confidence 99999999764321 11111111 11100000000 000 000 123467888999999
Q ss_pred CCcccccchhhHHHHHHhhh
Q 041230 150 PDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 150 p~~RP~m~~v~~~L~~i~~~ 169 (485)
|++||++.++...++.+...
T Consensus 260 P~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 260 FDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp TTCCCCHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHH
Confidence 99999999999998887553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=5.1e-18 Score=166.77 Aligned_cols=79 Identities=34% Similarity=0.496 Sum_probs=71.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 143 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 143 HRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp CSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred cCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999876555445567899999999999888899999999999999999999999865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.6e-18 Score=167.79 Aligned_cols=79 Identities=32% Similarity=0.532 Sum_probs=70.8
Q ss_pred CCCCCCCcEEECCCC----cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM----TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~----~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++ .+||+|||+++...........+||+.|+|||...+..++.++|||||||++|+|++|..|
T Consensus 137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999999887 7999999999876554444567899999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 217 f~~ 219 (326)
T 2y0a_A 217 FLG 219 (326)
T ss_dssp SCC
T ss_pred CCC
Confidence 864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.8e-18 Score=174.07 Aligned_cols=79 Identities=32% Similarity=0.431 Sum_probs=70.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|+||+||++|||++|+.||..
T Consensus 176 HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred eccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999999999998632 33344567899999999999999999999999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.9e-18 Score=168.40 Aligned_cols=79 Identities=29% Similarity=0.475 Sum_probs=71.6
Q ss_pred CCCCCCCcEEECC--CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDD--EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~--~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++. ++.+||+|||+++............||+.|+|||...+..++.++||||+||++|+|++|..||.
T Consensus 125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999987 78999999999987765555566789999999999988888999999999999999999999996
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 205 ~ 205 (321)
T 1tki_A 205 A 205 (321)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-18 Score=168.05 Aligned_cols=79 Identities=41% Similarity=0.703 Sum_probs=64.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||...+..++.++||||+|+++|+|++|+.||.
T Consensus 134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654332 2234679999999999988889999999999999999999999996
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 214 ~ 214 (294)
T 4eqm_A 214 G 214 (294)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-18 Score=167.77 Aligned_cols=137 Identities=23% Similarity=0.329 Sum_probs=92.0
Q ss_pred CCCCCCCcEEECCCCc-EEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMT-AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~-~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++. +||+|||++...... .....||+.|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 128 H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred cCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 9999999999998876 799999999754322 2345699999999999888899999999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.... ...... .+.. ......... ....+.++...|++.+|.+||++.++
T Consensus 206 ~~~~---~~~~~~--------~~~~--------------~~~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~~el 254 (307)
T 2eva_A 206 IGGP---AFRIMW--------AVHN--------------GTRPPLIKN------LPKPIESLMTRCWSKDPSQRPSMEEI 254 (307)
T ss_dssp TCSS---HHHHHH--------HHHT--------------TCCCCCBTT------CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hCcc---HHHHHH--------HHhc--------------CCCCCcccc------cCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 3211 000000 0000 000000000 01124567889999999999999999
Q ss_pred hHHHHHHhhhh
Q 041230 160 ESRLRSIKMKL 170 (485)
Q Consensus 160 ~~~L~~i~~~~ 170 (485)
.+.++.+....
T Consensus 255 l~~L~~~~~~~ 265 (307)
T 2eva_A 255 VKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHGGGC
T ss_pred HHHHHHHHHhc
Confidence 99998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-18 Score=166.65 Aligned_cols=139 Identities=29% Similarity=0.458 Sum_probs=88.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC---CceeecccccCcccccccC---CCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFIDVMGTIGYVAPEYGM---GSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+. ...++.++||||+|+++|+|++|+
T Consensus 143 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (289)
T 3og7_A 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222 (289)
T ss_dssp CSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred cccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence 9999999999999999999999999765421 1233467999999999876 556788999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.||.+... ...+..... .......+ ...... +...+.++...|++.+|.+||
T Consensus 223 ~p~~~~~~----~~~~~~~~~----~~~~~~~~-----------~~~~~~---------~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 223 LPYSNINN----RDQIIEMVG----RGSLSPDL-----------SKVRSN---------CPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp CTTSSCCC----HHHHHHHHH----HTSCCCCT-----------TSSCTT---------SCHHHHHHHHHHTCSSGGGSC
T ss_pred CCccccch----HHHHHHHhc----ccccCcch-----------hhcccc---------CCHHHHHHHHHHccCChhhCC
Confidence 99864321 111100000 00000000 000000 112345778899999999999
Q ss_pred ccchhhHHHHHHh
Q 041230 155 DINDVESRLRSIK 167 (485)
Q Consensus 155 ~m~~v~~~L~~i~ 167 (485)
++.++.+.++++.
T Consensus 275 s~~ell~~L~~l~ 287 (289)
T 3og7_A 275 SFPRILAEIEELA 287 (289)
T ss_dssp CHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHh
Confidence 9999999887653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-18 Score=174.21 Aligned_cols=136 Identities=24% Similarity=0.367 Sum_probs=97.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++|||||||++|||++ |+.|
T Consensus 216 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 295 (359)
T 3vhe_A 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295 (359)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCC
Confidence 99999999999999999999999998654332 2234678999999999888889999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+...+ ..-... .....+ ...+.++...|++.+|.+||++
T Consensus 296 ~~~~~~~-----~~~~~~~----~~~~~~--------------~~~~~~---------~~~l~~li~~~l~~dP~~Rps~ 343 (359)
T 3vhe_A 296 YPGVKID-----EEFCRRL----KEGTRM--------------RAPDYT---------TPEMYQTMLDCWHGEPSQRPTF 343 (359)
T ss_dssp STTCCCS-----HHHHHHH----HHTCCC--------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCccchh-----HHHHHHH----HcCCCC--------------CCCCCC---------CHHHHHHHHHHccCChhhCCCH
Confidence 8653211 1000000 000000 000000 1124567789999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...|+.+..
T Consensus 344 ~ell~~L~~~~~ 355 (359)
T 3vhe_A 344 SELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=7.4e-18 Score=163.70 Aligned_cols=133 Identities=22% Similarity=0.368 Sum_probs=93.0
Q ss_pred CCCCCCCcEEECCCCc-----EEEEeccCccccCCCCceeecccccCcccccccC--CCCCCCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFLDDEMT-----AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM--GSEVSSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~-----~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~~G 73 (485)
||||||+|||++.++. +||+|||+++.... ......||+.|+|||.+. ...++.++||||+|+++|||++|
T Consensus 147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g 224 (287)
T 4f0f_A 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224 (287)
T ss_dssp CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHS
T ss_pred cCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcC
Confidence 9999999999988776 99999999975432 334568999999999873 44568899999999999999999
Q ss_pred CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 74 LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 74 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
+.||........ ..... +....+. ......+ ...+.++...|++.+|.+|
T Consensus 225 ~~pf~~~~~~~~---~~~~~--------~~~~~~~----------~~~~~~~---------~~~l~~li~~~l~~dp~~R 274 (287)
T 4f0f_A 225 EGPFDEYSYGKI---KFINM--------IREEGLR----------PTIPEDC---------PPRLRNVIELCWSGDPKKR 274 (287)
T ss_dssp SCTTTTCCCCHH---HHHHH--------HHHSCCC----------CCCCTTS---------CHHHHHHHHHHTCSSGGGS
T ss_pred CCCCccccccHH---HHHHH--------HhccCCC----------CCCCccc---------CHHHHHHHHHHhcCChhhC
Confidence 999864321110 00000 0000000 0000000 1134577889999999999
Q ss_pred cccchhhHHHHH
Q 041230 154 MDINDVESRLRS 165 (485)
Q Consensus 154 P~m~~v~~~L~~ 165 (485)
|++.++.+.+++
T Consensus 275 ps~~~ll~~L~~ 286 (287)
T 4f0f_A 275 PHFSYIVKELSE 286 (287)
T ss_dssp CCHHHHHHHHHT
T ss_pred cCHHHHHHHHHh
Confidence 999999988764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=166.36 Aligned_cols=79 Identities=25% Similarity=0.380 Sum_probs=70.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||.+.+..++.++|+||+||++|||++|+.||.+
T Consensus 128 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 999999999999999999999999986432 2334567899999999999988899999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.4e-18 Score=173.91 Aligned_cols=80 Identities=33% Similarity=0.485 Sum_probs=67.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC----------------------CceeecccccCcccccccCC-CCCCCc
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----------------------TSFIDVMGTIGYVAPEYGMG-SEVSSY 57 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~ 57 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||.+.+ ..++.+
T Consensus 132 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (388)
T 3oz6_A 132 HRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG 211 (388)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH
T ss_pred eCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh
Confidence 9999999999999999999999999865321 11234689999999999876 568899
Q ss_pred cchhhHHHHHHHHHhCCCCCCCC
Q 041230 58 GDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 58 ~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
+||||+||++|||++|+.||.+.
T Consensus 212 ~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 212 IDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.71 E-value=5.5e-18 Score=165.40 Aligned_cols=149 Identities=26% Similarity=0.330 Sum_probs=95.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....|++.|+|||...+..++.++||||||+++|||++|..|
T Consensus 137 H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 216 (295)
T 3ugc_A 137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216 (295)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCT
T ss_pred cCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999987643321 1234577889999998888899999999999999999999988
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhH--HHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIE--EEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
+.... ........ .....+... ..+........ .... .+...+..+...|++.+|.+||
T Consensus 217 ~~~~~------~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~l~~li~~~l~~dp~~Rp 277 (295)
T 3ugc_A 217 SKSPP------AEFMRMIG--------NDKQGQMIVFHLIELLKNNGRL-PRPD----GCPDEIYMIMTECWNNNVNQRP 277 (295)
T ss_dssp TCSHH------HHHHHHHC--------TTCCTHHHHHHHHHHHHTTCCC-CCCT----TCCHHHHHHHHHHSCSSGGGSC
T ss_pred cCCCh------HHHHhhhc--------CccccchhHHHHHHHHhccCcC-CCCc----CcCHHHHHHHHHHcCCChhhCC
Confidence 74311 00000000 000000000 00000000000 0000 0112356788999999999999
Q ss_pred ccchhhHHHHHHhh
Q 041230 155 DINDVESRLRSIKM 168 (485)
Q Consensus 155 ~m~~v~~~L~~i~~ 168 (485)
++.++...++++..
T Consensus 278 s~~el~~~L~~l~~ 291 (295)
T 3ugc_A 278 SFRDLALRVDQIRD 291 (295)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999988765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=7.3e-18 Score=167.09 Aligned_cols=79 Identities=28% Similarity=0.432 Sum_probs=70.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||||+++|||++|+.||.+
T Consensus 164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998665432 23456899999999999888899999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.6e-18 Score=171.19 Aligned_cols=79 Identities=38% Similarity=0.578 Sum_probs=70.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC---CCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG---SEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||++.. ..++.++||||+||++|||++|+.||
T Consensus 138 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 999999999999999999999999987765555567889999999999864 35788999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
..
T Consensus 218 ~~ 219 (384)
T 4fr4_A 218 HI 219 (384)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=168.78 Aligned_cols=79 Identities=33% Similarity=0.523 Sum_probs=71.1
Q ss_pred CCCCCCCcEEECCCC----cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM----TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~----~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++ .+||+|||+++...........+||+.|+|||.+.+..++.++||||+||++|+|++|..|
T Consensus 138 HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999998877 7999999999876655445567899999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 218 f~~ 220 (361)
T 2yab_A 218 FLG 220 (361)
T ss_dssp SCC
T ss_pred CCC
Confidence 965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-18 Score=167.92 Aligned_cols=79 Identities=30% Similarity=0.405 Sum_probs=58.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCccccccc----CCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG----MGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||.+ ....++.++||||+|+++|+|++|+.|
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred cCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876544434445799999999995 455678899999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|..
T Consensus 213 ~~~ 215 (290)
T 3fme_A 213 YDS 215 (290)
T ss_dssp SCC
T ss_pred ccc
Confidence 864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-18 Score=175.94 Aligned_cols=78 Identities=35% Similarity=0.499 Sum_probs=63.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCC-----------CCCCCccchhhHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMG-----------SEVSSYGDVYSFGIL 66 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~ 66 (485)
||||||+|||++ ++.+||+|||+++.+.... .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 178 HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 178 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp CCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred ecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 999999999996 5889999999998764332 1235689999999998754 357889999999999
Q ss_pred HHHHHhCCCCCCC
Q 041230 67 LLEMFTGLRPNNG 79 (485)
Q Consensus 67 l~el~~G~~p~~~ 79 (485)
+|||++|+.||..
T Consensus 257 l~ell~G~~Pf~~ 269 (390)
T 2zmd_A 257 LYYMTYGKTPFQQ 269 (390)
T ss_dssp HHHHHHSSCTTTT
T ss_pred HHHHHHCCCcchh
Confidence 9999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=168.56 Aligned_cols=80 Identities=33% Similarity=0.402 Sum_probs=61.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.
T Consensus 150 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp CSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998665443344578999999999998888999999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.7e-18 Score=167.42 Aligned_cols=135 Identities=24% Similarity=0.271 Sum_probs=82.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce-------------eecccccCccccccc---CCCCCCCccchhhHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF-------------IDVMGTIGYVAPEYG---MGSEVSSYGDVYSFG 64 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G 64 (485)
||||||+|||++.++.+||+|||+++........ ....||+.|+|||.+ .+..++.++||||||
T Consensus 161 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG 240 (337)
T 3ll6_A 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240 (337)
T ss_dssp CCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHH
T ss_pred EccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHH
Confidence 9999999999999999999999999876432211 135699999999987 556678899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHh
Q 041230 65 ILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVA 144 (485)
Q Consensus 65 v~l~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 144 (485)
+++|+|++|+.||...... ....... ... ....+. ..+..+...
T Consensus 241 ~il~el~~g~~p~~~~~~~-----~~~~~~~--------~~~--------------~~~~~~---------~~~~~li~~ 284 (337)
T 3ll6_A 241 CILYLLCFRQHPFEDGAKL-----RIVNGKY--------SIP--------------PHDTQY---------TVFHSLIRA 284 (337)
T ss_dssp HHHHHHHHSSCCC-----------------C--------CCC--------------TTCCSS---------GGGHHHHHH
T ss_pred HHHHHHHhCCCCCcchhHH-----HhhcCcc--------cCC--------------cccccc---------hHHHHHHHH
Confidence 9999999999998642111 0000000 000 000000 013457788
Q ss_pred hhccCCCcccccchhhHHHHHHhhhhc
Q 041230 145 CSAELPDERMDINDVESRLRSIKMKLL 171 (485)
Q Consensus 145 C~~~~p~~RP~m~~v~~~L~~i~~~~~ 171 (485)
|++.+|.+||++.++...++.+.....
T Consensus 285 ~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 285 MLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HccCChhhCcCHHHHHHHHHHHHhccC
Confidence 999999999999999999988776543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.1e-18 Score=174.71 Aligned_cols=134 Identities=23% Similarity=0.352 Sum_probs=96.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+
T Consensus 312 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCCCHhhEEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999998543221 23467889999999988899999999999999999998 9999875
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.... .....+.... .. .....| ...+.++...|++.+|.+||++.++
T Consensus 390 ~~~~--~~~~~i~~~~--------~~--------------~~p~~~---------~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 390 IPLK--DVVPRVEKGY--------KM--------------DAPDGC---------PPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp SCTT--THHHHHHTTC--------CC--------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHH--HHHHHHHcCC--------CC--------------CCCCcC---------CHHHHHHHHHHcCCChhHCcCHHHH
Confidence 4221 1111000000 00 000111 1234577889999999999999999
Q ss_pred hHHHHHHhhh
Q 041230 160 ESRLRSIKMK 169 (485)
Q Consensus 160 ~~~L~~i~~~ 169 (485)
...|+.+...
T Consensus 437 ~~~L~~i~~~ 446 (450)
T 1k9a_A 437 REQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999887653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-18 Score=172.67 Aligned_cols=148 Identities=16% Similarity=0.196 Sum_probs=100.4
Q ss_pred CCCCCCCcEEECCCC--cEEEEeccCccccCCCC--------ceeecccccCcccccccCCCCCCCccchhhHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEM--TAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEM 70 (485)
Q Consensus 1 HrDlk~~NiLl~~~~--~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el 70 (485)
||||||+|||++.++ .+||+|||+++.+.... ......||+.|+|||...+..++.++||||||+++|||
T Consensus 182 H~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 261 (352)
T 2jii_A 182 HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261 (352)
T ss_dssp CSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 999999999999998 89999999998654221 11235799999999999888899999999999999999
Q ss_pred HhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCC
Q 041230 71 FTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELP 150 (485)
Q Consensus 71 ~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p 150 (485)
++|+.||.+..... ... .... ..... ........+...... ...+..+...|++.+|
T Consensus 262 ~~g~~pf~~~~~~~---~~~-~~~~----~~~~~------------~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 262 LYGFLPWTNCLPNT---EDI-MKQK----QKFVD------------KPGPFVGPCGHWIRP---SETLQKYLKVVMALTY 318 (352)
T ss_dssp HHSCCTTGGGTTCH---HHH-HHHH----HHHHH------------SCCCEECTTSCEECC---CHHHHHHHHHHHTCCT
T ss_pred HhCCCCcccCCcCH---HHH-HHHH----HhccC------------ChhhhhhhccccCCC---cHHHHHHHHHHHhCCh
Confidence 99999986432110 000 0000 00000 000000001000000 1224567889999999
Q ss_pred CcccccchhhHHHHHHhhhhc
Q 041230 151 DERMDINDVESRLRSIKMKLL 171 (485)
Q Consensus 151 ~~RP~m~~v~~~L~~i~~~~~ 171 (485)
.+||++.++.+.++.+.....
T Consensus 319 ~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 319 EEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCCCCHHHHHHHHHHHHHHTT
T ss_pred hhCCCHHHHHHHHHHHHHhcC
Confidence 999999999999988766543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-17 Score=166.90 Aligned_cols=79 Identities=32% Similarity=0.483 Sum_probs=69.4
Q ss_pred CCCCCCCcEEECC-CCcEEEEeccCccccCCCCceeecccccCcccccccCCCC-CCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDD-EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSE-VSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~-~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++. ++.+||+|||+++............||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.
T Consensus 154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 9999999999997 8999999999998766554445578999999999886544 7899999999999999999999997
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 234 ~ 234 (360)
T 3e3p_A 234 G 234 (360)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=6e-18 Score=171.56 Aligned_cols=135 Identities=25% Similarity=0.323 Sum_probs=96.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce---eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++........ ....+++.|+|||.+....++.++|||||||++|||++ |..|
T Consensus 236 HrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p 315 (377)
T 3cbl_A 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315 (377)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999864432211 12345778999999888888999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+... .... +.+.... .......| ...+.++...|++.+|++||++
T Consensus 316 ~~~~~~-----~~~~---------~~~~~~~----------~~~~~~~~---------~~~l~~li~~cl~~dP~~Rps~ 362 (377)
T 3cbl_A 316 YPNLSN-----QQTR---------EFVEKGG----------RLPCPELC---------PDAVFRLMEQCWAYEPGQRPSF 362 (377)
T ss_dssp STTSCH-----HHHH---------HHHHTTC----------CCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCH-----HHHH---------HHHHcCC----------CCCCCCCC---------CHHHHHHHHHHcCCCchhCcCH
Confidence 864311 1100 0000000 00000011 1134578889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...|+.+..
T Consensus 363 ~~i~~~L~~i~~ 374 (377)
T 3cbl_A 363 STIYQELQSIRK 374 (377)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999988765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-18 Score=172.94 Aligned_cols=78 Identities=36% Similarity=0.507 Sum_probs=61.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCC-----------CCCCCccchhhHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMG-----------SEVSSYGDVYSFGIL 66 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~ 66 (485)
||||||+|||++ ++.+||+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 131 HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i 209 (343)
T 3dbq_A 131 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 209 (343)
T ss_dssp CCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred cCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence 999999999997 5789999999998764332 1234679999999998753 567889999999999
Q ss_pred HHHHHhCCCCCCC
Q 041230 67 LLEMFTGLRPNNG 79 (485)
Q Consensus 67 l~el~~G~~p~~~ 79 (485)
+|||++|+.||..
T Consensus 210 l~ell~g~~pf~~ 222 (343)
T 3dbq_A 210 LYYMTYGKTPFQQ 222 (343)
T ss_dssp HHHHHHSSCTTTT
T ss_pred HHHHHhCCCcchh
Confidence 9999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.5e-18 Score=164.50 Aligned_cols=132 Identities=27% Similarity=0.385 Sum_probs=87.9
Q ss_pred CCCCCCCcEEECC--------CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh
Q 041230 1 HCDLKPSNVFLDD--------EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT 72 (485)
Q Consensus 1 HrDlk~~NiLl~~--------~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~ 72 (485)
||||||+|||++. ++.+||+|||+++...... .....||+.|+|||...+..++.++||||||+++|+|++
T Consensus 131 H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 209 (271)
T 3dtc_A 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209 (271)
T ss_dssp CSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH
T ss_pred ecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999986 6789999999998654332 224579999999999888888999999999999999999
Q ss_pred CCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCc
Q 041230 73 GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDE 152 (485)
Q Consensus 73 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~ 152 (485)
|+.||.+... .... ..+....+. ......+ ...+.++...|++.+|.+
T Consensus 210 g~~p~~~~~~-----~~~~--------~~~~~~~~~----------~~~~~~~---------~~~~~~li~~~l~~~p~~ 257 (271)
T 3dtc_A 210 GEVPFRGIDG-----LAVA--------YGVAMNKLA----------LPIPSTC---------PEPFAKLMEDCWNPDPHS 257 (271)
T ss_dssp CCCTTTTSCH-----HHHH--------HHHHTSCCC----------CCCCTTC---------CHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCCH-----HHHH--------HhhhcCCCC----------CCCCccc---------CHHHHHHHHHHhcCCccc
Confidence 9999864211 0000 000000000 0000000 113457788999999999
Q ss_pred ccccchhhHHHHH
Q 041230 153 RMDINDVESRLRS 165 (485)
Q Consensus 153 RP~m~~v~~~L~~ 165 (485)
||++.++.+.|++
T Consensus 258 Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 258 RPSFTNILDQLTT 270 (271)
T ss_dssp SCCHHHHHHHHHC
T ss_pred CcCHHHHHHHHhc
Confidence 9999999988764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.2e-18 Score=168.69 Aligned_cols=79 Identities=32% Similarity=0.491 Sum_probs=70.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||..
T Consensus 153 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred EeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 999999999999999999999999987765555556789999999999887776 7789999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4e-18 Score=169.44 Aligned_cols=135 Identities=21% Similarity=0.361 Sum_probs=92.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++|||||||++|||++ |+.|
T Consensus 140 H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987643221 223456888999999988889999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... .+...+.... .. .....+ ...+..+...|++.+|.+||++
T Consensus 220 ~~~~~~~--~~~~~~~~~~--------~~--------------~~~~~~---------~~~l~~li~~~l~~dp~~Rps~ 266 (327)
T 3lzb_A 220 YDGIPAS--EISSILEKGE--------RL--------------PQPPIC---------TIDVYMIMRKCWMIDADSRPKF 266 (327)
T ss_dssp TTTCCGG--GHHHHHHTTC--------CC--------------CCCTTB---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH--HHHHHHHcCC--------CC--------------CCCccC---------CHHHHHHHHHHcCCChhHCcCH
Confidence 8653211 1111000000 00 000000 1124567889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...++.+..
T Consensus 267 ~ell~~L~~~~~ 278 (327)
T 3lzb_A 267 RELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHh
Confidence 999999887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=162.47 Aligned_cols=145 Identities=29% Similarity=0.472 Sum_probs=99.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+ .++.++||||||+++|+|++|+.||
T Consensus 156 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999999998654322 1223579999999998764 5788999999999999999999998
Q ss_pred CCCCCCCCChhHHHhhhc--hhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 78 NGMFKDDLNLPNLVKSAL--PARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
....... .+..+..... .......++..+ .. ........+..+...|++.+|..||+
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-----~~~~~~~~l~~li~~cl~~~p~~Rps 293 (307)
T 2nru_A 235 DEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKM---------------ND-----ADSTSVEAMYSVASQCLHEKKNKRPD 293 (307)
T ss_dssp CTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSC---------------SC-----CCHHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred ccCcchH-HHHHHHHHhhhhhhhhhhhccccc---------------cc-----cchHHHHHHHHHHHHHcCCCcccCcC
Confidence 7543221 1111111100 000111111100 00 00122334567889999999999999
Q ss_pred cchhhHHHHHHh
Q 041230 156 INDVESRLRSIK 167 (485)
Q Consensus 156 m~~v~~~L~~i~ 167 (485)
+.++.+.|+++.
T Consensus 294 ~~~l~~~L~~l~ 305 (307)
T 2nru_A 294 IKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHHHHh
Confidence 999999988764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-18 Score=174.72 Aligned_cols=78 Identities=14% Similarity=0.205 Sum_probs=68.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG--SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999865422 224567799999999977 678999999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 295 ~~ 296 (371)
T 3q60_A 295 LV 296 (371)
T ss_dssp BC
T ss_pred Cc
Confidence 64
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=169.42 Aligned_cols=79 Identities=32% Similarity=0.419 Sum_probs=70.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++... ........+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+
T Consensus 162 HrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999998643 22334567899999999999988899999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=167.96 Aligned_cols=79 Identities=29% Similarity=0.489 Sum_probs=69.6
Q ss_pred CCCCCCCcEEECCCC---cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEM---TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~---~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++ .+||+|||+++...........+||+.|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus 151 H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 230 (362)
T 2bdw_A 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230 (362)
T ss_dssp CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 999999999998654 59999999998765544445678999999999998888999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 231 ~~ 232 (362)
T 2bdw_A 231 WD 232 (362)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=166.30 Aligned_cols=79 Identities=34% Similarity=0.552 Sum_probs=70.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||.+.+..++.++|+||+||++|||++|+.||.+
T Consensus 141 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 141 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999986432 2234567899999999999988899999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-17 Score=168.63 Aligned_cols=137 Identities=26% Similarity=0.373 Sum_probs=99.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 214 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654322 1223567889999999988889999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+.. ...+..... .-... .....+ ...+..+...|++.+|.+||++
T Consensus 294 ~~~~~-----~~~~~~~~~-----~~~~~--------------~~~~~~---------~~~l~~li~~~l~~dP~~Rps~ 340 (382)
T 3tt0_A 294 YPGVP-----VEELFKLLK-----EGHRM--------------DKPSNC---------TNELYMMMRDCWHAVPSQRPTF 340 (382)
T ss_dssp STTCC-----HHHHHHHHH-----TTCCC--------------CCCSSC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCC-----HHHHHHHHH-----cCCCC--------------CCCccC---------CHHHHHHHHHHcCCChhhCcCH
Confidence 86421 111111000 00000 000001 1124567889999999999999
Q ss_pred chhhHHHHHHhhhh
Q 041230 157 NDVESRLRSIKMKL 170 (485)
Q Consensus 157 ~~v~~~L~~i~~~~ 170 (485)
.++.+.++.+....
T Consensus 341 ~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 341 KQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHH
Confidence 99999998876544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=6.7e-18 Score=169.74 Aligned_cols=79 Identities=33% Similarity=0.421 Sum_probs=66.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 147 HrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 999999999999999999999999985432 2234457899999999999888899999999999999999999999965
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-17 Score=166.28 Aligned_cols=136 Identities=25% Similarity=0.368 Sum_probs=95.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|||++ |..
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987643321 122456788999999988888999999999999999999 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+.. ......... ..... ..... +...+.++...|++.+|.+||+
T Consensus 254 p~~~~~-----~~~~~~~~~-----~~~~~--------------~~~~~---------~~~~l~~li~~~l~~dp~~Rps 300 (325)
T 3kul_A 254 PYWNMT-----NRDVISSVE-----EGYRL--------------PAPMG---------CPHALHQLMLDCWHKDRAQRPR 300 (325)
T ss_dssp TTTTSC-----HHHHHHHHH-----TTCCC--------------CCCTT---------CCHHHHHHHHHHTCSSGGGSCC
T ss_pred CcccCC-----HHHHHHHHH-----cCCCC--------------CCCCC---------cCHHHHHHHHHHccCChhhCcC
Confidence 985421 111110000 00000 00000 1123457888999999999999
Q ss_pred cchhhHHHHHHhhh
Q 041230 156 INDVESRLRSIKMK 169 (485)
Q Consensus 156 m~~v~~~L~~i~~~ 169 (485)
+.++.+.|+.+...
T Consensus 301 ~~eil~~L~~l~~~ 314 (325)
T 3kul_A 301 FSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHhC
Confidence 99999999887553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.2e-18 Score=164.91 Aligned_cols=79 Identities=25% Similarity=0.424 Sum_probs=67.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCC---CCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSE---VSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+.. ++.++|||||||++|+|++|+.|
T Consensus 160 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 160 HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999998765432 234568999999999987654 36788999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|..
T Consensus 240 f~~ 242 (298)
T 2zv2_A 240 FMD 242 (298)
T ss_dssp SCC
T ss_pred CCC
Confidence 864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.69 E-value=8.8e-18 Score=172.51 Aligned_cols=120 Identities=16% Similarity=0.170 Sum_probs=88.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCccccccc----------CCCCCCCccchhhHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG----------MGSEVSSYGDVYSFGILLLEM 70 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gv~l~el 70 (485)
||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++ ....++.++|||||||++|||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999999876432 2345678 999999998 555678899999999999999
Q ss_pred HhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCC
Q 041230 71 FTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELP 150 (485)
Q Consensus 71 ~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p 150 (485)
++|+.||.+...... ... ++. .+...+ ..+..+...|++.+|
T Consensus 311 ltg~~Pf~~~~~~~~-----~~~--------~~~-------------------~~~~~~------~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 311 WCADLPNTDDAALGG-----SEW--------IFR-------------------SCKNIP------QPVRALLEGFLRYPK 352 (413)
T ss_dssp HHSSCCCCTTGGGSC-----SGG--------GGS-------------------SCCCCC------HHHHHHHHHHTCSSG
T ss_pred HHCCCCCCCcchhhh-----HHH--------HHh-------------------hcccCC------HHHHHHHHHHccCCh
Confidence 999999965321110 000 000 000000 124567789999999
Q ss_pred CcccccchhhH
Q 041230 151 DERMDINDVES 161 (485)
Q Consensus 151 ~~RP~m~~v~~ 161 (485)
.+||++.++.+
T Consensus 353 ~~Rpt~~~~l~ 363 (413)
T 3dzo_A 353 EDRLLPLQAME 363 (413)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCcCHHHHHh
Confidence 99999887643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.69 E-value=7.3e-18 Score=175.27 Aligned_cols=135 Identities=27% Similarity=0.447 Sum_probs=97.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......+++.|+|||.+....++.++|||||||++|||++ |+.||
T Consensus 307 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~ 386 (454)
T 1qcf_A 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386 (454)
T ss_dssp CSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998754321 1123456788999999988889999999999999999999 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ........ ...+ .......| ...+..+...|++.+|++||++.
T Consensus 387 ~~~~-----~~~~~~~i---------~~~~----------~~~~~~~~---------~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 387 PGMS-----NPEVIRAL---------ERGY----------RMPRPENC---------PEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp TTCC-----HHHHHHHH---------HHTC----------CCCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC-----HHHHHHHH---------HcCC----------CCCCCCCC---------CHHHHHHHHHHccCChhHCcCHH
Confidence 6531 11111000 0000 00000011 12356788999999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++...|+.+..
T Consensus 434 ~i~~~L~~~~~ 444 (454)
T 1qcf_A 434 YIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHTSSS
T ss_pred HHHHHHHHHHh
Confidence 99998877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.2e-18 Score=167.79 Aligned_cols=80 Identities=35% Similarity=0.549 Sum_probs=68.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++.+.... .....+||+.|+|||.+.+..+ +.++||||+||++|+|++|+.|
T Consensus 128 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 207 (323)
T 3tki_A 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (323)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998653222 2235689999999999877665 6789999999999999999999
Q ss_pred CCCC
Q 041230 77 NNGM 80 (485)
Q Consensus 77 ~~~~ 80 (485)
|...
T Consensus 208 f~~~ 211 (323)
T 3tki_A 208 WDQP 211 (323)
T ss_dssp CSSS
T ss_pred CCCC
Confidence 9653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.7e-18 Score=172.27 Aligned_cols=120 Identities=12% Similarity=0.086 Sum_probs=87.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCC-----------CCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-----------EVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||++.++.+||+|||+++... ......+| +.|+|||++.+. .++.++|||||||++||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999999999999999998533 23345678 999999998876 78999999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccC
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAEL 149 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 149 (485)
|++|+.||.+...... .... .. . ...+ ...+.++...|++.+
T Consensus 306 lltg~~Pf~~~~~~~~-~~~~------------~~-----~-----------~~~~---------~~~~~~li~~~L~~d 347 (377)
T 3byv_A 306 IWCADLPITKDAALGG-SEWI------------FR-----S-----------CKNI---------PQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHSSCCC------CC-SGGG------------GS-----S-----------CCCC---------CHHHHHHHHHHTCSS
T ss_pred HHHCCCCCcccccccc-hhhh------------hh-----h-----------ccCC---------CHHHHHHHHHHcCCC
Confidence 9999999865322110 0000 00 0 0000 012346778999999
Q ss_pred CCcccccchhhH
Q 041230 150 PDERMDINDVES 161 (485)
Q Consensus 150 p~~RP~m~~v~~ 161 (485)
|.+||++.++.+
T Consensus 348 p~~Rpt~~e~l~ 359 (377)
T 3byv_A 348 KEDRLLPLQAME 359 (377)
T ss_dssp GGGCCCHHHHHT
T ss_pred chhCCCHHHHhh
Confidence 999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=3.4e-17 Score=168.51 Aligned_cols=80 Identities=34% Similarity=0.453 Sum_probs=68.7
Q ss_pred CCCCCCCcEEECCC-CcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~-~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.+ +.+||+|||+++.+.........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 179 HrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999965 56899999999876544444456899999999998664 68999999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 259 ~~ 260 (420)
T 1j1b_A 259 GD 260 (420)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.69 E-value=7.2e-18 Score=167.16 Aligned_cols=79 Identities=27% Similarity=0.362 Sum_probs=69.0
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++ .+||+|||+++............|++.|+|||...+ ..++.++||||+||++|+|++|+.||.
T Consensus 153 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred eCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999999999999776 899999999987665544555689999999999876 568899999999999999999999985
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
.
T Consensus 233 ~ 233 (330)
T 3nsz_A 233 H 233 (330)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-17 Score=166.56 Aligned_cols=79 Identities=32% Similarity=0.431 Sum_probs=70.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccC-CCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++... ........+||+.|+|||.+.+..++.++|+||+||++|||++|+.||..
T Consensus 133 HrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 99999999999999999999999998643 22334557899999999999988899999999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.6e-17 Score=164.29 Aligned_cols=77 Identities=36% Similarity=0.497 Sum_probs=68.3
Q ss_pred CCCCCCCcEEECC-------------------------CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCC
Q 041230 1 HCDLKPSNVFLDD-------------------------EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVS 55 (485)
Q Consensus 1 HrDlk~~NiLl~~-------------------------~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 55 (485)
||||||+|||++. ++.+||+|||+++..... .....||+.|+|||.+.+..++
T Consensus 160 HrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 160 HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp CSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCC
T ss_pred eCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCC
Confidence 9999999999975 788999999999864432 2356799999999999988999
Q ss_pred CccchhhHHHHHHHHHhCCCCCCC
Q 041230 56 SYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 56 ~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
.++|||||||++|+|++|+.||.+
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccchHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999965
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-17 Score=162.49 Aligned_cols=76 Identities=32% Similarity=0.592 Sum_probs=65.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-------------ceeecccccCcccccccCCCCCCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-------------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 67 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||...+..++.++||||+||++
T Consensus 187 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 266 (332)
T 3qd2_B 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266 (332)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHH
T ss_pred ecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHH
Confidence 99999999999999999999999998765431 12235799999999999888899999999999999
Q ss_pred HHHHhCCCC
Q 041230 68 LEMFTGLRP 76 (485)
Q Consensus 68 ~el~~G~~p 76 (485)
|||++|..|
T Consensus 267 ~el~~~~~~ 275 (332)
T 3qd2_B 267 FELLYSFST 275 (332)
T ss_dssp HHHHSCCCC
T ss_pred HHHHHcCCC
Confidence 999998665
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=159.42 Aligned_cols=131 Identities=23% Similarity=0.319 Sum_probs=96.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||...+..++.++||||||+++|+|++|..|+...
T Consensus 145 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 224 (284)
T 2a19_B 145 NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224 (284)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred eccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH
Confidence 99999999999999999999999998765544444567999999999998888999999999999999999998775210
Q ss_pred CCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchhh
Q 041230 81 FKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVE 160 (485)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v~ 160 (485)
... ...+.. ......+ -..+..+...|++.+|.+||++.++.
T Consensus 225 -------~~~--------~~~~~~--------------~~~~~~~---------~~~~~~li~~~l~~dp~~Rps~~e~l 266 (284)
T 2a19_B 225 -------SKF--------FTDLRD--------------GIISDIF---------DKKEKTLLQKLLSKKPEDRPNTSEIL 266 (284)
T ss_dssp -------HHH--------HHHHHT--------------TCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -------HHH--------HHHhhc--------------ccccccC---------CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 000 000000 0000000 01234677899999999999999999
Q ss_pred HHHHHHhhh
Q 041230 161 SRLRSIKMK 169 (485)
Q Consensus 161 ~~L~~i~~~ 169 (485)
..+..++..
T Consensus 267 ~~l~~~~~~ 275 (284)
T 2a19_B 267 RTLTVWKKS 275 (284)
T ss_dssp HHHHHHTC-
T ss_pred HHHHHHhhC
Confidence 988776543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.8e-18 Score=169.90 Aligned_cols=79 Identities=30% Similarity=0.545 Sum_probs=59.7
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++. ++.+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 9999999999975 8899999999998665443344578999999999998888999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
..
T Consensus 251 ~~ 252 (349)
T 2w4o_A 251 YD 252 (349)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.6e-18 Score=163.33 Aligned_cols=135 Identities=24% Similarity=0.402 Sum_probs=87.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++....... .....|++.|+|||...+..++.++||||||+++|||++ |..||
T Consensus 139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf 218 (281)
T 1mp8_A 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218 (281)
T ss_dssp CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999986543321 223457789999999888888999999999999999997 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.... .... .+..... ......+ ...+..+...|++.+|.+||++.
T Consensus 219 ~~~~~~-----~~~~--------~i~~~~~-----------~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~ 265 (281)
T 1mp8_A 219 QGVKNN-----DVIG--------RIENGER-----------LPMPPNC---------PPTLYSLMTKCWAYDPSRRPRFT 265 (281)
T ss_dssp TTCCGG-----GHHH--------HHHTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCCHH-----HHHH--------HHHcCCC-----------CCCCCCC---------CHHHHHHHHHHccCChhhCcCHH
Confidence 653211 1110 0000000 0000001 11245678899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++.+.++.+..
T Consensus 266 ~l~~~l~~~~~ 276 (281)
T 1mp8_A 266 ELKAQLSTILE 276 (281)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99998887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.8e-17 Score=170.29 Aligned_cols=79 Identities=29% Similarity=0.495 Sum_probs=69.2
Q ss_pred CCCCCCCcEEEC---CCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLD---DEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~---~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++ .++.+||+|||+++...... .....+||+.|+|||.+.+..++.++||||+||++|+|++|..|
T Consensus 133 HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~P 212 (444)
T 3soa_A 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212 (444)
T ss_dssp CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 999999999998 46789999999998665432 33457899999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 213 f~~ 215 (444)
T 3soa_A 213 FWD 215 (444)
T ss_dssp CCC
T ss_pred CCC
Confidence 864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=161.41 Aligned_cols=81 Identities=35% Similarity=0.557 Sum_probs=68.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.
T Consensus 142 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999876433 23344678999999998866 457899999999999999999999997
Q ss_pred CCC
Q 041230 79 GMF 81 (485)
Q Consensus 79 ~~~ 81 (485)
+..
T Consensus 222 ~~~ 224 (311)
T 3niz_A 222 GVT 224 (311)
T ss_dssp CSS
T ss_pred CCC
Confidence 643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-17 Score=164.24 Aligned_cols=135 Identities=27% Similarity=0.419 Sum_probs=97.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....|++.|+|||...+..++.++||||+|+++|||++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986643322 123457889999999888888999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... .+...+.... ... ....+ ...+..+...|++.+|..||++
T Consensus 253 ~~~~~~~--~~~~~~~~~~--------~~~--------------~~~~~---------~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 253 YPGIPPE--RLFNLLKTGH--------RME--------------RPDNC---------SEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp STTCCGG--GHHHHHHTTC--------CCC--------------CCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH--HHHHHhhcCC--------cCC--------------CCccC---------CHHHHHHHHHHccCChhhCcCH
Confidence 8653211 0111000000 000 00000 1124567889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.++++..
T Consensus 300 ~~l~~~l~~~~~ 311 (314)
T 2ivs_A 300 ADISKDLEKMMV 311 (314)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999998887644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=9.1e-18 Score=164.94 Aligned_cols=137 Identities=23% Similarity=0.357 Sum_probs=98.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|||++ |+.|
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986644322 223567889999999888888999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+. ..+...+ ..... .. ....+..+...|++.+|..||++
T Consensus 248 ~~~~~~~-----~~~~--------~~~~~~~-----------~~~~~--~~------~~~~l~~li~~~l~~dp~~Rps~ 295 (313)
T 1t46_A 248 YPGMPVD-----SKFY--------KMIKEGF-----------RMLSP--EH------APAEMYDIMKTCWDADPLKRPTF 295 (313)
T ss_dssp STTCCSS-----HHHH--------HHHHHTC-----------CCCCC--TT------SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcccch-----hHHH--------HHhccCC-----------CCCCc--cc------CCHHHHHHHHHHcCCCchhCcCH
Confidence 8653211 0000 0000000 00000 00 01124567889999999999999
Q ss_pred chhhHHHHHHhhh
Q 041230 157 NDVESRLRSIKMK 169 (485)
Q Consensus 157 ~~v~~~L~~i~~~ 169 (485)
.++.+.++++...
T Consensus 296 ~ell~~L~~~~~~ 308 (313)
T 1t46_A 296 KQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999998876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=169.24 Aligned_cols=132 Identities=21% Similarity=0.291 Sum_probs=83.8
Q ss_pred CCCCCCCcEEECCCC---cEEEEeccCccccCCCCceeecccccCcccccccCC---CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEM---TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG---SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~---~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++ .+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 262 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp CSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999999999997544 599999999987665444456789999999998753 56778999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.||...... ..+...+....... .+.. ... ....+.++...|++.+|.+||
T Consensus 342 ~pf~~~~~~-~~~~~~i~~~~~~~-----~~~~----------~~~-------------~~~~~~~li~~~L~~dP~~Rp 392 (419)
T 3i6u_A 342 PPFSEHRTQ-VSLKDQITSGKYNF-----IPEV----------WAE-------------VSEKALDLVKKLLVVDPKARF 392 (419)
T ss_dssp CSSCCCSSS-CCHHHHHHTTCCCC-----CHHH----------HTT-------------SCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCCCCcch-HHHHHHHhcCCCCC-----Cchh----------hcc-------------cCHHHHHHHHHHccCChhHCc
Confidence 999753221 12211111110000 0000 000 011245677899999999999
Q ss_pred ccchhhH
Q 041230 155 DINDVES 161 (485)
Q Consensus 155 ~m~~v~~ 161 (485)
++.++.+
T Consensus 393 s~~e~l~ 399 (419)
T 3i6u_A 393 TTEEALR 399 (419)
T ss_dssp CHHHHHH
T ss_pred CHHHHhC
Confidence 9987653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.9e-17 Score=164.83 Aligned_cols=79 Identities=30% Similarity=0.432 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCc---EEEEeccCccccCCCCc-eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMT---AHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~---~kl~dfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++. +||+|||+++....... ....+||+.|+|||.+.+..++.++||||+||++|+|++|+.|
T Consensus 153 HrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp CSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 9999999999987654 99999999987654332 3456899999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 233 f~~ 235 (351)
T 3c0i_A 233 FYG 235 (351)
T ss_dssp SCS
T ss_pred CCC
Confidence 864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=165.38 Aligned_cols=79 Identities=34% Similarity=0.457 Sum_probs=70.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .......+||+.|+|||.+.+..++.++|+||+||++|||++|+.||.+
T Consensus 144 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 999999999999999999999999986432 2234467899999999999888899999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2e-17 Score=162.62 Aligned_cols=144 Identities=27% Similarity=0.371 Sum_probs=90.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...... ......|++.|+|||...+..++.++||||||+++|+|++|+.||.+
T Consensus 159 H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp CCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999999999998654332 22345789999999999888899999999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. .....+... +....+ .... ... .-..+..+...|++.+|..||++.++
T Consensus 239 ~~---~~~~~~~~~--------~~~~~~--------------~~~~--~~~---~~~~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 239 DK---MNLYSLCKK--------IEQCDY--------------PPLP--SDH---YSEELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp -----CCHHHHHHH--------HHTTCS--------------CCCC--TTT---SCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cc---hhHHHHHHH--------hhcccC--------------CCCc--ccc---cCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 21 111111100 000000 0000 000 01124567889999999999999999
Q ss_pred hHHHHHHhhhhccCc
Q 041230 160 ESRLRSIKMKLLKTP 174 (485)
Q Consensus 160 ~~~L~~i~~~~~~~~ 174 (485)
...++.+......++
T Consensus 289 l~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 289 YDVAKRMHACTASSL 303 (310)
T ss_dssp HHHHHHHHHHHC---
T ss_pred HHHHHHHHHhhhhhh
Confidence 999998877654443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-17 Score=166.63 Aligned_cols=78 Identities=32% Similarity=0.471 Sum_probs=68.5
Q ss_pred CCCCCCCcEEEC--CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLD--DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~--~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++ .++.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 182 HrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 182 HCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999994 4788999999999865432 335689999999999998889999999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 260 ~~ 261 (382)
T 2vx3_A 260 GA 261 (382)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=168.48 Aligned_cols=138 Identities=22% Similarity=0.352 Sum_probs=90.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~ 74 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++|||||||++|||++ |.
T Consensus 215 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~ 294 (373)
T 3c1x_A 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294 (373)
T ss_dssp CSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcC
Confidence 99999999999999999999999998653221 1123467889999999888889999999999999999999 66
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.||...... .....+.... .. .....+ ...+..+...|++.+|++||
T Consensus 295 ~p~~~~~~~--~~~~~~~~~~----------~~------------~~p~~~---------~~~l~~li~~cl~~dp~~RP 341 (373)
T 3c1x_A 295 PPYPDVNTF--DITVYLLQGR----------RL------------LQPEYC---------PDPLYEVMLKCWHPKAEMRP 341 (373)
T ss_dssp CSCTTSCSS--CHHHHHHTTC----------CC------------CCCTTC---------CHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCHH--HHHHHHHcCC----------CC------------CCCCCC---------CHHHHHHHHHHcCCChhhCc
Confidence 676543211 1111100000 00 000001 11245678899999999999
Q ss_pred ccchhhHHHHHHhhhhc
Q 041230 155 DINDVESRLRSIKMKLL 171 (485)
Q Consensus 155 ~m~~v~~~L~~i~~~~~ 171 (485)
++.++.+.++.+.....
T Consensus 342 s~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 342 SFSELVSRISAIFSTFI 358 (373)
T ss_dssp CHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHHHHhcc
Confidence 99999999988766443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=165.53 Aligned_cols=152 Identities=22% Similarity=0.308 Sum_probs=99.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||+|+++|+|++|..|
T Consensus 157 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 236 (318)
T 3lxp_A 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236 (318)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCc
Confidence 999999999999999999999999987654332 1235678889999999888888999999999999999999998
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+...... ...... ....... ................ .. .+...+.++...|++.+|.+||++
T Consensus 237 ~~~~~~~---~~~~~~--~~~~~~~--------~~~~~~~~~~~~~~~~-~~----~~~~~l~~li~~~l~~dP~~Rps~ 298 (318)
T 3lxp_A 237 SQSPPTK---FLELIG--IAQGQMT--------VLRLTELLERGERLPR-PD----KCPAEVYHLMKNCWETEASFRPTF 298 (318)
T ss_dssp GGSHHHH---HHHHHC--SCCHHHH--------HHHHHHHHHTTCCCCC-CT----TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccccchh---hhhhhc--ccccchh--------HHHHHHHHhcccCCCC-Cc----cccHHHHHHHHHHcCCCcccCcCH
Confidence 7531100 000000 0000000 0000000000000000 00 011235678889999999999999
Q ss_pred chhhHHHHHHhhhh
Q 041230 157 NDVESRLRSIKMKL 170 (485)
Q Consensus 157 ~~v~~~L~~i~~~~ 170 (485)
.++.+.++.+....
T Consensus 299 ~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 299 ENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhh
Confidence 99999998876644
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=166.79 Aligned_cols=80 Identities=30% Similarity=0.436 Sum_probs=70.0
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++ .++.+||+|||+++............||+.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 164 HrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999 7899999999999876554444557889999999988664 58999999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 244 ~~ 245 (394)
T 4e7w_A 244 GE 245 (394)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=167.93 Aligned_cols=79 Identities=22% Similarity=0.192 Sum_probs=69.6
Q ss_pred CCCCCCCcEEECC-----------CCcEEEEeccCccccC---CCCceeecccccCcccccccCCCCCCCccchhhHHHH
Q 041230 1 HCDLKPSNVFLDD-----------EMTAHLGDFGIARFLP---VETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGIL 66 (485)
Q Consensus 1 HrDlk~~NiLl~~-----------~~~~kl~dfG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~ 66 (485)
||||||+|||++. ++.+||+|||+++.+. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 195 HrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 274 (365)
T 3e7e_A 195 HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274 (365)
T ss_dssp CCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHH
T ss_pred cCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHH
Confidence 9999999999998 8999999999997543 2333455789999999999998889999999999999
Q ss_pred HHHHHhCCCCCCC
Q 041230 67 LLEMFTGLRPNNG 79 (485)
Q Consensus 67 l~el~~G~~p~~~ 79 (485)
+|||++|+.||..
T Consensus 275 l~elltg~~pf~~ 287 (365)
T 3e7e_A 275 VYCMLFGTYMKVK 287 (365)
T ss_dssp HHHHHHSSCCCEE
T ss_pred HHHHHhCCCcccc
Confidence 9999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=164.79 Aligned_cols=79 Identities=30% Similarity=0.504 Sum_probs=66.1
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++. ++.+||+|||+++...........+||+.|+|||...+..++.++||||+|+++|+|++|+.||
T Consensus 154 H~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 233 (327)
T 3lm5_A 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233 (327)
T ss_dssp CSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999998 7899999999998765444445578999999999998888999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 234 ~~ 235 (327)
T 3lm5_A 234 VG 235 (327)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=4.1e-17 Score=161.23 Aligned_cols=79 Identities=29% Similarity=0.476 Sum_probs=69.4
Q ss_pred CCCCCCCcEEE----CCCCcEEEEeccCccccCCCCceeecccccCcccccccC--------CCCCCCccchhhHHHHHH
Q 041230 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM--------GSEVSSYGDVYSFGILLL 68 (485)
Q Consensus 1 HrDlk~~NiLl----~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gv~l~ 68 (485)
||||||+|||+ +.++.+||+|||+++............||+.|+|||.+. +..++.++|||||||++|
T Consensus 135 H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 214 (319)
T 4euu_A 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (319)
T ss_dssp CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHH
Confidence 99999999999 888889999999998776555555678999999999865 467889999999999999
Q ss_pred HHHhCCCCCCC
Q 041230 69 EMFTGLRPNNG 79 (485)
Q Consensus 69 el~~G~~p~~~ 79 (485)
||++|+.||..
T Consensus 215 el~~g~~pf~~ 225 (319)
T 4euu_A 215 HAATGSLPFRP 225 (319)
T ss_dssp HHHHSSCSEEC
T ss_pred HHHhCCCCCCC
Confidence 99999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.9e-18 Score=170.52 Aligned_cols=136 Identities=24% Similarity=0.322 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCC---cEEEEeccCccccCC---CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-C
Q 041230 1 HCDLKPSNVFLDDEM---TAHLGDFGIARFLPV---ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-G 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~---~~kl~dfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G 73 (485)
||||||+|||++.++ .+||+|||+++.... ........||+.|+|||.+.+..++.++|||||||++|||++ |
T Consensus 204 HrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 283 (367)
T 3l9p_A 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 283 (367)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999554 599999999975421 122234678999999999888889999999999999999998 9
Q ss_pred CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 74 LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 74 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
..||.+.. ...+.... ... ........ +...+.++...|++.+|.+|
T Consensus 284 ~~pf~~~~-----~~~~~~~i--------~~~--------------~~~~~~~~------~~~~l~~li~~~l~~dP~~R 330 (367)
T 3l9p_A 284 YMPYPSKS-----NQEVLEFV--------TSG--------------GRMDPPKN------CPGPVYRIMTQCWQHQPEDR 330 (367)
T ss_dssp CCSSTTCC-----HHHHHHHH--------HTT--------------CCCCCCTT------CCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCC-----HHHHHHHH--------HcC--------------CCCCCCcc------CCHHHHHHHHHHcCCCHhHC
Confidence 99986431 11111000 000 00000000 01124578889999999999
Q ss_pred cccchhhHHHHHHhhh
Q 041230 154 MDINDVESRLRSIKMK 169 (485)
Q Consensus 154 P~m~~v~~~L~~i~~~ 169 (485)
|++.++.+.++.+...
T Consensus 331 ps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 331 PNFAIILERIEYCTQD 346 (367)
T ss_dssp CCHHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHhhC
Confidence 9999999998776553
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=8.8e-18 Score=170.16 Aligned_cols=136 Identities=23% Similarity=0.407 Sum_probs=87.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....+++.|+|||...+..++.++||||||+++||+++ |+.
T Consensus 170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987643221 112345788999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.... ...+.. .+...+ .. .... .+...+.++...|++.+|..||+
T Consensus 250 P~~~~~-----~~~~~~---------~i~~~~------------~~-~~~~------~~~~~l~~li~~cl~~dp~~RPs 296 (373)
T 2qol_A 250 PYWEMS-----NQDVIK---------AVDEGY------------RL-PPPM------DCPAALYQLMLDCWQKDRNNRPK 296 (373)
T ss_dssp TTTTCC-----HHHHHH---------HHHTTE------------EC-CCCT------TCBHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCC-----HHHHHH---------HHHcCC------------CC-CCCc------cccHHHHHHHHHHhCcChhhCcC
Confidence 985421 111110 000000 00 0000 01123567889999999999999
Q ss_pred cchhhHHHHHHhhh
Q 041230 156 INDVESRLRSIKMK 169 (485)
Q Consensus 156 m~~v~~~L~~i~~~ 169 (485)
+.++.+.|+.+...
T Consensus 297 ~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 297 FEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHhC
Confidence 99999999887553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.68 E-value=9.3e-18 Score=165.11 Aligned_cols=136 Identities=24% Similarity=0.369 Sum_probs=97.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|+|++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986543321 234568899999999888888999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+...+ ..-... .....+ ...+.++...|++.+|.+||++
T Consensus 251 ~~~~~~~-----~~~~~~~----~~~~~~--------------~~~~~~---------~~~l~~li~~~l~~dp~~Rps~ 298 (316)
T 2xir_A 251 YPGVKID-----EEFCRRL----KEGTRM--------------RAPDYT---------TPEMYQTMLDCWHGEPSQRPTF 298 (316)
T ss_dssp STTCCCS-----HHHHHHH----HHTCCC--------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred Ccccchh-----HHHHHHh----ccCccC--------------CCCCCC---------CHHHHHHHHHHcCCChhhCcCH
Confidence 8653211 0000000 000000 000000 1124567789999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...++.+..
T Consensus 299 ~ell~~L~~~~~ 310 (316)
T 2xir_A 299 SELVEHLGNLLQ 310 (316)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999887654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=9.7e-18 Score=165.83 Aligned_cols=136 Identities=21% Similarity=0.330 Sum_probs=92.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....|++.|+|||...+..++.++|||||||++|||++ |+.|
T Consensus 160 H~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 239 (323)
T 3qup_A 160 HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239 (323)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986543321 123456788999999888889999999999999999999 8999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..... +.... ...... .....+.++...|++.+|.+||++
T Consensus 240 ~~~~~~~-----~~~~~--------~~~~~--------------~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~ 286 (323)
T 3qup_A 240 YAGIENA-----EIYNY--------LIGGN--------------RLKQPP------ECMEEVYDLMYQCWSADPKQRPSF 286 (323)
T ss_dssp TTTCCGG-----GHHHH--------HHTTC--------------CCCCCT------TCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred ccccChH-----HHHHH--------HhcCC--------------CCCCCC------ccCHHHHHHHHHHccCChhhCcCH
Confidence 8653211 11100 00000 000000 001134578889999999999999
Q ss_pred chhhHHHHHHhhh
Q 041230 157 NDVESRLRSIKMK 169 (485)
Q Consensus 157 ~~v~~~L~~i~~~ 169 (485)
.++.+.++++...
T Consensus 287 ~~l~~~l~~~l~~ 299 (323)
T 3qup_A 287 TCLRMELENILGH 299 (323)
T ss_dssp HHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHH
Confidence 9999999887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=2.4e-17 Score=160.72 Aligned_cols=139 Identities=23% Similarity=0.296 Sum_probs=97.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+|||++.++.+||+|||+++...... ......|++.|+|||...+..++.++||||||+++|+|++|..
T Consensus 147 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 226 (298)
T 3pls_A 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226 (298)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred cCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCC
Confidence 99999999999999999999999998553321 1234568899999999988889999999999999999999666
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
|+...... ..+...+.... . ....... ...+..+...|++.+|.+||+
T Consensus 227 ~~~~~~~~-~~~~~~~~~~~--------~-----------------~~~~~~~------~~~l~~li~~~l~~~p~~Rps 274 (298)
T 3pls_A 227 PPYRHIDP-FDLTHFLAQGR--------R-----------------LPQPEYC------PDSLYQVMQQCWEADPAVRPT 274 (298)
T ss_dssp CTTTTSCG-GGHHHHHHTTC--------C-----------------CCCCTTC------CHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCccCCH-HHHHHHhhcCC--------C-----------------CCCCccc------hHHHHHHHHHHccCChhhCcC
Confidence 64321110 00100000000 0 0000000 112456788999999999999
Q ss_pred cchhhHHHHHHhhhhc
Q 041230 156 INDVESRLRSIKMKLL 171 (485)
Q Consensus 156 m~~v~~~L~~i~~~~~ 171 (485)
+.++...++++.....
T Consensus 275 ~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 275 FRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHh
Confidence 9999999988776544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=2.3e-17 Score=167.96 Aligned_cols=79 Identities=29% Similarity=0.488 Sum_probs=70.2
Q ss_pred CCCCCCCcEEECC--CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDD--EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~--~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++. ++.+||+|||+++...........+||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 9999999999974 46799999999987765544555689999999999988889999999999999999999999986
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 252 ~ 252 (387)
T 1kob_A 252 G 252 (387)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.9e-17 Score=163.04 Aligned_cols=80 Identities=33% Similarity=0.521 Sum_probs=51.0
Q ss_pred CCCCCCCcEEECCCC---cEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM---TAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~---~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++ .+||+|||+++...... .....+||+.|+|||.+.+..++.++||||+||++|+|++|+.|
T Consensus 129 H~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 208 (325)
T 3kn6_A 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208 (325)
T ss_dssp CCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 999999999997665 89999999998654332 33456899999999999888899999999999999999999999
Q ss_pred CCCC
Q 041230 77 NNGM 80 (485)
Q Consensus 77 ~~~~ 80 (485)
|.+.
T Consensus 209 f~~~ 212 (325)
T 3kn6_A 209 FQSH 212 (325)
T ss_dssp TC--
T ss_pred CCCC
Confidence 9753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=6.3e-18 Score=168.70 Aligned_cols=136 Identities=26% Similarity=0.352 Sum_probs=97.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||++........ .....||+.|+|||...+..++.++||||||+++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986543221 223567889999999888889999999999999999998 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+..... .+...+.... ... ....+ ...+..+...|++.+|..||++
T Consensus 275 ~~~~~~~~-~~~~~~~~~~--------~~~--------------~~~~~---------~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 275 YPGIPVDA-NFYKLIQNGF--------KMD--------------QPFYA---------TEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp STTCCCSH-HHHHHHHTTC--------CCC--------------CCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred cccCCcHH-HHHHHHhcCC--------CCC--------------CCCCC---------CHHHHHHHHHHcCCCchhCcCH
Confidence 86532110 0000000000 000 00000 1124567889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.++.+..
T Consensus 323 ~~l~~~l~~~~~ 334 (344)
T 1rjb_A 323 PNLTSFLGCQLA 334 (344)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHHHH
Confidence 999998877544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-17 Score=166.43 Aligned_cols=76 Identities=30% Similarity=0.441 Sum_probs=66.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccC---CCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM---GSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++..... ...+||+.|+|||.+. ...++.++|||||||++|||++|+.||
T Consensus 177 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 253 (348)
T 1u5q_A 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253 (348)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999865432 3467999999999874 466888999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 254 ~~ 255 (348)
T 1u5q_A 254 FN 255 (348)
T ss_dssp TT
T ss_pred CC
Confidence 54
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.4e-17 Score=165.39 Aligned_cols=79 Identities=25% Similarity=0.347 Sum_probs=69.2
Q ss_pred CCCCCCCcEEECCCC-------------------------------------------------cEEEEeccCccccCCC
Q 041230 1 HCDLKPSNVFLDDEM-------------------------------------------------TAHLGDFGIARFLPVE 31 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-------------------------------------------------~~kl~dfG~a~~~~~~ 31 (485)
||||||+|||++.++ .+||+|||+++.....
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~ 249 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence 999999999999775 7999999999865432
Q ss_pred CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 041230 32 TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMF 81 (485)
Q Consensus 32 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~~ 81 (485)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 250 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 250 --FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp --SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred --CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 334679999999999988889999999999999999999999997643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=161.16 Aligned_cols=135 Identities=18% Similarity=0.313 Sum_probs=94.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......|++.|+|||...+..++.++||||||+++|+|++ |+.||
T Consensus 136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~ 215 (281)
T 3cc6_A 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215 (281)
T ss_dssp CCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999998654332 1223457889999999888888999999999999999998 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
...... .....+... ... .....+ ...+..+...|++.+|..||++.
T Consensus 216 ~~~~~~--~~~~~~~~~--------~~~--------------~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~ 262 (281)
T 3cc6_A 216 FWLENK--DVIGVLEKG--------DRL--------------PKPDLC---------PPVLYTLMTRCWDYDPSDRPRFT 262 (281)
T ss_dssp TTSCGG--GHHHHHHHT--------CCC--------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccCChH--HHHHHHhcC--------CCC--------------CCCCCC---------CHHHHHHHHHHccCCchhCcCHH
Confidence 642211 000000000 000 000000 11245678899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++...++.+..
T Consensus 263 ell~~L~~~~~ 273 (281)
T 3cc6_A 263 ELVCSLSDVYQ 273 (281)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99998877644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.2e-17 Score=166.07 Aligned_cols=79 Identities=33% Similarity=0.464 Sum_probs=70.2
Q ss_pred CCCCCCCcEEE--CCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFL--DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl--~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||+ +.++.+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 210 H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999 6678899999999987665544455679999999999988888999999999999999999999986
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 290 ~ 290 (373)
T 2x4f_A 290 G 290 (373)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.9e-17 Score=170.32 Aligned_cols=79 Identities=27% Similarity=0.397 Sum_probs=69.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 272 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999999864322 234457899999999999888999999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.6e-17 Score=161.09 Aligned_cols=79 Identities=33% Similarity=0.523 Sum_probs=70.7
Q ss_pred CCCCCCCcEEECCCC----cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM----TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~----~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++ .+||+|||+++............||+.|+|||...+..++.++||||||+++|+|++|..|
T Consensus 138 H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred cCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence 999999999999887 7999999999876654444556799999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 218 f~~ 220 (321)
T 2a2a_A 218 FLG 220 (321)
T ss_dssp SCC
T ss_pred CCC
Confidence 864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2e-17 Score=162.88 Aligned_cols=79 Identities=38% Similarity=0.646 Sum_probs=62.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC----ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||...+..++.++||||||+++|||++|+.|
T Consensus 139 H~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~p 218 (311)
T 3ork_A 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218 (311)
T ss_dssp CCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654321 12345799999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 219 f~~ 221 (311)
T 3ork_A 219 FTG 221 (311)
T ss_dssp CCC
T ss_pred CCC
Confidence 865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-17 Score=158.66 Aligned_cols=79 Identities=29% Similarity=0.487 Sum_probs=69.7
Q ss_pred CCCCCCCcEEECCCCc---EEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMT---AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~---~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++. +||+|||++.............||+.|+|||...+..++.++||||+|+++|+|++|+.||
T Consensus 128 H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 207 (284)
T 3kk8_A 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207 (284)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCC
Confidence 9999999999987655 9999999998765544445578999999999998888999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 208 ~~ 209 (284)
T 3kk8_A 208 WD 209 (284)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=2.8e-17 Score=157.92 Aligned_cols=135 Identities=24% Similarity=0.377 Sum_probs=96.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce--eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF--IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++........ ....||+.|+|||...+..++.++||||+|+++|+|++ |+.||
T Consensus 127 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp ESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999999866543321 23456778999999888888999999999999999999 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.... ....... +... ......... ...+.++...|++.+|.+||++.
T Consensus 207 ~~~~-----~~~~~~~--------~~~~--------------~~~~~~~~~------~~~l~~li~~~l~~~p~~Rps~~ 253 (268)
T 3sxs_A 207 DLYT-----NSEVVLK--------VSQG--------------HRLYRPHLA------SDTIYQIMYSCWHELPEKRPTFQ 253 (268)
T ss_dssp TTSC-----HHHHHHH--------HHTT--------------CCCCCCTTS------CHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cccC-----hHHHHHH--------HHcC--------------CCCCCCCcC------hHHHHHHHHHHcCCChhhCcCHH
Confidence 5421 1111000 0000 000000000 01245678899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++.+.++.++.
T Consensus 254 ~ll~~L~~l~~ 264 (268)
T 3sxs_A 254 QLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHGGGCC
T ss_pred HHHHHHHHhhh
Confidence 99999877643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-17 Score=161.04 Aligned_cols=136 Identities=22% Similarity=0.327 Sum_probs=94.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhC-C
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTG-L 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G-~ 74 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||+|+++|++++| .
T Consensus 151 H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 230 (298)
T 3f66_A 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230 (298)
T ss_dssp CSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998654322 12235678899999998888889999999999999999995 4
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.|+.+.... .....+.... .. .....+ ...+.++...|++.+|.+||
T Consensus 231 ~~~~~~~~~--~~~~~~~~~~----------~~------------~~~~~~---------~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 231 PPYPDVNTF--DITVYLLQGR----------RL------------LQPEYC---------PDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp CSSTTSCTT--THHHHHHTTC----------CC------------CCCTTC---------CHHHHHHHHHHTCSSGGGSC
T ss_pred CCCccCCHH--HHHHHHhcCC----------CC------------CCCccC---------CHHHHHHHHHHcCCChhhCc
Confidence 455432111 1110000000 00 000000 01245678899999999999
Q ss_pred ccchhhHHHHHHhhh
Q 041230 155 DINDVESRLRSIKMK 169 (485)
Q Consensus 155 ~m~~v~~~L~~i~~~ 169 (485)
++.++.+.++++...
T Consensus 278 s~~ell~~L~~~~~~ 292 (298)
T 3f66_A 278 SFSELVSRISAIFST 292 (298)
T ss_dssp CHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHh
Confidence 999999999887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.8e-18 Score=162.05 Aligned_cols=135 Identities=26% Similarity=0.381 Sum_probs=96.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||+|+++|+|++ |+.||
T Consensus 129 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~ 208 (269)
T 4hcu_A 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 208 (269)
T ss_dssp CSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999998654322 1223456788999999888889999999999999999999 89998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ....... +... + ....+. .. ...+.++...|++.+|.+||++.
T Consensus 209 ~~~~-----~~~~~~~--------~~~~-~-----------~~~~~~--~~------~~~~~~li~~~l~~~p~~Rps~~ 255 (269)
T 4hcu_A 209 ENRS-----NSEVVED--------ISTG-F-----------RLYKPR--LA------STHVYQIMNHCWRERPEDRPAFS 255 (269)
T ss_dssp TTCC-----HHHHHHH--------HHTT-C-----------CCCCCT--TS------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC-----HHHHHHH--------HhcC-c-----------cCCCCC--cC------CHHHHHHHHHHccCCcccCcCHH
Confidence 6421 1111100 0000 0 000000 00 11245678899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++.+.++++..
T Consensus 256 ~ll~~l~~l~~ 266 (269)
T 4hcu_A 256 RLLRQLAEIAE 266 (269)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7e-18 Score=167.57 Aligned_cols=136 Identities=27% Similarity=0.407 Sum_probs=97.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|||++ |..|
T Consensus 187 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp CSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986533221 223567889999999888888999999999999999998 8889
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+. ..+...+. ......+ ...+..+...|++.+|..||++
T Consensus 267 ~~~~~~~-----~~~~--------~~~~~~~~----------~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~ 314 (333)
T 2i1m_A 267 YPGILVN-----SKFY--------KLVKDGYQ----------MAQPAFA---------PKNIYSIMQACWALEPTHRPTF 314 (333)
T ss_dssp STTCCSS-----HHHH--------HHHHHTCC----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred Ccccchh-----HHHH--------HHHhcCCC----------CCCCCCC---------CHHHHHHHHHHhccChhhCcCH
Confidence 8653211 0000 00000000 0000000 1124567889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.++.+..
T Consensus 315 ~~l~~~L~~~~~ 326 (333)
T 2i1m_A 315 QQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
Confidence 999998877654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.9e-17 Score=177.00 Aligned_cols=79 Identities=34% Similarity=0.457 Sum_probs=70.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||||+.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 465 HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp CCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 999999999999999999999999986432 2334567899999999999999999999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.6e-18 Score=166.99 Aligned_cols=79 Identities=37% Similarity=0.453 Sum_probs=50.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCccccccc----CCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYG----MGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||.. .+..++.++||||||+++|+|++|+.|
T Consensus 149 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp CSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred ECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999876544333445799999999997 455688899999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 229 f~~ 231 (327)
T 3aln_A 229 YPK 231 (327)
T ss_dssp SSC
T ss_pred CCC
Confidence 865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-17 Score=159.35 Aligned_cols=77 Identities=34% Similarity=0.509 Sum_probs=66.2
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++ .++.+||+|||++...... ......||+.|+|||... ..++.++||||+|+++|+|++|+.||..
T Consensus 154 H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999998 7899999999999754432 234567999999999876 4588999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4.8e-17 Score=164.20 Aligned_cols=79 Identities=34% Similarity=0.574 Sum_probs=69.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC------CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG------SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||++..+.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 223 H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 999999999999999999999999987765554556789999999998752 35788999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 303 ~pf~~ 307 (365)
T 2y7j_A 303 PPFWH 307 (365)
T ss_dssp CSSCC
T ss_pred CCCCC
Confidence 99864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=7e-17 Score=159.93 Aligned_cols=77 Identities=36% Similarity=0.582 Sum_probs=69.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ....+||+.|+|||.+.+..++.++|+||+||++|||++|+.||.+
T Consensus 129 HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999865432 2356899999999999888899999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.5e-17 Score=168.03 Aligned_cols=78 Identities=31% Similarity=0.477 Sum_probs=69.0
Q ss_pred CCCCCCCcEEECCCCc--EEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMT--AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~--~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++. +||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 223 HrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 223 HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp CSCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCHHHeEEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 9999999999999887 999999999764322 334689999999999998899999999999999999999999987
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 301 ~~ 302 (429)
T 3kvw_A 301 GE 302 (429)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5e-17 Score=160.62 Aligned_cols=80 Identities=39% Similarity=0.580 Sum_probs=68.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 131 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999876432 223456799999999998764 57899999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 211 ~~ 212 (317)
T 2pmi_A 211 GT 212 (317)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5.9e-17 Score=172.11 Aligned_cols=80 Identities=34% Similarity=0.547 Sum_probs=72.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 309 HrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred ccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999999998776555455678999999999998888999999999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.6e-17 Score=176.26 Aligned_cols=137 Identities=25% Similarity=0.339 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....+++.|+|||++....++.++|||||||++|||++ |+.
T Consensus 459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999987643221 122346789999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+... ..+.... .... .......| ...+.+++..|++.+|++||+
T Consensus 539 Pf~~~~~-----~~~~~~i--------~~~~-----------~~~~p~~~---------~~~l~~li~~cl~~dP~~RPs 585 (613)
T 2ozo_A 539 PYKKMKG-----PEVMAFI--------EQGK-----------RMECPPEC---------PPELYALMSDCWIYKWEDRPD 585 (613)
T ss_dssp TTTTCCS-----HHHHHHH--------HTTC-----------CCCCCTTC---------CHHHHHHHHHTTCSSTTTSCC
T ss_pred CCCCCCH-----HHHHHHH--------HcCC-----------CCCCCCcC---------CHHHHHHHHHHcCCChhHCcC
Confidence 9875321 1111100 0000 00000011 123567889999999999999
Q ss_pred cchhhHHHHHHhhhh
Q 041230 156 INDVESRLRSIKMKL 170 (485)
Q Consensus 156 m~~v~~~L~~i~~~~ 170 (485)
+.++...|+.+....
T Consensus 586 ~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 586 FLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHh
Confidence 999999998865543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-17 Score=166.13 Aligned_cols=80 Identities=31% Similarity=0.453 Sum_probs=58.2
Q ss_pred CCCCCCCcEEECCCCc--EEEEeccCccccCCCCceeecccccCcccccccCCCCCCCc-cchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMT--AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY-GDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~--~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++. +||+|||+++...........+||+.|+|||.+.+..++.+ +||||+||++|+|++|+.||
T Consensus 139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf 218 (361)
T 3uc3_A 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218 (361)
T ss_dssp SCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCC
Confidence 9999999999987765 99999999985443333445689999999999887777655 89999999999999999999
Q ss_pred CCC
Q 041230 78 NGM 80 (485)
Q Consensus 78 ~~~ 80 (485)
.+.
T Consensus 219 ~~~ 221 (361)
T 3uc3_A 219 EDP 221 (361)
T ss_dssp C--
T ss_pred CCC
Confidence 653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-17 Score=175.35 Aligned_cols=133 Identities=23% Similarity=0.414 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++....... .....+++.|+|||.+....++.++|||||||++|||++ |+.||
T Consensus 341 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987643321 122456788999999888889999999999999999999 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+... ..+.. .+...+. ......| ...+..+...|++.+|.+||++.
T Consensus 421 ~~~~~-----~~~~~---------~~~~~~~----------~~~~~~~---------~~~l~~li~~cl~~dP~~RPs~~ 467 (495)
T 1opk_A 421 PGIDL-----SQVYE---------LLEKDYR----------MERPEGC---------PEKVYELMRACWQWNPSDRPSFA 467 (495)
T ss_dssp TTCCG-----GGHHH---------HHHTTCC----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCH-----HHHHH---------HHHcCCC----------CCCCCCC---------CHHHHHHHHHHcCcChhHCcCHH
Confidence 65321 11110 0000000 0000011 12345678899999999999999
Q ss_pred hhhHHHHHH
Q 041230 158 DVESRLRSI 166 (485)
Q Consensus 158 ~v~~~L~~i 166 (485)
++.+.|+.+
T Consensus 468 el~~~L~~~ 476 (495)
T 1opk_A 468 EIHQAFETM 476 (495)
T ss_dssp HHHHHHHTS
T ss_pred HHHHHHHHH
Confidence 999888764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=7.7e-17 Score=155.65 Aligned_cols=78 Identities=28% Similarity=0.425 Sum_probs=68.7
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||+ +.++.+||+|||++.............||+.|+|||...+ .++.++||||+|+++|+|++|+.||
T Consensus 129 H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF 207 (277)
T ss_dssp CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCC
Confidence 99999999999 7889999999999987655544556789999999998765 4889999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 208 ~~ 209 (277)
T 3f3z_A 208 SA 209 (277)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-17 Score=165.01 Aligned_cols=135 Identities=22% Similarity=0.420 Sum_probs=96.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||||+++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999997653221 1234568899999999888889999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.. ...+.. .+.+... ......+ ...+..+...|++.+|.+||++
T Consensus 277 ~~~~~-----~~~~~~--------~~~~~~~-----------~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 277 YYGMA-----HEEVIY--------YVRDGNI-----------LACPENC---------PLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp TTTSC-----HHHHHH--------HHHTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCC-----hHHHHH--------HHhCCCc-----------CCCCCCC---------CHHHHHHHHHHcccCcccCCCH
Confidence 86421 111110 0000000 0000001 1134577889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.++++..
T Consensus 324 ~~~~~~L~~~~~ 335 (343)
T 1luf_A 324 CSIHRILQRMCE 335 (343)
T ss_dssp HHHHHHHHHTTC
T ss_pred HHHHHHHHHHHh
Confidence 999999877644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.67 E-value=2.5e-17 Score=171.18 Aligned_cols=135 Identities=27% Similarity=0.466 Sum_probs=92.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||
T Consensus 303 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~ 382 (452)
T 1fmk_A 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382 (452)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654322 1223457789999999888889999999999999999999 89998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+... ...... +. ......+.. .+...+..+...|++.+|++||++.
T Consensus 383 ~~~~~-----~~~~~~--------i~---------------~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~ 429 (452)
T 1fmk_A 383 PGMVN-----REVLDQ--------VE---------------RGYRMPCPP-----ECPESLHDLMCQCWRKEPEERPTFE 429 (452)
T ss_dssp TTCCH-----HHHHHH--------HH---------------TTCCCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCH-----HHHHHH--------HH---------------cCCCCCCCC-----CCCHHHHHHHHHHccCChhhCcCHH
Confidence 65321 111100 00 000000000 0112345788999999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++...|+.+..
T Consensus 430 ~l~~~L~~~~~ 440 (452)
T 1fmk_A 430 YLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHTTTS
T ss_pred HHHHHHHHHhc
Confidence 99998877543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.3e-17 Score=161.23 Aligned_cols=136 Identities=24% Similarity=0.323 Sum_probs=92.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......|++.|+|||...+..++.++||||||+++|+|++ |..|
T Consensus 170 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp CCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999998654322 1123457889999999988889999999999999999999 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+... ....... ..... ...... ....+..+...|++.+|..||++
T Consensus 250 ~~~~~~-----~~~~~~~--------~~~~~-----------~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~ 296 (313)
T 3brb_A 250 YPGVQN-----HEMYDYL--------LHGHR-----------LKQPED---------CLDELYEIMYSCWRTDPLDRPTF 296 (313)
T ss_dssp STTCCG-----GGHHHHH--------HTTCC-----------CCCBTT---------CCHHHHHHHHHTTCSSGGGSCCH
T ss_pred CccCCH-----HHHHHHH--------HcCCC-----------CCCCcc---------ccHHHHHHHHHHcCCChhhCcCH
Confidence 864321 1111000 00000 000000 01134567889999999999999
Q ss_pred chhhHHHHHHhhh
Q 041230 157 NDVESRLRSIKMK 169 (485)
Q Consensus 157 ~~v~~~L~~i~~~ 169 (485)
.++...++.+...
T Consensus 297 ~~l~~~L~~l~~~ 309 (313)
T 3brb_A 297 SVLRLQLEKLLES 309 (313)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999998887553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.2e-17 Score=167.14 Aligned_cols=79 Identities=32% Similarity=0.454 Sum_probs=69.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCC----CCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSE----VSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+++....... ..+.+||+.|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 191 HrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~ 270 (410)
T 3v8s_A 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270 (410)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSS
T ss_pred eccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCC
Confidence 999999999999999999999999987654432 23578999999999987654 778999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 271 ~Pf~~ 275 (410)
T 3v8s_A 271 TPFYA 275 (410)
T ss_dssp CTTCC
T ss_pred CCCCC
Confidence 99964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.1e-17 Score=170.33 Aligned_cols=127 Identities=29% Similarity=0.440 Sum_probs=93.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+..+ +.++||||+||++|+|++|+.||.+
T Consensus 139 HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 999999999999999999999999987665544556789999999999887765 6789999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
. +...+... +.+..+. ....+ -..+..+...|+..+|.+||++.++
T Consensus 219 ~-----~~~~~~~~--------i~~~~~~------------~p~~~---------s~~~~~Li~~~L~~dP~~Rpt~~ei 264 (476)
T 2y94_A 219 D-----HVPTLFKK--------ICDGIFY------------TPQYL---------NPSVISLLKHMLQVDPMKRATIKDI 264 (476)
T ss_dssp S-----SSHHHHHH--------HHTTCCC------------CCTTC---------CHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred C-----CHHHHHHH--------HhcCCcC------------CCccC---------CHHHHHHHHHHcCCCchhCcCHHHH
Confidence 2 11221111 1110000 00000 0123467789999999999999987
Q ss_pred hH
Q 041230 160 ES 161 (485)
Q Consensus 160 ~~ 161 (485)
..
T Consensus 265 l~ 266 (476)
T 2y94_A 265 RE 266 (476)
T ss_dssp HT
T ss_pred Hh
Confidence 54
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.66 E-value=7.1e-17 Score=170.81 Aligned_cols=80 Identities=34% Similarity=0.503 Sum_probs=71.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++....... ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+
T Consensus 312 HrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 999999999999999999999999987654332 3346899999999999988899999999999999999999999975
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 392 ~ 392 (543)
T 3c4z_A 392 R 392 (543)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.66 E-value=8e-18 Score=164.10 Aligned_cols=78 Identities=28% Similarity=0.463 Sum_probs=67.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCC-CCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSE-VSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+.. ++.++||||+||++|||++|..|+.
T Consensus 124 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 99999999999999999999999998764332 334567899999999987665 7899999999999999999988853
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-17 Score=177.40 Aligned_cols=135 Identities=28% Similarity=0.417 Sum_probs=95.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 571 (635)
T 4fl3_A 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571 (635)
T ss_dssp CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987643321 223457889999999988889999999999999999998 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+... ..+.. .+.. .....+.. .+...+.++...|++.+|++||+
T Consensus 572 Pf~~~~~-----~~~~~---------~i~~--------------~~~~~~p~-----~~~~~l~~li~~cl~~dP~~RPs 618 (635)
T 4fl3_A 572 PYRGMKG-----SEVTA---------MLEK--------------GERMGCPA-----GCPREMYDLMNLCWTYDVENRPG 618 (635)
T ss_dssp SSTTCCH-----HHHHH---------HHHT--------------TCCCCCCT-----TCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCH-----HHHHH---------HHHc--------------CCCCCCCC-----CCCHHHHHHHHHHcCCCHhHCcC
Confidence 9865321 11100 0000 00000000 01123457888999999999999
Q ss_pred cchhhHHHHHHhh
Q 041230 156 INDVESRLRSIKM 168 (485)
Q Consensus 156 m~~v~~~L~~i~~ 168 (485)
+.++.+.|+.+..
T Consensus 619 ~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 619 FAAVELRLRNYYY 631 (635)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999887644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-17 Score=158.49 Aligned_cols=134 Identities=25% Similarity=0.354 Sum_probs=91.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++...... .....+++.|+|||...+..++.++||||||+++|+|++ |+.|+..
T Consensus 140 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ccCCCcceEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999998754332 223467899999999888888999999999999999998 9999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ........... .... ....+ ...+..+...|++.+|..||++.++
T Consensus 218 ~~-----~~~~~~~~~~~-----~~~~--------------~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 218 IP-----LKDVVPRVEKG-----YKMD--------------APDGC---------PPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp SC-----GGGHHHHHTTT-----CCCC--------------CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CC-----HHHHHHHHhcC-----CCCC--------------CcccC---------CHHHHHHHHHHhcCChhhCCCHHHH
Confidence 31 11111100000 0000 00000 1124567789999999999999999
Q ss_pred hHHHHHHhhh
Q 041230 160 ESRLRSIKMK 169 (485)
Q Consensus 160 ~~~L~~i~~~ 169 (485)
...++.++..
T Consensus 265 ~~~L~~i~~~ 274 (278)
T 1byg_A 265 REQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999887654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.66 E-value=9.4e-17 Score=166.94 Aligned_cols=74 Identities=28% Similarity=0.464 Sum_probs=59.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC----------------------------ceeecccccCccccccc-CC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET----------------------------SFIDVMGTIGYVAPEYG-MG 51 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~ 51 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++ ..
T Consensus 179 HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 258 (458)
T 3rp9_A 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258 (458)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC
T ss_pred CCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC
Confidence 99999999999999999999999998653211 12346789999999975 45
Q ss_pred CCCCCccchhhHHHHHHHHHhCC
Q 041230 52 SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 52 ~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
..++.++|||||||++|||++|.
T Consensus 259 ~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 259 ENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CCCCcHhHHHHHHHHHHHHHHhc
Confidence 66899999999999999999943
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.66 E-value=4e-17 Score=158.84 Aligned_cols=79 Identities=34% Similarity=0.553 Sum_probs=64.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp CSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654322 23346789999999988654 57899999999999999999999986
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 203 ~ 203 (288)
T 1ob3_A 203 G 203 (288)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=163.95 Aligned_cols=80 Identities=26% Similarity=0.428 Sum_probs=62.8
Q ss_pred CCCCCCCcEEE----CCCCcEEEEeccCccccCCC----CceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHH
Q 041230 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMF 71 (485)
Q Consensus 1 HrDlk~~NiLl----~~~~~~kl~dfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~ 71 (485)
||||||+|||+ +.++.+||+|||+++..... ......+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 151 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 230 (405)
T 3rgf_A 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230 (405)
T ss_dssp CCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence 99999999999 77789999999999865432 123356899999999998764 4788999999999999999
Q ss_pred hCCCCCCCC
Q 041230 72 TGLRPNNGM 80 (485)
Q Consensus 72 ~G~~p~~~~ 80 (485)
+|+.||.+.
T Consensus 231 ~g~~pf~~~ 239 (405)
T 3rgf_A 231 TSEPIFHCR 239 (405)
T ss_dssp HSSCTTCCC
T ss_pred hCCCCCCCc
Confidence 999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.9e-17 Score=156.77 Aligned_cols=131 Identities=19% Similarity=0.218 Sum_probs=92.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCC---ccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSS---YGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.++++|||++..... ....||+.|+|||...+..++. ++||||||+++|||++|+.||
T Consensus 136 H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 211 (271)
T 3kmu_A 136 RHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211 (271)
T ss_dssp TCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTT
T ss_pred cCCCccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 999999999999999999999998764332 2357899999999987765544 799999999999999999998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ......... ....... ....+ ...+..+...|++.+|..||++.
T Consensus 212 ~~~~-----~~~~~~~~~----~~~~~~~--------------~~~~~---------~~~~~~li~~~l~~~p~~Rps~~ 259 (271)
T 3kmu_A 212 ADLS-----NMEIGMKVA----LEGLRPT--------------IPPGI---------SPHVSKLMKICMNEDPAKRPKFD 259 (271)
T ss_dssp TTSC-----HHHHHHHHH----HSCCCCC--------------CCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccC-----hHHHHHHHH----hcCCCCC--------------CCCCC---------CHHHHHHHHHHcCCChhhCcCHH
Confidence 6421 111100000 0000000 00000 11245677889999999999999
Q ss_pred hhhHHHHHHh
Q 041230 158 DVESRLRSIK 167 (485)
Q Consensus 158 ~v~~~L~~i~ 167 (485)
++.+.++.+.
T Consensus 260 ~il~~L~~l~ 269 (271)
T 3kmu_A 260 MIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHHhh
Confidence 9999987764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-17 Score=160.51 Aligned_cols=135 Identities=23% Similarity=0.362 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+..++.++||||+|+++|+|++ |+.||
T Consensus 143 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~ 222 (283)
T 3gen_A 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222 (283)
T ss_dssp CSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999998654321 1123456788999999888888999999999999999998 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
..... ..... .+.... ..... ... -..+..+...|++.+|.+||++.
T Consensus 223 ~~~~~-----~~~~~--------~~~~~~------------~~~~~--~~~------~~~l~~li~~~l~~~p~~Rps~~ 269 (283)
T 3gen_A 223 ERFTN-----SETAE--------HIAQGL------------RLYRP--HLA------SEKVYTIMYSCWHEKADERPTFK 269 (283)
T ss_dssp TTSCH-----HHHHH--------HHHTTC------------CCCCC--TTC------CHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cccCh-----hHHHH--------HHhccc------------CCCCC--CcC------CHHHHHHHHHHccCChhHCcCHH
Confidence 64211 11000 000000 00000 000 01245678899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++.+.+..+..
T Consensus 270 ~ll~~L~~~~~ 280 (283)
T 3gen_A 270 ILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99998877643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=4.4e-17 Score=162.71 Aligned_cols=77 Identities=29% Similarity=0.455 Sum_probs=68.0
Q ss_pred CCCCCCCcEEE-------------------CCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchh
Q 041230 1 HCDLKPSNVFL-------------------DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61 (485)
Q Consensus 1 HrDlk~~NiLl-------------------~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 61 (485)
||||||+|||+ +.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||
T Consensus 146 H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 223 (355)
T 2eu9_A 146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVW 223 (355)
T ss_dssp CCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred cCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchH
Confidence 99999999999 56789999999999864332 2346799999999999888899999999
Q ss_pred hHHHHHHHHHhCCCCCCC
Q 041230 62 SFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 62 s~Gv~l~el~~G~~p~~~ 79 (485)
||||++|||++|+.||.+
T Consensus 224 slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 224 SIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp HHHHHHHHHHHSSCSCCC
T ss_pred HHHHHHHHHHhCCCCCCC
Confidence 999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-17 Score=161.56 Aligned_cols=136 Identities=26% Similarity=0.371 Sum_probs=94.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|+|++ |+.
T Consensus 144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 223 (291)
T 1u46_A 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223 (291)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654321 123467889999999888788899999999999999999 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+.. ....+... .... ....... .....+.++...|++.+|.+||+
T Consensus 224 p~~~~~-----~~~~~~~~--------~~~~-------------~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps 271 (291)
T 1u46_A 224 PWIGLN-----GSQILHKI--------DKEG-------------ERLPRPE------DCPQDIYNVMVQCWAHKPEDRPT 271 (291)
T ss_dssp TTTTCC-----HHHHHHHH--------HTSC-------------CCCCCCT------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CcccCC-----HHHHHHHH--------HccC-------------CCCCCCc------CcCHHHHHHHHHHccCCcccCcC
Confidence 986431 11111100 0000 0000000 00123457788999999999999
Q ss_pred cchhhHHHHHHhh
Q 041230 156 INDVESRLRSIKM 168 (485)
Q Consensus 156 m~~v~~~L~~i~~ 168 (485)
+.++.+.++++..
T Consensus 272 ~~~l~~~l~~~~~ 284 (291)
T 1u46_A 272 FVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHHHHHC-
T ss_pred HHHHHHHHHHhCc
Confidence 9999998877543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=4.9e-17 Score=156.70 Aligned_cols=80 Identities=35% Similarity=0.549 Sum_probs=67.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+||+++.++.+||+|||++....... ......|++.|+|||...+..+ +.++||||||+++|+|++|+.|
T Consensus 128 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 207 (276)
T 2yex_A 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (276)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998653221 1234679999999999877665 6789999999999999999999
Q ss_pred CCCC
Q 041230 77 NNGM 80 (485)
Q Consensus 77 ~~~~ 80 (485)
|...
T Consensus 208 ~~~~ 211 (276)
T 2yex_A 208 WDQP 211 (276)
T ss_dssp CSCS
T ss_pred CCCC
Confidence 9653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.66 E-value=8e-17 Score=160.61 Aligned_cols=79 Identities=29% Similarity=0.410 Sum_probs=64.5
Q ss_pred CCCCCCCcEEECCCC--cEEEEeccCccccCCCC-----ceeecccccCcccccccCC--CCCCCccchhhHHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEM--TAHLGDFGIARFLPVET-----SFIDVMGTIGYVAPEYGMG--SEVSSYGDVYSFGILLLEMF 71 (485)
Q Consensus 1 HrDlk~~NiLl~~~~--~~kl~dfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~ 71 (485)
||||||+|||++.++ .+||+|||+++.+.... ......||+.|+|||.+.+ ..++.++||||||+++|||+
T Consensus 191 H~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 270 (345)
T 3hko_A 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270 (345)
T ss_dssp CCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHH
T ss_pred ccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999998776 89999999998653211 1234679999999998865 56788999999999999999
Q ss_pred hCCCCCCC
Q 041230 72 TGLRPNNG 79 (485)
Q Consensus 72 ~G~~p~~~ 79 (485)
+|+.||.+
T Consensus 271 ~g~~pf~~ 278 (345)
T 3hko_A 271 MGAVPFPG 278 (345)
T ss_dssp HSSCSSCC
T ss_pred HCCCCCCC
Confidence 99999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=160.29 Aligned_cols=77 Identities=29% Similarity=0.414 Sum_probs=69.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ....+||+.|+|||.+.+..++.++|+|||||++|||++|+.||.+
T Consensus 164 HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 9999999999999999999999999865432 2356899999999999888899999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.4e-17 Score=160.87 Aligned_cols=77 Identities=30% Similarity=0.422 Sum_probs=67.9
Q ss_pred CCCCCCCcEEECC-------------------CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchh
Q 041230 1 HCDLKPSNVFLDD-------------------EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVY 61 (485)
Q Consensus 1 HrDlk~~NiLl~~-------------------~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 61 (485)
||||||+|||++. ++.+||+|||+++..... .....||+.|+|||...+..++.++|||
T Consensus 141 H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 218 (339)
T 1z57_A 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVW 218 (339)
T ss_dssp CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHH
T ss_pred CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhH
Confidence 9999999999987 667999999999864432 2346799999999999888899999999
Q ss_pred hHHHHHHHHHhCCCCCCC
Q 041230 62 SFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 62 s~Gv~l~el~~G~~p~~~ 79 (485)
||||++|||++|+.||.+
T Consensus 219 slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 219 SIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp HHHHHHHHHHHSSCSCCC
T ss_pred HHHHHHHHHHhCCCCCCC
Confidence 999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=160.36 Aligned_cols=79 Identities=28% Similarity=0.479 Sum_probs=67.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-----CceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-----TSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 147 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 226 (351)
T 3mi9_A 147 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226 (351)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999865422 12234678999999998875 45789999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 227 ~pf~~ 231 (351)
T 3mi9_A 227 PIMQG 231 (351)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 99875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.66 E-value=7.3e-17 Score=160.53 Aligned_cols=137 Identities=24% Similarity=0.355 Sum_probs=98.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|||++ |..|
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986654322 123457889999999888888999999999999999999 9999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.. ...+..... .-.. ......+ ...+..+...|++.+|..||++
T Consensus 260 ~~~~~-----~~~~~~~~~-----~~~~--------------~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~ 306 (334)
T 2pvf_A 260 YPGIP-----VEELFKLLK-----EGHR--------------MDKPANC---------TNELYMMMRDCWHAVPSQRPTF 306 (334)
T ss_dssp STTCC-----HHHHHHHHH-----HTCC--------------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCcCC-----HHHHHHHHh-----cCCC--------------CCCCccC---------CHHHHHHHHHHccCChhhCcCH
Confidence 86421 111110000 0000 0000001 1124567889999999999999
Q ss_pred chhhHHHHHHhhhh
Q 041230 157 NDVESRLRSIKMKL 170 (485)
Q Consensus 157 ~~v~~~L~~i~~~~ 170 (485)
.++...++.+....
T Consensus 307 ~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 307 KQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcc
Confidence 99999998876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.1e-17 Score=166.70 Aligned_cols=78 Identities=29% Similarity=0.466 Sum_probs=63.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----------------------ceeecccccCccccccc-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----------------------SFIDVMGTIGYVAPEYG-MGSEVSS 56 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~ 56 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||.+ ....++.
T Consensus 152 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 231 (432)
T 3n9x_A 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231 (432)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCT
T ss_pred CCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCc
Confidence 99999999999999999999999998754321 12456899999999985 5566899
Q ss_pred ccchhhHHHHHHHHHhCCCCCC
Q 041230 57 YGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 57 ~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
++||||+||++|||++|..|+.
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccchHHHHHHHHHhcccccc
Confidence 9999999999999999766653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.4e-17 Score=158.44 Aligned_cols=78 Identities=31% Similarity=0.520 Sum_probs=61.9
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||+ +.++.+||+|||+++............||+.|+|||... ..++.++||||+|+++|||++|+.||
T Consensus 147 H~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp CCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCC
Confidence 99999999999 556789999999998765444445568999999999875 56788999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 226 ~~ 227 (285)
T 3is5_A 226 TG 227 (285)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.66 E-value=7.8e-17 Score=155.99 Aligned_cols=79 Identities=34% Similarity=0.546 Sum_probs=66.0
Q ss_pred CCCCCCCcEEECCCC----cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM----TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~----~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+||+++.++ .+||+|||++.............|++.|+|||...+..++.++||||||+++|+|++|+.|
T Consensus 131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 210 (283)
T 3bhy_A 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210 (283)
T ss_dssp CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCC
Confidence 999999999998877 7999999999876544444456799999999999888899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 211 ~~~ 213 (283)
T 3bhy_A 211 FLG 213 (283)
T ss_dssp TCC
T ss_pred CCC
Confidence 865
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-17 Score=163.10 Aligned_cols=137 Identities=24% Similarity=0.317 Sum_probs=94.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----------eeecccccCcccccccCCCC---CCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----------FIDVMGTIGYVAPEYGMGSE---VSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l 67 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+.. ++.++||||||+++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875432110 11245799999999886543 68899999999999
Q ss_pred HHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 68 LEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 68 ~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|+|++|+.||.............+... + .... .... ...+..+...|++
T Consensus 237 ~el~~g~~p~~~~~~~~~~~~~~~~~~------------~------------~~~~-~~~~------~~~l~~li~~~l~ 285 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGDSVALAVQNQ------------L------------SIPQ-SPRH------SSALWQLLNSMMT 285 (317)
T ss_dssp HHHHHSSCTTHHHHHTTSCHHHHHHCC--------------------------CCC-CTTS------CHHHHHHHHHHTC
T ss_pred HHHHhCCCChhhhhcccchhhHHhhcc------------C------------CCCc-cccC------CHHHHHHHHHHhh
Confidence 999999999843211111111000000 0 0000 0000 1124567889999
Q ss_pred cCCCcccccchhhHHHHHHhh
Q 041230 148 ELPDERMDINDVESRLRSIKM 168 (485)
Q Consensus 148 ~~p~~RP~m~~v~~~L~~i~~ 168 (485)
.+|.+||++.++.+.++.+..
T Consensus 286 ~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 286 VDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp SSGGGSCCHHHHHHHHHHTCC
T ss_pred cChhhCCCHHHHHHHhhhcCC
Confidence 999999999999999877644
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-17 Score=162.97 Aligned_cols=144 Identities=13% Similarity=0.090 Sum_probs=99.0
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCC--------------cchHHHHHHHHHHHhcCCCcceeEeeeec
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--------------GGARSFKSECKAAINIRHRNIVRVFTAVS 261 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~--------------~~~~~f~~E~~~l~~l~H~niv~l~~~~~ 261 (485)
-|+....||+|+||.||+|...+|+.||||+++.... .....++.++++.+...|+|++++.....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3778899999999999999988899999998753210 01123334444444444555555533211
Q ss_pred cccc-CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceE
Q 041230 262 GVDY-QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVL 340 (485)
Q Consensus 262 ~~~~-~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NIL 340 (485)
.... ......+|||||+++++|.++.... ....++.+++.+|.||| ..+||||||||.|||
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~---------------~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVP---------------DPASLYADLIALILRLA---KHGLIHGDFNEFNIL 237 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCS---------------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccH---------------HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence 1000 0011236999999999987654321 12357899999999999 568999999999999
Q ss_pred ecCCC----------cEEEeecccccc
Q 041230 341 LDDEM----------IGHVGDFSMARF 357 (485)
Q Consensus 341 ld~~~----------~~ki~DFGla~~ 357 (485)
+++++ .+.|.||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 98876 489999997754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.6e-16 Score=157.77 Aligned_cols=79 Identities=35% Similarity=0.523 Sum_probs=63.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.
T Consensus 147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999865432 223446799999999998765 67889999999999999999999986
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 227 ~ 227 (331)
T 4aaa_A 227 G 227 (331)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=2.4e-17 Score=160.66 Aligned_cols=136 Identities=27% Similarity=0.413 Sum_probs=96.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce----eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF----IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++........ ....|++.|+|||...+..++.++||||||+++|+|++ |+.
T Consensus 140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 219 (291)
T 1xbb_A 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219 (291)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999876543221 22356788999999888788899999999999999999 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+... ...... +.. ........ .....+..+...|++.+|..||+
T Consensus 220 p~~~~~~-----~~~~~~--------~~~---------------~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps 266 (291)
T 1xbb_A 220 PYRGMKG-----SEVTAM--------LEK---------------GERMGCPA-----GCPREMYDLMNLCWTYDVENRPG 266 (291)
T ss_dssp SSTTCCH-----HHHHHH--------HHT---------------TCCCCCCT-----TCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCH-----HHHHHH--------HHc---------------CCCCCCCC-----CCCHHHHHHHHHHcCCChhhCcC
Confidence 9864211 111000 000 00000000 00113457788999999999999
Q ss_pred cchhhHHHHHHhhh
Q 041230 156 INDVESRLRSIKMK 169 (485)
Q Consensus 156 m~~v~~~L~~i~~~ 169 (485)
+.++.+.++.+-..
T Consensus 267 ~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 267 FAAVELRLRNYYYD 280 (291)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999998886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=157.77 Aligned_cols=135 Identities=24% Similarity=0.342 Sum_probs=84.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||++....... ......|++.|+|||...+..++.++||||||+++|+|++|+.||.
T Consensus 157 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp CSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999997654322 2234679999999999988888999999999999999999999986
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc-ccc
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM-DIN 157 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP-~m~ 157 (485)
+... ..+... ........ ......+ ...+..+...|++.+|++|| ++.
T Consensus 237 ~~~~------~~~~~~----~~~~~~~~------------~~~~~~~---------~~~l~~li~~~l~~dP~~Rp~s~~ 285 (309)
T 2h34_A 237 GDQL------SVMGAH----INQAIPRP------------STVRPGI---------PVAFDAVIARGMAKNPEDRYVTCG 285 (309)
T ss_dssp SCHH------HHHHHH----HHSCCCCG------------GGTSTTC---------CTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CchH------HHHHHH----hccCCCCc------------cccCCCC---------CHHHHHHHHHhccCCHHHHHHhHH
Confidence 4210 000000 00000000 0000000 01245677899999999999 888
Q ss_pred hhhHHHHHH
Q 041230 158 DVESRLRSI 166 (485)
Q Consensus 158 ~v~~~L~~i 166 (485)
++...++..
T Consensus 286 ~l~~~l~~~ 294 (309)
T 2h34_A 286 DLSAAAHAA 294 (309)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHH
Confidence 888777654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=162.27 Aligned_cols=80 Identities=30% Similarity=0.432 Sum_probs=69.5
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++ .++.+||+|||+++............||+.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 999999999998 6889999999999876554444556889999999987765 48999999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 244 ~~ 245 (383)
T 3eb0_A 244 GE 245 (383)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.65 E-value=7.4e-17 Score=163.99 Aligned_cols=80 Identities=19% Similarity=0.219 Sum_probs=67.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--------ceeecccccCcccccccCC--CCCCCccchhhHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMG--SEVSSYGDVYSFGILLLEM 70 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el 70 (485)
||||||+|||++.++.+||+|||.+....... .....+||+.|+|||.+.+ ..++.++||||+||++|||
T Consensus 151 HrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 230 (389)
T 3gni_B 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230 (389)
T ss_dssp CCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHH
Confidence 99999999999999999999999886432111 1122478999999999877 5789999999999999999
Q ss_pred HhCCCCCCCC
Q 041230 71 FTGLRPNNGM 80 (485)
Q Consensus 71 ~~G~~p~~~~ 80 (485)
++|+.||.+.
T Consensus 231 ~~g~~pf~~~ 240 (389)
T 3gni_B 231 ANGHVPFKDM 240 (389)
T ss_dssp HHSSCTTTTC
T ss_pred HHCCCCCCCC
Confidence 9999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4.6e-17 Score=159.16 Aligned_cols=145 Identities=23% Similarity=0.380 Sum_probs=96.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||..|+|||...+..++.++||||+|+++|+|++|..|
T Consensus 149 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (302)
T 4e5w_A 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS 228 (302)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred cCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCC
Confidence 999999999999999999999999987654332 2235688889999998888888999999999999999999887
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHH---HHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEE---ETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
+... .........+ . ....... ............. .....+.++...|++.+|.+|
T Consensus 229 ~~~~------~~~~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~R 287 (302)
T 4e5w_A 229 DSSP------MALFLKMIGP---------T-HGQMTVTRLVNTLKEGKRLPCPP-----NCPDEVYQLMRKCWEFQPSNR 287 (302)
T ss_dssp GGSH------HHHHHHHHCS---------C-CGGGHHHHHHHHHHTTCCCCCCT-----TCCHHHHHHHHHTTCSSGGGS
T ss_pred Ccch------hhHHhhccCC---------c-ccccCHHHHHHHHhccCCCCCCC-----CCCHHHHHHHHHHcCCCCCCC
Confidence 5321 1110000000 0 0000000 0000000000000 011235678889999999999
Q ss_pred cccchhhHHHHHH
Q 041230 154 MDINDVESRLRSI 166 (485)
Q Consensus 154 P~m~~v~~~L~~i 166 (485)
|++.++.+.++.+
T Consensus 288 ps~~~ll~~L~~l 300 (302)
T 4e5w_A 288 TSFQNLIEGFEAL 300 (302)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHH
Confidence 9999999998765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-16 Score=158.00 Aligned_cols=79 Identities=37% Similarity=0.521 Sum_probs=65.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||.+
T Consensus 144 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp CCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999999754322 223456899999999999888899999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=165.70 Aligned_cols=132 Identities=20% Similarity=0.355 Sum_probs=85.5
Q ss_pred CCCCCCCcEEECCC-------------CcEEEEeccCccccCCCCc-----eeecccccCcccccccCC-------CCCC
Q 041230 1 HCDLKPSNVFLDDE-------------MTAHLGDFGIARFLPVETS-----FIDVMGTIGYVAPEYGMG-------SEVS 55 (485)
Q Consensus 1 HrDlk~~NiLl~~~-------------~~~kl~dfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~ 55 (485)
||||||+|||++.+ +.+||+|||+++....... ....+||+.|+|||++.+ ..++
T Consensus 138 HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 217 (434)
T 2rio_A 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217 (434)
T ss_dssp CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc
Confidence 99999999999754 4899999999987654321 234679999999999865 5678
Q ss_pred CccchhhHHHHHHHHHh-CCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHH
Q 041230 56 SYGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILEC 134 (485)
Q Consensus 56 ~~~Dv~s~Gv~l~el~~-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (485)
.++|||||||++|||++ |+.||...... ...++... .... ...+... ...
T Consensus 218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~i~~~~--------~~~~---------------~~~~~~~---~~~ 268 (434)
T 2rio_A 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSR---ESNIIRGI--------FSLD---------------EMKCLHD---RSL 268 (434)
T ss_dssp THHHHHHHHHHHHHHHTTSCCTTCSTTTH---HHHHHHTC--------CCCC---------------CCTTCCC---HHH
T ss_pred hhhhhHhHHHHHHHHHhCCCCCCCCchhh---HHHHhcCC--------CCcc---------------ccccccc---ccc
Confidence 89999999999999999 89998542211 00111000 0000 0000000 011
Q ss_pred HHHHHHHHHhhhccCCCcccccchhhH
Q 041230 135 LISICRIGVACSAELPDERMDINDVES 161 (485)
Q Consensus 135 ~~~~~~l~~~C~~~~p~~RP~m~~v~~ 161 (485)
...+.++...|++.+|..||++.++.+
T Consensus 269 ~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 269 IAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 123457788999999999999988753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.1e-17 Score=162.64 Aligned_cols=136 Identities=24% Similarity=0.309 Sum_probs=95.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++............+++.|+|||...+..++.++||||||+++|||++ |+.||.+
T Consensus 165 H~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 165 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999999975432222233467889999999888788999999999999999998 9999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ...+..... . .+. ......+ ...+..+...|+..+|.+||++.++
T Consensus 245 ~~-----~~~~~~~~~--------~-~~~----------~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 245 MT-----CAELYEKLP--------Q-GYR----------LEKPLNC---------DDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp CC-----HHHHHHHGG--------G-TCC----------CCCCTTB---------CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred Cc-----HHHHHHHhh--------c-CCC----------CCCCCCC---------CHHHHHHHHHHccCChhhCcCHHHH
Confidence 31 111111100 0 000 0000000 1124567889999999999999999
Q ss_pred hHHHHHHhhh
Q 041230 160 ESRLRSIKMK 169 (485)
Q Consensus 160 ~~~L~~i~~~ 169 (485)
...++.+...
T Consensus 292 l~~L~~~~~~ 301 (327)
T 1fvr_A 292 LVSLNRMLEE 301 (327)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHHHh
Confidence 9988876654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.9e-17 Score=161.74 Aligned_cols=79 Identities=37% Similarity=0.507 Sum_probs=58.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccC-----CCCCCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM-----GSEVSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+|||++.++.+||+|||++.............||+.|+|||... ...++.++||||||+++|||++|+.
T Consensus 148 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred eCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 99999999999999999999999997665444344567999999999984 4567889999999999999999999
Q ss_pred CCCC
Q 041230 76 PNNG 79 (485)
Q Consensus 76 p~~~ 79 (485)
||..
T Consensus 228 pf~~ 231 (318)
T 2dyl_A 228 PYKN 231 (318)
T ss_dssp TTTT
T ss_pred CCCC
Confidence 9864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.65 E-value=4.4e-17 Score=158.20 Aligned_cols=136 Identities=23% Similarity=0.379 Sum_probs=97.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+||+++.++.+||+|||++........ .....||+.|+|||...+..++.++||||+|+++|+|++ |..|+
T Consensus 134 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~ 213 (288)
T 3kfa_A 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213 (288)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987654322 223567889999999888888999999999999999999 98888
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+... ....... ....... ....+ ...+.++...|+..+|.+||++.
T Consensus 214 ~~~~~-----~~~~~~~-----~~~~~~~--------------~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ 260 (288)
T 3kfa_A 214 PGIDL-----SQVYELL-----EKDYRME--------------RPEGC---------PEKVYELMRACWQWNPSDRPSFA 260 (288)
T ss_dssp TTCCG-----GGHHHHH-----HTTCCCC--------------CCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCH-----HHHHHHH-----hccCCCC--------------CCCCC---------CHHHHHHHHHHhCCChhhCcCHH
Confidence 64321 1111000 0000000 00000 11245678899999999999999
Q ss_pred hhhHHHHHHhhh
Q 041230 158 DVESRLRSIKMK 169 (485)
Q Consensus 158 ~v~~~L~~i~~~ 169 (485)
++.+.++.+...
T Consensus 261 ~~~~~l~~~~~~ 272 (288)
T 3kfa_A 261 EIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999988776553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-17 Score=165.35 Aligned_cols=151 Identities=23% Similarity=0.340 Sum_probs=97.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|+|++|..|
T Consensus 150 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp CSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987654332 1234688889999998888889999999999999999999998
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.... .......... . +....... .......... .... .+...+.++...|++.+|.+||++
T Consensus 230 ~~~~~------~~~~~~~~~~--~---~~~~~~~~--~~~~~~~~~~-~~~~----~~~~~l~~li~~~l~~dP~~Rps~ 291 (327)
T 3lxl_A 230 SCSPS------AEFLRMMGCE--R---DVPALSRL--LELLEEGQRL-PAPP----ACPAEVHELMKLCWAPSPQDRPSF 291 (327)
T ss_dssp GGSHH------HHHHHHCC---------CCHHHHH--HHHHHTTCCC-CCCT----TCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred Ccccc------chhhhhcccc--c---ccccHHHH--HHHhhcccCC-CCCC----cccHHHHHHHHHHcCCChhhCcCH
Confidence 75311 0000000000 0 00000000 0000000000 0000 011234578889999999999999
Q ss_pred chhhHHHHHHhhh
Q 041230 157 NDVESRLRSIKMK 169 (485)
Q Consensus 157 ~~v~~~L~~i~~~ 169 (485)
.++.+.++.+...
T Consensus 292 ~ell~~L~~~~~~ 304 (327)
T 3lxl_A 292 SALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHHHHC---
T ss_pred HHHHHHHHHHHhh
Confidence 9999998876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.65 E-value=1.6e-16 Score=156.98 Aligned_cols=80 Identities=33% Similarity=0.495 Sum_probs=71.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||...+..++.++||||||+++|+|++|+.||.+.
T Consensus 143 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 143 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999998665433344567999999999998888999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=4.1e-17 Score=158.65 Aligned_cols=137 Identities=26% Similarity=0.373 Sum_probs=98.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce----eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF----IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++........ ....||+.|+|||...+..++.++||||||+++|||++ |+.
T Consensus 133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876433221 23456889999999887888999999999999999998 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+... ........ .-... .....+ ...+..+...|++.+|..||+
T Consensus 213 p~~~~~~-----~~~~~~i~-----~~~~~--------------~~~~~~---------~~~l~~li~~~l~~~p~~Rps 259 (287)
T 1u59_A 213 PYKKMKG-----PEVMAFIE-----QGKRM--------------ECPPEC---------PPELYALMSDCWIYKWEDRPD 259 (287)
T ss_dssp TTTTCCT-----HHHHHHHH-----TTCCC--------------CCCTTC---------CHHHHHHHHHTTCSSGGGSCC
T ss_pred CcccCCH-----HHHHHHHh-----cCCcC--------------CCCCCc---------CHHHHHHHHHHcCCChhhCcC
Confidence 9864321 11110000 00000 000001 113456788999999999999
Q ss_pred cchhhHHHHHHhhhh
Q 041230 156 INDVESRLRSIKMKL 170 (485)
Q Consensus 156 m~~v~~~L~~i~~~~ 170 (485)
+.++...++.+....
T Consensus 260 ~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 260 FLTVEQRMRACYYSL 274 (287)
T ss_dssp HHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhc
Confidence 999999988876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=156.71 Aligned_cols=80 Identities=30% Similarity=0.507 Sum_probs=63.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||...+ ..++.++||||+|+++|+|++|+.||.
T Consensus 125 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 204 (311)
T 4agu_A 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP 204 (311)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998765332 2345679999999998865 567899999999999999999999986
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 205 ~~ 206 (311)
T 4agu_A 205 GK 206 (311)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=7.7e-17 Score=162.03 Aligned_cols=79 Identities=29% Similarity=0.398 Sum_probs=60.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||...+ ..++.++||||+||++|+|++|+.||.+
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999986544444445689999999998876 5688999999999999999999999965
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=159.15 Aligned_cols=135 Identities=27% Similarity=0.390 Sum_probs=91.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||||+++|||++ |+.
T Consensus 170 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999986543221 122346788999999988889999999999999999999 999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+.. ...+... +.+.. .. .... .....+.++...|++.+|..||+
T Consensus 250 pf~~~~-----~~~~~~~--------~~~~~-------------~~-~~~~------~~~~~l~~li~~~l~~~p~~Rps 296 (333)
T 1mqb_A 250 PYWELS-----NHEVMKA--------INDGF-------------RL-PTPM------DCPSAIYQLMMQCWQQERARRPK 296 (333)
T ss_dssp TTTTCC-----HHHHHHH--------HHTTC-------------CC-CCCT------TCBHHHHHHHHHHTCSSTTTSCC
T ss_pred CcccCC-----HHHHHHH--------HHCCC-------------cC-CCcc------cCCHHHHHHHHHHcCCChhhCcC
Confidence 985421 1111100 00000 00 0000 00113457888999999999999
Q ss_pred cchhhHHHHHHhh
Q 041230 156 INDVESRLRSIKM 168 (485)
Q Consensus 156 m~~v~~~L~~i~~ 168 (485)
+.++.+.++.+..
T Consensus 297 ~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 297 FADIVSILDKLIR 309 (333)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999887654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.65 E-value=4.3e-17 Score=157.60 Aligned_cols=136 Identities=26% Similarity=0.428 Sum_probs=97.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||++........ .....|++.|+|||...+..++.++||||||+++|||++ |+.||
T Consensus 132 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 211 (279)
T 1qpc_A 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (279)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987654321 123457789999999887788999999999999999999 88888
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ........ .. .+ . ...... ....+..+...|++.+|++||++.
T Consensus 212 ~~~~-----~~~~~~~~--------~~-~~-----------~--~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~ 258 (279)
T 1qpc_A 212 PGMT-----NPEVIQNL--------ER-GY-----------R--MVRPDN------CPEELYQLMRLCWKERPEDRPTFD 258 (279)
T ss_dssp TTCC-----HHHHHHHH--------HT-TC-----------C--CCCCTT------CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccC-----HHHHHHHH--------hc-cc-----------C--CCCccc------ccHHHHHHHHHHhccChhhCCCHH
Confidence 6421 11111000 00 00 0 000000 011345678899999999999999
Q ss_pred hhhHHHHHHhhh
Q 041230 158 DVESRLRSIKMK 169 (485)
Q Consensus 158 ~v~~~L~~i~~~ 169 (485)
++.+.++.+...
T Consensus 259 ~l~~~l~~~~~~ 270 (279)
T 1qpc_A 259 YLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999998876553
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=160.35 Aligned_cols=79 Identities=30% Similarity=0.454 Sum_probs=68.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||.+.+. .++.++|||||||++|||++|..||.
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999999999866432 233456899999999988654 47889999999999999999999886
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 215 ~ 215 (346)
T 1ua2_A 215 G 215 (346)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=158.16 Aligned_cols=131 Identities=24% Similarity=0.354 Sum_probs=90.7
Q ss_pred CCCCCCCcEEECCCCc---EEEEeccCccccCCCCceeecccccCcccccccC---CCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMT---AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM---GSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~---~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++. +||+|||+++............||+.|+|||.+. ...++.++|||||||++|+|++|.
T Consensus 137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216 (322)
T ss_dssp CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999987654 9999999998765443334567999999999863 456788999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.||...... ..+...+..... .+... ... .....+.++...|+..+|.+||
T Consensus 217 ~pf~~~~~~-~~~~~~~~~~~~---------~~~~~------~~~-------------~~~~~~~~li~~~l~~dP~~Rp 267 (322)
T 2ycf_A 217 PPFSEHRTQ-VSLKDQITSGKY---------NFIPE------VWA-------------EVSEKALDLVKKLLVVDPKARF 267 (322)
T ss_dssp CSSCSTTCS-SCHHHHHHHTCC---------CCCHH------HHT-------------TSCHHHHHHHHHHSCSSTTTSC
T ss_pred CCCcccchH-HHHHHHHHhCcc---------ccCch------hhh-------------hcCHHHHHHHHHHcccCHhhCC
Confidence 998653221 111111111000 00000 000 0011245678899999999999
Q ss_pred ccchhh
Q 041230 155 DINDVE 160 (485)
Q Consensus 155 ~m~~v~ 160 (485)
++.++.
T Consensus 268 s~~~~l 273 (322)
T 2ycf_A 268 TTEEAL 273 (322)
T ss_dssp CHHHHH
T ss_pred CHHHHh
Confidence 998865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.2e-16 Score=159.60 Aligned_cols=77 Identities=31% Similarity=0.467 Sum_probs=64.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.... .....+||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+
T Consensus 167 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 167 HRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp CSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcCHHHeEECCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999985432 2334678999999998876 6788999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-16 Score=160.00 Aligned_cols=78 Identities=32% Similarity=0.480 Sum_probs=59.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+
T Consensus 155 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 155 HRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999864322 334689999999999876 5788999999999999999999999975
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 233 ~ 233 (367)
T 2fst_X 233 T 233 (367)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.8e-17 Score=164.88 Aligned_cols=160 Identities=18% Similarity=0.244 Sum_probs=100.1
Q ss_pred CCCCCCCcEEE----CCCCcEEEEeccCccccCCCCceeecccccCcccccccCC--------CCCCCccchhhHHHHHH
Q 041230 1 HCDLKPSNVFL----DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG--------SEVSSYGDVYSFGILLL 68 (485)
Q Consensus 1 HrDlk~~NiLl----~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gv~l~ 68 (485)
||||||+|||+ +.++.+||+|||+++...........+||+.|+|||...+ ..++.++|||||||++|
T Consensus 135 H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~ 214 (396)
T 4eut_A 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (396)
T ss_dssp CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHH
T ss_pred ECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHH
Confidence 99999999999 7788899999999987665544556789999999998754 45678899999999999
Q ss_pred HHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhc---hhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhh
Q 041230 69 EMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILD---VAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVAC 145 (485)
Q Consensus 69 el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 145 (485)
||++|+.||......... ...+...+......... ......+.+. ......+.-. ...-..+..+...|
T Consensus 215 el~tg~~Pf~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~l~---~~~~~~l~~ll~~~ 286 (396)
T 4eut_A 215 HAATGSLPFRPFEGPRRN-KEVMYKIITGKPSGAISGVQKAENGPIDWS----GDMPVSCSLS---RGLQVLLTPVLANI 286 (396)
T ss_dssp HHHHSSCSEECTTCTTTC-HHHHHHHHHSCCTTCCEEEECSTTCCEEEE----SSCCTTCSSC---HHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCcccch-HHHHHHHhcCCCcccchhheeccCCCcccC----ccCCcccccc---hHHHhhchHHHHHh
Confidence 999999998653322211 11111111100000000 0000000000 0000001101 11222345788899
Q ss_pred hccCCCcccccchhhHHHHHHhh
Q 041230 146 SAELPDERMDINDVESRLRSIKM 168 (485)
Q Consensus 146 ~~~~p~~RP~m~~v~~~L~~i~~ 168 (485)
++.+|++||++.++...+..+..
T Consensus 287 L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 287 LEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp SCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hccChhhhccHHHHHHHHHHHhh
Confidence 99999999999998877766543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.8e-17 Score=160.17 Aligned_cols=80 Identities=31% Similarity=0.519 Sum_probs=63.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.
T Consensus 123 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (324)
T 3mtl_A 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202 (324)
T ss_dssp ESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654322 2344678999999998876 567899999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 203 ~~ 204 (324)
T 3mtl_A 203 GS 204 (324)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=154.52 Aligned_cols=80 Identities=30% Similarity=0.497 Sum_probs=49.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||+++.++.+||+|||++....... ......||+.|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus 135 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp CSSCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998654322 22346799999999999888889999999999999999999999865
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 215 ~ 215 (278)
T 3cok_A 215 D 215 (278)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=3.2e-17 Score=157.24 Aligned_cols=135 Identities=26% Similarity=0.380 Sum_probs=96.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+||+++.++.+||+|||+++...... ......|++.|+|||...+..++.++|+||+|+++|+|++ |+.||
T Consensus 127 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp CSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCC
Confidence 99999999999999999999999998654321 1123457788999999887888999999999999999999 88888
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.... ....... +... + ..... .. ....+.++...|++.+|..||++.
T Consensus 207 ~~~~-----~~~~~~~--------i~~~-~-----------~~~~~--~~------~~~~l~~li~~~l~~~p~~Rps~~ 253 (267)
T 3t9t_A 207 ENRS-----NSEVVED--------ISTG-F-----------RLYKP--RL------ASTHVYQIMNHCWRERPEDRPAFS 253 (267)
T ss_dssp TTCC-----HHHHHHH--------HHTT-C-----------CCCCC--TT------SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC-----HHHHHHH--------HhcC-C-----------cCCCC--cc------CcHHHHHHHHHHccCChhhCcCHH
Confidence 6421 1111100 0000 0 00000 00 011245678899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++...++.+..
T Consensus 254 ~ll~~L~~l~~ 264 (267)
T 3t9t_A 254 RLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999887654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=6.2e-17 Score=157.19 Aligned_cols=132 Identities=20% Similarity=0.226 Sum_probs=91.2
Q ss_pred CCCCCCCcEEECCCCc--------EEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMT--------AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMF 71 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~--------~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~ 71 (485)
||||||+|||++.++. +||+|||++...... ....||+.|+|||...+ ..++.++||||||+++|||+
T Consensus 136 H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 9999999999998887 999999998754322 23568999999999877 66889999999999999999
Q ss_pred hCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCC
Q 041230 72 TGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPD 151 (485)
Q Consensus 72 ~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~ 151 (485)
+|..|+.... ...... ..... ......... ..+..+...|++.+|.
T Consensus 213 ~g~~~~~~~~----~~~~~~---------~~~~~------------~~~~~~~~~---------~~l~~li~~~l~~dp~ 258 (289)
T 4fvq_A 213 SGGDKPLSAL----DSQRKL---------QFYED------------RHQLPAPKA---------AELANLINNCMDYEPD 258 (289)
T ss_dssp TTTCCTTTTS----CHHHHH---------HHHHT------------TCCCCCCSS---------CTTHHHHHHHSCSSGG
T ss_pred cCCCCCcccc----chHHHH---------HHhhc------------cCCCCCCCC---------HHHHHHHHHHcCCChh
Confidence 9655542211 110000 00000 000000000 1234677899999999
Q ss_pred cccccchhhHHHHHHhhh
Q 041230 152 ERMDINDVESRLRSIKMK 169 (485)
Q Consensus 152 ~RP~m~~v~~~L~~i~~~ 169 (485)
+||++.++.+.++++...
T Consensus 259 ~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 259 HRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp GSCCHHHHHHHHHTCC--
T ss_pred HCcCHHHHHHHHHHhcCC
Confidence 999999999998876553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.8e-16 Score=159.35 Aligned_cols=79 Identities=33% Similarity=0.505 Sum_probs=66.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCC--CCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMG--SEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 182 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp CCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998653221 2234689999999999875 3467899999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|..
T Consensus 262 f~~ 264 (355)
T 1vzo_A 262 FTV 264 (355)
T ss_dssp TSC
T ss_pred Ccc
Confidence 864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=157.95 Aligned_cols=133 Identities=21% Similarity=0.355 Sum_probs=95.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||...+..++.++||||+|+++|+|++ |..|
T Consensus 161 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 161 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986543221 123467889999999888888999999999999999999 8888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+.. ....... +.... ....... ....+..+...|++.+|..||++
T Consensus 241 ~~~~~-----~~~~~~~--------~~~~~--------------~~~~~~~------~~~~l~~li~~~l~~dp~~Rps~ 287 (322)
T 1p4o_A 241 YQGLS-----NEQVLRF--------VMEGG--------------LLDKPDN------CPDMLFELMRMCWQYNPKMRPSF 287 (322)
T ss_dssp TTTSC-----HHHHHHH--------HHTTC--------------CCCCCTT------CCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cccCC-----HHHHHHH--------HHcCC--------------cCCCCCC------CCHHHHHHHHHHcCCCcccCcCH
Confidence 85421 1111100 00000 0000000 01124567889999999999999
Q ss_pred chhhHHHHHH
Q 041230 157 NDVESRLRSI 166 (485)
Q Consensus 157 ~~v~~~L~~i 166 (485)
.++.+.++..
T Consensus 288 ~e~l~~L~~~ 297 (322)
T 1p4o_A 288 LEIISSIKEE 297 (322)
T ss_dssp HHHHHHHGGG
T ss_pred HHHHHHHHHh
Confidence 9999888765
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=8.1e-17 Score=162.30 Aligned_cols=80 Identities=31% Similarity=0.466 Sum_probs=67.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... ....+||+.|+|||.+.+ ..++.++||||+||++|+|++|+.
T Consensus 151 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999986543221 234689999999998654 447899999999999999999999
Q ss_pred CCCCC
Q 041230 76 PNNGM 80 (485)
Q Consensus 76 p~~~~ 80 (485)
||.+.
T Consensus 231 pf~~~ 235 (364)
T 3qyz_A 231 IFPGK 235 (364)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 99753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8.3e-17 Score=158.51 Aligned_cols=81 Identities=26% Similarity=0.472 Sum_probs=63.0
Q ss_pred CCCCCCCcEEECCCCc---EEEEeccCccccCCCC--------ceeecccccCcccccccCC-----CCCCCccchhhHH
Q 041230 1 HCDLKPSNVFLDDEMT---AHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMG-----SEVSSYGDVYSFG 64 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~---~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G 64 (485)
||||||+|||++.++. +||+|||+++...... .....+||+.|+|||.+.. ..++.++||||+|
T Consensus 134 H~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 213 (316)
T 2ac3_A 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213 (316)
T ss_dssp CCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred eCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence 9999999999998776 9999999987653211 1223569999999998764 4578899999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 041230 65 ILLLEMFTGLRPNNGMF 81 (485)
Q Consensus 65 v~l~el~~G~~p~~~~~ 81 (485)
|++|||++|+.||.+..
T Consensus 214 ~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 214 VILYILLSGYPPFVGRC 230 (316)
T ss_dssp HHHHHHHHSSCSCCCCC
T ss_pred HHHHHHHHCCCCCcccc
Confidence 99999999999997654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.7e-17 Score=159.79 Aligned_cols=136 Identities=22% Similarity=0.203 Sum_probs=88.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC------CceeecccccCcccccccCC---------CCCCCccchhhHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE------TSFIDVMGTIGYVAPEYGMG---------SEVSSYGDVYSFGI 65 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gv 65 (485)
||||||+|||++ ++.+||+|||+++..... .......|++.|+|||.... ..++.++||||||+
T Consensus 153 H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~ 231 (319)
T 2y4i_B 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231 (319)
T ss_dssp CCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred ccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence 999999999998 679999999998754321 11233569999999998764 34678899999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhh
Q 041230 66 LLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVAC 145 (485)
Q Consensus 66 ~l~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 145 (485)
++|||++|+.||.+.. ........ ..-.... .. .... ...+..+...|
T Consensus 232 il~el~~g~~p~~~~~-----~~~~~~~~-----~~~~~~~--------------~~--~~~~------~~~l~~li~~~ 279 (319)
T 2y4i_B 232 IWYELHAREWPFKTQP-----AEAIIWQM-----GTGMKPN--------------LS--QIGM------GKEISDILLFC 279 (319)
T ss_dssp HHHHHHHSSCSSSSCC-----HHHHHHHH-----HTTCCCC--------------CC--CSSC------CTTHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCC-----HHHHHHHh-----ccCCCCC--------------CC--cCCC------CHHHHHHHHHH
Confidence 9999999999986421 11110000 0000000 00 0000 01245678899
Q ss_pred hccCCCcccccchhhHHHHHHhhh
Q 041230 146 SAELPDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 146 ~~~~p~~RP~m~~v~~~L~~i~~~ 169 (485)
+..+|.+||++.++...++.+...
T Consensus 280 l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 280 WAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HCSSTTTSCCHHHHHHHHTTC---
T ss_pred hcCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999998876554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2e-16 Score=165.72 Aligned_cols=78 Identities=35% Similarity=0.595 Sum_probs=65.9
Q ss_pred CCCCCCCcEEEC---CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLD---DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~---~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++ .++.+||+|||+++...........+||+.|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999995 456799999999987665554556789999999999865 5889999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 223 ~~ 224 (486)
T 3mwu_A 223 YG 224 (486)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=161.42 Aligned_cols=78 Identities=32% Similarity=0.453 Sum_probs=68.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ....+||+.|+|||.+.+ ..++.++||||+||+++||++|+.||.+
T Consensus 151 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999865432 334678999999998776 6789999999999999999999999975
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 229 ~ 229 (367)
T 1cm8_A 229 S 229 (367)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=153.45 Aligned_cols=78 Identities=31% Similarity=0.531 Sum_probs=65.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++...... ......|++.|+|||...+..++.++||||+|+++|+|++|..||..
T Consensus 132 H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp ECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999998654332 22346799999999999888889999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-16 Score=158.81 Aligned_cols=78 Identities=26% Similarity=0.427 Sum_probs=65.6
Q ss_pred CCCCCCCcEEEC------CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLD------DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~------~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++ ..+.+||+|||+++..... .....||+.|+|||...+..++.++|||||||++|||++|+
T Consensus 155 H~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 155 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999994 4457999999999865432 23457999999999998888999999999999999999999
Q ss_pred CCCCCC
Q 041230 75 RPNNGM 80 (485)
Q Consensus 75 ~p~~~~ 80 (485)
.||.+.
T Consensus 233 ~pf~~~ 238 (373)
T 1q8y_A 233 FLFEPD 238 (373)
T ss_dssp CCC---
T ss_pred CCCCCC
Confidence 999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=3.7e-16 Score=152.28 Aligned_cols=127 Identities=25% Similarity=0.308 Sum_probs=92.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++...... .......||+.|+|||...+..++.++|+||+|+++|+|++|+.||..
T Consensus 138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999865432 223346799999999999888889999999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ...... .+.... ....... -..+..+...|++.+|.+||++.++
T Consensus 218 ~~-----~~~~~~--------~~~~~~---------------~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~l 263 (294)
T 2rku_A 218 SC-----LKETYL--------RIKKNE---------------YSIPKHI------NPVAASLIQKMLQTDPTARPTINEL 263 (294)
T ss_dssp SS-----HHHHHH--------HHHTTC---------------CCCCTTS------CHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CC-----HHHHHH--------HHhhcc---------------CCCcccc------CHHHHHHHHHHcccChhhCcCHHHH
Confidence 21 111100 000000 0000000 0123467789999999999999998
Q ss_pred hH
Q 041230 160 ES 161 (485)
Q Consensus 160 ~~ 161 (485)
..
T Consensus 264 l~ 265 (294)
T 2rku_A 264 LN 265 (294)
T ss_dssp GG
T ss_pred hh
Confidence 65
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-16 Score=157.95 Aligned_cols=152 Identities=24% Similarity=0.384 Sum_probs=98.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce----eecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF----IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++........ ....|+..|+|||...+..++.++||||||+++|||++|..|
T Consensus 168 H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~ 247 (326)
T 2w1i_A 168 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247 (326)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCG
T ss_pred ccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999876543321 224577889999998888888999999999999999999888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+... ................ ....+ .+.+...... .... .+...+..+...|++.+|.+||++
T Consensus 248 ~~~~------~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~-~~~~----~~~~~l~~li~~cl~~dP~~Rps~ 310 (326)
T 2w1i_A 248 SKSP------PAEFMRMIGNDKQGQM----IVFHL--IELLKNNGRL-PRPD----GCPDEIYMIMTECWNNNVNQRPSF 310 (326)
T ss_dssp GGSH------HHHHHHHHCTTCCTHH----HHHHH--HHHHHTTCCC-CCCT----TCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCC------HHHHHHhhccccchhh----hHHHH--HHHhhcCCCC-CCCC----cccHHHHHHHHHHcCCChhhCcCH
Confidence 6421 0000000000000000 00000 0000000000 0000 011235678899999999999999
Q ss_pred chhhHHHHHHhhh
Q 041230 157 NDVESRLRSIKMK 169 (485)
Q Consensus 157 ~~v~~~L~~i~~~ 169 (485)
.++...++.+...
T Consensus 311 ~el~~~L~~l~~~ 323 (326)
T 2w1i_A 311 RDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999887653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.63 E-value=8.2e-17 Score=170.80 Aligned_cols=134 Identities=25% Similarity=0.438 Sum_probs=96.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......++..|+|||.+....++.++|||||||++|||++ |+.||
T Consensus 386 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~ 465 (535)
T 2h8h_A 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465 (535)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred CCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998654321 1123456788999999888889999999999999999999 89998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+... ...+.. +. ..+. ......| ...+.++...|++.+|++||++.
T Consensus 466 ~~~~~-----~~~~~~--------i~-~~~~----------~~~~~~~---------~~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 466 PGMVN-----REVLDQ--------VE-RGYR----------MPCPPEC---------PESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp TTCCH-----HHHHHH--------HH-TTCC----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCH-----HHHHHH--------HH-cCCC----------CCCCCCC---------CHHHHHHHHHHcCCChhHCcCHH
Confidence 65311 111100 00 0000 0000011 12345788899999999999999
Q ss_pred hhhHHHHHHh
Q 041230 158 DVESRLRSIK 167 (485)
Q Consensus 158 ~v~~~L~~i~ 167 (485)
++...|+.+.
T Consensus 513 ~l~~~L~~~~ 522 (535)
T 2h8h_A 513 YLQAFLEDYF 522 (535)
T ss_dssp HHHHHHHTSS
T ss_pred HHHHHHHHHh
Confidence 9998887653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=165.53 Aligned_cols=78 Identities=31% Similarity=0.577 Sum_probs=68.0
Q ss_pred CCCCCCCcEEECCC---CcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDE---MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~---~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.. +.+||+|||+++...........+||+.|+|||++. ..++.++||||+||++|+|++|..||
T Consensus 159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99999999999764 459999999998766555555678999999999875 56899999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 238 ~~ 239 (494)
T 3lij_A 238 GG 239 (494)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-16 Score=155.40 Aligned_cols=79 Identities=34% Similarity=0.466 Sum_probs=69.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||+++.++.+||+|||++....... ......|++.|+|||...+..++.++||||||+++|+|++|+.||..
T Consensus 148 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999997654332 23346799999999999888899999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=167.75 Aligned_cols=78 Identities=35% Similarity=0.603 Sum_probs=68.6
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||+ +.++.+||+|||+++...........+||+.|+|||.+.+ .++.++||||+||++|+|++|..||
T Consensus 149 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 99999999999 5678899999999987665544455789999999998865 6889999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 228 ~~ 229 (484)
T 3nyv_A 228 NG 229 (484)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.8e-17 Score=159.56 Aligned_cols=78 Identities=37% Similarity=0.526 Sum_probs=60.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCC-----------CCCCCccchhhHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMG-----------SEVSSYGDVYSFGIL 66 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~ 66 (485)
||||||+|||++. +.+||+|||+++....... .....||+.|+|||...+ ..++.++||||||++
T Consensus 150 H~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i 228 (313)
T 3cek_A 150 HSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228 (313)
T ss_dssp CCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred ecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence 9999999999974 8999999999986543221 234579999999998765 367789999999999
Q ss_pred HHHHHhCCCCCCC
Q 041230 67 LLEMFTGLRPNNG 79 (485)
Q Consensus 67 l~el~~G~~p~~~ 79 (485)
+|||++|+.||..
T Consensus 229 l~el~~g~~pf~~ 241 (313)
T 3cek_A 229 LYYMTYGKTPFQQ 241 (313)
T ss_dssp HHHHHHSSCTTTT
T ss_pred HHHHHhCCCchhh
Confidence 9999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.3e-16 Score=160.83 Aligned_cols=78 Identities=31% Similarity=0.505 Sum_probs=60.0
Q ss_pred CCCCCCCcEEECC-----CCcEEEEeccCccccCCCC----ceeecccccCcccccccC---CCCCCCccchhhHHHHHH
Q 041230 1 HCDLKPSNVFLDD-----EMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGM---GSEVSSYGDVYSFGILLL 68 (485)
Q Consensus 1 HrDlk~~NiLl~~-----~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~ 68 (485)
||||||+|||++. ...+||+|||+++...... .....+||+.|+|||++. ...++.++|||||||++|
T Consensus 141 HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ 220 (432)
T 3p23_A 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY 220 (432)
T ss_dssp CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHH
T ss_pred eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHH
Confidence 9999999999953 3458899999998765331 223467999999999987 345677899999999999
Q ss_pred HHHh-CCCCCC
Q 041230 69 EMFT-GLRPNN 78 (485)
Q Consensus 69 el~~-G~~p~~ 78 (485)
||++ |..||.
T Consensus 221 ellt~g~~pf~ 231 (432)
T 3p23_A 221 YVISEGSHPFG 231 (432)
T ss_dssp HHHTTSCBTTB
T ss_pred HHHcCCCCCcc
Confidence 9999 888874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=3.7e-16 Score=155.65 Aligned_cols=79 Identities=32% Similarity=0.504 Sum_probs=69.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... .......||+.|+|||...+..++.++||||||+++|+|++|+.||..
T Consensus 164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 9999999999999999999999999865432 223446799999999999888889999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=156.68 Aligned_cols=79 Identities=33% Similarity=0.460 Sum_probs=69.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++....... ......||+.|+|||...+..++.++||||||+++|+|++|+.|+..
T Consensus 142 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 99999999999999999999999998654332 23346799999999999888899999999999999999999999854
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-16 Score=165.12 Aligned_cols=79 Identities=29% Similarity=0.427 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccC-----CCCCCCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGM-----GSEVSSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~~G 73 (485)
||||||+|||++.++.+||+|||+++....... ....+||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 198 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG 277 (437)
T 4aw2_A 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277 (437)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS
T ss_pred ecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC
Confidence 999999999999999999999999986644332 23468999999999976 45688999999999999999999
Q ss_pred CCCCCC
Q 041230 74 LRPNNG 79 (485)
Q Consensus 74 ~~p~~~ 79 (485)
+.||.+
T Consensus 278 ~~Pf~~ 283 (437)
T 4aw2_A 278 ETPFYA 283 (437)
T ss_dssp SCTTCC
T ss_pred CCCCCC
Confidence 999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-16 Score=160.38 Aligned_cols=79 Identities=37% Similarity=0.541 Sum_probs=67.0
Q ss_pred CCCCCCCcEEECCC----CcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDE----MTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~----~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+|||+..+ +.+||+|||+++..... ......+||+.|+|||.+.+..++.++||||+||++|||++|..
T Consensus 139 HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 218 (342)
T 2qr7_A 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218 (342)
T ss_dssp CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCC
Confidence 99999999998543 35999999999866433 23345789999999999887778899999999999999999999
Q ss_pred CCCC
Q 041230 76 PNNG 79 (485)
Q Consensus 76 p~~~ 79 (485)
||.+
T Consensus 219 Pf~~ 222 (342)
T 2qr7_A 219 PFAN 222 (342)
T ss_dssp SSCS
T ss_pred CCCC
Confidence 9964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=156.65 Aligned_cols=79 Identities=33% Similarity=0.511 Sum_probs=60.5
Q ss_pred CCCCCCCcEEE-----CCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFL-----DDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl-----~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G 73 (485)
||||||+|||+ +.++.+||+|||+++..... ......+||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 234 (329)
T 3gbz_A 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234 (329)
T ss_dssp CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999 45556999999999865432 223446789999999998764 478999999999999999999
Q ss_pred CCCCCC
Q 041230 74 LRPNNG 79 (485)
Q Consensus 74 ~~p~~~ 79 (485)
+.||.+
T Consensus 235 ~~pf~~ 240 (329)
T 3gbz_A 235 TPLFPG 240 (329)
T ss_dssp SCSSCC
T ss_pred CCCcCC
Confidence 999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.8e-17 Score=156.09 Aligned_cols=130 Identities=28% Similarity=0.339 Sum_probs=91.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++....... .....|++.|+|||...+..++.++||||||+++|+|++|+.||..
T Consensus 139 H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp CCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 999999999999999999999999986544322 2345789999999999888889999999999999999999999864
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ...+.. .+.... ........ -..+..+...|++.+|.+||++.++
T Consensus 219 ~~-----~~~~~~--------~i~~~~--------------~~~~~~~~------~~~l~~li~~~l~~~p~~Rps~~~l 265 (279)
T 2w5a_A 219 FS-----QKELAG--------KIREGK--------------FRRIPYRY------SDELNEIITRMLNLKDYHRPSVEEI 265 (279)
T ss_dssp SS-----HHHHHH--------HHHHTC--------------CCCCCTTS------CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cC-----HHHHHH--------HHhhcc--------------cccCCccc------CHHHHHHHHHHcCCCcccCCCHHHH
Confidence 31 111110 000000 00000000 1124567789999999999999887
Q ss_pred hHHH
Q 041230 160 ESRL 163 (485)
Q Consensus 160 ~~~L 163 (485)
...+
T Consensus 266 l~~~ 269 (279)
T 2w5a_A 266 LENP 269 (279)
T ss_dssp HTST
T ss_pred HhCh
Confidence 7643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=157.95 Aligned_cols=78 Identities=33% Similarity=0.500 Sum_probs=66.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++...... ......||+.|+|||...+..++.++|||||||++|+|++|+.||..
T Consensus 155 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999998754221 12346799999999999888899999999999999999999999865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.1e-16 Score=152.96 Aligned_cols=79 Identities=34% Similarity=0.531 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccC------CCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM------GSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+||+++.++.+||+|||++.............|++.|+|||... ...++.++||||||+++|+|++|+
T Consensus 147 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 147 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 99999999999999999999999998765544445578999999999864 445788999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 227 ~p~~~ 231 (298)
T 1phk_A 227 PPFWH 231 (298)
T ss_dssp CSSCC
T ss_pred CCCcC
Confidence 99854
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.7e-16 Score=150.61 Aligned_cols=79 Identities=33% Similarity=0.561 Sum_probs=59.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||++.............|++.|+|||...+..+ +.++|+||+|+++|+|++|+.||..
T Consensus 134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999987654443445679999999999887665 5789999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.2e-16 Score=171.24 Aligned_cols=135 Identities=24% Similarity=0.385 Sum_probs=94.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 514 HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987643322 123457789999999888889999999999999999997 99998
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ....+.. +.... .......+ ...+..+...|++.+|..||++.
T Consensus 594 ~~~~-----~~~~~~~--------i~~~~-----------~~~~~~~~---------~~~l~~li~~~l~~dP~~RPs~~ 640 (656)
T 2j0j_A 594 QGVK-----NNDVIGR--------IENGE-----------RLPMPPNC---------PPTLYSLMTKCWAYDPSRRPRFT 640 (656)
T ss_dssp TTCC-----HHHHHHH--------HHHTC-----------CCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC-----HHHHHHH--------HHcCC-----------CCCCCccc---------cHHHHHHHHHHcCCChhHCcCHH
Confidence 6431 1111100 00000 00000011 12345778899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++...|+.+..
T Consensus 641 el~~~L~~il~ 651 (656)
T 2j0j_A 641 ELKAQLSTILE 651 (656)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99998887643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.2e-16 Score=164.06 Aligned_cols=78 Identities=31% Similarity=0.605 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCC---cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEM---TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~---~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++ .+||+|||+++...........+||+.|+|||.+. ..++.++||||+||++|+|++|..||
T Consensus 169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCC
Confidence 999999999998775 69999999998776555555678999999999876 46899999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 248 ~~ 249 (504)
T 3q5i_A 248 GG 249 (504)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.61 E-value=2.3e-16 Score=156.13 Aligned_cols=77 Identities=32% Similarity=0.469 Sum_probs=66.0
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++ .++.+||+|||+++..... ......||+.|+|||...+..+ +.++||||||+++|||++|+.||.
T Consensus 172 H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 999999999999 7789999999999865432 2334679999999998876665 677899999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.61 E-value=5.6e-16 Score=150.25 Aligned_cols=78 Identities=27% Similarity=0.484 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+||+++.++.+||+|||++...... ......|++.|+|||...+..++.++|+||||+++|+|++|+.||..
T Consensus 137 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999998765432 22346799999999999888899999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=8e-17 Score=156.78 Aligned_cols=78 Identities=29% Similarity=0.435 Sum_probs=65.2
Q ss_pred CCCCCCCcEEECC-CCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCC--CCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDD-EMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSE--VSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~-~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++. ++.+||+|||+++...... ......|++.|+|||...+.. ++.++||||||+++|+|++|+.|
T Consensus 145 H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (295)
T 2clq_A 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224 (295)
T ss_dssp CCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred ccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999987 8999999999998654322 233467999999999876543 78899999999999999999999
Q ss_pred CC
Q 041230 77 NN 78 (485)
Q Consensus 77 ~~ 78 (485)
|.
T Consensus 225 f~ 226 (295)
T 2clq_A 225 FY 226 (295)
T ss_dssp TG
T ss_pred cc
Confidence 85
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.5e-16 Score=155.74 Aligned_cols=79 Identities=30% Similarity=0.413 Sum_probs=60.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccC-----CCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGM-----GSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||++....... ......||+.|+|||.+. ...++.++|||||||++|+|++|+
T Consensus 152 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 152 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSS
T ss_pred ccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998654322 223467999999999876 456788999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||..
T Consensus 232 ~p~~~ 236 (326)
T 2x7f_A 232 PPLCD 236 (326)
T ss_dssp CTTTT
T ss_pred CCCCC
Confidence 99854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-16 Score=157.70 Aligned_cols=80 Identities=33% Similarity=0.497 Sum_probs=66.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----------ceeecccccCcccccccCC-CCCCCccchhhHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----------SFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLL 68 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~ 68 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||.+.. ..++.++|||||||++|
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 214 (353)
T 2b9h_A 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214 (353)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHH
T ss_pred cCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHH
Confidence 99999999999999999999999998654221 1123578999999997654 67888999999999999
Q ss_pred HHHhCCCCCCCC
Q 041230 69 EMFTGLRPNNGM 80 (485)
Q Consensus 69 el~~G~~p~~~~ 80 (485)
+|++|+.||.+.
T Consensus 215 ~l~~g~~pf~~~ 226 (353)
T 2b9h_A 215 ELFLRRPIFPGR 226 (353)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHhCCCCCCCC
Confidence 999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-16 Score=161.39 Aligned_cols=79 Identities=30% Similarity=0.474 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccC-------CCCCCCccchhhHHHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGM-------GSEVSSYGDVYSFGILLLEMF 71 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gv~l~el~ 71 (485)
||||||+|||++.++++||+|||+++....... ....+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 185 HrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell 264 (412)
T 2vd5_A 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264 (412)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred ecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence 999999999999999999999999987654332 23468999999999876 356889999999999999999
Q ss_pred hCCCCCCC
Q 041230 72 TGLRPNNG 79 (485)
Q Consensus 72 ~G~~p~~~ 79 (485)
+|+.||.+
T Consensus 265 tG~~Pf~~ 272 (412)
T 2vd5_A 265 YGQTPFYA 272 (412)
T ss_dssp HSSCTTCC
T ss_pred hCCCCCCC
Confidence 99999965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-16 Score=158.63 Aligned_cols=79 Identities=27% Similarity=0.400 Sum_probs=49.7
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++. ++.+||+|||+++..... .....+||+.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999976 455999999999865432 233567899999999998888899999999999999999999998
Q ss_pred CCC
Q 041230 78 NGM 80 (485)
Q Consensus 78 ~~~ 80 (485)
.+.
T Consensus 230 ~~~ 232 (336)
T 3fhr_A 230 YSN 232 (336)
T ss_dssp ---
T ss_pred CCc
Confidence 653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8.9e-17 Score=156.95 Aligned_cols=79 Identities=30% Similarity=0.515 Sum_probs=63.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC------ceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET------SFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTG 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G 73 (485)
||||||+|||++.++.+||+|||++....... ......||+.|+|||.... ..++.++||||||+++|+|++|
T Consensus 144 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 223 (303)
T 2vwi_A 144 HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223 (303)
T ss_dssp CCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999987654321 1234579999999998765 4578899999999999999999
Q ss_pred CCCCCC
Q 041230 74 LRPNNG 79 (485)
Q Consensus 74 ~~p~~~ 79 (485)
+.||..
T Consensus 224 ~~pf~~ 229 (303)
T 2vwi_A 224 AAPYHK 229 (303)
T ss_dssp SCTTTT
T ss_pred CCCCcc
Confidence 999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.60 E-value=4.7e-16 Score=152.40 Aligned_cols=78 Identities=29% Similarity=0.480 Sum_probs=67.9
Q ss_pred CCCCCCCcEEE---CCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl---~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||+ +.++.+||+|||+++..... .....+||+.|+|||...+..++.++||||+|+++|+|++|+.||
T Consensus 129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999 78899999999999754322 223457999999999998888999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 208 ~~ 209 (304)
T 2jam_A 208 YE 209 (304)
T ss_dssp TT
T ss_pred CC
Confidence 64
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=3.9e-16 Score=156.47 Aligned_cols=77 Identities=32% Similarity=0.482 Sum_probs=64.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... .....||+.|+|||...+ ..++.++||||+||++|+|++|+.||.+
T Consensus 149 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp CSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred cCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999864322 234678999999998876 5678999999999999999999999865
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=9.5e-16 Score=150.00 Aligned_cols=127 Identities=24% Similarity=0.358 Sum_probs=89.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC---CceeecccccCcccccccCCCC--CCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFIDVMGTIGYVAPEYGMGSE--VSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+|||++.++.+||+|||++...... .......||+.|+|||...+.. ++.++||||||+++|||++|+.
T Consensus 132 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (305)
T 2wtk_C 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211 (305)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865422 2233467999999999987643 3678999999999999999999
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+. +....... +....+ .....+ ...+..+...|++.+|.+||+
T Consensus 212 p~~~~-----~~~~~~~~--------i~~~~~------------~~~~~~---------~~~l~~li~~~l~~dp~~Rps 257 (305)
T 2wtk_C 212 PFEGD-----NIYKLFEN--------IGKGSY------------AIPGDC---------GPPLSDLLKGMLEYEPAKRFS 257 (305)
T ss_dssp SCCCS-----SHHHHHHH--------HHHCCC------------CCCSSS---------CHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCc-----hHHHHHHH--------HhcCCC------------CCCCcc---------CHHHHHHHHHHccCChhhCCC
Confidence 98642 11111100 000000 000001 112346778999999999999
Q ss_pred cchhhH
Q 041230 156 INDVES 161 (485)
Q Consensus 156 m~~v~~ 161 (485)
+.++.+
T Consensus 258 ~~~ll~ 263 (305)
T 2wtk_C 258 IRQIRQ 263 (305)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-16 Score=157.44 Aligned_cols=135 Identities=24% Similarity=0.351 Sum_probs=94.1
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-C
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-G 73 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G 73 (485)
||||||+|||++. +..+||+|||+++...... ......||+.|+|||...+..++.++||||||+++|+|++ |
T Consensus 163 H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 242 (327)
T 2yfx_A 163 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG 242 (327)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999984 4569999999987543221 1234568899999999888888999999999999999998 8
Q ss_pred CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 74 LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 74 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
..||.... ....... +..... ......+ ...+..+...|++.+|..|
T Consensus 243 ~~p~~~~~-----~~~~~~~--------~~~~~~-----------~~~~~~~---------~~~l~~li~~~l~~dp~~R 289 (327)
T 2yfx_A 243 YMPYPSKS-----NQEVLEF--------VTSGGR-----------MDPPKNC---------PGPVYRIMTQCWQHQPEDR 289 (327)
T ss_dssp CCSSTTCC-----HHHHHHH--------HHTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCcC-----HHHHHHH--------HhcCCC-----------CCCCCCC---------CHHHHHHHHHHhcCChhhC
Confidence 88885421 1111100 000000 0000000 1134567889999999999
Q ss_pred cccchhhHHHHHHhh
Q 041230 154 MDINDVESRLRSIKM 168 (485)
Q Consensus 154 P~m~~v~~~L~~i~~ 168 (485)
|++.++...+..+..
T Consensus 290 ps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 290 PNFAIILERIEYCTQ 304 (327)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHhc
Confidence 999999998877654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.7e-16 Score=155.06 Aligned_cols=79 Identities=30% Similarity=0.374 Sum_probs=63.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCccccccc-----CCCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYG-----MGSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||++...... .......||+.|+|||.. ....++.++||||||+++|+|++|+
T Consensus 140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 219 (302)
T 2j7t_A 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219 (302)
T ss_dssp CCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999987532211 112345789999999987 3566788999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.|+..
T Consensus 220 ~p~~~ 224 (302)
T 2j7t_A 220 PPHHE 224 (302)
T ss_dssp CTTTT
T ss_pred CCCcc
Confidence 99864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=150.32 Aligned_cols=80 Identities=29% Similarity=0.532 Sum_probs=65.2
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCC----CceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++ .++.+||+|||+++..... .......|++.|+|||.... ..++.++||||||+++|||++|+
T Consensus 143 H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCC
Confidence 999999999997 5678999999999865422 12234567999999998755 56888999999999999999999
Q ss_pred CCCCCC
Q 041230 75 RPNNGM 80 (485)
Q Consensus 75 ~p~~~~ 80 (485)
.||.+.
T Consensus 223 ~pf~~~ 228 (320)
T 2i6l_A 223 TLFAGA 228 (320)
T ss_dssp CSSCCS
T ss_pred CCCCCC
Confidence 999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.2e-16 Score=155.55 Aligned_cols=79 Identities=29% Similarity=0.494 Sum_probs=68.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCC-ccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSS-YGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||++...... ......|++.|+|||...+. .++. ++||||||+++|||++|+.||.
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999999865433 33456799999999998876 5655 8999999999999999999987
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 254 ~~ 255 (348)
T 2pml_X 254 LK 255 (348)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-15 Score=147.88 Aligned_cols=78 Identities=35% Similarity=0.589 Sum_probs=66.4
Q ss_pred CCCCCCCcEEECCC---CcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDE---MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~---~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.+ +.+||+|||++.............|++.|+|||...+ .++.++||||||+++|+|++|..||
T Consensus 144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCC
Confidence 99999999999764 4699999999987655444445679999999998765 4888999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 223 ~~ 224 (287)
T 2wei_A 223 YG 224 (287)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.9e-15 Score=148.56 Aligned_cols=120 Identities=28% Similarity=0.434 Sum_probs=88.1
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCC-CccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVS-SYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++ .++.+||+|||+++..... ......|++.|+|||...+..+. .++||||+|+++|+|++|+.||.
T Consensus 162 H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 162 HRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 999999999999 7899999999999865433 23456799999999987766554 48999999999999999999985
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccch
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIND 158 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~ 158 (485)
.. ........ .+ ...+ -..+..+...|++.+|+.||++.+
T Consensus 241 ~~-------~~~~~~~~----------~~--------------~~~~---------~~~~~~li~~~l~~~p~~Rps~~e 280 (312)
T 2iwi_A 241 RD-------QEILEAEL----------HF--------------PAHV---------SPDCCALIRRCLAPKPSSRPSLEE 280 (312)
T ss_dssp SH-------HHHHHTCC----------CC--------------CTTS---------CHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred Ch-------HHHhhhcc----------CC--------------cccC---------CHHHHHHHHHHccCChhhCcCHHH
Confidence 31 01000000 00 0000 012356778999999999999988
Q ss_pred hhH
Q 041230 159 VES 161 (485)
Q Consensus 159 v~~ 161 (485)
+.+
T Consensus 281 ~l~ 283 (312)
T 2iwi_A 281 ILL 283 (312)
T ss_dssp HHH
T ss_pred Hhc
Confidence 764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-15 Score=147.78 Aligned_cols=74 Identities=19% Similarity=0.304 Sum_probs=61.4
Q ss_pred CCCCCCCcEEECC-------------------CCcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccch
Q 041230 1 HCDLKPSNVFLDD-------------------EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDV 60 (485)
Q Consensus 1 HrDlk~~NiLl~~-------------------~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 60 (485)
||||||+|||++. ...+||+|||++....... ...||+.|+|||...+. .++.++||
T Consensus 138 H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di 214 (289)
T 1x8b_A 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADI 214 (289)
T ss_dssp CSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHH
T ss_pred ecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhH
Confidence 9999999999984 4479999999998664332 34689999999998765 55678999
Q ss_pred hhHHHHHHHHHhCCCCC
Q 041230 61 YSFGILLLEMFTGLRPN 77 (485)
Q Consensus 61 ~s~Gv~l~el~~G~~p~ 77 (485)
||||+++|+|++|..++
T Consensus 215 ~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 215 FALALTVVCAAGAEPLP 231 (289)
T ss_dssp HHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHHHhcCCCCC
Confidence 99999999999998765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=7.2e-15 Score=157.97 Aligned_cols=79 Identities=34% Similarity=0.484 Sum_probs=70.3
Q ss_pred CCCCCCCcEEECCCCc---EEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMT---AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~---~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++. +||+|||++.............||+.|+|||...+..++.++||||||+++|++++|..||
T Consensus 144 HrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 9999999999997664 9999999998766554445678999999999998889999999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 224 ~~ 225 (676)
T 3qa8_A 224 LP 225 (676)
T ss_dssp CS
T ss_pred Cc
Confidence 64
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 485 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-23 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-17 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-28 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-17 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-17 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-19 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-19 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-20 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-16 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-26 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-17 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-17 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-20 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-15 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-24 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-16 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-24 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-13 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-17 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-17 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-23 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-19 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-15 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-23 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-16 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-23 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-20 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-16 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-13 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-18 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-14 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-14 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-22 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-17 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-22 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-16 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-22 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-13 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-21 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-15 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-21 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-15 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-12 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-12 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-14 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-11 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-19 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-13 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-16 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-11 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-11 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-18 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-15 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-13 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-12 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-17 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-12 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-17 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-15 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-11 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-09 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-16 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-10 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-13 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-15 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-07 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-15 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-10 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-14 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-10 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-13 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-10 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-13 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 6e-32
Identities = 58/280 (20%), Positives = 103/280 (36%), Gaps = 40/280 (14%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVFT 258
IG+G+FG+VY G +AVK+ N+ P ++FK+E RH NI+
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM- 70
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
Y A A+V ++ SL LH + F + K +DIA A+ +
Sbjct: 71 -----GYSTAPQLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGM 117
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ---TRFIGKLN--- 372
YLH I H +LK +N+ L +++ +GDF +A + G +
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 373 ---VRNFVKMALSQRV----------EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSI 419
+R K S + E + I + + +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 420 ILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459
C ++ + C ++ ER + + + L+ + +
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (243), Expect = 2e-23
Identities = 40/176 (22%), Positives = 72/176 (40%), Gaps = 34/176 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLK +N+FL +++T +GDFG+A + F + G+I ++APE + + Y
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 58 G---DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEE 114
DVY+FGI+L E+ TG P + + D + + + L ++
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS---------- 236
Query: 115 ETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKL 170
C ++ R+ C + DER + + + + L
Sbjct: 237 ------------------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-30
Identities = 58/290 (20%), Positives = 115/290 (39%), Gaps = 38/290 (13%)
Query: 174 PVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG 233
P +E++ + + K + +GAG FG V+ G T +AVK
Sbjct: 2 PWWEDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSM 50
Query: 234 GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDT 293
+F +E ++H+ +VR++ V Q + ++ ++M NGSL ++L
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLY----AVVTQEPIY--IITEYMENGSLVDFLKTPS-- 102
Query: 294 HWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353
I K LD+A +A + ++ + H +L+ +N+L+ D + + DF
Sbjct: 103 -----GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG 154
Query: 354 MARFLPDTDEQTRFIGKLNVRNFVKMALSQRVEEILND-FNL-QEIEEDRTMCMHASSSS 411
+AR + D + R K ++ A++ I +D ++ + E T
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 412 STSTHVSIILE---------CVNSICEIGVACSAERPRERMKLNDVESRL 452
+ + + C + ++ C ERP +R + + S L
Sbjct: 215 TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 8e-17
Identities = 34/168 (20%), Positives = 59/168 (35%), Gaps = 34/168 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID--VMGTIGYVAPEYGMGSEVSSYG 58
H DL+ +N+ + D ++ + DFG+AR + I + APE +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
DV+SFGILL E+ T R + + NL + R + + +
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----------- 240
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
++ C E P++R + + S L
Sbjct: 241 ----------QLMRLCW-----------KERPEDRPTFDYLRSVLEDF 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (279), Expect = 3e-28
Identities = 54/301 (17%), Positives = 110/301 (36%), Gaps = 46/301 (15%)
Query: 186 SFKDLYDATNGFSSA---------NLIGAGNFGSVYNGTLF----DGTTIAVKVFNL-IR 231
+F+D +A F+ +IGAG FG V +G L +A+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 232 PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKD 291
R F SE H N++ + + ++ +FM NGSL+ +L D
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGV-----VTKSTPVMIITEFMENGSLDSFLRQND 122
Query: 292 DTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351
+ + + + +A +KYL H +L N+L++ ++ V D
Sbjct: 123 GQF--------TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSD 171
Query: 352 FSMARFLPDTDEQTRFIGKLNVRNFVK-----MALSQRVEEILNDFNLQEIEEDRTMCMH 406
F ++RFL D + L + ++ ++ + ++ + +
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 407 ASSSSSTSTHV----------SIILECVNSICEIGVACSAERPRERMKLNDVESRL-RLI 455
T+ V ++C +++ ++ + C + R K + + L ++I
Sbjct: 232 RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
Query: 456 R 456
R
Sbjct: 292 R 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 80.6 bits (198), Expect = 2e-17
Identities = 37/181 (20%), Positives = 72/181 (39%), Gaps = 44/181 (24%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE------TSFIDVMGTIGYVAPEYGMGSEV 54
H DL N+ ++ + + DFG++RFL + TS + I + APE +
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210
Query: 55 SSYGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEE 113
+S DV+S+GI++ E+ + G RP M D+ IE+
Sbjct: 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDV----------------------INAIEQ 248
Query: 114 EETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKLLKT 173
+ L ++C ++ ++ + C + + R + + L K+++
Sbjct: 249 DYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD----KMIRN 293
Query: 174 P 174
P
Sbjct: 294 P 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 4e-28
Identities = 52/284 (18%), Positives = 92/284 (32%), Gaps = 35/284 (12%)
Query: 188 KDLYDATNGFSSANL-IGAGNFGSVYNGTLF---DGTTIAVKVFNL-IRPGGARSFKSEC 242
K L+ + A++ +G GNFGSV G +A+KV E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 243 KAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDF 302
+ + + IVR+ +V + G L ++L GK +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKREE--------I 106
Query: 303 LIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
+ ++ V+ +KYL H +L NVLL + + DF +++ L D
Sbjct: 107 PVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 363 EQ--TRFIGKLNVRNFVKMALSQRVEEILNDF-----NLQEIEEDRTMCMHASSSSSTST 415
R GK ++ + ++ R +D + E
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223
Query: 416 HV------SIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453
+ EC + + C + +R VE R+R
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 2e-17
Identities = 37/179 (20%), Positives = 64/179 (35%), Gaps = 38/179 (21%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID----VMGTIGYVAPEYGMGSEVSS 56
H DL NV L + A + DFG+++ L + S+ + + APE + SS
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
DV+S+G+ + E + G +P M ++ IE+ +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------------MAFIEQGK 229
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKLLKTP 174
+ EC + + C ++R D VE R+R+ L
Sbjct: 230 RM-----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 5e-28
Identities = 54/263 (20%), Positives = 102/263 (38%), Gaps = 28/263 (10%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V+ GT T +A+K +F E + +RH +V+++
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLY--- 78
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+V ++M GSL ++L G+ + RL + +D+A +A + Y
Sbjct: 79 ---AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL-------PQLVDMAAQIASGMAY 128
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNFVKMA 380
+ H +L+ +N+L+ + ++ V DF +AR + D + R K ++ A
Sbjct: 129 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 381 LSQRVEEILND-----FNLQEIEEDRTMCMHASSSSSTSTHV------SIILECVNSICE 429
I +D L E+ + + V EC S+ +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 430 IGVACSAERPRERMKLNDVESRL 452
+ C + P ER +++ L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 6e-19
Identities = 35/168 (20%), Positives = 61/168 (36%), Gaps = 34/168 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP--VETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL+ +N+ + + + + DFG+AR + T+ I + APE + +
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
DV+SFGILL E+ T R + + E L
Sbjct: 196 DVWSFGILLTELTTKGRV------------------------------PYPGMVNREVLD 225
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+ + EC S+ + C + P+ER +++ L
Sbjct: 226 QVERG--YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 55/300 (18%), Positives = 103/300 (34%), Gaps = 58/300 (19%)
Query: 203 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSG 262
IG G FG V+ G G +AVK+F+ R + ++E + +RH NI+ A +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 263 VDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLH 322
+ + +V + +GSL ++L+ + ++ + +A+ A L +LH
Sbjct: 69 DNGTWTQL-WLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHLH 117
Query: 323 CDC-----QPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNFV 377
+ +P IAH +LK N+L+ + D +A + V
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 378 KMA--------------LSQRVE---------EILNDFNLQEIEEDRTMCMHASSSSSTS 414
MA +R + EI ++ I ED + + S S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 415 THV-----------------SIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457
E + + +I C R+ ++ L + +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 2e-19
Identities = 35/178 (19%), Positives = 56/178 (31%), Gaps = 23/178 (12%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-----VMGTIGYVAPEYGMGSEVS 55
H DLK N+ + T + D G+A T ID +GT Y+APE S
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 56 SYG------DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQ 109
+ D+Y+ G++ E+ L +LV S
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP------------SV 238
Query: 110 EIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIK 167
E + +K E L + +I C R+ ++ L +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 4e-27
Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 18/175 (10%)
Query: 193 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGARSFKSECKAAINIRH 250
+ F + +GAGN G V+ + G +A K+ +L I+P E +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
IV + A + ++ + M GSL++ L ++L +
Sbjct: 64 PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---------GKV 109
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
+I V + L YL +I H ++KPSN+L++ + DF ++ L D+ +
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 2e-20
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KPSN+ ++ L DFG++ L + V GT Y++PE G+ S D+
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDI 186
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNL 87
+S G+ L+EM G P +L L
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKELEL 213
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 17/165 (10%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG G FG V G G +AVK A++F +E +RH N+V++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL--- 66
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
GV + +V ++M GSL ++L + + L ++DV A++Y
Sbjct: 67 -GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-------LGGDCLLKFSLDVCEAMEY 118
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
L H +L NVL+ ++ + V DF + + T +
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.6 bits (188), Expect = 2e-16
Identities = 30/167 (17%), Positives = 52/167 (31%), Gaps = 34/167 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DL NV + ++ A + DFG+ + + + APE + S+ DV
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDV 183
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKK 120
+SFGILL E+++ R +P + K + +
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY------------- 230
Query: 121 ASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIK 167
++ C R + +L IK
Sbjct: 231 --------EVMKNCW-----------HLDAAMRPSFLQLREQLEHIK 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (264), Expect = 3e-26
Identities = 52/312 (16%), Positives = 97/312 (31%), Gaps = 46/312 (14%)
Query: 184 NLSFKDLYDATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNL-IRPGGAR 236
N L N IG G FG V+ T +AVK+
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 237 SFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWR 296
F+ E + NIV++ + +++++M G L E+L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGV-----CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 297 LLNFDFL---------------IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLL 341
L+ L ++L IA VA + YL + + H +L N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV 173
Query: 342 DDEMIGHVGDFSMARFLPDTDEQTRF------IGKLNVRNFVKMALSQRVEEILNDFNLQ 395
+ M+ + DF ++R + D I + + + + L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 396 EIEEDRTMCMHASSSSSTSTHV------SIILECVNSICEIGVACSAERPRERMKLNDVE 449
EI + + +V + C + + C ++ P +R +
Sbjct: 234 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 450 SRLRLIRKKILE 461
L +++ E
Sbjct: 294 RIL----QRMCE 301
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.5 bits (195), Expect = 5e-17
Identities = 27/169 (15%), Positives = 60/169 (35%), Gaps = 35/169 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP---VETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DL N + + M + DFG++R + + + I ++ PE + ++
Sbjct: 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 222
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETL 117
DV+++G++L E+F+ + + EE +
Sbjct: 223 SDVWAYGVVLWEIFSYGLQ------------------------------PYYGMAHEEVI 252
Query: 118 YKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
Y + C + + + C ++LP +R + L+ +
Sbjct: 253 YYVRDG--NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 3e-26
Identities = 36/185 (19%), Positives = 66/185 (35%), Gaps = 23/185 (12%)
Query: 182 INNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGARS 237
+ L FKD D FS IG G+FG+VY + + +A+K + +
Sbjct: 4 VAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 238 FKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRL 297
E + +RH N ++ Y +V ++ + + K
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGC-----YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 298 LNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357
+ + + L YLH + H ++K N+LL + + +GDF A
Sbjct: 117 I---------AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 358 LPDTD 362
+ +
Sbjct: 165 MAPAN 169
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 80.8 bits (199), Expect = 2e-17
Identities = 27/88 (30%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H D+K N+ L + LGDFG A + SF+ GT ++APE + + Y
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTPYWMAPEVILAMDEGQYDGK 194
Query: 59 -DVYSFGILLLEMFTGLRPNNGMFKDDL 85
DV+S GI +E+ P M
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSA 222
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 6e-26
Identities = 38/171 (22%), Positives = 63/171 (36%), Gaps = 13/171 (7%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVF 257
IG G++G DG + K + + + SE ++H NIVR +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+ + +V ++ G L + L + L + + A
Sbjct: 70 DRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLD-----EEFVLRVMTQLTLA 121
Query: 318 LKYLH--CDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
LK H D + H +LKP+NV LD + +GDF +AR L +
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 172
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (217), Expect = 4e-20
Identities = 34/86 (39%), Positives = 48/86 (55%), Gaps = 1/86 (1%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI-DVMGTIGYVAPEYGMGSEVSSYGD 59
H DLKP+NVFLD + LGDFG+AR L +TSF +GT Y++PE + D
Sbjct: 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSD 196
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDL 85
++S G LL E+ + P + +L
Sbjct: 197 IWSLGCLLYELCALMPPFTAFSQKEL 222
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-24
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 17/166 (10%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V G +A+K+ F E K +N+ H +V+++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGV- 67
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
R ++ ++M NG L +L F ++ L++ DV A++Y
Sbjct: 68 ----CTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEY 115
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
L + H +L N L++D+ + V DF ++R++ D + +
Sbjct: 116 LES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 3e-15
Identities = 31/168 (18%), Positives = 64/168 (38%), Gaps = 34/168 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL N ++D+ + DFG++R++ + TS + + + PE M S+ SS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
D+++FG+L+ E+++ + F + ++ + R + +
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY----------- 231
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+I+ C E DER + S + +
Sbjct: 232 ----------TIMYSCW-----------HEKADERPTFKILLSNILDV 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-24
Identities = 31/166 (18%), Positives = 57/166 (34%), Gaps = 17/166 (10%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTA 259
+G G FG VY A KV + + E + H NIV++ A
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
+ ++ +F G+++ + + + + AL
Sbjct: 78 -----FYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALN 124
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
YLH +I H +LK N+L + + DF ++ T ++
Sbjct: 125 YLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.3 bits (190), Expect = 2e-16
Identities = 24/86 (27%), Positives = 36/86 (41%), Gaps = 6/86 (6%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLP-VETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H DLK N+ + L DFG++ +GT ++APE M
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 59 ----DVYSFGILLLEMFTGLRPNNGM 80
DV+S GI L+EM P++ +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHEL 218
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 4e-24
Identities = 39/183 (21%), Positives = 64/183 (34%), Gaps = 25/183 (13%)
Query: 201 NLIGAGNFGSVYNGTLF------DGTTIAVKVFNL-IRPGGARSFKSECKAAINI-RHRN 252
+GAG FG V T + T+AVK+ + SE K + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI-------- 304
IV + A V+ ++ G L +L K D+ ++
Sbjct: 89 IVNLLGA-----CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 305 -KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ L + VA+ + +L H +L N+LL I + DF +AR + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 364 QTR 366
Sbjct: 201 YVV 203
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 2e-13
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DL N+ L + DFG+AR + +++++ + + ++APE +
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALP 96
DV+S+GI L E+F+ D ++K
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 5e-24
Identities = 52/273 (19%), Positives = 99/273 (36%), Gaps = 32/273 (11%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG+G FG V+ G + +A+K F E + + + H +V+++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGV- 68
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+V++FM +G L ++L + + L + +DV + Y
Sbjct: 69 ----CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--------AETLLGMCLDVCEGMAY 116
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNFVKMA 380
L + + H +L N L+ + + V DF M RF+ D + K V+
Sbjct: 117 L---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 173
Query: 381 LSQRVEEILNDF-----NLQEIEEDRTMCMHASSSSSTSTHVSIILE------CVNSICE 429
S +D + E+ + + S+S +S + +
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233
Query: 430 IGVACSAERPRERMKLNDVESRLRLIRKKILET 462
I C ERP +R + + +L +I E+
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQL----AEIAES 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 4e-17
Identities = 32/168 (19%), Positives = 61/168 (36%), Gaps = 34/168 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL N + + + DFG+ RF+ + TS + + +PE S SS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
DV+SFG+L+ E+F+ + + + + + + ++ +Q
Sbjct: 184 DVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKPRLASTHVYQ--------- 233
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
I+ C E P++R + + +L I
Sbjct: 234 -----------IMNHCW-----------KERPEDRPAFSRLLRQLAEI 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 9e-24
Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 44/284 (15%)
Query: 201 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVR 255
+IG G+FG VY+GTL D AVK N I G F +E + H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ G+ + VV +M +G L ++ + + +K + + VA
Sbjct: 93 LL----GICLRSEGSPLVVLPYMKHGDLRNFIRNE--------THNPTVKDLIGFGLQVA 140
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRN 375
+ + + H +L N +LD++ V DF +AR + D + + + +
Sbjct: 141 KGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV-----HNKT 192
Query: 376 FVKMALSQRVEEILNDFNLQE----------IEEDRTMCMHASSSSSTSTHVSIILE--- 422
K+ + E L + E T +T +L+
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 252
Query: 423 ------CVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKIL 460
C + + E+ + C + R +++ SR+ I +
Sbjct: 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 36/190 (18%), Positives = 67/190 (35%), Gaps = 37/190 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-----TSFIDVMGTIGYVAPEYGMGSEVS 55
H DL N LD++ T + DFG+AR + + + + ++A E + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 56 SYGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
+ DV+SFG+LL E+ T P D+N ++ L R +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLLQPE----------- 257
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKLLKTPV 175
C + + + C + R +++ SR+ +I +
Sbjct: 258 -----------------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300
Query: 176 YEEKQTINNL 185
T N+
Sbjct: 301 VHVNATYVNV 310
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 1e-23
Identities = 37/169 (21%), Positives = 67/169 (39%), Gaps = 17/169 (10%)
Query: 203 IGAGNFGSVYNGTL-FDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVFTA 259
IG G+F +VY G +A + + FK E + ++H NIVR + +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
+G + +V + M +G+L+ +L ++L + + L+
Sbjct: 77 WESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL---------RSWCRQILKGLQ 126
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTR 366
+LH P I H +LK N+ + G V GD +A + +
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAV 173
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (211), Expect = 2e-19
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 3/105 (2%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
H DLK N+F+ + +GD G+A + V+GT ++APE + D
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEM-YEEKYDESVD 194
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILD 104
VY+FG+ +LEM T P + + PA +++
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 1e-23
Identities = 36/190 (18%), Positives = 64/190 (33%), Gaps = 30/190 (15%)
Query: 202 LIGAGNFGSVYNGTLFD------GTTIAVKVFNL-IRPGGARSFKSECKAAINI-RHRNI 253
++G+G FG V N T + +AVK+ + SE K + H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDT--------------HWRLLN 299
V + A + +++++ G L +L K +
Sbjct: 104 VNLLGA-----CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 300 FDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLP 359
+ L A VA+ +++L H +L NVL+ + + DF +AR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 360 DTDEQTRFIG 369
Sbjct: 216 SDSNYVVRGN 225
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 7e-16
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 3/99 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DL NV + + DFG+AR + + + + ++APE +
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALP 96
DV+S+GILL E+F+ D N L+++
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.3 bits (244), Expect = 1e-23
Identities = 49/285 (17%), Positives = 97/285 (34%), Gaps = 32/285 (11%)
Query: 201 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTA 259
+ +G G +G VY G T+AVK F E I+H N+V++
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
++ +FM G+L ++L + + L +A ++ A++
Sbjct: 82 -----CTREPPFYIITEFMTYGNLLDYLRECN-------RQEVSAVVLLYMATQISSAME 129
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNFVKM 379
YL + H +L N L+ + + V DF ++R + K ++
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 380 AL-----SQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHV------SIILECVNSIC 428
+L S + + L EI S + C +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 246
Query: 429 EIGVACSAERPRERMKLNDVESRLRLIRKKILETSVCPEDKKKKI 473
E+ AC P +R ++ + + + S ++ +K++
Sbjct: 247 ELMRACWQWNPSDRPSFAEIHQAF----ETMFQESSISDEVEKEL 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 73.6 bits (180), Expect = 4e-15
Identities = 31/168 (18%), Positives = 60/168 (35%), Gaps = 34/168 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DL N + + + DFG++R + + T+ I + APE ++ S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
DV++FG+LL E+ T ++L + ++L+ + E E
Sbjct: 198 DVWAFGVLLWEIATYGMS----PYPGIDLSQVY---------ELLEKDYRMERPE----- 239
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
C + + AC P +R ++ ++
Sbjct: 240 --------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 47/285 (16%), Positives = 94/285 (32%), Gaps = 29/285 (10%)
Query: 195 NGFSSANLIGAGNFGSVYNGTLFDG---TTIAVKVFNLI-RPGGARSFKSECKAAINI-R 249
N ++IG GNFG V + A+K R F E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK-- 307
H NI+ + A + + + ++ P+G+L ++L
Sbjct: 70 HPNIINLLGA-----CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 308 -----LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTD 362
L A DVAR + YL Q + H +L N+L+ + + + DF ++R
Sbjct: 125 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 363 EQTRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILE 422
++T + + S + E ++ + + + +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 423 ---------CVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458
C + + ++ C E+P ER + L + ++
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 4e-16
Identities = 33/186 (17%), Positives = 63/186 (33%), Gaps = 35/186 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DL N+ + + A + DFG++R V + ++A E S ++ DV
Sbjct: 150 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 209
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKK 120
+S+G+LL E+ + + L ++++ + L
Sbjct: 210 WSYGVLLWEIVSLGGT----PYCGMTCAEL-----------------YEKLPQGYRL--- 245
Query: 121 ASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKL---LKTPVYE 177
L C + + C E P ER + L + + + T +YE
Sbjct: 246 --------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
Query: 178 EKQTIN 183
+
Sbjct: 298 KFTYAG 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 3e-23
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 21/169 (12%)
Query: 201 NLIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G FG+VY +A+KV L + G + E + ++RH NI+R+
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
+ + A ++ ++ P G++ L + ++A
Sbjct: 72 YGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT---------ATYITELAN 117
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
AL Y H R+ H ++KP N+LL + DF + P + T
Sbjct: 118 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT 163
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.0 bits (215), Expect = 8e-20
Identities = 28/133 (21%), Positives = 50/133 (37%), Gaps = 24/133 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H D+KP N+ L + DFG + P + + GT+ Y+ PE G D+
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 187
Query: 61 YSFGILLLEMFTGLRPNNG---------MFKDDLNLP--------NLVKSAL---PAR-- 98
+S G+L E G P + + + P +L+ L P++
Sbjct: 188 WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRP 247
Query: 99 -AEQILDVAFFQE 110
++L+ +
Sbjct: 248 MLREVLEHPWITA 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 4e-23
Identities = 34/171 (19%), Positives = 62/171 (36%), Gaps = 23/171 (13%)
Query: 201 NLIGAGNFGSVYNGTLFD---GTTIAVKVFN--LIRPGGARSFKSECKAAINIRHRNIVR 255
+G+GNFG+V G T+AVK+ P +E + + IVR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ A +V + G L ++L + + +++ V+
Sbjct: 73 MI------GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVS 117
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
+KYL H +L NVLL + + DF +++ L + +
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.5 bits (185), Expect = 7e-16
Identities = 38/171 (22%), Positives = 62/171 (36%), Gaps = 38/171 (22%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H DL NV L + A + DFG+++ L + + + + APE + SS
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 57 YGDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEE 115
DV+SFG+L+ E F+ G +P GM ++ +E+ E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------------TAMLEKGE 227
Query: 116 TLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+ A ++ C + R VE RLR+
Sbjct: 228 RMGCPAGCPREMYDLMNLCW-----------TYDVENRPGFAAVELRLRNY 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 4e-23
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 24/172 (13%)
Query: 203 IGAGNFGSVYNGTLF----DGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVR 255
+G G+FG V G ++AVK L +P F E A ++ HRN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
++ V + +V + P GSL + L FL+ A+ VA
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVA 121
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
+ YL R H +L N+LL + +GDF + R LP D+
Sbjct: 122 EGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 3e-13
Identities = 34/171 (19%), Positives = 52/171 (30%), Gaps = 35/171 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI----DVMGTIGYVAPEYGMGSEVSS 56
H DL N+ L +GDFG+ R LP + APE S
Sbjct: 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 57 YGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEET 116
D + FG+ L EMFT + + + +
Sbjct: 194 ASDTWMFGVTLWEMFTYGQE------------------------------PWIGLNGSQI 223
Query: 117 LYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIK 167
L+K + +C I + V C A P++R + L +
Sbjct: 224 LHKIDKEGE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 7e-23
Identities = 58/280 (20%), Positives = 103/280 (36%), Gaps = 35/280 (12%)
Query: 197 FSSANLIGAGNFGSVYNGTLFDGT-----TIAVKVFNL-IRPGGARSFKSECKAAINIRH 250
+ +IGAG FG VY G L + +A+K F E H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
NI+R+ GV + + E +G D R + +F + + + +
Sbjct: 69 HNIIRLE----GVISKYKPMMII---------TEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--TRFI 368
+A +KYL H +L N+L++ ++ V DF ++R L D E T
Sbjct: 116 LRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 369 GKLNVRNFVKMALSQRVEEILNDFN-----LQEIEEDRTMCMHASSSSSTSTHV------ 417
GK+ +R A+S R +D + E+ S+ +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 418 SIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457
++C ++I ++ + C + R K D+ S L + +
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 3e-18
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 36/170 (21%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H DL N+ ++ + + DFG++R L + + I + APE + +S
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 192
Query: 57 YGDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEET 116
DV+SFGI++ E+ T + E+ E
Sbjct: 193 ASDVWSFGIVMWEVMTYGER------------------------------PYWELSNHEV 222
Query: 117 LYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+ + ++C +I ++ + C + R D+ S L +
Sbjct: 223 MKAINDG--FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 1e-22
Identities = 47/273 (17%), Positives = 94/273 (34%), Gaps = 33/273 (12%)
Query: 202 LIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPGGARS-FKSECKAAINIRHRNIVRV 256
IG G FG V+ G +A+K R F E H +IV++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
++ + G L +L + + + + A ++
Sbjct: 74 I------GVITENPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLST 119
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVRNF 376
AL YL R H ++ NVL+ +GDF ++R++ D+ GKL ++
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176
Query: 377 VKMALSQRVEEILNDFN-----LQEIEEDRTMCMHASSSSSTSTHV------SIILECVN 425
+++ R +D + EI ++ + + C
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 426 SICEIGVACSAERPRERMKLNDVESRLRLIRKK 458
++ + C A P R + +++++L I ++
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 7e-14
Identities = 37/169 (21%), Positives = 66/169 (39%), Gaps = 36/169 (21%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI--DVMGTIGYVAPEYGMGSEVSSYG 58
H D+ NV + LGDFG++R++ T + I ++APE +S
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 59 DVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETL 117
DV+ FG+ + E+ G++P G+ +D+ IE E L
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNNDV----------------------IGRIENGERL 228
Query: 118 YKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+ T S++ +C A P R +++++L +I
Sbjct: 229 PMPPNCPPTLYSLMTKCW-----------AYDPSRRPRFTELKAQLSTI 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 96.3 bits (239), Expect = 2e-22
Identities = 39/217 (17%), Positives = 79/217 (36%), Gaps = 30/217 (13%)
Query: 156 INDVESRLRSIKMKLLKTPVYEEKQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT 215
IND + I K + PV ++ ++ D YD +G+G FG V+
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVY-----DYYDILE------ELGSGAFGVVHRCV 49
Query: 216 -LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274
G K N P + K+E + H ++ + A ++ ++
Sbjct: 50 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMVLI 104
Query: 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNL 334
+F+ G L + + + ++ + ++ LK++H + I H ++
Sbjct: 105 LEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 335 KPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
KP N++ + + V DF +A L +
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 190
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 72.0 bits (176), Expect = 2e-14
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 11/115 (9%)
Query: 1 HCDLKPSNVFLDDEMTAH--LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D+KP N+ + + + + DFG+A L + T + APE V Y
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 59 DVYSFGILLLEMFTGLRPNNG---------MFKDDLNLPNLVKSALPARAEQILD 104
D+++ G+L + +GL P G + + D S++ A+ +
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 96.3 bits (239), Expect = 2e-22
Identities = 32/171 (18%), Positives = 61/171 (35%), Gaps = 19/171 (11%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G FG V+ T G A K + + E + +RH +V + A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 91
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
++ ++Y+FM G L E + + + + ++ V + L +
Sbjct: 92 ----FEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGLCH 139
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQTRFIG 369
+H + H +LKP N++ + + DF + L G
Sbjct: 140 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 79.3 bits (195), Expect = 9e-17
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 11/115 (9%)
Query: 1 HCDLKPSNVFLDDEMTAH--LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ + + L DFG+ L + S GT + APE G V Y
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 59 DVYSFGILLLEMFTGLRPNNGM---------FKDDLNLPNLVKSALPARAEQILD 104
D++S G+L + +GL P G D N+ + S + + +
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (232), Expect = 4e-22
Identities = 29/169 (17%), Positives = 57/169 (33%), Gaps = 19/169 (11%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFT 258
+G G +G V +AVK+ ++ R + K E + H N+V+ +
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
+ + + ++ G L + + + +
Sbjct: 71 H-----RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMAGV 116
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
YLH I H ++KP N+LLD+ + DF +A + +
Sbjct: 117 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.0 bits (189), Expect = 2e-16
Identities = 28/96 (29%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSY 57
H D+KP N+ LD+ + DFG+A + GT+ YVAPE E +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 58 G-DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVK 92
DV+S GI+L M G P + + +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 6e-22
Identities = 47/290 (16%), Positives = 91/290 (31%), Gaps = 37/290 (12%)
Query: 201 NLIGAGNFGSVYNGTLF------DGTTIAVKVFNL-IRPGGARSFKSECKAAINIRHRNI 253
+G G FG V F T+AVK+ R+ SE K I+I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK------ 307
V G + V+ +F G+L +L K + + K
Sbjct: 79 VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 308 -LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
+ + VA+ +++L + H +L N+LL ++ + + DF +AR + + R
Sbjct: 136 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 367 ---FIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILE- 422
L + + + E ++ L+
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 252
Query: 423 ---------CVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKILETS 463
+ + + C P +R +++ L +L+ +
Sbjct: 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL----GNLLQAN 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 2e-13
Identities = 34/169 (20%), Positives = 61/169 (36%), Gaps = 34/169 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DL N+ L ++ + DFG+AR + + ++ D + ++APE +
Sbjct: 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 216
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETL 117
DV+SFG+LL E+F+ K D +K RA +Q
Sbjct: 217 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ-------- 268
Query: 118 YKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+L+C P +R +++ L ++
Sbjct: 269 ------------TMLDCW-----------HGEPSQRPTFSELVEHLGNL 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (230), Expect = 1e-21
Identities = 32/178 (17%), Positives = 66/178 (37%), Gaps = 19/178 (10%)
Query: 192 DATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRH 250
D ++ IG G G+VY + G +A++ NL + +E ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
NIV + Y VV +++ GSL + + ++ +
Sbjct: 77 PNIVNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------V 121
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFI 368
+ +AL++LH ++ H ++K N+LL + + DF + + +
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.0 bits (184), Expect = 1e-15
Identities = 31/144 (21%), Positives = 54/144 (37%), Gaps = 27/144 (18%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFID-VMGTIGYVAPEYGMGSEVSSYGD 59
H D+K N+ L + + L DFG + E S ++GT ++APE D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 60 VYSFGILLLEMFTGLRPNNGM------------FKDDLNLP--------NLVKSAL---P 96
++S GI+ +EM G P +L P + + L
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 97 AR---AEQILDVAFFQEIEEEETL 117
+ A+++L F + + +L
Sbjct: 259 EKRGSAKELLQHQFLKIAKPLSSL 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 1e-21
Identities = 32/170 (18%), Positives = 59/170 (34%), Gaps = 21/170 (12%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRV 256
++G G+F +V L A+K+ +I+ E + H V++
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
+ +Q + NG L +++ + A
Sbjct: 74 YFT-----FQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDET-------CTRFYTAE 116
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
+ L I H +LKP N+LL+++M + DF A+ L +Q R
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (186), Expect = 6e-16
Identities = 34/153 (22%), Positives = 61/153 (39%), Gaps = 32/153 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N+ L+++M + DFG A+ L E+ +GT YV+PE
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190
Query: 58 GDVYSFGILLLEMFTGLRPNNG---------MFKDDLNLP--------NLVKSAL---PA 97
D+++ G ++ ++ GL P + K + + P +LV+ L
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDAT 250
Query: 98 R---AEQILDVA------FFQEIEEEETLYKKA 121
+ E++ FF+ + E +
Sbjct: 251 KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 2e-21
Identities = 49/299 (16%), Positives = 102/299 (34%), Gaps = 35/299 (11%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-----FNLIRPGGARSFKSECKAAINIRH 250
F ++G+G FG+VY G + +G + + V P + E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
++ R+ Q ++ + MP G L +++ D + L+
Sbjct: 71 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGS--------QYLLNW 116
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGK 370
+ +A+ + YL R+ H +L NVL+ + DF +A+ L +++ G
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 371 LNVRNFVKM--ALSQRVEEILNDFNLQEIE-EDRTMCMHASSSSSTSTHVSIILE----- 422
++ + L + + ++ E T S SI+ +
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
Query: 423 ----CVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKILETSVCPEDKKKKISMPL 477
C + I V C R K ++ + + V D++ + P
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 1e-15
Identities = 36/193 (18%), Positives = 65/193 (33%), Gaps = 37/193 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE---TSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DL NV + + DFG+A+ L E I ++A E + +
Sbjct: 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEET 116
DV+S+G+ + E+ T G +P +G+ ++ +E+ E
Sbjct: 194 SDVWSYGVTVWELMTFGSKPYDGIPASEI----------------------SSILEKGER 231
Query: 117 LYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIKMKLLKTPVY 176
L C I + I V C D R ++ + + V
Sbjct: 232 L-----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 280
Query: 177 EEKQTINNLSFKD 189
+ + ++ S D
Sbjct: 281 QGDERMHLPSPTD 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.8 bits (222), Expect = 3e-20
Identities = 36/174 (20%), Positives = 59/174 (33%), Gaps = 24/174 (13%)
Query: 195 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGG------ARSFKSECKAAIN 247
N FS +IG G FG VY D G A+K + R A + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
IV + A + + + M G L L + F
Sbjct: 64 GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------- 111
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
A ++ L+++H + + +LKP+N+LLD+ + D +A
Sbjct: 112 --YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.8 bits (157), Expect = 6e-12
Identities = 34/152 (22%), Positives = 60/152 (39%), Gaps = 33/152 (21%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGM-GSEVSSYGD 59
+ DLKP+N+ LD+ + D G+A + +GT GY+APE G S D
Sbjct: 130 YRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDSSAD 188
Query: 60 VYSFGILLLEMFTGLRPNNG------------MFKDDLNLP--------NLVKSAL---P 96
+S G +L ++ G P + LP +L++ L
Sbjct: 189 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 248
Query: 97 AR--------AEQILDVAFFQEIEEEETLYKK 120
R A+++ + FF+ ++ + +K
Sbjct: 249 NRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 4e-20
Identities = 49/273 (17%), Positives = 91/273 (33%), Gaps = 28/273 (10%)
Query: 201 NLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNI 253
+G G+FG VY G T +A+K N F +E ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL-IKKKLDIAI 312
VR+ VS V+ + M G L+ +L + K + +A
Sbjct: 86 VRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLN 372
++A + YL + H +L N ++ ++ +GDF M R + +TD + L
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 373 VRNFV--KMALSQRVEEILNDF----NLQEIEEDRTMCMHASSSSSTSTHV------SII 420
++ + + + L EI S+ V
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 421 LECVNSICEIGVACSAERPRERMKLNDVESRLR 453
C + + E+ C P+ R ++ S ++
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 2e-12
Identities = 29/170 (17%), Positives = 56/170 (32%), Gaps = 35/170 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI---DVMGTIGYVAPEYGMGSEVSSY 57
H DL N + ++ T +GDFG+ R + + + + +++PE ++Y
Sbjct: 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 215
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETL 117
DV+SFG++L E+ T +Q + E+ L
Sbjct: 216 SDVWSFGVVLWEIATLAEQ------------------------------PYQGLSNEQVL 245
Query: 118 YKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSIK 167
C + + C P R ++ S ++
Sbjct: 246 RFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 87.1 bits (215), Expect = 7e-20
Identities = 35/169 (20%), Positives = 66/169 (39%), Gaps = 17/169 (10%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVF 257
++G G V+ L +AVKV P F+ E + A + H IV V+
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
G +V +++ +L + +H + + +++ D +A
Sbjct: 74 DTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEGPMTPKRA---------IEVIADACQA 123
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTR 366
L + Q I H ++KP+N+++ V DF +AR + D+
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 70.5 bits (172), Expect = 3e-14
Identities = 35/117 (29%), Positives = 53/117 (45%), Gaps = 13/117 (11%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+KP+N+ + + DFGIAR + T V+GT Y++PE G V +
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193
Query: 57 YGDVYSFGILLLEMFTGLRPNNGM---------FKDDLNLPNLVKSALPARAEQILD 104
DVYS G +L E+ TG P G ++D P+ L A + ++
Sbjct: 194 RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 1e-19
Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 16/175 (9%)
Query: 197 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVR 255
++ +IG G+FG VY L D G +A+K + R E + + H NIVR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 256 VFTAV-SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
+ S + + + +V ++P H + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQL 131
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFSMARFLPDTDEQTRFI 368
R+L Y+H I H ++KP N+LLD D + + DF A+ L + +I
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 7e-11
Identities = 41/194 (21%), Positives = 72/194 (37%), Gaps = 9/194 (4%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+KP N+ LD D L DFG A+ L + + + Y APE G+ +
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 204
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
DV+S G +L E+ G G D L ++K EQI ++ + +
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESR--LRSIKMKLLKTPVY 176
+ + E + R P R+ + + ++ +K P
Sbjct: 264 AHPWTKVFRPRTPPEAIALCSR----LLEYTPTARLTPLEACAHSFFDELRDPNVKLPNG 319
Query: 177 EEKQTINNLSFKDL 190
+ + N + ++L
Sbjct: 320 RDTPALFNFTTQEL 333
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.6 bits (214), Expect = 2e-19
Identities = 35/185 (18%), Positives = 68/185 (36%), Gaps = 23/185 (12%)
Query: 188 KDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAI 246
K+LY+ + A +G G FG V+ T K ++ K E
Sbjct: 1 KELYEK---YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILN 56
Query: 247 NIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKK 306
RHRNI+ + + ++ ++++F+ + E ++ F+ ++
Sbjct: 57 IARHRNILHLHES-----FESMEELVMIFEFISGLDIFERINTS--------AFELNERE 103
Query: 307 KLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV--GDFSMARFLPDTDEQ 364
+ V AL++LH I H +++P N++ + +F AR L D
Sbjct: 104 IVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 365 TRFIG 369
Sbjct: 161 RLLFT 165
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.9 bits (168), Expect = 2e-13
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 1 HCDLKPSNVFLDDEMTAH--LGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H D++P N+ ++ + +FG AR L +F + Y APE VS+
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDL 85
D++S G L+ + +G+ P +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQI 211
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (212), Expect = 4e-19
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 21/165 (12%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRV 256
+G G+FG V+ +G A+KV ++R E + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 257 FTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVAR 316
+ +Q A+ ++ ++ G L L + F A +V
Sbjct: 70 WGT-----FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF---------YAAEVCL 115
Query: 317 ALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
AL+YLH I + +LKP N+LLD + DF A+++PD
Sbjct: 116 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.6 bits (193), Expect = 1e-16
Identities = 36/148 (24%), Positives = 60/148 (40%), Gaps = 30/148 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
+ DLKP N+ LD + DFG A+++P + GT Y+APE + D
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 61 YSFGILLLEMFTGLRPNNGM---------FKDDLNLP--------NLVKSAL---PAR-- 98
+SFGIL+ EM G P +L P +L+ + ++
Sbjct: 185 WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRL 244
Query: 99 ------AEQILDVAFFQEIEEEETLYKK 120
E + + +F+E+ E+ L +
Sbjct: 245 GNLQNGTEDVKNHPWFKEVVWEKLLSRN 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 4e-19
Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 16/182 (8%)
Query: 190 LYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGARSFKSECKAAIN 247
++D +++ + IG G +G V + + +A+K + + E K +
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 248 IRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK 307
RH NI+ + +A + M + L L G D L
Sbjct: 63 FRHENIIGINDI----------IRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHI 111
Query: 308 LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
+ R LKY+H + H +LKPSN+LL+ + DF +AR + T F
Sbjct: 112 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 368 IG 369
+
Sbjct: 169 LT 170
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (152), Expect = 2e-11
Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE----TSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKPSN+ L+ + DFG+AR + + + T Y APE + S+ +
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 57 Y-GDVYSFGILLLEMFTGLRPNNGMFKDDL 85
D++S G +L EM + G D
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 221
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 8e-19
Identities = 36/183 (19%), Positives = 65/183 (35%), Gaps = 25/183 (13%)
Query: 201 NLIGAGNFGSVYNGTL--------FDGTTIAVKVFNL-IRPGGARSFKSECKAAINI-RH 250
+G G FG V T +AVK+ SE + I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKK--- 307
+NI+ + V+ ++ G+L E+L + ++
Sbjct: 79 KNIINLL-----GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 308 ----LDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
+ A VAR ++YL + H +L NVL+ ++ + + DF +AR + D
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 364 QTR 366
+
Sbjct: 191 YKK 193
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 5e-11
Identities = 35/170 (20%), Positives = 62/170 (36%), Gaps = 37/170 (21%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF---IDVMGTIGYVAPEYGMGSEVSSY 57
H DL NV + ++ + DFG+AR + + + + ++APE +
Sbjct: 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217
Query: 58 GDVYSFGILLLEMFT-GLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEET 116
DV+SFG+LL E+FT G P G+ ++L F+ ++E
Sbjct: 218 SDVWSFGVLLWEIFTLGGSPYPGVPVEEL----------------------FKLLKEGHR 255
Query: 117 LYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDVESRLRSI 166
+ C + + C +P +R + L I
Sbjct: 256 M-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 83.2 bits (205), Expect = 2e-18
Identities = 37/180 (20%), Positives = 63/180 (35%), Gaps = 28/180 (15%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGA---------RSFKSECKAAINIR- 249
++G G V AVK+ ++ G + E +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 250 HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLD 309
H NI+++ Y+ F +V+ M G L ++L K +
Sbjct: 69 HPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET---------RK 114
Query: 310 IAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG 369
I + + LH + I H +LKP N+LLDD+M + DF + L ++ G
Sbjct: 115 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 171
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 74.3 bits (182), Expect = 2e-15
Identities = 38/143 (26%), Positives = 57/143 (39%), Gaps = 33/143 (23%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-- 58
H DLKP N+ LDD+M L DFG + L +V GT Y+APE S ++
Sbjct: 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 59 ----DVYSFGILLLEMFTGLRPNNG---------MFKDDLNLP------------NLVKS 93
D++S G+++ + G P + + +LV
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 94 AL---PAR---AEQILDVAFFQE 110
L P + AE+ L FFQ+
Sbjct: 253 FLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.2 bits (205), Expect = 3e-18
Identities = 34/171 (19%), Positives = 63/171 (36%), Gaps = 21/171 (12%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTA 259
++G G G V A+K+ + E + + +IVR+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALK 319
+ Y G + +V + + G L + + D F ++ +I + A++
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQ 125
Query: 320 YLHCDCQPRIAHCNLKPSNVLLDDEM---IGHVGDFSMARFLPDTDEQTRF 367
YLH IAH ++KP N+L + I + DF A+ + T
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (163), Expect = 9e-13
Identities = 22/83 (26%), Positives = 33/83 (39%), Gaps = 3/83 (3%)
Query: 1 HCDLKPSNVFLDDEM---TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H D+KP N+ + L DFG A+ S T YVAPE +
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 193
Query: 58 GDVYSFGILLLEMFTGLRPNNGM 80
D++S G+++ + G P
Sbjct: 194 CDMWSLGVIMYILLCGYPPFYSN 216
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.4 bits (203), Expect = 5e-18
Identities = 31/185 (16%), Positives = 61/185 (32%), Gaps = 16/185 (8%)
Query: 187 FKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGAR-SFKSECKA 244
+K D + + +++G G F V +A+K G S ++E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLI 304
I+H NIV + Y+ ++ + + G L + + K +
Sbjct: 61 LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGF---------YTE 106
Query: 305 KKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364
+ + V A+KYLH LD++ + DF +++
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166
Query: 365 TRFIG 369
+ G
Sbjct: 167 STACG 171
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 63.9 bits (155), Expect = 8e-12
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 1 HCDLKPSNVFL---DDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSY 57
H DLKP N+ D++ + DFG+++ + GT GYVAPE S
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 58 GDVYSFGILLLEMFTGLRPNNGMFKDDL 85
D +S G++ + G P L
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKL 217
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 1e-17
Identities = 36/176 (20%), Positives = 63/176 (35%), Gaps = 23/176 (13%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-----IRPGGARSFKSECKAAINIRHRNIV 254
+ +G G F +VY +A+K L + G R+ E K + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
+ A + ++V+ FM + +
Sbjct: 64 GLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA---------YMLMT 109
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGK 370
+ L+YLH Q I H +LKP+N+LLD+ + + DF +A+ +
Sbjct: 110 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 5e-12
Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H DLKP+N+ LD+ L DFG+A+ ++ + T Y APE G+ + G
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDL 85
D+++ G +L E+ + G D
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQ 209
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 2e-17
Identities = 34/176 (19%), Positives = 59/176 (33%), Gaps = 18/176 (10%)
Query: 201 NLIGAGNFGSVYNGT--LFDGTTIAVKVFNL--IRPGGARSFKSE---CKAAINIRHRNI 253
IG G +G V+ G +A+K + G S E + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
VR+F + +V++ + + + D+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------VPTETIKDMMFQ 124
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG 369
+ R L +LH R+ H +LKP N+L+ + DF +AR T +
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.4 bits (179), Expect = 5e-15
Identities = 34/159 (21%), Positives = 55/159 (34%), Gaps = 7/159 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKP N+ + L DFG+AR + + V+ T+ Y APE + S ++ D+
Sbjct: 139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 198
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKK 120
+S G + EMF G D L ++ E +
Sbjct: 199 WSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQP 257
Query: 121 ASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159
T + + L+ C P +R+
Sbjct: 258 IEKFVTDIDELGKDLLL------KCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 34/167 (20%), Positives = 58/167 (34%), Gaps = 19/167 (11%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFT 258
IG G +G VY G T A+K L + G + E ++H NIV+++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY- 66
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
V++ + E L + + + +
Sbjct: 67 -------------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT 365
Y H R+ H +LKP N+L++ E + DF +AR +
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 60.7 bits (146), Expect = 7e-11
Identities = 34/161 (21%), Positives = 66/161 (40%), Gaps = 7/161 (4%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H DLKP N+ ++ E + DFG+AR + + + T+ Y AP+ MGS+ S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
D++S G + EM G G+ + D L + + ++ +V + + T+Y
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159
+ + + + + P++R+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 8e-17
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 23/175 (13%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKA-AINIRHRNIVR 255
++G G+FG V+ A+K ++ E + ++ H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 256 VFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+F +Q V +++ G L + F + + A ++
Sbjct: 68 MFCT-----FQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEII 113
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ-TRFIG 369
L++L I + +LK N+LLD + + DF M + D + F G
Sbjct: 114 LGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG 165
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.2 bits (179), Expect = 7e-15
Identities = 37/146 (25%), Positives = 57/146 (39%), Gaps = 25/146 (17%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL-PVETSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
+ DLK N+ LD + + DFG+ + + GT Y+APE +G + + D
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVD 185
Query: 60 VYSFGILLLEMFTGLRPNNG---------MFKDDLNLP--------NLVKSAL------- 95
+SFG+LL EM G P +G + D+ P +L+
Sbjct: 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
Query: 96 PARAEQILDVAFFQEIEEEETLYKKA 121
I F+EI EE K+
Sbjct: 246 LGVRGDIRQHPLFREINWEELERKEI 271
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 79.1 bits (194), Expect = 8e-17
Identities = 40/204 (19%), Positives = 76/204 (37%), Gaps = 30/204 (14%)
Query: 175 VYEEKQTINNLSFKDLYDATNGFSSAN------LIGAGNFGSVYNGT-LFDGTTIAVKVF 227
VY + T + D + + + +G G + V+ + + + VK+
Sbjct: 9 VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI- 67
Query: 228 NLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEW 286
++P + K E K N+R NI+ + V +R A+V++ + N ++
Sbjct: 68 --LKPVKKKKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQL 122
Query: 287 LHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE-M 345
D R ++ +AL Y H I H ++KP NV++D E
Sbjct: 123 YQTLTDYDIR------------FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHR 167
Query: 346 IGHVGDFSMARFLPDTDEQTRFIG 369
+ D+ +A F E +
Sbjct: 168 KLRLIDWGLAEFYHPGQEYNVRVA 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 57.5 bits (138), Expect = 1e-09
Identities = 22/78 (28%), Positives = 36/78 (46%), Gaps = 2/78 (2%)
Query: 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+KP NV +D E L D+G+A F + + + + PE + ++ Y
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211
Query: 59 DVYSFGILLLEMFTGLRP 76
D++S G +L M P
Sbjct: 212 DMWSLGCMLASMIFRKEP 229
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.4 bits (192), Expect = 1e-16
Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 12/166 (7%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVF 257
IG G FG V+ G +A+K + + G + E K ++H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
R K +Y ++ + F + + + +
Sbjct: 76 EICRTKASPYNRCKGSIYLVF------DFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDE 363
L L+ + +I H ++K +NVL+ + + + DF +AR
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 4e-12
Identities = 33/167 (19%), Positives = 63/167 (37%), Gaps = 12/167 (7%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-----TSFIDVMGTIGYVAPEYGMGSEVS 55
H D+K +NV + + L DFG+AR + + + + T+ Y PE +G
Sbjct: 140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 199
Query: 56 SYG-DVYSFGILLLEMFTGLRPNNGMFKDDL--NLPNLVKSALPARAEQILDVAFFQEIE 112
D++ G ++ EM+T G + + L S P + + ++++E
Sbjct: 200 GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259
Query: 113 EEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159
+ +K L I + P +R+D +D
Sbjct: 260 LVKGQKRKVKDRLKAYVRDPYALDLIDK----LLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.4 bits (184), Expect = 9e-16
Identities = 30/172 (17%), Positives = 58/172 (33%), Gaps = 20/172 (11%)
Query: 201 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNIVRVF 257
IG G +G+V+ +A+K L G S E ++H+NIVR+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 258 TAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+ +V++F + + D ++ + +
Sbjct: 68 DV-----LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS---------FLFQLLKG 113
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIG 369
L + H + H +LKP N+L++ + +F +AR
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.0 bits (144), Expect = 1e-10
Identities = 28/161 (17%), Positives = 50/161 (31%), Gaps = 6/161 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFL--PVETSFIDVMGTIGYVAPEYGMGSEVSSYG 58
H DLKP N+ ++ L +FG+AR PV +V+ S+
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 59 DVYSFGILLLEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLY 118
D++S G + E+ RP D L + + EQ + + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 119 KKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159
S + + P +R+ +
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQN----LLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 1e-15
Identities = 31/178 (17%), Positives = 57/178 (32%), Gaps = 21/178 (11%)
Query: 195 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRH 250
N F L+G G FG V G A+K+ +I +E + N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
+ + A +Q V ++ G L L F ++
Sbjct: 65 PFLTALKYA-----FQTHDRLCFVMEYANGGELFFHLSR---------ERVFTEERARFY 110
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFI 368
++ AL + + ++K N++LD + + DF + + +
Sbjct: 111 GAEIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 3e-15
Identities = 30/149 (20%), Positives = 60/149 (40%), Gaps = 29/149 (19%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGD 59
+ D+K N+ LD + + DFG+ + + + GT Y+APE ++ D
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 187
Query: 60 VYSFGILLLEMFTGLRPNNGM---------FKDDLNLP--------NLVKSAL------- 95
+ G+++ EM G P +++ P +L+ L
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 96 ----PARAEQILDVAFFQEIEEEETLYKK 120
P+ A+++++ FF I ++ + KK
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKK 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 1e-15
Identities = 32/130 (24%), Positives = 54/130 (41%), Gaps = 20/130 (15%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG- 58
H D+K N+ +D + L DFG L +T + D GT Y PE+
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191
Query: 59 DVYSFGILLLEMFTGLRP---NNGMFKDDLNLP--------NLVKSAL---PAR---AEQ 101
V+S GILL +M G P + + + + +L++ L P+ E+
Sbjct: 192 AVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251
Query: 102 ILDVAFFQEI 111
I + + Q++
Sbjct: 252 IQNHPWMQDV 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.6 bits (167), Expect = 2e-13
Identities = 31/175 (17%), Positives = 60/175 (34%), Gaps = 26/175 (14%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR------PGGARSFKSECK--AAINIRHRN 252
L+G+G FGSVY+G + D +A+K R E ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
++R+ + F ++ + P L +++ + L
Sbjct: 71 VIRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---------RSFFW 117
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFSMARFLPDTDEQTR 366
V A+++ + H ++K N+L+D + + DF L DT
Sbjct: 118 QVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (183), Expect = 2e-15
Identities = 31/154 (20%), Positives = 56/154 (36%), Gaps = 31/154 (20%)
Query: 1 HCDLKPSNVFLDDEMTA----HLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H DLKP N+ L D + DFG+A + F ++ GT +VAPE +
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 195
Query: 57 YGDVYSFGILLLEMFTGLRPNNGMFKDDL---------------------NLPNLVKSAL 95
D++S G++ + +G P G K + + ++ L
Sbjct: 196 EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLL 255
Query: 96 ---PAR---AEQILDVAFFQEIEEEETLYKKASS 123
P + + L + + + ++ L S
Sbjct: 256 VKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 4e-15
Identities = 33/179 (18%), Positives = 63/179 (35%), Gaps = 28/179 (15%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARS------FKSECKAAINIRHRNIV 254
+G+G F V G A K R +R + E I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 255 RVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDV 314
+ Y+ ++ + + G L ++L K+ + +
Sbjct: 77 TLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEE------------EATEFL 119
Query: 315 ARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG----HVGDFSMARFLPDTDEQTRFIG 369
+ L ++ +IAH +LKP N++L D + + DF +A + +E G
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 178
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 3e-15
Identities = 31/178 (17%), Positives = 66/178 (37%), Gaps = 18/178 (10%)
Query: 188 KDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSECKA 244
K ++ + +G+G +G+V + G +A+K A+ E +
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 245 AINIRHRNIVRVFTAVSGVDYQGARFK-AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFL 303
++RH N++ + + + +V FM + H K
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----------LG 119
Query: 304 IKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
+ + + + L+Y+H I H +LKP N+ ++++ + DF +AR
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 2e-07
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-D 59
H DLKP N+ ++++ + DFG+AR E + + T Y APE + + D
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVILNWMRYTQTVD 201
Query: 60 VYSFGILLLEMFTGLRPNNGMFKDDLN 86
++S G ++ EM TG G D
Sbjct: 202 IWSVGCIMAEMITGKTLFKGSDHLDQL 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 4e-15
Identities = 34/171 (19%), Positives = 58/171 (33%), Gaps = 19/171 (11%)
Query: 197 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGARSFKSECKAAINIRHRNI 253
F IG G +G VY G +A+K L G + E + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 254 VRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAID 313
V++ D K + + L++++ T +
Sbjct: 64 VKLL------DVIHTENKLYLVFEFLHQDLKKFMDASALTGIP-------LPLIKSYLFQ 110
Query: 314 VARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ 364
+ + L + R+ H +LKP N+L++ E + DF +AR
Sbjct: 111 LLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 4e-11
Identities = 28/82 (34%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFI-DVMGTIGYVAPEYGMGSEVSSYG- 58
H DLKP N+ ++ E L DFG+AR V + T+ Y APE +G + S
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 59 DVYSFGILLLEMFTGLRPNNGM 80
D++S G + EM T G
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGD 206
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 5e-15
Identities = 30/177 (16%), Positives = 59/177 (33%), Gaps = 19/177 (10%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGARSFKSECKAAINIRHRNIVRVFT 258
IG+G G V +A+K + A+ E + H+NI+ +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 259 AVSGVD-YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARA 317
+ + + +V + M + D + +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------------YLLYQMLCG 131
Query: 318 LKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
+K+LH H +LKPSN+++ + + DF +AR + T ++ R
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (141), Expect = 4e-10
Identities = 26/85 (30%), Positives = 37/85 (43%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
H DLKPSN+ + + T + DFG+AR + T Y APE +G D+
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDL 85
+S G ++ EM G D
Sbjct: 202 WSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.5 bits (177), Expect = 1e-14
Identities = 27/163 (16%), Positives = 58/163 (35%), Gaps = 21/163 (12%)
Query: 203 IGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGARSFKSECKAAINIRHRNIVRVFT 258
+G G+FG V G A+K+ + +++ +E + + +V++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 259 AVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARAL 318
++ +V +++ G + L A +
Sbjct: 109 -----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---------RFYAAQIVLTF 154
Query: 319 KYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDT 361
+YLH + + +LKP N+L+D + V DF A+ +
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 29/148 (19%), Positives = 55/148 (37%), Gaps = 30/148 (20%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDV 60
+ DLKP N+ +D + + DFG A+ V+ + GT +APE + + D
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGYNKAVDW 221
Query: 61 YSFGILLLEMFTGLRPNNGMFKDDL-----------------NLPNLVKSAL---PAR-- 98
++ G+L+ EM G P + +L +L+++ L +
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
Query: 99 ------AEQILDVAFFQEIEEEETLYKK 120
I + +F + +K
Sbjct: 282 GNLKNGVNDIKNHKWFATTDWIAIYQRK 309
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 2e-14
Identities = 35/186 (18%), Positives = 73/186 (39%), Gaps = 20/186 (10%)
Query: 179 KQTINNLSFKDLYDATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGA 235
+Q +N K +++ + + + +G+G +GSV G +AVK + A
Sbjct: 6 RQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 236 RSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW 295
+ E + +++H N++ + + + + L + + T
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 296 RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355
+ + + R LKY+H I H +LKPSN+ ++++ + DF +A
Sbjct: 122 HVQFLIY----------QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 356 RFLPDT 361
R D
Sbjct: 169 RHTDDE 174
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (120), Expect = 2e-07
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 3/81 (3%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYG-D 59
H DLKPSN+ ++++ + DFG+AR + + T Y APE + + D
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVD 201
Query: 60 VYSFGILLLEMFTGLRPNNGM 80
++S G ++ E+ TG G
Sbjct: 202 IWSVGCIMAELLTGRTLFPGT 222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.0 bits (168), Expect = 3e-14
Identities = 29/168 (17%), Positives = 52/168 (30%), Gaps = 31/168 (18%)
Query: 201 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL----------IRPGGARSFKSECKAAINIRH 250
L+G G +V+N VK + R G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDI 310
R + ++ VY + N L E + K+ R+ N ++
Sbjct: 66 RALQKLQGL----------AVPKVYAWEGNAVLMELIDAKELYRVRVENP-------DEV 108
Query: 311 AIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFL 358
+ + + I H +L NVL+ +E I + DF + +
Sbjct: 109 LDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.5 bits (169), Expect = 9e-14
Identities = 28/170 (16%), Positives = 58/170 (34%), Gaps = 22/170 (12%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG+G+FG +Y GT + G +A+K+ E K ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTI--- 68
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+ +V + + + + + + L +A + ++Y
Sbjct: 69 -RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTV---------LLLADQMISRIEY 118
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHV---GDFSMARFLPDTDEQTRF 367
+H H ++KP N L+ G++ DF +A+ D
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.5 bits (143), Expect = 2e-10
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 11/96 (11%)
Query: 1 HCDLKPSNVF---LDDEMTAHLGDFGIARFLPVETSFI--------DVMGTIGYVAPEYG 49
H D+KP N ++ DFG+A+ + ++ GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 50 MGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDL 85
+G E S D+ S G +L+ G P G+
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 3e-13
Identities = 26/175 (14%), Positives = 59/175 (33%), Gaps = 24/175 (13%)
Query: 201 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLI----RPGGARSFKSECKAAINIRHRN 252
++G G +G V+ G A+KV + ++E + +IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 253 IVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAI 312
+ +Q ++ ++ G L L ++ ++ I
Sbjct: 90 FLVTL----HYAFQTETKLHLILDYINGGELFTHLSQRERFTEH------------EVQI 133
Query: 313 DVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQTRF 367
V + L + I + ++K N+LLD + DF +++ + + +
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 3e-10
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 38/157 (24%)
Query: 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE--TSFIDVMGTIGYVAPEYGMGSEVSSYG 58
+ D+K N+ LD L DFG+++ + D GTI Y+AP+ G + S +
Sbjct: 152 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD-SGHD 210
Query: 59 ---DVYSFGILLLEMFTGLRP-------------NNGMFKDDLNLP--------NLVKSA 94
D +S G+L+ E+ TG P + + K + P +L++
Sbjct: 211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 270
Query: 95 L-----------PARAEQILDVAFFQEIEEEETLYKK 120
L P A++I + FFQ+I ++ KK
Sbjct: 271 LMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 66.4 bits (161), Expect = 9e-13
Identities = 31/170 (18%), Positives = 58/170 (34%), Gaps = 24/170 (14%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
IG G+FG ++ GT L + +A+K R A + E + + + V
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPN---V 66
Query: 261 SGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKY 320
+G V + L + L F +K A + ++
Sbjct: 67 YYFGQEGLHNVLV----------IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 321 LHCDCQPRIAHCNLKPSNVLLDDEMIGHVG-----DFSMARFLPDTDEQT 365
+H + + + ++KP N L+ + DF M +F D +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 66.4 bits (161), Expect = 1e-12
Identities = 19/98 (19%), Positives = 38/98 (38%), Gaps = 13/98 (13%)
Query: 1 HCDLKPSNVFLDDEMTAH-----LGDFGIARFLPVETS--------FIDVMGTIGYVAPE 47
+ D+KP N + + + + DFG+ +F + ++ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 48 YGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGMFKDDL 85
+G E S D+ + G + + G P G+
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 27/183 (14%), Positives = 61/183 (33%), Gaps = 13/183 (7%)
Query: 202 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAV 260
+G G+F +V+ + + T +A+K+ + + E K + + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 261 SGVDYQGARFKAVVYKFMPNGSL-----EEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVA 315
+ + PNG E + + + I+ +
Sbjct: 79 A---NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 316 RALKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFSMARFLPDTDEQTRFIGKLNVR 374
L Y+H C I H ++KP NVL++ + ++ +A + + R
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 375 NFV 377
+
Sbjct: 194 EYR 196
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 20/83 (24%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 1 HCDLKPSNVFLD-DEMTAHLGDFGIARF---LPVETSFIDVMGTIGYVAPEYGMGSEVSS 56
H D+KP NV ++ + +L IA + + + + T Y +PE +G+
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGC 208
Query: 57 YGDVYSFGILLLEMFTGLRPNNG 79
D++S L+ E+ TG
Sbjct: 209 GADIWSTACLIFELITGDFLFEP 231
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 485 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.89 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.86 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.86 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.86 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.85 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.85 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.85 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.85 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.85 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.85 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.85 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.85 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.85 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.84 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.84 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.84 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.84 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.84 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.83 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.83 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.82 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.82 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.82 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.82 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.82 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.82 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.82 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.81 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.81 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.8 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.8 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.8 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.8 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.8 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.8 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.8 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.8 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.8 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.8 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.79 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.79 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.79 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.79 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.79 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.77 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.77 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.77 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.76 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.76 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.74 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.74 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.74 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.72 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.71 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.71 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.69 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.69 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.68 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.66 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.63 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.61 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 97.85 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.89 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=319.89 Aligned_cols=236 Identities=22% Similarity=0.338 Sum_probs=169.3
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++.+++|||||+++|+|... ...++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEE
Confidence 467778899999999999999888889999998753 33457899999999999999999999998642 357899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.+++.... ..++|..++.|+.|||.||.||| ..+|+||||||+|||+|+++.+||+|||+
T Consensus 79 ~E~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR--------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp EECCTTCBHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred EEecCCCcHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccch
Confidence 99999999999997643 35788999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccc-cchhhhhhhhhhhcccCCCCCC
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILND-FNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~-~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
|+........ ..++...++++|+...++--. ...... ....+... ...... ....
T Consensus 148 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~---~i~~~~-~~~~ 223 (263)
T d1sm2a_ 148 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGF-RLYK 223 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH---HHHHTC-CCCC
T ss_pred heeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH---HHHhcC-CCCC
Confidence 9876432211 123334577777654433110 000000 00000000 000000 0000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+ ..+...+.+++..||+.+|++||||.||+++|++|++
T Consensus 224 p------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 P------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1 1234456789999999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-40 Score=318.73 Aligned_cols=236 Identities=22% Similarity=0.352 Sum_probs=172.8
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++|...+.||+|+||+||+|.+.+++.||||+++... ...+.|.+|+.++++++|||||+++|+|.. +..++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeEE
Confidence 45788889999999999999998888899999997533 345789999999999999999999998753 23589
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++..... ..++|..+++|+.|||+||.||| ..+|+||||||+|||||+++.+||+|||
T Consensus 85 v~Ey~~~g~L~~~~~~~~~-------~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp EEECCTTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeCCCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecccc
Confidence 9999999999998875321 35899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhh-hhccccchhhhhhhhhhhcccCCCCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVE-EILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+|+.+.+.... ..++...++++++...+.--.. ........ ..+........ .....
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~~-~~~~~ 231 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERG-YRMVR 231 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT-CCCCC
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhc-CCCCC
Confidence 99987543211 1233345667776544331110 00000000 00000000000 00101
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
+ ..+...+.+++..||+.+|++||||.+|+++|+.+
T Consensus 232 p------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 P------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1 12334567899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-40 Score=321.58 Aligned_cols=248 Identities=22% Similarity=0.375 Sum_probs=165.3
Q ss_pred cCccchhhhcccc---------ccceeecccCceEEEEeEee-CCc---EEEEEEeeccCC-cchHHHHHHHHHHHhcCC
Q 041230 185 LSFKDLYDATNGF---------SSANLIGAGNFGSVYNGTLF-DGT---TIAVKVFNLIRP-GGARSFKSECKAAINIRH 250 (485)
Q Consensus 185 ~~~~~l~~~t~~f---------~~~~~iG~G~fg~Vy~g~~~-~~~---~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H 250 (485)
++|+++..++.+| ...++||+|+||+||+|... +|+ .||||.+..... ...+.|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4455555555444 44578999999999999864 232 588898764332 334679999999999999
Q ss_pred CcceeEeeeecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 041230 251 RNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIA 330 (485)
Q Consensus 251 ~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~iv 330 (485)
||||+++|+|... ...++|||||++|+|.+++.... ..++|..++.|+.|||+||.||| +.+|+
T Consensus 87 pnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~~~~--------~~l~~~~~~~i~~qia~gl~yLH---~~~ii 150 (299)
T d1jpaa_ 87 PNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQND--------GQFTVIQLVGMLRGIAAGMKYLA---DMNYV 150 (299)
T ss_dssp TTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHTTT--------TCSCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred CCCccEEEEEeeC-----CEEEEEEEecCCCcceeeecccc--------CCCCHHHHHHHHHHHHHHHHHHh---hCCCc
Confidence 9999999998642 35799999999999999987643 35889999999999999999999 67899
Q ss_pred eeccCCCceEecCCCcEEEeecccccccCCCCcc-----------------------eeeeccccHHHHHHHHhhhhh-h
Q 041230 331 HCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ-----------------------TRFIGKLNVRNFVKMALSQRV-E 386 (485)
Q Consensus 331 HrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~-----------------------~~~~~~~~l~~~~~~~~~~~~-~ 386 (485)
||||||+|||||.++++||+|||+|+.+...... ..++...++++++...++--. .
T Consensus 151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g 230 (299)
T d1jpaa_ 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230 (299)
T ss_dssp CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence 9999999999999999999999999876443211 112223456666544332110 0
Q ss_pred hhccccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 387 EILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 387 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.. |.......+............ . +.++...+.+++..||+.+|++||||.||++.|+++.+
T Consensus 231 ~~--Pf~~~~~~~~~~~i~~~~~~~-~------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 231 ER--PYWDMTNQDVINAIEQDYRLP-P------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CC--TTTTCCHHHHHHHHHTTCCCC-C------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC--CCCCCCHHHHHHHHHcCCCCC-C------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 00 000000000000000110000 0 11244567789999999999999999999999988744
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=318.10 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=170.1
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
.++|...+.||+|+||+||+|+.. ..||||+++... ....+.|.+|+.+|.+++|||||+++|+|.. ...
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~~ 78 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQL 78 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cEE
Confidence 467888899999999999999753 469999986432 3345789999999999999999999998753 246
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+++|||.++|+... ..++|..++.|+.|||+||.||| +.+||||||||+|||||.++.+||+|
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~D 147 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE--------TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGD 147 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECC
T ss_pred EEEEecCCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEcc
Confidence 89999999999999997643 25789999999999999999999 67899999999999999999999999
Q ss_pred cccccccCCCCcc-----------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccC
Q 041230 352 FSMARFLPDTDEQ-----------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 352 FGla~~~~~~~~~-----------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 408 (485)
||+|+........ ..++...++++|+...++--.....-..... ............
T Consensus 148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~ 226 (276)
T d1uwha_ 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGY 226 (276)
T ss_dssp CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTS
T ss_pred ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCC
Confidence 9999876432211 0122334677776544331111110000000 000000000000
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
..... .....++...+.++...||+.+|++||||.||+++|+.+++
T Consensus 227 ~~p~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 227 LSPDL---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCCG---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcc---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00000 01111244567789999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-39 Score=314.61 Aligned_cols=239 Identities=18% Similarity=0.284 Sum_probs=172.7
Q ss_pred hhccccccceeecccCceEEEEeEee-CCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~~-~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
-..++|...+.||+|+||+||+|... +|+.||||+++... ...++|.+|+++|++++|||||+++|+|... ..
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 87 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 87 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC-----Ce
Confidence 34567888899999999999999864 58899999987533 3467899999999999999999999998642 35
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|..... ..++|..++.|+.|||.||.||| ..+|+||||||+|||||+++.+||+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred eEEEeecccCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEc
Confidence 7899999999999999975432 36889999999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhh-hccccchhhhhhhhhhhcccCCC
Q 041230 351 DFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEE-ILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 351 DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
|||+|+........ ..++...++++++...+.--... ...+. .............. .
T Consensus 158 DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i~~~~-~ 234 (287)
T d1opja_ 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKDY-R 234 (287)
T ss_dssp CCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTC-C
T ss_pred cccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHHHHHHhcCC-C
Confidence 99999987544321 11222345555554333211000 00000 00000000000000 0
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
...+ ..+...+.+++..||+.+|++||||.||++.|+.+
T Consensus 235 ~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 MERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCC------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0001 12334567899999999999999999999988865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=306.27 Aligned_cols=240 Identities=20% Similarity=0.309 Sum_probs=170.3
Q ss_pred cccccccee-ecccCceEEEEeEee---CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANL-IGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~-iG~G~fg~Vy~g~~~---~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+. ||+|+||+||+|... ++..||||+++.... ...+.|.+|+++|.+++|||||+++|+|..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 345666664 999999999999753 345799999975432 335689999999999999999999999853
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
+..++||||+++|+|.+++.... ..++|..++.|+.|||.||.||| +.+|+||||||+||||+.++.+|
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKR--------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT--------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred CeEEEEEEeCCCCcHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCcee
Confidence 24689999999999999987543 25788999999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+|+.+...... ..++...++++++...++--. ... |+......+.......
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~--Pf~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQ 227 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC--TTTTCCTHHHHHHHHT
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC--CCCCCCHHHHHHHHHc
Confidence 9999999876543221 112234456666544332100 000 0000000000000111
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
+.. ...+ ..+...+.+|...||+.+|++||||.+|+++|+.+...+
T Consensus 228 ~~~-~~~p------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 228 GKR-MECP------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp TCC-CCCC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC-CCCC------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 110 0011 124456778999999999999999999999998776543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=306.99 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=166.2
Q ss_pred ccccccceeecccCceEEEEeEeeCC-----cEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~-----~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
.+.|+..++||+|+||+||+|.+.+. ..||||+++..... ....|.+|+.++.+++|||||+++|+|...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~---- 81 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY---- 81 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS----
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC----
Confidence 34578889999999999999987543 36999998654332 345799999999999999999999998642
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++|+||+.+|+|.+++.... ..++|..+++|+.|||.||.||| +.+|+||||||+|||||.++.+
T Consensus 82 -~~~~~v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 82 -KPMMIITEYMENGALDKFLREKD--------GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp -SSEEEEEECCTTEEHHHHHHHTT--------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred -CceEEEEEecccCcchhhhhccc--------ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeE
Confidence 35789999999999999886543 35889999999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhhhhccccch-hhhhhhhhhhc
Q 041230 348 HVGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNL-QEIEEDRTMCM 405 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~ 405 (485)
||+|||+|+.+...... ..+....++++++...++--.... +... ....+......
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~--~~~~~~~~~~~~~~i~ 227 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE--RPYWELSNHEVMKAIN 227 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC--CTTTTCCHHHHHHHHH
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCC--CccccCCHHHHHHHHh
Confidence 99999999876443211 112223466666644332110000 0000 00000000001
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
...... . ..++...+.+|+..||+.+|++||||.||+++|+.+.+
T Consensus 228 ~~~~~~-~------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 DGFRLP-T------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCCCC-C------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ccCCCC-C------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 111101 1 11244567799999999999999999999999988765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-38 Score=300.11 Aligned_cols=233 Identities=21% Similarity=0.340 Sum_probs=172.0
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||+||+|+..+++.||||+++... ...++|.+|+.++++++|||||+++|+|.. ....++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEE
Confidence 5778889999999999999998888899999997543 345789999999999999999999999864 2457999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|..++.... ..+.|..+.+|+.|+|+||.||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 78 ~Ey~~~g~l~~~~~~~~--------~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR--------HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp EECCTTEEHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEccCCCcHHHhhhccc--------cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchh
Confidence 99999999999987543 35788899999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcccCCCCCC
Q 041230 355 ARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 355 a~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
++........ ..++...++++|+...++--. ... .......+. ....... .....
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~~~i~~~-~~~~~ 222 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHIAQG-LRLYR 222 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHHTT-CCCCC
T ss_pred heeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---HHHHHhC-CCCCC
Confidence 9876443221 112334566666654432111 010 000000110 0000111 11111
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRL 454 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~ 454 (485)
+ ..+...+.++...||+.+|++||||.++++.|..
T Consensus 223 p------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 P------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp C------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred c------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1 1233456789999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=306.19 Aligned_cols=236 Identities=22% Similarity=0.352 Sum_probs=168.2
Q ss_pred ccccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++|...+.||+|+||+||+|...+++.||||+++.. ....+.|.+|+.++.+++|||||+++|+|.. +..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeEE
Confidence 4678889999999999999999888889999998743 3345789999999999999999999999853 23689
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|..++..... ..++|..++.|+.+||.||.||| ..+|+||||||+|||||.++++||+|||
T Consensus 89 v~Ey~~~g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp EECCCTTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEEecCCCchhhhhhhccc-------ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccc
Confidence 9999999999999875321 35899999999999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhhhhhccccc-hhhhhhhhhhhcccCCCCCC
Q 041230 354 MARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRVEEILNDFN-LQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 354 la~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~~~~~~~~ 413 (485)
+|+...+.... ..++...++++++...+.--... .+.. .....+.............
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~--~p~~~~~~~~~~~~~i~~~~~~~~- 235 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG--RVPYPGMVNREVLDQVERGYRMPC- 235 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT--CCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCC--CCCCCCCCHHHHHHHHHhcCCCCC-
Confidence 99876433211 11223345666654433211000 0000 0000000011111111111
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
+ ..+...+.+++..||+.+|++||+|.+|+++|+..
T Consensus 236 ~------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 236 P------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred C------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 1 12334567899999999999999999999888763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-38 Score=310.10 Aligned_cols=252 Identities=19% Similarity=0.253 Sum_probs=177.0
Q ss_pred chhhhccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeec
Q 041230 189 DLYDATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVS 261 (485)
Q Consensus 189 ~l~~~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~ 261 (485)
+++...++|...+.||+|+||+||+|+.. +++.||||+++..... ..+.|.+|++++++++|||||+++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 45556788999999999999999999864 3578999998754332 3467999999999999999999999986
Q ss_pred ccccCCceeeEEEEEecCCCCHHHhhcCCCCccc---------------ccccccccHHHHHHHHHHHHHHHHHhhcCCC
Q 041230 262 GVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHW---------------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQ 326 (485)
Q Consensus 262 ~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~---------------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~ 326 (485)
.. ...++|+||+++|+|.++|+....... ......++|..++.|+.|+|.||.||| .
T Consensus 87 ~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~ 158 (301)
T d1lufa_ 87 VG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---E 158 (301)
T ss_dssp SS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---c
Confidence 42 357899999999999999975332100 011135889999999999999999999 6
Q ss_pred CCeeeeccCCCceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhh
Q 041230 327 PRIAHCNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVE 386 (485)
Q Consensus 327 ~~ivHrdlK~~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~ 386 (485)
.+||||||||+|||||.++.+||+|||+|+...+.... ..++...++++|+...++--..
T Consensus 159 ~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 159 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 78999999999999999999999999999865332211 1123345667776544331111
Q ss_pred hhccccchhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 387 EILNDFNLQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 387 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
. ..+.......+............ . +..+...+.+|...||+.+|++||||.||+++|++|.
T Consensus 239 ~-~~p~~~~~~~e~~~~v~~~~~~~-~------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 239 G-LQPYYGMAHEEVIYYVRDGNILA-C------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp T-CCTTTTSCHHHHHHHHHTTCCCC-C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred C-CCCCCCCCHHHHHHHHHcCCCCC-C------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0 00110000000000000011100 0 1123456779999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=306.77 Aligned_cols=236 Identities=22% Similarity=0.358 Sum_probs=167.2
Q ss_pred eeecccCceEEEEeEeeCC----cEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~~----~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
++||+|+||+||+|.+.++ ..||||+++... ....+.|.+|+++|++++|||||+++|+|... ....++||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv~ 108 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVVL 108 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEEE
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEEE
Confidence 6899999999999986442 258999987432 33457799999999999999999999998642 23578999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
|||++|+|.++++... ..+.+..+++++.|+|.||.||| +.+|+||||||+|||||+++.+||+|||++
T Consensus 109 E~~~~g~l~~~~~~~~--------~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET--------HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp ECCTTCBHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred EEeecCchhhhhcccc--------ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccch
Confidence 9999999999998654 34677889999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCcc----------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 356 RFLPDTDEQ----------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 356 ~~~~~~~~~----------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+........ ..++...++++|+...++--........ .....+.......+. ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~-~~~~~~~~~~i~~g~-~~~~ 255 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVYLLQGR-RLLQ 255 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC-CCCC
T ss_pred hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCC-CCCC
Confidence 876443211 1122234566666544321100000000 000000000000011 0111
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKKI 459 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~~ 459 (485)
+ ..+...+.+++..||+.+|++||+|.||+++|+++.+.+
T Consensus 256 p------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 256 P------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred c------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1 123345778999999999999999999999999997754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=299.77 Aligned_cols=230 Identities=21% Similarity=0.286 Sum_probs=163.3
Q ss_pred eeecccCceEEEEeEeeC---CcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEEE
Q 041230 201 NLIGAGNFGSVYNGTLFD---GTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVVY 275 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~---~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV~ 275 (485)
+.||+|+||+||+|.+.+ ++.||||+++... ....+.|.+|+.+|++++|||||+++|+|.. +..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 579999999999998654 4579999986432 2234679999999999999999999999853 2358999
Q ss_pred EecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecccc
Q 041230 276 KFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMA 355 (485)
Q Consensus 276 ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGla 355 (485)
||+++|+|.++++.. ..++|..++.|+.|||.||.||| +.+|+||||||+||||+.++.+||+|||+|
T Consensus 87 E~~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN---------RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp ECCTTEEHHHHHHHC---------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EcCCCCcHHHHHhhc---------cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhh
Confidence 999999999999753 25789999999999999999999 678999999999999999999999999999
Q ss_pred cccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCC
Q 041230 356 RFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 356 ~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+.+...... ..++...++++++...++--. ... |+......+......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~--Pf~~~~~~~~~~~i~~~~-~~~~ 231 (277)
T d1xbba_ 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGE-RMGC 231 (277)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC--SSTTCCHHHHHHHHHTTC-CCCC
T ss_pred hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC--CCCCCCHHHHHHHHHcCC-CCCC
Confidence 876443221 112234456666544332100 010 000000000000111111 0111
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+ ..+...+.+|...||+.+|++||||.+|+++|+..-.
T Consensus 232 p------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 232 P------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp C------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1 1234566789999999999999999999999987643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=297.79 Aligned_cols=237 Identities=21% Similarity=0.311 Sum_probs=166.2
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
++|...+.||+|+||.||+|.. .|+.||||+++.. ...+.|.+|++++++++|||||+++|+|... ....++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEEE
Confidence 4566778999999999999986 5889999998643 3457899999999999999999999998532 2346899
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeeccc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFSM 354 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFGl 354 (485)
|||+++|+|.++|+.... ..++|..+++|+.|||.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~ey~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccccc
Confidence 999999999999974321 35889999999999999999999 67899999999999999999999999999
Q ss_pred ccccCCCCcc---------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccCCCCCCcchhh
Q 041230 355 ARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHASSSSSTSTHVS 418 (485)
Q Consensus 355 a~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (485)
++........ ..++...++++|+...++--. ........ ...+........ .....
T Consensus 150 s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~-~~~~~----- 221 (262)
T d1byga_ 150 TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKG-YKMDA----- 221 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTT-CCCCC-----
T ss_pred ceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcC-CCCCC-----
Confidence 9975433211 123344567777654333110 11111100 000000000000 01111
Q ss_pred hHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 419 IILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 419 ~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+..+...+.++...||+.+|.+||||.+|+++|+.++.
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11233456789999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-36 Score=294.67 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=168.5
Q ss_pred ccccceeecccCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHH--HHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSEC--KAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~--~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.|...+.||+|+||.||+|++ +|+.||||+++.. ..+.+..|. ..+.+++|||||+++|+|...+ ......++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 455667899999999999985 7899999998632 334444444 4556789999999999997543 22345789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeeccCCCceEecCCCcEE
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC-----QPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~-----~~~ivHrdlK~~NILld~~~~~k 348 (485)
|||||++|+|.++|+.. .++|..+++++.++|.||.|||+.. .++|+||||||+|||||.++.+|
T Consensus 79 v~Ey~~~g~L~~~l~~~----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred EEecccCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 99999999999999752 4789999999999999999999531 47999999999999999999999
Q ss_pred EeecccccccCCCCcce-----e-----------------------eeccccHHHHHHHHhhhhhhhhcc--------cc
Q 041230 349 VGDFSMARFLPDTDEQT-----R-----------------------FIGKLNVRNFVKMALSQRVEEILN--------DF 392 (485)
Q Consensus 349 i~DFGla~~~~~~~~~~-----~-----------------------~~~~~~l~~~~~~~~~~~~~~~~d--------~~ 392 (485)
|+|||+++......... . ++...++++|+...++--...... +.
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 99999998764432110 0 111245666654433211000000 00
Q ss_pred c-----hhhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 393 N-----LQEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 393 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
. ................++..+..+ ...++...+.+++..||+.+|++||||.||+++|+++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0 000000111111111111111111 1224666788999999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-36 Score=296.48 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=165.5
Q ss_pred ccccccceeecccCceEEEEeEeeCC------cEEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCcceeEeeeeccccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFDG------TTIAVKVFNLI-RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~~------~~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~ 265 (485)
.++|...+.||+|+||+||+|+.... ..||||.+... .......|.+|+.+|.++ +|||||+++++|...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 46788889999999999999986432 26899988543 233456799999999998 899999999998642
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcc--------------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTH--------------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAH 331 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~--------------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivH 331 (485)
...++||||+++|+|.++|+...... .......++|..++.|+.|||.||.||| +.+|||
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiH 187 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 187 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 35799999999999999998653210 0011135899999999999999999999 678999
Q ss_pred eccCCCceEecCCCcEEEeecccccccCCCCcce--------------------eeeccccHHHHHHHHhhhhh-hhhcc
Q 041230 332 CNLKPSNVLLDDEMIGHVGDFSMARFLPDTDEQT--------------------RFIGKLNVRNFVKMALSQRV-EEILN 390 (485)
Q Consensus 332 rdlK~~NILld~~~~~ki~DFGla~~~~~~~~~~--------------------~~~~~~~l~~~~~~~~~~~~-~~~~d 390 (485)
|||||+|||++.++.+||+|||+|+......... .++...++++++...+.--. ...
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~-- 265 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-- 265 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC--
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC--
Confidence 9999999999999999999999998764433211 12223455565543332110 000
Q ss_pred ccchhhh-hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHH
Q 041230 391 DFNLQEI-EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLR 453 (485)
Q Consensus 391 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~ 453 (485)
|...... ........ .......+ ..+...+.+|...|++.+|++||||.||+++|.
T Consensus 266 Pf~~~~~~~~~~~~~~-~~~~~~~p------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYKLIQ-NGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHHHHH-TTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHh-cCCCCCCC------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 0000000 00000000 11111111 123345678999999999999999999999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-36 Score=296.49 Aligned_cols=237 Identities=17% Similarity=0.332 Sum_probs=168.2
Q ss_pred cccccceeecccCceEEEEeEee-CCc----EEEEEEeecc-CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF-DGT----TIAVKVFNLI-RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
++|...+.||+|+||+||+|... +|+ .||||+++.. .....+.|.+|+.++++++|||||+++|+|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 35888899999999999999853 444 5888888643 23456789999999999999999999999864
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++++||+.+|+|.+++.... ..++|..+++|+.|||.||.||| +.+|+||||||+||||+.++.+|
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~--------~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~k 151 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHK--------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 151 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTS--------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEE
T ss_pred CCeeEEEEeccCCcccccccccc--------cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeE
Confidence 23578999999999999887543 35788999999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhh-ccccchhhhhhhhhhhcc
Q 041230 349 VGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEI-LNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 349 i~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~-~d~~~~~~~~~~~~~~~~ 406 (485)
|+|||+|+........ ..++...++++|+...++--. ... .+.....++. .....
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~---~~i~~ 228 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEK 228 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH---HHHHH
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc
Confidence 9999999976443221 112334456666544332110 000 0000000000 00000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
+. .... +..+...+.++...||+.+|++||||.||++.|+.+...
T Consensus 229 ~~-~~~~------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 GE-RLPQ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp TC-CCCC------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC-CCCC------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 00 0000 112445677899999999999999999999999988653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-36 Score=294.72 Aligned_cols=247 Identities=19% Similarity=0.305 Sum_probs=170.9
Q ss_pred cccccceeecccCceEEEEeEeeC-Cc--EEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD-GT--TIAVKVFNLI-RPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~-~~--~vavK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||+||+|...+ |. .||||+++.. .....+.|.+|+++|.++ +|||||+++|+|.. ..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 567778899999999999998654 44 4788887643 233456799999999998 79999999999874 24
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD 342 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld 342 (485)
..++||||+++|+|.++|+...... .......++|..++.++.|||.||.||| ..+|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence 6799999999999999998653110 0011246899999999999999999999 67899999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhc
Q 041230 343 DEMIGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCM 405 (485)
Q Consensus 343 ~~~~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 405 (485)
.++.+||+|||+|+........ ..++...++++|+...+.--.... -+.-.....+......
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~-~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-TPYCGMTCAELYEKLP 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC-CTTTTCCHHHHHHHGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCC-CCCCCCCHHHHHHHHH
Confidence 9999999999999865322111 223345577777654433111000 0000000000001111
Q ss_pred ccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 406 HASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
.... ...+ ..+...+.++...||+.+|++||||.+|++.|+.+.+
T Consensus 241 ~~~~-~~~~------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 QGYR-LEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GTCC-CCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCC-CCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 1011 1233456789999999999999999999999998865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=298.80 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=170.8
Q ss_pred hccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeeccccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDY 265 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~ 265 (485)
..++|...+.||+|+||+||+|... +++.||||+++.... .....|.+|+.++.+++|||||+++|+|..
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--- 94 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 94 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec---
Confidence 3467888899999999999999863 357899999874332 233568999999999999999999999864
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcc-cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTH-WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
....++||||+++|+|.++++...... .......++|..+++|+.++|+||.||| ..+|+||||||+|||||++
T Consensus 95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCC
Confidence 235799999999999999997532110 0011134688999999999999999999 6789999999999999999
Q ss_pred CcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhh
Q 041230 345 MIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMC 404 (485)
Q Consensus 345 ~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 404 (485)
+++||+|||+|+.+...... ..+....++++|+...+.--... --+.......+.....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~-~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-EQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS-CCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Confidence 99999999999876433221 11222345666654332211000 0000000000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
.... .... +..+...+.+++..||+.+|++||||.+|+++|+...
T Consensus 249 ~~~~-~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 MEGG-LLDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTTC-CCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HhCC-CCCC------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0000 0000 1123456789999999999999999999999987653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-36 Score=288.59 Aligned_cols=239 Identities=18% Similarity=0.306 Sum_probs=161.2
Q ss_pred ccccccceeecccCceEEEEeEeeC----CcEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCcceeEeeeecccccCCc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPG-GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGA 268 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 268 (485)
.++|...+.||+|+||+||+|.... +..||||.++..... ..+.|.+|+.++++++|||||+++|+|..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 3578888999999999999998533 346888887643332 34679999999999999999999999853
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+|||++.++.+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~--------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~K 148 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 148 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT--------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred CeEEEEEEeccCCcHHhhhhccC--------CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEE
Confidence 34689999999999999876543 35788999999999999999999 67899999999999999999999
Q ss_pred EeecccccccCCCCcc-------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhhhhhhcccC
Q 041230 349 VGDFSMARFLPDTDEQ-------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 349 i~DFGla~~~~~~~~~-------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~ 408 (485)
|+|||+|+.+...... ..++...++++++...++--. ... |.......+.........
T Consensus 149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~--P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC--TTTTCCGGGHHHHHHTTC
T ss_pred EccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCC--CCCCCCHHHHHHHHHcCC
Confidence 9999999876432211 112223456666543332100 000 000000000000000000
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
... .+ ..+...+.++...||+.+|++||||.||++.|+.|.+.
T Consensus 227 ~~~-~~------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLP-MP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCC-CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-CC------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 000 11 12345567899999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-36 Score=288.66 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=160.4
Q ss_pred cccccceeecccCceEEEEeEeeC--C--cEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFD--G--TTIAVKVFNLIR---PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~--~--~~vavK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|...+.||+|+||+||+|+... + ..||||+++... ....+.|.+|+.+|++++|||||+++|+|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 457778899999999999998643 2 368999886432 2334689999999999999999999999863
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
...++|+||+++|+|.+++.... ..++|..++.++.|+|.||.||| +.+|+||||||+||||+.++.+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~v 150 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ--------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 150 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG--------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEE
T ss_pred -cchheeeeeecCcchhhhhhccc--------CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccce
Confidence 23589999999999999887432 35889999999999999999999 6789999999999999999999
Q ss_pred EEeecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhh-hhhccccchhhhhhh-hhhh
Q 041230 348 HVGDFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQEIEED-RTMC 404 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~~~~~~-~~~~ 404 (485)
||+|||+++........ ..++...++++|+...++--. ... |.......+. ..+.
T Consensus 151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~--Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKID 228 (273)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC--TTTTCCHHHHHHHHH
T ss_pred eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC--CCCCcCHHHHHHHHH
Confidence 99999999987544321 112223466666544332110 011 1100000000 0011
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLI 455 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i 455 (485)
... .....+ ..+...+.++...||+.+|++||||.+|++.|+++
T Consensus 229 ~~~-~~~~~~------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 229 KEG-ERLPRP------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TSC-CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCC-CCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111 111111 12334567899999999999999999999988764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-36 Score=287.03 Aligned_cols=148 Identities=20% Similarity=0.339 Sum_probs=127.2
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.|.+|++++++++|||||++++++.. ....+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----CceeE
Confidence 5688889999999999999985 5689999999875432 334679999999999999999999999764 34679
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+||||+++|+|.++|.... .+++.....|+.|++.||.||| +.+|+||||||+|||+++++.+||+||
T Consensus 80 ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp EEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccc
Confidence 9999999999999997532 5788888999999999999999 678999999999999999999999999
Q ss_pred ccccccC
Q 041230 353 SMARFLP 359 (485)
Q Consensus 353 Gla~~~~ 359 (485)
|+|+...
T Consensus 148 G~a~~~~ 154 (271)
T d1nvra_ 148 GLATVFR 154 (271)
T ss_dssp TTCEECE
T ss_pred hhheeec
Confidence 9998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=291.01 Aligned_cols=246 Identities=19% Similarity=0.247 Sum_probs=160.7
Q ss_pred cccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecccccC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 266 (485)
++|...+.||+|+||+||+|... +++.||||+++.... ...+.|.+|...+.++ +|+|||.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence 56888899999999999999853 246899999874332 3346788888888877 789999999887532
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
....++|||||++|+|.++|+...... .......++|..++.|+.|||+||.||| +.+||||||||+||
T Consensus 90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NI 165 (299)
T d1ywna1 90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 165 (299)
T ss_dssp -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccce
Confidence 345789999999999999997543210 0011235889999999999999999999 67899999999999
Q ss_pred EecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhhh-hh-c-cccchhh
Q 041230 340 LLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRVE-EI-L-NDFNLQE 396 (485)
Q Consensus 340 Lld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~~-~~-~-d~~~~~~ 396 (485)
||++++.+||+|||+|+........ ..++...++++++...+.--.. .. . .......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999875433221 1122334566665443321000 00 0 0000000
Q ss_pred hhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 397 IEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
+.. ...... ....+ ..+...+.+++..|++.+|++||||.||+++|+.+.+
T Consensus 246 ~~~---~~~~~~-~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 FCR---RLKEGT-RMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHH---HHHHTC-CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH---HHhcCC-CCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 000 000000 00001 1133456789999999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-35 Score=284.12 Aligned_cols=229 Identities=17% Similarity=0.223 Sum_probs=163.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.|...+.||+|+||+||+|.. .+|+.||||+++.......+.|.+|++++++++|||||++++++.. .+..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence 4577788999999999999984 5689999999976555556789999999999999999999998764 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++... .+++.....|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 95 vmEy~~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp EEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccch
Confidence 99999999999987642 3677888899999999999999 6789999999999999999999999999
Q ss_pred cccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhc--cccchhhhhhhhhhhcccCCCCCC
Q 041230 354 MARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFNLQEIEEDRTMCMHASSSSST 413 (485)
Q Consensus 354 la~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~ 413 (485)
+|+.+...... ..++...++++++...+.--..... +....... .............
T Consensus 162 ~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~~~~~~~~ 238 (293)
T d1yhwa1 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATNGTPELQN 238 (293)
T ss_dssp TCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHHCSCCCSS
T ss_pred hheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH---HHHHhCCCCCCCC
Confidence 99876433211 1123345666665443321111100 00000000 0000000000000
Q ss_pred cchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 414 STHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 414 ~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
+ . ..-..+.++...|++.+|++|||+.|+++
T Consensus 239 ~---~---~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 P---E---KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp G---G---GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c---c---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1 11234557889999999999999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-35 Score=279.57 Aligned_cols=229 Identities=20% Similarity=0.284 Sum_probs=164.2
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|+. .+|+.||||++... .....+.|.+|+.++++++|||||++++++.. ...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence 4688889999999999999986 46889999998642 23345678999999999999999999999764 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|... ..+++.....|+.|++.||.||| +.+|+||||||+||||+.++.+||+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~---------~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~ 148 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKL---------SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeecCCCcHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeec
Confidence 89999999999999999743 24778889999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 351 DFSMARFLPDTDEQ----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 351 DFGla~~~~~~~~~----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
|||+|+........ ..++...++.+++...+.--.... |.......+........ ....+
T Consensus 149 DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~--Pf~~~~~~~~~~~i~~~--~~~~p 224 (263)
T d2j4za1 149 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP--PFEANTYQETYKRISRV--EFTFP 224 (263)
T ss_dssp CCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC--TTCCSSHHHHHHHHHTT--CCCCC
T ss_pred ccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCC--CCCCCCHHHHHHHHHcC--CCCCC
Confidence 99999876544321 112334566666544332111111 00000000000000000 00000
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
. ..-..+.++...|++.+|++|||+.||++
T Consensus 225 ---~---~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 ---D---FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---c---cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 01233457888999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-35 Score=284.56 Aligned_cols=148 Identities=20% Similarity=0.264 Sum_probs=130.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.|...+.||+|+||+||+|.. .+|+.||||+++.......+.|.+|+++|++++|||||++++++.. ....++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence 4577788999999999999985 4688999999986656667889999999999999999999998764 246799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+++|+|.+++.... ..+++.....|+.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 87 vmEy~~~g~L~~~~~~~~--------~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG 155 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE--------RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG 155 (288)
T ss_dssp EEECCTTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEech
Confidence 999999999999986432 24788889999999999999999 6789999999999999999999999999
Q ss_pred ccccc
Q 041230 354 MARFL 358 (485)
Q Consensus 354 la~~~ 358 (485)
+|+..
T Consensus 156 ~a~~~ 160 (288)
T d2jfla1 156 VSAKN 160 (288)
T ss_dssp TCEEC
T ss_pred hhhcc
Confidence 99764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-35 Score=286.97 Aligned_cols=249 Identities=19% Similarity=0.209 Sum_probs=171.6
Q ss_pred hccccccceeecccCceEEEEeEee------CCcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeecccc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGVD 264 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~~------~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~ 264 (485)
..++|...+.||+|+||.||+|++. +++.||||+++.... .....|.+|+.+++++ +|||||+++|+|...
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~- 99 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence 3467888899999999999999853 356899999975433 2345799999999999 699999999998642
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCccc---------ccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHW---------RLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLK 335 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~---------~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK 335 (485)
...++|||||++|+|.++|+....... ......+++..+..|+.|||.||.||| ..+|+|||||
T Consensus 100 ----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLK 172 (311)
T d1t46a_ 100 ----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 172 (311)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred ----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccc
Confidence 357999999999999999985432100 011235889999999999999999999 6789999999
Q ss_pred CCceEecCCCcEEEeecccccccCCCCcce--------------------eeeccccHHHHHHHHhhhhh-hhhccccch
Q 041230 336 PSNVLLDDEMIGHVGDFSMARFLPDTDEQT--------------------RFIGKLNVRNFVKMALSQRV-EEILNDFNL 394 (485)
Q Consensus 336 ~~NILld~~~~~ki~DFGla~~~~~~~~~~--------------------~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~ 394 (485)
|+|||++.++.+||+|||+++......... .++...++++++...+.--. .........
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999999765433211 11223355555543322100 000010000
Q ss_pred hhhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 395 QEIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
. ............ ....+ ..+...+.+|...||+.+|++||||.+|+++|+++-.
T Consensus 253 ~-~~~~~~~i~~~~-~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 253 V-DSKFYKMIKEGF-RMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp S-SHHHHHHHHHTC-CCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHHHHHhcCC-CCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 0 000000100000 00011 0123456789999999999999999999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=281.48 Aligned_cols=233 Identities=21% Similarity=0.283 Sum_probs=159.7
Q ss_pred ccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEEE
Q 041230 198 SSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAVV 274 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lV 274 (485)
.....||+|+||+||+|.. .++..||||.+.... ....+.|.+|+++|++++|||||++++++... ..+....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 3446799999999999985 457899999986533 22346799999999999999999999987542 2234567999
Q ss_pred EEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec-CCCcEEEeecc
Q 041230 275 YKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD-DEMIGHVGDFS 353 (485)
Q Consensus 275 ~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld-~~~~~ki~DFG 353 (485)
|||+++|+|.++|... ..+++.....|+.|++.||.|||+. .++|+||||||+||||+ +++.+||+|||
T Consensus 91 mE~~~~g~L~~~l~~~---------~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EeCCCCCcHHHHHhcc---------ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 9999999999999743 2477888899999999999999942 24499999999999996 57899999999
Q ss_pred cccccCCCCcc---------------eeeeccccHHHHHHHHhhhhhhhhc--cccchhhhhhhhhhhcccCCCCCCcch
Q 041230 354 MARFLPDTDEQ---------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFNLQEIEEDRTMCMHASSSSSTSTH 416 (485)
Q Consensus 354 la~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (485)
+|+........ ..++...++++++...+.--..... +........ ...... ... .
T Consensus 161 la~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~---~~i~~~-~~~--~-- 232 (270)
T d1t4ha_ 161 LATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSG-VKP--A-- 232 (270)
T ss_dssp GGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTT-CCC--G--
T ss_pred cceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH---HHHHcC-CCC--c--
Confidence 99875443221 1123345666665443321111100 000000000 000000 000 0
Q ss_pred hhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 417 VSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 417 ~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.....+...+.++...|++.+|++|||+.|+++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 000012234568899999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=285.80 Aligned_cols=239 Identities=18% Similarity=0.188 Sum_probs=156.0
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||+||+|.. .+|+.||||.++.... ...+.|.+|++++.+++|||||++++++.+. .....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 5788889999999999999985 5689999999875432 2345689999999999999999999987532 22457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCC--CCCeeeeccCCCceEecCCCcEEE
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDC--QPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~--~~~ivHrdlK~~NILld~~~~~ki 349 (485)
++||||+++|||.+++..... ....+++.....|+.|++.||.|||+.. ..+|+||||||+||||+.++.+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~-----~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTK-----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred EEEEecCCCCcHHHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 899999999999999864211 0135788899999999999999999532 346999999999999999999999
Q ss_pred eecccccccCCCCcc------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCC
Q 041230 350 GDFSMARFLPDTDEQ------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 350 ~DFGla~~~~~~~~~------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
+|||+|+.+...... ..++...++++++...+.--.... |.......+............
T Consensus 156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~--Pf~~~~~~~~~~~i~~~~~~~ 233 (269)
T d2java1 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFTAFSQKELAGKIREGKFRR 233 (269)
T ss_dssp CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC--SCCCSSHHHHHHHHHHTCCCC
T ss_pred eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCC--CCCCCCHHHHHHHHHcCCCCC
Confidence 999999876432211 112334566666654433111110 000000000000000000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.+ . .+-..+.++...|++.+|++|||+.|+++
T Consensus 234 -~~---~---~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -IP---Y---RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CC---T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC---c---ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01 0 12234567888999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-35 Score=284.96 Aligned_cols=229 Identities=17% Similarity=0.224 Sum_probs=163.0
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..|+..+.||+|+||+||+|.. .+|+.||||+++..... ..+.|.+|+.+|.+++|||||++++++.. ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 4578889999999999999984 56889999998754322 23568999999999999999999999764 246
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|||||++|+|..++... ..+++.....|+.||+.||.||| +.+|+||||||+||||+.++.+||+
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~---------~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~ 157 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHK---------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred EEEEEEecCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEe
Confidence 89999999999998776533 25788899999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhh--ccccchhhhhhhhhhhcccCCCC
Q 041230 351 DFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEI--LNDFNLQEIEEDRTMCMHASSSS 411 (485)
Q Consensus 351 DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~--~d~~~~~~~~~~~~~~~~~~~~~ 411 (485)
|||+|+........ ..++...++++++...+.--.... .+........ ... ......
T Consensus 158 DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~---~i~-~~~~~~ 233 (309)
T d1u5ra_ 158 DFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIA-QNESPA 233 (309)
T ss_dssp CCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH-HSCCCC
T ss_pred ecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH---HHH-hCCCCC
Confidence 99999876432210 123445667777654433111110 0000000000 000 000000
Q ss_pred CCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 412 STSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
... . .+-..+.++...|++.+|++|||+.|+++
T Consensus 234 ~~~---~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQS---G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSC---T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---C---CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 001 0 11234567889999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=283.04 Aligned_cols=246 Identities=20% Similarity=0.257 Sum_probs=165.5
Q ss_pred ccccccceeecccCceEEEEeEeeC--------CcEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCcceeEeeeeccc
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRP-GGARSFKSECKAAINI-RHRNIVRVFTAVSGV 263 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~~~--------~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~ 263 (485)
.+.|...+.||+|+||.||+|+... +..||||+++.... ....+|.+|+..+.++ +|||||+++++|...
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3567777899999999999997532 24799999875433 2346788999999888 899999999998742
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcc-------cccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTH-------WRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKP 336 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~-------~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~ 336 (485)
...++||||+++|+|.++|....... .......+++..++.++.|+|.||.||| +.+||||||||
T Consensus 92 -----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp 163 (299)
T d1fgka_ 92 -----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA 163 (299)
T ss_dssp -----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred -----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecc
Confidence 35799999999999999997643210 0111235899999999999999999999 67899999999
Q ss_pred CceEecCCCcEEEeecccccccCCCCcc--------------------eeeeccccHHHHHHHHhhhhh-hhhccccchh
Q 041230 337 SNVLLDDEMIGHVGDFSMARFLPDTDEQ--------------------TRFIGKLNVRNFVKMALSQRV-EEILNDFNLQ 395 (485)
Q Consensus 337 ~NILld~~~~~ki~DFGla~~~~~~~~~--------------------~~~~~~~~l~~~~~~~~~~~~-~~~~d~~~~~ 395 (485)
+|||++.++.+||+|||+++........ ..++...++++++...+.--. ........
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-- 241 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 241 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC--
Confidence 9999999999999999999876432211 122334566666544332100 01000000
Q ss_pred hhhhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHH
Q 041230 396 EIEEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIR 456 (485)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~ 456 (485)
............ .....+ ..+...+.++...|++.+|++||||.||+++|++|-
T Consensus 242 ~~~~~~~~i~~~-~~~~~p------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 242 PVEELFKLLKEG-HRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp CHHHHHHHHHTT-CCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcC-CCCCCC------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 000000000000 001111 112345678999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=285.66 Aligned_cols=150 Identities=24% Similarity=0.303 Sum_probs=130.0
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+.+|++++|||||+++++|.. ...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 356898999999999999999985 468899999987543 3335679999999999999999999999864 245
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.++|... ..+++.....++.|++.||.|||+ ..+|+||||||+||||+.++.+||+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~---------~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA---------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEe
Confidence 79999999999999999743 247788889999999999999994 2479999999999999999999999
Q ss_pred eccccccc
Q 041230 351 DFSMARFL 358 (485)
Q Consensus 351 DFGla~~~ 358 (485)
|||+|+..
T Consensus 148 DFGla~~~ 155 (322)
T d1s9ja_ 148 DFGVSGQL 155 (322)
T ss_dssp CCCCCHHH
T ss_pred eCCCcccc
Confidence 99999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-33 Score=281.36 Aligned_cols=152 Identities=20% Similarity=0.324 Sum_probs=131.3
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
++|...+.||+|+||+||+|.. .+|+.||||++........+.|.+|+.+|.+++|||||++++++.. ....++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 5788889999999999999985 5689999999875544455778999999999999999999998764 346899
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec--CCCcEEEee
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD--DEMIGHVGD 351 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld--~~~~~ki~D 351 (485)
|||||++|+|.++|.... ..+++.....|+.||+.||.||| +.+||||||||+||||+ .++.+||+|
T Consensus 101 vmE~~~gg~L~~~l~~~~--------~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 169 (350)
T ss_dssp EECCCCSCBHHHHHTCTT--------SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred EEEcCCCCCHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEee
Confidence 999999999999996543 24788999999999999999999 67999999999999996 468899999
Q ss_pred cccccccCCCC
Q 041230 352 FSMARFLPDTD 362 (485)
Q Consensus 352 FGla~~~~~~~ 362 (485)
||+|+.+....
T Consensus 170 FG~a~~~~~~~ 180 (350)
T d1koaa2 170 FGLTAHLDPKQ 180 (350)
T ss_dssp CTTCEECCTTS
T ss_pred cchheeccccc
Confidence 99999875543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-33 Score=280.86 Aligned_cols=234 Identities=15% Similarity=0.193 Sum_probs=164.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.|...+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.. ....++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 4688889999999999999984 5689999999876444445678899999999999999999998753 346799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec--CCCcEEEee
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD--DEMIGHVGD 351 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld--~~~~~ki~D 351 (485)
||||+++|+|.+++.... ..+++.....|+.||+.||.||| +.+|+||||||+||||+ .++.+||+|
T Consensus 104 vmE~~~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~D 172 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIID 172 (352)
T ss_dssp EEECCCCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred EEEcCCCChHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEee
Confidence 999999999999886543 35788889999999999999999 67999999999999998 678999999
Q ss_pred cccccccCCCCcce-----------------eeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCCCCCc
Q 041230 352 FSMARFLPDTDEQT-----------------RFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSSSSTS 414 (485)
Q Consensus 352 FGla~~~~~~~~~~-----------------~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 414 (485)
||+|+.+....... .++...++++++...+..-.... |.................... ..
T Consensus 173 FGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~--Pf~~~~~~~~~~~i~~~~~~~-~~ 249 (352)
T d1koba_ 173 FGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS--PFAGEDDLETLQNVKRCDWEF-DE 249 (352)
T ss_dssp CTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC--SSCCSSHHHHHHHHHHCCCCC-CS
T ss_pred cccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCC--CCCCCCHHHHHHHHHhCCCCC-Cc
Confidence 99999875543221 12233455555544332111110 000000000000000000000 00
Q ss_pred chhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 415 THVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 415 ~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
..+. ..-..+.++...|++.+|.+|||+.|+++
T Consensus 250 ~~~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccc---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 11233458899999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-34 Score=278.01 Aligned_cols=235 Identities=16% Similarity=0.188 Sum_probs=152.3
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
..+.|...+.||+|+||+||+|.. .+|+.||||++..... .....|.+|+.+|++++|||||++++++.. ...
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 345688889999999999999985 4588999999875432 234568899999999999999999998753 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec---CCCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD---DEMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld---~~~~~ 347 (485)
.++||||+++|||.++|.... .+++.....|+.|++.||.||| +.+|+||||||+|||+. +++.+
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceE
Confidence 899999999999999997542 4788889999999999999999 67899999999999994 57899
Q ss_pred EEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCCC
Q 041230 348 HVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASSS 410 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 410 (485)
||+|||+|+........ ..++...++++++...+..-.... |.......+...........
T Consensus 150 kl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~--Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 150 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP--PFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp EECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC--SCCCSSHHHHHHHHHTTCCC
T ss_pred EEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCC--CCCCCCHHHHHHHHhccCCC
Confidence 99999999876433211 112334556666544332111110 00000000000000000000
Q ss_pred CCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 411 SSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
.... .+. ..-..+.++...|++.+|++|||+.|+++
T Consensus 228 ~~~~-~~~---~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSP-YWD---DISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTT-TTT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCc-ccc---CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0000 000 11234568899999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-33 Score=270.67 Aligned_cols=150 Identities=24% Similarity=0.347 Sum_probs=129.6
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcc---------hHHHHHHHHHHHhcC-CCcceeEeeeeccc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG---------ARSFKSECKAAINIR-HRNIVRVFTAVSGV 263 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~---------~~~f~~E~~~l~~l~-H~niv~l~~~~~~~ 263 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.++++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 5678889999999999999985 568899999997543221 235889999999997 9999999999764
Q ss_pred ccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC
Q 041230 264 DYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD 343 (485)
Q Consensus 264 ~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~ 343 (485)
....++|||||++|||.++|... ..+++.....++.||+.||.||| ..+|+||||||+|||++.
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~---------~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~ 145 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEK---------VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDD 145 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred ----CcceEEEEEcCCCchHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcC
Confidence 34689999999999999999743 25788999999999999999999 678999999999999999
Q ss_pred CCcEEEeecccccccCCC
Q 041230 344 EMIGHVGDFSMARFLPDT 361 (485)
Q Consensus 344 ~~~~ki~DFGla~~~~~~ 361 (485)
++.+||+|||+++.....
T Consensus 146 ~~~~kl~DFG~a~~~~~~ 163 (277)
T d1phka_ 146 DMNIKLTDFGFSCQLDPG 163 (277)
T ss_dssp TCCEEECCCTTCEECCTT
T ss_pred CCCeEEccchheeEccCC
Confidence 999999999999886543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-33 Score=270.25 Aligned_cols=233 Identities=16% Similarity=0.191 Sum_probs=162.6
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC------cchHHHHHHHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP------GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
+.|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.|.+|+.+|.+++|||||++++++..
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----- 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----- 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 4578889999999999999985 5689999999864321 124679999999999999999999999764
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC--
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-- 345 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-- 345 (485)
....++|||||++|+|.++|... ..+++.....|+.|++.||.||| +.+|+||||||+|||++.++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~---------~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK---------ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH---------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSS
T ss_pred CCEEEEEEEcCCCccccchhccc---------cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCc
Confidence 34689999999999999999753 24788888999999999999999 67899999999999999876
Q ss_pred --cEEEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcc
Q 041230 346 --IGHVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMH 406 (485)
Q Consensus 346 --~~ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 406 (485)
.+||+|||+|+........ ..++...++.+++...+.--.... |.......+.......
T Consensus 153 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~--Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSA 230 (293)
T ss_dssp SCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC--SSCCSSHHHHHHHHHT
T ss_pred ccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCC--CCCCCCHHHHHHHHHh
Confidence 4999999999876543221 113334566666544332111111 0000000000000000
Q ss_pred cCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 407 ASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
... .... .....+-..+.++...|++.+|++|||+.|+++
T Consensus 231 ~~~-~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNY-EFED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCC-CCCH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCC-CCCc---hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000 000112234557889999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=272.94 Aligned_cols=148 Identities=22% Similarity=0.347 Sum_probs=129.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|.. .+|+.||||+++.. .....+.|.+|++++++++|||||++++++.. .+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 5688889999999999999985 56899999998642 23445679999999999999999999998753 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++...+ .+++.....++.|++.||.||| +.+|+||||||+|||+++++.+||+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~ 150 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEec
Confidence 799999999999999987532 4778888999999999999999 6789999999999999999999999
Q ss_pred ecccccccC
Q 041230 351 DFSMARFLP 359 (485)
Q Consensus 351 DFGla~~~~ 359 (485)
|||+|+.+.
T Consensus 151 DFG~a~~~~ 159 (288)
T d1uu3a_ 151 DFGTAKVLS 159 (288)
T ss_dssp CCTTCEECC
T ss_pred ccccceecc
Confidence 999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-32 Score=266.28 Aligned_cols=244 Identities=17% Similarity=0.225 Sum_probs=167.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
+.|...+.||+|+||+||+|.. .+|+.||||+++..... ..+.|.+|++++++++|||||++++++...+ .....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence 4577889999999999999984 56899999999754322 2357899999999999999999999876432 12345
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|.+++... ..+++.....|+.|++.||.||| +.+|+||||||+||||+.++..+|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---------~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---------GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhccc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceee
Confidence 78999999999999988643 25788899999999999999999 6789999999999999999999999
Q ss_pred ecccccccCCCCcc---------------------eeeeccccHHHHHHHHhhhhhhhhccccchhhhhhhhhhhcccCC
Q 041230 351 DFSMARFLPDTDEQ---------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQEIEEDRTMCMHASS 409 (485)
Q Consensus 351 DFGla~~~~~~~~~---------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 409 (485)
|||+++........ ..++...++++++...+.--.... |+......+..........
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~--Pf~~~~~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP--PFTGDSPVSVAYQHVREDP 231 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC--SCCCSSHHHHHHHHHHCCC
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC--CCCCcCHHHHHHHHHhcCC
Confidence 99998765332210 112233456666544332111110 0000000000000000000
Q ss_pred CCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCC-CHHHHHHHHHHHHH
Q 041230 410 SSSTSTHVSIILECVNSICEIGVACSAERPRERM-KLNDVESRLRLIRK 457 (485)
Q Consensus 410 ~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP-~m~~V~~~L~~i~~ 457 (485)
. .+. .........+.++...|++.+|++|| |+.++...|.++++
T Consensus 232 ~--~~~--~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 232 I--PPS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp C--CGG--GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred C--CCc--hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0 000 00001123456788899999999999 89999999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.9e-32 Score=266.52 Aligned_cols=151 Identities=21% Similarity=0.308 Sum_probs=128.4
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||+++.. ......+.+|+++|..++|||||++++++.. ....+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 35677889999999999999985 46889999998753 2234568899999999999999999998653 34689
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC--CCcEEEe
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD--EMIGHVG 350 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~--~~~~ki~ 350 (485)
+|||||++|+|.++|.... ..+++.+...|+.|++.||.||| +.+|+||||||+|||++. ...+||+
T Consensus 78 lvmE~~~gg~L~~~i~~~~--------~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~ 146 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKII 146 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEecCCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEc
Confidence 9999999999999997543 25788889999999999999999 679999999999999985 4589999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||+++.....
T Consensus 147 DFG~~~~~~~~ 157 (321)
T d1tkia_ 147 EFGQARQLKPG 157 (321)
T ss_dssp CCTTCEECCTT
T ss_pred ccchhhccccC
Confidence 99999886544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.5e-32 Score=266.85 Aligned_cols=237 Identities=16% Similarity=0.224 Sum_probs=159.7
Q ss_pred ccccccc-eeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCcceeEeeeecccccCCcee
Q 041230 194 TNGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINI-RHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 194 t~~f~~~-~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 270 (485)
.++|... ++||+|+||+||+|.. .+|+.||||+++. ...+.+|+.++.++ +|||||++++++... +.....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 3567665 4699999999999984 5689999999863 35678899987665 899999999987532 223456
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC---CCcE
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD---EMIG 347 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~---~~~~ 347 (485)
.++|||||++|||.++|..... ..+++.....|+.|++.||.||| ..+|+||||||+|||++. ++.+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccc
Confidence 8999999999999999975432 25888899999999999999999 679999999999999986 5679
Q ss_pred EEeecccccccCCCCcc-----------------eeeeccccHHHHHHHHhhhhhhhhc--cccchhhhhhhhhhhcccC
Q 041230 348 HVGDFSMARFLPDTDEQ-----------------TRFIGKLNVRNFVKMALSQRVEEIL--NDFNLQEIEEDRTMCMHAS 408 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-----------------~~~~~~~~l~~~~~~~~~~~~~~~~--d~~~~~~~~~~~~~~~~~~ 408 (485)
||+|||+|+........ ..++...++++++...+.--..... +......... +.....
T Consensus 154 Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~ 230 (335)
T d2ozaa1 154 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIR 230 (335)
T ss_dssp EECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred cccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHh
Confidence 99999999876443221 1122344666665443321111100 0000000000 000000
Q ss_pred CCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHH
Q 041230 409 SSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVES 450 (485)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~ 450 (485)
....... .......-..+.++...|++.+|++|||+.|+++
T Consensus 231 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQYEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCSSSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 0111122345668889999999999999999865
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.4e-31 Score=263.13 Aligned_cols=150 Identities=27% Similarity=0.368 Sum_probs=129.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++.. .....+.|.+|+.++++++|||||++++++.. ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 4688889999999999999985 56899999998642 23345789999999999999999999998754 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++||||+++|+|..++.... .+.+.....++.|++.||.||| +.+|+||||||+||||+.++.+||+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~ 146 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eeeEeeecCCccccccccccc---------cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEe
Confidence 899999999999999987543 3566677789999999999999 7899999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||+|+.....
T Consensus 147 DFG~a~~~~~~ 157 (316)
T d1fota_ 147 DFGFAKYVPDV 157 (316)
T ss_dssp CCSSCEECSSC
T ss_pred cCccceEeccc
Confidence 99999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-31 Score=264.54 Aligned_cols=149 Identities=21% Similarity=0.257 Sum_probs=129.1
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||++.. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.. ...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----ccc
Confidence 5788889999999999999985 56899999999642 23345778999999999999999999998754 356
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|||||++|+|.+++.... .++......++.|++.||.||| +.+|+||||||+||||++++.+||+
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~ 147 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKIT 147 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred cccceeccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEe
Confidence 899999999999999987532 4566677789999999999999 6899999999999999999999999
Q ss_pred ecccccccCC
Q 041230 351 DFSMARFLPD 360 (485)
Q Consensus 351 DFGla~~~~~ 360 (485)
|||+|+....
T Consensus 148 DFG~a~~~~~ 157 (337)
T d1o6la_ 148 DFGLCKEGIS 157 (337)
T ss_dssp CCTTCBCSCC
T ss_pred eccccccccc
Confidence 9999987543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.1e-31 Score=268.84 Aligned_cols=150 Identities=23% Similarity=0.259 Sum_probs=124.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC---CcchHHHHH---HHHHHHhcCCCcceeEeeeecccccCC
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGARSFKS---ECKAAINIRHRNIVRVFTAVSGVDYQG 267 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 267 (485)
++|...+.||+|+||+||+|+. .+|+.||||++.... ......+.+ |+.++..++|||||++++++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----- 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence 5788899999999999999985 468999999986321 122233444 4667778899999999998754
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+++|+|.++|.... .+.+.....|+.+|+.||.||| ..+||||||||+||||+.++.+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~i 146 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 146 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCE
T ss_pred CCEEEEEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcE
Confidence 346899999999999999997532 4667788889999999999999 6899999999999999999999
Q ss_pred EEeecccccccCCC
Q 041230 348 HVGDFSMARFLPDT 361 (485)
Q Consensus 348 ki~DFGla~~~~~~ 361 (485)
||+|||+|+.+...
T Consensus 147 Kl~DFGla~~~~~~ 160 (364)
T d1omwa3 147 RISDLGLACDFSKK 160 (364)
T ss_dssp EECCCTTCEECSSS
T ss_pred EEeeeceeeecCCC
Confidence 99999999976543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=259.23 Aligned_cols=150 Identities=22% Similarity=0.377 Sum_probs=123.9
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
++|...+.||+|+||+||+|.. .+|+.||||+++... ....+.|.+|+++|++++|||||++++++.. ....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 5788899999999999999985 568999999986432 2335789999999999999999999999764 2467
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++||||+.++.+ +++..... ..+++.....++.|++.||.||| +.+||||||||+|||++.++.+||+|
T Consensus 77 ~iv~e~~~~~~~-~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~D 145 (298)
T d1gz8a_ 77 YLVFEFLHQDLK-KFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 145 (298)
T ss_dssp EEEEECCSEEHH-HHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred eEEEeecCCchh-hhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceecc
Confidence 999999986544 44432211 35788999999999999999999 67899999999999999999999999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||+|+....
T Consensus 146 FG~a~~~~~ 154 (298)
T d1gz8a_ 146 FGLARAFGV 154 (298)
T ss_dssp TTHHHHHCC
T ss_pred CCcceeccC
Confidence 999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=2.8e-31 Score=257.53 Aligned_cols=149 Identities=21% Similarity=0.336 Sum_probs=127.9
Q ss_pred cccccceeecccCceEEEEeEeeCCcEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
+.|...+.||+|+||+||+|+..+|+.||||+++... ....+.|.+|+.+|++++|||||++++++.. ....+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCcee
Confidence 4677789999999999999998889999999986543 2235789999999999999999999988764 34578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeec
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDF 352 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DF 352 (485)
+++||+.++.+..+.... ..++......|+.||+.||.||| +.+|+||||||+|||++.++.+|++||
T Consensus 77 i~~e~~~~~~~~~~~~~~---------~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~Df 144 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCE---------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (286)
T ss_dssp EEEECCSEEHHHHHHTST---------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred EEEEeehhhhHHHHHhhc---------CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEeccc
Confidence 999999988877776543 24777888999999999999999 678999999999999999999999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|+|.....
T Consensus 145 G~a~~~~~ 152 (286)
T d1ob3a_ 145 GLARAFGI 152 (286)
T ss_dssp THHHHHCC
T ss_pred ccceeccc
Confidence 99987543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-31 Score=259.67 Aligned_cols=144 Identities=24% Similarity=0.336 Sum_probs=118.2
Q ss_pred ceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc-----chHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 200 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-----GARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 200 ~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
.++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+.++.+++|||||++++++.. ....++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~i 77 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNISL 77 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCceee
Confidence 36899999999999985 46899999998643221 23568999999999999999999999764 245799
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEeecc
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGDFS 353 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~DFG 353 (485)
||||+.+|++..++.... .+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 78 vmE~~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG 145 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 145 (299)
T ss_dssp EEECCSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred hhhhhcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCc
Confidence 999999988877665432 3555677889999999999999 6789999999999999999999999999
Q ss_pred cccccCC
Q 041230 354 MARFLPD 360 (485)
Q Consensus 354 la~~~~~ 360 (485)
+|+....
T Consensus 146 ~a~~~~~ 152 (299)
T d1ua2a_ 146 LAKSFGS 152 (299)
T ss_dssp GGSTTTS
T ss_pred cccccCC
Confidence 9987644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=6.9e-31 Score=261.71 Aligned_cols=150 Identities=19% Similarity=0.269 Sum_probs=129.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCcee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARF 270 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 270 (485)
++|...+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+.+|..++|||||++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 5688889999999999999985 46899999998642 23345678999999999999999999998753 346
Q ss_pred eEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEe
Q 041230 271 KAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVG 350 (485)
Q Consensus 271 ~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~ 350 (485)
.++|+||+.+|+|..++.... .+++.....|+.|++.||.||| +.+||||||||+||||+.++.+||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEee
Confidence 789999999999999997532 4677888899999999999999 6789999999999999999999999
Q ss_pred ecccccccCCC
Q 041230 351 DFSMARFLPDT 361 (485)
Q Consensus 351 DFGla~~~~~~ 361 (485)
|||+|+.....
T Consensus 184 DFG~a~~~~~~ 194 (350)
T d1rdqe_ 184 DFGFAKRVKGR 194 (350)
T ss_dssp CCTTCEECSSC
T ss_pred eceeeeecccc
Confidence 99999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.3e-31 Score=258.03 Aligned_cols=148 Identities=20% Similarity=0.284 Sum_probs=125.8
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeecc---CCcchHHHHHHHHHHH-hcCCCcceeEeeeecccccCCce
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGARSFKSECKAAI-NIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++.. .....+.+..|..++. .++|||||++++++.. ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 5688889999999999999985 46889999999642 2334566777877765 6899999999998764 34
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+++|+|.++|+... .++......++.+|+.||.||| +.+|+||||||+|||+++++.+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl 144 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI 144 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred ceeEEEeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceec
Confidence 6899999999999999997532 4667788899999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||+++...
T Consensus 145 ~DFG~a~~~~ 154 (320)
T d1xjda_ 145 ADFGMCKENM 154 (320)
T ss_dssp CCCTTCBCCC
T ss_pred cccchhhhcc
Confidence 9999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-30 Score=259.88 Aligned_cols=152 Identities=24% Similarity=0.333 Sum_probs=121.0
Q ss_pred ccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCceeeEE
Q 041230 196 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGARFKAV 273 (485)
Q Consensus 196 ~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~l 273 (485)
.|...++||+|+||+||+|+. .+|+.||||+++.... .+.+|+++|++++|||||++++++..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 466778999999999999985 4689999999875332 23479999999999999999998754321 23446789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEEEeec
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGHVGDF 352 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~ki~DF 352 (485)
||||+++|.+..+.+.... ...+++.....|+.|++.||.||| +.+|+||||||+||||+.++ .+||+||
T Consensus 97 v~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecc
Confidence 9999997755444331111 135788889999999999999999 78999999999999999775 8999999
Q ss_pred ccccccCC
Q 041230 353 SMARFLPD 360 (485)
Q Consensus 353 Gla~~~~~ 360 (485)
|+++....
T Consensus 168 G~a~~~~~ 175 (350)
T d1q5ka_ 168 GSAKQLVR 175 (350)
T ss_dssp TTCEECCT
T ss_pred cchhhccC
Confidence 99987643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-30 Score=257.50 Aligned_cols=153 Identities=22% Similarity=0.331 Sum_probs=124.7
Q ss_pred hhccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 192 DATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 192 ~~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
..++.|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|.+++|||||++++++....+....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3455688889999999999999984 5799999999975432 2346789999999999999999999998754443333
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
. +++++|+.+|||.+++... .+++.....++.|++.||.||| +.+||||||||+||||+.++.+||
T Consensus 85 ~-~~l~~~~~~g~L~~~l~~~----------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 85 D-VYLVTHLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp C-EEEEEECCCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred e-EEEEEeecCCchhhhhhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEE
Confidence 3 4455677899999999642 4678888999999999999999 679999999999999999999999
Q ss_pred eeccccccc
Q 041230 350 GDFSMARFL 358 (485)
Q Consensus 350 ~DFGla~~~ 358 (485)
+|||+|+..
T Consensus 151 ~DfG~a~~~ 159 (345)
T d1pmea_ 151 CDFGLARVA 159 (345)
T ss_dssp CCCTTCEEC
T ss_pred cccCceeec
Confidence 999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=255.91 Aligned_cols=149 Identities=19% Similarity=0.250 Sum_probs=123.5
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCc------chHHHHHHHHHHHhcC--CCcceeEeeeeccccc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GARSFKSECKAAINIR--HRNIVRVFTAVSGVDY 265 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~~~~~~~~~ 265 (485)
+.|...+.||+|+||+||+|.. .+|+.||||+++..... ....+.+|+.++.+++ |||||++++++..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--- 80 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--- 80 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC---
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee---
Confidence 4577889999999999999985 56899999998743211 1234778999999986 9999999998754
Q ss_pred CCceeeEEEEEecCC-CCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 266 QGARFKAVVYKFMPN-GSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~-GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
.+..++||||+.+ +++.+++... ..+++.....++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~---------~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~ 146 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITER---------GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 146 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH---------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETT
T ss_pred --CCeEEEEEEeccCcchHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecC
Confidence 3467999999975 6888887643 25778888999999999999999 6889999999999999855
Q ss_pred -CcEEEeecccccccCC
Q 041230 345 -MIGHVGDFSMARFLPD 360 (485)
Q Consensus 345 -~~~ki~DFGla~~~~~ 360 (485)
+.+||+|||+|+....
T Consensus 147 ~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 147 RGELKLIDFGSGALLKD 163 (273)
T ss_dssp TTEEEECCCTTCEECCS
T ss_pred CCeEEECccccceeccc
Confidence 7999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-30 Score=251.66 Aligned_cols=155 Identities=21% Similarity=0.331 Sum_probs=124.6
Q ss_pred ccccccceeecccCceEEEEeEe-eC-CcEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCcceeEeeeecccccC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FD-GTTIAVKVFNLIR--PGGARSFKSECKAAINI---RHRNIVRVFTAVSGVDYQ 266 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~-~~~vavK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~~~~~~~~~~ 266 (485)
.+.|...+.||+|+||+||+|.. .+ ++.||||+++... ......+.+|+.++..+ +|||||+++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35788889999999999999985 34 5679999986432 22344567788776655 899999999998654444
Q ss_pred CceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCc
Q 041230 267 GARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMI 346 (485)
Q Consensus 267 ~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~ 346 (485)
.....++++||+.+|++........ ..+++.....|+.|++.||.||| +.+|+||||||+|||+++++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCC
Confidence 4557899999999988865554332 24677788889999999999999 678999999999999999999
Q ss_pred EEEeecccccccC
Q 041230 347 GHVGDFSMARFLP 359 (485)
Q Consensus 347 ~ki~DFGla~~~~ 359 (485)
+||+|||+++...
T Consensus 155 ~kl~dfg~~~~~~ 167 (305)
T d1blxa_ 155 IKLADFGLARIYS 167 (305)
T ss_dssp EEECSCCSCCCCC
T ss_pred eeecchhhhhhhc
Confidence 9999999998653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.4e-30 Score=247.04 Aligned_cols=149 Identities=20% Similarity=0.307 Sum_probs=128.3
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceee
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFK 271 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 271 (485)
+.|...+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++... ...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 3577889999999999999985 5688999999975432 3357899999999999999999999988643 457
Q ss_pred EEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEEee
Q 041230 272 AVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHVGD 351 (485)
Q Consensus 272 ~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki~D 351 (485)
++|++|+.+++|..++.... .+.+.....++.|++.||+||| ..+|+||||||+|||++.++.+||+|
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~D 144 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred eEEeeecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeee
Confidence 89999999999998887543 4567778899999999999999 67899999999999999999999999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||+++....
T Consensus 145 FG~a~~~~~ 153 (292)
T d1unla_ 145 FGLARAFGI 153 (292)
T ss_dssp CTTCEECCS
T ss_pred cchhhcccC
Confidence 999987644
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=6.6e-30 Score=249.31 Aligned_cols=242 Identities=16% Similarity=0.182 Sum_probs=158.4
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcceeEeeeecccccCCceeeEE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGARFKAV 273 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 273 (485)
+.|...+.||+|+||+||+|.. .+|+.||||++.... ..+.+..|++++.+++|+|+|..++.|.. .....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence 3588889999999999999984 568899999886432 23468899999999999888877766542 2346789
Q ss_pred EEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEec---CCCcEEEe
Q 041230 274 VYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLD---DEMIGHVG 350 (485)
Q Consensus 274 V~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld---~~~~~ki~ 350 (485)
||||+. |+|...+.... ..+++.....++.+++.||+||| +.+|+||||||+|||++ .+..+||+
T Consensus 81 vme~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp EEECCC-CBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred EEEEcC-Cchhhhhhhcc--------CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeee
Confidence 999994 56666654322 35788899999999999999999 67899999999999875 45689999
Q ss_pred ecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhccccchh-hhhhhhhhh
Q 041230 351 DFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEILNDFNLQ-EIEEDRTMC 404 (485)
Q Consensus 351 DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~ 404 (485)
|||+|+.+.+.... ..++...++.+|+...+.--.....-..... .........
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999976433211 0122234566665443321111100000000 000000000
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHH
Q 041230 405 MHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRK 457 (485)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~ 457 (485)
..... ..+ .......+...+.++...|++.+|++||++.++.+.|+.+..
T Consensus 229 ~~~~~--~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 229 SEKKM--STP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHH--HSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hcccC--CCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000 000 000001133557789999999999999999999888887643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=5.1e-29 Score=246.18 Aligned_cols=145 Identities=22% Similarity=0.351 Sum_probs=123.3
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+++|.+++ |||||++++++... .....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence 5788999999999999999985 5688999999864 34567899999999995 99999999987532 234678
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC-cEEEee
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM-IGHVGD 351 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~-~~ki~D 351 (485)
+||||+++|+|..+.. .++......|+.||+.||.||| +.+|+||||||+|||++.++ .+||+|
T Consensus 109 ~v~e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp EEEECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEeecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecc
Confidence 9999999999976643 3566778889999999999999 68899999999999998654 699999
Q ss_pred cccccccCC
Q 041230 352 FSMARFLPD 360 (485)
Q Consensus 352 FGla~~~~~ 360 (485)
||+|+....
T Consensus 174 FG~a~~~~~ 182 (328)
T d3bqca1 174 WGLAEFYHP 182 (328)
T ss_dssp GGGCEECCT
T ss_pred cccceeccC
Confidence 999987644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=250.00 Aligned_cols=154 Identities=19% Similarity=0.272 Sum_probs=122.0
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCc
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGA 268 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~ 268 (485)
..+.|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+. ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 356788889999999999999984 5689999999874322 234578899999999999999999999865332 123
Q ss_pred eeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEE
Q 041230 269 RFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGH 348 (485)
Q Consensus 269 ~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~k 348 (485)
...++||||+ +++|..+++. ..+++.....|+.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecc-cccHHHHHHh----------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccc
Confidence 3568999999 5678777653 24788889999999999999999 67999999999999999999999
Q ss_pred EeecccccccCC
Q 041230 349 VGDFSMARFLPD 360 (485)
Q Consensus 349 i~DFGla~~~~~ 360 (485)
++|||+|+....
T Consensus 162 l~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 162 ILDFGLARQADS 173 (346)
T ss_dssp ECCCTTCEECCS
T ss_pred cccccceeccCC
Confidence 999999987644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.2e-29 Score=244.43 Aligned_cols=154 Identities=20% Similarity=0.299 Sum_probs=123.8
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCcceeEeeeeccccc---CC
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGARSFKSECKAAINIRHRNIVRVFTAVSGVDY---QG 267 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 267 (485)
.+.|...+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|.+++||||+++++.+..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46788889999999999999985 57899999998543 23345778999999999999999999998754221 12
Q ss_pred ceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcE
Q 041230 268 ARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIG 347 (485)
Q Consensus 268 ~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ 347 (485)
....++||||+.+|++..+..... .+.......|+.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcE
Confidence 235789999999888876655332 3555667789999999999999 6799999999999999999999
Q ss_pred EEeecccccccC
Q 041230 348 HVGDFSMARFLP 359 (485)
Q Consensus 348 ki~DFGla~~~~ 359 (485)
||+|||+++...
T Consensus 157 kl~dfg~~~~~~ 168 (318)
T d3blha1 157 KLADFGLARAFS 168 (318)
T ss_dssp EECCCTTCEECC
T ss_pred Eeeecceeeecc
Confidence 999999998654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-29 Score=247.74 Aligned_cols=154 Identities=19% Similarity=0.286 Sum_probs=124.5
Q ss_pred hccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeecccccCCce
Q 041230 193 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 193 ~t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 269 (485)
.++.|...+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|.+++|||||++++++.........
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 456788899999999999999984 5799999999874332 2345788999999999999999999887543322233
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..+++++|+.+|+|.++++.+ .+++.....|+.|++.||.||| +.+|+||||||+|||++.++.+|+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccc
Confidence 446778889999999999643 3677888899999999999999 678999999999999999999999
Q ss_pred eecccccccC
Q 041230 350 GDFSMARFLP 359 (485)
Q Consensus 350 ~DFGla~~~~ 359 (485)
+|||++....
T Consensus 163 ~dfg~a~~~~ 172 (348)
T d2gfsa1 163 LDFGLARHTD 172 (348)
T ss_dssp CCC----CCT
T ss_pred cccchhcccC
Confidence 9999997653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=9.1e-29 Score=240.52 Aligned_cols=238 Identities=16% Similarity=0.163 Sum_probs=162.3
Q ss_pred cccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCC-CcceeEeeeecccccCCceeeE
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIRH-RNIVRVFTAVSGVDYQGARFKA 272 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~~~~ 272 (485)
++|...+.||+|+||+||+|+. .+|+.||||+++... ....+.+|++.+..+.| +|++.+++++.. ....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccE
Confidence 4688889999999999999984 468899999886432 33567889999999976 899999887653 24578
Q ss_pred EEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecC-----CCcE
Q 041230 273 VVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDD-----EMIG 347 (485)
Q Consensus 273 lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~-----~~~~ 347 (485)
+||||+ +|+|.+++.... ..+++.....|+.+++.||.||| +.+|+||||||+|||++. ++.+
T Consensus 78 ~vme~~-~~~l~~~~~~~~--------~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~v 145 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCG--------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI 145 (293)
T ss_dssp EEEECC-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred EEEEec-CCCHHHHHHhhc--------cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCce
Confidence 999998 689999987543 24788889999999999999999 789999999999999974 5789
Q ss_pred EEeecccccccCCCCcc-------------------------eeeeccccHHHHHHHHhhhhhhhhcc----cc-chhhh
Q 041230 348 HVGDFSMARFLPDTDEQ-------------------------TRFIGKLNVRNFVKMALSQRVEEILN----DF-NLQEI 397 (485)
Q Consensus 348 ki~DFGla~~~~~~~~~-------------------------~~~~~~~~l~~~~~~~~~~~~~~~~d----~~-~~~~~ 397 (485)
||+|||+|+...+.... ..++...++.+|+...+.--.....- .. ....+
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence 99999999876432211 01222345666654433211111000 00 00000
Q ss_pred hhhhhhhcccCCCCCCcchhhhHHHHHHHHHHHHHhccCCCcCCCCCHHHHHHHHHHHHHH
Q 041230 398 EEDRTMCMHASSSSSTSTHVSIILECVNSICEIGVACSAERPRERMKLNDVESRLRLIRKK 458 (485)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ial~C~~~~p~~RP~m~~V~~~L~~i~~~ 458 (485)
...... . . ... .......+...+.++...|++.+|++||+.+.+.+.|+.+-++
T Consensus 226 ~~i~~~---~-~--~~~-~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 226 ERIGEK---K-Q--STP-LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHHH---H-H--HSC-HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhc---c-C--CCC-hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 000000 0 0 000 0000011334577888899999999999999988888876544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.9e-29 Score=246.30 Aligned_cols=148 Identities=20% Similarity=0.275 Sum_probs=123.8
Q ss_pred cccccceeecccCceEEEEeEe----eCCcEEEEEEeeccC----CcchHHHHHHHHHHHhcCC-CcceeEeeeeccccc
Q 041230 195 NGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGARSFKSECKAAINIRH-RNIVRVFTAVSGVDY 265 (485)
Q Consensus 195 ~~f~~~~~iG~G~fg~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~f~~E~~~l~~l~H-~niv~l~~~~~~~~~ 265 (485)
++|...+.||+|+||+||+|.. .+|+.||||.++... ....+.|.+|++++.+++| |||+++++++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 5788899999999999999974 247899999986422 1234678899999999976 899999988654
Q ss_pred CCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCC
Q 041230 266 QGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEM 345 (485)
Q Consensus 266 ~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~ 345 (485)
....++|+||+.+|+|.+++.... .+.......++.|++.||.||| +.+|+||||||+||||+.++
T Consensus 101 --~~~~~~v~e~~~~~~L~~~i~~~~---------~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 101 --ETKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred --CCceeeeeecccccHHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCC
Confidence 246899999999999999997543 2344566778999999999999 67899999999999999999
Q ss_pred cEEEeecccccccC
Q 041230 346 IGHVGDFSMARFLP 359 (485)
Q Consensus 346 ~~ki~DFGla~~~~ 359 (485)
.+||+|||+++.+.
T Consensus 167 ~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFV 180 (322)
T ss_dssp CEEESCSSEEEECC
T ss_pred CEEEeeccchhhhc
Confidence 99999999998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-27 Score=237.80 Aligned_cols=152 Identities=18% Similarity=0.216 Sum_probs=119.3
Q ss_pred ccccccceeecccCceEEEEeEe-eCCcEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCcceeEeeeeccccc-CCce
Q 041230 194 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGARSFKSECKAAINIRHRNIVRVFTAVSGVDY-QGAR 269 (485)
Q Consensus 194 t~~f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 269 (485)
.+.|...+.||+|+||+||+|.. .+|+.||||+++.... .....+.+|+.++++++|||||++++++..... ....
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 35688889999999999999985 4689999999975432 233568899999999999999999998864322 2345
Q ss_pred eeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCCCcEEE
Q 041230 270 FKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDEMIGHV 349 (485)
Q Consensus 270 ~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~~~~ki 349 (485)
..++||||+.+|.+ +.++. .+++.....++.|++.||.||| ..+|+||||||+|||++.++..|+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~-----------~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchHHH-Hhhhc-----------CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceee
Confidence 78999999976555 44432 3677788889999999999999 679999999999999999999999
Q ss_pred eecccccccCC
Q 041230 350 GDFSMARFLPD 360 (485)
Q Consensus 350 ~DFGla~~~~~ 360 (485)
+|||+++....
T Consensus 161 ~df~~~~~~~~ 171 (355)
T d2b1pa1 161 LDFGLARTAGT 171 (355)
T ss_dssp CCCCC------
T ss_pred echhhhhcccc
Confidence 99999886543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.89 E-value=1.6e-23 Score=208.97 Aligned_cols=152 Identities=20% Similarity=0.224 Sum_probs=113.6
Q ss_pred cccceeecccCceEEEEeEe-eCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-----------CCcceeEeeeecccc
Q 041230 197 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-----------HRNIVRVFTAVSGVD 264 (485)
Q Consensus 197 f~~~~~iG~G~fg~Vy~g~~-~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~~~~~~~~ 264 (485)
|.....||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++.+++ |+|||++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~- 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK- 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE-
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec-
Confidence 77889999999999999985 578999999987432 23467788999888875 57788888876532
Q ss_pred cCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCceEecCC
Q 041230 265 YQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNVLLDDE 344 (485)
Q Consensus 265 ~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NILld~~ 344 (485)
+....+++++++..+........... ...+.+.....++.+++.||.|||+ ..+|+||||||+||||+.+
T Consensus 93 --~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 93 --GPNGVHVVMVFEVLGENLLALIKKYE------HRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp --ETTEEEEEEEECCCCEEHHHHHHHTT------TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEE
T ss_pred --cccceeeeeeeccccccccccccccc------ccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeecc
Confidence 23345677777765544333221111 1346667778899999999999994 3689999999999999866
Q ss_pred C------cEEEeecccccccCC
Q 041230 345 M------IGHVGDFSMARFLPD 360 (485)
Q Consensus 345 ~------~~ki~DFGla~~~~~ 360 (485)
+ .+|++|||.|+....
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE 184 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB
T ss_pred CcccccceeeEeeccccccccc
Confidence 5 499999999986543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.8e-24 Score=204.93 Aligned_cols=140 Identities=29% Similarity=0.454 Sum_probs=95.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCC---CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMG---SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+||||+.++.+||+|||+|+...... ......||+.|||||++.+ ..++.++|||||||++|||+||+
T Consensus 127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 99999999999999999999999998764322 2345689999999999764 34788999999999999999999
Q ss_pred CCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccc
Q 041230 75 RPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERM 154 (485)
Q Consensus 75 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP 154 (485)
.||.+... ... +.... ......+.+ ......| ...+.++..+|++.+|.+||
T Consensus 207 ~Pf~~~~~----~~~-~~~~~---~~~~~~p~~-----------~~~~~~~---------~~~l~~li~~cl~~dp~~RP 258 (276)
T d1uwha_ 207 LPYSNINN----RDQ-IIFMV---GRGYLSPDL-----------SKVRSNC---------PKAMKRLMAECLKKKRDERP 258 (276)
T ss_dssp CTTTTCCC----HHH-HHHHH---HHTSCCCCG-----------GGSCTTC---------CHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCh----HHH-HHHHH---hcCCCCCcc-----------hhccccc---------hHHHHHHHHHHcCCCHhHCc
Confidence 99965321 111 10000 000000000 0000111 11345788999999999999
Q ss_pred ccchhhHHHHHHhh
Q 041230 155 DINDVESRLRSIKM 168 (485)
Q Consensus 155 ~m~~v~~~L~~i~~ 168 (485)
++.++.+.|+.+..
T Consensus 259 t~~~il~~Le~l~~ 272 (276)
T d1uwha_ 259 LFPQILASIELLAR 272 (276)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999887765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.2e-22 Score=182.43 Aligned_cols=133 Identities=18% Similarity=0.184 Sum_probs=102.8
Q ss_pred ccceeecccCceEEEEeEeeCCcEEEEEEeeccCCc------------------chHHHHHHHHHHHhcCCCcceeEeee
Q 041230 198 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------------------GARSFKSECKAAINIRHRNIVRVFTA 259 (485)
Q Consensus 198 ~~~~~iG~G~fg~Vy~g~~~~~~~vavK~~~~~~~~------------------~~~~f~~E~~~l~~l~H~niv~l~~~ 259 (485)
+..+.||+|+||+||+|...+|+.||||+++..... ....+..|...+.++.|.|++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346899999999999999888999999987532110 01234568889999999999988755
Q ss_pred ecccccCCceeeEEEEEecCCCCHHHhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhcCCCCCeeeeccCCCce
Q 041230 260 VSGVDYQGARFKAVVYKFMPNGSLEEWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHCDCQPRIAHCNLKPSNV 339 (485)
Q Consensus 260 ~~~~~~~~~~~~~lV~ey~~~GsL~~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~~~~~~ivHrdlK~~NI 339 (485)
. ..+++|||++++.+.++ .......++.+++.+|.||| ..+|+||||||+||
T Consensus 83 ~---------~~~lvme~~~~~~~~~l----------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NI 134 (191)
T d1zara2 83 E---------GNAVLMELIDAKELYRV----------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV 134 (191)
T ss_dssp E---------TTEEEEECCCCEEGGGC----------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred c---------CCEEEEEeeccccccch----------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhhe
Confidence 2 13799999998665432 11223568999999999999 67899999999999
Q ss_pred EecCCCcEEEeecccccccC
Q 041230 340 LLDDEMIGHVGDFSMARFLP 359 (485)
Q Consensus 340 Lld~~~~~ki~DFGla~~~~ 359 (485)
|+++++ ++|+|||+|+...
T Consensus 135 Lv~~~~-~~liDFG~a~~~~ 153 (191)
T d1zara2 135 LVSEEG-IWIIDFPQSVEVG 153 (191)
T ss_dssp EEETTE-EEECCCTTCEETT
T ss_pred eeeCCC-EEEEECCCcccCC
Confidence 999654 8999999997653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=5e-23 Score=200.53 Aligned_cols=157 Identities=22% Similarity=0.230 Sum_probs=100.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----ceeecccccCcccccccCCCC------CCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----SFIDVMGTIGYVAPEYGMGSE------VSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++||
T Consensus 131 HrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred ccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHH
Confidence 99999999999999999999999998764332 123467999999999876542 5678999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccC
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAEL 149 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 149 (485)
|+||..|+................. .....+.+. .......+.........++...+..++..|++.+
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~----------~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKV----------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSS--CCHHHHHHH----------HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSS
T ss_pred HhhCCCCCCcccccccchhhccccc--chHHHHHHH----------HhccccCCCCCcccCChHHHHHHHHHHHHHcccC
Confidence 9999887654322211111110000 000000000 0000000001111111233445678999999999
Q ss_pred CCcccccchhhHHHHHHhhh
Q 041230 150 PDERMDINDVESRLRSIKMK 169 (485)
Q Consensus 150 p~~RP~m~~v~~~L~~i~~~ 169 (485)
|.+||++.++.+.|+++...
T Consensus 279 p~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 279 GAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999887653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=2.4e-23 Score=200.78 Aligned_cols=136 Identities=24% Similarity=0.330 Sum_probs=91.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC----ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|||||++.+..++.++|||||||++|||++|..|
T Consensus 133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence 99999999999999999999999998764322 12235689999999999999999999999999999999997666
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+... .+...++... .... ....... +...+.++..+|++.+|++||++
T Consensus 213 ~~~~----~~~~~~~~~i---------~~~~----------~~~~~~~---------~~~~l~~li~~cl~~~p~~RPt~ 260 (283)
T d1mqba_ 213 PYWE----LSNHEVMKAI---------NDGF----------RLPTPMD---------CPSAIYQLMMQCWQQERARRPKF 260 (283)
T ss_dssp TTTT----CCHHHHHHHH---------HTTC----------CCCCCTT---------CBHHHHHHHHHHTCSSTTTSCCH
T ss_pred cccc----CCHHHHHHHH---------hccC----------CCCCchh---------hHHHHHHHHHHHCcCCHhHCcCH
Confidence 5321 1111111100 0000 0000000 11235678899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.|+.+..
T Consensus 261 ~eil~~L~~l~~ 272 (283)
T d1mqba_ 261 ADIVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHhh
Confidence 999998877654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3e-23 Score=198.99 Aligned_cols=135 Identities=24% Similarity=0.361 Sum_probs=96.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+||||+.++.+||+|||+|+....... .....||+.|+|||++....++.++|||||||++|||+||..|+.
T Consensus 132 HrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999999999997754432 234578999999999988889999999999999999999766543
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccch
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIND 158 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~ 158 (485)
.. .+....+.... .-... .....+ ...+.++...|++.+|++||++.+
T Consensus 212 ~~----~~~~~~~~~i~-----~~~~~--------------~~p~~~---------~~~l~~li~~cl~~~P~~Rpt~~e 259 (272)
T d1qpca_ 212 PG----MTNPEVIQNLE-----RGYRM--------------VRPDNC---------PEELYQLMRLCWKERPEDRPTFDY 259 (272)
T ss_dssp TT----CCHHHHHHHHH-----TTCCC--------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CC----CCHHHHHHHHH-----hcCCC--------------CCcccC---------hHHHHHHHHHHcCCCHhHCcCHHH
Confidence 21 11111111000 00000 000001 112457889999999999999999
Q ss_pred hhHHHHHHh
Q 041230 159 VESRLRSIK 167 (485)
Q Consensus 159 v~~~L~~i~ 167 (485)
+.+.|+...
T Consensus 260 i~~~L~~~f 268 (272)
T d1qpca_ 260 LRSVLEDFF 268 (272)
T ss_dssp HHHHHHHHH
T ss_pred HHHHhhhhh
Confidence 998887653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=4.9e-23 Score=196.49 Aligned_cols=136 Identities=23% Similarity=0.302 Sum_probs=88.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||+|+..|+.
T Consensus 124 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp CTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 99999999999999999999999998765432 2234678999999999999999999999999999999999644432
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccch
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIND 158 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~ 158 (485)
.. .+...++..... -.. ......| ...+.++...|++.+|++||++.+
T Consensus 204 ~~----~~~~~~~~~i~~-----~~~--------------~~~p~~~---------~~~l~~li~~cl~~~p~~Rps~~~ 251 (263)
T d1sm2a_ 204 EN----RSNSEVVEDIST-----GFR--------------LYKPRLA---------STHVYQIMNHCWKERPEDRPAFSR 251 (263)
T ss_dssp CS----CCHHHHHHHHHH-----TCC--------------CCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CC----CCHHHHHHHHHh-----cCC--------------CCCcccc---------CHHHHHHHHHHccCCHhHCcCHHH
Confidence 21 111111111000 000 0000011 113467889999999999999999
Q ss_pred hhHHHHHHhh
Q 041230 159 VESRLRSIKM 168 (485)
Q Consensus 159 v~~~L~~i~~ 168 (485)
+.+.|+++..
T Consensus 252 il~~L~~i~e 261 (263)
T d1sm2a_ 252 LLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999887643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=5.1e-23 Score=200.02 Aligned_cols=135 Identities=24% Similarity=0.326 Sum_probs=91.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCC-CC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGL-RP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~-~p 76 (485)
||||||+||||+.++.+||+|||+|+...... ......||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus 157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654332 223467999999999998889999999999999999999975 56
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... ..+...+ .... .......+ ...+.++...|++.+|++||++
T Consensus 237 ~~~~~~~-----~~~~~~~--------~~~~----------~~~~~~~~---------~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 237 YPGVKID-----EEFCRRL--------KEGT----------RMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp STTCCCS-----HHHHHHH--------HHTC----------CCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH-----HHHHHHH--------hcCC----------CCCCCccC---------CHHHHHHHHHHcCCChhHCcCH
Confidence 6542111 1111000 0000 00000001 1124578889999999999999
Q ss_pred chhhHHHHHHh
Q 041230 157 NDVESRLRSIK 167 (485)
Q Consensus 157 ~~v~~~L~~i~ 167 (485)
.++.+.|+++.
T Consensus 285 ~eil~~L~~il 295 (299)
T d1ywna1 285 SELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999887753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.85 E-value=1.9e-22 Score=196.01 Aligned_cols=135 Identities=23% Similarity=0.409 Sum_probs=89.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc------eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-C
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS------FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-G 73 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G 73 (485)
||||||+||||+.++.+||+|||+++.+..... .....||+.|||||...+..++.++|||||||++|||+| |
T Consensus 151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g 230 (299)
T d1jpaa_ 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230 (299)
T ss_dssp CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence 999999999999999999999999987643321 112467899999999988899999999999999999998 8
Q ss_pred CCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcc
Q 041230 74 LRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDER 153 (485)
Q Consensus 74 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~R 153 (485)
+.||.+.. ...++.... . .. ....... +...+.+++..|++.+|.+|
T Consensus 231 ~~Pf~~~~-----~~~~~~~i~--------~-~~----------~~~~~~~---------~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 231 ERPYWDMT-----NQDVINAIE--------Q-DY----------RLPPPMD---------CPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp CCTTTTCC-----HHHHHHHHH--------T-TC----------CCCCCTT---------CCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCC-----HHHHHHHHH--------c-CC----------CCCCCcc---------chHHHHHHHHHHcCCCHhHC
Confidence 99986431 111111000 0 00 0000000 11234578899999999999
Q ss_pred cccchhhHHHHHHhh
Q 041230 154 MDINDVESRLRSIKM 168 (485)
Q Consensus 154 P~m~~v~~~L~~i~~ 168 (485)
|++.++.+.|+++..
T Consensus 278 Ps~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 278 PKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHhc
Confidence 999999999877644
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=9.8e-23 Score=195.07 Aligned_cols=80 Identities=35% Similarity=0.549 Sum_probs=69.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++.+||+|||+|+...... .....+||+.|||||++.+..+ +.++||||+||++|||++|+.|
T Consensus 126 HrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p 205 (271)
T d1nvra_ 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205 (271)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence 99999999999999999999999998764332 2345789999999999888776 5679999999999999999999
Q ss_pred CCCC
Q 041230 77 NNGM 80 (485)
Q Consensus 77 ~~~~ 80 (485)
|...
T Consensus 206 f~~~ 209 (271)
T d1nvra_ 206 WDQP 209 (271)
T ss_dssp CSSS
T ss_pred CCCC
Confidence 9653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.8e-22 Score=193.14 Aligned_cols=77 Identities=34% Similarity=0.504 Sum_probs=67.0
Q ss_pred CCCCCCCcEEEC-CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLD-DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~-~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++ .++.+||+|||+++..... ...+.+||+.|||||.+.+ .++.++|||||||++|||++|+.||.+
T Consensus 137 HrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 999999999996 5789999999999864432 2346789999999998865 689999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=5.5e-23 Score=202.25 Aligned_cols=132 Identities=27% Similarity=0.371 Sum_probs=97.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+|+...... ...+..||+.|||||.+.+..++.++|||||||++|||+| |+.|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 99999999999999999999999998654332 2234678999999999988899999999999999999998 8999
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+..... .+...+.... .. .....+ ...+.++...|++.+|++||++
T Consensus 267 f~~~~~~~-~~~~~~~~~~--------~~--------------~~p~~~---------~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 267 YPGIPVDA-NFYKLIQNGF--------KM--------------DQPFYA---------TEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp STTCCCSH-HHHHHHHTTC--------CC--------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHHH-HHHHHHhcCC--------CC--------------CCCCcC---------CHHHHHHHHHHcCCChhHCcCH
Confidence 87532210 1111111000 00 000011 1134578899999999999999
Q ss_pred chhhHHHH
Q 041230 157 NDVESRLR 164 (485)
Q Consensus 157 ~~v~~~L~ 164 (485)
.++.+.|.
T Consensus 315 ~ei~~~L~ 322 (325)
T d1rjba_ 315 PNLTSFLG 322 (325)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99988874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=3.9e-22 Score=190.02 Aligned_cols=78 Identities=29% Similarity=0.511 Sum_probs=70.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+...... ....+||+.|||||.+.+..++.++|||||||++|||++|+.||.+
T Consensus 129 HrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eeeeccccceecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 99999999999999999999999998765432 3457899999999999998899999999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=9.3e-23 Score=195.09 Aligned_cols=79 Identities=39% Similarity=0.595 Sum_probs=63.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.+.... .....+||+.|||||.+.+..++.++|||||||++|||++|+.||.+
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 99999999999999999999999998765433 23457899999999999888999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=3e-22 Score=193.74 Aligned_cols=79 Identities=29% Similarity=0.448 Sum_probs=71.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++.+.... .....+||+.|+|||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 139 HrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 99999999999999999999999998765432 34557899999999999998999999999999999999999999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=2e-22 Score=194.44 Aligned_cols=136 Identities=25% Similarity=0.330 Sum_probs=100.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++.+..... ....+||+.|+|||++....++.++|||||||++|||+| |+.
T Consensus 132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence 999999999999999999999999997654332 123578999999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+.. ..++.... .... .......| ...+.++...|++.+|++||+
T Consensus 212 Pf~~~~-----~~~~~~~i--------~~~~-----------~~~~p~~~---------~~~l~~li~~cl~~~p~~RPs 258 (285)
T d1u59a_ 212 PYKKMK-----GPEVMAFI--------EQGK-----------RMECPPEC---------PPELYALMSDCWIYKWEDRPD 258 (285)
T ss_dssp TTTTCC-----THHHHHHH--------HTTC-----------CCCCCTTC---------CHHHHHHHHHTTCSSGGGSCC
T ss_pred CCCCCC-----HHHHHHHH--------HcCC-----------CCCCCCcC---------CHHHHHHHHHHcCCCHhHCcC
Confidence 986532 11111110 0000 00000111 113457889999999999999
Q ss_pred cchhhHHHHHHhhh
Q 041230 156 INDVESRLRSIKMK 169 (485)
Q Consensus 156 m~~v~~~L~~i~~~ 169 (485)
+.++.+.|+.....
T Consensus 259 ~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 259 FLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999988776543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.84 E-value=7.3e-23 Score=199.18 Aligned_cols=134 Identities=21% Similarity=0.385 Sum_probs=96.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCC-CC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGL-RP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~-~p 76 (485)
||||||+|||++.++.+||+|||+++...... ...+.+|++.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998654322 223467899999999999889999999999999999999986 46
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+. +...+... +.+... ......+ ...+.++..+|++.+|.+||++
T Consensus 243 ~~~~-----~~~e~~~~--------v~~~~~-----------~~~p~~~---------~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 243 YYGM-----AHEEVIYY--------VRDGNI-----------LACPENC---------PLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp TTTS-----CHHHHHHH--------HHTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCC-----CHHHHHHH--------HHcCCC-----------CCCCccc---------hHHHHHHHHHHcCCChhHCcCH
Confidence 6432 11111110 000000 0000011 1134578999999999999999
Q ss_pred chhhHHHHHHh
Q 041230 157 NDVESRLRSIK 167 (485)
Q Consensus 157 ~~v~~~L~~i~ 167 (485)
.+|.+.|+++.
T Consensus 290 ~ev~~~L~~i~ 300 (301)
T d1lufa_ 290 CSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHhc
Confidence 99999988763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=2e-22 Score=193.66 Aligned_cols=134 Identities=27% Similarity=0.377 Sum_probs=96.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCce----eecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSF----IDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+|++|||+++.+...... ....||+.|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~ 209 (277)
T d1xbba_ 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209 (277)
T ss_dssp CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC
Confidence 9999999999999999999999999876543221 23578999999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+.. ..++... +.... .......| ...+.++...|++.+|++||+
T Consensus 210 Pf~~~~-----~~~~~~~--------i~~~~-----------~~~~p~~~---------~~~~~~li~~cl~~dp~~RPs 256 (277)
T d1xbba_ 210 PYRGMK-----GSEVTAM--------LEKGE-----------RMGCPAGC---------PREMYDLMNLCWTYDVENRPG 256 (277)
T ss_dssp SSTTCC-----HHHHHHH--------HHTTC-----------CCCCCTTC---------CHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCC-----HHHHHHH--------HHcCC-----------CCCCCccc---------CHHHHHHHHHHcCCCHhHCcC
Confidence 986431 1111110 00000 00000111 113457889999999999999
Q ss_pred cchhhHHHHHHh
Q 041230 156 INDVESRLRSIK 167 (485)
Q Consensus 156 m~~v~~~L~~i~ 167 (485)
+.++...|+...
T Consensus 257 ~~~i~~~L~~~~ 268 (277)
T d1xbba_ 257 FAAVELRLRNYY 268 (277)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHhhCHH
Confidence 999988887643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.84 E-value=1.6e-22 Score=195.38 Aligned_cols=134 Identities=22% Similarity=0.355 Sum_probs=96.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc--eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS--FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+|+....... .....|++.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 138 HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999997654432 223468999999999988899999999999999999999777653
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccch
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIND 158 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~ 158 (485)
.. .+...+.. .+...+. ......+ ...+.++...|++.+|++||++.+
T Consensus 218 ~~----~~~~~~~~---------~i~~~~~----------~~~~~~~---------~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 218 PG----IDLSQVYE---------LLEKDYR----------MERPEGC---------PEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp TT----CCHHHHHH---------HHHTTCC----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred Cc----chHHHHHH---------HHhcCCC----------CCCCccc---------hHHHHHHHHHHcCCCHhHCcCHHH
Confidence 21 11111111 1100000 0000011 113457889999999999999999
Q ss_pred hhHHHHHH
Q 041230 159 VESRLRSI 166 (485)
Q Consensus 159 v~~~L~~i 166 (485)
+.+.|+.+
T Consensus 266 i~~~L~~~ 273 (287)
T d1opja_ 266 IHQAFETM 273 (287)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHH
Confidence 98887664
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=4.5e-22 Score=195.37 Aligned_cols=79 Identities=33% Similarity=0.484 Sum_probs=69.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+|+..... ...+.+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 128 HRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred ccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999999865321 223578999999999999999999999999999999999999999753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1e-21 Score=191.78 Aligned_cols=137 Identities=22% Similarity=0.304 Sum_probs=98.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc-----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS-----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+||||+.++.+||+|||+++....... .....||+.|+|||......++.++||||||+++|||++|..
T Consensus 153 HrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~ 232 (311)
T d1r0pa_ 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232 (311)
T ss_dssp CSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCC
Confidence 999999999999999999999999987643321 123568999999999888899999999999999999999888
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
|+....... .+...+..... . .....| ...+.+++.+|++.+|++||+
T Consensus 233 p~~~~~~~~-~~~~~i~~g~~-----~-----------------~~p~~~---------~~~l~~li~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 233 PPYPDVNTF-DITVYLLQGRR-----L-----------------LQPEYC---------PDPLYEVMLKCWHPKAEMRPS 280 (311)
T ss_dssp CSCC-------CHHHHHTTCC-----C-----------------CCCTTC---------CHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCHH-HHHHHHHcCCC-----C-----------------CCcccC---------cHHHHHHHHHHcCCCHhHCcC
Confidence 875422111 11111100000 0 000001 112457889999999999999
Q ss_pred cchhhHHHHHHhhh
Q 041230 156 INDVESRLRSIKMK 169 (485)
Q Consensus 156 m~~v~~~L~~i~~~ 169 (485)
|.+|.+.|+++...
T Consensus 281 ~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 281 FSELVSRISAIFST 294 (311)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999887653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=5.1e-22 Score=194.55 Aligned_cols=135 Identities=22% Similarity=0.364 Sum_probs=96.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.|
T Consensus 134 HrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p 213 (317)
T d1xkka_ 134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213 (317)
T ss_dssp CSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999999997654322 223568999999999988899999999999999999998 7888
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+.... .+...+.... . ......| ...+.++...|++.+|.+||++
T Consensus 214 ~~~~~~~--~~~~~i~~~~--------~--------------~~~p~~~---------~~~~~~li~~cl~~dP~~RPs~ 260 (317)
T d1xkka_ 214 YDGIPAS--EISSILEKGE--------R--------------LPQPPIC---------TIDVYMIMVKCWMIDADSRPKF 260 (317)
T ss_dssp TTTSCGG--GHHHHHHHTC--------C--------------CCCCTTB---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH--HHHHHHHcCC--------C--------------CCCCccc---------CHHHHHHHHHhCCCChhhCcCH
Confidence 8653211 1111110000 0 0000111 1234578889999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++...+..+..
T Consensus 261 ~eil~~l~~~~~ 272 (317)
T d1xkka_ 261 RELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999888776543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=6.1e-22 Score=191.23 Aligned_cols=80 Identities=30% Similarity=0.397 Sum_probs=68.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccC-----CCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGM-----GSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+|+..... ....+.+||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 133 HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~ 212 (288)
T d2jfla1 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212 (288)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred EeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence 9999999999999999999999999765322 1233578999999999873 455788999999999999999999
Q ss_pred CCCCCC
Q 041230 75 RPNNGM 80 (485)
Q Consensus 75 ~p~~~~ 80 (485)
.||.+.
T Consensus 213 ~Pf~~~ 218 (288)
T d2jfla1 213 PPHHEL 218 (288)
T ss_dssp CTTTTS
T ss_pred CCCCCC
Confidence 999653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=2.2e-21 Score=187.27 Aligned_cols=79 Identities=32% Similarity=0.619 Sum_probs=68.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+|+.+.... ...+.+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 131 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (288)
T d1uu3a_ 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210 (288)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCC
Confidence 99999999999999999999999999765332 234568999999999999999999999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 211 ~~ 212 (288)
T d1uu3a_ 211 RA 212 (288)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.82 E-value=2.2e-21 Score=189.04 Aligned_cols=79 Identities=29% Similarity=0.480 Sum_probs=57.7
Q ss_pred CCCCCCCcEEEC---CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLD---DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~---~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||+. .++.+||+|||+++.........+.+||+.|||||.+.+..++.++||||+||++|||++|+.||
T Consensus 130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp CSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 999999999995 57889999999998766555555678999999999999989999999999999999999999999
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 210 ~~ 211 (307)
T d1a06a_ 210 YD 211 (307)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=8.9e-22 Score=188.65 Aligned_cols=134 Identities=27% Similarity=0.376 Sum_probs=95.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc----eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS----FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~ 75 (485)
||||||+|||++.++.+||+|||+++....... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.
T Consensus 134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999997654322 123567889999999988889999999999999999998 899
Q ss_pred CCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccc
Q 041230 76 PNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMD 155 (485)
Q Consensus 76 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~ 155 (485)
||.+. +....+.... ..... ......+ ...+.++...|++.+|++||+
T Consensus 214 Pf~~~-----~~~~~~~~i~--------~~~~~----------~~~~~~~---------~~~l~~li~~cl~~dp~~RPt 261 (273)
T d1u46a_ 214 PWIGL-----NGSQILHKID--------KEGER----------LPRPEDC---------PQDIYNVMVQCWAHKPEDRPT 261 (273)
T ss_dssp TTTTC-----CHHHHHHHHH--------TSCCC----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCc-----CHHHHHHHHH--------hCCCC----------CCCcccc---------cHHHHHHHHHHcCCChhHCcC
Confidence 98643 2211111110 00000 0000000 113457889999999999999
Q ss_pred cchhhHHHHHH
Q 041230 156 INDVESRLRSI 166 (485)
Q Consensus 156 m~~v~~~L~~i 166 (485)
+.++...|.+.
T Consensus 262 ~~ei~~~L~~~ 272 (273)
T d1u46a_ 262 FVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhc
Confidence 99998887653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=1.3e-21 Score=187.53 Aligned_cols=135 Identities=24% Similarity=0.395 Sum_probs=88.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++.+.... ......||+.|+|||.+.+..++.++|||||||++|||++ |..|+
T Consensus 131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~ 210 (273)
T d1mp8a_ 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210 (273)
T ss_dssp CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCC
Confidence 99999999999999999999999998765332 2234578999999999988899999999999999999998 88888
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+... ..+... +..... ......+ ...+..+...|++.+|++||++.
T Consensus 211 ~~~~~-----~~~~~~--------i~~~~~-----------~~~~~~~---------~~~~~~li~~cl~~dp~~Rps~~ 257 (273)
T d1mp8a_ 211 QGVKN-----NDVIGR--------IENGER-----------LPMPPNC---------PPTLYSLMTKCWAYDPSRRPRFT 257 (273)
T ss_dssp TTCCG-----GGHHHH--------HHTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCH-----HHHHHH--------HHcCCC-----------CCCCCCC---------CHHHHHHHHHHcCCCHhHCcCHH
Confidence 65321 111110 000000 0000111 11245778899999999999999
Q ss_pred hhhHHHHHHhh
Q 041230 158 DVESRLRSIKM 168 (485)
Q Consensus 158 ~v~~~L~~i~~ 168 (485)
++.+.|+++..
T Consensus 258 ei~~~L~~i~~ 268 (273)
T d1mp8a_ 258 ELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99988877643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=6e-22 Score=190.94 Aligned_cols=135 Identities=23% Similarity=0.338 Sum_probs=91.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||++....++.++|||||||++|||++|..|+.
T Consensus 136 H~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp CSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence 99999999999999999999999998764332 2234679999999999998899999999999999999999766653
Q ss_pred CCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccch
Q 041230 79 GMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIND 158 (485)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~ 158 (485)
... ....++..... -... .....| ...+.++..+|++.+|++||++.+
T Consensus 216 ~~~----~~~~~~~~i~~-----~~~~--------------~~~~~~---------~~~l~~li~~cl~~dP~~Rps~~~ 263 (285)
T d1fmka3 216 PGM----VNREVLDQVER-----GYRM--------------PCPPEC---------PESLHDLMCQCWRKEPEERPTFEY 263 (285)
T ss_dssp TTC----CHHHHHHHHHT-----TCCC--------------CCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCC----CHHHHHHHHHh-----cCCC--------------CCCccc---------CHHHHHHHHHHcccCHhHCcCHHH
Confidence 211 11111111000 0000 000011 113457889999999999999999
Q ss_pred hhHHHHHHh
Q 041230 159 VESRLRSIK 167 (485)
Q Consensus 159 v~~~L~~i~ 167 (485)
|...|+...
T Consensus 264 i~~~L~~~~ 272 (285)
T d1fmka3 264 LQAFLEDYF 272 (285)
T ss_dssp HHHHHHTTT
T ss_pred HHHHHhhhh
Confidence 988877644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.82 E-value=2.3e-21 Score=188.97 Aligned_cols=76 Identities=30% Similarity=0.447 Sum_probs=66.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC---CCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG---SEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++..... ...+||+.|||||++.+ ..++.++|||||||++|||++|+.||
T Consensus 138 HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCcceEEECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999865432 34689999999998754 45788999999999999999999998
Q ss_pred CC
Q 041230 78 NG 79 (485)
Q Consensus 78 ~~ 79 (485)
.+
T Consensus 215 ~~ 216 (309)
T d1u5ra_ 215 FN 216 (309)
T ss_dssp TT
T ss_pred CC
Confidence 64
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=2e-21 Score=184.58 Aligned_cols=132 Identities=23% Similarity=0.336 Sum_probs=96.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~ 77 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||
T Consensus 123 H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf 202 (258)
T d1k2pa_ 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202 (258)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCC
Confidence 99999999999999999999999998665432 2234678999999999988899999999999999999998 88898
Q ss_pred CCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccc
Q 041230 78 NGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDIN 157 (485)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~ 157 (485)
.+.. ..++.... .... .......+ ...+..+...||+.+|++||++.
T Consensus 203 ~~~~-----~~~~~~~i--------~~~~-----------~~~~p~~~---------~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 203 ERFT-----NSETAEHI--------AQGL-----------RLYRPHLA---------SEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp TTSC-----HHHHHHHH--------HTTC-----------CCCCCTTC---------CHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCC-----HHHHHHHH--------HhCC-----------CCCCcccc---------cHHHHHHHHHHccCCHhHCcCHH
Confidence 6532 11111100 0000 00000001 11346788999999999999999
Q ss_pred hhhHHHHH
Q 041230 158 DVESRLRS 165 (485)
Q Consensus 158 ~v~~~L~~ 165 (485)
++.+.|..
T Consensus 250 eil~~L~d 257 (258)
T d1k2pa_ 250 ILLSNILD 257 (258)
T ss_dssp HHHHHHHC
T ss_pred HHHHHhhC
Confidence 98887643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.6e-20 Score=184.97 Aligned_cols=79 Identities=25% Similarity=0.380 Sum_probs=71.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCC-CCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPV-ETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 128 HRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence 999999999999999999999999987643 3344568999999999999999999999999999999999999999965
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=8.2e-21 Score=184.66 Aligned_cols=80 Identities=33% Similarity=0.495 Sum_probs=72.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNGM 80 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~~ 80 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999998765544555678999999999999999999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.80 E-value=1.1e-20 Score=187.31 Aligned_cols=79 Identities=35% Similarity=0.592 Sum_probs=71.7
Q ss_pred CCCCCCCcEEECC--CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDD--EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~--~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++. ++.+||+|||+++.+.........+||+.|||||++.+..++.++||||+||++|||++|+.||.
T Consensus 147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 9999999999964 57899999999998776666667899999999999999899999999999999999999999996
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 227 ~ 227 (350)
T d1koaa2 227 G 227 (350)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.80 E-value=2e-20 Score=182.82 Aligned_cols=77 Identities=36% Similarity=0.582 Sum_probs=70.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+..... ..+.+||+.|||||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 127 HrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 127 YRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccCchheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 9999999999999999999999999876533 3357899999999999988999999999999999999999999965
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.1e-20 Score=186.15 Aligned_cols=80 Identities=28% Similarity=0.389 Sum_probs=71.5
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPN 77 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~ 77 (485)
||||||+|||++. .+.+||+|||+++...........+||+.|+|||++.+..++.++||||+||++|+|++|+.||
T Consensus 134 HRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp CCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred cccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 9999999999985 4579999999999776555556678999999999999889999999999999999999999999
Q ss_pred CCC
Q 041230 78 NGM 80 (485)
Q Consensus 78 ~~~ 80 (485)
.+.
T Consensus 214 ~~~ 216 (335)
T d2ozaa1 214 YSN 216 (335)
T ss_dssp EET
T ss_pred CCC
Confidence 653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.80 E-value=1.2e-20 Score=187.12 Aligned_cols=79 Identities=29% Similarity=0.490 Sum_probs=72.5
Q ss_pred CCCCCCCcEEEC--CCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLD--DEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~--~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++ .++.+||+|||+|+.+.........+||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 999999999998 568999999999998776665667889999999999999999999999999999999999999996
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 230 ~ 230 (352)
T d1koba_ 230 G 230 (352)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=9.6e-21 Score=180.20 Aligned_cols=134 Identities=25% Similarity=0.354 Sum_probs=91.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p~~~ 79 (485)
||||||+|||++.++.+|++|||+++..... .....+++.|+|||++.+..++.++|||||||++|||+| |+.|+..
T Consensus 126 H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999999865432 234578999999999988899999999999999999998 6777654
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
.. ..++....... .... ....+ ...+.++...|++.+|.+||++.++
T Consensus 204 ~~-----~~~~~~~i~~~-----~~~~--------------~~~~~---------~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 204 IP-----LKDVVPRVEKG-----YKMD--------------APDGC---------PPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp SC-----GGGHHHHHTTT-----CCCC--------------CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CC-----HHHHHHHHHcC-----CCCC--------------CCccC---------CHHHHHHHHHHcccCHhHCcCHHHH
Confidence 21 11111111000 0000 00001 1134567889999999999999999
Q ss_pred hHHHHHHhhh
Q 041230 160 ESRLRSIKMK 169 (485)
Q Consensus 160 ~~~L~~i~~~ 169 (485)
.+.|+.++..
T Consensus 251 ~~~L~~i~~~ 260 (262)
T d1byga_ 251 REQLEHIKTH 260 (262)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhC
Confidence 9999887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1e-20 Score=184.62 Aligned_cols=136 Identities=24% Similarity=0.353 Sum_probs=97.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+|++|||+++...... .....+||+.|+|||.+....++.++|||||||++|||+| |.+|
T Consensus 168 HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765432 2234689999999999988889999999999999999999 4555
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+.... ..+...+.... +..... . ....+.++...|++.+|.+||++
T Consensus 248 ~~~~~~~-~~~~~~i~~~~-----------------------~~~~~~--~------~~~~l~~Li~~cl~~dP~~RPs~ 295 (311)
T d1t46a_ 248 YPGMPVD-SKFYKMIKEGF-----------------------RMLSPE--H------APAEMYDIMKTCWDADPLKRPTF 295 (311)
T ss_dssp STTCCSS-HHHHHHHHHTC-----------------------CCCCCT--T------SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH-HHHHHHHhcCC-----------------------CCCCcc--c------ccHHHHHHHHHHcCCChhHCcCH
Confidence 5432111 00111111000 000000 0 01134678899999999999999
Q ss_pred chhhHHHHHHhh
Q 041230 157 NDVESRLRSIKM 168 (485)
Q Consensus 157 ~~v~~~L~~i~~ 168 (485)
.++.+.|+++..
T Consensus 296 ~~il~~L~~~i~ 307 (311)
T d1t46a_ 296 KQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHhhc
Confidence 999998877543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=7.1e-21 Score=184.75 Aligned_cols=134 Identities=26% Similarity=0.407 Sum_probs=98.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC---ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET---SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFT-GLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~-G~~p 76 (485)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 158 HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 99999999999999999999999998664322 2234678999999999988899999999999999999998 6777
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
|.+. +...+.... .+ .. .......+ ...+.++...|++.+|.+||++
T Consensus 238 ~~~~-----~~~~~~~~i--------~~-~~----------~~~~p~~~---------~~~l~~li~~cl~~dP~~Rps~ 284 (299)
T d1fgka_ 238 YPGV-----PVEELFKLL--------KE-GH----------RMDKPSNC---------TNELYMMMRDCWHAVPSQRPTF 284 (299)
T ss_dssp STTC-----CHHHHHHHH--------HT-TC----------CCCCCSSC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCC-----CHHHHHHHH--------Hc-CC----------CCCCCccc---------hHHHHHHHHHHccCCHhHCcCH
Confidence 7532 111111100 00 00 00000001 1135678899999999999999
Q ss_pred chhhHHHHHHh
Q 041230 157 NDVESRLRSIK 167 (485)
Q Consensus 157 ~~v~~~L~~i~ 167 (485)
.++.+.|+++.
T Consensus 285 ~eil~~L~~i~ 295 (299)
T d1fgka_ 285 KQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.5e-20 Score=180.34 Aligned_cols=79 Identities=32% Similarity=0.532 Sum_probs=71.4
Q ss_pred CCCCCCCcEEECCCC----cEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEM----TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~----~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++ .+|++|||+++............||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus 136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999999998776 4999999999887655555667899999999999988899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 216 f~~ 218 (293)
T d1jksa_ 216 FLG 218 (293)
T ss_dssp SCC
T ss_pred CCC
Confidence 975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.1e-21 Score=188.22 Aligned_cols=136 Identities=23% Similarity=0.288 Sum_probs=96.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCC-CCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLR-PNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~-p~~~ 79 (485)
||||||+|||++.++.+||+|||+++............||+.|+|||.+....++.++|||||||++|||++|.. |+.+
T Consensus 150 HrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 150 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999986543333334679999999999988899999999999999999999765 5543
Q ss_pred CCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCcccccchh
Q 041230 80 MFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDINDV 159 (485)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m~~v 159 (485)
. +...+....... ... .....+ ...+..+...|++.+|++||++.++
T Consensus 230 ~-----~~~~~~~~i~~~-----~~~--------------~~~~~~---------~~~~~~li~~cl~~dP~~RPs~~ei 276 (309)
T d1fvra_ 230 M-----TCAELYEKLPQG-----YRL--------------EKPLNC---------DDEVYDLMRQCWREKPYERPSFAQI 276 (309)
T ss_dssp C-----CHHHHHHHGGGT-----CCC--------------CCCTTB---------CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C-----CHHHHHHHHHhc-----CCC--------------CCCccC---------CHHHHHHHHHHcCCChhHCcCHHHH
Confidence 2 222221111100 000 000001 1134577889999999999999999
Q ss_pred hHHHHHHhhh
Q 041230 160 ESRLRSIKMK 169 (485)
Q Consensus 160 ~~~L~~i~~~ 169 (485)
.+.|+++...
T Consensus 277 l~~L~~i~~~ 286 (309)
T d1fvra_ 277 LVSLNRMLEE 286 (309)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHHhc
Confidence 9998887653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.9e-21 Score=186.72 Aligned_cols=133 Identities=21% Similarity=0.365 Sum_probs=96.4
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCc---eeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCC-CC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETS---FIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGL-RP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~-~p 76 (485)
||||||+|||++.++.+||+|||+++.+..... .....||+.|+|||.+.+..++.++|||||||++|||+||. .|
T Consensus 156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986643322 23357899999999998888999999999999999999985 55
Q ss_pred CCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccCCCccccc
Q 041230 77 NNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAELPDERMDI 156 (485)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~p~~RP~m 156 (485)
+.+. +..++.... .+... ......+ ...+.++..+|++.+|++||++
T Consensus 236 ~~~~-----~~~~~~~~i--------~~~~~-----------~~~p~~~---------~~~l~~li~~cl~~~P~~RPs~ 282 (308)
T d1p4oa_ 236 YQGL-----SNEQVLRFV--------MEGGL-----------LDKPDNC---------PDMLFELMRMCWQYNPKMRPSF 282 (308)
T ss_dssp TTTS-----CHHHHHHHH--------HTTCC-----------CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCC-----CHHHHHHHH--------HhCCC-----------CCCcccc---------hHHHHHHHHHHcCCChhHCcCH
Confidence 5432 222211111 10000 0000111 1235678899999999999999
Q ss_pred chhhHHHHHH
Q 041230 157 NDVESRLRSI 166 (485)
Q Consensus 157 ~~v~~~L~~i 166 (485)
.++.+.|++.
T Consensus 283 ~~il~~L~~~ 292 (308)
T d1p4oa_ 283 LEIISSIKEE 292 (308)
T ss_dssp HHHHHHHGGG
T ss_pred HHHHHHHHHh
Confidence 9999887654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.79 E-value=1.8e-20 Score=179.82 Aligned_cols=79 Identities=38% Similarity=0.646 Sum_probs=63.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC----ceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+|||++.++..+++|||.++...... .....+||+.|+|||.+.+..++.++||||+||++|||++|+.|
T Consensus 134 HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp CCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCC
Confidence 99999999999999999999999987654322 23456899999999999988899999999999999999999999
Q ss_pred CCC
Q 041230 77 NNG 79 (485)
Q Consensus 77 ~~~ 79 (485)
|.+
T Consensus 214 f~~ 216 (277)
T d1o6ya_ 214 FTG 216 (277)
T ss_dssp CCC
T ss_pred CCC
Confidence 964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.79 E-value=1.4e-20 Score=187.47 Aligned_cols=79 Identities=30% Similarity=0.472 Sum_probs=69.3
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+.+.... ....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+
T Consensus 130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 130 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ceeeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998765432 345689999999999864 5689999999999999999999999975
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 209 ~ 209 (364)
T d1omwa3 209 H 209 (364)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.79 E-value=3.6e-20 Score=183.60 Aligned_cols=77 Identities=29% Similarity=0.414 Sum_probs=70.2
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||++|+.||.+
T Consensus 164 HRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999876432 3357899999999999999999999999999999999999999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.79 E-value=3.4e-20 Score=179.78 Aligned_cols=142 Identities=20% Similarity=0.214 Sum_probs=95.7
Q ss_pred CCCCCCCcEEECC---CCcEEEEeccCccccCCCC--------ceeecccccCcccccccCCCCCCCccchhhHHHHHHH
Q 041230 1 HCDLKPSNVFLDD---EMTAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLE 69 (485)
Q Consensus 1 HrDlk~~NiLl~~---~~~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e 69 (485)
||||||+|||++. +..+|++|||+|+.+.... .....+||+.|+|||...+..++.++|||||||++||
T Consensus 126 HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~e 205 (299)
T d1ckia_ 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 205 (299)
T ss_dssp CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHH
T ss_pred eccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHH
Confidence 9999999999864 4569999999998764321 1234679999999999999889999999999999999
Q ss_pred HHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhccC
Q 041230 70 MFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSAEL 149 (485)
Q Consensus 70 l~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~~ 149 (485)
|++|+.||.......... . +.... ...... . .. .....+ ...+.++...|++.+
T Consensus 206 l~tg~~P~~~~~~~~~~~-~-~~~~~----~~~~~~----~---~~----~~~~~~---------p~~~~~li~~cl~~~ 259 (299)
T d1ckia_ 206 FNLGSLPWQGLKAATKRQ-K-YERIS----EKKMST----P---IE----VLCKGY---------PSEFATYLNFCRSLR 259 (299)
T ss_dssp HHHSSCTTCCCC---------HHHHH----HHHHHS----C---HH----HHTTTS---------CHHHHHHHHHHHHSC
T ss_pred HHhCCCcccccchHHHHH-H-HHHhh----cccCCC----C---hh----HhccCC---------CHHHHHHHHHHccCC
Confidence 999999997543221110 0 00000 000000 0 00 000001 112456788999999
Q ss_pred CCcccccchhhHHHHHHhh
Q 041230 150 PDERMDINDVESRLRSIKM 168 (485)
Q Consensus 150 p~~RP~m~~v~~~L~~i~~ 168 (485)
|++||++.++.+.++.+..
T Consensus 260 p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 260 FDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TTCCCCHHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHHH
Confidence 9999999988887776543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.2e-19 Score=177.51 Aligned_cols=79 Identities=34% Similarity=0.537 Sum_probs=71.1
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCC-CceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVE-TSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+||+|||+++..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 126 HrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999865433 233457899999999999999999999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.8e-20 Score=179.42 Aligned_cols=78 Identities=32% Similarity=0.433 Sum_probs=66.3
Q ss_pred CCCCCCCcEEECCC-CcEEEEeccCccccCCCCceeecccccCcccccccCCCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDE-MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEV-SSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~-~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.+ +.+||+|||+|+..... ...+.+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.
T Consensus 133 HrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 133 HRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 99999999999854 78999999999865432 3345789999999999877665 566899999999999999999985
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 212 ~ 212 (273)
T d1xwsa_ 212 H 212 (273)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.77 E-value=2e-19 Score=173.93 Aligned_cols=142 Identities=16% Similarity=0.188 Sum_probs=96.3
Q ss_pred CCCCCCCcEEECC-----CCcEEEEeccCccccCCCC--------ceeecccccCcccccccCCCCCCCccchhhHHHHH
Q 041230 1 HCDLKPSNVFLDD-----EMTAHLGDFGIARFLPVET--------SFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILL 67 (485)
Q Consensus 1 HrDlk~~NiLl~~-----~~~~kl~dfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l 67 (485)
||||||+|||++. ++.+||+|||+|+.+.... .....+||+.|||||...+..++.++|||||||++
T Consensus 124 HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHH
Confidence 9999999999974 5779999999998754321 12346899999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCChhHHHhhhchhhHHhhhchhhhhhhHHHHHHHhhhhccccchhhHHHHHHHHHHHHHhhhc
Q 041230 68 LEMFTGLRPNNGMFKDDLNLPNLVKSALPARAEQILDVAFFQEIEEEETLYKKASSTCTQSSIILECLISICRIGVACSA 147 (485)
Q Consensus 68 ~el~~G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 147 (485)
|||++|+.||.+.... ....... .+...... ...+.....+ ...+.++...|+.
T Consensus 204 ~elltg~~Pf~~~~~~--~~~~~~~--------~i~~~~~~-------~~~~~l~~~~---------p~~l~~ii~~~~~ 257 (293)
T d1csna_ 204 MYFLRGSLPWQGLKAA--TNKQKYE--------RIGEKKQS-------TPLRELCAGF---------PEEFYKYMHYARN 257 (293)
T ss_dssp HHHHHSSCTTSSCCSC--CHHHHHH--------HHHHHHHH-------SCHHHHTTTS---------CHHHHHHHHHHHH
T ss_pred HHHHhCCCcCCCccch--hHHHHHH--------HHHhccCC-------CChHHhcCCC---------CHHHHHHHHHHhc
Confidence 9999999999754221 1111000 00000000 0000000001 0124566778999
Q ss_pred cCCCcccccchhhHHHHHHhh
Q 041230 148 ELPDERMDINDVESRLRSIKM 168 (485)
Q Consensus 148 ~~p~~RP~m~~v~~~L~~i~~ 168 (485)
.+|++||+...+...++++..
T Consensus 258 ~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 258 LAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp CCTTCCCCHHHHHHHHHHHHH
T ss_pred CCcccCcCHHHHHHHHHHHHH
Confidence 999999998887777766543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.76 E-value=1.6e-19 Score=173.03 Aligned_cols=79 Identities=34% Similarity=0.529 Sum_probs=69.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCC------CCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG------SEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 133 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 999999999999999999999999998765555556789999999998642 34678899999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 213 ~Pf~~ 217 (277)
T d1phka_ 213 PPFWH 217 (277)
T ss_dssp CSSCC
T ss_pred CCCCC
Confidence 99975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.2e-20 Score=180.07 Aligned_cols=80 Identities=30% Similarity=0.439 Sum_probs=69.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||.+... .++.++||||+||++|||++|..||.
T Consensus 123 HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 99999999999999999999999998765432 33456899999999987654 57899999999999999999999986
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 203 ~~ 204 (299)
T d1ua2a_ 203 GD 204 (299)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.9e-19 Score=178.45 Aligned_cols=79 Identities=34% Similarity=0.474 Sum_probs=69.3
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCCCCceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++ .+||+|||+++.........+.+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus 145 HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred ccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence 999999999999775 899999999987765555556789999999998765 468999999999999999999999996
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 225 ~ 225 (350)
T d1q5ka_ 225 G 225 (350)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=3.9e-19 Score=173.97 Aligned_cols=79 Identities=29% Similarity=0.476 Sum_probs=70.7
Q ss_pred CCCCCCCcEEECCC--CcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDE--MTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~--~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.+ ..+|++|||+++...........+||+.|+|||...+..++.++||||+||++|+|++|+.||.
T Consensus 125 HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 99999999999854 4799999999987765555566789999999999988899999999999999999999999996
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
+
T Consensus 205 ~ 205 (321)
T d1tkia_ 205 A 205 (321)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.8e-19 Score=176.16 Aligned_cols=79 Identities=28% Similarity=0.479 Sum_probs=67.7
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-----ceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-----SFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++.+|++|||+++...... .....+||+.|+|||.+.+. .++.++||||+||++|||++|+
T Consensus 140 HrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~ 219 (318)
T d3blha1 140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219 (318)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCC
Confidence 99999999999999999999999998654322 12346799999999987655 5789999999999999999999
Q ss_pred CCCCC
Q 041230 75 RPNNG 79 (485)
Q Consensus 75 ~p~~~ 79 (485)
.||.+
T Consensus 220 ~pf~~ 224 (318)
T d3blha1 220 PIMQG 224 (318)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 99975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.7e-18 Score=167.62 Aligned_cols=80 Identities=35% Similarity=0.524 Sum_probs=68.8
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCC-CCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSE-VSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+||+|||+|+...... ......||+.|+|||...... ++.++|+||+||++|+|++|+.||.
T Consensus 125 HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp CSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 99999999999999999999999998765432 334568999999999876655 4788999999999999999999997
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 205 ~~ 206 (298)
T d1gz8a_ 205 GD 206 (298)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.2e-18 Score=170.31 Aligned_cols=80 Identities=31% Similarity=0.452 Sum_probs=67.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC----ceeecccccCcccccccCC-CCCCCccchhhHHHHHHHHHhCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET----SFIDVMGTIGYVAPEYGMG-SEVSSYGDVYSFGILLLEMFTGLR 75 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~~G~~ 75 (485)
||||||+|||++.++.+||+|||+++...... .....+||+.|+|||.+.. ..++.++||||+||++|||++|+.
T Consensus 132 HRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCC
Confidence 99999999999999999999999998654322 1244679999999998754 456888999999999999999999
Q ss_pred CCCCC
Q 041230 76 PNNGM 80 (485)
Q Consensus 76 p~~~~ 80 (485)
||.+.
T Consensus 212 pf~~~ 216 (345)
T d1pmea_ 212 IFPGK 216 (345)
T ss_dssp SCCCS
T ss_pred CCCCC
Confidence 99653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.71 E-value=3.9e-19 Score=171.12 Aligned_cols=80 Identities=34% Similarity=0.553 Sum_probs=65.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+|++|||++....... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus 123 HrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp CSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 99999999999999999999999998764332 23345789999999988654 46899999999999999999999996
Q ss_pred CC
Q 041230 79 GM 80 (485)
Q Consensus 79 ~~ 80 (485)
+.
T Consensus 203 ~~ 204 (286)
T d1ob3a_ 203 GV 204 (286)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.1e-17 Score=163.55 Aligned_cols=80 Identities=31% Similarity=0.479 Sum_probs=67.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC--ceeecccccCcccccccCCC--CCCCccchhhHHHHHHHHHhCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET--SFIDVMGTIGYVAPEYGMGS--EVSSYGDVYSFGILLLEMFTGLRP 76 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~~G~~p 76 (485)
||||||+||||+.++.+||+|||+++.+.... ...+..|++.|++||...+. .++.++||||+||++|||++|+.|
T Consensus 152 HrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 152 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp CCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred eccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998664322 23456899999999987654 357789999999999999999999
Q ss_pred CCCC
Q 041230 77 NNGM 80 (485)
Q Consensus 77 ~~~~ 80 (485)
|.+.
T Consensus 232 F~~~ 235 (322)
T d1vzoa_ 232 FTVD 235 (322)
T ss_dssp TSCT
T ss_pred CCCC
Confidence 9764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=1.2e-17 Score=165.68 Aligned_cols=79 Identities=32% Similarity=0.378 Sum_probs=61.9
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+|++|||+++...........+||+.|+|||.+.+..++.++||||+||+++||++|+.||.+
T Consensus 142 HrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp CSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 9999999999999999999999999876655555667899999999999998999999999999999999999999965
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=5.8e-18 Score=167.29 Aligned_cols=78 Identities=31% Similarity=0.430 Sum_probs=68.0
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+|++|||+++.... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+
T Consensus 144 HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 144 HRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccCcchhhcccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 999999999999999999999999986543 23456899999999987654 468899999999999999999999865
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 222 ~ 222 (346)
T d1cm8a_ 222 S 222 (346)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.66 E-value=7.8e-18 Score=165.10 Aligned_cols=79 Identities=27% Similarity=0.354 Sum_probs=68.5
Q ss_pred CCCCCCCcEEECCCC-cEEEEeccCccccCCCCceeecccccCcccccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEM-TAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGS-EVSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~-~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++ .+||+|||+|+...........+||+.|+|||...+. .++.++|+||+||+++|+++|+.||.
T Consensus 152 HrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 999999999998755 5899999999877655555567899999999997765 46889999999999999999999986
Q ss_pred C
Q 041230 79 G 79 (485)
Q Consensus 79 ~ 79 (485)
.
T Consensus 232 ~ 232 (328)
T d3bqca1 232 H 232 (328)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=1.3e-17 Score=160.55 Aligned_cols=78 Identities=28% Similarity=0.463 Sum_probs=66.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCC-ceeecccccCcccccccCCCC-CCCccchhhHHHHHHHHHhCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVET-SFIDVMGTIGYVAPEYGMGSE-VSSYGDVYSFGILLLEMFTGLRPNN 78 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~~G~~p~~ 78 (485)
||||||+|||++.++.+|++|||.++...... ......+++.|+|||.+.... ++.++||||+||++|||++|+.|+.
T Consensus 124 HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred eecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 99999999999999999999999998765433 233456788999999877665 5889999999999999999999964
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.61 E-value=1.2e-16 Score=158.49 Aligned_cols=78 Identities=26% Similarity=0.388 Sum_probs=65.8
Q ss_pred CCCCCCCcEEECCCCc------EEEEeccCccccCCCCceeecccccCcccccccCCCCCCCccchhhHHHHHHHHHhCC
Q 041230 1 HCDLKPSNVFLDDEMT------AHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSEVSSYGDVYSFGILLLEMFTGL 74 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~------~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~~G~ 74 (485)
||||||+|||++.++. ++++|||.+...... ....+||+.|+|||......++.++|+||+||++++|++|+
T Consensus 149 HrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCC
Confidence 9999999999986653 899999999765432 23568999999999998888999999999999999999999
Q ss_pred CCCCCC
Q 041230 75 RPNNGM 80 (485)
Q Consensus 75 ~p~~~~ 80 (485)
.||...
T Consensus 227 ~pF~~~ 232 (362)
T d1q8ya_ 227 FLFEPD 232 (362)
T ss_dssp CCC---
T ss_pred CCCCCC
Confidence 998653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.9e-16 Score=156.28 Aligned_cols=78 Identities=31% Similarity=0.455 Sum_probs=63.5
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeecccccCcccccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCC
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMGTIGYVAPEYGMGSE-VSSYGDVYSFGILLLEMFTGLRPNNG 79 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~~G~~p~~~ 79 (485)
||||||+|||++.++.+|++|||++.... ....+..||+.|+|||...+.. ++.++||||+||++|+|++|+.||.+
T Consensus 144 HrDiKp~NILi~~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 144 HRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CCCCCGGGEEECTTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccCCccccccccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999997543 2234567999999999866654 57899999999999999999999975
Q ss_pred C
Q 041230 80 M 80 (485)
Q Consensus 80 ~ 80 (485)
.
T Consensus 222 ~ 222 (348)
T d2gfsa1 222 T 222 (348)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.00 E-value=2.9e-05 Score=71.06 Aligned_cols=132 Identities=12% Similarity=0.100 Sum_probs=81.0
Q ss_pred cCceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCcceeEeeeecccccCCceeeEEEEEecCCCCHH
Q 041230 206 GNFGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIR-HRNIVRVFTAVSGVDYQGARFKAVVYKFMPNGSLE 284 (485)
Q Consensus 206 G~fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lV~ey~~~GsL~ 284 (485)
++.+.||+.. .+++.+.||+...........+.+|...+..+. +--+-++++++.. ....++||+++++.++.
T Consensus 25 ~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-----~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 25 MSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCSSEEHH
T ss_pred CCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----CCceEEEEEeccccccc
Confidence 3346899876 356667788775443334445778888876653 2223455555432 23568999999998886
Q ss_pred HhhcCCCCcccccccccccHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 041230 285 EWLHGKDDTHWRLLNFDFLIKKKLDIAIDVARALKYLHC----------------------------------------- 323 (485)
Q Consensus 285 ~~L~~~~~~~~~~~~~~l~~~~r~~ia~~ia~gL~yLH~----------------------------------------- 323 (485)
+....... +-.++.++++.|.-||.
T Consensus 99 ~~~~~~~~--------------~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 99 EEYEDEQS--------------PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp HHTTTCSC--------------HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred cccccccc--------------HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 54322110 11123333333333331
Q ss_pred ------------C---CCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 324 ------------D---CQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 324 ------------~---~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
. ....++|+|+.+.|||++++...-|.||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 022378999999999999887778999998764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=97.85 E-value=1.4e-06 Score=76.71 Aligned_cols=61 Identities=20% Similarity=0.125 Sum_probs=37.6
Q ss_pred CCCCCCCcEEECCCCcEEEEeccCccccCCCCceeeccc-ccCcccccccCCCCCCCccchhhHHH
Q 041230 1 HCDLKPSNVFLDDEMTAHLGDFGIARFLPVETSFIDVMG-TIGYVAPEYGMGSEVSSYGDVYSFGI 65 (485)
Q Consensus 1 HrDlk~~NiLl~~~~~~kl~dfG~a~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~Dv~s~Gv 65 (485)
||||||+|||++.+ .++|+|||.|.......... ... ....+ .++. ...|+.++|+||..-
T Consensus 126 HrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~-~l~rd~~~~-~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 126 HGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE-ILERDVRNI-ITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp CSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH-HHHHHHHHH-HHHH-HHHHCCCCCHHHHHH
T ss_pred EccCChhheeeeCC-CEEEEECCCcccCCCCCcHH-HHHHHHHHH-HHHH-cCCCCCcccHHHHHH
Confidence 99999999999965 58999999997654332110 000 00000 0111 245778899999753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.36 E-value=0.00079 Score=60.74 Aligned_cols=144 Identities=16% Similarity=0.126 Sum_probs=79.2
Q ss_pred ecccC-ceEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCc--ceeEeeeecccccCCceeeEEEEEecC
Q 041230 203 IGAGN-FGSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRN--IVRVFTAVSGVDYQGARFKAVVYKFMP 279 (485)
Q Consensus 203 iG~G~-fg~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~~~~~lV~ey~~ 279 (485)
+..|. -+.||+....++..+.+|.-.. .....+..|...+..+.... +.++++++.. ....++||+|++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~---~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLS---GALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECS---CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCc---cCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEeee
Confidence 34444 3678988776777788887542 23345667777776654333 4456655442 234689999998
Q ss_pred CCCHHHh-----------------hcCCCCcccccccccccHHHHHHHHH--------------------HHHHHHHHhh
Q 041230 280 NGSLEEW-----------------LHGKDDTHWRLLNFDFLIKKKLDIAI--------------------DVARALKYLH 322 (485)
Q Consensus 280 ~GsL~~~-----------------L~~~~~~~~~~~~~~l~~~~r~~ia~--------------------~ia~gL~yLH 322 (485)
+-++.+. ||..... .......+..++.-.. .....+..+.
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPA---TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGG---GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChh---hCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 7665331 1211100 0000011111110000 0111222222
Q ss_pred c----CCCCCeeeeccCCCceEecCCCcEEEeecccccc
Q 041230 323 C----DCQPRIAHCNLKPSNVLLDDEMIGHVGDFSMARF 357 (485)
Q Consensus 323 ~----~~~~~ivHrdlK~~NILld~~~~~ki~DFGla~~ 357 (485)
. ...+.++|+|+.|.|||++++..+-|.||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 1123479999999999999887788999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.45 E-value=0.0066 Score=58.61 Aligned_cols=75 Identities=19% Similarity=0.172 Sum_probs=44.1
Q ss_pred eeecccCceEEEEeEeeC-CcEEEEEEeec----cCC---cchHHHHHHHHHHHhcC-C--CcceeEeeeecccccCCce
Q 041230 201 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNL----IRP---GGARSFKSECKAAINIR-H--RNIVRVFTAVSGVDYQGAR 269 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~-~~~vavK~~~~----~~~---~~~~~f~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~~~ 269 (485)
..||.|....||+....+ ++.|.||.-.. ... -.......|.+.|..+. + ..+.++++++. .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~ 104 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E 104 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence 458999999999987654 56888986421 111 11233445777766542 2 34555665532 2
Q ss_pred eeEEEEEecCCCC
Q 041230 270 FKAVVYKFMPNGS 282 (485)
Q Consensus 270 ~~~lV~ey~~~Gs 282 (485)
..++||||+++..
T Consensus 105 ~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 MAVTVMEDLSHLK 117 (392)
T ss_dssp TTEEEECCCTTSE
T ss_pred CCEEEEeccCCcc
Confidence 3479999998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.91 E-value=0.021 Score=53.28 Aligned_cols=73 Identities=15% Similarity=0.091 Sum_probs=44.5
Q ss_pred eEEEEeEeeCCcEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcc--eeEeeeecccccCCceeeEEEEEecCCCC
Q 041230 209 GSVYNGTLFDGTTIAVKVFNLIRPGGARSFKSECKAAINIRHRNI--VRVFTAVSGVDYQGARFKAVVYKFMPNGS 282 (485)
Q Consensus 209 g~Vy~g~~~~~~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~~~~lV~ey~~~Gs 282 (485)
-.||+....+|..+++|+..... ...+++..|...+..|...++ +..+...-+.........+.+++|+++..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999999999999999875322 234667788888877643332 22221111111112345688999997543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.23 E-value=0.038 Score=52.92 Aligned_cols=72 Identities=14% Similarity=0.240 Sum_probs=43.4
Q ss_pred eeecccCceEEEEeEeeCC--------cEEEEEEeeccCCcchHHHHHHHHHHHhcCCCcce-eEeeeecccccCCceee
Q 041230 201 NLIGAGNFGSVYNGTLFDG--------TTIAVKVFNLIRPGGARSFKSECKAAINIRHRNIV-RVFTAVSGVDYQGARFK 271 (485)
Q Consensus 201 ~~iG~G~fg~Vy~g~~~~~--------~~vavK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~~~~~~~~~~~~~~~ 271 (485)
..|+.|-.-.+|+....++ ..|.+++.- .. ...-.-.+|..++..+.-.+++ ++++++.+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--------- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG--------- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---------
Confidence 4566777788898776443 345555543 22 2223345677777766434554 67766542
Q ss_pred EEEEEecCCCCH
Q 041230 272 AVVYKFMPNGSL 283 (485)
Q Consensus 272 ~lV~ey~~~GsL 283 (485)
.+|+||+++-+|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999986544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.89 E-value=0.28 Score=44.73 Aligned_cols=32 Identities=22% Similarity=0.296 Sum_probs=28.6
Q ss_pred CCCCeeeeccCCCceEecCCCcEEEeeccccc
Q 041230 325 CQPRIAHCNLKPSNVLLDDEMIGHVGDFSMAR 356 (485)
Q Consensus 325 ~~~~ivHrdlK~~NILld~~~~~ki~DFGla~ 356 (485)
...++||+|+.+.||+++++...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 45789999999999999999888899999875
|